file_name	file_id	cases.0.samples.0.portions.0.analytes.0.aliquots.0.submitter_id	cases.0.samples.0.portions.0.analytes.0.submitter_id	cases.0.samples.0.portions.0.slides.0.submitter_id	cases.0.samples.0.portions.0.slides.1.submitter_id	cases.0.samples.0.portions.0.slides.2.submitter_id	cases.0.samples.0.portions.0.submitter_id	cases.0.samples.0.submitter_id	cases.0.submitter_id	cases.0.case_id	cases.0.disease_type	cases.0.primary_site	cases.0.project.project_id	cases.0.samples.0.days_to_collection	cases.0.samples.0.initial_weight	cases.0.samples.0.is_ffpe	cases.0.samples.0.oct_embedded	cases.0.samples.0.pathology_report_uuid	cases.0.samples.0.portions.0.analytes.0.a260_a280_ratio	cases.0.samples.0.portions.0.analytes.0.aliquots.0.aliquot_id	cases.0.samples.0.portions.0.analytes.0.aliquots.0.concentration	cases.0.samples.0.portions.0.analytes.0.aliquots.0.source_center	cases.0.samples.0.portions.0.analytes.0.aliquots.0.state	cases.0.samples.0.portions.0.analytes.0.analyte_id	cases.0.samples.0.portions.0.analytes.0.analyte_type	cases.0.samples.0.portions.0.analytes.0.analyte_type_id	cases.0.samples.0.portions.0.analytes.0.concentration	cases.0.samples.0.portions.0.analytes.0.spectrophotometer_method	cases.0.samples.0.portions.0.analytes.0.state	cases.0.samples.0.portions.0.is_ffpe	cases.0.samples.0.portions.0.portion_id	cases.0.samples.0.portions.0.portion_number	cases.0.samples.0.portions.0.slides.0.percent_lymphocyte_infiltration	cases.0.samples.0.portions.0.slides.0.percent_monocyte_infiltration	cases.0.samples.0.portions.0.slides.0.percent_necrosis	cases.0.samples.0.portions.0.slides.0.percent_neutrophil_infiltration	cases.0.samples.0.portions.0.slides.0.percent_normal_cells	cases.0.samples.0.portions.0.slides.0.percent_stromal_cells	cases.0.samples.0.portions.0.slides.0.percent_tumor_cells	cases.0.samples.0.portions.0.slides.0.percent_tumor_nuclei	cases.0.samples.0.portions.0.slides.0.section_location	cases.0.samples.0.portions.0.slides.0.slide_id	cases.0.samples.0.portions.0.slides.0.state	cases.0.samples.0.portions.0.slides.1.percent_lymphocyte_infiltration	cases.0.samples.0.portions.0.slides.1.percent_monocyte_infiltration	cases.0.samples.0.portions.0.slides.1.percent_necrosis	cases.0.samples.0.portions.0.slides.1.percent_neutrophil_infiltration	cases.0.samples.0.portions.0.slides.1.percent_normal_cells	cases.0.samples.0.portions.0.slides.1.percent_stromal_cells	cases.0.samples.0.portions.0.slides.1.percent_tumor_cells	cases.0.samples.0.portions.0.slides.1.percent_tumor_nuclei	cases.0.samples.0.portions.0.slides.1.section_location	cases.0.samples.0.portions.0.slides.1.slide_id	cases.0.samples.0.portions.0.slides.1.state	cases.0.samples.0.portions.0.slides.2.percent_lymphocyte_infiltration	cases.0.samples.0.portions.0.slides.2.percent_monocyte_infiltration	cases.0.samples.0.portions.0.slides.2.percent_neutrophil_infiltration	cases.0.samples.0.portions.0.slides.2.percent_normal_cells	cases.0.samples.0.portions.0.slides.2.percent_tumor_cells	cases.0.samples.0.portions.0.slides.2.section_location	cases.0.samples.0.portions.0.slides.2.slide_id	cases.0.samples.0.portions.0.slides.2.state	cases.0.samples.0.portions.0.state	cases.0.samples.0.portions.0.weight	cases.0.samples.0.sample_id	cases.0.samples.0.sample_type	cases.0.samples.0.sample_type_id	cases.0.samples.0.state	cases.0.samples.0.tissue_type	cases.0.state	cases.0.demographic.submitter_id	cases.0.demographic.age_at_index	cases.0.demographic.days_to_birth	cases.0.demographic.days_to_death	cases.0.demographic.demographic_id	cases.0.demographic.ethnicity	cases.0.demographic.gender	cases.0.demographic.race	cases.0.demographic.state	cases.0.demographic.vital_status	cases.0.demographic.year_of_birth	cases.0.demographic.year_of_death	cases.0.exposures.0.submitter_id	cases.0.exposures.0.alcohol_history	cases.0.exposures.0.bmi	cases.0.exposures.0.exposure_id	cases.0.exposures.0.height	cases.0.exposures.0.state	cases.0.exposures.0.weight	cases.0.diagnoses.0.submitter_id	cases.0.diagnoses.0.age_at_diagnosis	cases.0.diagnoses.0.classification_of_tumor	cases.0.diagnoses.0.days_to_diagnosis	cases.0.diagnoses.0.days_to_last_follow_up	cases.0.diagnoses.0.diagnosis_id	cases.0.diagnoses.0.figo_stage	cases.0.diagnoses.0.icd_10_code	cases.0.diagnoses.0.last_known_disease_status	cases.0.diagnoses.0.morphology	cases.0.diagnoses.0.primary_diagnosis	cases.0.diagnoses.0.prior_malignancy	cases.0.diagnoses.0.prior_treatment	cases.0.diagnoses.0.progression_or_recurrence	cases.0.diagnoses.0.site_of_resection_or_biopsy	cases.0.diagnoses.0.state	cases.0.diagnoses.0.synchronous_malignancy	cases.0.diagnoses.0.tissue_or_organ_of_origin	cases.0.diagnoses.0.tumor_grade	cases.0.diagnoses.0.tumor_stage	cases.0.diagnoses.0.year_of_diagnosis	cases.0.diagnoses.0.treatments.0.submitter_id	cases.0.diagnoses.0.treatments.1.submitter_id	cases.0.diagnoses.0.treatments.0.state	cases.0.diagnoses.0.treatments.0.treatment_id	cases.0.diagnoses.0.treatments.0.treatment_or_therapy	cases.0.diagnoses.0.treatments.0.treatment_type	cases.0.diagnoses.0.treatments.1.state	cases.0.diagnoses.0.treatments.1.treatment_id	cases.0.diagnoses.0.treatments.1.treatment_or_therapy	cases.0.diagnoses.0.treatments.1.treatment_type	id
f40d273f-5343-4e57-995b-6adcfdc7c7d3.htseq.counts.gz	ecbe8846-24fa-4347-9640-0e0ca39d7fef	TCGA-AX-A06H-01A-11R-A118-07	TCGA-AX-A06H-01A-11R	TCGA-AX-A06H-01A-01-BS1	TCGA-AX-A06H-01A-01-MS1		TCGA-AX-A06H-01A-11	TCGA-AX-A06H-01A	TCGA-AX-A06H	e5d74e47-b63f-410a-8b7a-c9aacc9aa337	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	654	110.0	False	false	493C5DDA-E629-4324-8574-AEC67223DA9E	1.9	fb8cfa19-3dfb-4ad5-a64e-7f51837e56cf	0.15	23	released	368464aa-a97e-4edc-b085-b8e50e643a10	RNA	R	0.15	UV Spec	released	False	69e9e629-10bd-49a2-a254-97053e4316ee	11	24.0	1.0	15.0	1.0	15.0	2.0	68.0	70.0	BOTTOM	a1e105e0-7ae5-4029-9624-ca57ff394b03	released	70.0	0.0	5.0	0.0	5.0	35.0	55.0	20.0	TOP	56925b0e-e308-42ef-a71d-ef22434a27ec	released									released	20.0	b26a6c7e-5eef-4129-b635-cc40e60df0dd	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A06H_demographic	60	-22270		d376f28e-2c9a-54ab-9426-adfa028674d4	not hispanic or latino	female	american indian or alaska native	released	Alive	1948		TCGA-AX-A06H_exposure	Not Reported	38.28125	e28ab080-7b0b-5cfc-853c-c35416cfdadc	160.0	released	98.0	TCGA-AX-A06H_diagnosis	22270	not reported	0	833	f8e76f0a-a24a-5a0b-8176-25c3681c2344	Stage IIIA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-AX-A06H_treatment_1	TCGA-AX-A06H_treatment	released	6d411677-f621-5521-95b9-710fa6689eb4	yes	Pharmaceutical Therapy, NOS	released	e46d0195-311d-5cee-81b3-ed09a98dec6a	no	Radiation Therapy, NOS	ecbe8846-24fa-4347-9640-0e0ca39d7fef
51500805-d88a-4f67-9beb-04a7228033c8.htseq.counts.gz	e7e7a670-aad1-45c1-ad34-2d6562a7fd3a	TCGA-A5-A0GN-01A-11R-A040-07	TCGA-A5-A0GN-01A-11R	TCGA-A5-A0GN-01A-01-BS1	TCGA-A5-A0GN-01A-01-TS1		TCGA-A5-A0GN-01A-11	TCGA-A5-A0GN-01A	TCGA-A5-A0GN	a2a2dbda-d10c-49c4-86a8-61baf6160cda	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1354	340.0	False	true	7A76BDC7-62D9-4A8D-AAEF-CECF9F819D58	1.82	53a3dd36-866d-4c44-9b79-b9f9564996b3	0.16	23	released	d8eed631-0535-4111-8bb3-5463b7229941	RNA	R	0.16	UV Spec	released	False	e15cd12c-7af8-429e-a042-368ad2350fed	11	1.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	BOTTOM	89bcb918-f801-44cd-a89c-aeeb7ccd3d92	released	1.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	TOP	0319e94a-cd9b-43b9-9426-9a7d1e647d7a	released									released	30.0	f6f9c40b-1e58-47a3-b518-9694fb5ff2cf	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A0GN_demographic	65	-24020		8dc88809-3a23-5cdf-8f5a-97e7747200b9	not hispanic or latino	female	white	released	Alive	1941		TCGA-A5-A0GN_exposure	Not Reported	25.28256989886972	8fbb5109-7518-55ef-9c99-7edf90cf42be	164.0	released	68.0	TCGA-A5-A0GN_diagnosis	24020	not reported	0	1841	03e39652-cda1-5257-a00c-b2959370daf1	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2006	TCGA-A5-A0GN_treatment	TCGA-A5-A0GN_treatment_1	released	ca7cd085-c216-51aa-b48b-5ade175dccfa	yes	Radiation Therapy, NOS	released	cdf39145-85f0-5072-856b-054cf6fa7a05	no	Pharmaceutical Therapy, NOS	e7e7a670-aad1-45c1-ad34-2d6562a7fd3a
c13fc444-6e7b-4ae1-9c90-e539d78417ca.htseq.counts.gz	b08a16e7-ae70-4c18-8594-d611d5dcd23a	TCGA-A5-A0VO-01A-21R-A109-07	TCGA-A5-A0VO-01A-21R	TCGA-A5-A0VO-01A-02-MSB	TCGA-A5-A0VO-01A-02-BSB		TCGA-A5-A0VO-01A-21	TCGA-A5-A0VO-01A	TCGA-A5-A0VO	0648f046-2206-4b97-9b6e-419c2e325b6d	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	133	320.0	False	true	6ABBA2C9-8920-4785-BFAB-40E560D2DBE6	1.86	b07b341a-32ba-4863-b202-6fae769d1dd2	0.17	23	released	f80755b3-8c07-4fe9-8300-b9aac4a836a4	RNA	R	0.17	UV Spec	released	False	490e3050-1cea-423f-af06-ff54082eae4b	21	0.0	0.0	0.0	0.0	0.0	10.0	90.0	70.0	TOP	e03a04e3-daf4-4227-80e4-6b2b6fdd7961	released	20.0	0.0	10.0	20.0	20.0	0.0	70.0	70.0	BOTTOM	e22a1156-04ad-4ac8-9576-20639e098c66	released									released	30.0	925bc760-6132-4b03-961e-7570acf33d5e	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A0VO_demographic	64	-23547	875	123d4916-d5a9-5a00-9e89-34b4acda61e5	not hispanic or latino	female	white	released	Dead	1946		TCGA-A5-A0VO_exposure	Not Reported	32.368549813692646	ee7c640b-ca61-5867-b9a7-d654aeb49589	163.0	released	86.0	TCGA-A5-A0VO_diagnosis	23547	not reported	0	364	2c7303ce-f4f8-5671-9283-42959b0788c2	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-A5-A0VO_treatment_1	TCGA-A5-A0VO_treatment	released	ee832260-5a10-5758-bfdb-26633664a9da	no	Pharmaceutical Therapy, NOS	released	1c203ba4-a944-5a35-8f30-275b1d3abe76	yes	Radiation Therapy, NOS	b08a16e7-ae70-4c18-8594-d611d5dcd23a
3949d143-ea2f-49b8-a003-5e49d06fde1a.htseq.counts.gz	0a4d509b-2545-4ca1-9573-66d280ee9515	TCGA-B5-A1N2-01A-21R-A144-07	TCGA-B5-A1N2-01A-21R	TCGA-B5-A1N2-01A-02-TSB			TCGA-B5-A1N2-01A-21	TCGA-B5-A1N2-01A	TCGA-B5-A1N2	d79e692c-5053-4484-a180-01a094c5ff45	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	93	540.0	False	true	CB8D6955-D74A-4A05-ACC3-F0DE49CC60A9	1.85	c45110ae-6ba6-44d7-8bff-5fa16c45d962	0.15	23	released	82790ce6-3c46-44d8-a25b-d69fd48d7ee4	RNA	R	0.15	UV Spec	released	False	7253e0cb-4f5f-4e2c-b410-9588d68466cf	21	30.0	5.0	0.0	3.0	0.0	30.0	70.0	70.0	TOP	0b277d6f-d369-4821-b068-e57a4eeafaa4	released																				released	30.0	a5058d90-cea2-4886-9823-501ff2262e13	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A1N2_demographic	70	-25612	954	da3707f8-f6ee-513d-b165-45858db4dcd1	not reported	female	black or african american	released	Dead	1940		TCGA-B5-A1N2_exposure	Not Reported	40.39115646258503	81e769ca-859d-5821-a1e6-15e71d3aa235	168.0	released	114.0	TCGA-B5-A1N2_diagnosis	25612	not reported	0	389	327134b5-089b-59d7-8f74-1504576e9298	Stage IIIC1	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-B5-A1N2_treatment	TCGA-B5-A1N2_treatment_1	released	1df98583-271a-521f-b524-eff3f9bb7f06	yes	Radiation Therapy, NOS	released	8bfe348b-2933-5ac5-9e10-78600faa949a	yes	Pharmaceutical Therapy, NOS	0a4d509b-2545-4ca1-9573-66d280ee9515
e250c5cd-1786-4b25-b143-c8da28a3b77c.htseq.counts.gz	3f2f99ad-3723-4c36-a720-dd30485bb456	TCGA-BG-A187-01A-11R-A12I-07	TCGA-BG-A187-01A-11R	TCGA-BG-A187-01A-01-TSA			TCGA-BG-A187-01A-11	TCGA-BG-A187-01A	TCGA-BG-A187	0f59bb0a-135c-4793-b1a7-5ad5172ed82d	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	97	360.0	False	true	CB8E915A-CE5D-4181-9303-22BD8CBCB80D	1.83	3486bd36-927d-46c7-8efe-5f2d6c80ac5e	0.16	23	released	066b80e6-7b89-498a-9a9a-7ccacf7b8daa	RNA	R	0.16	UV Spec	released	False	c484bfe7-7e72-477b-a239-4d8f9556cdd2	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	70.0	TOP	ef51e171-34c5-4b11-acff-8fad08440a53	released																				released	20.0	1738b7d6-c860-449a-aae9-065ef65a149b	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A187_demographic	65	-24099		0f4a1aa0-c451-5604-8efd-ca457cdff74c	not hispanic or latino	female	white	released	Alive	1945		TCGA-BG-A187_exposure	Not Reported	23.828125	d65d846e-71c0-5f2f-97b2-d597b935cf6d	160.0	released	61.0	TCGA-BG-A187_diagnosis	24099	not reported	0	448	e8487744-febb-5b64-a59f-86367bf55cd4	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-BG-A187_treatment_1	TCGA-BG-A187_treatment	released	784fd5b4-b0a5-52ec-af2c-b384621eb803	no	Pharmaceutical Therapy, NOS	released	d3514da6-ca59-52b6-91c3-6d8386390293	yes	Radiation Therapy, NOS	3f2f99ad-3723-4c36-a720-dd30485bb456
b95c9bdd-1cc0-4b8f-959b-4c1de981135c.htseq.counts.gz	1a6f7562-aff8-464a-8379-0d3bc84f6881	TCGA-B5-A11Z-01A-11R-A10J-07	TCGA-B5-A11Z-01A-11R	TCGA-B5-A11Z-01A-01-TSA	TCGA-B5-A11Z-01A-01-BSA		TCGA-B5-A11Z-01A-11	TCGA-B5-A11Z-01A	TCGA-B5-A11Z	cc141997-edab-4aae-a056-0c079eaa7362	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	213	340.0	False	true	62C170A9-710F-45C0-B6BB-3F491A86A7E4	1.78	640190cd-cd16-4a1a-8e63-9e41db6c3f89	0.15	23	released	e072b5c0-c2f7-4ebc-a2ad-e48ca0edc4e3	RNA	R	0.15	UV Spec	released	False	1c8862af-aab1-48ad-b10c-009d488b1d05	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	90.0	TOP	f410f4c3-60ec-45bb-bf5c-7dfc75e4da5c	released	0.0	0.0	0.0	0.0	0.0	0.0	100.0	85.0	BOTTOM	579feafb-e8e2-41f8-a0c2-b7c8679f0ac7	released									released	30.0	2a8af07b-b514-4cd0-bf20-03a5f5abdb38	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A11Z_demographic	61	-22505		e62a79ee-848d-50f1-a4e5-e32f4eb1605b	not reported	female	white	released	Alive	1949		TCGA-B5-A11Z_exposure	Not Reported	28.393726338561383	145cb85d-d954-587e-b314-620843e2bbc6	172.0	released	84.0	TCGA-B5-A11Z_diagnosis	22505	not reported	0	528	d6c19cf3-0ae9-5911-ae67-1e2664af27a8	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-B5-A11Z_treatment_1	TCGA-B5-A11Z_treatment	released	aad7d2a8-7ec4-5b6b-a91e-014001e0d2d4	no	Pharmaceutical Therapy, NOS	released	5f3f631b-6729-5489-a9ab-cfaa34c91631	no	Radiation Therapy, NOS	1a6f7562-aff8-464a-8379-0d3bc84f6881
98ac488f-bf05-4175-b9f2-b33cb46665e3.htseq.counts.gz	ec1e3e8e-270d-48d9-9ef4-c11f6ad769d6	TCGA-DF-A2KU-01A-11R-A180-07	TCGA-DF-A2KU-01A-11R	TCGA-DF-A2KU-01A-01-TSA			TCGA-DF-A2KU-01A-11	TCGA-DF-A2KU-01A	TCGA-DF-A2KU	95eefb47-3f96-4a6d-8773-4d22843f0a6a	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC		380.0	False	false	6F425E9F-E02A-4EFB-A0DE-00BF09D9BB98	1.79	ee0873f1-b89d-44ef-9aad-d40c5a8999f1	0.18	23	released	b7973f3c-1a43-4466-83a5-2fe1aa45783d	RNA	R	0.18	UV Spec	released	False	18d99902-ab35-41e8-a39f-690a4adde898	11	15.0	3.0	0.0	3.0	0.0	10.0	90.0	90.0	TOP	10aa0e57-2087-4983-8ed3-be95e7151f58	released																				released	30.0	341b9ad3-2aa4-4e8c-9a41-1915ab6cdba8	Primary Tumor	01	released	Not Reported	released	TCGA-DF-A2KU_demographic				a1f289cf-dd76-53da-85d7-8289e9f6d3fa	not reported	female	not reported	released	Alive			TCGA-DF-A2KU_exposure	Not Reported		62a45313-ac77-54e5-8c01-0b7b63da04ff		released		TCGA-DF-A2KU_diagnosis		not reported		3067	d8d39996-51aa-594d-a4df-fbeebce320eb	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported		TCGA-DF-A2KU_treatment_1	TCGA-DF-A2KU_treatment	released	3a46c7d6-8b71-5290-b6e6-7d1087707645	no	Pharmaceutical Therapy, NOS	released	e4f76860-c1f8-5f10-b979-503d75caba06	yes	Radiation Therapy, NOS	ec1e3e8e-270d-48d9-9ef4-c11f6ad769d6
a638e045-eb92-4f48-afe8-e57f0e4307eb.htseq.counts.gz	3fd4f45f-e1be-4fc9-92b6-3110bca85252	TCGA-D1-A101-01A-12R-A10J-07	TCGA-D1-A101-01A-12R	TCGA-D1-A101-01A-01-TSA	TCGA-D1-A101-01A-01-BSA		TCGA-D1-A101-01A-12	TCGA-D1-A101-01A	TCGA-D1-A101	9da5ecd0-a287-4e67-84b6-af9077a98009	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	349	150.0	False	false	2D6287C8-9C22-4046-8F14-3886DDE62695	1.86	df97f5e0-e49a-4f34-911c-92502e7df570	0.17	23	released	8b140cc5-5406-48b1-9520-8a63c6e3efdf	RNA	R	0.17	UV Spec	released	False	bde9be50-18a3-48dc-a629-bb211c78af4c	12	0.0	0.0	0.0	0.0	35.0	0.0	65.0	60.0	TOP	ce0d439c-7005-40d5-805e-b93f56928476	released	0.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	BOTTOM	cef0d641-1d2e-4914-a704-58f70d356496	released									released	20.0	34fcec04-7c8f-4964-83eb-c7f81c475c79	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A101_demographic	60	-22078		c049a25f-94b1-5f01-a13c-0ec35b371750	not hispanic or latino	female	white	released	Alive	1949		TCGA-D1-A101_exposure	Not Reported	36.44444444444444	b1a86196-2237-5995-9e8d-17da4b4c8765	150.0	released	82.0	TCGA-D1-A101_diagnosis	22078	not reported	0	53	af7710fa-9154-5b82-bcfb-9c50c2290f88	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-D1-A101_treatment	TCGA-D1-A101_treatment_1	released	1a69ff9e-1d7b-5c93-9646-47a367eb1a29	no	Radiation Therapy, NOS	released	65b1f9ae-5407-5241-a34f-244da7fe314b	no	Pharmaceutical Therapy, NOS	3fd4f45f-e1be-4fc9-92b6-3110bca85252
f2e7119a-29c3-4f45-9af5-28c3610b0385.htseq.counts.gz	66ddc6ec-467a-48e4-a204-9b096d65479c	TCGA-EC-A24G-01A-11R-A16F-07	TCGA-EC-A24G-01A-11R	TCGA-EC-A24G-01A-01-TSA			TCGA-EC-A24G-01A-11	TCGA-EC-A24G-01A	TCGA-EC-A24G	b5c1e511-baf2-45b3-9919-110e8941e3c2	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	78	410.0	False	true	5DE142C5-7A0D-4C5E-8EF6-2809B10378C4	1.78	92f1d13e-3dbb-4a41-aac4-5887b50bc19f	0.18	23	released	27566bae-72dd-4257-bc03-513d61846b31	RNA	R	0.18	UV Spec	released	False	75f34509-2881-497c-8bd5-868ef657487d	11	10.0	3.0	0.0	3.0	0.0	15.0	85.0	85.0	TOP	e313a49e-2b27-465d-b504-5ba0bdea0703	released																				released	30.0	2fea9b96-3434-4a38-bd69-a5fec3d8f960	Primary Tumor	01	released	Not Reported	released	TCGA-EC-A24G_demographic	57	-20857		93b52e42-bee1-5a84-973a-5dec59c6e5ed	not hispanic or latino	female	white	released	Alive	1954		TCGA-EC-A24G_exposure	Not Reported	42.457998539079625	4da33fd8-7da3-5be0-8c1a-1030f257b863	148.0	released	93.0	TCGA-EC-A24G_diagnosis	20857	not reported	0	511	647de959-f4f7-552e-b46f-a335e3ee30d7	Stage II	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-EC-A24G_treatment	TCGA-EC-A24G_treatment_1	released	002afe07-a1a0-5d19-babf-29c713364fa6	yes	Radiation Therapy, NOS	released	7b92cbd0-16a5-525f-abbe-e0d9e6c4c8e9	yes	Pharmaceutical Therapy, NOS	66ddc6ec-467a-48e4-a204-9b096d65479c
dae5e5d9-b037-4d4a-90e4-b95fbfeed478.htseq.counts.gz	093193a0-b9e2-4b26-a260-5807396350a5	TCGA-D1-A15W-01A-11R-A118-07	TCGA-D1-A15W-01A-11R	TCGA-D1-A15W-01A-01-TS1			TCGA-D1-A15W-01A-11	TCGA-D1-A15W-01A	TCGA-D1-A15W	d6562acf-6d82-4f08-a779-82cdc5df16f9	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	906	190.0	False	false	1C938760-9492-4F4E-87CE-85CE3C15BBCA	1.87	9def1496-a891-431c-b5c2-75d258e7ec29	0.16	23	released	f9877fe4-fad6-4f5b-b41f-c03479b7c0b2	RNA	R	0.16	UV Spec	released	False	99856b4b-6116-4aad-a15c-80732f1d869f	11	0.0	0.0	0.0	0.0	5.0	0.0	95.0	80.0	TOP	94afb8d6-ecdb-43e0-b844-8dc2fc4c6f22	released																				released	30.0	1ac48153-0577-4bc0-ab8c-f77453ebfbb0	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A15W_demographic	58	-21545		5e8f2da5-7f61-5140-9364-25325bf20cad	not hispanic or latino	female	white	released	Alive	1950		TCGA-D1-A15W_exposure	Not Reported	46.280991735537185	025d48e7-661f-506e-809a-b68b9ebf186d	165.0	released	126.0	TCGA-D1-A15W_diagnosis	21545	not reported	0	915	54ec6618-ae60-5df8-9a0e-32da9a95aeb4	Stage IIIC	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-D1-A15W_treatment_1	TCGA-D1-A15W_treatment	released	7f44b25d-a78a-598a-ada2-79df465e7314	yes	Pharmaceutical Therapy, NOS	released	6ea57f75-1f3e-5422-b62a-ba1a9e573765	yes	Radiation Therapy, NOS	093193a0-b9e2-4b26-a260-5807396350a5
ecf78283-0eb3-4710-8e5a-30f56da510bd.htseq.counts.gz	b973c600-7235-4e34-99c7-03225d92156d	TCGA-AX-A2HD-11A-11R-A32Y-07	TCGA-AX-A2HD-11A-11R	TCGA-AX-A2HD-11A-01-TSA			TCGA-AX-A2HD-11A-11	TCGA-AX-A2HD-11A	TCGA-AX-A2HD	a8def1a0-a136-47f4-9ad9-60ebcf9b726b	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1175	110.0	False	false		1.75	773d237c-995c-4e0b-aaf1-3b78763ae704	0.18	23	released	eb6ac8cd-ae49-499d-9b29-0782610f884f	RNA	R	0.18	UV Spec	released	False	416b6377-b861-4b1d-8b4e-2e106c14b8c8	11	0.0	0.0	3.0	0.0	97.0	0.0	0.0	0.0	TOP	04eec40c-697e-4d90-bfe1-ecd5e80ea5a8	released																				released	30.0	26bc3b4c-b0bc-4d05-9dbf-334f27f1cb89	Solid Tissue Normal	11	released	Not Reported	released	TCGA-AX-A2HD_demographic	69	-25499		0cbf6c30-6909-56ac-9390-67b1bba5eaac	not hispanic or latino	female	white	released	Alive	1939		TCGA-AX-A2HD_exposure	Not Reported	22.97193820098194	9c6b1c0f-6943-5a5f-be42-039f5d5fb4ee	149.0	released	51.0	TCGA-AX-A2HD_diagnosis	25499	not reported	0	1414	c3080851-f81c-5b94-b205-562399603585	Stage IIIA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-AX-A2HD_treatment	TCGA-AX-A2HD_treatment_1	released	61f8a04d-cded-5f19-aa28-ea114d0f140d	no	Radiation Therapy, NOS	released	335e6652-9cdb-5121-b941-fb07f550b61f	no	Pharmaceutical Therapy, NOS	b973c600-7235-4e34-99c7-03225d92156d
08b60e36-2683-4650-bcf4-0fe4af20607f.htseq.counts.gz	00ec434d-b51a-4e74-b486-e7b607f1b04c	TCGA-AX-A2IN-01A-12R-A180-07	TCGA-AX-A2IN-01A-12R	TCGA-AX-A2IN-01A-01-TSA			TCGA-AX-A2IN-01A-12	TCGA-AX-A2IN-01A	TCGA-AX-A2IN	fe79ebe1-cd0a-4ce2-a86d-637c28354ed9	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1321	60.0	False	false	3C67A037-8A4C-4345-B842-43F1F0A6A53E	1.82	af153b10-b6c0-4345-b242-9ad4c676e6c4	0.17	23	released	27990249-d5be-413c-8050-0955e9e5d032	RNA	R	0.17	UV Spec	released	False	19c68ff2-8cdc-4fc4-ad8d-75726d4b774e	12	6.0	0.0	10.0	0.0	20.0	20.0	60.0	80.0	TOP	03af3834-8515-46d9-a2f8-43d9179289fe	released																				released	30.0	c28c7656-4790-485f-bd27-c8a6a35d2dd1	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A2IN_demographic	63	-23275	947	3c71ccb1-7bdf-5b48-9bbf-b4dfe7809100	not reported	female	white	released	Dead	1944	2009	TCGA-AX-A2IN_exposure	Not Reported	40.56959714390036	39eb6b89-6cdd-59c8-bf13-1c6c7659ae2b	157.0	released	100.0	TCGA-AX-A2IN_diagnosis	23275	not reported	0		101ca4ed-726d-5b08-9e58-34d3a6cd9d81	Stage IC	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2007	TCGA-AX-A2IN_treatment_1	TCGA-AX-A2IN_treatment	released	fe24a5dc-c39d-5f73-a561-b0a6026b833e	no	Pharmaceutical Therapy, NOS	released	afb31d48-c65b-5ff7-8d73-ee08eb562d16	yes	Radiation Therapy, NOS	00ec434d-b51a-4e74-b486-e7b607f1b04c
57cd1c25-3305-4bc2-a946-e664a6e3eab1.htseq.counts.gz	9c9ded4a-57e2-4914-b0b3-230ed54c9a4e	TCGA-D1-A2G7-01A-21R-A180-07	TCGA-D1-A2G7-01A-21R	TCGA-D1-A2G7-01A-02-TSB			TCGA-D1-A2G7-01A-21	TCGA-D1-A2G7-01A	TCGA-D1-A2G7	32b5d0e4-a242-44d1-ac20-6e5ca2f35b71	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	1339	110.0	False	true	5D25FD0B-EEE9-435C-82C7-BC44B0758A14	1.78	bddd28d0-8d22-4949-b890-9cd54a4a0f29	0.17	23	released	760cb960-c405-4ba1-b374-9879c1c6cc51	RNA	R	0.17	UV Spec	released	False	45945f32-8f50-4929-bc74-a7cb3ff2bff6	21	10.0	0.0	20.0	10.0	20.0	0.0	60.0	80.0	TOP	744a0f72-653c-486f-8f9f-4d0f92874225	released																				released	30.0	9c10d27c-4372-4c1f-8a92-f84a387a1161	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A2G7_demographic	65	-23913	1793	7a1a5571-514e-589e-afbb-0c731011e50c	not hispanic or latino	female	white	released	Dead	1942		TCGA-D1-A2G7_exposure	Not Reported	49.44973230220107	56eaffbd-49cc-5acc-88e7-5c7bede08b8c	164.0	released	133.0	TCGA-D1-A2G7_diagnosis	23913	not reported	0	1365	37e5cf6e-ef1e-500e-8588-bbba65048663	Stage IB	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2007	TCGA-D1-A2G7_treatment_1	TCGA-D1-A2G7_treatment	released	b3e5c23b-4c50-5d77-b375-7b4124427dd9	no	Pharmaceutical Therapy, NOS	released	96f6d679-6203-54a2-9a1e-b4162d4516ac	no	Radiation Therapy, NOS	9c9ded4a-57e2-4914-b0b3-230ed54c9a4e
f3b6c5d9-6d0c-41db-b369-2b60bc2f44a6.htseq.counts.gz	11756653-2722-428b-add0-f9cfad604550	TCGA-D1-A16G-01A-31R-A12I-07	TCGA-D1-A16G-01A-31R	TCGA-D1-A16G-01A-03-TS3			TCGA-D1-A16G-01A-31	TCGA-D1-A16G-01A	TCGA-D1-A16G	16e69011-c295-479f-b521-86e66fba498d	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	769	250.0	False	false	778F9F58-841E-48F3-B6EA-7CF58463808B	1.91	deeb2238-8ed6-4651-8b63-428c76914c94	0.16	23	released	15665d54-3bab-4df7-8bb7-e330b978614f	RNA	R	0.16	UV Spec	released	False	a7688e3b-76f9-4274-9a9a-c880b7d0b05b	31	10.0	0.0	0.0	30.0	0.0	40.0	60.0	60.0	TOP	07c2e2e7-7541-4d59-bbf1-bbafb95cdb72	released																				released	30.0	4c34ecb0-9351-4a55-9ff5-2062b7cb391a	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A16G_demographic	74	-27065	834	3078ca72-dee9-5c7d-8a6a-a75206adc1bd	not hispanic or latino	female	white	released	Dead	1934	2010	TCGA-D1-A16G_exposure	Not Reported	25.05930702662969	b917f59e-8638-508b-b956-7166198e6edf	173.0	released	75.0	TCGA-D1-A16G_diagnosis	27065	not reported	0		e5f2e1a4-d619-5852-88a9-7951d63188d1	Stage IV	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-D1-A16G_treatment_1	TCGA-D1-A16G_treatment	released	2b2aa8fa-88a3-57d0-9b0b-fc69a8d73423	yes	Pharmaceutical Therapy, NOS	released	2ce1e51d-937d-5861-81d1-3df10bf5369a	yes	Radiation Therapy, NOS	11756653-2722-428b-add0-f9cfad604550
39ff47a9-877b-43c5-9e73-46dab12bf4c4.htseq.counts.gz	3f80c194-17e9-47e3-8e5d-bbd0a8a5642f	TCGA-AP-A3K1-01A-11R-A213-07	TCGA-AP-A3K1-01A-11R	TCGA-AP-A3K1-01A-01-TSA			TCGA-AP-A3K1-01A-11	TCGA-AP-A3K1-01A	TCGA-AP-A3K1	211b2c52-1ad8-4d33-af0b-69ec1a56c821	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	450	190.0	False	true	A2E4C9FE-F82D-440E-AA52-88379EBC2442	1.81	c6b592eb-d131-4344-9135-7d9964143c28	0.17	23	released	b436c88e-c9a5-48e2-8d9a-df697f078f93	RNA	R	0.17	UV Spec	released	False	3fc9464a-dcdc-44c4-a90d-3136d33a9d97	11	1.0	0.0	0.0	0.0	0.0	0.0	100.0	95.0	TOP	dc088cbf-4362-4820-91be-2208b620afa8	released																				released	30.0	8a78f37c-8bc5-4a51-bb76-e77ded648289	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A3K1_demographic	56	-20594	666	26763d38-c1a0-5f96-bad2-1a24c1c5555b	not hispanic or latino	female	white	released	Dead	1954		TCGA-AP-A3K1_exposure	Not Reported	24.341758286340216	6b853ec4-f9df-50af-a109-7ff2b76e2390	157.0	released	60.0	TCGA-AP-A3K1_diagnosis	20594	not reported	0	555	d168edea-fbee-5c65-b2e7-ad373b611c87	Stage IVB	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-AP-A3K1_treatment_1	TCGA-AP-A3K1_treatment	released	34a8fec3-6fb1-541e-b1f8-5cfc283ebe33	yes	Pharmaceutical Therapy, NOS	released	6fc79bdc-4403-54d8-801a-e8030d10d55c	no	Radiation Therapy, NOS	3f80c194-17e9-47e3-8e5d-bbd0a8a5642f
0362fa45-2de2-4d3a-a8bc-a0e3bd23c939.htseq.counts.gz	2ef3833c-cdb1-47c0-bb51-2634a773cc86	TCGA-AX-A2H8-11A-11R-A17B-07	TCGA-AX-A2H8-11A-11R	TCGA-AX-A2H8-11A-01-TSA			TCGA-AX-A2H8-11A-11	TCGA-AX-A2H8-11A	TCGA-AX-A2H8	da0474b3-48ab-4398-ae4b-f15e27e99b2d	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1974	140.0	False	false		1.96	8e59d005-8361-457f-9316-04c989d0b74f	0.17	23	released	0aba10e2-2c23-4dee-bc90-9dbfe87f9270	RNA	R	0.17	UV Spec	released	False	f6fd31e8-7e4e-4796-85b3-8f3b5c3c8ced	11	0.0	0.0	0.0	0.0	100.0	0.0	0.0	0.0	TOP	33194e61-d0e6-46c0-8050-081050d68e57	released																				released	30.0	98d62bf5-889b-40f9-b4da-fc29313acf9e	Solid Tissue Normal	11	released	Not Reported	released	TCGA-AX-A2H8_demographic	64	-23448		abe07506-82c6-5605-8235-f6792943c654	not hispanic or latino	female	white	released	Alive	1942		TCGA-AX-A2H8_exposure	Not Reported	44.140625	c1b39e28-562f-5b2b-a6d4-e20bfcfe5d27	160.0	released	113.0	TCGA-AX-A2H8_diagnosis	23448	not reported	0	1861	f34ddcc1-6f19-596f-ac77-2fdf5ddf1507	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2006	TCGA-AX-A2H8_treatment_1	TCGA-AX-A2H8_treatment	released	e56d9121-28b4-568f-8869-45f20d539c36	no	Pharmaceutical Therapy, NOS	released	a405c0db-a0a9-5eb9-a91d-da06b48951d4	yes	Radiation Therapy, NOS	2ef3833c-cdb1-47c0-bb51-2634a773cc86
6bfd36c9-7c8c-40ad-9888-e3986d80f357.htseq.counts.gz	048b2970-a98e-40f2-b4aa-4252a18ec298	TCGA-AX-A0IZ-01A-11R-A118-07	TCGA-AX-A0IZ-01A-11R	TCGA-AX-A0IZ-01A-01-BSA	TCGA-AX-A0IZ-01A-01-TSA		TCGA-AX-A0IZ-01A-11	TCGA-AX-A0IZ-01A	TCGA-AX-A0IZ	11285dc5-8742-477a-8692-af1b6e2c1434	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1114	200.0	False	false	1DEA7C0C-3280-4E11-B0A4-13562DDF307B	1.85	e76c4434-3eaf-4ab2-a994-6c27237d344d	0.16	23	released	62cc9aef-299b-4463-a4c4-f4e86c5f5850	RNA	R	0.16	UV Spec	released	False	c995d4e8-60ff-46fd-addf-89fe636f109f	11	4.0	0.0	3.0	0.0	0.0	40.0	57.0	55.0	BOTTOM	52e564e7-95f0-444a-8edc-53ef50e8b0e4	released	4.0	0.0	3.0	0.0	0.0	40.0	57.0	60.0	TOP	1a4e8665-1030-4ec9-be94-097380f6040e	released									released	30.0	4c64f7c4-f1ee-4590-8bdc-b6a81e92b328	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A0IZ_demographic	53	-19364		400b2e1e-7ebf-56da-a404-7bc683ec14ce	not hispanic or latino	female	white	released	Alive	1954		TCGA-AX-A0IZ_exposure	Not Reported	23.4375	37e36409-538a-5401-8e30-97f40c5c253e	160.0	released	60.0	TCGA-AX-A0IZ_diagnosis	19364	not reported	0	1333	fa08e52e-a08c-5dff-992d-48d8f2399ce4	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2007	TCGA-AX-A0IZ_treatment_1	TCGA-AX-A0IZ_treatment	released	4e7e3bc3-75fe-5ad4-817d-44fd076f05d2	no	Pharmaceutical Therapy, NOS	released	81d10302-589d-5a62-be62-0151793a6cea	no	Radiation Therapy, NOS	048b2970-a98e-40f2-b4aa-4252a18ec298
393232a1-d0de-40a1-9e75-24b22e1356ad.htseq.counts.gz	d524c764-de58-495b-8dd4-d72dd86dc626	TCGA-BK-A13C-01A-11R-A118-07	TCGA-BK-A13C-01A-11R	TCGA-BK-A13C-01A-01-TS1	TCGA-BK-A13C-01A-01-BS1		TCGA-BK-A13C-01A-11	TCGA-BK-A13C-01A	TCGA-BK-A13C	ce73d0aa-bb3d-4aa3-8ed3-e9912cf25d38	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	146	310.0	False	false	2043D579-6785-4775-8A28-CDE3F1400BA2	1.87	a7dc4fdb-a62d-4d84-b351-16d84ab202e3	0.16	23	released	fbdd40ae-0a2e-4404-a0ec-babe3db426b2	RNA	R	0.16	UV Spec	released	False	f11c024d-4b65-4e46-ad47-1b103fd2e8de	11	20.0	10.0	20.0	20.0	10.0	10.0	60.0	80.0	TOP	db0344ee-6f00-4f53-85f8-734fc308f98a	released	10.0	0.0	10.0	0.0	10.0	0.0	80.0	90.0	BOTTOM	b97e487f-7343-4f67-946a-0c25cfedc5b1	released									released	30.0	7cc1bcb4-63a2-4585-b936-30a9e23caccc	Primary Tumor	01	released	Not Reported	released	TCGA-BK-A13C_demographic	47	-17317		51289bbf-8cc2-5022-bfdd-b1377b17ce22	not hispanic or latino	female	black or african american	released	Alive	1963		TCGA-BK-A13C_exposure	Not Reported	33.74945565394106	cc6f1bed-847c-5811-a3bc-2e3f40b3ba70	166.0	released	93.0	TCGA-BK-A13C_diagnosis	17317	not reported	0	760	609011ba-d2fd-5a6c-a353-3959ab108622	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-BK-A13C_treatment	TCGA-BK-A13C_treatment_1	released	ae363043-0668-5e9f-82b7-125cf2d2d6cc	no	Radiation Therapy, NOS	released	6ceb7a98-17df-53e0-a3b2-b49f1bfbecb4	no	Pharmaceutical Therapy, NOS	d524c764-de58-495b-8dd4-d72dd86dc626
9177b3c7-86c7-4eb8-a227-c6c33ee3451a.htseq.counts.gz	900b3b9b-e8d0-4b87-b372-d59d8df397b3	TCGA-BG-A0M0-01A-11R-A104-07	TCGA-BG-A0M0-01A-11R	TCGA-BG-A0M0-01A-01-TSA	TCGA-BG-A0M0-01A-01-BSA		TCGA-BG-A0M0-01A-11	TCGA-BG-A0M0-01A	TCGA-BG-A0M0	8bf0b156-6eb4-45e8-9cbb-0979efbea898	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	147	800.0	False	true	BDDACDFC-E3D4-4EA7-9591-DB6371713E8E	1.78	5343a292-c0ee-4764-8051-ee24716cf79d	0.14	23	released	e1d74a2b-175a-49c0-ad63-1e49092f2ef1	RNA	R	0.14	UV Spec	released	False	b471fbcc-c7c9-4cec-a762-27d3d37398df	11	0.0	2.0	0.0	2.0	0.0	0.0	100.0	95.0	TOP	1455a3e3-be65-45ab-af05-3be56eb85166	released	0.0	2.0	0.0	2.0	0.0	0.0	100.0	95.0	BOTTOM	aaddcd61-b4d4-4271-9a01-6cb2bf8a8afb	released									released	20.0	e3f599db-19cf-4086-8e5d-d3527119120f	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A0M0_demographic	66	-24427		253415bb-94cc-5a4a-8235-d20cb0ee900e	not hispanic or latino	female	white	released	Alive	1944		TCGA-BG-A0M0_exposure	Not Reported	42.97520661157024	03b98b05-5ddf-5e81-83d5-3eff846b9d5f	165.0	released	117.0	TCGA-BG-A0M0_diagnosis	24427	not reported	0	588	3232eb69-feda-59db-907e-136c7f3f6721	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-BG-A0M0_treatment_1	TCGA-BG-A0M0_treatment	released	7d8bfce8-0793-5bda-9687-0123f0f24a37	no	Pharmaceutical Therapy, NOS	released	001809bd-11a9-5bdc-8abd-682e42f4297a	no	Radiation Therapy, NOS	900b3b9b-e8d0-4b87-b372-d59d8df397b3
6acc4fa9-8557-4812-9ebd-8eb838432f06.htseq.counts.gz	0bb89e38-897d-4ab6-81d8-b905c46e7641	TCGA-D1-A179-01A-11R-A12I-07	TCGA-D1-A179-01A-11R	TCGA-D1-A179-01A-01-TS1			TCGA-D1-A179-01A-11	TCGA-D1-A179-01A	TCGA-D1-A179	37d5c1d9-3ff5-44fe-afdc-ff430a0f3510	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	230	250.0	False	false	F8F4C024-B723-424C-B98D-AA885C38CDFB	1.86	c64d52eb-c0aa-4ebe-a21d-0e7f11be7d09	0.15	23	released	056c7cc3-708e-4cf0-813d-a4b0d366e5d7	RNA	R	0.15	UV Spec	released	False	7e329ecf-7120-4612-af2e-c9ca19b1c9c9	11	40.0	10.0	20.0	40.0	0.0	10.0	70.0	70.0	TOP	3975398f-c750-4d42-9d59-6b24043b653d	released																				released	30.0	ba812542-9161-4060-93cd-8b730adb4d40	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A179_demographic	76	-28037	448	81cd252c-e9e4-51f3-8c0f-6b4b20f25bf4	hispanic or latino	female	white	released	Dead	1934		TCGA-D1-A179_exposure	Not Reported	36.19875019051974	fad08a06-54d8-5318-a690-d2824525517d	162.0	released	95.0	TCGA-D1-A179_diagnosis	28037	not reported	0	206	09cbb646-8d49-589d-8ef2-f934f3dfd0be	Stage IIIC	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-D1-A179_treatment	TCGA-D1-A179_treatment_1	released	9bad8611-91b3-5a82-a51b-bf1aff93f46a	no	Radiation Therapy, NOS	released	bbe7975f-fb60-578a-bb4d-277dbc880582	yes	Pharmaceutical Therapy, NOS	0bb89e38-897d-4ab6-81d8-b905c46e7641
4258a78b-4224-4d50-b935-0233805a37d1.htseq.counts.gz	109ceb04-751c-4e47-b6b1-c3357e0dfa4d	TCGA-BS-A0VI-01A-11R-A14D-07	TCGA-BS-A0VI-01A-11R	TCGA-BS-A0VI-01A-01-TS1			TCGA-BS-A0VI-01A-11	TCGA-BS-A0VI-01A	TCGA-BS-A0VI	3405c549-7da5-48ee-ba48-177a67bbcc5d	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1514	340.0	False	false	EC10AA0B-A597-4224-8807-52F7228C6D07	1.82	eb32a70b-8e73-4c44-8a44-c623158e87b1	0.15	23	released	db7a56e7-2a09-410e-9133-63a45769d0e6	RNA	R	0.15	UV Spec	released	False	5c2dc624-280f-4b02-99ce-0ee186011d04	11	40.0	20.0	10.0	20.0	0.0	20.0	70.0	70.0	TOP	a95e3df8-dfa9-4372-99c8-bc960746a524	released																				released	30.0	698a5085-0137-4bd8-a8c0-f749d03fbd95	Primary Tumor	01	released	Not Reported	released	TCGA-BS-A0VI_demographic	58	-21198		7a1bcab4-1dc6-5dff-bebc-6d77458d082e	not hispanic or latino	female	white	released	Alive	1948		TCGA-BS-A0VI_exposure	Not Reported	34.25044224472129	4224c6ab-8894-5e63-98e6-9de7ebb40439	163.0	released	91.0	TCGA-BS-A0VI_diagnosis	21198	not reported	0	2646	a960398d-abc0-599d-9f97-3f67d347ca15	Stage IIB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2006	TCGA-BS-A0VI_treatment	TCGA-BS-A0VI_treatment_1	released	2fce146a-389a-5380-b325-fff653bc5446	no	Radiation Therapy, NOS	released	9dbd0bdf-cd3f-5af9-b384-e5cf6ba05f25	no	Pharmaceutical Therapy, NOS	109ceb04-751c-4e47-b6b1-c3357e0dfa4d
db7b7f18-8a34-466f-b93a-087309fd68b9.htseq.counts.gz	0ae57911-b760-40d9-843a-f090e5784d63	TCGA-FI-A3PV-01A-11R-A22K-07	TCGA-FI-A3PV-01A-11R	TCGA-FI-A3PV-01A-01-TS1			TCGA-FI-A3PV-01A-11	TCGA-FI-A3PV-01A	TCGA-FI-A3PV	60e307dd-e11e-40ba-93c1-7e8a1f669f60	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	3199	60.0	False	true	0EBA5D54-65AC-4F79-ACE9-29FB1F924E3A	1.85	af1f390e-abd4-4ed2-bc65-0b1080b786a9	0.16	23	released	2c0044c9-506b-4ab4-9193-d7ef168b9923	RNA	R	0.16	UV Spec	released	False	b4bb66cb-afd3-4b5b-b5dd-c98fed197bbf	11	0.0	0.0	0.0	0.0	0.0	35.0	65.0	65.0	TOP	44cfdf0b-147e-4057-8b59-1a4b43171e6c	released																				released	30.0	1d775e4c-dfb0-4db1-9495-13cea9aba532	Primary Tumor	01	released	Not Reported	released	TCGA-FI-A3PV_demographic	68	-24898	1249	587919ff-fbe2-59f6-8ffe-fe75b6f4f3a7	not hispanic or latino	female	black or african american	released	Dead	1935	2006	TCGA-FI-A3PV_exposure	Not Reported	34.68093539437178	3e3e577f-c6d3-5cb7-a1c0-8874e160eb8d	174.0	released	105.0	TCGA-FI-A3PV_diagnosis	24898	not reported	0		fef8958c-b1db-5946-91a8-30531aa6f1b3	Stage IA	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2003	TCGA-FI-A3PV_treatment	TCGA-FI-A3PV_treatment_1	released	22470e63-4901-58a1-bd91-d730bfb65ada	not reported	Radiation Therapy, NOS	released	69245703-bdd8-5d77-9cf5-6487629c560d	not reported	Pharmaceutical Therapy, NOS	0ae57911-b760-40d9-843a-f090e5784d63
8ec3195f-156f-4b0a-bcdf-c27ff378c0be.htseq.counts.gz	96ae23a7-8d7c-4222-a5b3-981b80ee64c8	TCGA-D1-A17N-01A-11R-A12I-07	TCGA-D1-A17N-01A-11R	TCGA-D1-A17N-01A-01-TS1			TCGA-D1-A17N-01A-11	TCGA-D1-A17N-01A	TCGA-D1-A17N	001e0309-9c50-42b0-9e38-347883ee2cd3	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	451	110.0	False	false	AD892375-1A50-4D9E-8235-A9A495C35B97	1.75	ab241aac-4962-4ccd-919c-140031a13dba	0.16	23	released	85511dab-f0df-42e4-9271-0d02d0f0bb0f	RNA	R	0.16	UV Spec	released	False	5696bced-e7d8-4195-aa5e-74fb6dea814c	11	0.0	0.0	0.0	0.0	15.0	0.0	85.0	80.0	TOP	14fe51ab-2a95-46f0-a293-c5662bd3311a	released																				released	30.0	f93931ba-8333-4e22-a430-ca02d9da3ffc	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A17N_demographic	46	-17045		e00830e7-7afa-5262-95b1-9ec093cf6ff4	not hispanic or latino	female	not reported	released	Alive	1963		TCGA-D1-A17N_exposure	Not Reported	48.62824793148497	c0426f0f-6801-5b8b-92ac-eced861458a5	166.0	released	134.0	TCGA-D1-A17N_diagnosis	17045	not reported	0	46	1973302c-ef19-59e0-b80f-4404565763c7	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-D1-A17N_treatment	TCGA-D1-A17N_treatment_1	released	d733b7ec-b2b8-5b4b-92bd-92dee7f97bf0	no	Radiation Therapy, NOS	released	6a26a01d-7746-553c-a5f7-2798efdff38b	no	Pharmaceutical Therapy, NOS	96ae23a7-8d7c-4222-a5b3-981b80ee64c8
73f75d25-384a-4d42-bc83-6bf5975abf8a.htseq.counts.gz	d10d071f-a21e-4fb9-b5f8-6850f2aca3e9	TCGA-PG-A916-01A-11R-A37O-07	TCGA-PG-A916-01A-11R	TCGA-PG-A916-01A-01-TSA			TCGA-PG-A916-01A-11	TCGA-PG-A916-01A	TCGA-PG-A916	5edaed6d-9914-4df2-a843-d6009c36cbcc	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	224	220.0	False	true	3E66FA38-0D87-47CA-A72D-63C0619A2182	1.9	a9430dc8-38cf-4ef1-8442-e20582f6d893	0.17	23	released	19ced2a8-a358-4044-9b83-51506251f513	RNA	R	0.17	UV Spec	released	False	6765da14-7335-416b-8964-b4200e7328b6	11	0.0	0.0	10.0	0.0	0.0	30.0	60.0	70.0	TOP	df6d6feb-bd09-4617-b95d-f8a0eab161b9	released																				released	30.0	2004ff38-a2bf-43be-8b72-b2994a53d890	Primary Tumor	01	released	Not Reported	released	TCGA-PG-A916_demographic	70	-25617		1b1c4e7b-2386-52da-929c-fc293a8cbad3	not hispanic or latino	female	black or african american	released	Alive	1943		TCGA-PG-A916_exposure	Not Reported		e81de8a8-6aa3-5bc9-b9e1-430bb5133be2		released		TCGA-PG-A916_diagnosis	25617	not reported	0	522	09927097-08c2-5dde-b4c6-4e05005aca23	Stage I	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2013	TCGA-PG-A916_treatment_1	TCGA-PG-A916_treatment	released	c134329d-eccc-568c-b3de-2453a1c6b0fb	no	Pharmaceutical Therapy, NOS	released	f2410677-ed5a-5ee7-8abf-9cdebe514bdb	no	Radiation Therapy, NOS	d10d071f-a21e-4fb9-b5f8-6850f2aca3e9
d06425f6-4ae5-4225-9ec3-0aa196c7885b.htseq.counts.gz	f7e1ef02-01b8-4d01-9f57-0a36c430603b	TCGA-BS-A0U9-01B-21R-A10J-07	TCGA-BS-A0U9-01B-21R	TCGA-BS-A0U9-01B-02-BSB	TCGA-BS-A0U9-01B-02-TSB		TCGA-BS-A0U9-01B-21	TCGA-BS-A0U9-01B	TCGA-BS-A0U9	5ffa2ec6-2d94-4b09-8fb9-3591cf38fa4f	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1637	430.0	False	false	029B0BBB-D88D-4492-AC9A-9094E0DD101C	1.79	b280c179-336d-4638-9309-0f51426f8054	0.15	23	released	4092809f-5005-4f5d-a3a1-52fea1c5c013	RNA	R	0.15	UV Spec	released	False	1ac8b701-420f-4291-979e-03715687d2c9	21	2.0	0.0	15.0	1.0	0.0	5.0	80.0	80.0	BOTTOM	850f5696-2fc8-4b63-be9d-dbdda77c3832	released	1.0	0.0	15.0	1.0	0.0	5.0	80.0	80.0	TOP	32ac844b-05c9-4a3d-b869-0e8a1f6362f5	released									released	30.0	99d6d536-af2c-4c9b-9995-5b4032d54479	Primary Tumor	01	released	Not Reported	released	TCGA-BS-A0U9_demographic	59	-21580		adc48981-fe38-5f10-b8d5-97a058523a5c	not hispanic or latino	female	native hawaiian or other pacific islander	released	Alive	1947		TCGA-BS-A0U9_exposure	Not Reported	34.2560553633218	fd0dab78-5e36-5e45-b3a7-94119c0bfb49	170.0	released	99.0	TCGA-BS-A0U9_diagnosis	21580	not reported	0	2825	97a94aa4-98f6-51d5-8f84-f33325cc9d45	Stage IIA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2006	TCGA-BS-A0U9_treatment_1	TCGA-BS-A0U9_treatment	released	f2520e60-1d61-5237-8c65-030326d0763d	no	Pharmaceutical Therapy, NOS	released	c983df28-1815-5382-8e67-b3967b6032c3	no	Radiation Therapy, NOS	f7e1ef02-01b8-4d01-9f57-0a36c430603b
f35f13c4-f12e-4a05-893a-8e70afb392b1.htseq.counts.gz	78e303d3-b61c-464b-8e39-82c56185e7c2	TCGA-BG-A0VZ-01A-11R-A109-07	TCGA-BG-A0VZ-01A-11R	TCGA-BG-A0VZ-01A-01-TS1	TCGA-BG-A0VZ-01A-01-BS1		TCGA-BG-A0VZ-01A-11	TCGA-BG-A0VZ-01A	TCGA-BG-A0VZ	edee2bf5-284c-4d77-823a-d037fe4c4b9e	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	876	70.0	False	true	6CCCA758-AB3D-4260-BD25-16716E34B3BB	1.88	740f4c64-0bc1-4691-8b37-7830ae67a080	0.17	23	released	b93c0eb5-f433-4b54-b5ec-fe7f416e4ce7	RNA	R	0.17	UV Spec	released	False	f801a9e3-7602-410e-a43e-5828473350b5	11	40.0	20.0	5.0	30.0	0.0	25.0	70.0	70.0	TOP	52f27067-10d6-40ae-b56c-997e9c1f9a7c	released	40.0	20.0	0.0	30.0	10.0	20.0	70.0	70.0	BOTTOM	b0824090-6d45-4266-8e2c-e66247cb08a8	released									released	30.0	fa28a6f2-c6d2-4cf1-8026-fed92675bdb9	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A0VZ_demographic	58	-21414		5671514e-c9d4-5f07-b12a-568226f20275	not hispanic or latino	female	white	released	Alive	1950		TCGA-BG-A0VZ_exposure	Not Reported	40.03673094582185	6617679b-2d4e-5f02-8ce7-4968d177c1fb	165.0	released	109.0	TCGA-BG-A0VZ_diagnosis	21414	not reported	0	1601	c803212c-f333-587d-97fe-c2c670473010	Stage IIIA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-BG-A0VZ_treatment_1	TCGA-BG-A0VZ_treatment	released	783cb635-dec3-5650-bb1a-53bc90e6ba8d	yes	Pharmaceutical Therapy, NOS	released	a2c944f8-8d9b-5965-b09f-a309743498d3	no	Radiation Therapy, NOS	78e303d3-b61c-464b-8e39-82c56185e7c2
e40a49a6-a4e9-4552-b78b-27c85d95c1a7.htseq.counts.gz	7d0c1f0a-20bb-405d-b063-e7b80e0bc8ce	TCGA-BG-A0M9-01A-21R-A104-07	TCGA-BG-A0M9-01A-21R	TCGA-BG-A0M9-01A-02-TSB	TCGA-BG-A0M9-01A-02-BSB		TCGA-BG-A0M9-01A-21	TCGA-BG-A0M9-01A	TCGA-BG-A0M9	4fd1cb59-6c50-4355-9d37-a341e1f4fad9	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	772	220.0	False	true	08D832C7-9B5F-4B6E-9C3E-2F3E58305016	1.9	55874b54-441d-4a28-b2a7-a90e96774ff9	0.15	23	released	f4381423-da7b-4245-911d-292a1e625faa	RNA	R	0.15	UV Spec	released	False	e90d4fcf-df50-490c-8494-fc0caa03d014	21	0.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	TOP	e99c7a7d-bf1a-4242-a5e7-15089c716edc	released	0.0	0.0	0.0	0.0	0.0	0.0	100.0	90.0	BOTTOM	0de4bd1e-fc47-4f35-aa76-9f0f59541d3e	released									released	30.0	dc487bbf-555b-423b-b7c0-3e92defa5a79	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A0M9_demographic	73	-26708		d762555b-0370-5081-905f-16fa84728790	not hispanic or latino	female	white	released	Alive	1935		TCGA-BG-A0M9_exposure	Not Reported	36.328125	882e92e8-5f94-5ac4-9613-8d69716795aa	160.0	released	93.0	TCGA-BG-A0M9_diagnosis	26708	not reported	0	2270	9f5c213e-be1c-526f-9212-a644cca7a5f4	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-BG-A0M9_treatment_1	TCGA-BG-A0M9_treatment	released	9b48b27e-354d-5d7a-b783-f8c4eb849353	no	Pharmaceutical Therapy, NOS	released	032c27f3-c02c-5276-9bba-8ef0c0c4b394	no	Radiation Therapy, NOS	7d0c1f0a-20bb-405d-b063-e7b80e0bc8ce
b0dabbd2-835b-4e75-bff2-0041db336d1b.htseq.counts.gz	d61726fd-77c7-4a83-8d8b-dbe6b119ab49	TCGA-AP-A0LM-01A-11R-A118-07	TCGA-AP-A0LM-01A-11R	TCGA-AP-A0LM-01A-01-BSA	TCGA-AP-A0LM-01A-01-TSA		TCGA-AP-A0LM-01A-11	TCGA-AP-A0LM-01A	TCGA-AP-A0LM	43e228ae-c890-444f-afbd-49385562e33a	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	2019	200.0	False	true	BF380986-0279-41FC-AAE8-BA9772456CE6	1.82	db91880d-1e53-4852-8a94-dd40e2b9aa6c	0.16	23	released	12fb0d32-1a6b-4f76-8a5d-74a7c7da984c	RNA	R	0.16	UV Spec	released	False	b7657997-7eda-4c56-95cd-386a89b6763a	11	0.0	0.0	0.0	0.0	60.0	0.0	40.0	30.0	BOTTOM	613751dc-6a2c-4487-b7da-fc8a0edf1a92	released	0.0	0.0	0.0	0.0	15.0	0.0	85.0	65.0	TOP	a7efc08a-f1a1-47bf-b3e8-c3d179058b3c	released									released	30.0	c8ab800a-ec4d-4a1c-bccf-8e17f7976978	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A0LM_demographic	33	-12309		be5b9e06-57b9-58e8-b0f2-c984c40219a7	not reported	female	black or african american	released	Alive	1971		TCGA-AP-A0LM_exposure	Not Reported	36.28973726230222	a2d5fcc4-5b76-5dab-aa2c-1e7067a1c5ff	166.0	released	100.0	TCGA-AP-A0LM_diagnosis	12309	not reported	0	825	9fb6fe5c-fc24-57b1-90fb-68128caf82bc	Stage IIIC2	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2004	TCGA-AP-A0LM_treatment	TCGA-AP-A0LM_treatment_1	released	fbc51e68-0315-5a79-9663-7e6c6be0dabd	yes	Radiation Therapy, NOS	released	69a69e40-5118-53d8-8636-bd3d7fc1b5df	yes	Pharmaceutical Therapy, NOS	d61726fd-77c7-4a83-8d8b-dbe6b119ab49
991941ca-9361-4727-831d-2454121ffde4.htseq.counts.gz	49685454-f6c2-4820-ab01-3739fbc612c5	TCGA-A5-A0GU-01A-11R-A16W-07	TCGA-A5-A0GU-01A-11R	TCGA-A5-A0GU-01A-01-TS1	TCGA-A5-A0GU-01A-01-MS1		TCGA-A5-A0GU-01A-11	TCGA-A5-A0GU-01A	TCGA-A5-A0GU	adc22472-e31d-419f-aeae-cb01b9423343	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	471	190.0	False	true	B284E409-4AC1-45E5-9133-39659987D7F9	1.85	95ea81fa-025d-4338-94db-ec7024562d8f	0.14	23	released	adc0e204-cf17-4e26-89b2-53e3886e6dd1	RNA	R	0.14	UV Spec	released	False	1342abbf-84bb-4c59-b8e2-df49f307d900	11	25.0	20.0	10.0	20.0	0.0	30.0	60.0	70.0	TOP	f44447b5-e30f-42a5-8221-e55d35666d48	released	4.0	3.0	10.0	1.0	0.0	8.0	82.0	90.0	BOTTOM	af20265b-8332-42ea-b34c-3373bfbb6ed9	released									released	30.0	074d4466-e072-42cd-9a6c-a595dc9363e7	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A0GU_demographic	58	-21192		33d6af45-80b9-546f-a040-7441d66a34d7	not reported	female	white	released	Alive	1951		TCGA-A5-A0GU_exposure	Not Reported	37.109375	da9439f1-81da-56a7-be45-69bfaae2b48e	160.0	released	95.0	TCGA-A5-A0GU_diagnosis	21192	not reported	0	860	ac66ac8a-c4c4-5b6b-8b90-daf06b5f6af7	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-A5-A0GU_treatment	TCGA-A5-A0GU_treatment_1	released	a8734643-9e1d-5435-8295-b23b0ece4ff1	no	Radiation Therapy, NOS	released	125e20f3-d3d5-536b-8d55-e3ff461b486c	no	Pharmaceutical Therapy, NOS	49685454-f6c2-4820-ab01-3739fbc612c5
6a970473-23a4-4b3a-b225-5adf592fbae8.htseq.counts.gz	e80be44c-36d8-47b9-98c4-c93d52b4535a	TCGA-EY-A1GR-01A-11R-A13S-07	TCGA-EY-A1GR-01A-11R	TCGA-EY-A1GR-01A-01-TSA			TCGA-EY-A1GR-01A-11	TCGA-EY-A1GR-01A	TCGA-EY-A1GR	70cdb758-26c9-4c11-a495-0c31cbc84949	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	263	410.0	False	false	1C53C957-1A0A-46AF-A53B-0287683D52F6	1.8	64b366d1-dfb2-4488-9fd1-e6b26998bb9d	0.16	23	released	9f7bad46-bc95-4028-9ab4-96c89f0435b4	RNA	R	0.16	UV Spec	released	False	8b2737ab-0fd1-4cc4-9c85-c53eff3fcf13	11	20.0	20.0	15.0	40.0	0.0	5.0	80.0	80.0	TOP	55471289-016f-41e6-a80a-9ef9a4948679	released																				released	30.0	1c1d49ed-4dea-4fd0-9952-393470502e81	Primary Tumor	01	released	Not Reported	released	TCGA-EY-A1GR_demographic	67	-24784		eb77bd79-bd4a-5ef4-a359-c918b069e1a3	not hispanic or latino	female	black or african american	released	Alive	1943		TCGA-EY-A1GR_exposure	Not Reported	34.15977961432507	3d762321-0bd7-5d90-89e5-c40873c5ba9f	165.0	released	93.0	TCGA-EY-A1GR_diagnosis	24784	not reported	0	536	47653fc8-6a4d-5033-aa3d-abf73d9340a4	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-EY-A1GR_treatment	TCGA-EY-A1GR_treatment_1	released	3c2a2349-2808-5e89-92d7-101c61829ba2	no	Radiation Therapy, NOS	released	9c88ae47-62a1-5eaf-89c6-2d353ab15c79	no	Pharmaceutical Therapy, NOS	e80be44c-36d8-47b9-98c4-c93d52b4535a
ee78a147-24c8-4487-a112-b46974641796.htseq.counts.gz	65f4deae-24b3-4203-86ba-2df85bee8c19	TCGA-AX-A0IW-01A-11R-A040-07	TCGA-AX-A0IW-01A-11R	TCGA-AX-A0IW-01A-01-BSA	TCGA-AX-A0IW-01A-01-TSA		TCGA-AX-A0IW-01A-11	TCGA-AX-A0IW-01A	TCGA-AX-A0IW	db21fccf-40cb-4235-a34d-336a03b8c8f4	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	854	190.0	False	false	DE971C2D-31E8-42AC-A943-29E76FCD8F68	1.85	60bb00e3-9ac9-4c61-bb38-b85b27bff865	0.16	23	released	1e0aac91-e3ec-405f-8a1b-638255e5f02d	RNA	R	0.16	UV Spec	released	False	e7082b6b-de6e-4675-b255-0f153055a596	11	0.0	0.0	5.0	0.0	0.0	5.0	90.0	95.0	BOTTOM	335d64f4-dc2d-4f86-9aef-458707175d39	released	15.0	0.0	5.0	0.0	0.0	25.0	70.0	75.0	TOP	8520b124-6364-434c-ad6e-725bf7b20ed1	released									released	30.0	874a1c5c-229b-4bce-b612-55eff238d533	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A0IW_demographic	67	-24488		c3177194-2df1-5361-a8c2-9a181bc27742	not hispanic or latino	female	white	released	Alive	1941		TCGA-AX-A0IW_exposure	Not Reported	22.959087658549436	b8e04e16-6bb3-5e78-9d80-aab67b3d1b71	163.0	released	61.0	TCGA-AX-A0IW_diagnosis	24488	not reported	0	1149	0bbc5122-2673-5345-9e8f-9129e7abfd59	Stage IIIA	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-AX-A0IW_treatment	TCGA-AX-A0IW_treatment_1	released	7fee2d3c-3619-51b0-8c3a-a734219ca77e	no	Radiation Therapy, NOS	released	ee423f00-bfe4-5830-87a7-c05f85ecef5d	yes	Pharmaceutical Therapy, NOS	65f4deae-24b3-4203-86ba-2df85bee8c19
4a242363-7c51-4e35-9892-1a0d944c7b47.htseq.counts.gz	cda2d2ea-328a-4157-bbfd-9510cc5fbd79	TCGA-BG-A0M2-01A-11R-A104-07	TCGA-BG-A0M2-01A-11R	TCGA-BG-A0M2-01A-01-BSA	TCGA-BG-A0M2-01A-01-TSA		TCGA-BG-A0M2-01A-11	TCGA-BG-A0M2-01A	TCGA-BG-A0M2	9731e0b3-c62d-43cb-8ae7-8f973d69ab19	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	185	510.0	False	true	A0087300-81E9-4733-8497-95E0F95575B4	1.81	4487eb24-a67d-4406-9a1f-b2c2fde39787	0.14	23	released	63041125-20e3-49d6-a1e9-7899fc2367e1	RNA	R	0.14	UV Spec	released	False	a069f5a0-84c7-43ad-8294-0c7c5ca6b85f	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	90.0	BOTTOM	811f4cc3-8e9d-4375-8dc0-0b328866e3d9	released	0.0	0.0	1.0	0.0	0.0	2.0	97.0	90.0	TOP	4551b683-c871-4a60-bdcf-d8ca86e7ddea	released									released	30.0	2af18345-2a71-4574-ac8e-83ddeed3ad57	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A0M2_demographic	62	-22822		e46162a7-b38d-5473-ba17-81b4e62c5c17	not hispanic or latino	female	white	released	Alive	1947		TCGA-BG-A0M2_exposure	Not Reported	26.927437641723355	23ddc56a-99e1-5b23-96d9-e002d7796205	168.0	released	76.0	TCGA-BG-A0M2_diagnosis	22822	not reported	0	637	be22f33f-6622-5a48-842b-2176fd309799	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-BG-A0M2_treatment	TCGA-BG-A0M2_treatment_1	released	9fc5b4dd-f556-55a2-adb3-a32ab6ee1233	yes	Radiation Therapy, NOS	released	6d321b91-5942-5738-9da3-b38aa763c3d8	no	Pharmaceutical Therapy, NOS	cda2d2ea-328a-4157-bbfd-9510cc5fbd79
1b114329-8e22-4cc4-a452-94a41f329bdf.htseq.counts.gz	77829d42-0d17-4bb3-945b-5c0e24a667b0	TCGA-AX-A1CI-01A-11R-A137-07	TCGA-AX-A1CI-01A-11R	TCGA-AX-A1CI-01A-01-TS1			TCGA-AX-A1CI-01A-11	TCGA-AX-A1CI-01A	TCGA-AX-A1CI	fba80122-d8b2-4d8d-a032-9767e8160f9f	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	2222	120.0	False	false	7F264403-0A76-4FAD-9A57-7C555F69375C	1.88	e54b7e44-82a3-4016-bc32-129799097b4c	0.15	23	released	ec675afa-2a7d-4bc7-93b0-c2ec6084cfdb	RNA	R	0.15	UV Spec	released	False	2016eca2-b9bb-4661-ba59-dbf0b287a428	11	2.0	0.0	1.0	0.0	3.0	3.0	93.0	95.0	TOP	3f21d211-56f5-4cca-8d9c-1d28adcfd7b5	released																				released	30.0	ddd2f9e0-0aa3-425b-9d74-74fcc638cb08	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A1CI_demographic	61	-22582		0cbd2001-5067-5109-838d-3c053cfcfa55	not hispanic or latino	female	white	released	Alive	1943		TCGA-AX-A1CI_exposure	Not Reported	27.51338488994646	15d6814f-19e0-5150-832d-700a652dde62	164.0	released	74.0	TCGA-AX-A1CI_diagnosis	22582	not reported	0	2600	d475ef4a-37c4-5638-88da-84f422483574	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2004	TCGA-AX-A1CI_treatment	TCGA-AX-A1CI_treatment_1	released	a69ff0d7-1ba1-51d6-9d28-de1cf44521a9	no	Radiation Therapy, NOS	released	1f9b8368-d0f0-5fd1-8a3f-04bbd166956c	no	Pharmaceutical Therapy, NOS	77829d42-0d17-4bb3-945b-5c0e24a667b0
9d069f52-1dbe-424a-b1f9-d88ce964c93e.htseq.counts.gz	0885b86b-69c0-4e85-a491-30d6f9534ff7	TCGA-EO-A3KX-01A-11R-A22K-07	TCGA-EO-A3KX-01A-11R	TCGA-EO-A3KX-01A-01-TSA			TCGA-EO-A3KX-01A-11	TCGA-EO-A3KX-01A	TCGA-EO-A3KX	fe2e89f7-8f4d-420a-a551-4877cf0fd1d3	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	184	150.0	False	false	BB1CD473-0D98-414E-801B-09037E1BF43E	1.83	babc3b9e-a99f-490b-a277-ab4e6f6b5449	0.17	23	released	dcf679f4-d7c2-4864-b93c-e8f148977939	RNA	R	0.17	UV Spec	released	False	8efe4a96-ee7b-43f0-b0c2-3c133bc357f3	11	1.0	1.0	15.0	0.0	0.0	0.0	85.0	95.0	TOP	3ced1ad2-8680-4d52-b4cc-d214c0fff6be	released																				released	30.0	a5cae971-eeb4-4a9e-afec-01814eab967e	Primary Tumor	01	released	Not Reported	released	TCGA-EO-A3KX_demographic	80	-29260		4bed5f1e-e85b-5763-bb8b-ea0029cf902d	hispanic or latino	female	white	released	Alive	1931		TCGA-EO-A3KX_exposure	Not Reported	20.92746730083234	583b0991-387a-5240-9631-155188524e6a	145.0	released	44.0	TCGA-EO-A3KX_diagnosis	29260	not reported	0	1170	413ae3c1-4e94-59f1-b639-f1c2a0b21c74	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-EO-A3KX_treatment	TCGA-EO-A3KX_treatment_1	released	a3f5b14c-0c42-59d0-8f57-64c6b0f72033	yes	Radiation Therapy, NOS	released	206479ba-2dc2-50b8-a8bb-3aa3f72065e8	no	Pharmaceutical Therapy, NOS	0885b86b-69c0-4e85-a491-30d6f9534ff7
3e1a02f1-6a15-44d9-b974-be537d0f4ad8.htseq.counts.gz	a474dcfe-8a7d-4848-8cc1-20551944308a	TCGA-AJ-A3EM-01A-11R-A213-07	TCGA-AJ-A3EM-01A-11R	TCGA-AJ-A3EM-01A-01-TS1			TCGA-AJ-A3EM-01A-11	TCGA-AJ-A3EM-01A	TCGA-AJ-A3EM	c856e031-bbd0-431f-b44f-b3ad9b39af7b	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	296	9.0	False	false	E5CE38FD-DB53-49D9-92B3-BA075BDDC5CF	1.85	4835dbe5-983f-458a-91d2-8e1d754259c3	0.15	23	released	fe1b1a44-c385-448a-8d2f-b58b0e60e172	RNA	R	0.15	UV Spec	released	False	12209cb2-44d1-4802-9f1d-f26e073b2995	11	0.0	0.0	20.0	0.0	0.0	5.0	75.0	80.0	TOP	4d36461a-2a3f-48be-9f4f-6875ff623bc3	released																				released	10.0	7dc99437-730f-44f3-88e8-ea6d7e9dbcc1	Primary Tumor	01	released	Not Reported	released	TCGA-AJ-A3EM_demographic	69	-25557		93778d19-dd7a-5e27-8b67-4fba294de047	not reported	female	white	released	Alive	1942		TCGA-AJ-A3EM_exposure	Not Reported	30.119375573921026	82871e59-7d9f-5d51-9047-73fc4ea7c86f	165.0	released	82.0	TCGA-AJ-A3EM_diagnosis	25557	not reported	0	677	701ef023-6d22-59d1-8dd7-d94dc341ee5a	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-AJ-A3EM_treatment_1	TCGA-AJ-A3EM_treatment	released	987ea90d-65b9-50f5-a739-667231a027d5	no	Pharmaceutical Therapy, NOS	released	4ad72b2f-f4ce-537b-a4fa-23b78f5f0992	no	Radiation Therapy, NOS	a474dcfe-8a7d-4848-8cc1-20551944308a
eae8f6bd-f4f2-4c48-a828-21efa4afbf7f.htseq.counts.gz	d6520311-d044-4004-b437-d4d508e47b1d	TCGA-AJ-A3NG-01A-11R-A22K-07	TCGA-AJ-A3NG-01A-11R	TCGA-AJ-A3NG-01A-01-TSA			TCGA-AJ-A3NG-01A-11	TCGA-AJ-A3NG-01A	TCGA-AJ-A3NG	1addcd66-79ab-4976-9679-37f0f31ba1df	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	101	150.0	False	false	32C3C850-5F65-424E-894C-75B4725BBD09	1.82	3bf26a40-da0a-4b9f-9c8d-ef307c8f239b	0.17	23	released	b24a8000-0fba-4c37-b705-75111e71d869	RNA	R	0.17	UV Spec	released	False	8289fdeb-b266-4281-a76b-569ff9141412	11	2.0	0.0	2.0	1.0	13.0	0.0	85.0	90.0	TOP	0a07456b-9eb8-4030-877b-bcc241ffb5b5	released																				released	30.0	c19de866-bec5-4ce7-9d50-883fec094838	Primary Tumor	01	released	Not Reported	released	TCGA-AJ-A3NG_demographic	83	-30351		2c8a958c-50b3-5c17-ad90-42e58160c400	not hispanic or latino	female	white	released	Alive	1928		TCGA-AJ-A3NG_exposure	Not Reported	38.70967741935483	ffb0023e-aa65-5492-b74a-15015d4bcb5a	155.0	released	93.0	TCGA-AJ-A3NG_diagnosis	30351	not reported	0	475	0f62a787-347f-5b47-b491-0d3bd876229e	Stage II	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-AJ-A3NG_treatment	TCGA-AJ-A3NG_treatment_1	released	1d73f60c-5dd4-5d8c-a79d-9ec14b486e78	yes	Radiation Therapy, NOS	released	51e10d11-d571-5c7e-8c20-4e979e44bb94	no	Pharmaceutical Therapy, NOS	d6520311-d044-4004-b437-d4d508e47b1d
eab25d32-0d61-4ddf-9b9f-5f3a592d6f31.htseq.counts.gz	71028464-8ac9-4084-a4fe-0459e8727499	TCGA-A5-A7WK-01A-11R-A34R-07	TCGA-A5-A7WK-01A-11R	TCGA-A5-A7WK-01A-01-TSA			TCGA-A5-A7WK-01A-11	TCGA-A5-A7WK-01A	TCGA-A5-A7WK	ded408ee-053a-43ed-9bcf-1d15cd203051	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	253	160.0	False	true	9101DD17-9216-4526-9A87-8C4E94B1F435	1.76	e2c72ce3-f010-4f7f-832b-6277b8409f87	0.16	23	released	9e3be584-e51b-49e1-ba99-c959a5f87177	RNA	R	0.16	UV Spec	released	False	35f117f3-2b18-479c-b4a1-5892179ba1dd	11	40.0	20.0	10.0	20.0	0.0	10.0	80.0	80.0	TOP	2fd5bb02-8ebc-44be-9086-42b1b5df3851	released																				released	30.0	69c891f3-536d-4cb8-bbd4-a387534c1283	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A7WK_demographic	71	-26044		24d1e0d9-dcac-5e22-be01-d00d6ccbf4ad	not hispanic or latino	female	black or african american	released	Alive	1942		TCGA-A5-A7WK_exposure	Not Reported	34.36791383219955	381721e9-7ddb-50ce-89c7-b7cd2316be11	168.0	released	97.0	TCGA-A5-A7WK_diagnosis	26044	not reported	0	560	ec380795-f14e-5b6a-bf51-f17431ec8566	Stage IA	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2013	TCGA-A5-A7WK_treatment_1	TCGA-A5-A7WK_treatment	released	7da59e80-2907-55af-b71d-1d08c6f2fb06	yes	Pharmaceutical Therapy, NOS	released	78db435b-9f3c-537a-98b3-7a59b1a25697	no	Radiation Therapy, NOS	71028464-8ac9-4084-a4fe-0459e8727499
4c3fe147-3214-49de-b0ea-6b76670d1f28.htseq.counts.gz	ea1e7cb0-91ce-4184-8b83-36749ac2e41b	TCGA-B5-A0K2-01A-12R-A104-07	TCGA-B5-A0K2-01A-12R	TCGA-B5-A0K2-01A-01-BS1	TCGA-B5-A0K2-01A-01-TS1		TCGA-B5-A0K2-01A-12	TCGA-B5-A0K2-01A	TCGA-B5-A0K2	a8079ea5-c37b-4f77-aca0-b043bf420675	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	534	270.0	False	true	5D780459-F4E6-4BB8-939D-5FDFD9BF7073	1.79	c30924bd-cb0b-43ee-832e-1b470ec39d21	0.15	23	released	381a446a-c911-4f1c-bbb8-2aa35e688fdc	RNA	R	0.15	UV Spec	released	False	0713ffc5-ae56-4661-be30-78c3eb7c4d60	12	0.0	0.0	0.0	0.0	0.0	0.0	100.0	75.0	BOTTOM	cc6ea95a-e461-4e34-ab1b-d3fc81614c96	released	0.0	0.0	0.0	0.0	0.0	0.0	100.0	90.0	TOP	810ef419-1871-4afb-ae27-f5533c377a4a	released									released	30.0	17122498-71c0-4094-a86e-863da3116463	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A0K2_demographic	54	-20080		8edb6f51-93e3-5ff9-88f6-e970cb486bb6	not reported	female	white	released	Alive	1954		TCGA-B5-A0K2_exposure	Not Reported	33.22653376053162	d420e1e5-a13a-5011-8450-e23c06dc8a65	159.0	released	84.0	TCGA-B5-A0K2_diagnosis	20080	not reported	0	2209	3b479bf2-eb91-5790-bda7-bf6c64a89476	Stage IIIA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-B5-A0K2_treatment_1	TCGA-B5-A0K2_treatment	released	a71ac3d7-b3a9-5cac-81e0-461a1eb4cd4c	yes	Pharmaceutical Therapy, NOS	released	1e1191a3-0b25-5019-82c7-0b995e1ccd88	no	Radiation Therapy, NOS	ea1e7cb0-91ce-4184-8b83-36749ac2e41b
26a30920-d41b-4400-ae17-a6d290ccbf76.htseq.counts.gz	d95877b3-4569-449c-8979-cbdd8d103dbc	TCGA-BG-A0MI-01A-11R-A040-07	TCGA-BG-A0MI-01A-11R	TCGA-BG-A0MI-01A-01-TSA	TCGA-BG-A0MI-01A-01-BSA		TCGA-BG-A0MI-01A-11	TCGA-BG-A0MI-01A	TCGA-BG-A0MI	b8588e0f-aad6-4ded-845e-3cff67a48d8f	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1014	100.0	False	true	1A0F6DD8-22A2-4A00-8AAD-04710DBBDFED	2.05	c199bab3-c6e3-4123-811c-2c50e8d44fae	0.13	23	released	f869c047-4aaf-49bd-9b39-4a213396c321	RNA	R	0.13	UV Spec	released	False	d0fa4ea2-7ca9-4bf0-96a1-ca6b08eee49a	11	5.0	2.0	10.0	1.0	0.0	15.0	75.0	85.0	TOP	53f3aeb0-fd8e-45af-a669-3ffab0acaece	released	5.0	2.0	12.0	1.0	0.0	8.0	80.0	88.0	BOTTOM	aa4484c2-ec55-4801-aea2-06f2b378dfcb	released									released	30.0	f030dae4-bd6f-4d0d-96e0-12b299057338	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A0MI_demographic	83	-30334	714	0fb4bc67-19f3-5554-b4f5-9cdc29776597	not hispanic or latino	female	white	released	Dead	1924	2008	TCGA-BG-A0MI_exposure	Not Reported	37.09825528007346	7f4d8eec-0390-502c-b7d9-ef6a77b60acb	165.0	released	101.0	TCGA-BG-A0MI_diagnosis	30334	not reported	0		0269ec13-6288-5b21-91f1-82f13a57ecd0	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2007	TCGA-BG-A0MI_treatment	TCGA-BG-A0MI_treatment_1	released	6122e669-a6d0-5f9b-89ab-8a52e1128891	no	Radiation Therapy, NOS	released	b5283fc0-84d1-5672-a8b8-acb3714e2413	no	Pharmaceutical Therapy, NOS	d95877b3-4569-449c-8979-cbdd8d103dbc
19229bc0-4bc2-44e8-a961-bd1eefe354de.htseq.counts.gz	f45e8c1e-eb45-4590-b057-c53d752d16e5	TCGA-BG-A18C-01A-11R-A12I-07	TCGA-BG-A18C-01A-11R	TCGA-BG-A18C-01A-01-TSA			TCGA-BG-A18C-01A-11	TCGA-BG-A18C-01A	TCGA-BG-A18C	66e305ca-8a16-44f0-b837-85e529b7ad55	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	52	340.0	False	true	2A6FB6E4-7FBF-45EA-B9B0-C4EDC78C35E2	1.86	484a9564-c6dd-4e54-a319-4d826f308d0c	0.16	23	released	11f5459c-6547-4523-92c6-e1ba313e27c6	RNA	R	0.16	UV Spec	released	False	7906ba08-9b47-4c46-85fe-69658c62b8ff	11	40.0	20.0	10.0	20.0	0.0	30.0	60.0	60.0	TOP	348cd7f6-57aa-40f6-b260-7ef53ff0f6bd	released																				released	30.0	37f209b1-c738-441c-b205-eaec4e2ade4e	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A18C_demographic	72	-26602		06e72bfd-79e9-5aa2-a14c-1c4bb7c4bd57	not hispanic or latino	female	white	released	Alive	1938		TCGA-BG-A18C_exposure	Not Reported	36.13233467574993	049ab97f-2226-57cc-b573-d154419bd09f	163.0	released	96.0	TCGA-BG-A18C_diagnosis	26602	not reported	0	470	8337ee7b-e16c-5f14-93f5-f8730b9788c5	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-BG-A18C_treatment	TCGA-BG-A18C_treatment_1	released	5b32ad9a-4607-583b-b0ae-f7534c108f8f	no	Radiation Therapy, NOS	released	5c3ca4e3-9a2f-57c2-9408-1a4671d6e938	no	Pharmaceutical Therapy, NOS	f45e8c1e-eb45-4590-b057-c53d752d16e5
40076d7f-32c0-47b4-a701-159a2efc2f58.htseq.counts.gz	254b1240-5a44-4241-86b7-ee37a290163c	TCGA-AX-A05S-01A-11R-A00V-07	TCGA-AX-A05S-01A-11R	TCGA-AX-A05S-01A-01-BS1	TCGA-AX-A05S-01A-01-TS1		TCGA-AX-A05S-01A-11	TCGA-AX-A05S-01A	TCGA-AX-A05S	3a4a6aff-4720-41fc-a114-85f38610ebb1	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	507	230.0	False	false	571B1EC2-3698-4FF2-89DD-7C5A8A048660	1.86	f9533750-9b2f-44a2-8b4e-941fe0c53acb	0.15	23	released	9f3f895a-20e3-49c4-a0bc-fc7ddee8065c	RNA	R	0.15	UV Spec	released	False	6489b452-1e63-4d7a-9086-b904fa192e7e	11	1.0	0.0	10.0	1.0	25.0	0.0	65.0	70.0	BOTTOM	a40fd806-db5e-4b99-a0fa-d6f7bc9b98fc	released	14.0	0.0	1.0	0.0	14.0	0.0	85.0	80.0	TOP	ab708406-0c86-406d-a97b-a64defb00f99	released									released	30.0	3d8f263f-6866-4b92-aaee-743ec5514865	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A05S_demographic	81	-29928	413	6fcf1e15-6b38-500f-9d76-b481914a30cb	not hispanic or latino	female	white	released	Dead	1927	2009	TCGA-AX-A05S_exposure	Not Reported	20.775623268698062	b77e2ab2-0227-51af-877e-01dd6f888ba3	152.0	released	48.0	TCGA-AX-A05S_diagnosis	29928	not reported	0		40d99eb2-715c-55b0-a86d-61e61cb4232d	Stage IIIC	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-AX-A05S_treatment	TCGA-AX-A05S_treatment_1	released	66071faf-6cc8-5867-9e12-8dac95934630	yes	Radiation Therapy, NOS	released	1e7dd1b8-dd21-5337-a2b7-893227fec9c5	yes	Pharmaceutical Therapy, NOS	254b1240-5a44-4241-86b7-ee37a290163c
b32e5c14-4034-488c-995a-a65fe3ccf534.htseq.counts.gz	493c67aa-8f8e-4b7c-85d2-2b285adefbf1	TCGA-AX-A1CI-11A-11R-A137-07	TCGA-AX-A1CI-11A-11R	TCGA-AX-A1CI-11A-01-TS1			TCGA-AX-A1CI-11A-11	TCGA-AX-A1CI-11A	TCGA-AX-A1CI	fba80122-d8b2-4d8d-a032-9767e8160f9f	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	2222	100.0	False	false		1.92	ce5b0ba0-2777-4c92-ac50-483174cc5dca	0.15	23	released	ec3d1c05-d310-49b3-97cb-2135b19f3a0b	RNA	R	0.15	UV Spec	released	False	f4f727ea-a4e0-4c14-a1fe-538bdddf57b3	11					100.0		0.0		TOP	320f9fb9-dee6-4e2f-a4e3-272204f2e297	released																				released	30.0	cad6c89d-f722-470b-93bc-e8b24c033f0f	Solid Tissue Normal	11	released	Not Reported	released	TCGA-AX-A1CI_demographic	61	-22582		0cbd2001-5067-5109-838d-3c053cfcfa55	not hispanic or latino	female	white	released	Alive	1943		TCGA-AX-A1CI_exposure	Not Reported	27.51338488994646	15d6814f-19e0-5150-832d-700a652dde62	164.0	released	74.0	TCGA-AX-A1CI_diagnosis	22582	not reported	0	2600	d475ef4a-37c4-5638-88da-84f422483574	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2004	TCGA-AX-A1CI_treatment	TCGA-AX-A1CI_treatment_1	released	a69ff0d7-1ba1-51d6-9d28-de1cf44521a9	no	Radiation Therapy, NOS	released	1f9b8368-d0f0-5fd1-8a3f-04bbd166956c	no	Pharmaceutical Therapy, NOS	493c67aa-8f8e-4b7c-85d2-2b285adefbf1
19788d0b-9f48-4c02-9b5e-4c7c5b36cc2c.htseq.counts.gz	3b308124-f49c-4002-a199-704532cb5b7c	TCGA-BG-A0W2-01A-11R-A109-07	TCGA-BG-A0W2-01A-11R	TCGA-BG-A0W2-01A-01-BS1	TCGA-BG-A0W2-01A-01-TS1		TCGA-BG-A0W2-01A-11	TCGA-BG-A0W2-01A	TCGA-BG-A0W2	f47df5f9-7c60-4b1a-b574-7036245af341	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1073	80.0	False	true	D9BDB0FB-9205-4E41-9D7D-B12C206A608E	1.87	8f9d6b78-c294-4f11-99ea-dc834a7f1741	0.16	23	released	ef987b6b-60b7-4c58-b0ca-0b35f6ba4a5e	RNA	R	0.16	UV Spec	released	False	1b168c9c-efe9-4caa-8cee-80e88fc4dc14	11	40.0	20.0	5.0	30.0	5.0	20.0	70.0	70.0	BOTTOM	3467b566-fdcc-4f2e-89e2-359d6ec16402	released	40.0	10.0	5.0	30.0	10.0	15.0	70.0	70.0	TOP	8a1c072d-fa15-4895-beae-96d3dc7c1d39	released									released	30.0	0945d625-8d4b-4f5a-a863-a61dad5ecd34	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A0W2_demographic	57	-20998		215f190d-5fd9-57db-9461-d00abcfae4e0	not reported	female	white	released	Alive	1950		TCGA-BG-A0W2_exposure	Not Reported	44.44444444444444	cc9f2b0a-0a8f-5803-97d9-5d33d48abf70	165.0	released	121.0	TCGA-BG-A0W2_diagnosis	20998	not reported	0	1721	2e957e13-19ba-579d-a39a-d6a1fa3d990f	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2007	TCGA-BG-A0W2_treatment_1	TCGA-BG-A0W2_treatment	released	5b5345bb-7ddc-5847-96f9-a93cb5aca5c1	no	Pharmaceutical Therapy, NOS	released	378ea897-c35f-53f3-8fda-3de9b9394435	no	Radiation Therapy, NOS	3b308124-f49c-4002-a199-704532cb5b7c
a707063f-e0dd-4900-82d9-8ae77286c285.htseq.counts.gz	e0814a5e-592e-4107-ae47-a7f13a5477d4	TCGA-AP-A0LD-01A-11R-A040-07	TCGA-AP-A0LD-01A-11R	TCGA-AP-A0LD-01A-01-TS1	TCGA-AP-A0LD-01A-01-BS1		TCGA-AP-A0LD-01A-11	TCGA-AP-A0LD-01A	TCGA-AP-A0LD	1200c8b7-a058-4c01-bbe2-04ec09a65245	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	2993	230.0	False	true	10B9E917-C1FB-480D-9DB2-8E93FA446ADC	1.89	c094698b-0de5-4f14-9b3e-7f2deedde428	0.14	23	released	0a20a604-abcc-4a47-afb7-2b41ed85ba1a	RNA	R	0.14	UV Spec	released	False	8638c26b-ac27-4141-8230-142700670f81	11	10.0	0.0	10.0	10.0	10.0	0.0	80.0	90.0	TOP	cba345f3-ea2e-4abd-864f-1583023cea4a	released	10.0	0.0	10.0	10.0	10.0	0.0	80.0	90.0	BOTTOM	406a0fd7-3184-4191-a8b8-f707b02edb1b	released									released	30.0	649dadda-5823-4b0d-b5a2-49f501adc029	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A0LD_demographic	63	-23216		89dd9b5b-71a2-599c-b86a-9631ef174de5	not reported	female	white	released	Alive	1939		TCGA-AP-A0LD_exposure	Not Reported	27.23922448325589	0906c4b6-640a-5ac1-9849-aa0c90791233	158.0	released	68.0	TCGA-AP-A0LD_diagnosis	23216	not reported	0	3589	66cf797e-30dd-5bbf-9874-1af349475018	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2002	TCGA-AP-A0LD_treatment_1	TCGA-AP-A0LD_treatment	released	d22d5d18-7d63-51e9-aa3d-5153d5411a52	no	Pharmaceutical Therapy, NOS	released	edeaddd9-bddb-507f-9589-3733e7be4968	yes	Radiation Therapy, NOS	e0814a5e-592e-4107-ae47-a7f13a5477d4
cea60138-25ed-4914-83c6-1610e6cebb3b.htseq.counts.gz	34093224-059c-4f32-af19-2035410b40d0	TCGA-AX-A2HG-01A-11R-A17B-07	TCGA-AX-A2HG-01A-11R	TCGA-AX-A2HG-01A-01-TSA			TCGA-AX-A2HG-01A-11	TCGA-AX-A2HG-01A	TCGA-AX-A2HG	7a2cf5ce-8317-4fff-946e-b9937afab815	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	582	150.0	False	false	EF863B73-4C80-42E6-8AAF-2EF72559212A	2.04	8d2b2907-863e-4db9-8d4b-ce877e562531	0.15	23	released	5456e03f-0375-4687-8e35-807b15e2633b	RNA	R	0.15	UV Spec	released	False	42327e89-76ea-4bc3-95c0-52824b430b03	11	20.0	0.0	1.0	0.0	20.0	9.0	70.0	70.0	TOP	1ac91f9c-428f-4f10-9e9b-1cba4364cf9b	released																				released	30.0	5e3d8501-5e81-443f-8b64-e02a0e0b3d1f	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A2HG_demographic	56	-20771		3505f603-e5fb-5a9e-8824-99e97c974956	hispanic or latino	female	white	released	Alive	1953		TCGA-AX-A2HG_exposure	Not Reported	46.655036715485416	634e5fcb-f21d-50e4-8c7b-e396e082868e	157.0	released	115.0	TCGA-AX-A2HG_diagnosis	20771	not reported	0	1163	cb06baac-9e6b-5d41-984c-1ccfebb0f5b5	Stage IC	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-AX-A2HG_treatment_1	TCGA-AX-A2HG_treatment	released	d6284cbf-4f23-588e-ae4f-6c96a6307f2d	no	Pharmaceutical Therapy, NOS	released	be30cb19-8b77-5966-9d16-2acff402db61	yes	Radiation Therapy, NOS	34093224-059c-4f32-af19-2035410b40d0
b0605c35-5b44-4a32-9af2-7bf863d8da81.htseq.counts.gz	9b4a60a2-5cd8-4997-9da9-e035b3619654	TCGA-H5-A2HR-01A-11R-A180-07	TCGA-H5-A2HR-01A-11R	TCGA-H5-A2HR-01A-01-TSA			TCGA-H5-A2HR-01A-11	TCGA-H5-A2HR-01A	TCGA-H5-A2HR	fdb395e7-ff30-400d-861e-0cf2462ee390	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1627	110.0	False	false	3747A4AC-811E-49A1-8459-93807BB363C6	1.81	9ed0c69e-a7e6-4c99-8c93-541d7bde4be6	0.18	23	released	68ed8045-4d79-4c93-a3da-f5e58b6ba879	RNA	R	0.18	UV Spec	released	False	3143932f-34d3-49fa-8c6d-5067c0cfabb5	11	20.0	0.0	20.0	10.0	0.0	10.0	70.0	90.0	TOP	458630a5-6c71-4c5b-b7b0-674fe7842df0	released																				released	30.0	731428d0-5cc9-4e8d-a2be-e2e3d57745b7	Primary Tumor	01	released	Not Reported	released	TCGA-H5-A2HR_demographic	71	-25986		489ef6fd-7a84-59ac-966e-51af8f004b77	not hispanic or latino	female	black or african american	released	Alive	1935		TCGA-H5-A2HR_exposure	Not Reported		52b28882-b157-50e8-8013-bebdc39b6912		released	95.0	TCGA-H5-A2HR_diagnosis	25986	not reported	0	53	6fc44a29-6ceb-53af-90e4-ae25365a33e0	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2006	TCGA-H5-A2HR_treatment	TCGA-H5-A2HR_treatment_1	released	f499d198-0fcd-5570-8409-f9d0707c2205	not reported	Radiation Therapy, NOS	released	f42dee54-3a30-5cee-95ce-a39707542863	not reported	Pharmaceutical Therapy, NOS	9b4a60a2-5cd8-4997-9da9-e035b3619654
392eda3e-b663-495c-9c57-a6b4eb3e803c.htseq.counts.gz	d26929d2-fd44-4f29-b950-464bcf71bb9b	TCGA-D1-A169-01A-11R-A12I-07	TCGA-D1-A169-01A-11R	TCGA-D1-A169-01A-01-TS1			TCGA-D1-A169-01A-11	TCGA-D1-A169-01A	TCGA-D1-A169	9a599f57-0e8d-4e1f-a181-791f5fdeadb7	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	800	180.0	False	false	F7B4C0DC-2259-4A0A-81D3-E145EFA91279	1.83	7a487d4e-9e11-4adc-86a1-cf6a7bde4f67	0.16	23	released	191032f1-b4a7-4cf5-b7c1-df53d0d39278	RNA	R	0.16	UV Spec	released	False	6f3936d6-069a-4fdd-9595-6028f9857de7	11	4.0	6.0	20.0	2.0	0.0	30.0	50.0	70.0	TOP	9764e8c0-c8a3-4d29-b8a2-44beaf1a2734	released																				released	30.0	9b36f264-55c3-4e08-a151-4b356871520c	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A169_demographic	63	-23238		32f9bc7f-6bbe-55fb-8c70-28e7cd114d27	not hispanic or latino	female	white	released	Alive	1945		TCGA-D1-A169_exposure	Not Reported	35.29411764705882	084bdc25-0423-5828-921a-b697e2467bea	170.0	released	102.0	TCGA-D1-A169_diagnosis	23238	not reported	0	1135	6475596b-d57b-55b5-add0-768e2e451294	Stage IV	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-D1-A169_treatment	TCGA-D1-A169_treatment_1	released	a4461901-15be-5e89-932b-23db942c34f5	no	Radiation Therapy, NOS	released	60931503-e023-5d1e-9134-99aad0add33b	yes	Pharmaceutical Therapy, NOS	d26929d2-fd44-4f29-b950-464bcf71bb9b
3e7a9494-07e7-4f19-a646-fcc7b9e2c89e.htseq.counts.gz	7b0ef1b4-930d-491b-a7de-1547cd140703	TCGA-EC-A1NJ-01A-31R-A14D-07	TCGA-EC-A1NJ-01A-31R	TCGA-EC-A1NJ-01A-03-TSC			TCGA-EC-A1NJ-01A-31	TCGA-EC-A1NJ-01A	TCGA-EC-A1NJ	b3aa16d6-1677-445d-a8d3-46657d4f8b43	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	60	620.0	False	true	8E02F7D6-EBE4-46CB-B05C-B41FDCDC1141	1.79	838b151f-4608-4981-89f3-0cba9ec540fb	0.17	23	released	541fc5b5-43b2-4243-acef-0346d04edab2	RNA	R	0.17	UV Spec	released	False	5de4a15e-cd0c-481a-a334-961639de2434	31	20.0	0.0	10.0	10.0	20.0	20.0	50.0	60.0	TOP	d0e12aae-7a65-46f1-bd29-1f7be1cef73a	released																				released	30.0	0a6212d0-cb90-4e24-add2-6ef723d2a701	Primary Tumor	01	released	Not Reported	released	TCGA-EC-A1NJ_demographic	73	-27002		83619ed1-a7ed-5029-ae2d-608ce3dcbf3f	not hispanic or latino	female	white	released	Alive	1937		TCGA-EC-A1NJ_exposure	Not Reported	26.48553974966893	113ac322-49d4-5f5c-85ec-78277c9ece14	153.0	released	62.0	TCGA-EC-A1NJ_diagnosis	27002	not reported	0	488	b4211663-bd7a-593e-8805-1813d9dee70c	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-EC-A1NJ_treatment	TCGA-EC-A1NJ_treatment_1	released	583f8f48-82b6-5360-93af-73f4090473f6	no	Radiation Therapy, NOS	released	bf8c739f-1f80-5eac-a186-da47176d5dfc	no	Pharmaceutical Therapy, NOS	7b0ef1b4-930d-491b-a7de-1547cd140703
3b76359a-6260-4248-9440-7c09d7bc6254.htseq.counts.gz	7e3fd3d2-e144-4d44-ada9-5e7cde52074f	TCGA-AJ-A23M-01A-11R-A157-07	TCGA-AJ-A23M-01A-11R	TCGA-AJ-A23M-01A-01-TSA			TCGA-AJ-A23M-01A-11	TCGA-AJ-A23M-01A	TCGA-AJ-A23M	d39df936-4bc6-404d-9e1d-f6416cc5a34c	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	274	90.0	False	false	B9651546-290B-405B-8275-24C8A53A10A3	1.87	9cde3009-e59c-4a08-bd85-e3f5ab521d41	0.16	23	released	5e58a5fc-fccd-48ec-bb91-abd3f0f5a6d5	RNA	R	0.16	UV Spec	released	False	db67a2bf-fc00-4316-87fa-06453d67f602	11	60.0	10.0	10.0	20.0	0.0	30.0	60.0	60.0	TOP	6682b6d5-0289-490f-aa12-fab5c3518233	released																				released	30.0	acbbc556-4e4e-4ebc-b408-55d69720a87d	Primary Tumor	01	released	Not Reported	released	TCGA-AJ-A23M_demographic	61	-22430	616	f103f7be-085d-52f8-a650-31b9e2c0bc56	not reported	female	white	released	Dead	1949		TCGA-AJ-A23M_exposure	Not Reported	61.02839335180055	b7e4b16f-56e0-57e8-9071-474eeb25cca6	152.0	released	141.0	TCGA-AJ-A23M_diagnosis	22430	not reported	0	36	d8cefeb1-6fae-59ae-ba9f-8421609c52e9	Stage II	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-AJ-A23M_treatment	TCGA-AJ-A23M_treatment_1	released	a161dcb0-d222-5abf-ba4e-669ad3d80968	yes	Radiation Therapy, NOS	released	e4ebb107-fb9c-52ce-aea7-1f2713c7e8d9	yes	Pharmaceutical Therapy, NOS	7e3fd3d2-e144-4d44-ada9-5e7cde52074f
4bf7c191-bbcb-4a92-bbf8-3e72db34f264.htseq.counts.gz	78adceb9-fabb-43d9-9771-95d8c9ba0eb5	TCGA-AX-A1CC-01A-11R-A137-07	TCGA-AX-A1CC-01A-11R	TCGA-AX-A1CC-01A-01-TS1			TCGA-AX-A1CC-01A-11	TCGA-AX-A1CC-01A	TCGA-AX-A1CC	bc02493a-0296-4329-939a-bf91a4d0c16a	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	356	90.0	False	false	C621C7A6-FF3F-453E-94A2-9789F66750E3	1.8	ac3b86dc-2dd8-41e8-832a-5625f5cd5a27	0.16	23	released	18b0b7d1-3330-4253-be4e-7a883f647091	RNA	R	0.16	UV Spec	released	False	7f8d443d-a801-4ecf-9392-42dd72db9180	11	20.0	1.0	2.0	1.0	10.0	20.0	68.0	65.0	TOP	8c38ebd9-f0ef-425d-bd2a-e4c52604045f	released																				released	30.0	86f051d5-f4a3-47e2-b377-88a516c29bc3	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A1CC_demographic	65	-23795		7c2e2f5f-ce78-504d-817b-73a479cd09f9	not hispanic or latino	female	white	released	Alive	1945		TCGA-AX-A1CC_exposure	Not Reported	40.68047337278106	9805d128-680a-5d92-b356-960c05dc9e03	156.0	released	99.0	TCGA-AX-A1CC_diagnosis	23795	not reported	0	788	272ec012-fe88-5946-b590-5fd2f36587aa	Stage IC	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-AX-A1CC_treatment	TCGA-AX-A1CC_treatment_1	released	9eea8624-2472-5365-a62f-6678bea3b959	no	Radiation Therapy, NOS	released	a514fe7b-c7df-5378-b76f-e3d705558bae	yes	Pharmaceutical Therapy, NOS	78adceb9-fabb-43d9-9771-95d8c9ba0eb5
5523b074-a164-44ad-bf0e-379ae270916d.htseq.counts.gz	2655b9c7-2634-4104-9efa-47fd9c1b7ac5	TCGA-SL-A6J9-01A-11R-A31O-07	TCGA-SL-A6J9-01A-11R	TCGA-SL-A6J9-01A-01-TS1			TCGA-SL-A6J9-01A-11	TCGA-SL-A6J9-01A	TCGA-SL-A6J9	c1f1dc90-2c67-4862-9e5f-078b861ffc6e	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	86	280.0	False	true	DFD43EFD-E91F-487F-A737-93C57C065A49	1.96	55477806-1928-4281-8ee4-69da5b60c6a8	0.17	23	released	977ca27f-e44b-4d1d-ac66-74e63608f6bd	RNA	R	0.17	UV Spec	released	False	646a3099-adc7-4fe5-a0d6-193e9fbdc799	11	0.0	5.0	0.0	0.0	0.0	10.0	90.0	90.0	TOP	45f298fc-0e92-439f-82f3-4c45f7ddccaf	released																				released	30.0	8a93e942-ee48-421a-a696-2b367c6c3867	Primary Tumor	01	released	Not Reported	released	TCGA-SL-A6J9_demographic	73	-26701		3171801b-ead8-54fc-a7b9-481100dfe39d	not hispanic or latino	female	black or african american	released	Alive	1940		TCGA-SL-A6J9_exposure	Not Reported	31.553659148768332	bb3cc5e5-c20c-509b-b802-18938fe25163	167.0	released	88.0	TCGA-SL-A6J9_diagnosis	26701	not reported	0	2	41c082af-250a-57a1-bdf3-11be4f195d17	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2013	TCGA-SL-A6J9_treatment_1	TCGA-SL-A6J9_treatment	released	303ecbf6-e0f8-5b8b-97de-d89fe2448971	not reported	Pharmaceutical Therapy, NOS	released	dc003f42-69b7-5ac8-bdd4-931f31c0559f	not reported	Radiation Therapy, NOS	2655b9c7-2634-4104-9efa-47fd9c1b7ac5
1e591edb-e556-4983-a028-ecb537514fb4.htseq.counts.gz	1e509b45-647d-4361-8b7d-e49815f4dace	TCGA-AX-A3G6-01A-11R-A213-07	TCGA-AX-A3G6-01A-11R	TCGA-AX-A3G6-01A-01-TS1			TCGA-AX-A3G6-01A-11	TCGA-AX-A3G6-01A	TCGA-AX-A3G6	e31db89c-15ac-45a4-9788-afb339b0f3bc	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	456	50.0	False	false	53586ED5-5C68-4517-8543-7508AF37F68C	1.86	99e76a2e-9162-4345-9155-cc7267c0325b	0.16	23	released	4a8006f7-7f80-4f15-b403-63351d0e5d0d	RNA	R	0.16	UV Spec	released	False	cdc0f4f0-e01a-48f4-8455-2f9a1c7d3ffa	11	1.0	0.0	8.0	1.0	0.0	2.0	90.0	94.0	TOP	ee2cd7d4-0275-40b5-a6cd-d103bfcd811c	released																				released	30.0	576ab148-2110-4f35-948a-4a0d00b4f48e	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A3G6_demographic	67	-24681		4cf21d71-f8d6-515e-ab34-b6ce4a4126db	not hispanic or latino	female	white	released	Alive	1943		TCGA-AX-A3G6_exposure	Not Reported	21.513858510523864	ed4ba322-0100-5cd0-ae16-b1c1dda68814	167.0	released	60.0	TCGA-AX-A3G6_diagnosis	24681	not reported	0	8	c9b92d64-fe19-550b-b12a-17efa6df460c	Stage IA	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-AX-A3G6_treatment_1	TCGA-AX-A3G6_treatment	released	5ef75fe4-e78d-5d0d-b0f0-9ab6045ab437	not reported	Pharmaceutical Therapy, NOS	released	91ddc979-9d46-5c1d-b995-49b4de1fbb37	not reported	Radiation Therapy, NOS	1e509b45-647d-4361-8b7d-e49815f4dace
70f03be4-71a2-4c45-9ada-c1343d2527f0.htseq.counts.gz	efc37849-e025-495d-8595-663f7e575bee	TCGA-AX-A3FZ-01A-11R-A22K-07	TCGA-AX-A3FZ-01A-11R	TCGA-AX-A3FZ-01A-01-TS1			TCGA-AX-A3FZ-01A-11	TCGA-AX-A3FZ-01A	TCGA-AX-A3FZ	5262d82d-fc43-41f4-9b23-c9ac6f237ff0	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	658	100.0	False	false	4989F66F-57F8-4B1C-97DD-69F3036EB0BA	1.8	da84a25d-fd15-40ff-80c1-e3f2d2b2b301	0.17	23	released	273e5857-dbac-4437-b7da-f90410fbd6d6	RNA	R	0.17	UV Spec	released	False	88534bcc-15c1-4001-a57f-af8008ef358c	11	1.0	0.0	3.0	0.0	0.0	3.0	94.0	96.0	TOP	0be8c3aa-52df-40c0-8024-eb0d7dc6ce5a	released																				released	30.0	3e114d9b-a96e-4b58-84a0-ad0ecf10b199	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A3FZ_demographic	33	-12331		22d6ec5d-0d1f-56e3-babd-8ee6d909622c	not hispanic or latino	female	white	released	Alive	1977		TCGA-AX-A3FZ_exposure	Not Reported	48.909279778393355	61608024-72c8-5044-b4db-1eb7933b310d	152.0	released	113.0	TCGA-AX-A3FZ_diagnosis	12331	not reported	0	6	327da626-cc15-56c4-8c4d-aefe97dee801	Stage IIIB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-AX-A3FZ_treatment_1	TCGA-AX-A3FZ_treatment	released	a9c97779-c1db-56d7-9e9b-235a362aab65	not reported	Pharmaceutical Therapy, NOS	released	b393e885-8aa9-5599-9315-f9c680b86c57	not reported	Radiation Therapy, NOS	efc37849-e025-495d-8595-663f7e575bee
885748d9-5913-4b02-af45-ec5093fbab46.htseq.counts.gz	eaf0dbd1-3c6e-4bee-9fac-0263ab571963	TCGA-D1-A16Q-01A-12R-A12I-07	TCGA-D1-A16Q-01A-12R	TCGA-D1-A16Q-01A-01-TS1			TCGA-D1-A16Q-01A-12	TCGA-D1-A16Q-01A	TCGA-D1-A16Q	7f4f3aed-69af-421e-817b-b258dcc0bac5	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	136	240.0	False	false	60635568-D27E-4C72-BFF2-238CF2992925	1.83	6f456a65-f075-469d-a0f9-365cae129564	0.17	23	released	034225cd-16c7-451b-aa78-142cff2b1c5e	RNA	R	0.17	UV Spec	released	False	a88d4fe8-7f4b-4f71-9854-1c6ea35121ee	12	30.0	0.0	20.0	10.0	0.0	10.0	70.0	90.0	TOP	c4b05cd8-ae6f-4a51-b9d1-311f988d90ca	released																				released	30.0	bfe3da05-506e-4837-ac72-a285fe079c58	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A16Q_demographic	54	-19873		fe1bd1e0-1b8f-5c74-bb5d-f068ea6327ed	not hispanic or latino	female	white	released	Alive	1956		TCGA-D1-A16Q_exposure	Not Reported	39.54840454299621	81f96f20-5e90-50c2-9d70-4ea6b23b10df	172.0	released	117.0	TCGA-D1-A16Q_diagnosis	19873	not reported	0	324	52a2d92b-2ab7-5fcd-b853-58703bf7770b	Stage II	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-D1-A16Q_treatment	TCGA-D1-A16Q_treatment_1	released	98a34762-ec10-51e9-b12b-489454074c15	yes	Radiation Therapy, NOS	released	5574349a-686f-537c-9483-a854bef571e7	yes	Pharmaceutical Therapy, NOS	eaf0dbd1-3c6e-4bee-9fac-0263ab571963
06ec38a2-40dc-49d6-a3f5-76da22205160.htseq.counts.gz	aba07d3f-f4a2-4125-a5d5-8e33f92eb9cd	TCGA-D1-A16J-01A-11R-A12I-07	TCGA-D1-A16J-01A-11R	TCGA-D1-A16J-01A-01-TSA			TCGA-D1-A16J-01A-11	TCGA-D1-A16J-01A	TCGA-D1-A16J	4db4d048-016a-4186-a519-bfbad237762f	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	735	150.0	False	false	7A1F7567-5D17-4074-B099-1E60C8069FA1	1.94	43ae3721-059e-467e-a8a3-7875e738ccef	0.16	23	released	73eeac9d-fe35-4f8c-ba91-7cddb6102f9e	RNA	R	0.16	UV Spec	released	False	6737e54f-c016-45fa-a39c-a17b42dc8373	11	0.0	0.0	0.0	0.0	0.0	20.0	80.0	65.0	TOP	ca1720b8-8d7e-480f-9fb6-c3ccb844cff3	released																				released	30.0	535b69fc-e529-4615-b789-3756eddda1cd	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A16J_demographic	61	-22319		e5131de6-df58-5310-8f3f-9792154e2d41	not hispanic or latino	female	white	released	Alive	1947		TCGA-D1-A16J_exposure	Not Reported	42.938300964460296	d5883074-83b2-5809-82f8-872d65cba2aa	174.0	released	130.0	TCGA-D1-A16J_diagnosis	22319	not reported	0	910	2f2c0c71-ca23-59b9-9d29-4677fde95ce5	Stage IIB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-D1-A16J_treatment_1	TCGA-D1-A16J_treatment	released	86c7a846-9448-5ce9-883c-cd6c62becc83	yes	Pharmaceutical Therapy, NOS	released	7f670e55-3386-5dfb-95ba-8273d709d922	yes	Radiation Therapy, NOS	aba07d3f-f4a2-4125-a5d5-8e33f92eb9cd
2fcddf35-0514-4eaf-86f2-64542dfe774e.htseq.counts.gz	8c6654d5-3766-4b8f-abb9-20d5b34f25f2	TCGA-B5-A0K1-01A-11R-A16W-07	TCGA-B5-A0K1-01A-11R	TCGA-B5-A0K1-01A-01-TS1	TCGA-B5-A0K1-01A-01-BS1		TCGA-B5-A0K1-01A-11	TCGA-B5-A0K1-01A	TCGA-B5-A0K1	40a3ed98-3892-449c-b07e-7b7612bd997e	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	636	180.0	False	true	826BF8E6-F928-4962-9322-78FA74F9FB0E	1.86	bacdb0de-d29b-4ac1-a163-35376a7b2b9b	0.16	23	released	687a482c-dd60-4682-82a7-877d72a2ff5c	RNA	R	0.16	UV Spec	released	False	d43f22a5-d609-4c3e-843f-64c94834437e	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	85.0	TOP	f4e3cd27-e087-45dc-9da5-402665521528	released	0.0	0.0	0.0	0.0	0.0	0.0	100.0	85.0	BOTTOM	2d24011d-0a77-4c61-956b-3f8d293ae2f9	released									released	30.0	b514f636-dee3-45f3-bb31-197ca6a171f1	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A0K1_demographic	69	-25291		3eb25b7a-aeb5-5adc-b873-2ff37b59675f	not reported	female	white	released	Alive	1939		TCGA-B5-A0K1_exposure	Not Reported	38.64447086801427	15910fc2-9b86-5dbc-bf5c-23d22a647661	174.0	released	117.0	TCGA-B5-A0K1_diagnosis	25291	not reported	0	1110	442389b3-5644-5d77-b051-326272c14d85	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-B5-A0K1_treatment_1	TCGA-B5-A0K1_treatment	released	1f4e4efe-3923-5f9a-8402-62d6dd5ef2f2	no	Pharmaceutical Therapy, NOS	released	7de3abe3-f926-51d2-a411-a8730af5d70c	no	Radiation Therapy, NOS	8c6654d5-3766-4b8f-abb9-20d5b34f25f2
477dd2e3-bf31-4ce1-b338-215a3d3d1373.htseq.counts.gz	499cbcfe-8ee5-4c31-980d-390285c0c30a	TCGA-AP-A1E4-01A-12R-A137-07	TCGA-AP-A1E4-01A-12R	TCGA-AP-A1E4-01A-01-TSA			TCGA-AP-A1E4-01A-12	TCGA-AP-A1E4-01A	TCGA-AP-A1E4	0b2eb188-dd23-4dbf-91bb-02e3c81a69bc	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	154	90.0	False	true	1E33ABA3-0B55-4021-A370-DB8E2CA4C022	1.58	2a549626-7bc3-4ba9-9822-35af631afd0c	0.17	23	released	ea24652d-3fce-4cfd-8b57-732cc572e92b	RNA	R	0.17	UV Spec	released	False	9c744a94-bcd4-46d7-9c28-4eed4c1c9c70	12	0.0	0.0	0.0	0.0	0.0	20.0	80.0	75.0	TOP	549613d7-3f51-4622-8c37-627582ecadda	released																				released	20.0	0e845d2c-7928-46a8-a751-a5df677e8041	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A1E4_demographic	54	-19814		82bb1cb6-76bd-50d7-9942-d28b2ec7d3d6	not reported	female	white	released	Alive	1956		TCGA-AP-A1E4_exposure	Not Reported	20.324438255109335	68e4e4bc-27ba-52a1-affb-ea0307581c0f	163.0	released	54.0	TCGA-AP-A1E4_diagnosis	19814	not reported	0	1555	f9ba839c-3e1d-5954-8333-9dc646667389	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-AP-A1E4_treatment	TCGA-AP-A1E4_treatment_1	released	f31bafdc-f2a9-5f90-adb3-f5ac66931044	yes	Radiation Therapy, NOS	released	ce60360f-b83a-5d49-a6b8-476323774531	yes	Pharmaceutical Therapy, NOS	499cbcfe-8ee5-4c31-980d-390285c0c30a
7afccfe4-4245-4f6c-9a56-b1ded4af45a3.htseq.counts.gz	f00aea62-94eb-4d65-b28b-f4bad86154c2	TCGA-B5-A0KB-01B-11R-A14D-07	TCGA-B5-A0KB-01B-11R	TCGA-B5-A0KB-01B-01-TSA			TCGA-B5-A0KB-01B-11	TCGA-B5-A0KB-01B	TCGA-B5-A0KB	e604f5d4-f2c0-4404-9073-b8dbc8396778	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	368	430.0	False	true	2C744545-8FF8-4A07-A8F2-A47D28B2A8E2	1.91	b5ee1a9b-caca-4abf-9317-d6bf673b8e65	0.17	23	released	befb5ecf-ad38-4a93-85e3-14b68b6f0079	RNA	R	0.17	UV Spec	released	False	4a5cb203-dd6d-4438-b193-00b703a43c6e	11	40.0	10.0	10.0	20.0	0.0	30.0	60.0	70.0	TOP	81781f54-de11-4d71-94a4-031093b1423c	released																				released	30.0	fb68c314-c79f-41fb-8a28-afe26c8e5580	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A0KB_demographic	62	-22669		2c9e2f40-5433-5194-ab7d-730d982de2f5	not reported	female	black or african american	released	Alive	1948		TCGA-B5-A0KB_exposure	Not Reported	29.319856487018246	a286396f-b102-5a6c-9739-896f8a125107	161.0	released	76.0	TCGA-B5-A0KB_diagnosis	22669	not reported	0	824	04bd0019-9fba-559e-8549-f05d73de63db	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	yes	Yes	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2010	TCGA-B5-A0KB_treatment_1	TCGA-B5-A0KB_treatment	released	493a5768-0a02-5641-8d1e-e699503848c8	yes	Pharmaceutical Therapy, NOS	released	a4dbf4c9-f936-5397-b5bc-a8ce8ada2980	yes	Radiation Therapy, NOS	f00aea62-94eb-4d65-b28b-f4bad86154c2
64c53ed9-c688-47fd-a5c7-0b2ece45f68e.htseq.counts.gz	0c3d4797-ad41-48f0-b998-44f95beaa855	TCGA-B5-A0K6-01A-11R-A040-07	TCGA-B5-A0K6-01A-11R	TCGA-B5-A0K6-01A-01-TSA	TCGA-B5-A0K6-01A-01-BSA		TCGA-B5-A0K6-01A-11	TCGA-B5-A0K6-01A	TCGA-B5-A0K6	5cba9441-6812-49c0-a0f6-7928ed4e5b81	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	206	110.0	False	true	B7F34F79-DB7F-4C98-B1B3-80C3187AE91C	1.89	4534628b-5eb9-4123-b56b-b00447ee730b	0.16	23	released	519b7d4e-f3ba-4c95-b191-81e5c4c8cde6	RNA	R	0.16	UV Spec	released	False	71a355d0-d466-457f-bc68-83d3a1cf4eaa	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	90.0	TOP	642e077e-3572-453d-b612-c0ea50006a08	released	0.0	0.0	0.0	0.0	0.0	20.0	80.0	60.0	BOTTOM	ff953551-3378-4a18-8ab0-22fc1bd8807f	released									released	30.0	69bf0d3a-b7ae-4ee1-b7d1-18a32fcfa67c	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A0K6_demographic	58	-21515		f2d6d9b4-f88a-5830-a5d4-499a571ee71f	not reported	female	white	released	Alive	1951		TCGA-B5-A0K6_exposure	Not Reported	47.3304887231525	2ef23f4f-4729-5e66-95ae-f65d640aaa08	167.0	released	132.0	TCGA-B5-A0K6_diagnosis	21515	not reported	0	1953	6dbbb44b-9cf8-556a-8d00-bb62669b4dc2	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-B5-A0K6_treatment_1	TCGA-B5-A0K6_treatment	released	bbf61d65-7947-5faa-bfdd-36430a9d5153	no	Pharmaceutical Therapy, NOS	released	503605e8-109f-5b95-880b-f8ef58552673	no	Radiation Therapy, NOS	0c3d4797-ad41-48f0-b998-44f95beaa855
9a151f86-9a12-4035-98cf-db29417a5fd2.htseq.counts.gz	2afc8429-4b21-4db4-9416-2f2d4761efe2	TCGA-PG-A915-01A-11R-A37O-07	TCGA-PG-A915-01A-11R	TCGA-PG-A915-01A-01-TSA			TCGA-PG-A915-01A-11	TCGA-PG-A915-01A	TCGA-PG-A915	ea95897e-3fe0-4c79-b170-88b0f229794c	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	238	410.0	False	true	F2869E10-B5EB-4AB7-9CC9-A7B2E5DDBB7C	1.89	c590ff56-1d2d-40ea-9fba-0768d66ec12c	0.18	23	released	f1e6d5fc-d3f0-4c38-9185-3ef4eb1374e1	RNA	R	0.18	UV Spec	released	False	77a4a074-94eb-43ec-a09d-b8be8e24f1bc	11	0.0	0.0	0.0	0.0	0.0	10.0	90.0	95.0	TOP	a1661cc6-b413-4413-bf28-6d7409f6b0e3	released																				released	30.0	caffe64c-1fb0-4229-b355-4b798d9506b0	Primary Tumor	01	released	Not Reported	released	TCGA-PG-A915_demographic	60	-22119		27d1bde4-7227-5326-82a1-ce3dcf173f2d	not hispanic or latino	female	black or african american	released	Alive	1953		TCGA-PG-A915_exposure	Not Reported		c8389749-aa97-589f-a8ab-4b3c0df261a5		released		TCGA-PG-A915_diagnosis	22119	not reported	0	249	f3055bcf-c763-590e-869a-dfd58ff0b510	Stage IA	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2013	TCGA-PG-A915_treatment_1	TCGA-PG-A915_treatment	released	0d32ff43-4916-57da-8e7d-dc5c19ad1bf2	no	Pharmaceutical Therapy, NOS	released	395b3137-55c4-5cba-9839-2c11f999844e	no	Radiation Therapy, NOS	2afc8429-4b21-4db4-9416-2f2d4761efe2
22000795-c497-4639-ac4d-689ed2589d5e.htseq.counts.gz	ec2b0c9f-e261-411a-9451-56f2a9bc454f	TCGA-PG-A5BC-01A-12R-A27V-07	TCGA-PG-A5BC-01A-12R	TCGA-PG-A5BC-01A-01-TSA			TCGA-PG-A5BC-01A-12	TCGA-PG-A5BC-01A	TCGA-PG-A5BC	22669a01-21d3-404c-ac19-cf0a6c03bb1d	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	205	120.0	False	true	040F4583-2683-42A8-B185-56A08874F3A0	1.79	47e8bbd2-fd10-4dc8-882e-cb88ca27338d	0.18	23	released	e38888b3-d14c-403e-9d21-75e552a0b885	RNA	R	0.18	UV Spec	released	False	40af8ad8-5bce-48a8-99ba-bc75134d24f6	12	2.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	TOP	1d7d81f6-69d9-4348-8f4d-2f801e392fba	released																				released	10.0	0a63bf84-a720-4b8b-8312-4ec59d14982e	Primary Tumor	01	released	Not Reported	released	TCGA-PG-A5BC_demographic	72	-26436		0feea406-ba2e-5a9f-b989-213d6a3964aa	not hispanic or latino	female	black or african american	released	Alive	1940		TCGA-PG-A5BC_exposure	Not Reported	32.744928299898376	e88c8640-fff8-5f71-b5fb-4e12e262b714	163.0	released	87.0	TCGA-PG-A5BC_diagnosis	26436	not reported	0	707	c2f153c2-baf7-5c96-90bb-fc25436f0e97	Stage II	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2012	TCGA-PG-A5BC_treatment	TCGA-PG-A5BC_treatment_1	released	0efbfe60-a787-5529-a05d-3399466a47a1	no	Radiation Therapy, NOS	released	5863c32e-d724-5b85-a9c2-f47747a3d26a	no	Pharmaceutical Therapy, NOS	ec2b0c9f-e261-411a-9451-56f2a9bc454f
77bee7c3-bb72-44da-896d-063c774e1fd9.htseq.counts.gz	7607f96f-3c68-430b-a718-10aa1ad297b9	TCGA-E6-A1M0-01A-11R-A144-07	TCGA-E6-A1M0-01A-11R	TCGA-E6-A1M0-01A-01-TSA			TCGA-E6-A1M0-01A-11	TCGA-E6-A1M0-01A	TCGA-E6-A1M0	e3dcde4e-5def-4b89-97b4-047b8288919b	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	360	160.0	False	false	F1AF61FE-BF05-49E2-85DA-F4CE37596DEA	1.83	e527020e-6b3f-4837-87d1-8f7ba68c19d6	0.17	23	released	7a5ccb7c-31b4-45a4-974d-193073d801cc	RNA	R	0.17	UV Spec	released	False	efa75421-2dad-4ce4-889a-b7914216a429	11	0.0	0.0	5.0	0.0	0.0	0.0	95.0	85.0	TOP	3549fa06-5d52-4e9c-81af-0b06cc201327	released																				released	30.0	7e75ca29-183d-4bad-9ddc-527871bd7554	Primary Tumor	01	released	Not Reported	released	TCGA-E6-A1M0_demographic	56	-20629		11bbbb3d-ec5c-5cb7-885c-50576834f378	not hispanic or latino	female	white	released	Alive	1954		TCGA-E6-A1M0_exposure	Not Reported	37.65358699960365	9627ae8c-07b0-5e1a-bd74-10bd95ef3272	174.0	released	114.0	TCGA-E6-A1M0_diagnosis	20629	not reported	0	1793	2613f1af-c343-5333-bf51-3cc30b0e4996	Stage IIIC	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-E6-A1M0_treatment_1	TCGA-E6-A1M0_treatment	released	68bd4957-9fcd-52d8-9b4f-aac0187085ec	yes	Pharmaceutical Therapy, NOS	released	1669c85b-f008-5ec1-aa37-a5811767f345	no	Radiation Therapy, NOS	7607f96f-3c68-430b-a718-10aa1ad297b9
3935d0b9-f79a-440e-abc3-d39a8ec88f11.htseq.counts.gz	cb9f351a-0c0a-4209-acd3-f14fac7ed0e5	TCGA-AX-A1CF-11A-11R-A137-07	TCGA-AX-A1CF-11A-11R	TCGA-AX-A1CF-11A-01-TS1			TCGA-AX-A1CF-11A-11	TCGA-AX-A1CF-11A	TCGA-AX-A1CF	20dcf91a-0529-4e96-99a2-362a41fbe4a4	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	2284	50.0	False	false		1.87	c588b29f-0abf-47c6-bff2-d0589ea506ee	0.18	23	released	ae35f9c9-9924-4ae4-b37f-d0bf9904fc5b	RNA	R	0.18	UV Spec	released	False	064863e5-bf37-4a85-9623-2b12370b5c66	11					100.0		0.0		TOP	fee0b9b5-08f2-4fc8-88c0-545f078b8185	released																				released	30.0	ca311bb9-f50f-4d7b-a18f-a0c5c5011c57	Solid Tissue Normal	11	released	Not Reported	released	TCGA-AX-A1CF_demographic	69	-25300		349f3d0a-a11d-5b87-9dd2-13ac1f4b68c2	not hispanic or latino	female	white	released	Alive	1935		TCGA-AX-A1CF_exposure	Not Reported	35.111111111111114	2508b214-bc0e-5d24-8bb4-1ccaee13fd7f	150.0	released	79.0	TCGA-AX-A1CF_diagnosis	25300	not reported	0	2337	151e2065-1540-58b5-b88a-fb97d6841ad8	Stage IVB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2004	TCGA-AX-A1CF_treatment	TCGA-AX-A1CF_treatment_1	released	c2f051d1-56b2-5b7d-8906-c5c26e591706	yes	Radiation Therapy, NOS	released	d526f076-1eca-57aa-9318-b582ec100739	yes	Pharmaceutical Therapy, NOS	cb9f351a-0c0a-4209-acd3-f14fac7ed0e5
731c2762-d3e9-4dbf-b28a-432a651b67dd.htseq.counts.gz	285b5b4d-f29d-41d5-a635-7a3238e15483	TCGA-BK-A139-02A-11R-A27V-07	TCGA-BK-A139-02A-11R	TCGA-BK-A139-02A-01-TS1			TCGA-BK-A139-02A-11	TCGA-BK-A139-02A	TCGA-BK-A139	8d9e4917-334b-4c76-aee1-1e22be772db0	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	874	430.0	False	false	FE6C557C-6F28-4F5C-B48C-E2A3BB7EF14F	1.98	923217e0-602c-4cf7-b17a-37269d9371c4	0.18	23	released	c322fb81-31c9-4591-aa88-d1aff9a03e32	RNA	R	0.18	UV Spec	released	False	f874d219-2ba9-4d3e-b660-064ba1403994	11	3.0	0.0	20.0	0.0	40.0	0.0	40.0	65.0	TOP	66e7ece0-48d6-4ea3-b99f-7e58840414f8	released																				released	30.0	a4ee1cc7-9cac-4e7e-96db-d38981e5f506	Recurrent Tumor	02	released	Not Reported	released	TCGA-BK-A139_demographic	74	-27077	943	283a931a-a653-50c4-992a-c69e21c6af1c	not hispanic or latino	female	white	released	Dead	1936		TCGA-BK-A139_exposure	Not Reported	24.87771968291449	8155bfc1-1c5f-5642-9a14-8b020eeb7bf3	154.0	released	59.0	TCGA-BK-A139_diagnosis	27077	not reported	0	309	fff68755-ed35-52d0-9a4f-86a4b19bc82e	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-BK-A139_treatment	TCGA-BK-A139_treatment_1	released	6c775c6a-d5bf-5bd8-8b8c-3a27635d6c8e	no	Radiation Therapy, NOS	released	de6d0cd2-02d1-51e0-9e71-feb4f4d24986	no	Pharmaceutical Therapy, NOS	285b5b4d-f29d-41d5-a635-7a3238e15483
44f2c75c-1de9-4100-8a58-c4841fa03c20.htseq.counts.gz	01f18af4-75e7-48d4-83fd-b15a56ea5f31	TCGA-AJ-A3NH-01A-11R-A22K-07	TCGA-AJ-A3NH-01A-11R	TCGA-AJ-A3NH-01A-01-TSA			TCGA-AJ-A3NH-01A-11	TCGA-AJ-A3NH-01A	TCGA-AJ-A3NH	7186180a-688a-4fcc-9a67-166eff032e4b	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	67	130.0	False	false	8FC0BB09-C917-4552-96A4-B4868FD33D27	1.86	1b48e1cd-3c89-4508-9326-7fdd69841776	0.16	23	released	20e95943-8b05-493e-b3b8-c46032de5416	RNA	R	0.16	UV Spec	released	False	46fba282-a9d6-4c2f-ab53-66404b450128	11	2.0	0.0	0.0	0.0	10.0	0.0	90.0	90.0	TOP	b274ee56-4edf-412e-85ef-b5a5fa38c32e	released																				released	30.0	892763d2-7038-479e-a623-8f56eeab1a27	Primary Tumor	01	released	Not Reported	released	TCGA-AJ-A3NH_demographic	90	-32871	1	5260b2a3-c911-50eb-a9f3-7ab433a02860	not hispanic or latino	female	white	released	Dead	1921		TCGA-AJ-A3NH_exposure	Not Reported	24.767565919829295	c411984a-753e-5855-8855-2fbf4a442b32	162.0	released	65.0	TCGA-AJ-A3NH_diagnosis	32871	not reported	0	1	05fae6e0-105f-517a-8fc6-bcc404aeb97a	Stage IB	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2011	TCGA-AJ-A3NH_treatment_1	TCGA-AJ-A3NH_treatment	released	2e65be50-2ef3-5b89-be19-2dab9dfa97af	yes	Pharmaceutical Therapy, NOS	released	6bd33564-ffec-5150-a2aa-74bb98c49f6f	no	Radiation Therapy, NOS	01f18af4-75e7-48d4-83fd-b15a56ea5f31
3189a475-b26f-491a-9223-201f36b2659e.htseq.counts.gz	9b595991-6de7-4310-bf04-0371eb19df98	TCGA-BG-A2AD-11A-11R-A16F-07	TCGA-BG-A2AD-11A-11R	TCGA-BG-A2AD-11A-01-TSA			TCGA-BG-A2AD-11A-11	TCGA-BG-A2AD-11A	TCGA-BG-A2AD	49adc60f-211b-4547-84f6-094257767409	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	45	120.0	False	true		1.87	be03335f-81c9-4cdc-8805-c47c3e7756a1	0.16	23	released	dd322ced-9aa2-4d10-83bd-c2daeb96c0bc	RNA	R	0.16	UV Spec	released	False	4aac87a9-edd8-42a4-a21a-e956decbb2bc	11	30.0	20.0	0.0	30.0	100.0	0.0	0.0	0.0	TOP	7fa33e34-c888-41e2-ae95-855ad726865f	released																				released	30.0	7d188988-d02b-4874-b3af-925c6173f51f	Solid Tissue Normal	11	released	Not Reported	released	TCGA-BG-A2AD_demographic	63	-23064		89d21b25-7c06-5b8c-b35c-4ae66fd0aa6d	not hispanic or latino	female	white	released	Alive	1948		TCGA-BG-A2AD_exposure	Not Reported	31.25	c6931bad-ae18-5a74-b5a5-bd4838e3ff01	160.0	released	80.0	TCGA-BG-A2AD_diagnosis	23064	not reported	0	609	4ae53ec5-18e1-548f-bc61-82359ef2e1f8	Stage IIIB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-BG-A2AD_treatment	TCGA-BG-A2AD_treatment_1	released	8c0ef4a5-2f57-5167-b4fb-6c811871c8ad	no	Radiation Therapy, NOS	released	a32d23ad-7cfa-5bdd-bb76-801a6eae45e6	yes	Pharmaceutical Therapy, NOS	9b595991-6de7-4310-bf04-0371eb19df98
6a7f4dc8-ba05-49ec-8764-8bc34f32473c.htseq.counts.gz	c48e9fab-445c-442f-b56c-b15821dba231	TCGA-EO-A1Y7-01A-11R-A157-07	TCGA-EO-A1Y7-01A-11R	TCGA-EO-A1Y7-01A-01-TSA			TCGA-EO-A1Y7-01A-11	TCGA-EO-A1Y7-01A	TCGA-EO-A1Y7	71ed2681-79bb-4ffb-985c-6d3cf18e9168	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	196	140.0	False	false	88AABD4B-ECB4-4748-B59F-BD4AE0621BFB	1.71	4da7543e-f58a-46f1-bf94-834d4ce4cbff	0.17	23	released	f073313a-a3d4-41f4-970c-9dabc16426c8	RNA	R	0.17	UV Spec	released	False	62297bfd-57b6-46ef-8877-eadf2734abec	11	4.0	8.0	0.0	0.0	0.0	10.0	90.0	90.0	TOP	b656332d-c763-4425-84c7-a27ee6ebc9a9	released																				released	30.0	c27f13ab-69dd-403c-b81e-fc4bc4bfa329	Primary Tumor	01	released	Not Reported	released	TCGA-EO-A1Y7_demographic	65	-24085		4197c40d-f4d9-5603-8712-f15525e88cf4	not reported	female	not reported	released	Alive	1945		TCGA-EO-A1Y7_exposure	Not Reported	34.89439853076217	970213ff-4701-5f50-ab58-1f08c8f3acaa	165.0	released	95.0	TCGA-EO-A1Y7_diagnosis	24085	not reported	0	1495	9120f880-1056-59e1-9717-b0e2a63d5702	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-EO-A1Y7_treatment	TCGA-EO-A1Y7_treatment_1	released	43e17df0-a242-5798-bda2-2e6444e243d4	yes	Radiation Therapy, NOS	released	e446f2a8-a89d-5181-9674-ccb2a9b095d4	yes	Pharmaceutical Therapy, NOS	c48e9fab-445c-442f-b56c-b15821dba231
f832affe-b7e5-45b0-bd2d-823cf6f48625.htseq.counts.gz	9d3109f8-923b-4f12-9807-c985e53e9636	TCGA-FL-A1YN-11A-11R-A32Y-07	TCGA-FL-A1YN-11A-11R	TCGA-FL-A1YN-11A-01-TS1			TCGA-FL-A1YN-11A-11	TCGA-FL-A1YN-11A	TCGA-FL-A1YN	d72264ec-d4d7-423a-9216-ae4485f81aba	Not Reported	Uterus, NOS	TCGA-UCEC		60.0	False	false	BA22BA6E-3DEF-4354-A52C-19B405A349FB	2.12	331785a5-59ba-441f-81dc-384d7f80905b	0.17	23	released	f8bace8b-dc5c-4e39-868f-e1ca45eacd95	RNA	R	0.17	UV Spec	released	False	fa1bd542-e49c-4ee8-a9e4-d9bfafa5d7e0	11					100.0		0.0		TOP	f81e300c-262d-4000-b85d-bcaf01258372	released																				released	30.0	ec811767-6af1-485a-967d-231764ef6797	Solid Tissue Normal	11	released	Not Reported	released																																																			9d3109f8-923b-4f12-9807-c985e53e9636
0862ad1d-8d29-4212-be68-8ce6140c12cf.htseq.counts.gz	6a398a39-8260-43e9-8b5f-72f857e799e2	TCGA-B5-A11S-01A-11R-A118-07	TCGA-B5-A11S-01A-11R	TCGA-B5-A11S-01A-01-TSA	TCGA-B5-A11S-01A-01-BSA		TCGA-B5-A11S-01A-11	TCGA-B5-A11S-01A	TCGA-B5-A11S	cfd096ac-4d0f-4b89-8822-00656bc7f516	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	615	200.0	False	true	A1E96BA3-7DFB-4E3C-A6CF-B0B99D4C44FA	1.84	eb6cac23-997e-4d0b-82cf-f74fd5fb57d2	0.15	23	released	a6e4e527-868d-420c-b0c4-50512eea3797	RNA	R	0.15	UV Spec	released	False	2c34c90e-332d-43d7-9788-0d96490de04a	11	35.0	6.0	0.0	3.0	5.0	5.0	90.0	95.0	TOP	59901d18-1da8-43f8-9b33-957ff230b7d9	released	30.0	6.0	0.0	10.0	10.0	40.0	50.0	60.0	BOTTOM	26021e2d-0be7-4b9c-b96b-8fee71cf9cb5	released									released	30.0	f36e52ee-22b3-4e9a-aacd-d74e7f7d4a51	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A11S_demographic	63	-23085		d2b3ab8b-b070-588b-b574-8ee86e7eff94	not reported	female	white	released	Alive	1946		TCGA-B5-A11S_exposure	Not Reported	47.87212462980242	9ecfb6ee-1a69-5b38-a4f5-bff63e473e15	157.0	released	118.0	TCGA-B5-A11S_diagnosis	23085	not reported	0	2229	10aae23f-e099-59e4-b255-22ec38998415	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-B5-A11S_treatment	TCGA-B5-A11S_treatment_1	released	24083fb0-14bf-5abf-bcbe-d0911ba93b0f	no	Radiation Therapy, NOS	released	eedab425-5097-5870-b287-34a65a661e7e	no	Pharmaceutical Therapy, NOS	6a398a39-8260-43e9-8b5f-72f857e799e2
15575a5e-1524-44fc-b25c-96b4598ccda1.htseq.counts.gz	85d1c995-d4b9-4cad-9d69-ee552287c453	TCGA-AP-A059-01A-21R-A118-07	TCGA-AP-A059-01A-21R	TCGA-AP-A059-01A-01-BS1	TCGA-AP-A059-01A-02-BS2		TCGA-AP-A059-01A-21	TCGA-AP-A059-01A	TCGA-AP-A059	4549bff6-6886-4102-a1de-02691b664c52	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1476	230.0	False	true	29A150D3-D5F0-4222-B082-6ABE35A2BB46	1.79	1d8b3e3b-590d-4087-9506-d6b0b2bab9a9	0.15	23	released	bff658d6-d8af-49de-a226-bc9fb955887c	RNA	R	0.15	UV Spec	released	False	4db1dfb6-0910-46d4-946f-a7bdf18ac24a	21	25.0	0.0	1.0	2.0	0.0	1.0	98.0	60.0	TOP	e10d472c-daac-4893-8885-581a0af20ce3	released	40.0	0.0	1.0	0.0	0.0	1.0	98.0	50.0	BOTTOM	7bba0166-2cb6-4d67-b584-fce022b56d7e	released									released	30.0	6d6c8e8b-3423-4380-a498-6cf5bc8b070b	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A059_demographic	69	-25311		18454974-897b-5a0c-8f4e-a15d6a2da0f9	not hispanic or latino	female	white	released	Alive	1937		TCGA-AP-A059_exposure	Not Reported	38.671875	67db3b7c-ea05-5419-81d6-28c8b2a36862	160.0	released	99.0	TCGA-AP-A059_diagnosis	25311	not reported	0	1461	465fd288-52d6-53c1-a237-9e067167a270	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2006	TCGA-AP-A059_treatment_1	TCGA-AP-A059_treatment	released	c4077bee-4205-53ea-8062-19c05a3744a6	no	Pharmaceutical Therapy, NOS	released	acb7d17f-61c2-5616-a447-397eb297b65c	yes	Radiation Therapy, NOS	85d1c995-d4b9-4cad-9d69-ee552287c453
14100499-dd37-452c-96bd-8aee7e0b9fcf.htseq.counts.gz	c491f8af-a63f-444d-afaf-27e0fdc12d6e	TCGA-PG-A6IB-01A-21R-A31O-07	TCGA-PG-A6IB-01A-21R	TCGA-PG-A6IB-01A-02-TS2			TCGA-PG-A6IB-01A-21	TCGA-PG-A6IB-01A	TCGA-PG-A6IB	e8c7195b-a26b-4d98-b1c5-0aa18385e9c8	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	160	100.0	False	true	C975AE5D-7370-4D1D-81AE-D3ABE5364055	1.86	55b5dd8f-9e80-4084-9cb2-c04ccf558802	0.18	23	released	b76cb949-6052-412f-9a71-f4d9e366295b	RNA	R	0.18	UV Spec	released	False	7ec4056f-5f09-48a7-99eb-ee3115db4150	21	1.0	1.0	10.0	2.0	10.0	20.0	60.0	60.0	TOP	ce1616f6-ebd3-4ae0-96d2-72839f1f8719	released																				released	20.0	c9c01ae7-bfdf-4077-b9d7-5d3698afd32f	Primary Tumor	01	released	Not Reported	released	TCGA-PG-A6IB_demographic	68	-24969		86dca230-c669-54c6-b78d-74b1fa5a7b19	not hispanic or latino	female	black or african american	released	Alive	1944		TCGA-PG-A6IB_exposure	Not Reported		749ba3f0-ff5f-5a7d-9f1e-05fce7035ae8		released		TCGA-PG-A6IB_diagnosis	24969	not reported	0	648	ea1ae058-a218-5194-81e9-51a1f83914d4	Stage IA	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2012	TCGA-PG-A6IB_treatment_1	TCGA-PG-A6IB_treatment	released	821d2dad-7451-59a4-aa06-39c1cfcdff67	not reported	Pharmaceutical Therapy, NOS	released	0bad11d8-8e1b-5320-864d-e636cebccba9	not reported	Radiation Therapy, NOS	c491f8af-a63f-444d-afaf-27e0fdc12d6e
74e8d5cd-2823-47bd-9b89-cf43ce6fa292.htseq.counts.gz	77133df7-491d-4b93-a79c-ec625fb4c478	TCGA-BG-A0M4-01A-11R-A104-07	TCGA-BG-A0M4-01A-11R	TCGA-BG-A0M4-01A-01-BSA	TCGA-BG-A0M4-01A-01-TSA		TCGA-BG-A0M4-01A-11	TCGA-BG-A0M4-01A	TCGA-BG-A0M4	73e5310d-ba8c-4cbc-aa4f-e06206f898f4	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	643	240.0	False	true	95002D96-C9D8-43BE-ADD1-072E93994194	1.88	174acfe1-d3ab-4912-9d05-7aa598ae1add	0.15	23	released	6d44bf6f-167b-4e10-add1-0cf6454cc130	RNA	R	0.15	UV Spec	released	False	ad7e9453-5f1f-4ef1-94d4-d818b381427a	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	90.0	BOTTOM	d55ae170-f484-4250-b370-8b3c870a3188	released	0.0	0.0	0.0	0.0	0.0	0.0	100.0	75.0	TOP	edd32c29-b009-4fb1-8d4d-03b66a7cb54a	released									released	30.0	e6e7e411-45cf-47a1-bcf0-7ae800a61a8d	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A0M4_demographic	60	-22090		ab7c810e-febe-5caa-a6c2-35ad0f421909	not hispanic or latino	female	white	released	Alive	1948		TCGA-BG-A0M4_exposure	Not Reported	30.614821360939274	868a17f8-aa1e-5dd2-a482-4737c90005cb	178.0	released	97.0	TCGA-BG-A0M4_diagnosis	22090	not reported	0	2167	004d6366-8402-56fe-9858-7f1ba606f8af	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-BG-A0M4_treatment_1	TCGA-BG-A0M4_treatment	released	05bb3713-7fa9-5116-b044-4cd4e7baa436	yes	Pharmaceutical Therapy, NOS	released	d44800d0-ae7d-5d29-bf22-b525a69afea8	no	Radiation Therapy, NOS	77133df7-491d-4b93-a79c-ec625fb4c478
357cd446-1a23-43b9-bbbe-2d230239f028.htseq.counts.gz	b3048efb-f58e-4cf5-8fa4-11c97685c2d8	TCGA-AX-A1CJ-01A-11R-A137-07	TCGA-AX-A1CJ-01A-11R	TCGA-AX-A1CJ-01A-01-TS1			TCGA-AX-A1CJ-01A-11	TCGA-AX-A1CJ-01A	TCGA-AX-A1CJ	abaf757b-f79f-40bd-96e3-e2c0f63061f0	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1758	90.0	False	false	AC9C3BB1-9B41-4B1F-BCEA-F6A0C68921B3	1.89	87d95a5d-174b-4f13-a00f-85a28bfd1fb7	0.16	23	released	9dcee026-f258-47ac-be55-c2dae9fb2ac6	RNA	R	0.16	UV Spec	released	False	7c84466e-5926-47f0-b1d5-35fa9fbd8cc3	11	8.0	2.0	2.0	2.0	0.0	7.0	91.0	90.0	TOP	a8895109-97c6-445b-8f1c-da2852c3e822	released																				released	30.0	72d06ddf-9fb2-4577-bfdb-b0e463105b4a	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A1CJ_demographic	59	-21655		dde39d8c-7e4a-5965-852b-cd6904b2e99e	not hispanic or latino	female	black or african american	released	Alive	1947		TCGA-AX-A1CJ_exposure	Not Reported	43.28352591365877	bfd739a6-aa39-520f-80b9-152d4d88c434	163.0	released	115.0	TCGA-AX-A1CJ_diagnosis	21655	not reported	0	2233	9255f42f-4135-576d-a2eb-8e25a8a9263d	Stage IC	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2006	TCGA-AX-A1CJ_treatment	TCGA-AX-A1CJ_treatment_1	released	f2e18f7d-746c-54ee-ba50-e6d17e039c4b	yes	Radiation Therapy, NOS	released	d6342517-fd86-5e1b-8941-d4ab81fd5212	no	Pharmaceutical Therapy, NOS	b3048efb-f58e-4cf5-8fa4-11c97685c2d8
02775fee-c277-4ece-9f1d-9e0705b210ea.htseq.counts.gz	6626757b-47c6-4e1d-8587-95a10ebfe849	TCGA-AX-A2H4-01A-21R-A18M-07	TCGA-AX-A2H4-01A-21R	TCGA-AX-A2H4-01A-02-TSB			TCGA-AX-A2H4-01A-21	TCGA-AX-A2H4-01A	TCGA-AX-A2H4	afa79b18-2ac6-4179-9c8c-5fa4d1d09a7e	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	1981	120.0	False	false	5230A27B-4AA6-4ED9-90BB-98C6671E0B2E	1.82	46eaeac0-bacb-4c76-b86d-5bd912229f69	0.17	23	released	f2c21d96-39be-4a61-ad82-fd353552458a	RNA	R	0.17	UV Spec	released	False	d7e5d226-69a5-4bfd-9336-64bd0573f9f7	21	10.0	1.0	5.0	2.0	0.0	35.0	60.0	80.0	TOP	e4077e33-365f-46b0-8382-ea1ace6d6f5d	released																				released	30.0	47b7fd2a-3437-4991-8c7c-7ff6ba88ef86	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A2H4_demographic	66	-24234	916	aa0c0ecd-e82a-5798-b1a4-a40911eaf464	not hispanic or latino	female	white	released	Dead	1940	2008	TCGA-AX-A2H4_exposure	Not Reported	34.0784616008763	ece868ed-1099-5d09-8441-bb49dd7341c8	157.0	released	84.0	TCGA-AX-A2H4_diagnosis	24234	not reported	0		e1162466-e10b-58a1-96ac-2399188c61ef	Stage IIIA	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2006	TCGA-AX-A2H4_treatment_1	TCGA-AX-A2H4_treatment	released	06510c54-2987-512f-b350-c467ea164ee9	no	Pharmaceutical Therapy, NOS	released	034af59b-5a06-55d2-b842-413567ec649a	no	Radiation Therapy, NOS	6626757b-47c6-4e1d-8587-95a10ebfe849
db50e76b-141a-44c3-b595-f709a22070da.htseq.counts.gz	f52a5c6c-16fb-4274-b69a-5642d13277eb	TCGA-BS-A0TI-01A-11R-A104-07	TCGA-BS-A0TI-01A-11R	TCGA-BS-A0TI-01A-01-TSA	TCGA-BS-A0TI-01A-01-BSA		TCGA-BS-A0TI-01A-11	TCGA-BS-A0TI-01A	TCGA-BS-A0TI	df857bc6-fd6a-4713-bef9-6ee1301e5fb1	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1507	250.0	False	false	60212550-2757-4AB0-B778-723AE046F6BE	1.78	4fefb750-f793-4c1f-92cc-bd8fd9998cc6	0.16	23	released	5e23cc8e-7a0e-4fab-b40e-d90b8c47bbab	RNA	R	0.16	UV Spec	released	False	ef9c965f-43ea-4175-8a7c-8fa285ea54d9	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	98.0	TOP	d2ff3c26-8eef-4dcb-a16d-27179cd22f41	released	0.0	0.0	0.0	0.0	0.0	0.0	100.0	98.0	BOTTOM	9f0bd313-96df-4dab-8de3-15ae8629ab67	released									released	10.0	2f52c850-8e70-4eab-88f3-d35dc55e385b	Primary Tumor	01	released	Not Reported	released	TCGA-BS-A0TI_demographic	64	-23705		031b9275-feab-5a98-ab1d-ea8def8bce56	not hispanic or latino	female	white	released	Alive	1942		TCGA-BS-A0TI_exposure	Not Reported	22.206330686137978	bc4f5a2b-c8b6-580a-90fc-46e1df772ffd	163.0	released	59.0	TCGA-BS-A0TI_diagnosis	23705	not reported	0	1882	8c930394-3164-5af8-b62d-d93d088d0760	Stage IC	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2006	TCGA-BS-A0TI_treatment	TCGA-BS-A0TI_treatment_1	released	bafba2f7-f1e5-5613-b47d-316f08719439	no	Radiation Therapy, NOS	released	ee281f79-1eb7-5d72-94ad-1140fddc2cdd	no	Pharmaceutical Therapy, NOS	f52a5c6c-16fb-4274-b69a-5642d13277eb
bee73975-5ec9-4e91-a760-efea24ad9c17.htseq.counts.gz	d0c13aa4-f84b-4b88-bc48-1ef9748f7958	TCGA-FL-A1YV-11A-12R-A32Y-07	TCGA-FL-A1YV-11A-12R	TCGA-FL-A1YV-11A-01-TSA			TCGA-FL-A1YV-11A-12	TCGA-FL-A1YV-11A	TCGA-FL-A1YV	42ebfec9-6e28-4d72-9b9f-23a836800921	Not Reported	Uterus, NOS	TCGA-UCEC		110.0	False	false	DE7868BF-DA24-4C11-B331-6064E4CCCEAF	1.96	da44c9b1-d38b-4b75-887c-ec1646969758	0.15	23	released	7afadb8e-c2b7-44e9-9ec5-784270896b97	RNA	R	0.15	UV Spec	released	False	8b732f0e-5004-455d-8a4c-6a987fe2ba14	12					100.0		0.0		TOP	b6ebeabd-2660-42d0-9955-2a2a8da0a416	released																				released	30.0	2748d061-eb8e-4331-a88f-f4559a5433c3	Solid Tissue Normal	11	released	Not Reported	released																																																			d0c13aa4-f84b-4b88-bc48-1ef9748f7958
f92d0fd3-73a5-40bf-b221-91af5ca52b1a.htseq.counts.gz	13f999f3-8311-48f8-9950-9ab7b57c23bf	TCGA-EO-A3L0-01A-11R-A22K-07	TCGA-EO-A3L0-01A-11R	TCGA-EO-A3L0-01A-01-TS1			TCGA-EO-A3L0-01A-11	TCGA-EO-A3L0-01A	TCGA-EO-A3L0	423da953-30aa-4f7e-96b5-1f6fd24f8874	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	422	110.0	False	false	AD1F0EEC-20B6-416B-9728-BC103D2B3B87	1.86	4383201e-ca97-4192-8e89-c63b10caaa0c	0.16	23	released	d5635271-eda9-4e96-aa16-09cca20cd1e5	RNA	R	0.16	UV Spec	released	False	54e7f9b8-68cb-4975-9e28-dcee6bf2b8f8	11	1.0	0.0	0.0	0.0	0.0	0.0	100.0	95.0	TOP	7fb4d425-4de9-4073-a8c7-7f8e86df0f40	released																				released	30.0	73d4918c-8bab-4753-9d47-355b51dbbbfa	Primary Tumor	01	released	Not Reported	released	TCGA-EO-A3L0_demographic	76	-28003		12fbd795-9cb8-5b5b-9c91-533a3df57bfc	not hispanic or latino	female	white	released	Alive	1934		TCGA-EO-A3L0_exposure	Not Reported	43.51093706736284	aca0d12f-3eac-591b-aac4-080757b8d9d4	159.0	released	110.0	TCGA-EO-A3L0_diagnosis	28003	not reported	0	1554	08eb6f0f-476b-5808-81b4-ccfa2541d5bd	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-EO-A3L0_treatment_1	TCGA-EO-A3L0_treatment	released	771cc516-8641-5e44-9b2e-3b0fc459a779	no	Pharmaceutical Therapy, NOS	released	fccef7e2-d697-541a-91fc-4807fca8bf5e	yes	Radiation Therapy, NOS	13f999f3-8311-48f8-9950-9ab7b57c23bf
e1225b5a-c7df-4305-a4cf-35ef372240f3.htseq.counts.gz	8cb68a3e-6625-4397-b75c-7d552263d5c3	TCGA-B5-A3F9-01A-21R-A22K-07	TCGA-B5-A3F9-01A-21R	TCGA-B5-A3F9-01A-02-TSB			TCGA-B5-A3F9-01A-21	TCGA-B5-A3F9-01A	TCGA-B5-A3F9	21941181-8ed5-4211-867d-516ad09fbe06	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	3159	110.0	False	true	E4AD1574-653C-444D-BB43-B4DE701B109F	1.85	654f3c17-dc98-4e53-8ff8-b1f92d6bd8bd	0.17	23	released	93a81dd3-7470-460b-8c87-1a57cd675957	RNA	R	0.17	UV Spec	released	False	3e5482d7-64fe-49b0-a526-25c0cbe669ad	21	1.0	2.0	3.0	0.0	0.0	0.0	97.0	95.0	TOP	ea577ad1-6d9a-4a18-b24c-b756dd76c55b	released																				released	30.0	7fc15cfc-2cd8-49af-bf92-913f0bc4c1a8	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A3F9_demographic	56	-20523		50c45796-e968-564d-9c4b-165c22625230	not reported	female	black or african american	released	Alive	1947		TCGA-B5-A3F9_exposure	Not Reported	56.24909275656844	1e2e3587-f4f2-5851-bbf4-0cb755c9c6ba	166.0	released	155.0	TCGA-B5-A3F9_diagnosis	20523	not reported	0	4155	75d7b4cd-1568-54e7-b463-0d5313354c90	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2003	TCGA-B5-A3F9_treatment	TCGA-B5-A3F9_treatment_1	released	56621181-87be-5d42-bdb2-fcfc5e0c6101	no	Radiation Therapy, NOS	released	12cec3dc-23cb-5cfd-aa5e-04c54aff0f15	no	Pharmaceutical Therapy, NOS	8cb68a3e-6625-4397-b75c-7d552263d5c3
6613cf15-369a-427a-85eb-485b16916806.htseq.counts.gz	36387f2e-0b9d-47e3-95b3-f75d57ea245c	TCGA-AJ-A2QO-01A-11R-A32Y-07	TCGA-AJ-A2QO-01A-11R	TCGA-AJ-A2QO-01A-01-TS1			TCGA-AJ-A2QO-01A-11	TCGA-AJ-A2QO-01A	TCGA-AJ-A2QO	dcf1beb9-bce4-4f4c-98dd-1226d8e0c125	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	174	16.0	False	false	5351BF98-9E1D-4F4D-A3EE-26A83B867D58	1.75	0ebc7d28-128d-4842-9e10-28abb1953b72	0.17	23	released	61b06cde-28d3-4e22-9bf6-5310e11cab78	RNA	R	0.17	UV Spec	released	False	69d6d366-e620-4449-9175-36a57de9812a	11	0.0	0.0	15.0	0.0	0.0	30.0	55.0	65.0	TOP	e73d0cb9-cea6-4259-ab8e-872f32736127	released																				released	16.0	32be3043-2dce-42c7-bb5c-a313f2c5e3a1	Primary Tumor	01	released	Not Reported	released	TCGA-AJ-A2QO_demographic	85	-31222	1045	150c9f58-1fa3-59d5-af58-ec8e150277bc	not reported	female	white	released	Dead	1926		TCGA-AJ-A2QO_exposure	Not Reported	24.60973370064279	fe3ebe52-7649-5f46-9136-abe20ee1fba3	165.0	released	67.0	TCGA-AJ-A2QO_diagnosis	31222	not reported	0	92	7e286786-b8d5-50d7-9097-a9ef232702c7	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-AJ-A2QO_treatment	TCGA-AJ-A2QO_treatment_1	released	967034e4-bd02-5092-a7f2-609080272db0	no	Radiation Therapy, NOS	released	551bc2ea-472a-5dbc-b7eb-05dedc4d1705	no	Pharmaceutical Therapy, NOS	36387f2e-0b9d-47e3-95b3-f75d57ea245c
76dba7d8-0b1f-4e14-857c-97fdd279bc60.htseq.counts.gz	2e425635-ab9d-4d2b-a53d-c0ede9e1f770	TCGA-D1-A0ZO-01A-11R-A118-07	TCGA-D1-A0ZO-01A-11R	TCGA-D1-A0ZO-01A-01-TS1	TCGA-D1-A0ZO-01A-01-BS1		TCGA-D1-A0ZO-01A-11	TCGA-D1-A0ZO-01A	TCGA-D1-A0ZO	b3d635b3-d7ac-4cf8-a318-0a9dd0073e89	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	586	50.0	False	false	13826E23-2184-4D03-B67C-B312BF4FA87E	1.9	0e70ff34-799d-4e88-9911-85357f2bb0a2	0.15	23	released	71dc862f-5b93-4f1d-8250-8e05e357d2e9	RNA	R	0.15	UV Spec	released	False	ea8bc9c8-b07e-4f32-8ad4-87080b4806e3	11	20.0	0.0	10.0	10.0	30.0	10.0	50.0	60.0	TOP	71fdc8a6-2b4d-4309-902c-6541baa3e82b	released	20.0	0.0	10.0	10.0	70.0	0.0	20.0	30.0	BOTTOM	5c9ccd64-fe4d-4053-9764-482baf585cde	released									released	30.0	9c617822-c9a8-42c5-aab7-d6f22887c325	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A0ZO_demographic	75	-27482		58b46677-323d-533b-980b-5a724af621af	not hispanic or latino	female	white	released	Alive	1934		TCGA-D1-A0ZO_exposure	Not Reported	40.4040404040404	4a4a2990-9fd5-56c3-a9b4-8f4acf5eb8f0	165.0	released	110.0	TCGA-D1-A0ZO_diagnosis	27482	not reported	0	602	63e70dd2-1a97-5c6d-a4cd-e5fb9d25e179	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2009	TCGA-D1-A0ZO_treatment	TCGA-D1-A0ZO_treatment_1	released	86376fa5-b08c-5bba-b265-e6d30d562a90	no	Radiation Therapy, NOS	released	2b9b9915-99c8-5453-bbb7-27d0b367108f	no	Pharmaceutical Therapy, NOS	2e425635-ab9d-4d2b-a53d-c0ede9e1f770
4e92e7a1-5a53-4296-8ce1-b655f4aaae3d.htseq.counts.gz	41df1766-abe6-44e6-ab21-8cd3e698b28e	TCGA-AX-A05Z-01A-11R-A00V-07	TCGA-AX-A05Z-01A-11R	TCGA-AX-A05Z-01A-01-BS1	TCGA-AX-A05Z-01A-01-TS1		TCGA-AX-A05Z-01A-11	TCGA-AX-A05Z-01A	TCGA-AX-A05Z	bf632368-8ce7-4b4b-8842-d1b1801e62ef	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1416	180.0	False	false	5938A010-17E7-41FB-9F4D-8B4F1A3C0F2F	1.78	5e6246e7-35a3-4ce5-b234-b4dec034a6a8	0.15	23	released	edc86c96-114c-4cde-b6c8-95478ce3ede8	RNA	R	0.15	UV Spec	released	False	d8640447-590d-4a31-ae1b-909adf87d6e7	11	5.0	0.0	10.0	0.0	0.0	10.0	80.0	80.0	BOTTOM	2da68cb9-e919-4478-8d2b-b38fdfef8ac8	released	10.0	0.0	10.0	0.0	0.0	10.0	80.0	80.0	TOP	ab503d7c-a2bf-4e96-82e1-71ef8e07b83e	released									released	30.0	acda9261-6c73-4b31-aab3-97a40eddb9bd	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A05Z_demographic	37	-13529		8a10a03b-4e16-529a-9ea8-d36aa532aad9	hispanic or latino	female	not reported	released	Alive	1969		TCGA-AX-A05Z_exposure	Not Reported	29.333333333333332	8fef4403-b6e9-527d-8549-997005b91b4d	150.0	released	66.0	TCGA-AX-A05Z_diagnosis	13529	not reported	0	2175	ac0b991f-ff86-5331-a54d-5a8367993517	Stage IIIA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2006	TCGA-AX-A05Z_treatment_1	TCGA-AX-A05Z_treatment	released	7bb388ef-c59a-564b-aa63-5863916e2192	yes	Pharmaceutical Therapy, NOS	released	5109d5e8-9ef2-5e9e-914e-287c53658681	no	Radiation Therapy, NOS	41df1766-abe6-44e6-ab21-8cd3e698b28e
50f3b3d3-dba8-4d48-bf8d-16d7ebaa18fd.htseq.counts.gz	e0a09fce-dc4c-47ea-b979-74d685871e34	TCGA-D1-A17L-01A-11R-A12I-07	TCGA-D1-A17L-01A-11R	TCGA-D1-A17L-01A-01-TS1			TCGA-D1-A17L-01A-11	TCGA-D1-A17L-01A	TCGA-D1-A17L	67ccb182-3021-4621-bffb-6565574dbc58	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	493	210.0	False	false	BCF17C02-8F6E-419F-AEDF-3AC03AA883E7	1.84	1622de43-ddd8-4a57-a89c-70c427d0a9f6	0.15	23	released	8d3fa01b-39be-4a92-ae19-86efe60b654d	RNA	R	0.15	UV Spec	released	False	a8d2d865-1a57-4906-8b7c-06a1d04b59e8	11	12.0	0.0	0.0	2.0	2.0	15.0	83.0	85.0	TOP	b6048e36-8cb0-4a8f-847b-71bd4bfb3187	released																				released	30.0	5507cf56-068f-406e-aafd-8231f5943cbf	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A17L_demographic	81	-29899		aa2b17e8-1a85-503a-b7ba-7847433aafaf	not hispanic or latino	female	white	released	Alive	1928		TCGA-D1-A17L_exposure	Not Reported	41.576527852893456	86d38bac-5945-5daf-b0b6-d219abc627cc	172.0	released	123.0	TCGA-D1-A17L_diagnosis	29899	not reported	0	802	e3ac8e2c-44a2-5714-87e5-36a3a6ad7198	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-D1-A17L_treatment	TCGA-D1-A17L_treatment_1	released	a36f788d-0a58-5518-9bff-1a14b262aec1	no	Radiation Therapy, NOS	released	a14edebd-e184-5a77-8b4a-8ff9f3925435	no	Pharmaceutical Therapy, NOS	e0a09fce-dc4c-47ea-b979-74d685871e34
63b4d44a-7744-4edc-8582-368958d3cb20.htseq.counts.gz	020e5f20-aba5-4ab0-8213-f52fb47cabb6	TCGA-A5-A0GQ-01A-11R-A118-07	TCGA-A5-A0GQ-01A-11R	TCGA-A5-A0GQ-01A-01-TSA	TCGA-A5-A0GQ-01A-01-MSA		TCGA-A5-A0GQ-01A-11	TCGA-A5-A0GQ-01A	TCGA-A5-A0GQ	c8d672ed-9910-4f80-b222-38c833f55850	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1022	140.0	False	true	7B57FD81-AA42-4C76-BF65-0BA2B3451065	1.81	2386cca4-1d9d-490e-b188-c0e266952a5f	0.16	23	released	cb1bf2ec-3fd1-4559-abe8-c1cf92668a80	RNA	R	0.16	UV Spec	released	False	d8141644-6ed7-4506-982e-831bb096b7b7	11	35.0	20.0	5.0	25.0	0.0	25.0	70.0	70.0	TOP	d2a2d47c-b218-402b-a89b-d1fcb79d0f5f	released	20.0	5.0	3.0	30.0	0.0	92.0	5.0	2.0	BOTTOM	c12ddd4b-5306-4fd7-9d6d-8bb3179f3fc3	released									released	30.0	4805287e-cd6d-48ff-ac6d-19d01052bf8b	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A0GQ_demographic	76	-28078		7847ae82-f710-579e-a09d-765bec5e27a0	not hispanic or latino	female	white	released	Alive	1931		TCGA-A5-A0GQ_exposure	Not Reported	25.333333333333332	255e30c6-58da-5872-aff3-36b8b8bd365e	150.0	released	57.0	TCGA-A5-A0GQ_diagnosis	28078	not reported	0	2247	eb9b510d-cb05-581d-a51b-fc771c65913e	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2007	TCGA-A5-A0GQ_treatment	TCGA-A5-A0GQ_treatment_1	released	c687623c-9fb3-5af2-9b9c-2efcfab2413f	no	Radiation Therapy, NOS	released	dfe64641-8403-5e30-9550-1deef9160a07	no	Pharmaceutical Therapy, NOS	020e5f20-aba5-4ab0-8213-f52fb47cabb6
2eb781e4-4315-4e12-872f-354bd71cc4b1.htseq.counts.gz	6298a24c-7030-4564-87eb-a2f6e14a568a	TCGA-AX-A3G1-01A-11R-A22K-07	TCGA-AX-A3G1-01A-11R	TCGA-AX-A3G1-01A-01-TS1			TCGA-AX-A3G1-01A-11	TCGA-AX-A3G1-01A	TCGA-AX-A3G1	9cc1b44a-ac26-408d-b12b-084e982ccadf	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	765	40.0	False	false	AEAB9EBE-7BDA-45E4-B2D8-82680BE9B4D4	1.77	b774f929-57f2-4f5a-9080-82b390a7a7f9	0.16	23	released	1b6b0c76-931e-4999-8faa-7269202a4cb5	RNA	R	0.16	UV Spec	released	False	d1c66cba-e954-4c86-83d2-1c0332e8ace3	11	3.0	1.0	2.0	0.0	0.0	5.0	93.0	92.0	TOP	0b0d8597-b264-488f-8532-f005dd88efd5	released																				released	20.0	582513c5-474c-484e-ad98-811f0d4e07c6	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A3G1_demographic	84	-31037	624	1991506f-07bc-5bae-9fb7-10ef9fb7c2e4	not hispanic or latino	female	white	released	Dead	1925	2010	TCGA-AX-A3G1_exposure	Not Reported	23.828125	c6e5d35f-8aa4-5eb4-80d7-d9b8f69b1aab	160.0	released	61.0	TCGA-AX-A3G1_diagnosis	31037	not reported	0		96f53917-5907-5e68-b0b1-aee826e436dc	Stage IC	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-AX-A3G1_treatment	TCGA-AX-A3G1_treatment_1	released	c2cf532f-34f5-5000-8181-a48f52295b59	no	Radiation Therapy, NOS	released	5b5cc22c-3bd2-578e-b127-f6b882a2cd6f	no	Pharmaceutical Therapy, NOS	6298a24c-7030-4564-87eb-a2f6e14a568a
34b0bd18-9125-44d0-a018-10fc664cf118.htseq.counts.gz	123aef3a-3347-4da5-8f46-0976cd661ba9	TCGA-BK-A0CC-01A-21R-A16W-07	TCGA-BK-A0CC-01A-21R	TCGA-BK-A0CC-01A-01-BS1	TCGA-BK-A0CC-01A-02-BS2		TCGA-BK-A0CC-01A-21	TCGA-BK-A0CC-01A	TCGA-BK-A0CC	2b865f8c-539f-4cb2-8f08-41709e9511e5	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	52	310.0	False	false	6A2AAC78-98B9-44D4-AF8D-9A132579CC2D	1.78	ac44efb2-7079-49a7-8bc6-285ae009ad89	0.15	23	released	81af7b1c-2c63-4d4e-b432-8016a39d1c54	RNA	R	0.15	UV Spec	released	False	c88e4282-7594-4921-879d-09693b5804d5	21	0.0	0.0	0.0	0.0	0.0	30.0	70.0	70.0	TOP	23e497e5-c8f5-464c-a30d-46ef45319bca	released	0.0	0.0	25.0	0.0	0.0	15.0	60.0	75.0	BOTTOM	8e809120-284a-41e9-8b5e-051de7337526	released									released	40.0	ed22cb10-ebde-4019-9b6d-e19ab573ca94	Primary Tumor	01	released	Not Reported	released	TCGA-BK-A0CC_demographic	69	-25479		f3903f35-c35d-54f4-be3d-4c655da416f4	hispanic or latino	female	black or african american	released	Alive	1941		TCGA-BK-A0CC_exposure	Not Reported	31.16343490304709	d11893ab-e091-5b1f-955d-00e087fb439a	152.0	released	72.0	TCGA-BK-A0CC_diagnosis	25479	not reported	0	1067	7924d7fd-572e-5f05-920f-de2bc56e759f	Stage IIIC	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-BK-A0CC_treatment_1	TCGA-BK-A0CC_treatment	released	8d9f977e-f86d-5d51-86f0-125038780ed2	yes	Pharmaceutical Therapy, NOS	released	af85e4ac-f4ce-532c-ad60-f6c582a60a9e	yes	Radiation Therapy, NOS	123aef3a-3347-4da5-8f46-0976cd661ba9
a5e01168-a45e-4546-b52e-50315aec4567.htseq.counts.gz	ac66b730-622a-4df8-abd6-a66c87bfcd1a	TCGA-D1-A1O8-01A-11R-A14D-07	TCGA-D1-A1O8-01A-11R	TCGA-D1-A1O8-01A-01-TSA			TCGA-D1-A1O8-01A-11	TCGA-D1-A1O8-01A	TCGA-D1-A1O8	21faf1a4-f6d3-4cc6-a49a-04b8541ef598	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	147	200.0	False	false	8E7FDFD5-892F-4671-8172-FC2BFB800AE9	1.77	980faf04-5313-4f74-99b7-ca004f698a93	0.16	23	released	26e613ad-8d3a-47ae-b48a-e7dd1a5d4b06	RNA	R	0.16	UV Spec	released	False	d1f1a2cf-f1eb-4337-8d89-ccc80433e1f0	11	30.0	30.0	10.0	30.0	0.0	10.0	80.0	80.0	TOP	ad550d7e-4eb0-4ec5-8abd-f896d891c6fe	released																				released	30.0	1efc3a5a-d36d-4973-a725-2eeb73cce08e	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A1O8_demographic	70	-25789	120	2e3c3f4c-ceef-53e4-b6b8-a078693197c6	not hispanic or latino	female	white	released	Dead	1940	2010	TCGA-D1-A1O8_exposure	Not Reported	31.221303948576676	350173d6-e34b-5828-bedd-8f24bd9a7533	165.0	released	85.0	TCGA-D1-A1O8_diagnosis	25789	not reported	0		161cef11-d172-5366-9b02-fd2be1a2bb60	Stage IIIC	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-D1-A1O8_treatment_1	TCGA-D1-A1O8_treatment	released	19e75ecb-77be-502c-a084-819e38dde0d5	no	Pharmaceutical Therapy, NOS	released	17f36da0-2cc8-5370-a870-ad3811c808c7	no	Radiation Therapy, NOS	ac66b730-622a-4df8-abd6-a66c87bfcd1a
ef56f0c2-dae0-4aa0-9240-f8b2d2d1acad.htseq.counts.gz	cb45df54-ffce-41be-82d3-8df7866487f1	TCGA-DI-A1NN-01A-11R-A16F-07	TCGA-DI-A1NN-01A-11R	TCGA-DI-A1NN-01A-01-TSA			TCGA-DI-A1NN-01A-11	TCGA-DI-A1NN-01A	TCGA-DI-A1NN	944a102f-3475-45aa-9e30-4b92d1449f00	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	813	300.0	False	false	EBBDE504-29C9-4662-8D06-44E8CBAD0741	1.62	1857cddd-76d1-403b-a14e-f14d0781f68b	0.16	23	released	6c5afeee-d8cb-4170-809f-a4563f8381e7	RNA	R	0.16	UV Spec	released	False	741adcaa-6173-4250-9c93-b67ffc59cd7d	11	40.0	10.0	10.0	30.0	0.0	10.0	80.0	80.0	TOP	3b1b22bc-b0b7-4b19-a597-ada548ed1063	released																				released	30.0	5fabce9c-0dfb-4b0d-8478-599fd181a84f	Primary Tumor	01	released	Not Reported	released	TCGA-DI-A1NN_demographic	63	-23026		603ef2c1-6a1b-5889-926a-2cb5e9eaaba8	not hispanic or latino	female	white	released	Alive	1945		TCGA-DI-A1NN_exposure	Not Reported	23.722810651876106	1c3f6dc1-9e72-5928-82eb-c87a4166b5fc	173.0	released	71.0	TCGA-DI-A1NN_diagnosis	23026	not reported	0	1076	3747482b-b1d6-5c36-9a94-1ab52a2ab851	Stage IIIC	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-DI-A1NN_treatment_1	TCGA-DI-A1NN_treatment	released	8cb75de4-f6ec-51d2-a0b4-feeb4135f148	yes	Pharmaceutical Therapy, NOS	released	f0d98b6f-8a12-5fa4-b2ff-bae5a61774fb	no	Radiation Therapy, NOS	cb45df54-ffce-41be-82d3-8df7866487f1
304a977a-e34e-4bf5-b4c0-3d06eb1d6519.htseq.counts.gz	c1d4ee98-e136-4db2-8515-2542022becbf	TCGA-B5-A0K9-01A-21R-A104-07	TCGA-B5-A0K9-01A-21R	TCGA-B5-A0K9-01A-02-TSB	TCGA-B5-A0K9-01A-02-BSB		TCGA-B5-A0K9-01A-21	TCGA-B5-A0K9-01A	TCGA-B5-A0K9	4485cc98-5d58-4eb4-8325-7d1a617b6461	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	182	600.0	False	true	8278F457-C0A5-4441-9105-3FC015E3F0EF	1.86	ac3970c9-575a-4d72-a2b3-45f1ab671bbb	0.16	23	released	dbeba3e1-271c-488a-b399-ad564295234a	RNA	R	0.16	UV Spec	released	False	df7d04b0-e641-43f2-8479-ef96b766b531	21	20.0	0.0	10.0	10.0	20.0	0.0	70.0	80.0	TOP	9c0b063a-0af6-4404-9a1b-7ee17daa8b7c	released	20.0	0.0	10.0	20.0	20.0	0.0	70.0	80.0	BOTTOM	99a06147-7fc5-45d9-8872-9206ec394beb	released									released	30.0	52a96216-708f-43f2-a923-130a1c35922d	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A0K9_demographic	88	-32289	409	7a511403-4d2c-5581-b0ba-8f177e17b6dc	not reported	female	white	released	Dead	1921		TCGA-B5-A0K9_exposure	Not Reported	25.390625	52641871-d85c-58a0-b473-0dd324e64ba9	160.0	released	65.0	TCGA-B5-A0K9_diagnosis	32289	not reported	0	335	309688e1-4ee9-5fba-8b99-74fd8ef540df	Stage II	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-B5-A0K9_treatment	TCGA-B5-A0K9_treatment_1	released	c96d3ae9-3d27-5d1c-8137-629d5df17dc1	yes	Radiation Therapy, NOS	released	9c4c7313-7287-59fc-a8cb-2b06c55ebb52	no	Pharmaceutical Therapy, NOS	c1d4ee98-e136-4db2-8515-2542022becbf
d3392d40-4c1e-44cf-9a92-7c496641e2f6.htseq.counts.gz	c9bf994f-0ee7-433b-be59-5a70169319bf	TCGA-FI-A2CY-01A-11R-A17B-07	TCGA-FI-A2CY-01A-11R	TCGA-FI-A2CY-01A-01-TS1			TCGA-FI-A2CY-01A-11	TCGA-FI-A2CY-01A	TCGA-FI-A2CY	b9ab4ab9-ba9c-4a01-9f61-55c82b924936	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	1067	110.0	False	true	2C4CE5F5-AD46-427E-A787-529DF9FA891A	1.91	4bcff10b-20ad-4635-bbcd-855826277b8a	0.18	23	released	25458bc2-0601-468e-be09-a1fb2595612c	RNA	R	0.18	UV Spec	released	False	f5ab21cf-3560-49ee-9659-0022765a8088	11	5.0	8.0	2.0	2.0	0.0	2.0	96.0	98.0	TOP	f893b64a-d23a-423b-9474-1371d91a30be	released																				released	30.0	047b688c-aa29-4a63-b555-9275af4b0cee	Primary Tumor	01	released	Not Reported	released	TCGA-FI-A2CY_demographic	60	-22098		fe1253ff-6372-59d4-95d5-b7799dd58660	not hispanic or latino	female	black or african american	released	Alive	1948		TCGA-FI-A2CY_exposure	Not Reported	47.56242568370987	d5dfd0ca-a27d-5859-a8a4-b315f9f4d065	145.0	released	100.0	TCGA-FI-A2CY_diagnosis	22098	not reported	0	2080	bf7ef25c-4fee-555f-a5ba-4f5029f881f0	Stage IA	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-FI-A2CY_treatment_1	TCGA-FI-A2CY_treatment	released	40b84949-b683-5f68-9450-2324242bbeaa	yes	Pharmaceutical Therapy, NOS	released	da046201-0637-5609-998e-7b8f436ca222	no	Radiation Therapy, NOS	c9bf994f-0ee7-433b-be59-5a70169319bf
a566f407-882f-461b-b029-6d8c1196daec.htseq.counts.gz	704970d8-97f3-491e-8ec8-01af464a4290	TCGA-AP-A1DR-01A-11R-A137-07	TCGA-AP-A1DR-01A-11R	TCGA-AP-A1DR-01A-01-TSA			TCGA-AP-A1DR-01A-11	TCGA-AP-A1DR-01A	TCGA-AP-A1DR	0f064588-2d7e-439a-90a6-dfa17bb8af15	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1095	270.0	False	true	75A10A08-04CB-49C2-8086-5F7B1D57524E	1.82	2aacc974-7ee5-4be2-b511-1543745df0bf	0.18	23	released	d6cc0fb3-b39c-423c-8736-517198c10b76	RNA	R	0.18	UV Spec	released	False	83a8deaa-6db9-4554-afb9-953c76d377a5	11	4.0	6.0	2.0	2.0	0.0	10.0	88.0	90.0	TOP	22258451-b020-41e5-a02e-7f8121c85285	released																				released	30.0	438480e7-9b80-44a4-89d8-6b7a27028f35	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A1DR_demographic	59	-21904		af4a58b5-00b5-54cb-9916-1f23f97edda9	not reported	female	black or african american	released	Alive	1949		TCGA-AP-A1DR_exposure	Not Reported	42.578125	07fb36b0-b3e2-5f89-82bc-2479fd1930ee	160.0	released	109.0	TCGA-AP-A1DR_diagnosis	21904	not reported	0	1495	7958c319-6c8a-5ba4-99d0-4133f679682f	Stage IIIC1	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-AP-A1DR_treatment	TCGA-AP-A1DR_treatment_1	released	7d3bee46-6a25-5eae-be92-a210085b7b0a	yes	Radiation Therapy, NOS	released	c3f81d20-552e-5271-b6ca-65243b33e894	yes	Pharmaceutical Therapy, NOS	704970d8-97f3-491e-8ec8-01af464a4290
dcaebf7f-b26f-4348-afb2-7092ee3a1e76.htseq.counts.gz	809f03a3-2ad4-4fda-a9e8-0e3a44245ada	TCGA-B5-A11Q-01A-11R-A118-07	TCGA-B5-A11Q-01A-11R	TCGA-B5-A11Q-01A-01-TS1	TCGA-B5-A11Q-01A-01-BS1		TCGA-B5-A11Q-01A-11	TCGA-B5-A11Q-01A	TCGA-B5-A11Q	af852215-5a4b-44b4-8e8e-b887dcb3cf8c	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	702	120.0	False	true	5117F490-9CE1-465F-BDF7-7B545B314703	1.82	3b8301c9-646f-43e7-9b8c-7690294d0356	0.16	23	released	89f82d06-03d9-4321-bce7-d34c70fe2c28	RNA	R	0.16	UV Spec	released	False	c74c3dad-9483-4f7c-9533-46149f99178d	11	1.0	1.0	2.0	0.0	0.0	30.0	68.0	70.0	TOP	45ec2811-42b4-4c1c-b370-085935633563	released	8.0	5.0	15.0	6.0	0.0	25.0	60.0	75.0	BOTTOM	792af7c6-c6c8-4e0d-af98-3bd9be86b1d5	released									released	30.0	c9b18c70-4d2b-4cd8-b0a8-a4226edab816	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A11Q_demographic	64	-23538		78723c73-98b3-5130-8a7b-d983311f213b	not reported	female	white	released	Alive	1944		TCGA-B5-A11Q_exposure	Not Reported	33.94930751128428	462ffbb6-c888-5fa9-a8ca-68abba7c96e6	161.0	released	88.0	TCGA-B5-A11Q_diagnosis	23538	not reported	0	976	4dd34623-3977-5703-a403-b19e465e46ab	Stage IIIA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-B5-A11Q_treatment	TCGA-B5-A11Q_treatment_1	released	9bc0ffaa-75f6-5a59-9284-3fb18baee886	yes	Radiation Therapy, NOS	released	562755f1-7760-5339-a1a6-61e0ea997562	yes	Pharmaceutical Therapy, NOS	809f03a3-2ad4-4fda-a9e8-0e3a44245ada
05cc0a39-c8b7-4126-9234-a842f093e6f7.htseq.counts.gz	d018a71f-cac1-496e-8dec-19103e159377	TCGA-BS-A0U7-01A-21R-A104-07	TCGA-BS-A0U7-01A-21R	TCGA-BS-A0U7-01A-02-TSB	TCGA-BS-A0U7-01A-02-BSB		TCGA-BS-A0U7-01A-21	TCGA-BS-A0U7-01A	TCGA-BS-A0U7	282ddc43-922d-4f1f-80c7-6ba2de23b7bc	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	2466	190.0	False	false	BE83021F-D4D5-4ECA-8484-8A37B2FE67C0	1.75	cf1bf8d7-3971-4919-93ef-2ef85b3dc61d	0.16	23	released	b96b6d73-476d-4c95-a281-b30a829b0630	RNA	R	0.16	UV Spec	released	False	22839ec3-102f-4651-8fc9-3f1b0cb21553	21	30.0	20.0	5.0	40.0	0.0	15.0	80.0	80.0	TOP	4dcaa447-1ca4-408e-969d-3f1064c1cc45	released	30.0	10.0	5.0	40.0	0.0	15.0	80.0	80.0	BOTTOM	b12f3b4c-40d9-43b8-ab29-84295ed11fda	released									released	30.0	803c6d51-0eba-475a-9c3c-7b3401787907	Primary Tumor	01	released	Not Reported	released	TCGA-BS-A0U7_demographic	63	-23166	935	4a0c54c1-ff0b-5393-b614-c022bb0a0ace	not hispanic or latino	female	white	released	Dead	1940	2005	TCGA-BS-A0U7_exposure	Not Reported	24.242424242424242	5ddc200a-7101-59e9-a9a0-5f46406544f9	165.0	released	66.0	TCGA-BS-A0U7_diagnosis	23166	not reported	0		fb3b9f51-ed44-507f-b588-e6080170cedf	Stage IC	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2003	TCGA-BS-A0U7_treatment_1	TCGA-BS-A0U7_treatment	released	44b315fd-75ff-50e0-8ec0-1ff7ef8c247c	no	Pharmaceutical Therapy, NOS	released	b9e5f331-24ec-5b4d-87ea-640d24b17ef0	no	Radiation Therapy, NOS	d018a71f-cac1-496e-8dec-19103e159377
1d8a9e65-6c5f-4243-bf27-aada9a0b8b6c.htseq.counts.gz	3a316df6-96dd-4454-b9d7-afca945c57e4	TCGA-A5-A0VQ-01A-11R-A104-07	TCGA-A5-A0VQ-01A-11R	TCGA-A5-A0VQ-01A-01-BSA	TCGA-A5-A0VQ-01A-01-TSA		TCGA-A5-A0VQ-01A-11	TCGA-A5-A0VQ-01A	TCGA-A5-A0VQ	23489245-48d7-4f19-8a42-e23b1181412b	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	133	320.0	False	true	6FE81DF0-D9DF-420F-8A91-40421175A12F	1.88	e8b8fe3e-29ff-4f1a-af7a-d12b8cd5560d	0.15	23	released	74bc971d-be37-408a-b5d1-d2f9de52c98e	RNA	R	0.15	UV Spec	released	False	80541928-e001-4bf2-8a46-610bf4f0e177	11	20.0	0.0	10.0	10.0	20.0	10.0	60.0	70.0	BOTTOM	ed5d178c-9d20-4b8c-8600-9de6fef1b83b	released	10.0	0.0	10.0	10.0	0.0	10.0	80.0	90.0	TOP	98c682c5-0192-4c14-90aa-99ad80ae3feb	released									released	30.0	952cb6a5-7527-470a-978e-edd44e3a368f	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A0VQ_demographic	62	-22995		a1684e59-c0e1-56da-b466-e8365faf08b9	hispanic or latino	female	not reported	released	Alive	1948		TCGA-A5-A0VQ_exposure	Not Reported	35.651337926614325	2c703da9-e449-5f9e-a2fb-74d325f0b3df	158.0	released	89.0	TCGA-A5-A0VQ_diagnosis	22995	not reported	0	485	ba1222b9-d518-5a52-8a8e-a57934b985f1	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-A5-A0VQ_treatment_1	TCGA-A5-A0VQ_treatment	released	960f4f2b-da42-516f-8261-48d5d80923b8	yes	Pharmaceutical Therapy, NOS	released	6ff4b65e-578e-5226-8c6a-276afbfda6ec	yes	Radiation Therapy, NOS	3a316df6-96dd-4454-b9d7-afca945c57e4
f5956574-d5c8-4e1e-accc-7198459a0cf5.htseq.counts.gz	d97ca398-31b0-4395-bfc5-1c19495a8322	TCGA-BS-A0TE-01A-11R-A104-07	TCGA-BS-A0TE-01A-11R	TCGA-BS-A0TE-01A-01-MS1	TCGA-BS-A0TE-01A-01-BS1		TCGA-BS-A0TE-01A-11	TCGA-BS-A0TE-01A	TCGA-BS-A0TE	09066fbf-6a1d-46c9-a4c5-c53340c3d1ba	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1835	50.0	False	false	8FD57BC9-19A1-4427-B68F-3E58639FEA40	1.82	8edc23c4-43f8-4dd3-8c40-257297393492	0.16	23	released	0da9ed06-b23b-47aa-9f9b-72f2566be73e	RNA	R	0.16	UV Spec	released	False	17623c7f-c680-4822-b893-5a4a9f8dda1b	11	40.0	20.0	10.0	30.0	0.0	10.0	80.0	80.0	TOP	f7dc183e-d3f4-4c00-8b8d-2ab62af3bd83	released	40.0	20.0	10.0	30.0	0.0	5.0	85.0	85.0	BOTTOM	6c8d0b82-77de-42e1-8513-fdd133c95db4	released									released	20.0	2d1226a1-1c88-422b-9a8d-316bebeb65fd	Primary Tumor	01	released	Not Reported	released	TCGA-BS-A0TE_demographic	35	-12983	146	23a46023-c970-5abe-aaaf-3bdc2e5b5cdb	not hispanic or latino	female	asian	released	Dead	1970	2005	TCGA-BS-A0TE_exposure	Not Reported	32.242063492063494	4894509c-6db8-53f0-9707-4932f8f9ca69	168.0	released	91.0	TCGA-BS-A0TE_diagnosis	12983	not reported	0		d5fa3d4b-bfb9-5720-8ce5-6dfeab7ef6a1	Stage IVB	C54.9	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Corpus uteri	released	No	Corpus uteri	not reported	not reported	2005	TCGA-BS-A0TE_treatment_1	TCGA-BS-A0TE_treatment	released	d70d5427-f069-50ee-80b2-6c18dd1183c5	yes	Pharmaceutical Therapy, NOS	released	603f066d-4e7e-52c4-a1f1-2fbe9a5366d7	yes	Radiation Therapy, NOS	d97ca398-31b0-4395-bfc5-1c19495a8322
059bcafc-4a14-4839-b3a5-f090afa886f5.htseq.counts.gz	494e8c5c-c42b-41c0-bf33-96897d815bc0	TCGA-BS-A0T9-01A-11R-A12I-07	TCGA-BS-A0T9-01A-11R	TCGA-BS-A0T9-01A-01-TSA	TCGA-BS-A0T9-01A-01-BSA		TCGA-BS-A0T9-01A-11	TCGA-BS-A0T9-01A	TCGA-BS-A0T9	4eb95566-0e73-4260-853e-f7df650667a0	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	2009	600.0	False	false	C9151621-D012-48F9-B7E1-F540567E791C	1.78	8947d611-8c3f-4096-9479-063660ee8607	0.15	23	released	3316e4da-ea92-442e-b8ed-2db8a0654cba	RNA	R	0.15	UV Spec	released	False	5b7d0948-f8ad-431c-8b14-8fe39bc6ed0f	11	40.0	5.0	15.0	20.0	0.0	15.0	70.0	70.0	TOP	f1c68c45-c2e2-447a-9798-a60e4ff5da69	released	40.0	10.0	5.0	30.0	0.0	15.0	80.0	80.0	BOTTOM	4e3e1a9f-9dc7-407f-844a-3b74a90dc800	released									released	30.0	3c9ff865-013f-427a-8d4d-c8e60ea346a1	Primary Tumor	01	released	Not Reported	released	TCGA-BS-A0T9_demographic	39	-14253	1428	d78ace8f-6085-5241-8f2c-ca6c81a6e286	not hispanic or latino	female	native hawaiian or other pacific islander	released	Dead	1966	2008	TCGA-BS-A0T9_exposure	Not Reported	40.03673094582185	5d92d908-9efc-583e-9ac1-358a855677e5	165.0	released	109.0	TCGA-BS-A0T9_diagnosis	14253	not reported	0		09579d8d-9ca2-5ee9-a9bb-ee05496857cf	Stage IVB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2005	TCGA-BS-A0T9_treatment_1	TCGA-BS-A0T9_treatment	released	b1807c17-f004-53cd-9155-f4e06373f2ec	yes	Pharmaceutical Therapy, NOS	released	a22838a0-ead2-59c5-bf1d-975911f5ca40	yes	Radiation Therapy, NOS	494e8c5c-c42b-41c0-bf33-96897d815bc0
e227370b-332f-4fba-9a48-b894f88df55f.htseq.counts.gz	30eb6981-43e3-4aff-a054-aa0782421af4	TCGA-AW-A1PO-01A-12R-A157-07	TCGA-AW-A1PO-01A-12R	TCGA-AW-A1PO-01A-01-TSA			TCGA-AW-A1PO-01A-12	TCGA-AW-A1PO-01A	TCGA-AW-A1PO	4cb4dd07-0ce5-4de7-a0bd-546183949efe	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	331	190.0	False	true	B5351001-32B2-4BA9-998D-F6631F6BE705	1.92	c9bdd9d8-f0f6-4abb-aca8-11d274f90995	0.16	23	released	feb5cf8a-fe87-4963-bfa4-daf0f6a9bdb3	RNA	R	0.16	UV Spec	released	False	c9b213f5-4469-43c8-bc6e-4b9fe9799e11	12	40.0	20.0	20.0	30.0	0.0	10.0	70.0	70.0	TOP	5340cd5f-f6d0-4789-905b-55ae39f3912d	released																				released	30.0	1576c6c1-b9f0-4acd-9a75-e5f2d5a4ecc1	Primary Tumor	01	released	Not Reported	released	TCGA-AW-A1PO_demographic	66	-24225		725602a2-1229-515a-b401-94a1ead148af	not hispanic or latino	female	white	released	Alive	1944		TCGA-AW-A1PO_exposure	Not Reported	22.100289590001523	02fc3e18-ba31-5456-b408-3aec1e39e596	162.0	released	58.0	TCGA-AW-A1PO_diagnosis	24225	not reported	0	17	35cb1cd4-f910-5479-81cf-31d0e38e0ee2	Stage IIIA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-AW-A1PO_treatment_1	TCGA-AW-A1PO_treatment	released	abee0683-764c-560e-a7c5-0516c49ab588	no	Pharmaceutical Therapy, NOS	released	ef2d4b93-0146-59e3-b0bf-3a126334bd82	no	Radiation Therapy, NOS	30eb6981-43e3-4aff-a054-aa0782421af4
26ab66b2-48c3-4916-b1db-d85d80726683.htseq.counts.gz	8d861770-7717-4b91-bdd4-1d1cdc589de6	TCGA-AJ-A3I9-01A-11R-A22K-07	TCGA-AJ-A3I9-01A-11R	TCGA-AJ-A3I9-01A-01-TS1			TCGA-AJ-A3I9-01A-11	TCGA-AJ-A3I9-01A	TCGA-AJ-A3I9	e5d64754-15e8-494e-b7f7-25cf2819fe4c	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	84	27.0	False	false	095789FC-7C20-4A6A-A6F0-13315481EBD0	1.75	e7517bb2-68d3-49c5-b298-4203845ae7db	0.17	23	released	3c04af05-74ac-4a25-99f9-366be58baec7	RNA	R	0.17	UV Spec	released	False	a63beb5c-aa8a-4a02-90a5-aeab21f16e18	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	TOP	628e78e1-1e95-4648-b0ee-7dd4c2e4335f	released																				released	27.0	53e1feb9-81c1-473d-a8ae-eb481a26b726	Primary Tumor	01	released	Not Reported	released	TCGA-AJ-A3I9_demographic	52	-19139	519	426e16e6-d6a6-50ae-a3ae-748b39b15a60	not hispanic or latino	female	white	released	Dead	1959		TCGA-AJ-A3I9_exposure	Not Reported	28.125	00001051-e0ee-5249-9d57-1607d3cef8a0	160.0	released	72.0	TCGA-AJ-A3I9_diagnosis	19139	not reported	0	39	f7872574-04be-5b1b-9731-c3f881015922	Stage II	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-AJ-A3I9_treatment	TCGA-AJ-A3I9_treatment_1	released	d54609df-37f6-560c-aa3b-5d650d6f6dec	yes	Radiation Therapy, NOS	released	59d2d0dc-a1a6-549c-9015-6ef9941fda7a	yes	Pharmaceutical Therapy, NOS	8d861770-7717-4b91-bdd4-1d1cdc589de6
de5213cf-c59a-4c75-910b-927029383c2b.htseq.counts.gz	978ce3b0-e37f-4a77-bac8-f57fa21d4d04	TCGA-AJ-A8CV-01A-11R-A37O-07	TCGA-AJ-A8CV-01A-11R	TCGA-AJ-A8CV-01A-01-TS1			TCGA-AJ-A8CV-01A-11	TCGA-AJ-A8CV-01A	TCGA-AJ-A8CV	4557d1fb-9786-4780-bd33-02e9da04b7e3	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	966	30.0	False	false	9A08EA28-EF0B-40CE-B2B4-0A0B0EE1EDA7	1.91	ff8eb6f4-876e-4b08-8ed7-8c7930765bee	0.15	23	released	25614d16-fbef-404d-af38-2eca2174ab2f	RNA	R	0.15	UV Spec	released	False	cf43f7e0-8d6e-4b0c-b79a-2158bd30daff	11	5.0	5.0	0.0	0.0	10.0	30.0	60.0	60.0	TOP	ec36b936-b8b7-4ea9-9040-50173ca4a907	released																				released	30.0	9388a1b3-fb16-4cfb-9359-b1a3fb7fb048	Primary Tumor	01	released	Not Reported	released	TCGA-AJ-A8CV_demographic	58	-21336		2a8d54bd-2634-51fc-86cf-c8e882f98f3b	not reported	female	black or african american	released	Alive	1953		TCGA-AJ-A8CV_exposure	Not Reported	35.33859303090072	975f1253-f4cb-506a-8e58-08ee4c050d11	156.0	released	86.0	TCGA-AJ-A8CV_diagnosis	21336	not reported	0	1068	de2aacc8-38c0-5d11-ba43-f8971d5d018b	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-AJ-A8CV_treatment_1	TCGA-AJ-A8CV_treatment	released	d87655eb-582a-5d4b-959b-61d2e0383b56	no	Pharmaceutical Therapy, NOS	released	75d14244-c9f0-56cf-9117-9e956bab128c	yes	Radiation Therapy, NOS	978ce3b0-e37f-4a77-bac8-f57fa21d4d04
32bd99f2-eefe-4dbf-ac0b-dcbe1d0da9d4.htseq.counts.gz	2bf7ae6f-5b9a-4556-815b-52691ba77d36	TCGA-B5-A121-01A-31R-A118-07	TCGA-B5-A121-01A-31R	TCGA-B5-A121-01A-03-TS3	TCGA-B5-A121-01A-03-BS3		TCGA-B5-A121-01A-31	TCGA-B5-A121-01A	TCGA-B5-A121	19511f9e-7b0e-4a06-998d-c1837d37c6ec	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	188	280.0	False	true	82B20A1F-99AC-4CC8-BAF2-B7132809D4F2	1.87	3e0f0d9d-31cc-4e48-b4ca-d53deec9b7d3	0.16	23	released	4b1f1fb5-2f05-4846-9fc8-5c1fb9f6ceae	RNA	R	0.16	UV Spec	released	False	d9209347-8eec-434a-83d7-aac36f7ae26b	31	25.0	3.0	0.0	0.0	0.0	15.0	85.0	85.0	TOP	f7e46d60-f100-429d-a482-75cbd14a1a69	released									BOTTOM	9c9b2d19-3901-4818-9c4f-d0a6f8e931ec	released									released	30.0	d7a7ecf1-7771-49c0-9756-302adba3a2c9	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A121_demographic	57	-21018		519905a6-d464-5f72-bbe1-83bc661c1821	not reported	female	white	released	Alive	1953		TCGA-B5-A121_exposure	Not Reported	29.38475665748393	4ee57eea-fd10-5615-9b3e-77b11ae176ab	165.0	released	80.0	TCGA-B5-A121_diagnosis	21018	not reported	0	504	c8c3a343-0666-5f03-866f-bdfe11bb12ed	Stage IIIA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-B5-A121_treatment_1	TCGA-B5-A121_treatment	released	976f508e-d8b5-5c40-a894-cab323008808	no	Pharmaceutical Therapy, NOS	released	9628bbe7-f630-591b-b8d4-a05ad6f7eddd	yes	Radiation Therapy, NOS	2bf7ae6f-5b9a-4556-815b-52691ba77d36
82417b86-9cdf-4cfa-a917-685b21836bc2.htseq.counts.gz	65049ff9-a159-44b7-886c-126092197d50	TCGA-AX-A1CN-01A-11R-A137-07	TCGA-AX-A1CN-01A-11R	TCGA-AX-A1CN-01A-01-TS1			TCGA-AX-A1CN-01A-11	TCGA-AX-A1CN-01A	TCGA-AX-A1CN	d70b3c6e-04da-4abc-a832-a461e4cfcc94	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	701	110.0	False	false	D0FB2179-60D4-4B3C-9D88-B07D802F772E	1.88	222512dc-7088-4c86-a82c-99c2e4cd427c	0.17	23	released	82bb7a35-4c00-446e-a0fb-576b4eaa6348	RNA	R	0.17	UV Spec	released	False	0756884a-ae2e-41e8-8abb-4fc9b40055f9	11	1.0	0.0	10.0	1.0	13.0	2.0	75.0	90.0	TOP	5940e78d-9fa5-436e-bb23-b4db5e9c415d	released																				released	30.0	785a9c46-0629-4e15-90c0-9437644ff9bf	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A1CN_demographic	54	-19860		5f17d402-31f5-519a-8045-d4092aead279	not hispanic or latino	female	white	released	Alive	1955		TCGA-AX-A1CN_exposure	Not Reported	47.673469387755105	6f684f0d-f908-5d53-8e69-293851d178cc	175.0	released	146.0	TCGA-AX-A1CN_diagnosis	19860	not reported	0	1143	05e7f7c9-ee29-5096-97c2-f5f08b948f5f	Stage IIB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-AX-A1CN_treatment	TCGA-AX-A1CN_treatment_1	released	ff0adede-d697-563d-b250-3b60006fddbc	yes	Radiation Therapy, NOS	released	9bd36123-3304-590f-9379-8e77bab80731	yes	Pharmaceutical Therapy, NOS	65049ff9-a159-44b7-886c-126092197d50
81f11356-bf0c-47ce-a5ed-6728f22c6dc3.htseq.counts.gz	8494cdcb-9896-4f1f-a369-27b7577fa3f2	TCGA-BK-A139-01A-11R-A118-07	TCGA-BK-A139-01A-11R	TCGA-BK-A139-01A-01-BSA	TCGA-BK-A139-01A-01-TSA		TCGA-BK-A139-01A-11	TCGA-BK-A139-01A	TCGA-BK-A139	8d9e4917-334b-4c76-aee1-1e22be772db0	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	175	770.0	False	false	5F8C376B-31F8-4566-8EBF-21E7F4E6499D	1.84	4b398b99-8916-440b-9ed5-9ed67db19b9b	0.15	23	released	e8da3efa-c60c-43a1-af72-3772da62d2b2	RNA	R	0.15	UV Spec	released	False	4e7f7eeb-0b1c-4f53-842c-229ea461c6d8	11	50.0	20.0	60.0	50.0	0.0	10.0	30.0	90.0	BOTTOM	08b415f6-1a0a-4b55-96a1-3a26b26e7c0b	released	20.0	10.0	20.0	20.0	0.0	20.0	60.0	80.0	TOP	18724d00-97cf-48c0-b7bb-638a80ef5e39	released									released	30.0	d777e49b-cb47-44f3-ad42-4d23af7e296c	Primary Tumor	01	released	Not Reported	released	TCGA-BK-A139_demographic	74	-27077	943	283a931a-a653-50c4-992a-c69e21c6af1c	not hispanic or latino	female	white	released	Dead	1936		TCGA-BK-A139_exposure	Not Reported	24.87771968291449	8155bfc1-1c5f-5642-9a14-8b020eeb7bf3	154.0	released	59.0	TCGA-BK-A139_diagnosis	27077	not reported	0	309	fff68755-ed35-52d0-9a4f-86a4b19bc82e	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-BK-A139_treatment	TCGA-BK-A139_treatment_1	released	6c775c6a-d5bf-5bd8-8b8c-3a27635d6c8e	no	Radiation Therapy, NOS	released	de6d0cd2-02d1-51e0-9e71-feb4f4d24986	no	Pharmaceutical Therapy, NOS	8494cdcb-9896-4f1f-a369-27b7577fa3f2
04e04502-153b-4d9f-b9d5-d3c93e707938.htseq.counts.gz	fda1235b-b703-430b-adc1-66d171a7447c	TCGA-AX-A2HA-11A-11R-A18M-07	TCGA-AX-A2HA-11A-11R	TCGA-AX-A2HA-11A-01-TSA			TCGA-AX-A2HA-11A-11	TCGA-AX-A2HA-11A	TCGA-AX-A2HA	9d84dff8-6c19-4881-93c6-56c98a3049b5	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	2188	100.0	False	false		2.0	0f659732-62d9-4b13-b4c4-cd6b231bdedb	0.18	23	released	01b3f072-daab-4c91-9bc3-f04e02ae90eb	RNA	R	0.18	UV Spec	released	False	59e667ec-493b-4863-99ba-b44b0dfe757b	11	1.0	0.0	1.0	0.0	99.0	0.0	0.0	0.0	TOP	39fd9b44-cd7d-42ab-ae80-90fa4b1402ab	released																				released	30.0	94bc7e3c-bfae-4148-8995-8ab104370a8f	Solid Tissue Normal	11	released	Not Reported	released	TCGA-AX-A2HA_demographic	35	-13142		dbd03450-1805-5569-9589-3d0455324e64	not reported	female	white	released	Alive	1970		TCGA-AX-A2HA_exposure	Not Reported	21.513858510523864	6b0affe5-8f9e-57cc-814d-5edb7d7d1245	167.0	released	60.0	TCGA-AX-A2HA_diagnosis	13142	not reported	0	2475	daae28ec-ef21-5f4d-9d8f-201866caca25	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2005	TCGA-AX-A2HA_treatment	TCGA-AX-A2HA_treatment_1	released	9fc2141a-cb1f-52c6-a705-83396cfe0c7b	no	Radiation Therapy, NOS	released	e3b3df41-6297-5045-b26d-fa07f07bb858	no	Pharmaceutical Therapy, NOS	fda1235b-b703-430b-adc1-66d171a7447c
3479c3d9-935a-43a9-93c5-17e268c01fa8.htseq.counts.gz	a44e99c8-99ab-4049-a4c8-636001ee78ce	TCGA-EY-A1G7-01A-11R-A13S-07	TCGA-EY-A1G7-01A-11R	TCGA-EY-A1G7-01A-01-TSA			TCGA-EY-A1G7-01A-11	TCGA-EY-A1G7-01A	TCGA-EY-A1G7	6b2e93b9-8271-4205-842e-0b7292b8115a	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1002	140.0	False	false	2803014E-7E68-463F-BF3C-C5E4DF9FA421	1.9	c3c8ccb3-db16-4cc6-b790-204473be0f25	0.18	23	released	3c4b416f-49d2-4cf0-bdea-f41d5fee56f9	RNA	R	0.18	UV Spec	released	False	d7447985-1171-41f1-b180-38029f36165c	11	20.0	0.0	20.0	20.0	20.0	10.0	50.0	70.0	TOP	1a8426f8-f491-44f9-9b60-773a7953e6ed	released																				released	30.0	730cb784-2266-4b5c-98b9-6cd7ebbe989d	Primary Tumor	01	released	Not Reported	released	TCGA-EY-A1G7_demographic	86	-31603	189	d186577b-35c7-5ccd-9d88-b083e445362f	not hispanic or latino	female	white	released	Dead	1922	2008	TCGA-EY-A1G7_exposure	Not Reported	37.27906670760054	03d8b791-b575-573e-aa4b-eec488297d28	151.0	released	85.0	TCGA-EY-A1G7_diagnosis	31603	not reported	0		f85591b5-ba91-59d8-9e44-7a4af2e80e25	Stage II	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2008	TCGA-EY-A1G7_treatment_1	TCGA-EY-A1G7_treatment	released	15b3c6f7-a6b4-5882-bfd0-fa971adbc01a	no	Pharmaceutical Therapy, NOS	released	52864ae8-530f-537e-a9eb-04e7a720d395	yes	Radiation Therapy, NOS	a44e99c8-99ab-4049-a4c8-636001ee78ce
6511edbd-3674-4aa2-9927-47575f33afd5.htseq.counts.gz	02703362-83cc-4b7c-815f-81f33f475c31	TCGA-BK-A6W3-01A-12R-A34R-07	TCGA-BK-A6W3-01A-12R	TCGA-BK-A6W3-01A-01-TS1			TCGA-BK-A6W3-01A-12	TCGA-BK-A6W3-01A	TCGA-BK-A6W3	119b1761-a5b4-42b6-9971-ece11fb0e0f6	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	94	150.0	False	false	15A94B35-48FD-4F94-94E4-25F8084F8B91	1.83	abec519f-1747-400d-944d-7e53d12d6dea	0.15	23	released	250c2c11-b1c8-4e0d-b0cf-e2e1c0cdd3bd	RNA	R	0.15	UV Spec	released	False	8c495337-fe9d-40c3-b875-4b32c9d922fe	12	5.0	1.0	0.0	1.0	10.0	10.0	80.0	80.0	TOP	be05c301-413d-4677-a8ed-6d62ba707bd5	released																				released	30.0	bb8c1148-9006-4819-920e-827bcfa9adb5	Primary Tumor	01	released	Not Reported	released	TCGA-BK-A6W3_demographic	34	-12590		50b47db9-0041-58d4-b3a7-b028b78418ec	not hispanic or latino	female	black or african american	released	Alive	1979		TCGA-BK-A6W3_exposure	Not Reported	31.912223457277065	a827836b-5c04-5260-9f8f-fb012c5e5685	167.0	released	89.0	TCGA-BK-A6W3_diagnosis	12590	not reported	0	305	5971e3ee-854f-5eef-a4bb-26c6b52d6ab7	Stage II	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2013	TCGA-BK-A6W3_treatment	TCGA-BK-A6W3_treatment_1	released	424728c5-477a-57f2-82b8-6b6bd092f1b1	no	Radiation Therapy, NOS	released	263c2461-e88f-5bb9-885a-65731c51c1c6	no	Pharmaceutical Therapy, NOS	02703362-83cc-4b7c-815f-81f33f475c31
ce095c55-67b4-4217-92e5-58ea6f5eb0bc.htseq.counts.gz	2d83f730-014e-42bd-9001-d7dc866aacf2	TCGA-FI-A2CX-01A-11R-A17B-07	TCGA-FI-A2CX-01A-11R	TCGA-FI-A2CX-01A-01-TSA			TCGA-FI-A2CX-01A-11	TCGA-FI-A2CX-01A	TCGA-FI-A2CX	dffc7091-bc27-452c-ad94-1ee214107593	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1067	80.0	False	true	0F6F56E4-C4F9-4915-BE4E-1FBF4C6D93AD	1.97	ab3e5a04-9d4c-4289-93ed-38dba3e619b2	0.16	23	released	6ae893f6-b98f-4e93-ad0d-95881be07545	RNA	R	0.16	UV Spec	released	False	1810a91b-afc1-428e-b11d-ab9aad82e74a	11	40.0	35.0	10.0	2.0	0.0	2.0	88.0	98.0	TOP	a118f244-b5aa-4165-ad1b-3272e446b419	released																				released	30.0	b6d24830-0d69-44d7-94cf-7dfdc49e52c4	Primary Tumor	01	released	Not Reported	released	TCGA-FI-A2CX_demographic	82	-30224		8bd8505e-e3b3-5167-adc2-d6abce781dc6	not hispanic or latino	female	white	released	Alive	1926		TCGA-FI-A2CX_exposure	Not Reported	21.64412070759625	47a78112-73a2-5136-9459-e17fc52abc91	155.0	released	52.0	TCGA-FI-A2CX_diagnosis	30224	not reported	0	2031	c9506856-ae38-5a48-ac59-1fe58579f840	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2008	TCGA-FI-A2CX_treatment	TCGA-FI-A2CX_treatment_1	released	759a432f-97b4-5b91-bc4a-b7feef85dfa0	no	Radiation Therapy, NOS	released	7221354a-9684-5e26-81f2-bc817c0cd495	no	Pharmaceutical Therapy, NOS	2d83f730-014e-42bd-9001-d7dc866aacf2
4010ade2-4193-44e8-91c3-2d83b5414e00.htseq.counts.gz	223719bf-fb99-4de0-a39e-1102bbdb7b43	TCGA-DI-A2QU-01A-11R-A18M-07	TCGA-DI-A2QU-01A-11R	TCGA-DI-A2QU-01A-01-TS1			TCGA-DI-A2QU-01A-11	TCGA-DI-A2QU-01A	TCGA-DI-A2QU	e9fa66f5-282c-416a-9dcf-46714ea12fcf	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	2296	240.0	False	false	43F1EE09-6F10-4BCE-A55C-147084A26999	1.8	94746e57-a703-4b53-bcdc-11107424eb23	0.17	23	released	3518a1d4-2bf8-4d50-a18e-66240e61afc8	RNA	R	0.17	UV Spec	released	False	6eee77ef-7b36-4f34-8c60-5ae75596050a	11	8.0	15.0	3.0	3.0	0.0	10.0	87.0	90.0	TOP	e602a9dd-b0e1-4a9b-b796-c7a01591cad4	released																				released	30.0	e319e562-6af4-4a5a-b82b-94ddfb325ae8	Primary Tumor	01	released	Not Reported	released	TCGA-DI-A2QU_demographic	67	-24488	946	74ad2067-0e7b-5ac0-8f46-6a3ca0f0e2c1	not hispanic or latino	female	white	released	Dead	1938	2007	TCGA-DI-A2QU_exposure	Not Reported	36.328125	848610b9-b2ba-58bb-8576-6a6c657cf90b	160.0	released	93.0	TCGA-DI-A2QU_diagnosis	24488	not reported	0		e65420d0-c503-5f87-b36b-859e397daaf4	Stage IVB	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2005	TCGA-DI-A2QU_treatment	TCGA-DI-A2QU_treatment_1	released	9cafd343-2663-5552-9e0e-03ff493eb811	not reported	Radiation Therapy, NOS	released	6464122f-f103-5a47-8273-ed662ba9cedf	not reported	Pharmaceutical Therapy, NOS	223719bf-fb99-4de0-a39e-1102bbdb7b43
f61547c0-5c1b-42d4-a4c0-b700cea657e6.htseq.counts.gz	8fa0229a-81f5-456a-ae74-a764b01c285c	TCGA-AP-A0LT-01A-11R-A040-07	TCGA-AP-A0LT-01A-11R	TCGA-AP-A0LT-01A-01-BS1	TCGA-AP-A0LT-01A-01-TS1		TCGA-AP-A0LT-01A-11	TCGA-AP-A0LT-01A	TCGA-AP-A0LT	43714e9a-e9c4-4206-af92-1d00d2a8ae35	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1404	200.0	False	true	4A25211C-354E-4FC8-B81B-29766B7962D4	1.8	cda60e53-f917-454b-b1f5-d1f0f8b8f130	0.14	23	released	a140cd41-ef62-4fdb-bd09-f894012c6b63	RNA	R	0.14	UV Spec	released	False	3e5c403d-45df-4670-9747-893bafd9f5f5	11	0.0	0.0	5.0	0.0	0.0	0.0	95.0	90.0	BOTTOM	4d77b90e-c3a2-4e6c-b9cd-8912c94941e9	released	0.0	0.0	15.0	0.0	0.0	0.0	85.0	80.0	TOP	9d20af32-e591-490f-8a58-51ed8595ebbd	released									released	30.0	c94dd7a5-dd58-4702-a7d1-8199d3f8c9cc	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A0LT_demographic	57	-21107		dbfb019a-7f60-5b22-9d2f-87c1f3c2f6fd	not reported	female	white	released	Alive	1949		TCGA-AP-A0LT_exposure	Not Reported	33.42516069788797	53b99fdc-901c-53df-a4a3-677374b20978	165.0	released	91.0	TCGA-AP-A0LT_diagnosis	21107	not reported	0	1497	7c15d92c-4f55-5d8d-9d22-73ed30c7c263	Stage II	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2006	TCGA-AP-A0LT_treatment	TCGA-AP-A0LT_treatment_1	released	1780bc7b-9a02-5689-afde-c779776cd6bf	yes	Radiation Therapy, NOS	released	245cb558-74c0-5aec-b096-a95ec411b973	no	Pharmaceutical Therapy, NOS	8fa0229a-81f5-456a-ae74-a764b01c285c
aecf2c25-b32e-412d-a2f5-34df2f4f865d.htseq.counts.gz	ad67cd0d-d587-40f8-b9ff-7585aa1aa641	TCGA-EO-A3AS-01A-11R-A19W-07	TCGA-EO-A3AS-01A-11R	TCGA-EO-A3AS-01A-01-TS1			TCGA-EO-A3AS-01A-11	TCGA-EO-A3AS-01A	TCGA-EO-A3AS	2c3e95b5-2c63-43c7-baa2-47ef914b25a8	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	850	70.0	False	false	844799B1-4C96-473A-8ECB-71ACB080F95E	1.85	0ce294d7-8111-474c-be3a-19195f5d49ab	0.17	23	released	31c37438-dd19-48b7-a50d-087c4fc2e5de	RNA	R	0.17	UV Spec	released	False	6b52a44d-1ab7-4c32-98ef-56da5833432c	11	0.0	0.0	2.0	0.0	0.0	18.0	80.0	80.0	TOP	037be131-53ea-4b16-9634-d2da2e9d655a	released																				released	30.0	ddb6e07d-8764-4278-978d-7a878522de6d	Primary Tumor	01	released	Not Reported	released	TCGA-EO-A3AS_demographic	86	-31450		15d4e11d-5881-5dc0-b3ab-6deca92452a2	not reported	female	not reported	released	Alive	1923		TCGA-EO-A3AS_exposure	Not Reported	26.840668240085147	b070a23e-2110-5b11-9cc8-6fc260fe0a3b	147.0	released	58.0	TCGA-EO-A3AS_diagnosis	31450	not reported	0	1046	8f40046d-b2de-5d19-a62d-566622b93e6c	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-EO-A3AS_treatment	TCGA-EO-A3AS_treatment_1	released	4896604c-0cf5-5425-93af-bc80f526a66c	no	Radiation Therapy, NOS	released	92901443-c7f6-51a4-8721-8dd9e3b9e2e2	no	Pharmaceutical Therapy, NOS	ad67cd0d-d587-40f8-b9ff-7585aa1aa641
46c3ad7f-0a11-4283-98a1-5a81ce0a5f4f.htseq.counts.gz	94c5d05c-b048-4d2d-b790-f84d3563fade	TCGA-E6-A1LZ-01A-11R-A144-07	TCGA-E6-A1LZ-01A-11R	TCGA-E6-A1LZ-01A-01-TSA			TCGA-E6-A1LZ-01A-11	TCGA-E6-A1LZ-01A	TCGA-E6-A1LZ	9205c164-7975-421a-90c3-edfe8def595c	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	1233	350.0	False	false	55F7B7D0-D30A-4E78-B91A-CE794784CA3C	1.83	4f4a8bd9-c07f-4930-8600-349ab60a37a7	0.17	23	released	6dec1819-bf4a-458d-8459-ae7152d43635	RNA	R	0.17	UV Spec	released	False	def1d8ac-59e6-450e-8421-e6567d12da7f	11	0.0	0.0	20.0	0.0	0.0	0.0	80.0	80.0	TOP	280462b7-50a4-40c4-be46-aeb2ef958183	released																				released	30.0	62bff77e-4fe6-4a9f-a867-345584608e7d	Primary Tumor	01	released	Not Reported	released	TCGA-E6-A1LZ_demographic	76	-28054		f4785965-fb92-5876-80dc-48eba5d1a988	not hispanic or latino	female	black or african american	released	Alive	1931		TCGA-E6-A1LZ_exposure	Not Reported		f1ac91e5-0fc9-53ed-bbf5-de4bf4c1726d		released	65.0	TCGA-E6-A1LZ_diagnosis	28054	not reported	0	2406	1f0bef4b-abd9-5bee-a57b-7fc404c4eada	Stage IA	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2007	TCGA-E6-A1LZ_treatment_1	TCGA-E6-A1LZ_treatment	released	d958ad39-ce65-5ddb-942d-8f8894b84bca	yes	Pharmaceutical Therapy, NOS	released	9d915d6b-aef4-59a9-bdc2-39c576c543bc	yes	Radiation Therapy, NOS	94c5d05c-b048-4d2d-b790-f84d3563fade
37dfd69b-aa9f-4311-a79e-92a2245e5219.htseq.counts.gz	914766ab-f6e4-4cb4-bd9f-6c7182d8bdcf	TCGA-AP-A1DO-01A-11R-A137-07	TCGA-AP-A1DO-01A-11R	TCGA-AP-A1DO-01A-01-TSA			TCGA-AP-A1DO-01A-11	TCGA-AP-A1DO-01A	TCGA-AP-A1DO	3348a7aa-f5c3-4fba-9968-68da5cedfd7e	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1210	220.0	False	true	EAC1A113-68BB-4D45-AB57-E59E392029BC	1.91	6ff22866-1896-4200-bef2-f05724bf15a3	0.17	23	released	258e2ca4-7b9b-47bb-82fa-33742f4cd331	RNA	R	0.17	UV Spec	released	False	487af34a-3b83-4627-8947-a4a8b59abc2e	11	2.0	1.0	20.0	2.0	0.0	2.0	78.0	98.0	TOP	de3b48ca-34de-4e56-9fd6-7c6751c97368	released																				released	30.0	f2b59490-86fe-409a-89f1-e11f744e0d75	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A1DO_demographic	62	-22787		2e4bcad2-f344-56f7-888b-3fca2afe52df	not hispanic or latino	female	white	released	Alive	1945		TCGA-AP-A1DO_exposure	Not Reported	32.87310979618672	34a4f505-23d3-5d3d-8c4c-3c71337ef343	156.0	released	80.0	TCGA-AP-A1DO_diagnosis	22787	not reported	0	952	58d53b8b-44f2-50b9-8188-a1b3b9ba9a9a	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2007	TCGA-AP-A1DO_treatment	TCGA-AP-A1DO_treatment_1	released	e378758c-1a50-506a-bee0-2ce85c6c7aa7	no	Radiation Therapy, NOS	released	01b54d88-e12a-5534-8be9-6286ce4638b7	no	Pharmaceutical Therapy, NOS	914766ab-f6e4-4cb4-bd9f-6c7182d8bdcf
6cac2144-f81d-4b96-9fe7-95b5c211478f.htseq.counts.gz	7e40ca21-6ba4-4248-9d04-0dd19d3aaa24	TCGA-AX-A2HC-01A-11R-A17B-07	TCGA-AX-A2HC-01A-11R	TCGA-AX-A2HC-01A-01-TSA			TCGA-AX-A2HC-01A-11	TCGA-AX-A2HC-01A	TCGA-AX-A2HC	53e8e07e-18f9-4c9b-9783-a5b67ceddcf7	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1786	120.0	False	false	90DC9BBA-4666-4702-8BA1-F57253E43CDD	1.65	3e40a983-aba5-4454-88df-a271c296ada6	0.16	23	released	1cc40be6-e9c6-467e-a5f6-735a8e567a84	RNA	R	0.16	UV Spec	released	False	dd91c247-a15e-4d97-82bf-474eba0e5cd3	11	0.0	0.0	3.0	0.0	0.0	3.0	94.0	98.0	TOP	ce4ae04a-d4d4-4349-aeac-4cdb6f060455	released																				released	30.0	1bacdcab-f02f-4c6e-89e5-4a221c2e3bc0	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A2HC_demographic	53	-19485		baa2500b-d4c9-5e0f-bc4a-41390e221f01	not hispanic or latino	female	black or african american	released	Alive	1953		TCGA-AX-A2HC_exposure	Not Reported	47.26806601506169	6308ecf6-0bd6-5496-9db7-67a1943c1fc2	158.0	released	118.0	TCGA-AX-A2HC_diagnosis	19485	not reported	0	1044	338fe46f-b6a4-50ed-8fc2-2ff30bca40e1	Stage IIIC	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2006	TCGA-AX-A2HC_treatment	TCGA-AX-A2HC_treatment_1	released	e28a8158-7cf7-535b-86c4-451eaa12d50a	yes	Radiation Therapy, NOS	released	7f3baa41-8e8f-5026-bda1-e93c874fb76f	yes	Pharmaceutical Therapy, NOS	7e40ca21-6ba4-4248-9d04-0dd19d3aaa24
b92b53ad-faad-497d-a4ff-ad850cd29884.htseq.counts.gz	c0a485ad-828a-4ed9-adbb-d24589ae7b01	TCGA-EC-A1QX-01A-31R-A16F-07	TCGA-EC-A1QX-01A-31R	TCGA-EC-A1QX-01A-03-TSC			TCGA-EC-A1QX-01A-31	TCGA-EC-A1QX-01A	TCGA-EC-A1QX	f17bb238-2651-48a5-9a47-5077218efe08	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	81	560.0	False	true	0C3EABFA-0F72-47C9-9A8B-6B14F2CD2D12	1.79	bfa1d102-0917-407f-a158-3125d4219c6c	0.17	23	released	c8fd621d-57c9-4035-a53f-3f182b7b8792	RNA	R	0.17	UV Spec	released	False	0cac7ee9-cb5e-4769-8826-ea56255d14ca	31	40.0	20.0	5.0	20.0	0.0	15.0	80.0	80.0	TOP	d9cf9cab-504d-4cd5-9647-96ff4cd6a3bd	released																				released	30.0	a86cd958-656b-45d1-ab59-453896a9e839	Primary Tumor	01	released	Not Reported	released	TCGA-EC-A1QX_demographic	71	-26259		81b84182-932d-5e2e-9d97-0000ec2b42db	not hispanic or latino	female	white	released	Alive	1939		TCGA-EC-A1QX_exposure	Not Reported	34.72088268199529	9ebf7955-2b0e-5732-9934-33fb1051575a	161.0	released	90.0	TCGA-EC-A1QX_diagnosis	26259	not reported	0	224	c06f4aec-8182-5dd8-a6c0-80cd29a1b683	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-EC-A1QX_treatment_1	TCGA-EC-A1QX_treatment	released	d6f6ad2c-8f3b-5519-afed-311957dc9366	yes	Pharmaceutical Therapy, NOS	released	7f9cfa80-e1c9-5b7b-af8a-df6c711f29af	yes	Radiation Therapy, NOS	c0a485ad-828a-4ed9-adbb-d24589ae7b01
d6ea3f1d-9186-40c4-a51e-4d94d07ea663.htseq.counts.gz	f9a762b8-e8b0-4030-9879-c38759982d49	TCGA-BG-A2AE-01A-11R-A16F-07	TCGA-BG-A2AE-01A-11R	TCGA-BG-A2AE-01A-01-TSA			TCGA-BG-A2AE-01A-11	TCGA-BG-A2AE-01A	TCGA-BG-A2AE	f384eb3f-92ab-4327-87eb-45b5f72a1580	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	50	460.0	False	true	BA5BC88E-6A6C-425E-84B4-EC33DB9AC146	1.9	7a5dd0ca-549d-452a-beb8-ea8a3f5528ec	0.18	23	released	34583eaf-46ca-41b8-8174-307c118c8149	RNA	R	0.18	UV Spec	released	False	d4998478-ff8d-4d6f-9941-57a3b2b5e09d	11	40.0	20.0	10.0	20.0	0.0	0.0	90.0	90.0	TOP	5f8063d7-18c0-4fd0-948d-14beb2210948	released																				released	30.0	273a3b52-7613-400e-8ae1-a68c36ab6968	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A2AE_demographic	57	-21069		8f20f1ea-97c6-5bcf-8305-b4b7451de028	not hispanic or latino	female	white	released	Alive	1954		TCGA-BG-A2AE_exposure	Not Reported	42.13351643207141	49177037-cd3c-5801-bd75-03aa338475a2	179.0	released	135.0	TCGA-BG-A2AE_diagnosis	21069	not reported	0	721	68451be9-1a15-568b-a1b9-2cc9f3b4009d	Stage IB	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-BG-A2AE_treatment_1	TCGA-BG-A2AE_treatment	released	8d7ad58c-5abb-5782-9834-3c6ac67f785b	yes	Pharmaceutical Therapy, NOS	released	ce1d2823-37fe-5088-8103-677f5225b794	yes	Radiation Therapy, NOS	f9a762b8-e8b0-4030-9879-c38759982d49
863ecfcc-9de4-4cce-a728-989ed9a0aee3.htseq.counts.gz	40c20c99-0e80-4de3-b222-7779bbe5aefd	TCGA-5S-A9Q8-01A-11R-A40A-07	TCGA-5S-A9Q8-01A-11R	TCGA-5S-A9Q8-01A-01-TSA			TCGA-5S-A9Q8-01A-11	TCGA-5S-A9Q8-01A	TCGA-5S-A9Q8	8751429b-4a11-451e-b978-dc9e9db0eb36	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	103	690.0	False	true	3F89A501-BE16-4E08-9846-41B4BBDDFCF9	1.9	5eb217b7-bf79-475d-8476-a66670ad9ed2	0.16	23	released	b671c387-5261-4a64-a59d-dbe384971953	RNA	R	0.16	UV Spec	released	False	a49c848b-486d-493e-b46b-2de7fa1e8681	11	2.0	0.0	3.0	0.0	2.0	5.0	90.0	90.0	TOP	4ca0d921-5924-4033-b405-086190bfd54d	released																				released	30.0	e5004b9a-a75d-4908-924f-d46e53d33e6b	Primary Tumor	01	released	Not Reported	released	TCGA-5S-A9Q8_demographic	51	-18785		9bc7569c-897a-5443-a8f7-f160ecba3605	not hispanic or latino	female	black or african american	released	Alive	1962		TCGA-5S-A9Q8_exposure	Not Reported	32.7693949093126	194023da-444b-5e6b-865d-34e67defa169	162.0	released	86.0	TCGA-5S-A9Q8_diagnosis	18785	not reported	0	313	d3102afa-c8e9-5eae-997f-1bf246a5b819	Stage IIIA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2013	TCGA-5S-A9Q8_treatment	TCGA-5S-A9Q8_treatment_1	released	610bbc3f-3888-5d71-b2ed-29af76ac3d7b	yes	Radiation Therapy, NOS	released	0e3912e1-87b3-5b83-9c4a-37e41c0a218a	yes	Pharmaceutical Therapy, NOS	40c20c99-0e80-4de3-b222-7779bbe5aefd
5e8b7557-3781-47b9-8b20-2c0416a9841f.htseq.counts.gz	2b40d866-2c51-4752-a312-e7da529e4c47	TCGA-AP-A0LS-01A-11R-A14D-07	TCGA-AP-A0LS-01A-11R	TCGA-AP-A0LS-01A-01-TSA	TCGA-AP-A0LS-01A-01-BSA		TCGA-AP-A0LS-01A-11	TCGA-AP-A0LS-01A	TCGA-AP-A0LS	c5a797d3-82ae-49dc-b2fe-0da64da271a2	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1421	200.0	False	true	E802CEF6-BC3F-4C35-85E8-2B37531571CD	1.87	929006f8-5f5c-4215-80a9-0ff6a91ef1d6	0.14	23	released	574934e1-dedd-4e17-abe2-c3c699718486	RNA	R	0.14	UV Spec	released	False	863f3d5e-b28b-45c0-8dc9-2fbc4b95a7d4	11	0.0	0.0	0.0	0.0	0.0	20.0	80.0	65.0	TOP	88b6ae2b-b318-4698-a3ba-fc41257fe0c0	released	0.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	BOTTOM	7ce21d5c-6c2d-4162-bd76-a5c440d42f24	released									released	30.0	c6f914f3-0888-4890-9323-6386f1035d81	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A0LS_demographic	63	-23126		ce0d78ee-e0db-55d8-88b5-227de3fbf4d2	not reported	female	white	released	Alive	1943		TCGA-AP-A0LS_exposure	Not Reported	28.36035152830783	822a0b4a-7ec6-592c-8999-64d61abf03b3	169.0	released	81.0	TCGA-AP-A0LS_diagnosis	23126	not reported	0	2904	19e6b67b-cc43-5b42-9709-aa36599dc30b	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2006	TCGA-AP-A0LS_treatment	TCGA-AP-A0LS_treatment_1	released	1c5375dd-4ad4-5ae0-9598-b653026cff01	yes	Radiation Therapy, NOS	released	2057d54b-089f-5ce6-95f0-afc80c87fd84	no	Pharmaceutical Therapy, NOS	2b40d866-2c51-4752-a312-e7da529e4c47
8fe8861f-0e44-458f-8bcc-159385185c56.htseq.counts.gz	c4288d17-25f9-4c03-ac24-fe9b62d1bea7	TCGA-D1-A1O5-01A-11R-A14D-07	TCGA-D1-A1O5-01A-11R	TCGA-D1-A1O5-01A-01-TSA			TCGA-D1-A1O5-01A-11	TCGA-D1-A1O5-01A	TCGA-D1-A1O5	f054a123-322f-444a-9971-53d3df371753	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	174	100.0	False	false	F8BEE46E-D0C9-4977-B1C3-DA87AF089B6D	1.79	7bc83c49-3fd8-4048-adf4-b461fcffcc00	0.17	23	released	e3cd3ab8-a341-47aa-bbf5-f2cd6543e2a3	RNA	R	0.17	UV Spec	released	False	7d260113-d1dc-4b9d-a302-6f0e3a38ebde	11	40.0	20.0	5.0	20.0	10.0	15.0	70.0	70.0	TOP	76e1db7a-7aa0-486b-8dea-48f9ca932599	released																				released	30.0	a2a2d119-29a0-4cdb-bbed-44219adddfcf	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A1O5_demographic	61	-22580		5af7b769-4f26-5003-8b0c-835175118797	not hispanic or latino	female	white	released	Alive	1949		TCGA-D1-A1O5_exposure	Not Reported	30.86300682844026	7bd64a8d-4499-5998-8dce-1f3e8c04bdbe	161.0	released	80.0	TCGA-D1-A1O5_diagnosis	22580	not reported	0	458	70b0e8e8-887f-58f8-9664-19fb14475c53	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-D1-A1O5_treatment	TCGA-D1-A1O5_treatment_1	released	de030ee2-e829-5b56-a962-2c5b08bec0ba	no	Radiation Therapy, NOS	released	e156ff87-429e-5ea0-9c16-36a6681ee555	no	Pharmaceutical Therapy, NOS	c4288d17-25f9-4c03-ac24-fe9b62d1bea7
3703b521-f9b6-405e-9f59-4adbaa7d4aca.htseq.counts.gz	93a911b0-b440-4188-a17b-9f4e6f94c0eb	TCGA-BK-A0CB-11A-33R-A104-07	TCGA-BK-A0CB-11A-33R	TCGA-BK-A0CB-11A-02-TS2	TCGA-BK-A0CB-11A-04-TS4	TCGA-BK-A0CB-11A-03-TS3	TCGA-BK-A0CB-11A-33	TCGA-BK-A0CB-11A	TCGA-BK-A0CB	59e9029a-8ddd-4447-b35a-72bc39f82a30	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	64	420.0	False	false		1.8	7865a23a-f7a6-43b0-b395-16c8306cea2f	0.16	23	released	9f856f9d-697d-4f76-9032-cf33864b764c	RNA	R	0.16	UV Spec	released	False	7fad667d-4279-44d7-a864-ed6666ea694c	33	5.0	0.0		0.0	100.0		0.0		TOP	2a22dc45-cd67-414d-a706-9a21523bf136	released	5.0	0.0		0.0	100.0		0.0		TOP	31b8cd48-1eaf-4c06-a64c-1703f9dfd57f	released	5.0	0.0	0.0	100.0	0.0	TOP	91a84b56-6c1b-489f-8dc0-484f5e49be06	released	released	240.0	f1d2d79c-ce6a-4160-9de2-c169f0dab321	Solid Tissue Normal	11	released	Not Reported	released	TCGA-BK-A0CB_demographic	60	-21930		1f26523e-25cd-56bb-9040-3a6c41c9990a	not hispanic or latino	female	white	released	Alive	1950		TCGA-BK-A0CB_exposure	Not Reported	46.80384550514421	e7ee05d7-b87a-522e-b770-bb7f1b74a1ee	154.0	released	111.0	TCGA-BK-A0CB_diagnosis	21930	not reported	0	1092	5a486ede-eca5-51a6-bbec-2e5edf372fae	Stage IIIC	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-BK-A0CB_treatment_1	TCGA-BK-A0CB_treatment	released	88b56b49-9b27-5e70-945a-2635a0f0eb30	yes	Pharmaceutical Therapy, NOS	released	08300f38-dec3-5766-bc08-c806044a2990	no	Radiation Therapy, NOS	93a911b0-b440-4188-a17b-9f4e6f94c0eb
ba3feee9-9672-4379-a9e8-12dc2c6494fc.htseq.counts.gz	671f212f-b63a-40b0-a8e8-bbeabf6c9381	TCGA-EY-A2OQ-01A-11R-A19W-07	TCGA-EY-A2OQ-01A-11R	TCGA-EY-A2OQ-01A-01-TS1			TCGA-EY-A2OQ-01A-11	TCGA-EY-A2OQ-01A	TCGA-EY-A2OQ	029f0f1d-dd22-44d2-a623-cb9a33cb9438	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	217	1.0	False	false	BD1FB0FF-176C-42D9-843E-2F2BF2EBCCC2	1.8	fe9055e4-f25c-4b7b-9479-a8468c36310f	0.18	23	released	f1489a2d-026e-415d-bbb6-d9fe9c427431	RNA	R	0.18	UV Spec	released	False	72c4a7bc-9ac2-4125-bef8-785dbd82da78	11	0.0	0.0	0.0	0.0	0.0	10.0	90.0	60.0	TOP	2bb3dd5b-ea1b-48be-9fd0-bd5714975dc5	released																				released	10.0	a5f68889-4f7d-44d7-a999-c01bcb0ee56e	Primary Tumor	01	released	Not Reported	released	TCGA-EY-A2OQ_demographic	61	-22309		30f06462-90ed-5004-81de-422d8ce9b270	not hispanic or latino	female	white	released	Alive	1950		TCGA-EY-A2OQ_exposure	Not Reported	32.882414151925076	fd1551a0-b902-539b-8480-49df933ae3a0	155.0	released	79.0	TCGA-EY-A2OQ_diagnosis	22309	not reported	0	885	cfe4c1f5-1020-5c29-9267-81b5d63b9c55	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-EY-A2OQ_treatment	TCGA-EY-A2OQ_treatment_1	released	b24a85dc-4b3f-5b43-bded-f68333ec9758	no	Radiation Therapy, NOS	released	4e38bc13-ae46-55d0-a9d0-97e84acf9ab1	no	Pharmaceutical Therapy, NOS	671f212f-b63a-40b0-a8e8-bbeabf6c9381
bd94b0f7-933f-40ce-ad26-e9f94defbbae.htseq.counts.gz	2589fe40-6f33-4236-8627-9ccb39791c2a	TCGA-AX-A1C9-01A-11R-A137-07	TCGA-AX-A1C9-01A-11R	TCGA-AX-A1C9-01A-01-TS1			TCGA-AX-A1C9-01A-11	TCGA-AX-A1C9-01A	TCGA-AX-A1C9	2714af93-e200-4b4a-9df8-7d837b37489f	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	521	110.0	False	false	54E63A5C-C0E4-408B-9911-CE822CECD362	1.91	a5a45936-135b-499e-a0bb-7c2d992ef962	0.17	23	released	2bc2e234-441b-4e78-84b0-be601c2f3246	RNA	R	0.17	UV Spec	released	False	49ad18f5-096a-42da-8832-27431259f97c	11	8.0	0.0	1.0	6.0	0.0	10.0	89.0	80.0	TOP	3053cc89-aa91-4041-acc6-dc1435041f79	released																				released	30.0	227cdca5-931d-4cda-a885-8e3aeb874d99	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A1C9_demographic	73	-26903		97f38906-f4fd-584b-9a15-679d55409e68	not hispanic or latino	female	white	released	Alive	1936		TCGA-AX-A1C9_exposure	Not Reported	31.596260387811633	3be60701-b63b-513f-9811-57f5182b88e0	152.0	released	73.0	TCGA-AX-A1C9_diagnosis	26903	not reported	0	802	22b7a7e7-adde-5ac9-9f96-19c6f2c6128a	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-AX-A1C9_treatment_1	TCGA-AX-A1C9_treatment	released	cd261557-6cd0-5760-92a2-919f1ba14e4a	no	Pharmaceutical Therapy, NOS	released	0a758b1f-d674-525d-a6ce-421ae5ed0567	no	Radiation Therapy, NOS	2589fe40-6f33-4236-8627-9ccb39791c2a
73fd698d-46d3-4a2a-ae52-91bd00e72b6a.htseq.counts.gz	9f53bb55-722f-4b9e-94dd-46376a4af2f1	TCGA-D1-A16R-01A-11R-A12I-07	TCGA-D1-A16R-01A-11R	TCGA-D1-A16R-01A-01-TS1			TCGA-D1-A16R-01A-11	TCGA-D1-A16R-01A	TCGA-D1-A16R	40f43483-b504-4ea7-ad24-40682b10caac	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	161	290.0	False	false	D9641375-D204-4469-989A-ED08DDE66408	1.28	16c07e59-0ad4-4a8d-82a0-a77c78119175	0.16	23	released	08d47677-c4ea-4bd1-b038-e0647ce30eab	RNA	R	0.16	UV Spec	released	False	3fc965ec-b774-4638-a70e-0912f5b34e34	11	10.0	0.0	20.0	0.0	10.0	20.0	50.0	70.0	TOP	46ccf388-57bd-4105-b94c-48b210bb4705	released																				released	30.0	f57eb4ed-4393-4dc3-9362-a4757ef8b21d	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A16R_demographic	39	-14465		f9768205-d7e5-5d5e-bf59-37e064d73669	not hispanic or latino	female	white	released	Alive	1971		TCGA-D1-A16R_exposure	Not Reported	41.53316720066453	1d09d225-660a-5d0a-8624-c0860743a0c3	159.0	released	105.0	TCGA-D1-A16R_diagnosis	14465	not reported	0	21	267a5524-e18d-51ad-a054-5e2ae97eb8c2	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-D1-A16R_treatment	TCGA-D1-A16R_treatment_1	released	354197a5-3d09-509d-ae82-ba787b2a26be	no	Radiation Therapy, NOS	released	8132b1be-c8c3-5494-8c35-45da1a653c29	no	Pharmaceutical Therapy, NOS	9f53bb55-722f-4b9e-94dd-46376a4af2f1
b70633b5-ea04-42bb-ac9c-9a8e5dd1cdcd.htseq.counts.gz	e6be6d3c-3562-4094-a410-5200120b2bbd	TCGA-AX-A0IS-01A-12R-A10J-07	TCGA-AX-A0IS-01A-12R	TCGA-AX-A0IS-01A-01-TSA	TCGA-AX-A0IS-01A-01-BSA		TCGA-AX-A0IS-01A-12	TCGA-AX-A0IS-01A	TCGA-AX-A0IS	2e5cf721-90b1-4470-b430-f055a1297c7f	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	805	90.0	False	false	35606B48-9820-4F59-8090-1F8D448DB9FB	1.73	0cbb432d-fbb9-4c0e-b126-3bb862ab8602	0.14	23	released	5bb9485b-97bb-4f90-b640-4526c13df4fd	RNA	R	0.14	UV Spec	released	False	86ccf475-4da8-470f-b476-5fe408a09669	12	8.0	0.0	3.0	1.0	10.0	10.0	77.0	80.0	TOP	940a4fcc-0a93-4a1c-8fb0-0ea7f3ae6dde	released	4.0	0.0	2.0	0.0	0.0	15.0	83.0	90.0	BOTTOM	2c300c3b-6b48-43b5-acc6-392052fd93e0	released									released	20.0	f46f87a5-2edd-469d-9d28-a37284bd077a	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A0IS_demographic	52	-19173	1858	811f735d-e0fb-5847-abb3-90d83e5f56da	not hispanic or latino	female	white	released	Dead	1956		TCGA-AX-A0IS_exposure	Not Reported	46.7687074829932	40793c86-8c9d-5529-85ed-e713735ed9e5	168.0	released	132.0	TCGA-AX-A0IS_diagnosis	19173	not reported	0	1541	50933fe1-0bd4-5217-b7aa-17045b465258	Stage IC	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-AX-A0IS_treatment	TCGA-AX-A0IS_treatment_1	released	d0266d3d-1b6e-5a98-9ece-15666d89b317	yes	Radiation Therapy, NOS	released	46feaf6b-af9e-5574-903a-2e7dc828c9a0	yes	Pharmaceutical Therapy, NOS	e6be6d3c-3562-4094-a410-5200120b2bbd
d4ab34ef-6630-476e-a85d-60eb0e2da469.htseq.counts.gz	d002e4cf-08ff-4b80-8a9a-414fc2627014	TCGA-EY-A1G8-01A-11R-A13S-07	TCGA-EY-A1G8-01A-11R	TCGA-EY-A1G8-01A-01-TSA			TCGA-EY-A1G8-01A-11	TCGA-EY-A1G8-01A	TCGA-EY-A1G8	db3a4986-55d5-4ecc-be73-59725dce3c33	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	771	100.0	False	false	2454950F-8B3D-4690-98CA-B94C79F99552	1.8	d653b50c-d568-48a1-bbed-5e36fbf525ac	0.16	23	released	e5325844-25be-4fc6-bed7-7bf517a5108d	RNA	R	0.16	UV Spec	released	False	333ff5da-6c4c-43a4-9f9a-89fe8f8a7e85	11	10.0	0.0	20.0	10.0	0.0	10.0	70.0	90.0	TOP	5334f4e4-c14d-4842-969c-1d55678b209a	released																				released	30.0	e95dde06-f397-4b0c-a854-dc91aa3c6f31	Primary Tumor	01	released	Not Reported	released	TCGA-EY-A1G8_demographic	83	-30517	456	76d2f9cb-ddcb-59c4-9316-1df7c9f3062d	not hispanic or latino	female	white	released	Dead	1925	2009	TCGA-EY-A1G8_exposure	Not Reported	19.140625	c9dd5123-bad8-505b-822d-eb6fc0edd68e	160.0	released	49.0	TCGA-EY-A1G8_diagnosis	30517	not reported	0		09ebfe76-e226-502d-ab70-4d55a5b86d6a	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-EY-A1G8_treatment	TCGA-EY-A1G8_treatment_1	released	ca239b3c-a104-5101-be77-1425fac0c419	no	Radiation Therapy, NOS	released	c589efaa-8c25-5419-a93b-a9419f5450b1	no	Pharmaceutical Therapy, NOS	d002e4cf-08ff-4b80-8a9a-414fc2627014
1a4b6897-3022-4818-89ab-c20d2844d140.htseq.counts.gz	0f197e2c-6887-4ecc-aa40-be12efacc23c	TCGA-EY-A1GW-01A-22R-A13S-07	TCGA-EY-A1GW-01A-22R	TCGA-EY-A1GW-01A-02-TSB			TCGA-EY-A1GW-01A-22	TCGA-EY-A1GW-01A	TCGA-EY-A1GW	f8ac5fd2-11f2-4b3a-a3a6-ff1a6d8e1cae	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	155	410.0	False	false	52C26330-540E-4409-ACDF-4D56EA1E7D7F	1.81	4e6ddf28-1fb2-4527-b415-30c714ecde09	0.16	23	released	f8cfda51-2338-4b6f-8ea3-4c08ea403deb	RNA	R	0.16	UV Spec	released	False	b27f3ba8-6cf2-48e1-ab4c-8ad05e498ac4	22	30.0	20.0	10.0	30.0	0.0	10.0	80.0	80.0	TOP	5bd9d55e-da9b-4782-a0a5-a9363bc412d4	released																				released	30.0	22cb3d87-7fab-419a-b071-1adc6b810719	Primary Tumor	01	released	Not Reported	released	TCGA-EY-A1GW_demographic	73	-26979	337	3bc93350-02f7-5561-97b2-11c92a32325d	hispanic or latino	female	white	released	Dead	1937		TCGA-EY-A1GW_exposure	Not Reported	36.48484302508896	09704ef4-c77d-56ef-9acb-adc84fe24f1f	149.0	released	81.0	TCGA-EY-A1GW_diagnosis	26979	not reported	0	260	ceb2ecff-f419-559d-b576-ccdbedc6a805	Stage IVB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Fundus uteri	released	No	Fundus uteri	not reported	not reported	2010	TCGA-EY-A1GW_treatment_1	TCGA-EY-A1GW_treatment	released	7aea9ca2-c003-5a61-8202-159e716ac652	yes	Pharmaceutical Therapy, NOS	released	e65a442e-f81e-5114-ba82-20b6a91aa90c	no	Radiation Therapy, NOS	0f197e2c-6887-4ecc-aa40-be12efacc23c
961f2c3c-1914-4b25-99ad-2eafaad4ab43.htseq.counts.gz	fcb2429c-c2d4-4d36-973e-d111f3994ae0	TCGA-BG-A0RY-01A-11R-A104-07	TCGA-BG-A0RY-01A-11R	TCGA-BG-A0RY-01A-01-TSA	TCGA-BG-A0RY-01A-01-BSA		TCGA-BG-A0RY-01A-11	TCGA-BG-A0RY-01A	TCGA-BG-A0RY	f299ad43-bb16-46ce-9617-48cc6c6f29e7	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	49	450.0	False	true	170B34D7-94B3-4129-9B4D-E36AF7A09897	1.9	514a9fc3-0b51-41f3-8c94-f6c8d8c0911e	0.15	23	released	b05e6b92-c261-4c35-aa5c-33f829e883fb	RNA	R	0.15	UV Spec	released	False	52f79534-7cab-4cce-b7ae-d92e155980f4	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	85.0	TOP	e48368cd-a080-432f-9cc1-e9a089b44035	released	0.0	0.0	0.0	0.0	0.0	0.0	100.0	90.0	BOTTOM	bd459d69-1e1d-4d9d-875f-44f5146c4201	released									released	30.0	260692e1-9b2c-4f8b-952d-1b95c042e659	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A0RY_demographic	68	-24952		5130114a-f1c7-5f3d-ae99-e5202537213c	not hispanic or latino	female	white	released	Alive	1942		TCGA-BG-A0RY_exposure	Not Reported	40.830449826989614	c2e79026-aab6-5333-9eac-5e9eed0f74d5	170.0	released	118.0	TCGA-BG-A0RY_diagnosis	24952	not reported	0	469	e7bfe550-1300-5fb3-8005-266f08b0bb5a	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-BG-A0RY_treatment	TCGA-BG-A0RY_treatment_1	released	cc9535db-b08f-5d96-875b-c6ae3c40b80b	yes	Radiation Therapy, NOS	released	671d6fe3-ff61-5bfd-b548-3d3b8c5b60e9	no	Pharmaceutical Therapy, NOS	fcb2429c-c2d4-4d36-973e-d111f3994ae0
2bbba516-be54-4391-b029-f73657997e02.htseq.counts.gz	439982cb-2371-4ecb-8e3b-efb9bf8dc9b8	TCGA-D1-A1NY-01A-11R-A16F-07	TCGA-D1-A1NY-01A-11R	TCGA-D1-A1NY-01A-01-TSA			TCGA-D1-A1NY-01A-11	TCGA-D1-A1NY-01A	TCGA-D1-A1NY	0a9faff7-ec4d-4b5a-aa83-6fa358f72074	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	199	110.0	False	false	8F963009-F6C3-4F45-B714-0E96F5D5E526	1.88	e0397750-69a4-41ef-bcb0-70bc4b2d7c87	0.17	23	released	d7aa5b67-e542-4c9f-83e5-116ee7e910ac	RNA	R	0.17	UV Spec	released	False	65d40dda-e75f-4c38-894c-810428d9ce8d	11	8.0	1.0	3.0	2.0	5.0	20.0	72.0	80.0	TOP	5a066661-053b-4165-90b3-4107e5a925e5	released																				released	30.0	4d1fc186-32c8-4f12-a4c3-f683cee53737	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A1NY_demographic	67	-24683		1d5ce98d-18ee-5c7e-8b0e-2fe2da9bb1e9	not hispanic or latino	female	white	released	Alive	1943		TCGA-D1-A1NY_exposure	Not Reported	34.36791383219955	7c4429b1-d131-5d8e-82b9-2391b25045d1	168.0	released	97.0	TCGA-D1-A1NY_diagnosis	24683	not reported	0	513	bd8b549a-18d5-511c-bb8b-1dfc8cf0b32a	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-D1-A1NY_treatment	TCGA-D1-A1NY_treatment_1	released	7881606d-f7c3-5b9b-b820-3215466d5aac	yes	Radiation Therapy, NOS	released	ee7aec30-2ab3-5e9b-8b0a-17a90526703e	yes	Pharmaceutical Therapy, NOS	439982cb-2371-4ecb-8e3b-efb9bf8dc9b8
bfd55f02-f569-46fe-8513-54a682d74d48.htseq.counts.gz	71fea95b-5b21-4144-80f6-3454a50bc08c	TCGA-B5-A3S1-01A-11R-A22K-07	TCGA-B5-A3S1-01A-11R	TCGA-B5-A3S1-01A-01-TS1			TCGA-B5-A3S1-01A-11	TCGA-B5-A3S1-01A	TCGA-B5-A3S1	3789ae3f-286b-42f0-a805-320ad69ea1df	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	127	140.0	False	true	72F97A0D-1245-4C80-B2D2-B7B217BEC06B	1.84	77db73b5-24ef-47a3-b54b-4457ae62d562	0.16	23	released	ba2ee445-09db-481a-a0d4-09eea4104497	RNA	R	0.16	UV Spec	released	False	1da1b044-1dc3-4c44-b444-9791989025bf	11	1.0	1.0	5.0	0.0	0.0	0.0	95.0	90.0	TOP	dd605e90-d91c-45a0-8cb0-2e4facbd78e2	released																				released	30.0	4715fda8-7e8e-40f5-9ddb-80349a38c626	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A3S1_demographic	71	-26031		f8e5ff46-e164-5917-9a43-dcb119802be6	not reported	female	white	released	Alive	1940		TCGA-B5-A3S1_exposure	Not Reported	28.303850156087407	433e26dd-30fd-5042-8420-3e0a7c832726	155.0	released	68.0	TCGA-B5-A3S1_diagnosis	26031	not reported	0	902	0abb0115-7e82-55e9-8956-7920cf4aa855	Stage IIIC1	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-B5-A3S1_treatment_1	TCGA-B5-A3S1_treatment	released	e1378a4d-e78c-5499-a5e4-94e3765e8554	yes	Pharmaceutical Therapy, NOS	released	a2b38aaa-1518-523c-890a-af4332701700	yes	Radiation Therapy, NOS	71fea95b-5b21-4144-80f6-3454a50bc08c
cc8c0bb8-aa5d-401c-b7e4-bb5b477a28ac.htseq.counts.gz	ab27b680-8f37-4f29-a564-3c16ec60dc89	TCGA-A5-A2K5-01A-11R-A180-07	TCGA-A5-A2K5-01A-11R	TCGA-A5-A2K5-01A-01-TS1			TCGA-A5-A2K5-01A-11	TCGA-A5-A2K5-01A	TCGA-A5-A2K5	cf77afe9-3785-45d4-ba2a-61c9cb706225	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	171	290.0	False	true	FF305857-5814-4815-90D3-B54BAA0DACB4	1.78	98327e51-9e30-4d72-a4b1-19b62b4d3cd2	0.17	23	released	2d484caa-07b5-489e-af1d-acf36441e7f6	RNA	R	0.17	UV Spec	released	False	aef3b317-4622-41ba-b2eb-9cd94d7ba187	11	5.0	3.0	5.0	0.0	0.0	20.0	75.0	90.0	TOP	5bf478ca-f1e0-4fd6-86f0-e4a3daa48dfb	released																				released	30.0	eca91844-e767-4045-a87f-e43dafbcc17a	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A2K5_demographic	76	-28057		90e1163b-6080-5f74-b548-83420da90baf	not hispanic or latino	female	white	released	Alive	1935		TCGA-A5-A2K5_exposure	Not Reported	47.80006774812751	0135d838-a478-587b-802a-d3cd8984b8e4	163.0	released	127.0	TCGA-A5-A2K5_diagnosis	28057	not reported	0	752	2a714244-9f8e-5acd-b228-19563cf28716	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-A5-A2K5_treatment	TCGA-A5-A2K5_treatment_1	released	db2b6dff-7eba-530d-8b9f-5d5db50d1ff3	yes	Radiation Therapy, NOS	released	7bdd99de-48e8-57b1-bb12-a620fab6d995	no	Pharmaceutical Therapy, NOS	ab27b680-8f37-4f29-a564-3c16ec60dc89
8ab6b107-0bc6-449b-9cc2-4ae0ac64e346.htseq.counts.gz	6bcbcf1c-56c7-4518-9333-76bdc1baf556	TCGA-AX-A062-01A-11R-A00V-07	TCGA-AX-A062-01A-11R	TCGA-AX-A062-01A-01-TSA	TCGA-AX-A062-01A-01-BSA		TCGA-AX-A062-01A-11	TCGA-AX-A062-01A	TCGA-AX-A062	4af65655-a3bd-4252-9b2f-2b2c4394f95c	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1610	200.0	False	false	FAAFB078-A6DF-4E1B-BD5F-A3B30E45BE1E	1.82	cfa7827b-f6bb-4714-ba9f-17e4adfdf3a9	0.16	23	released	7ae9dfda-54c9-46e9-9884-cef61259fb5d	RNA	R	0.16	UV Spec	released	False	367f2e1c-80fc-44f7-816e-83e5e07a3692	11	1.0	0.0	5.0	0.0	14.0	1.0	80.0	85.0	TOP	ce9b635c-2ead-4691-a6df-bc1c5213027c	released	1.0	0.0	7.0	1.0	11.0	2.0	80.0	85.0	BOTTOM	cf299089-97eb-4847-a7d1-5298b21624f6	released									released	30.0	9eac701b-9927-4aca-81eb-b516f90c643c	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A062_demographic	53	-19643		afb64fd6-7906-5bd8-87a9-03b43fb69900	not reported	female	white	released	Alive	1952		TCGA-AX-A062_exposure	Not Reported	40.76313942998429	3dcfc97d-d368-5ae0-9311-e97362913e0c	173.0	released	122.0	TCGA-AX-A062_diagnosis	19643	not reported	0	1399	19b9b525-2fae-5676-b5d0-dde681d32629	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2005	TCGA-AX-A062_treatment	TCGA-AX-A062_treatment_1	released	dfbd7fb2-ab5b-5a4e-b9be-dcb03e361957	no	Radiation Therapy, NOS	released	51e14872-a3ee-5ce1-9210-cd65c5e23e3f	no	Pharmaceutical Therapy, NOS	6bcbcf1c-56c7-4518-9333-76bdc1baf556
ec3365db-eb52-41f6-9f89-34f546fca076.htseq.counts.gz	67db9451-d507-4a3c-9eff-5bf74c6332fc	TCGA-BS-A0WQ-01A-21R-A109-07	TCGA-BS-A0WQ-01A-21R	TCGA-BS-A0WQ-01A-02-BSB	TCGA-BS-A0WQ-01A-02-TSB		TCGA-BS-A0WQ-01A-21	TCGA-BS-A0WQ-01A	TCGA-BS-A0WQ	e095a927-d985-4fbd-8093-46c1c6ace4de	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1696	140.0	False	false	207B2565-ABB2-4F05-8B54-2280DAC57AD3	1.83	432f025e-4ece-432e-b573-01a8e6f9a1e5	0.16	23	released	87fe2e03-1b1a-43f7-af26-6d7449062bcc	RNA	R	0.16	UV Spec	released	False	6591d247-d9a2-4fe1-93b4-033247b4c332	21	0.0	0.0	0.0	0.0	0.0	0.0	100.0	85.0	BOTTOM	b7efa40e-ff74-4b3e-9bba-482cc203a820	released	0.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	TOP	81c6cec3-158e-408f-9aa7-56c17a85ee07	released									released	30.0	b19275ba-cff5-4ec7-ac23-d6be497adef2	Primary Tumor	01	released	Not Reported	released	TCGA-BS-A0WQ_demographic	55	-20131		fbe59fad-77f1-5a5c-be08-9129ca24a265	not hispanic or latino	female	asian	released	Alive	1951		TCGA-BS-A0WQ_exposure	Not Reported	36.328125	85897cea-5047-5e9c-96d9-fbec70b0720f	160.0	released	93.0	TCGA-BS-A0WQ_diagnosis	20131	not reported	0	2022	8c6d3454-af03-5c35-9e05-1102360a1563	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2006	TCGA-BS-A0WQ_treatment_1	TCGA-BS-A0WQ_treatment	released	7a936b9c-c7a8-5a25-8f58-b40bf18b979a	no	Pharmaceutical Therapy, NOS	released	cb6ae894-4038-5502-9a71-501fa8b8bc77	no	Radiation Therapy, NOS	67db9451-d507-4a3c-9eff-5bf74c6332fc
78d880d7-acf4-4a92-98a7-2d69985b1741.htseq.counts.gz	5506e097-a2fe-4ff8-b0ea-9db4719a9d25	TCGA-FI-A2EY-01A-12R-A18M-07	TCGA-FI-A2EY-01A-12R	TCGA-FI-A2EY-01A-01-TSA			TCGA-FI-A2EY-01A-12	TCGA-FI-A2EY-01A	TCGA-FI-A2EY	787c3e2f-a708-4985-a5b1-b2383c7bfc52	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	1866	140.0	False	true	D529A633-2FC9-4C28-BEA4-994BABD51A48	1.83	c23bc644-ff87-4c84-a156-686903524aaa	0.17	23	released	8df98207-4ffe-4b93-b403-f304906494f9	RNA	R	0.17	UV Spec	released	False	830330fa-f309-4dd5-8ba9-1a377afcd59c	12	40.0	20.0	10.0	20.0	0.0	5.0	85.0	85.0	TOP	45db3839-8439-4fa3-a540-7c977513df90	released																				released	30.0	8c8e5dd2-b8ef-4e5c-9cd6-7d3717e4cdef	Primary Tumor	01	released	Not Reported	released	TCGA-FI-A2EY_demographic	63	-23042	880	631fe89e-04fb-56a0-ab68-80e604dfdaac	not hispanic or latino	female	white	released	Dead	1943	2008	TCGA-FI-A2EY_exposure	Not Reported	28.666129176744604	dcfa66c8-8749-58ae-8f21-bf2507490949	183.0	released	96.0	TCGA-FI-A2EY_diagnosis	23042	not reported	0		b7a3cfff-2bf8-5264-a606-25b3a131db3d	Stage IIIA	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2006	TCGA-FI-A2EY_treatment	TCGA-FI-A2EY_treatment_1	released	a1f852b2-9aec-5d51-8222-6cd8c64a1822	no	Radiation Therapy, NOS	released	1f4a9d3b-99cf-54b7-9eca-0db0104198b8	yes	Pharmaceutical Therapy, NOS	5506e097-a2fe-4ff8-b0ea-9db4719a9d25
93bc97c3-4943-47e3-82ce-8517b2a65c30.htseq.counts.gz	eee3f4ad-3dd7-4726-9923-e092747a6cd7	TCGA-A5-A0R8-01A-11R-A104-07	TCGA-A5-A0R8-01A-11R	TCGA-A5-A0R8-01A-01-TSA	TCGA-A5-A0R8-01A-01-BSA		TCGA-A5-A0R8-01A-11	TCGA-A5-A0R8-01A	TCGA-A5-A0R8	06d16b6b-9ca6-4cec-a785-f27aa4323cec	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	155	180.0	False	true	CA537524-B83F-4AC5-B721-38570E5B21BB	1.82	414c904a-29d0-44d0-bceb-ce7d024f1a58	0.13	23	released	9aa48c97-5f2f-44a3-aeb2-c9b358b4d71b	RNA	R	0.13	UV Spec	released	False	d00bf723-ad13-4048-b331-9f45e773502b	11	30.0	20.0	5.0	30.0	0.0	20.0	75.0	75.0	TOP	35ffff87-d27b-4b80-854c-dfda7289d623	released	30.0	30.0	10.0	30.0	0.0	20.0	70.0	70.0	BOTTOM	8436f37d-8adc-4dcb-a451-31a0a7e7ac56	released									released	30.0	5b5cc2ba-6a10-4279-a0aa-8ddae94d56ea	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A0R8_demographic	81	-29777		ee2f47ac-33f2-5a9e-8205-33f5961263b8	not hispanic or latino	female	white	released	Alive	1929		TCGA-A5-A0R8_exposure	Not Reported	24.21875	9a3b9763-c28e-5614-b373-67b590fcc410	160.0	released	62.0	TCGA-A5-A0R8_diagnosis	29777	not reported	0	596	ab21d7de-ea75-54ed-9d30-65a64b56122b	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-A5-A0R8_treatment	TCGA-A5-A0R8_treatment_1	released	5271e7b4-b7b4-5dc1-ac6d-170f56e2d9d4	yes	Radiation Therapy, NOS	released	c9f8e06c-4088-5f56-9cb4-c442d897e3dd	no	Pharmaceutical Therapy, NOS	eee3f4ad-3dd7-4726-9923-e092747a6cd7
37510c26-3396-4083-b06c-02d145829e30.htseq.counts.gz	df8834be-84fe-46ea-8a66-905aa22fee3d	TCGA-FL-A3WE-11A-11R-A22K-07	TCGA-FL-A3WE-11A-11R	TCGA-FL-A3WE-11A-01-TS1			TCGA-FL-A3WE-11A-11	TCGA-FL-A3WE-11A	TCGA-FL-A3WE	50edd97a-f440-40af-b94c-d88eca55d845	Not Reported	Uterus, NOS	TCGA-UCEC		80.0	False	true	803BA1B3-9F78-43B8-B9CA-81D309E9FEDA	1.84	6b961695-40e4-4c88-976a-8fb6c99b4f0f	0.16	23	released	fe23cfa6-61d5-4949-bd32-57e2ca2f7c18	RNA	R	0.16	UV Spec	released	False	0dcdb8ff-adf3-4af5-807e-416344668e17	11	0.0	0.0	0.0	0.0	30.0	70.0	0.0	0.0	TOP	2d1146a7-7d78-46f5-bd8d-7270875fa9ee	released																				released	30.0	70c3b243-d83a-4d15-b803-999bdd1576a8	Solid Tissue Normal	11	released	Not Reported	released																																																			df8834be-84fe-46ea-8a66-905aa22fee3d
c904d92e-b3bb-402c-ae37-fea2b8328970.htseq.counts.gz	41f628ef-e7ef-40f2-8e03-d17e8b5e492e	TCGA-A5-A0G3-01A-11R-A040-07	TCGA-A5-A0G3-01A-11R	TCGA-A5-A0G3-01A-01-BS1	TCGA-A5-A0G3-01A-01-TS1		TCGA-A5-A0G3-01A-11	TCGA-A5-A0G3-01A	TCGA-A5-A0G3	8432401d-799f-4f2f-b536-e79e1e8be064	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	987	230.0	False	true	66DEDB33-CA2C-4967-8074-1EFC1FC3CF29	1.93	cf384574-5895-4708-b29c-6906de020406	0.16	23	released	7760750a-676b-416c-a870-e38a4ab4c636	RNA	R	0.16	UV Spec	released	False	4f9edecc-6156-462e-84ef-22cb31d8c41b	11	0.0	0.0	5.0	0.0	0.0	0.0	95.0	90.0	BOTTOM	37e944fa-afd3-46f8-a08c-6d29ff5fe1c2	released	0.0	0.0	20.0	0.0	0.0	0.0	80.0	90.0	TOP	cd672fbe-b1d5-4279-be11-eb92d6da3f97	released									released	30.0	e462c0f0-4a2e-4571-af18-879e41d01aad	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A0G3_demographic	61	-22421		1919a3a7-a04e-5f06-bbe2-d190bee937e0	not reported	female	black or african american	released	Alive	1946		TCGA-A5-A0G3_exposure	Not Reported	23.507805325987142	15021f1c-1ffb-5a84-8ab4-15a96aba214b	165.0	released	64.0	TCGA-A5-A0G3_diagnosis	22421	not reported	0	1428	4acaf19b-207d-54a9-942c-57da493776cb	Stage IIIC2	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2007	TCGA-A5-A0G3_treatment	TCGA-A5-A0G3_treatment_1	released	c73162f8-a544-5db3-9016-966af22d8bd8	yes	Radiation Therapy, NOS	released	4facaada-2fc8-505e-96c6-a06fc372e47d	yes	Pharmaceutical Therapy, NOS	41f628ef-e7ef-40f2-8e03-d17e8b5e492e
5aba468f-4f91-41b7-a675-30b157a535de.htseq.counts.gz	3b291f4d-7a69-4df6-87f0-b1ceb99e0529	TCGA-AP-A054-01A-11R-A16W-07	TCGA-AP-A054-01A-11R	TCGA-AP-A054-01A-01-TS1	TCGA-AP-A054-01A-01-BS1		TCGA-AP-A054-01A-11	TCGA-AP-A054-01A	TCGA-AP-A054	d77e4dbc-b239-4742-8cb7-efd427010d13	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	2086	410.0	False	true	72028DF7-DAD0-487E-914B-C3AA69A1E6C4	1.86	2fc92e79-f56f-46b9-b378-a242dd7642d6	0.15	23	released	2f3d66d7-03de-4230-936a-542e8f8d333d	RNA	R	0.15	UV Spec	released	False	f213819b-662c-4ee1-a038-f4330a31d118	11	0.0	0.0	8.0	0.0	23.0	2.0	67.0	88.0	TOP	cf06e2fb-c9bf-4161-87dd-152deb208062	released	0.0	0.0	20.0	0.0	8.0	2.0	70.0	94.0	BOTTOM	d296e33e-f6e6-488f-9582-d4a94c63eeda	released									released	30.0	ddffb9c7-185f-402f-99b8-8058b40086d9	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A054_demographic	64	-23404	709	d6f05fb4-474c-5dc6-af92-61624f0f0d4c	not hispanic or latino	female	white	released	Dead	1940	2005	TCGA-AP-A054_exposure	Not Reported	26.89232313815483	c6d729f9-018a-5cb9-a133-6c1c1eb4ace8	167.0	released	75.0	TCGA-AP-A054_diagnosis	23404	not reported	0		2b7347af-8dcf-51f7-a56d-c994d6a4fc35	Stage IIIC1	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2004	TCGA-AP-A054_treatment_1	TCGA-AP-A054_treatment	released	d52f864d-01b9-58be-a741-bdc69913e30b	yes	Pharmaceutical Therapy, NOS	released	f4e752ef-f88e-5b9b-8a14-31201292e799	no	Radiation Therapy, NOS	3b291f4d-7a69-4df6-87f0-b1ceb99e0529
d09dc15d-98ac-44c1-a474-a9710f87b8ae.htseq.counts.gz	edb4cee6-b9eb-4bc0-9f9d-caf2fe16116b	TCGA-A5-A0GX-01A-11R-A040-07	TCGA-A5-A0GX-01A-11R	TCGA-A5-A0GX-01A-01-BSA	TCGA-A5-A0GX-01A-01-TSA		TCGA-A5-A0GX-01A-11	TCGA-A5-A0GX-01A	TCGA-A5-A0GX	553f0ccd-4e6f-4ae2-9b39-97529eb3d826	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1654	250.0	False	true	AE5229ED-8906-4D55-9B11-4E8E214D6446	1.8	d98e99e1-ee3e-4427-90ec-24e624aa1b46	0.15	23	released	5c93f939-94b1-4565-8a4b-819eadf58845	RNA	R	0.15	UV Spec	released	False	88dd1be5-a195-41aa-a3b9-12a0914f5d27	11	0.0	0.0	0.0	0.0	10.0	0.0	90.0	85.0	BOTTOM	32dc4f47-f23e-4628-97b9-fdb6100ded86	released	0.0	0.0	0.0	0.0	10.0	0.0	90.0	85.0	TOP	45a8237f-5025-4858-a511-4ce774062c07	released									released	30.0	983a35a9-c825-4961-86c0-4c6133b5c9c1	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A0GX_demographic	53	-19625		129632b7-438f-510e-9eab-1d43fc365cc0	not reported	female	white	released	Alive	1952		TCGA-A5-A0GX_exposure	Not Reported	40.15466983938132	61616f36-63e0-57b8-bd6a-a53bc4610fa5	164.0	released	108.0	TCGA-A5-A0GX_diagnosis	19625	not reported	0	2088	cb8a0d82-3cce-5564-b5ab-04b7cec178c1	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2005	TCGA-A5-A0GX_treatment_1	TCGA-A5-A0GX_treatment	released	ee7b412c-c0e9-51e3-99ca-d3e0d7af96a2	no	Pharmaceutical Therapy, NOS	released	7f31b194-84d2-520a-ad5c-e5a6ace5ab8b	yes	Radiation Therapy, NOS	edb4cee6-b9eb-4bc0-9f9d-caf2fe16116b
0620b847-eb91-4a7e-a743-0a6621b3d8c5.htseq.counts.gz	62c9cb95-b0a7-4d48-94cf-724a325a4211	TCGA-DI-A2QY-01A-12R-A19W-07	TCGA-DI-A2QY-01A-12R	TCGA-DI-A2QY-01A-01-TS1			TCGA-DI-A2QY-01A-12	TCGA-DI-A2QY-01A	TCGA-DI-A2QY	6524a6d3-a9f0-4a46-ac0b-7beb0cd1b915	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	2957	120.0	False	false	C78D0C27-34C3-44C4-9814-94EEE8A8AB95	1.96	ea5e5dcc-54e2-43a4-bcc6-ab7b81c87927	0.16	23	released	322fd1e5-ff6a-477d-8f77-0dc6556b9e29	RNA	R	0.16	UV Spec	released	False	e1c1aec2-ff42-410d-9d7a-634f58df802b	12	40.0	20.0	5.0	20.0	0.0	5.0	90.0	90.0	TOP	62316960-36e9-4919-be3f-f89f3ce464ed	released																				released	20.0	e86df94d-784d-41e0-8610-46ded1032f00	Primary Tumor	01	released	Not Reported	released	TCGA-DI-A2QY_demographic	64	-23398	3349	1bf3a85e-3bba-5f86-bdac-e4b82c02dbf6	not hispanic or latino	female	white	released	Dead	1939		TCGA-DI-A2QY_exposure	Not Reported	33.203125	03abc5eb-1514-5a39-8ba9-2b04141c412d	160.0	released	85.0	TCGA-DI-A2QY_diagnosis	23398	not reported	0	2797	16ba3979-eeba-5a99-a3e4-50daa96f30cd	Stage IIB	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2003	TCGA-DI-A2QY_treatment	TCGA-DI-A2QY_treatment_1	released	80c89912-4642-58ff-9420-bcf75d9bb5a7	yes	Radiation Therapy, NOS	released	b96031fa-5e06-59d7-9021-f30999cfc018	yes	Pharmaceutical Therapy, NOS	62c9cb95-b0a7-4d48-94cf-724a325a4211
c29adb10-8038-42d3-b08f-d5a447606b93.htseq.counts.gz	61d097eb-e56b-4435-ba68-772b73b90884	TCGA-EY-A1GC-01A-11R-A13S-07	TCGA-EY-A1GC-01A-11R	TCGA-EY-A1GC-01A-01-TSA			TCGA-EY-A1GC-01A-11	TCGA-EY-A1GC-01A	TCGA-EY-A1GC	ebc25a41-becb-4395-ae33-483a304b07d8	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	519	290.0	False	false	62D18250-0D82-43AB-AADE-E152D6FF74BB	1.82	b408b777-f98b-4660-b01b-89fa0c607c3b	0.18	23	released	0c05631e-65b8-470f-a67b-ec546c1fea90	RNA	R	0.18	UV Spec	released	False	9183d282-dd1f-40a1-94ff-3da0206bc3ed	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	85.0	TOP	04b631ae-2ae9-48a9-a891-3f64e3c9d678	released																				released	30.0	06be0e15-e48e-4243-ad8d-86cca9da68f9	Primary Tumor	01	released	Not Reported	released	TCGA-EY-A1GC_demographic	62	-22656		7dd5c05e-762f-5589-8195-2e1094cbb70d	not hispanic or latino	female	white	released	Alive	1947		TCGA-EY-A1GC_exposure	Not Reported	34.42217361683818	0c29e8f5-09f5-5d0b-8e8b-447979b446de	167.0	released	96.0	TCGA-EY-A1GC_diagnosis	22656	not reported	0	1647	703cdc4e-e025-5a91-aaf0-de0ac7d672d3	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-EY-A1GC_treatment_1	TCGA-EY-A1GC_treatment	released	4adad445-8682-5298-bfcd-8fd99153a7d8	no	Pharmaceutical Therapy, NOS	released	381dfebc-8325-5e88-b190-1ac9d2d9166e	no	Radiation Therapy, NOS	61d097eb-e56b-4435-ba68-772b73b90884
773ee6c9-89ca-46f2-a9b9-8a3773bcc4cc.htseq.counts.gz	2d72b48f-338f-49ab-b10d-c290163b57ea	TCGA-A5-A0GI-01A-11R-A040-07	TCGA-A5-A0GI-01A-11R	TCGA-A5-A0GI-01A-01-BSA	TCGA-A5-A0GI-01A-01-TSA		TCGA-A5-A0GI-01A-11	TCGA-A5-A0GI-01A	TCGA-A5-A0GI	3b21b47e-a15c-4b10-9702-62a14afdfb8c	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1779	130.0	False	true	F1D23669-8247-4727-8D38-BD444C16FAAE	1.87	ccf469e7-f403-4661-b5c4-e3ea020901b5	0.16	23	released	14c8618e-5e85-42d7-bfe7-48fab69c690b	RNA	R	0.16	UV Spec	released	False	54ecb70d-b317-4ed5-8c55-a86a45746faa	11	1.0	0.0	0.0	0.0	0.0	0.0	100.0	90.0	BOTTOM	b7416c08-b846-4919-894b-aa5664dd2aab	released	1.0	0.0	0.0	0.0	0.0	0.0	100.0	90.0	TOP	d892734a-77e3-4f66-ba1b-2333e861019e	released									released	30.0	dd02a477-06c0-4bda-9752-896491eddd95	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A0GI_demographic	63	-23195		542d2c0f-96a1-52fb-89c7-b31e2e9cd8b9	not hispanic or latino	female	white	released	Alive	1942		TCGA-A5-A0GI_exposure	Not Reported	23.3843537414966	a1be734a-3f3c-5e88-9cae-071ee9d1669e	168.0	released	66.0	TCGA-A5-A0GI_diagnosis	23195	not reported	0	2682	31803be2-1086-5476-b922-3506e5f2d6c0	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2005	TCGA-A5-A0GI_treatment_1	TCGA-A5-A0GI_treatment	released	b48a7164-669b-571d-8b86-cf730587bd3a	no	Pharmaceutical Therapy, NOS	released	0ac03464-cc57-51b5-a427-3e0e8b6ae472	yes	Radiation Therapy, NOS	2d72b48f-338f-49ab-b10d-c290163b57ea
7564b1ea-846a-4c77-9cb9-ceb2e865dbf0.htseq.counts.gz	ae3b5608-8df9-4c4d-9a74-f5770fb45afe	TCGA-D1-A17S-01A-11R-A12I-07	TCGA-D1-A17S-01A-11R	TCGA-D1-A17S-01A-01-TSA			TCGA-D1-A17S-01A-11	TCGA-D1-A17S-01A	TCGA-D1-A17S	24434832-46fc-485a-9ff4-2aa95c3d3936	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	419	280.0	False	false	54337BED-9366-4CB6-BA95-BB5999CBF342	1.73	dcd43fa2-2529-47e6-9d9f-931cbf8d4da5	0.17	23	released	a29659b2-7eb6-4d6f-9f58-4813e5b619e0	RNA	R	0.17	UV Spec	released	False	f55f98f2-7c75-403e-be32-43b08e5c2774	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	90.0	TOP	c9fa012c-3785-4f79-9294-d9501d5c722e	released																				released	30.0	5f4de8f1-b75f-4a53-9b4d-6a2f5422d6ca	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A17S_demographic	59	-21794		b85bd397-ef0d-53ff-a97e-1078fd412234	not hispanic or latino	female	white	released	Alive	1950		TCGA-D1-A17S_exposure	Not Reported	42.578125	89feeb90-6c29-56c6-ae4c-0aaa2078987d	160.0	released	109.0	TCGA-D1-A17S_diagnosis	21794	not reported	0	739	9aac47c0-49ae-5dc3-963a-a75f57f52e1d	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-D1-A17S_treatment	TCGA-D1-A17S_treatment_1	released	491783be-d724-5305-bb44-aa53c2d2f7cd	no	Radiation Therapy, NOS	released	b2ca04bc-72e6-5ed6-a825-ecf8f82abd79	no	Pharmaceutical Therapy, NOS	ae3b5608-8df9-4c4d-9a74-f5770fb45afe
414b7dc4-d43b-4a93-b3d6-249f45be606b.htseq.counts.gz	08e20b07-dfef-4dca-aa04-5252e96e7a2c	TCGA-EY-A5W2-01A-11R-A31O-07	TCGA-EY-A5W2-01A-11R	TCGA-EY-A5W2-01A-01-TS1			TCGA-EY-A5W2-01A-11	TCGA-EY-A5W2-01A	TCGA-EY-A5W2	1944e155-b765-48c3-9602-6787c105e551	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	105	870.0	False	false	C09EED3C-50CC-47CB-BA81-96D05E53D9F0	1.83	894b867a-591d-4d05-b008-db1a90b18a60	0.17	23	released	f67fdc7c-2430-4a3e-a722-ebb356e1418b	RNA	R	0.17	UV Spec	released	False	830e980e-468b-46de-836b-49571d8c1672	11	0.0	0.0	0.0	0.0	0.0	20.0	80.0	80.0	TOP	98509a6c-f812-4678-89db-dc9e4e4006b6	released																				released	30.0	d50bb383-3384-47d9-92b8-1f0604ac2725	Primary Tumor	01	released	Not Reported	released	TCGA-EY-A5W2_demographic	72	-26498		e7a98c2c-539d-501e-8a18-f269636399ec	not hispanic or latino	female	black or african american	released	Alive	1940		TCGA-EY-A5W2_exposure	Not Reported	32.02036958450677	22aac06c-86ee-5665-874d-4b3c71ce81a1	161.0	released	83.0	TCGA-EY-A5W2_diagnosis	26498	not reported	0	516	c192dd75-28e1-5ce0-9b66-234a0ad768d9	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2012	TCGA-EY-A5W2_treatment	TCGA-EY-A5W2_treatment_1	released	355c8539-8e1b-5d0d-abdf-69bea260650a	yes	Radiation Therapy, NOS	released	cab68deb-420a-51df-ae73-3a53bc423aac	no	Pharmaceutical Therapy, NOS	08e20b07-dfef-4dca-aa04-5252e96e7a2c
9f82261f-432a-483c-8214-56afecb937e0.htseq.counts.gz	3eab9e02-8992-4e49-969f-c20accd66dab	TCGA-D1-A1NU-01A-11R-A14D-07	TCGA-D1-A1NU-01A-11R	TCGA-D1-A1NU-01A-01-TSA			TCGA-D1-A1NU-01A-11	TCGA-D1-A1NU-01A	TCGA-D1-A1NU	e56491af-718f-4ca1-b3cd-0e5b3154697b	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	87	120.0	False	false	08AE92E6-EDAB-4059-AF51-4A8522EDD463	1.81	543b9907-bf2a-4f64-b83f-13cc4289310b	0.18	23	released	a9bafdd4-2323-48d5-a1c8-c8c02d1beda2	RNA	R	0.18	UV Spec	released	False	32e8339a-2a46-4eb6-ad03-19b5c35e00a4	11	40.0	20.0	10.0	20.0	0.0	25.0	65.0	65.0	TOP	0d827293-8620-4e50-8eac-aaa35fd414b0	released																				released	30.0	7901f084-c220-4865-a034-da0144d63a28	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A1NU_demographic	74	-27272		0309ac57-a9e4-5985-afaa-1c22c3de13d7	not hispanic or latino	female	white	released	Alive	1936		TCGA-D1-A1NU_exposure	Not Reported	40.78768475066883	594b6c30-8a08-5346-9b03-18628d0cae05	151.0	released	93.0	TCGA-D1-A1NU_diagnosis	27272	not reported	0	402	95c39d78-414a-58f7-ba98-0b27c5bbe04c	Stage IA	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-D1-A1NU_treatment_1	TCGA-D1-A1NU_treatment	released	462c092a-c458-52ce-b702-036da6f52384	yes	Pharmaceutical Therapy, NOS	released	d7507d19-229a-5024-a6ac-8829617c5e74	yes	Radiation Therapy, NOS	3eab9e02-8992-4e49-969f-c20accd66dab
65315477-9c5f-4e48-baaf-67027c502f15.htseq.counts.gz	15ab74bf-898b-44de-9240-ca6858a3dc78	TCGA-BG-A18A-01A-21R-A12I-07	TCGA-BG-A18A-01A-21R	TCGA-BG-A18A-01A-02-TSB			TCGA-BG-A18A-01A-21	TCGA-BG-A18A-01A	TCGA-BG-A18A	feb3e930-3638-44b4-ac0f-a5dcb01fed76	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	146	130.0	False	true	099561AC-A5E7-4CA9-8F07-EEA7B3A96EEA	1.81	71679725-d65f-47d4-b851-e4467f9d3f62	0.15	23	released	0d5d627f-924c-4909-81c5-abbf5b193b28	RNA	R	0.15	UV Spec	released	False	96bf06eb-1bad-440f-893b-accf585dacc1	21	0.0	0.0	0.0	0.0	0.0	30.0	70.0	60.0	TOP	de21c689-b0c8-4436-9eb6-31599c686221	released																				released	30.0	8fd0971d-40ba-46c2-b3c4-8e48a3e6c122	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A18A_demographic	74	-27086		b2815b75-c7ba-5b55-bcdc-21aabbed3b28	not hispanic or latino	female	white	released	Alive	1936		TCGA-BG-A18A_exposure	Not Reported	32.007315957933244	30600b66-bf82-55d6-b907-4990f8da47e9	162.0	released	84.0	TCGA-BG-A18A_diagnosis	27086	not reported	0	426	b97bcb90-bc6a-5bf9-8f36-37104b8ed2e3	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-BG-A18A_treatment	TCGA-BG-A18A_treatment_1	released	3858cbca-1afb-5859-a4d7-9c10d0f02411	yes	Radiation Therapy, NOS	released	a7dcd32c-bf34-53bf-8426-a47a05900608	no	Pharmaceutical Therapy, NOS	15ab74bf-898b-44de-9240-ca6858a3dc78
d1666bf1-50fa-44ec-8681-8f46e479daee.htseq.counts.gz	da49c5d3-27f4-408e-aced-b350aa7c60c0	TCGA-BK-A26L-01A-11R-A277-07	TCGA-BK-A26L-01A-11R	TCGA-BK-A26L-01A-01-TS1			TCGA-BK-A26L-01A-11	TCGA-BK-A26L-01A	TCGA-BK-A26L	ab7adf74-6e87-4117-9742-54e323348e06	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	131	320.0	False	false	979388A8-CC61-4C03-BADC-BEF9EC50C40A	1.95	ff504261-6803-4f5f-920c-7e82fa5ac9e3	0.18	23	released	5802796b-ea96-497c-b6bd-619d7f1c0f40	RNA	R	0.18	UV Spec	released	False	adeae27b-9627-4ac2-bc0c-e3a52c293084	11	40.0	20.0	5.0	20.0	0.0	25.0	70.0	70.0	TOP	fbc3731f-ad7b-4b2d-85f1-d09f9caa666a	released																				released	30.0	cfde53b1-a992-4180-b747-b4c1d3ed2e2b	Primary Tumor	01	released	Not Reported	released	TCGA-BK-A26L_demographic	71	-26002		cd6ec347-4caf-5ff7-a22e-34c0c62a99b3	not hispanic or latino	female	white	released	Alive	1939		TCGA-BK-A26L_exposure	Not Reported	32.46191135734072	457ac974-3e7b-5b32-ad48-70007f173b72	152.0	released	75.0	TCGA-BK-A26L_diagnosis	26002	not reported	0	734	d2b10490-3a90-5a92-bf52-ee5faaa52852	Stage IIIC1	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-BK-A26L_treatment_1	TCGA-BK-A26L_treatment	released	3426f7dd-1628-5a65-b5a0-df833a4a6c5d	yes	Pharmaceutical Therapy, NOS	released	a800f1f1-88f2-5f57-be1e-c504f5f2d832	yes	Radiation Therapy, NOS	da49c5d3-27f4-408e-aced-b350aa7c60c0
45b3cbd9-b757-42bb-9230-e55ef6041761.htseq.counts.gz	7ecc75e9-41c0-4ec7-96a8-65a92bf53cce	TCGA-D1-A0ZU-01A-11R-A10J-07	TCGA-D1-A0ZU-01A-11R	TCGA-D1-A0ZU-01A-01-BS1	TCGA-D1-A0ZU-01A-01-TS1		TCGA-D1-A0ZU-01A-11	TCGA-D1-A0ZU-01A	TCGA-D1-A0ZU	d74bc72e-8103-4aed-8958-5f40953d48eb	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	508	180.0	False	false	D0BC0903-390B-4344-A613-48ABF71CF08D	1.86	8708462d-d090-4fa2-95a6-f6021ce0489b	0.16	23	released	a476f599-ab31-4ddf-ba35-fb7626bb419e	RNA	R	0.16	UV Spec	released	False	d39d7dc6-8782-41f1-b3e4-457337b288b4	11	10.0	0.0	10.0	10.0	20.0	0.0	70.0	80.0	BOTTOM	19f8bd4c-f8ae-4f5c-9560-f92839226651	released	10.0	0.0	10.0	10.0	10.0	10.0	70.0	80.0	TOP	24650b19-645b-476f-91cf-85a8c0db5dc3	released									released	30.0	7b90b0fe-1088-48e9-8903-6102f27e4485	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A0ZU_demographic	34	-12458		ee1002c1-689a-5594-a725-effa8b8af1dc	not hispanic or latino	female	white	released	Alive	1975		TCGA-D1-A0ZU_exposure	Not Reported	32.52595155709342	4f987bcb-1e39-5e41-86c3-d8b25429138c	170.0	released	94.0	TCGA-D1-A0ZU_diagnosis	12458	not reported	0	872	b4a356da-fe64-55c9-af8e-cfb83379916a	Stage IB	C54.1	not reported	8382/3	Endometrioid adenocarcinoma, secretory variant	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-D1-A0ZU_treatment_1	TCGA-D1-A0ZU_treatment	released	f617f60d-ba67-57f1-8c10-3a954855dece	yes	Pharmaceutical Therapy, NOS	released	6e8af011-3c03-57b3-8a0b-40bdfc7655c3	yes	Radiation Therapy, NOS	7ecc75e9-41c0-4ec7-96a8-65a92bf53cce
1e7bf118-08f2-4abd-901e-8a588c14f858.htseq.counts.gz	13a3f505-ea6e-456c-87ec-5b0aeb0f4f51	TCGA-AP-A1E1-01A-11R-A137-07	TCGA-AP-A1E1-01A-11R	TCGA-AP-A1E1-01A-01-TSA			TCGA-AP-A1E1-01A-11	TCGA-AP-A1E1-01A	TCGA-AP-A1E1	2b85b84f-e680-4b5c-93ea-3c71567227e8	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	470	260.0	False	true	E8873536-294D-4E41-9165-EE403A11B439	1.81	2e11f69d-8c0d-484e-8f22-1ad97f26c78d	0.17	23	released	6d602654-6a9c-4669-bf4d-05bc31ad36d3	RNA	R	0.17	UV Spec	released	False	b25d8369-84e9-4f22-80d4-f7fd4222db98	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	70.0	TOP	63c5d357-4ab2-4f5b-9ec6-8eed98998ebe	released																				released	30.0	1a9a1020-c9ee-4bbf-98e8-fbe5041a6099	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A1E1_demographic	74	-27072		b9d31f87-628e-584a-b7ad-d7a6d69e6f91	not reported	female	white	released	Alive	1935		TCGA-AP-A1E1_exposure	Not Reported	28.515625	8efb30f9-cde3-5d4d-87bd-c1a88f16c2fd	160.0	released	73.0	TCGA-AP-A1E1_diagnosis	27072	not reported	0	1395	9797428f-80a0-5e9e-a2a2-83a4610630c9	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-AP-A1E1_treatment_1	TCGA-AP-A1E1_treatment	released	1be9f7ae-9f83-5cfe-a210-5e9017390a4a	no	Pharmaceutical Therapy, NOS	released	2fbb8ff6-5b57-5765-87b7-703703ff0c3f	no	Radiation Therapy, NOS	13a3f505-ea6e-456c-87ec-5b0aeb0f4f51
97c0b9ba-e792-4e0c-af06-f6789ab37e40.htseq.counts.gz	12bfd0f8-a97b-44c1-8a9e-b5fd9a023514	TCGA-KP-A3VZ-01A-11R-A22K-07	TCGA-KP-A3VZ-01A-11R	TCGA-KP-A3VZ-01A-01-TSA			TCGA-KP-A3VZ-01A-11	TCGA-KP-A3VZ-01A	TCGA-KP-A3VZ	6b35a816-f9c4-44d4-9824-5dee4804b80d	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	633	200.0	False	true	FF834E31-78F7-4A56-8EC0-E026BE940FD4	1.85	0f347f95-e4bc-480e-ab1a-84c9df4018c9	0.16	23	released	171ca5c0-9f8c-4e41-a517-cdf86dfafdcb	RNA	R	0.16	UV Spec	released	False	05af429d-e995-4941-9ccc-05ee82c41f6d	11	60.0	20.0	5.0	10.0	0.0	5.0	90.0	90.0	TOP	03e30840-a2f5-4309-97d1-8b6a3e2d7a7b	released																				released	30.0	f73c1ce5-2813-45b2-951f-8ab539b32988	Primary Tumor	01	released	Not Reported	released	TCGA-KP-A3VZ_demographic	69	-25366		847fa83d-736f-5a87-a0db-2dfbe7973176	not hispanic or latino	female	white	released	Alive	1941		TCGA-KP-A3VZ_exposure	Not Reported	20.700816741315066	5c932d84-d8f1-538a-82b3-a05938e364a1	163.0	released	55.0	TCGA-KP-A3VZ_diagnosis	25366	not reported	0	722	15ac85f0-1a5c-5f57-8c36-8d0d94fb9c8c	Stage IV	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2010	TCGA-KP-A3VZ_treatment	TCGA-KP-A3VZ_treatment_1	released	7ee161da-2958-5ec8-b78d-b2204b1306cb	not reported	Radiation Therapy, NOS	released	f07d9c4e-0ad6-593a-bcf3-664ac82f95b2	not reported	Pharmaceutical Therapy, NOS	12bfd0f8-a97b-44c1-8a9e-b5fd9a023514
6e30a4b7-b56d-4b61-a853-387b50ca75b3.htseq.counts.gz	0265cc02-40b5-4906-bda0-68caaaed047d	TCGA-AP-A05O-01A-12R-A118-07	TCGA-AP-A05O-01A-12R	TCGA-AP-A05O-01A-01-BSA	TCGA-AP-A05O-01A-01-TSA		TCGA-AP-A05O-01A-12	TCGA-AP-A05O-01A	TCGA-AP-A05O	49431740-7ed1-4c67-8d66-730629825895	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	209	270.0	False	true	9C8BD34A-DC49-4547-850A-80DCD2D073F8	1.87	00186124-cecf-4580-9dca-cef7c09f741c	0.16	23	released	1c1178fe-3036-451c-8afc-e8cee0967f56	RNA	R	0.16	UV Spec	released	False	53647516-3017-408c-8dc6-9e81419bc0f8	12	10.0	20.0	10.0	20.0	0.0	50.0	40.0	45.0	BOTTOM	cb794653-c825-4dea-b2db-f05fa6c2625d	released	20.0	20.0	5.0	20.0	0.0	35.0	60.0	60.0	TOP	ed321c6a-a6fb-4042-bcb3-cdd2b5aa6384	released									released	20.0	4f1edc7f-e2ff-40f5-8227-d89a1006042c	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A05O_demographic	68	-24978		a7d5fa96-a744-5b60-90ae-aecdafa90d04	not reported	female	white	released	Alive	1941		TCGA-AP-A05O_exposure	Not Reported	41.25941355551995	0c22462e-f9a6-5cc8-8ed8-f427a71e4e90	158.0	released	103.0	TCGA-AP-A05O_diagnosis	24978	not reported	0	384	2efa2af1-2122-5915-b315-b04d67565aad	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-AP-A05O_treatment	TCGA-AP-A05O_treatment_1	released	23d756a9-9cf5-55b0-91f0-13288b48e198	yes	Radiation Therapy, NOS	released	4630e686-5d5b-55df-a18f-4e4538ac5eb5	yes	Pharmaceutical Therapy, NOS	0265cc02-40b5-4906-bda0-68caaaed047d
b9c86d45-14b0-412d-aebf-ac2745e4af56.htseq.counts.gz	bf9cb396-588b-49ec-a22b-5e34ba3bc18d	TCGA-AJ-A3BF-01A-11R-A213-07	TCGA-AJ-A3BF-01A-11R	TCGA-AJ-A3BF-01A-01-TS1			TCGA-AJ-A3BF-01A-11	TCGA-AJ-A3BF-01A	TCGA-AJ-A3BF	40287cdc-19dd-4370-a6a0-f324960e1148	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	92	150.0	False	false	3673A111-6F2E-4374-A0E7-BA436D644F0D	1.37	f282d6e9-6a6a-4515-8efd-d5fff0367ee8	0.16	23	released	3a50ead7-dcdd-41f5-b05b-e90c50080e3f	RNA	R	0.16	UV Spec	released	False	61dcd5dd-f7b8-41e6-9175-17c93301facc	11	2.0	1.0	2.0	0.0	5.0	3.0	90.0	90.0	TOP	649ac754-02cd-421e-9a2f-776a2e39c0a7	released																				released	30.0	ef33dd67-2e71-4a81-91dc-f5e404fb25f7	Primary Tumor	01	released	Not Reported	released	TCGA-AJ-A3BF_demographic	65	-23906		ffc30aed-dee2-51e6-b47a-6040fd685f9e	not hispanic or latino	female	white	released	Alive	1946		TCGA-AJ-A3BF_exposure	Not Reported	39.10034602076124	1f4c9689-496d-57ed-9ec9-2d864d77b7d3	170.0	released	113.0	TCGA-AJ-A3BF_diagnosis	23906	not reported	0	551	4919e8d0-23a1-55d8-a0b0-5e138272b8e3	Stage IIIC2	C54.1	not reported	8460/3	Papillary serous cystadenocarcinoma	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-AJ-A3BF_treatment	TCGA-AJ-A3BF_treatment_1	released	444dfdac-c3b7-523a-9fb6-4326cef8fdd0	yes	Radiation Therapy, NOS	released	8441dd4d-8448-544a-8bf0-105ead9800b1	yes	Pharmaceutical Therapy, NOS	bf9cb396-588b-49ec-a22b-5e34ba3bc18d
bfb6877d-175e-4861-9554-8a4d052cc30a.htseq.counts.gz	ff0072c6-2a20-41c5-a7a2-63eaa7d17899	TCGA-BG-A0VT-01A-11R-A10J-07	TCGA-BG-A0VT-01A-11R	TCGA-BG-A0VT-01A-01-BSA	TCGA-BG-A0VT-01A-01-MSA		TCGA-BG-A0VT-01A-11	TCGA-BG-A0VT-01A	TCGA-BG-A0VT	cc058b8c-df40-4f9e-88e3-3d1131b22b41	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	87	70.0	False	true	0BC38740-A7B9-4086-9F03-A139287B33CC	1.84	666ecfed-75d2-412a-bd7f-24b9775db969	0.16	23	released	0994329c-a931-40b4-9477-fb9a051d8dc8	RNA	R	0.16	UV Spec	released	False	47159fec-afa8-4a67-b36c-8b826e392d82	11	30.0	20.0	10.0	40.0	0.0	20.0	70.0	70.0	BOTTOM	152b81ef-e8ed-446a-b00f-776ba3df3bec	released	1.0	0.0	10.0	0.0	30.0	0.0	60.0	70.0	TOP	7425fe9f-c4ba-4867-8ca5-b921ca5e3138	released									released	30.0	0cfbcb61-c5e2-47f7-beb6-504f3cd4605b	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A0VT_demographic	56	-20602		e994a2fd-e48e-59d3-8f79-518983164bf1	not hispanic or latino	female	white	released	Alive	1954		TCGA-BG-A0VT_exposure	Not Reported	49.82698961937716	9bdc9340-4e96-5c13-aba3-3daa119ab453	170.0	released	144.0	TCGA-BG-A0VT_diagnosis	20602	not reported	0	1568	3d11de4e-227e-54c3-a47f-a4bd36c33697	Stage IIIA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-BG-A0VT_treatment_1	TCGA-BG-A0VT_treatment	released	bbf985c6-be68-5b22-a9e8-7db4a78c66f1	yes	Pharmaceutical Therapy, NOS	released	56e89139-ad72-5a22-961d-c5865816bc0c	no	Radiation Therapy, NOS	ff0072c6-2a20-41c5-a7a2-63eaa7d17899
267bb319-5f6e-4686-9ffc-d64cb4172a05.htseq.counts.gz	24acec0a-220c-499b-8b51-963539fd868d	TCGA-AP-A0L9-01A-11R-A040-07	TCGA-AP-A0L9-01A-11R	TCGA-AP-A0L9-01A-01-TSA	TCGA-AP-A0L9-01A-01-BSA		TCGA-AP-A0L9-01A-11	TCGA-AP-A0L9-01A	TCGA-AP-A0L9	7b9947d5-e86b-4006-8890-ea5209584a88	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	3402	140.0	False	true	62E44C56-838D-4318-B8F7-80476A148C03	1.72	43abe272-41cb-4b54-b6f6-50a27c670e46	0.14	23	released	bf9e4a9b-b28e-4003-bde8-130cd6db65a4	RNA	R	0.14	UV Spec	released	False	42cf146c-34bf-42bf-b095-8e689460dc07	11	20.0	0.0	20.0	20.0	0.0	0.0	80.0	100.0	TOP	f43521cb-85c1-4eda-90b7-c8dbe2af7b62	released	20.0	0.0	20.0	20.0	0.0	0.0	80.0	100.0	BOTTOM	575ffdcb-b260-4848-80ab-36e3c6eb5429	released									released	30.0	53d0521f-10d6-4f70-9277-d99025a6b963	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A0L9_demographic	71	-26185		05c600f7-24d5-5768-9a0b-9c03dc374335	not reported	female	white	released	Alive	1930		TCGA-AP-A0L9_exposure	Not Reported	25.969529085872576	c1607987-3ecb-56d2-8a5e-0efa9ab26be3	152.0	released	60.0	TCGA-AP-A0L9_diagnosis	26185	not reported	0	3815	e04d0c32-8452-5a7c-b2f2-449dd19152c6	Stage IA	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2001	TCGA-AP-A0L9_treatment_1	TCGA-AP-A0L9_treatment	released	83ce7d6f-6a49-5874-b3bb-270f70367536	no	Pharmaceutical Therapy, NOS	released	4efab499-95b4-51eb-9c79-96e89696e61f	no	Radiation Therapy, NOS	24acec0a-220c-499b-8b51-963539fd868d
41f3a303-50f4-4127-8f05-a1367a5606e6.htseq.counts.gz	d85f05d2-1543-44a6-ac62-2394b11b46eb	TCGA-D1-A0ZP-01A-21R-A10J-07	TCGA-D1-A0ZP-01A-21R	TCGA-D1-A0ZP-01A-02-BS2	TCGA-D1-A0ZP-01A-02-MS2		TCGA-D1-A0ZP-01A-21	TCGA-D1-A0ZP-01A	TCGA-D1-A0ZP	ac216bb5-15e4-4462-955e-8a522380690e	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	552	180.0	False	false	FD46BB74-914F-4B4E-819A-5AD5F4548672	1.85	2188d23d-209d-4d3c-b737-f48892e08d31	0.17	23	released	9fd0bb5a-3130-49c4-8f79-d538deb7462d	RNA	R	0.17	UV Spec	released	False	b7ff3f0a-22eb-4700-bf14-8bb70511afa0	21	10.0	0.0	10.0	10.0	0.0	10.0	80.0	90.0	BOTTOM	3dd0e2a4-ec53-4cfa-8935-6e4b7c087167	released	8.0	0.0	0.0	1.0	2.0	23.0	75.0	75.0	TOP	83a2289d-0752-4cc5-8127-05c2e7d4b2d1	released									released	30.0	41a4ef51-9560-4089-a08a-624a64a168d5	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A0ZP_demographic	59	-21581		0ecef8f0-f148-5b31-8f6d-ea0e4f2440da	not hispanic or latino	female	white	released	Alive	1950		TCGA-D1-A0ZP_exposure	Not Reported	22.375679950619187	c4ab6cbc-7064-52ec-8ad1-a23820dbebcd	161.0	released	58.0	TCGA-D1-A0ZP_diagnosis	21581	not reported	0	911	a50ec4a3-5106-583e-a55c-bd33dfc9c68e	Stage IVA	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-D1-A0ZP_treatment_1	TCGA-D1-A0ZP_treatment	released	fcd9ff96-5359-57f4-af80-fec6a0b3f573	yes	Pharmaceutical Therapy, NOS	released	f1b231a6-bbdb-5a33-8a1a-4e9fc0585b84	yes	Radiation Therapy, NOS	d85f05d2-1543-44a6-ac62-2394b11b46eb
5f6523cd-6344-457c-bd3d-8c0f57891739.htseq.counts.gz	0e494570-86ab-4998-bf91-4c8dc1886dd1	TCGA-EY-A1GT-01A-11R-A13S-07	TCGA-EY-A1GT-01A-11R	TCGA-EY-A1GT-01A-01-TSA			TCGA-EY-A1GT-01A-11	TCGA-EY-A1GT-01A	TCGA-EY-A1GT	e0d13e2d-cf48-4b66-bfc2-88f872f67d79	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	225	380.0	False	false	2F5AE4E7-9411-461D-ACD9-EB7D51CEF872	1.7	654f3e2f-00c7-4db6-b092-e2d0d50845da	0.15	23	released	6188fe9d-7073-4b92-b450-a1ab42487419	RNA	R	0.15	UV Spec	released	False	34cd0df5-dbf9-4ab5-b1ad-c9635da37467	11	40.0	20.0	10.0	20.0	0.0	30.0	60.0	60.0	TOP	3ae1b8f8-f89c-4b62-a87b-c984f7cf9279	released																				released	30.0	20983a85-478b-4cc1-bbf9-e136773f6288	Primary Tumor	01	released	Not Reported	released	TCGA-EY-A1GT_demographic	68	-25151		82aaf7e3-9a30-5061-b417-624d521b0883	not hispanic or latino	female	white	released	Alive	1942		TCGA-EY-A1GT_exposure	Not Reported	24.8015873015873	411d2072-61e2-5bbd-9f78-590172514046	168.0	released	70.0	TCGA-EY-A1GT_diagnosis	25151	not reported	0	490	c5270936-62ce-5d17-aea2-139f36582dbf	Stage IIIA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-EY-A1GT_treatment	TCGA-EY-A1GT_treatment_1	released	e36d3534-acfc-5e37-bd23-6b571fac137e	no	Radiation Therapy, NOS	released	88e25456-5d9d-5ca9-a0b4-02d3597fd5fa	yes	Pharmaceutical Therapy, NOS	0e494570-86ab-4998-bf91-4c8dc1886dd1
d4356740-60db-41b1-901b-a8c2134b7c7f.htseq.counts.gz	7f1701a9-236b-4e10-856e-d47bfe838a29	TCGA-BK-A0CC-01B-04R-A277-07	TCGA-BK-A0CC-01B-04R	TCGA-BK-A0CC-01B-04-BS4	TCGA-BK-A0CC-01B-03-BS3		TCGA-BK-A0CC-01B-04	TCGA-BK-A0CC-01B	TCGA-BK-A0CC	2b865f8c-539f-4cb2-8f08-41709e9511e5	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	645		True	false	6A2AAC78-98B9-44D4-AF8D-9A132579CC2D	1.85	80ab3bb7-f083-4414-8d50-122ea25e6526	0.15	23	released	31e8158b-0dc7-4aad-b9ae-728359c68faf	RNA	R	0.15	UV Spec	released	True	35a08123-ef8e-43e3-a58b-f06283017fac	04	4.0	0.0	0.0	2.0	0.0	0.0	100.0	60.0	BOTTOM	5dc72acb-fc02-4eba-8909-5d75449e0ead	released	4.0	0.0	0.0	2.0	0.0	0.0	100.0	60.0	TOP	78178275-d31a-46e1-a050-3e6e55f281e1	released									released	400.0	23659618-8933-4944-8cb2-adf8ed51d7a5	Primary Tumor	01	released	Not Reported	released	TCGA-BK-A0CC_demographic	69	-25479		f3903f35-c35d-54f4-be3d-4c655da416f4	hispanic or latino	female	black or african american	released	Alive	1941		TCGA-BK-A0CC_exposure	Not Reported	31.16343490304709	d11893ab-e091-5b1f-955d-00e087fb439a	152.0	released	72.0	TCGA-BK-A0CC_diagnosis	25479	not reported	0	1067	7924d7fd-572e-5f05-920f-de2bc56e759f	Stage IIIC	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-BK-A0CC_treatment_1	TCGA-BK-A0CC_treatment	released	8d9f977e-f86d-5d51-86f0-125038780ed2	yes	Pharmaceutical Therapy, NOS	released	af85e4ac-f4ce-532c-ad60-f6c582a60a9e	yes	Radiation Therapy, NOS	7f1701a9-236b-4e10-856e-d47bfe838a29
ed406c54-68f2-449e-a178-7f7df60540d5.htseq.counts.gz	17081581-de84-433b-96cc-0884fdc8acc8	TCGA-D1-A16Y-01A-31R-A12I-07	TCGA-D1-A16Y-01A-31R	TCGA-D1-A16Y-01A-03-TS3			TCGA-D1-A16Y-01A-31	TCGA-D1-A16Y-01A	TCGA-D1-A16Y	0e9c36fd-2d5d-48da-8364-f8c5edc3d873	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	610	220.0	False	false	0A0451C4-2A58-4404-934E-3517443E4CEE	1.84	486755e1-9b18-4310-a1bb-ddd325f212b0	0.16	23	released	c910f364-b904-4a0e-89d6-ab20d9459bb9	RNA	R	0.16	UV Spec	released	False	e899a9fd-d75b-4a9e-ba2d-10c8ec0cf2df	31	4.0	2.0	0.0	1.0	0.0	25.0	75.0	75.0	TOP	758c48e8-05e0-4699-ad05-5b2af3043dd5	released																				released	30.0	56b2dbc4-9ab6-43ef-9d86-a39d4a60a18d	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A16Y_demographic	56	-20455		8802988a-0d68-5a09-bdc4-3b21e28f31f8	not hispanic or latino	female	white	released	Alive	1953		TCGA-D1-A16Y_exposure	Not Reported	35.74950690335305	e4c724b9-9f82-54fa-96c7-86b6218ac8c6	156.0	released	87.0	TCGA-D1-A16Y_diagnosis	20455	not reported	0	532	8bc6d042-8041-55ba-93f4-86fc56b8bcf6	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-D1-A16Y_treatment	TCGA-D1-A16Y_treatment_1	released	82762a59-3efa-5b1f-8d1f-3bf5927c05dd	no	Radiation Therapy, NOS	released	edf27cc3-ad09-50d9-8879-63468efe772f	no	Pharmaceutical Therapy, NOS	17081581-de84-433b-96cc-0884fdc8acc8
3709268e-3ae2-457b-b166-c1d19bcea7a3.htseq.counts.gz	11345413-daec-411e-b2b0-e4ae601ded58	TCGA-A5-A0R7-01A-31R-A16W-07	TCGA-A5-A0R7-01A-31R	TCGA-A5-A0R7-01A-03-BSC	TCGA-A5-A0R7-01A-03-MSC		TCGA-A5-A0R7-01A-31	TCGA-A5-A0R7-01A	TCGA-A5-A0R7	02b25675-094d-4098-96da-51d121380fec	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	173	290.0	False	true	3BBA7591-082A-44CE-829F-23D16A91772D	1.91	0824e6ac-f3f0-4b71-81a3-7ee671a256eb	0.16	23	released	8160c1e1-300d-4dfb-a38c-00a3176df4d3	RNA	R	0.16	UV Spec	released	False	8d90e4ab-c4a7-4ad9-bb88-95b67a1133d7	31	40.0	10.0	0.0	20.0	0.0	30.0	70.0	70.0	BOTTOM	4383ecfb-54c6-4419-97bb-4b95ee449c25	released	40.0	30.0	5.0	30.0	0.0	25.0	70.0	70.0	TOP	916eec2a-d8a0-4bf1-a596-98bb4399aeb0	released									released	30.0	550c6341-260a-4156-b00c-0ae9031d647f	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A0R7_demographic	55	-20250		65b14ddc-7ed2-577d-b70b-affa93ccebdd	not hispanic or latino	female	white	released	Alive	1955		TCGA-A5-A0R7_exposure	Not Reported	49.95408631772268	63615cb5-ba1f-58b0-9fdc-07f788207315	165.0	released	136.0	TCGA-A5-A0R7_diagnosis	20250	not reported	0	535	527f39b6-f271-5c52-b8cb-5decddec860d	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-A5-A0R7_treatment_1	TCGA-A5-A0R7_treatment	released	96d965aa-d2fe-523c-84d5-8f1af8af3517	no	Pharmaceutical Therapy, NOS	released	5ab445cf-b9da-5100-9c92-916dcfdd43be	no	Radiation Therapy, NOS	11345413-daec-411e-b2b0-e4ae601ded58
6e8a406c-b5e0-4eb1-b4bc-77e57ef72350.htseq.counts.gz	008103cb-a478-4d89-9c1e-9db32b7393f8	TCGA-BG-A186-01A-11R-A12I-07	TCGA-BG-A186-01A-11R	TCGA-BG-A186-01A-01-TSA			TCGA-BG-A186-01A-11	TCGA-BG-A186-01A	TCGA-BG-A186	fe4db898-3a9f-4dff-adcb-7b8c30137350	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	104	100.0	False	true	76C588F1-ED43-485D-8FFF-32F4C5D92202	1.81	fcf451be-340a-4479-86ed-d6757d680386	0.16	23	released	c3c22d6d-e257-40e1-bc8a-97e22db8c3e4	RNA	R	0.16	UV Spec	released	False	db04e7ca-fe31-4a70-8bb5-67c8ca0901c8	11	0.0	0.0	0.0	0.0	20.0	0.0	80.0	70.0	TOP	48d96243-8e15-4adc-b83a-8c52c15393b9	released																				released	30.0	b1645a83-57b7-4357-b977-63a5b6aee39e	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A186_demographic	61	-22370		6a5cc3fe-7b5a-5d21-ae88-14f40340a5ca	not hispanic or latino	female	black or african american	released	Alive	1949		TCGA-BG-A186_exposure	Not Reported	28.577960676726107	1121a4da-a194-5229-ad12-bf3a6b1eb0e8	162.0	released	75.0	TCGA-BG-A186_diagnosis	22370	not reported	0	419	fcee2d50-0927-56be-85d4-78b119adb2bb	Stage IIIA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-BG-A186_treatment	TCGA-BG-A186_treatment_1	released	2c10ea7f-da05-57fc-a377-0336e6869672	yes	Radiation Therapy, NOS	released	4fdf1d6a-ec9f-5044-9065-46ad5558a922	yes	Pharmaceutical Therapy, NOS	008103cb-a478-4d89-9c1e-9db32b7393f8
e0320565-92ec-4cb0-a70d-043ff60fb7fc.htseq.counts.gz	a87e174e-3d46-43d5-a43e-8a3522e9d391	TCGA-BS-A0TD-01A-11R-A104-07	TCGA-BS-A0TD-01A-11R	TCGA-BS-A0TD-01A-01-TSA	TCGA-BS-A0TD-01A-01-BSA		TCGA-BS-A0TD-01A-11	TCGA-BS-A0TD-01A	TCGA-BS-A0TD	ffaa98a0-2b69-46dc-aee5-c5c3f2abbc38	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	2004	150.0	False	false	51ABEFF0-EEA1-48CA-9E00-CC57D1A2DEB0	2.0	ca81a393-ec7d-4538-a64a-417ed188a320	0.16	23	released	ee077e3e-dba6-4fb6-b654-6903539eda9a	RNA	R	0.16	UV Spec	released	False	407773d8-77dd-4dc3-aaaa-d1d91c71edbf	11	40.0	10.0	0.0	20.0	0.0	20.0	80.0	80.0	TOP	a89530c1-1494-4b21-957d-6293a07c8446	released	40.0	20.0	5.0	20.0	0.0	15.0	80.0	80.0	BOTTOM	dba1647e-2099-4546-9230-092e3e2488dd	released									released	30.0	8bb3a057-8958-4f62-af81-976da2e92df7	Primary Tumor	01	released	Not Reported	released	TCGA-BS-A0TD_demographic	65	-23950		29722ebf-3505-5430-ab99-d9f747ae451e	not hispanic or latino	female	asian	released	Alive	1940		TCGA-BS-A0TD_exposure	Not Reported	35.37981269510926	4642b0ee-e511-5f07-a594-309b52967410	155.0	released	85.0	TCGA-BS-A0TD_diagnosis	23950	not reported	0	2379	a3b06160-0aca-5799-91fe-d4b9b8999908	Stage IB	C54.9	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Corpus uteri	released	No	Corpus uteri	not reported	not reported	2005	TCGA-BS-A0TD_treatment_1	TCGA-BS-A0TD_treatment	released	18b3e8f2-d739-5b10-9088-c494df51ddb3	no	Pharmaceutical Therapy, NOS	released	c70e675a-5824-505d-9e3f-9058682a71b3	no	Radiation Therapy, NOS	a87e174e-3d46-43d5-a43e-8a3522e9d391
01a18e55-cd8c-45be-929d-30fb27d9a252.htseq.counts.gz	893272fb-320a-45de-b85c-ac1a570a5623	TCGA-EY-A2ON-01A-21R-A18M-07	TCGA-EY-A2ON-01A-21R	TCGA-EY-A2ON-01A-02-TSB			TCGA-EY-A2ON-01A-21	TCGA-EY-A2ON-01A	TCGA-EY-A2ON	bee58be0-c2b0-4cdc-adf6-b99243da586a	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	80	650.0	False	false	AB1B272C-E1ED-4E7B-AAD2-F6B7E741E134	1.8	10a6bc01-f811-400f-a205-caf7879008fe	0.18	23	released	a6fc0794-0b64-4970-afb6-9200bc86ee24	RNA	R	0.18	UV Spec	released	False	91012b27-cc2c-4fbc-9f61-4606734c636e	21	40.0	10.0	15.0	30.0	0.0	5.0	80.0	80.0	TOP	636d15e8-e56e-4cb7-8e12-ad38efabbd32	released																				released	30.0	d7090a2c-648a-43dc-a639-a78dfda2a0ec	Primary Tumor	01	released	Not Reported	released	TCGA-EY-A2ON_demographic	61	-22624	610	0f0b8383-5c08-5e28-93eb-571ce71c030e	not hispanic or latino	female	black or african american	released	Dead	1950		TCGA-EY-A2ON_exposure	Not Reported	36.73094582185491	900e258e-3fe8-55c8-beb8-db3956070ca5	165.0	released	100.0	TCGA-EY-A2ON_diagnosis	22624	not reported	0	409	c98972bf-f5fa-5a9e-9e88-1125fc8fb704	Stage IVB	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-EY-A2ON_treatment	TCGA-EY-A2ON_treatment_1	released	ee98f21c-ff70-5cab-a7e2-4bca9e5979eb	no	Radiation Therapy, NOS	released	4e69586c-ef15-5f0f-bba8-e7583936a955	yes	Pharmaceutical Therapy, NOS	893272fb-320a-45de-b85c-ac1a570a5623
95ae164b-c207-4811-9ff4-fdea9537e738.htseq.counts.gz	d5fd27ac-14af-44ff-bf57-29b865463f1f	TCGA-AJ-A3OJ-01A-11R-A22K-07	TCGA-AJ-A3OJ-01A-11R	TCGA-AJ-A3OJ-01A-01-TS1			TCGA-AJ-A3OJ-01A-11	TCGA-AJ-A3OJ-01A	TCGA-AJ-A3OJ	76f98002-e8df-4dfa-926e-8bb2d5114966	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	97	260.0	False	false	89CAF35B-187A-499C-9E01-3992A0DEBCFD	1.85	f141342e-fbed-4ccf-8e4a-7299397e6e77	0.16	23	released	36eb25d7-11a0-45e1-8dcb-e0ebb1529a5a	RNA	R	0.16	UV Spec	released	False	af8e6134-a69f-443e-908d-22093d97f722	11	5.0	1.0	5.0	2.0	5.0	0.0	90.0	80.0	TOP	06d34766-621e-4778-a81f-b1836ab0f933	released																				released	30.0	654f67ed-7295-4360-ada6-830d4528b17d	Primary Tumor	01	released	Not Reported	released	TCGA-AJ-A3OJ_demographic	54	-19826		2d640521-fd23-5176-bb37-d5e66cbca59a	not hispanic or latino	female	white	released	Alive	1957		TCGA-AJ-A3OJ_exposure	Not Reported	42.192381029656374	75792d92-75af-5590-8d39-2f88ec1227c3	157.0	released	104.0	TCGA-AJ-A3OJ_diagnosis	19826	not reported	0	467	5588105e-6eed-5a1e-89c4-3a05d2f11428	Stage II	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-AJ-A3OJ_treatment_1	TCGA-AJ-A3OJ_treatment	released	a6c5b0f8-3b07-5c3f-8b3f-29fcea31a3fe	yes	Pharmaceutical Therapy, NOS	released	09a45c05-f663-5293-8e4f-066f0455b87c	yes	Radiation Therapy, NOS	d5fd27ac-14af-44ff-bf57-29b865463f1f
a706fe8c-8ac8-4938-ae21-90b51b1f90fa.htseq.counts.gz	cf906b7c-8a99-408e-b8ae-4c44079a42c7	TCGA-BS-A0TJ-01A-11R-A104-07	TCGA-BS-A0TJ-01A-11R	TCGA-BS-A0TJ-01A-01-BS1	TCGA-BS-A0TJ-01A-01-TS1		TCGA-BS-A0TJ-01A-11	TCGA-BS-A0TJ-01A	TCGA-BS-A0TJ	f74da4c6-4291-46d2-abd4-7d7f6ef03b00	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1431	270.0	False	false	17D921D9-F2ED-4F8E-8C6F-729C9A0FE5B0	1.79	3ecbfdb2-c75a-47ce-9db6-ae7d36eab559	0.16	23	released	94d62fc1-26d5-4f99-9920-d80e1dfc78e4	RNA	R	0.16	UV Spec	released	False	03769bc9-37e3-4cb3-9f6c-220c3868e7c4	11	1.0	1.0	0.0	1.0	0.0	10.0	90.0	90.0	BOTTOM	d3d4e92d-be6b-4425-9c62-f3109c70dac0	released	1.0	0.0	2.0	0.0	0.0	2.0	96.0	96.0	TOP	de698387-3e14-4189-b75c-558f9dfb3bfd	released									released	30.0	ac35307b-ac7f-49fc-a237-5e03ab2e2276	Primary Tumor	01	released	Not Reported	released	TCGA-BS-A0TJ_demographic	59	-21663		0cc93255-8851-55bd-a9eb-0619ad5f924b	not hispanic or latino	female	asian	released	Alive	1947		TCGA-BS-A0TJ_exposure	Not Reported	38.08864265927978	0437cab5-7535-5ecf-9b06-935f303fa392	152.0	released	88.0	TCGA-BS-A0TJ_diagnosis	21663	not reported	0	2068	fd64c7b5-399a-538f-9858-421b3f51f8d7	Stage IC	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2006	TCGA-BS-A0TJ_treatment	TCGA-BS-A0TJ_treatment_1	released	a6902149-e5e1-5fa4-b2bf-ba353bdb5130	yes	Radiation Therapy, NOS	released	a095d2df-1b1f-5865-b1a8-2c7e842f67cf	no	Pharmaceutical Therapy, NOS	cf906b7c-8a99-408e-b8ae-4c44079a42c7
98074e6d-d665-4a7d-a161-2d6b6acd9b4f.htseq.counts.gz	431db1b7-a2be-481e-8961-6c37f4c68383	TCGA-K6-A3WQ-01A-11R-A22K-07	TCGA-K6-A3WQ-01A-11R	TCGA-K6-A3WQ-01A-01-TS1			TCGA-K6-A3WQ-01A-11	TCGA-K6-A3WQ-01A	TCGA-K6-A3WQ	d6303a05-f705-4413-8860-506a105d5b08	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	63	440.0	False	true	16F848AA-C14C-45F7-A756-414615853761	1.82	8fac215c-7172-42ed-af07-00b27c05d3a6	0.16	23	released	ea9731be-3699-4de3-bb76-21de1e6ded99	RNA	R	0.16	UV Spec	released	False	dd37e24e-85de-4b6f-ba70-bfd4946d9f60	11	50.0	10.0	2.0	20.0	0.0	3.0	95.0	95.0	TOP	330ac99f-8b36-416f-a76e-f62e10746cb1	released																				released	30.0	702c78d1-352a-4050-a17e-501bbfd0317a	Primary Tumor	01	released	Not Reported	released	TCGA-K6-A3WQ_demographic	60	-22092	427	66209a4f-b667-5200-a6b9-4b39cfdb6f72	not hispanic or latino	female	white	released	Dead	1952		TCGA-K6-A3WQ_exposure	Not Reported	33.856571252693136	3b0a3a0a-066e-5645-8e83-f4790a90fc2d	171.0	released	99.0	TCGA-K6-A3WQ_diagnosis	22092	not reported	0	400	9542a14c-2521-575a-8430-31ef6aa00d50	Stage IVB	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2012	TCGA-K6-A3WQ_treatment	TCGA-K6-A3WQ_treatment_1	released	97826b3a-bd76-5325-8bf3-1c89eaf34e26	yes	Radiation Therapy, NOS	released	64b35476-9741-5170-816e-1d2a60660a0f	yes	Pharmaceutical Therapy, NOS	431db1b7-a2be-481e-8961-6c37f4c68383
3dcd981c-dc04-40c8-8799-de094c55c4a2.htseq.counts.gz	c26ecfcf-05d1-400e-a710-724cb000b2f3	TCGA-D1-A3JP-01A-31R-A22K-07	TCGA-D1-A3JP-01A-31R	TCGA-D1-A3JP-01A-03-TSC			TCGA-D1-A3JP-01A-31	TCGA-D1-A3JP-01A	TCGA-D1-A3JP	4846cb23-d7e7-47f4-972f-3abe229f7bdb	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	101	170.0	False	true	62290E86-409F-4590-AA2C-D3D2F77148FF	1.8	f579f0dc-d6e3-4960-9769-5038e69aa712	0.17	23	released	5209dfb0-4fcf-4151-9533-2313023c7df7	RNA	R	0.17	UV Spec	released	False	21edbd0a-0969-4838-b109-1161bcb2c517	31	0.0	0.0	0.0	0.0	0.0	0.0	100.0	60.0	TOP	22aedcb8-b8d6-4e48-a7fa-eb136726eb06	released																				released	20.0	29a581ed-3dca-4a65-ab6b-5a9656674f92	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A3JP_demographic	61	-22538		4c77a875-5eef-5480-b468-2ba87b6173ea	not hispanic or latino	female	white	released	Alive	1950		TCGA-D1-A3JP_exposure	Not Reported	23.337684427040067	9eb18dc5-7c7b-5f04-b06b-f43ca73b9d65	159.0	released	59.0	TCGA-D1-A3JP_diagnosis	22538	not reported	0	515	7f1cd09a-dbb3-551c-a67d-4f353409f807	Stage IA	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2011	TCGA-D1-A3JP_treatment_1	TCGA-D1-A3JP_treatment	released	1d2b01ca-2306-55aa-ac04-ca88863f82d0	no	Pharmaceutical Therapy, NOS	released	81dee702-5f57-5326-8857-fc80b738e1e9	yes	Radiation Therapy, NOS	c26ecfcf-05d1-400e-a710-724cb000b2f3
ad417a8f-bc1e-4a1d-84ca-83bcc26ca179.htseq.counts.gz	7305c3c1-2337-47ed-b5e1-3116f31f8122	TCGA-QS-A744-01A-11R-A34R-07	TCGA-QS-A744-01A-11R	TCGA-QS-A744-01A-01-TS1			TCGA-QS-A744-01A-11	TCGA-QS-A744-01A	TCGA-QS-A744	8e8f19bd-dbaa-4738-bad2-207f634cd63d	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	44	310.0	False	false	F37C9C5C-8AAA-47FB-8BAD-AE2EB0F70B4F	1.89	2eede096-06aa-4026-9c23-2a2d1d9015c1	0.17	23	released	25ba155c-5347-44fd-aa52-2a7ce51dbe8e	RNA	R	0.17	UV Spec	released	False	c878c12b-6faa-44a8-b519-96fc8a3349ff	11	40.0	20.0	5.0	20.0	0.0	15.0	80.0	80.0	TOP	1caf4bea-3f5b-4a72-9aef-5124a848ca82	released																				released	30.0	100f19f6-f2c6-456b-8a54-e6ed68b1fb05	Primary Tumor	01	released	Not Reported	released	TCGA-QS-A744_demographic	86	-31520		4bb8f00c-d398-5777-8070-31fa84085acd	not hispanic or latino	female	black or african american	released	Alive	1927		TCGA-QS-A744_exposure	Not Reported	28.60476495163536	e707809f-cb22-55dd-a206-99464982bd3e	163.0	released	76.0	TCGA-QS-A744_diagnosis	31520	not reported	0	451	6da0b164-4420-596e-8f3f-26edad13cbba	Stage IIIB	C54.0	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Isthmus uteri	released	No	Isthmus uteri	not reported	not reported	2013	TCGA-QS-A744_treatment	TCGA-QS-A744_treatment_1	released	12a33213-0967-53c4-baf7-90d174f101ae	no	Radiation Therapy, NOS	released	6f1a092c-63ab-5a22-b2de-2efb24bbb2b4	yes	Pharmaceutical Therapy, NOS	7305c3c1-2337-47ed-b5e1-3116f31f8122
516bc7d9-0764-4d31-8134-4d6a0f3983cc.htseq.counts.gz	eab1249a-c581-4cc3-a99a-c72b71346f75	TCGA-BK-A4ZD-01A-11R-A27V-07	TCGA-BK-A4ZD-01A-11R	TCGA-BK-A4ZD-01A-01-TS1			TCGA-BK-A4ZD-01A-11	TCGA-BK-A4ZD-01A	TCGA-BK-A4ZD	1c4d225e-e065-4e26-9413-78f54a7e0cf5	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	92	300.0	False	false	388C7674-9CA2-446C-A67D-9639A28ADEB4	2.02	31bd06c7-98c1-4d2e-81ff-4e210e7bba75	0.18	23	released	d312542b-42f9-4713-8c56-628c562af64f	RNA	R	0.18	UV Spec	released	False	e2c29bcf-1d07-403b-90e9-a8ebc1048bbd	11	3.0	0.0	0.0	0.0	0.0	0.0	100.0	75.0	TOP	532c0c42-5519-41f3-b328-6fdc51aa8275	released																				released	30.0	115d93c2-9396-48bd-ba90-4cc4888ab821	Primary Tumor	01	released	Not Reported	released	TCGA-BK-A4ZD_demographic	42	-15536		932b5f34-279f-58a1-b7ea-5ac264c68f39	not hispanic or latino	female	black or african american	released	Alive	1970		TCGA-BK-A4ZD_exposure	Not Reported	53.44574504121344	fa681863-042a-56d1-bae9-ace2cce9c4f7	163.0	released	142.0	TCGA-BK-A4ZD_diagnosis	15536	not reported	0	506	52ef00ac-cc39-502a-9e36-18076721f0be	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2012	TCGA-BK-A4ZD_treatment_1	TCGA-BK-A4ZD_treatment	released	9ef670d7-1bdf-5138-89c9-41ecea75db1e	no	Pharmaceutical Therapy, NOS	released	8b8b5ac1-2427-574c-aad5-0051111ddbf0	no	Radiation Therapy, NOS	eab1249a-c581-4cc3-a99a-c72b71346f75
18413883-6df2-43bc-bbe3-79ad68247940.htseq.counts.gz	fdddaf20-0fc4-4c11-be69-4bb95774c4d6	TCGA-D1-A160-01A-11R-A118-07	TCGA-D1-A160-01A-11R	TCGA-D1-A160-01A-01-TSA			TCGA-D1-A160-01A-11	TCGA-D1-A160-01A	TCGA-D1-A160	170bbbac-940f-4e1b-b0b8-60fa36d0fa23	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	895	100.0	False	false	F349C87E-F324-4A8E-81E1-153C99173E21	1.87	ac9c8753-ae35-4367-9aef-d42522bc8db7	0.16	23	released	860b0e56-ed28-4234-b0f5-747efbd206c2	RNA	R	0.16	UV Spec	released	False	a648846c-0389-46db-a79b-4b298957c0fb	11	0.0	0.0	0.0	0.0	0.0	5.0	95.0	85.0	TOP	64e12c1a-6c19-4eb8-8597-948cbbee9b7b	released																				released	30.0	b36ecf21-9d51-43dc-b2fb-6f6156e85875	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A160_demographic	70	-25673		0225e9ef-fd53-5fbb-8fe7-d11be0fd4d83	not hispanic or latino	female	white	released	Alive	1938		TCGA-D1-A160_exposure	Not Reported	41.238507301243914	e0638df4-37ec-54cc-b654-f051afb9675f	172.0	released	122.0	TCGA-D1-A160_diagnosis	25673	not reported	0	112	3851b957-4645-5b14-9890-0123848bfb32	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-D1-A160_treatment	TCGA-D1-A160_treatment_1	released	7d5bd713-96d1-5014-b55c-08eb26b1bae4	no	Radiation Therapy, NOS	released	db639547-effb-5cbd-9c2d-12eacbd0ccd4	no	Pharmaceutical Therapy, NOS	fdddaf20-0fc4-4c11-be69-4bb95774c4d6
e9f65d45-a80f-41fa-b17a-bd53703c9b6a.htseq.counts.gz	b5c0ccde-894c-421a-8554-6e9d0db5a29b	TCGA-A5-A3LP-01A-11R-A22K-07	TCGA-A5-A3LP-01A-11R	TCGA-A5-A3LP-01A-01-TSA			TCGA-A5-A3LP-01A-11	TCGA-A5-A3LP-01A	TCGA-A5-A3LP	9becf65d-01f2-4e84-a256-106002e22526	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	111	150.0	False	true	A20CDB07-D90C-42B7-AE0A-254E27C6153B	1.77	5359ca45-0d86-43b9-b318-adbee53c7381	0.16	23	released	4017dc76-46c6-4e5d-b024-aae649d1bd54	RNA	R	0.16	UV Spec	released	False	82eb8e9a-e0f2-449e-b73a-25bfead99809	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	75.0	TOP	6d75cf4c-8e78-40f4-ac55-ae210686d686	released																				released	30.0	6d328d5d-7225-437a-afb1-d293d2d45866	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A3LP_demographic	74	-27131		ce8a91da-f81d-51b6-a2e5-82541798e6b9	not hispanic or latino	female	white	released	Alive	1937		TCGA-A5-A3LP_exposure	Not Reported	18.19548277362446	6f5d8c98-d10d-586d-8959-eb9b0a49adbd	159.0	released	46.0	TCGA-A5-A3LP_diagnosis	27131	not reported	0	455	64e2a390-b639-56d8-89e6-dd4dadc1c92f	Stage IB	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-A5-A3LP_treatment_1	TCGA-A5-A3LP_treatment	released	732e0c74-cfc6-563d-b1e6-02c281b20dde	yes	Pharmaceutical Therapy, NOS	released	63fe62b7-1e26-5fc5-a9cb-becaeac66d7b	no	Radiation Therapy, NOS	b5c0ccde-894c-421a-8554-6e9d0db5a29b
fdc50973-2298-4b0a-ba8c-96bf01882f72.htseq.counts.gz	24587ce1-663f-4972-bcb7-e0f750786b78	TCGA-D1-A176-01A-11R-A12I-07	TCGA-D1-A176-01A-11R	TCGA-D1-A176-01A-01-TSA			TCGA-D1-A176-01A-11	TCGA-D1-A176-01A	TCGA-D1-A176	6d061ca9-ba7e-4b82-ab3c-34e33f244a54	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	555	100.0	False	false	6F361A45-F13E-44F7-8F3C-00C8B30ACB7A	1.31	8e075c0e-43b4-48b0-9bdc-b27b6d6568b3	0.17	23	released	58b04258-7308-43f8-a9b2-e0b49984d7dd	RNA	R	0.17	UV Spec	released	False	db8fe441-8cfc-492e-a93d-51559a1dcf08	11	40.0	20.0	10.0	20.0	0.0	20.0	70.0	70.0	TOP	f3b7fdbb-09f7-46c1-ae8f-6735c1ab0845	released																				released	30.0	b66b5979-62a1-4938-a655-aeff90d2d472	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A176_demographic	67	-24521		93c550da-55b4-5bf1-be9c-bbc05ba86643	not hispanic or latino	female	white	released	Alive	1942		TCGA-D1-A176_exposure	Not Reported	33.70504499982072	79e1cf85-12e8-5eed-8b69-d638f855ba0f	167.0	released	94.0	TCGA-D1-A176_diagnosis	24521	not reported	0	917	e673f6da-029d-577f-a452-0853e53851b4	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-D1-A176_treatment	TCGA-D1-A176_treatment_1	released	09de01e2-8c9c-5ffa-814c-be7c2f7fc5e2	no	Radiation Therapy, NOS	released	2e035b92-f20d-56c3-a10e-d057840da097	no	Pharmaceutical Therapy, NOS	24587ce1-663f-4972-bcb7-e0f750786b78
596e0340-9bb6-49eb-a926-f51f8ec9727d.htseq.counts.gz	e30689bf-2321-4d37-b0ef-3889a2adef62	TCGA-AJ-A3BG-01A-11R-A19W-07	TCGA-AJ-A3BG-01A-11R	TCGA-AJ-A3BG-01A-01-TS1			TCGA-AJ-A3BG-01A-11	TCGA-AJ-A3BG-01A	TCGA-AJ-A3BG	77ed36ad-222f-4693-8668-0ecf9073d6e8	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	137	24.0	False	false	3D42566F-92B2-4530-BF6A-624DA6E979B9	1.78	f3004f55-be95-4c2c-92f8-9ec3e96701cd	0.15	23	released	765c7fc8-313c-4291-8d32-b99eefdad90c	RNA	R	0.15	UV Spec	released	False	9f8f6b9e-ce42-4f68-9bc2-093c3f6b3bf5	11	0.0	0.0	5.0	0.0	0.0	0.0	95.0	80.0	TOP	fdb1b2a0-9aad-460c-a874-aa69895c8cc8	released																				released	24.0	0eeb2802-5276-4a2f-ae20-926a3feced91	Primary Tumor	01	released	Not Reported	released	TCGA-AJ-A3BG_demographic	65	-23861		5b4a1e6c-e831-5826-949b-e548534065f8	not hispanic or latino	female	white	released	Alive	1946		TCGA-AJ-A3BG_exposure	Not Reported	24.84098008957808	a1946990-4d03-5c4f-8545-091a409c976b	163.0	released	66.0	TCGA-AJ-A3BG_diagnosis	23861	not reported	0	550	03aaa2cc-0cbd-5e47-b13d-c4fe8c4cb7b5	Stage IA	C54.1	not reported	8460/3	Papillary serous cystadenocarcinoma	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2011	TCGA-AJ-A3BG_treatment_1	TCGA-AJ-A3BG_treatment	released	6ef8c588-82c4-5fff-9284-c93c8fd1b4eb	yes	Pharmaceutical Therapy, NOS	released	195855e6-4a3c-5a3b-897a-3b8b5bae8ecf	yes	Radiation Therapy, NOS	e30689bf-2321-4d37-b0ef-3889a2adef62
e01732d2-be57-4d3c-aa99-326d38ec2226.htseq.counts.gz	262129c1-5107-43e6-99e8-20d6824fe30a	TCGA-AX-A3FT-01A-11R-A22K-07	TCGA-AX-A3FT-01A-11R	TCGA-AX-A3FT-01A-01-TS1			TCGA-AX-A3FT-01A-11	TCGA-AX-A3FT-01A	TCGA-AX-A3FT	8b4cf993-1e16-4009-a37f-a629528b7d7e	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	524	110.0	False	false	EF16D53F-14A2-4127-B5F7-F318EC60C5C0	1.84	9c9dcb46-e9c5-4a85-9bf5-00d7cd9e871b	0.15	23	released	e09b063d-3b22-4dbb-8039-39b8e83d440d	RNA	R	0.15	UV Spec	released	False	29302b27-6ee9-4a64-b0cf-165b15bbafe4	11	10.0	0.0	2.0	0.0	8.0	20.0	70.0	80.0	TOP	a7e05063-a1f2-449a-bb2e-11aaa9d0985d	released																				released	30.0	6176a2e7-9c0b-4a9c-b8d6-cf669419959d	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A3FT_demographic	64	-23543		a0b12635-e4b8-5c98-8598-5d12f61f0f2a	not hispanic or latino	female	white	released	Alive	1946		TCGA-AX-A3FT_exposure	Not Reported	31.634581999151262	fb974c37-14e9-5fc3-a9e4-ed99220d857f	161.0	released	82.0	TCGA-AX-A3FT_diagnosis	23543	not reported	0	6	87f6a4eb-1096-5d7a-8994-9394e567c502	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-AX-A3FT_treatment_1	TCGA-AX-A3FT_treatment	released	88f5a942-2e80-5429-a4eb-48ba788ed706	not reported	Pharmaceutical Therapy, NOS	released	a813bcfb-5f99-5ff2-8f53-8f6842292720	not reported	Radiation Therapy, NOS	262129c1-5107-43e6-99e8-20d6824fe30a
a1749cd8-a737-48c6-ac4c-e2d6c2f8b23f.htseq.counts.gz	d2e62f35-1f82-473a-8726-232610bd6627	TCGA-AX-A1C7-01A-11R-A137-07	TCGA-AX-A1C7-01A-11R	TCGA-AX-A1C7-01A-01-TS1			TCGA-AX-A1C7-01A-11	TCGA-AX-A1C7-01A	TCGA-AX-A1C7	755d7ab7-4563-408a-9135-f852048af975	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	423	90.0	False	false	10458026-49D7-40EC-BC7B-0D6A381FB025	1.9	284f6163-92f2-4e21-8649-45dcfce6634f	0.16	23	released	26781bce-6b09-4427-8f97-78a34332cbd8	RNA	R	0.16	UV Spec	released	False	f883e003-d857-47f5-9d57-7e4d0b362b71	11	1.0	1.0	2.0	1.0	0.0	5.0	93.0	94.0	TOP	3d218a2e-bb8b-4fec-88fd-68d22ba6f17b	released																				released	30.0	a4b56935-7bb9-4c84-9176-e8d694f37faa	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A1C7_demographic	77	-28198		3814abc2-97c0-50d9-9f26-8ef2db2993f8	not hispanic or latino	female	white	released	Alive	1932		TCGA-AX-A1C7_exposure	Not Reported	25.969529085872576	d6f5514f-d015-5f38-a9ce-96d40e52104d	152.0	released	60.0	TCGA-AX-A1C7_diagnosis	28198	not reported	0	1054	1ecfef7e-3108-57a3-a81c-4fa7f00ce512	Stage IB	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-AX-A1C7_treatment_1	TCGA-AX-A1C7_treatment	released	b11177ae-1be7-5e18-ab9b-95d6ec4915ed	yes	Pharmaceutical Therapy, NOS	released	0827e0de-da65-50ef-b937-bf0d23a55873	no	Radiation Therapy, NOS	d2e62f35-1f82-473a-8726-232610bd6627
f1e3383c-b4c6-4ed6-b096-6c57bf80a802.htseq.counts.gz	6a6baaba-f12a-4f4a-9538-af06af932c96	TCGA-D1-A16D-01A-11R-A12I-07	TCGA-D1-A16D-01A-11R	TCGA-D1-A16D-01A-01-TSA			TCGA-D1-A16D-01A-11	TCGA-D1-A16D-01A	TCGA-D1-A16D	5693302a-4548-4c0b-8725-0cb7c67bc4f8	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	799	130.0	False	false	795A5264-493A-498D-A731-87ECB0A7F612	1.86	619e7a96-8900-484b-b1e2-54ef91b9109d	0.15	23	released	9d3bf3c7-e34b-44b3-b54d-6099ca1374cf	RNA	R	0.15	UV Spec	released	False	4b64ab88-2e07-491f-83eb-0272caf6c330	11	5.0	8.0	10.0	12.0	0.0	40.0	50.0	60.0	TOP	29eabeda-3653-4927-b660-8ce21a7fcc7a	released																				released	30.0	007bdfd3-81b6-42c3-a4a6-c4ddaf1be0ae	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A16D_demographic	49	-17933		202ea12b-b0a4-5b04-be06-d9780a653387	not hispanic or latino	female	white	released	Alive	1959		TCGA-D1-A16D_exposure	Not Reported	56.142177275431294	9423c63b-449c-5391-9ff5-9f74f203b791	164.0	released	151.0	TCGA-D1-A16D_diagnosis	17933	not reported	0	1141	f7f506c6-1101-55e6-b065-dd8d8b34b67c	Stage IC	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-D1-A16D_treatment_1	TCGA-D1-A16D_treatment	released	3a1896c3-892c-54a9-8571-1d92e02b85e2	yes	Pharmaceutical Therapy, NOS	released	f54eb415-176d-555a-b62f-b00ccdd0d020	yes	Radiation Therapy, NOS	6a6baaba-f12a-4f4a-9538-af06af932c96
8437c884-964f-4e10-8ee8-c914d9b87e88.htseq.counts.gz	ea6699e1-ee2c-4060-906a-b6585fd73405	TCGA-EO-A3KU-01A-11R-A22K-07	TCGA-EO-A3KU-01A-11R	TCGA-EO-A3KU-01A-01-TSA			TCGA-EO-A3KU-01A-11	TCGA-EO-A3KU-01A	TCGA-EO-A3KU	db67a9cd-65ba-4d6f-a799-031b6b3df599	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	93	110.0	False	false	B6945BE4-FA4A-4ED4-9233-B32123F41C95	1.87	91238210-9f8d-4c09-8016-fd0a7d135023	0.18	23	released	4024a437-2b78-4b23-8f90-c42535e744e2	RNA	R	0.18	UV Spec	released	False	74bc7ff6-6d75-4f37-b09a-8537e7b14cde	11	5.0	5.0	10.0	15.0	0.0	10.0	80.0	90.0	TOP	e86bfdf1-6ab9-49be-afa4-006b9387a535	released																				released	30.0	72940768-0848-4134-8d1d-c81a02f92134	Primary Tumor	01	released	Not Reported	released	TCGA-EO-A3KU_demographic	68	-25116		97fe2fbf-2085-5ffe-a6f9-5133af42f12d	not reported	female	not reported	released	Alive	1943		TCGA-EO-A3KU_exposure	Not Reported	24.464601603372348	cb5c7ff4-e5b4-51b8-9b86-399cdb98aa99	163.0	released	65.0	TCGA-EO-A3KU_diagnosis	25116	not reported	0	677	4075524a-4217-50e3-b313-06ebf63c29c8	Stage II	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-EO-A3KU_treatment	TCGA-EO-A3KU_treatment_1	released	1f18a7e3-3945-5bf9-8943-3437b951df50	yes	Radiation Therapy, NOS	released	50e72d78-bc73-5f88-860b-4a7970920fbe	yes	Pharmaceutical Therapy, NOS	ea6699e1-ee2c-4060-906a-b6585fd73405
41b4a929-42ae-411a-9578-a3e7ae35e338.htseq.counts.gz	f2b37f38-4902-46c7-bfc5-d82b180c0de8	TCGA-D1-A1NZ-01A-21R-A14D-07	TCGA-D1-A1NZ-01A-21R	TCGA-D1-A1NZ-01A-02-TSB			TCGA-D1-A1NZ-01A-21	TCGA-D1-A1NZ-01A	TCGA-D1-A1NZ	e49f545f-3268-4d25-b7a3-4da8e6ab2578	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	191	140.0	False	false	0AFDCBC0-FA0A-4138-A0BE-E374AEB3CB25	1.77	e947ba64-793a-4462-9447-5c02a4a9ff39	0.17	23	released	142ba0f7-1e5c-4bc8-8d21-b7eb65ac08b0	RNA	R	0.17	UV Spec	released	False	179dff2a-ab4e-43df-92ab-f857243df32e	21	50.0	20.0	5.0	20.0	10.0	15.0	70.0	70.0	TOP	e3566570-da09-43b7-a58c-adbe3c9106ac	released																				released	30.0	7239e42a-f0ef-43dd-9d1f-a5a507e0e66c	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A1NZ_demographic	60	-22027		4a83af41-f0dd-5db8-a0bf-609e86d91d4a	not hispanic or latino	female	white	released	Alive	1950		TCGA-D1-A1NZ_exposure	Not Reported	35.59985760056959	220ef95e-9f1f-5b86-b085-130b6faa7b52	159.0	released	90.0	TCGA-D1-A1NZ_diagnosis	22027	not reported	0	548	58aae1bc-5d1c-5cc3-b192-dd6b10ecf0ac	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-D1-A1NZ_treatment	TCGA-D1-A1NZ_treatment_1	released	413c8fad-cff8-5dc0-a9f6-f79a7b5e1c27	no	Radiation Therapy, NOS	released	b23d96d7-841c-597e-990b-2d37386e3069	no	Pharmaceutical Therapy, NOS	f2b37f38-4902-46c7-bfc5-d82b180c0de8
c9936adb-0c96-4651-b37f-1df1c92ae307.htseq.counts.gz	ab9bbaa2-e778-4c2e-a5b4-8fad4dacd97f	TCGA-AP-A1DM-01A-21R-A137-07	TCGA-AP-A1DM-01A-21R	TCGA-AP-A1DM-01A-02-TSB			TCGA-AP-A1DM-01A-21	TCGA-AP-A1DM-01A	TCGA-AP-A1DM	ca7f9d8b-2abc-4606-bf95-4c42791b38bd	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1309	110.0	False	true	E25BA7AD-5C24-4953-B9C3-7509AE6E9F4C	1.93	631c96e1-7e11-4c0f-a6ea-49cd942f4390	0.18	23	released	4eb59733-f8e8-4e49-aab3-75fa1a2f73bf	RNA	R	0.18	UV Spec	released	False	6ad8ea8a-a726-4145-a64c-ae6091a121e1	21	20.0	20.0	20.0	20.0	20.0	20.0	40.0	60.0	TOP	ccdf9dc0-1bbf-4fbd-a23d-d2aba12fb625	released																				released	30.0	7f4344cf-a5d7-4623-abe8-9f046723ea0a	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A1DM_demographic	60	-22239		eb14ffb2-f120-5873-8146-038dadc0fba8	not reported	female	white	released	Alive	1947		TCGA-AP-A1DM_exposure	Not Reported	36.39096554724892	24f87471-9ef6-57e4-8417-a67113179a95	159.0	released	92.0	TCGA-AP-A1DM_diagnosis	22239	not reported	0	1700	313fd825-764e-5f76-a974-459faf3c2800	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2007	TCGA-AP-A1DM_treatment_1	TCGA-AP-A1DM_treatment	released	d8ab8db5-e508-5401-90af-1c41911ce5f6	no	Pharmaceutical Therapy, NOS	released	83c24cd8-ff03-58dc-8f63-07839c3f1456	yes	Radiation Therapy, NOS	ab9bbaa2-e778-4c2e-a5b4-8fad4dacd97f
28de6e16-4391-4f06-89c8-f5bc7cdb8184.htseq.counts.gz	ff8dc5c0-9703-4a6c-9263-0075914ea9f9	TCGA-D1-A103-01A-11R-A10J-07	TCGA-D1-A103-01A-11R	TCGA-D1-A103-01A-01-MS1	TCGA-D1-A103-01A-01-BS1		TCGA-D1-A103-01A-11	TCGA-D1-A103-01A	TCGA-D1-A103	7427f9e8-1140-45fd-9613-78b72b13a7ba	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	376	170.0	False	false	AE2FAD3D-FA6A-4648-90A5-2D2C442796AF	1.78	ba50902a-fcf9-4023-bdbc-3e7d61c7011b	0.16	23	released	720759a9-4304-47dc-b34b-7e7178aca1e4	RNA	R	0.16	UV Spec	released	False	af6dd9d7-ef2b-453c-9bd2-58ae872b7249	11	40.0	30.0	5.0	20.0	0.0	15.0	80.0	80.0	TOP	5138d46f-c062-4c3a-a189-7b405daa0956	released	0.0	0.0	0.0	0.0	0.0	15.0	85.0	70.0	BOTTOM	57f8c7b7-1aa4-4149-9ef4-4afc7a2b1f74	released									released	30.0	7430a6c2-758a-4a56-8168-865b3463c2db	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A103_demographic	87	-31841		d93c3f44-61a7-53ce-9bd8-a934eb81d151	not hispanic or latino	female	white	released	Alive	1922		TCGA-D1-A103_exposure	Not Reported	26.666666666666668	a829be73-7cd9-5b5b-939d-4b3935060946	150.0	released	60.0	TCGA-D1-A103_diagnosis	31841	not reported	0	669	9667b64a-e27e-5ad8-8da6-b356444005ba	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-D1-A103_treatment_1	TCGA-D1-A103_treatment	released	2419ca98-9b41-54da-b276-03556e5c5346	no	Pharmaceutical Therapy, NOS	released	1ec1ddde-d7ec-581b-9c2b-532e10d6cb8f	no	Radiation Therapy, NOS	ff8dc5c0-9703-4a6c-9263-0075914ea9f9
eb1dab43-c88d-4f09-894b-12d3e1903015.htseq.counts.gz	3422fed4-285c-4ed9-afa3-7c58b0943bab	TCGA-FI-A2D4-01A-12R-A17B-07	TCGA-FI-A2D4-01A-12R	TCGA-FI-A2D4-01A-01-TSA			TCGA-FI-A2D4-01A-12	TCGA-FI-A2D4-01A	TCGA-FI-A2D4	490ae247-ee67-48d4-94ed-93df5b9bbefe	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	853	50.0	False	true	A6419790-A6CE-47E2-8035-437820EC63EC	1.8	c3c9142f-d5c8-44ef-90c2-9ae69846dc60	0.18	23	released	74105fa7-a8fb-4b10-97fc-573f4f745746	RNA	R	0.18	UV Spec	released	False	ad3474bf-a6a3-4fed-8e2f-62765a30ceb6	12	5.0	10.0	5.0	8.0	0.0	15.0	80.0	85.0	TOP	8412ad8d-d3ee-4f6b-b718-000362d6c1d5	released																				released	10.0	a8393121-29df-4525-bf4f-fce0deaf25f5	Primary Tumor	01	released	Not Reported	released	TCGA-FI-A2D4_demographic	44	-16163	243	f8b39abc-ffd6-56f1-8b85-2075bcb14cf2	not reported	female	white	released	Dead	1965	2009	TCGA-FI-A2D4_exposure	Not Reported	42.154390455041586	60f23e20-46db-5425-817e-5836d43e5534	163.0	released	112.0	TCGA-FI-A2D4_diagnosis	16163	not reported	0		5c53c6e5-1b23-58c4-bfaa-18a833c3d53e	Stage IIIC	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-FI-A2D4_treatment_1	TCGA-FI-A2D4_treatment	released	f55d2476-e07f-57ea-a1d6-030068572e71	yes	Pharmaceutical Therapy, NOS	released	c66873ab-1c74-560f-b865-a81cb0ac3ec8	no	Radiation Therapy, NOS	3422fed4-285c-4ed9-afa3-7c58b0943bab
4c957647-48b4-4470-85ea-3c403a7dcefa.htseq.counts.gz	873c1d46-0399-47fb-9cf8-52726f8f62aa	TCGA-FL-A1YI-11A-11R-A16F-07	TCGA-FL-A1YI-11A-11R	TCGA-FL-A1YI-11A-01-TSA			TCGA-FL-A1YI-11A-11	TCGA-FL-A1YI-11A	TCGA-FL-A1YI	09621bd6-3eed-4af4-8416-cdacffce68d9	Not Reported	Uterus, NOS	TCGA-UCEC		120.0	False	false	BC17ABB4-DBAA-43FD-BBBA-C48C71BEDE62	1.71	0c5df2a7-417c-478d-9a7e-675a8777747c	0.16	23	released	3f0b831d-6851-4c32-8b59-02a48cf237f5	RNA	R	0.16	UV Spec	released	False	e10ebe87-615e-4870-b8e2-2f0bf5dc1ec0	11					100.0		0.0		TOP	6d819055-db2e-443f-b7c2-6b0e4475f95e	released																				released	30.0	5cd8fef0-e1f7-4d00-b2bb-357bac222d9c	Solid Tissue Normal	11	released	Not Reported	released																																																			873c1d46-0399-47fb-9cf8-52726f8f62aa
33a9aa63-b07f-4da6-a95d-e838c112f17e.htseq.counts.gz	989231f0-c8bb-4b02-984c-a6a45a20d7a5	TCGA-BK-A0CC-01A-21R-A277-07	TCGA-BK-A0CC-01A-21R	TCGA-BK-A0CC-01A-01-BS1	TCGA-BK-A0CC-01A-02-BS2		TCGA-BK-A0CC-01A-21	TCGA-BK-A0CC-01A	TCGA-BK-A0CC	2b865f8c-539f-4cb2-8f08-41709e9511e5	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	52	310.0	False	false	6A2AAC78-98B9-44D4-AF8D-9A132579CC2D	1.78	00055bad-54b7-4898-a9ae-3dd8036e62d3	0.15	23	released	81af7b1c-2c63-4d4e-b432-8016a39d1c54	RNA	R	0.15	UV Spec	released	False	c88e4282-7594-4921-879d-09693b5804d5	21	0.0	0.0	0.0	0.0	0.0	30.0	70.0	70.0	TOP	23e497e5-c8f5-464c-a30d-46ef45319bca	released	0.0	0.0	25.0	0.0	0.0	15.0	60.0	75.0	BOTTOM	8e809120-284a-41e9-8b5e-051de7337526	released									released	40.0	ed22cb10-ebde-4019-9b6d-e19ab573ca94	Primary Tumor	01	released	Not Reported	released	TCGA-BK-A0CC_demographic	69	-25479		f3903f35-c35d-54f4-be3d-4c655da416f4	hispanic or latino	female	black or african american	released	Alive	1941		TCGA-BK-A0CC_exposure	Not Reported	31.16343490304709	d11893ab-e091-5b1f-955d-00e087fb439a	152.0	released	72.0	TCGA-BK-A0CC_diagnosis	25479	not reported	0	1067	7924d7fd-572e-5f05-920f-de2bc56e759f	Stage IIIC	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-BK-A0CC_treatment_1	TCGA-BK-A0CC_treatment	released	8d9f977e-f86d-5d51-86f0-125038780ed2	yes	Pharmaceutical Therapy, NOS	released	af85e4ac-f4ce-532c-ad60-f6c582a60a9e	yes	Radiation Therapy, NOS	989231f0-c8bb-4b02-984c-a6a45a20d7a5
02ae3e1a-390c-4f9c-8435-6141296b578e.htseq.counts.gz	034abaea-db54-4ff4-8e0b-b44dbee1c13d	TCGA-BS-A0TC-01A-11R-A104-07	TCGA-BS-A0TC-01A-11R	TCGA-BS-A0TC-01A-01-BS1	TCGA-BS-A0TC-01A-01-TS1		TCGA-BS-A0TC-01A-11	TCGA-BS-A0TC-01A	TCGA-BS-A0TC	7b7d2d2b-abe6-4f32-add0-3715096995d1	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	2227	120.0	False	false	8AA64402-A062-410D-85B8-24DAD320916D	1.91	0b2aa3d5-f8cd-4047-91cf-295e6b4c8891	0.17	23	released	df520c62-c310-4ae8-8f92-4b5a8fd54739	RNA	R	0.17	UV Spec	released	False	f3ac605f-ff86-43df-8e7a-2400f2e4efdd	11	20.0	0.0	0.0	5.0	0.0	10.0	90.0	90.0	BOTTOM	c6fe04a9-c77a-4820-9369-67cf2f30648b	released	50.0	10.0	0.0	20.0	0.0	10.0	90.0	90.0	TOP	9fe73928-2cfe-4398-8987-3dca33bd29ea	released									released	30.0	c4c99327-b778-4e29-a111-75569ad38696	Primary Tumor	01	released	Not Reported	released	TCGA-BS-A0TC_demographic	69	-25560		9d386311-6715-5417-a3fb-06d248c6e813	not hispanic or latino	female	asian	released	Alive	1935		TCGA-BS-A0TC_exposure	Not Reported	31.46836966078948	3f8cb9ad-6613-5852-931b-3e63e383b4fd	147.0	released	68.0	TCGA-BS-A0TC_diagnosis	25560	not reported	0	2602	6fb8ef5d-caed-5f93-8238-73f5291b6370	Stage IB	C54.3	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Fundus uteri	released	No	Fundus uteri	not reported	not reported	2004	TCGA-BS-A0TC_treatment_1	TCGA-BS-A0TC_treatment	released	e0185256-3f64-5696-88a4-99e5670fe16e	no	Pharmaceutical Therapy, NOS	released	94cbf165-19f0-56fc-908b-7050937cb943	no	Radiation Therapy, NOS	034abaea-db54-4ff4-8e0b-b44dbee1c13d
a1884346-d2e7-4ec6-aa0a-0d043537ee00.htseq.counts.gz	e3f42ee9-01f2-4062-addd-c563bf4f07b5	TCGA-B5-A1MS-01B-11R-A22K-07	TCGA-B5-A1MS-01B-11R	TCGA-B5-A1MS-01B-01-TSA			TCGA-B5-A1MS-01B-11	TCGA-B5-A1MS-01B	TCGA-B5-A1MS	b2aa0220-6387-4eea-b6d4-a4fa0f15b2d9	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	3117	440.0	False	true	5FF9FC65-FBCD-40E8-8382-DDD0B8EFD22B	1.82	6acf7672-ec9d-4765-85db-43c311d5f124	0.18	23	released	e247a723-eefe-4451-80f4-763bb53cc102	RNA	R	0.18	UV Spec	released	False	65aac6a8-71c6-45f3-8858-3569635cf6f2	11	1.0	2.0	5.0	0.0	0.0	0.0	95.0	90.0	TOP	aa633dd8-5291-40fe-9d8b-f2dd9abb2e89	released																				released	30.0	077a804e-8053-4319-80be-65d33bc2cf41	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A1MS_demographic	60	-22068	3112	2f5073c6-d784-534d-8170-ca24a733d556	not hispanic or latino	female	white	released	Dead	1943	2011	TCGA-B5-A1MS_exposure	Not Reported	26.85440557410364	bf8ce5c1-b920-5ec6-b2fd-368f1a0d679c	166.0	released	74.0	TCGA-B5-A1MS_diagnosis	22068	not reported	0		ff1c9ded-fbef-52e6-ba9d-e89ba8446649	Stage IC	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2003	TCGA-B5-A1MS_treatment_1	TCGA-B5-A1MS_treatment	released	e65f1700-0cb5-5ae5-9abb-409a459e6469	no	Pharmaceutical Therapy, NOS	released	9e5b530f-ec1e-5c73-8e79-d35b98157eed	yes	Radiation Therapy, NOS	e3f42ee9-01f2-4062-addd-c563bf4f07b5
302d3923-3985-4669-b68a-2d51d508bb8d.htseq.counts.gz	7380bf12-eb49-4a92-89cd-ec436cc40afe	TCGA-DF-A2KZ-01A-11R-A213-07	TCGA-DF-A2KZ-01A-11R	TCGA-DF-A2KZ-01A-01-TS1			TCGA-DF-A2KZ-01A-11	TCGA-DF-A2KZ-01A	TCGA-DF-A2KZ	3b218ab7-5c2e-4458-a0ac-5152ec3d2b94	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC		450.0	False	false	D69C73D1-1CEB-4AF5-AAF2-8E707EF4CA38	1.73	dff76521-f81c-4de8-9a80-d75d18fe7982	0.15	23	released	7a460195-d92b-4b74-a168-139fbebf957e	RNA	R	0.15	UV Spec	released	False	fe465d53-bedc-4270-9ee8-93cb17e536c5	11	0.0	0.0	0.0	0.0	0.0	25.0	75.0	75.0	TOP	ee9d1389-ee04-4791-a4d9-a60e079c1931	released																				released	30.0	76d43b40-612e-4580-abd7-d1837d8fd5d0	Primary Tumor	01	released	Not Reported	released	TCGA-DF-A2KZ_demographic	87	-31973		1b0c592e-7c31-555e-bf54-a9b7dc83eaa5	not reported	female	not reported	released	Alive			TCGA-DF-A2KZ_exposure	Not Reported		ab646904-b25d-5bac-96ba-865546c8afec		released		TCGA-DF-A2KZ_diagnosis	31973	not reported	0	826	3d756b40-2ccd-55bc-bef9-5e5e5c2cd5c3	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported		TCGA-DF-A2KZ_treatment	TCGA-DF-A2KZ_treatment_1	released	36b28f02-115f-5576-a922-2e892bd9708a	yes	Radiation Therapy, NOS	released	3699e8c1-18a6-5ee5-b975-d286f4a44c0b	no	Pharmaceutical Therapy, NOS	7380bf12-eb49-4a92-89cd-ec436cc40afe
ee289426-59e8-4050-aedf-c5a71e9860d0.htseq.counts.gz	2dc90ef8-7ab7-47df-8f2f-181e2e0e897b	TCGA-B5-A11P-01B-11R-A14D-07	TCGA-B5-A11P-01B-11R	TCGA-B5-A11P-01B-01-TS1			TCGA-B5-A11P-01B-11	TCGA-B5-A11P-01B	TCGA-B5-A11P	d1c65e6a-098e-4c10-9183-c303ba66015a	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	979	120.0	False	true	77639636-9C18-4C81-9FCF-04BA2D92110E	2.04	2d49f9b3-88bc-4e99-a2ea-ba900713563d	0.16	23	released	621c2063-0b1f-4185-abc1-52e9640defee	RNA	R	0.16	UV Spec	released	False	2b8fb9b7-78c7-4dd5-a5b8-de26eb221264	11	8.0	2.0	5.0	4.0	0.0	5.0	90.0	95.0	TOP	5ec7f65a-5202-4d4c-a850-2aeb95df7314	released																				released	30.0	64bf25f8-67bb-4f32-bad5-e879d1ad7736	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A11P_demographic	87	-32047		55b042ff-89d8-5610-8f99-d3f469e6edd4	not reported	female	white	released	Alive	1921		TCGA-B5-A11P_exposure	Not Reported		ed8724e5-89c3-5128-94fc-b5cb0f9782b4		released	74.0	TCGA-B5-A11P_diagnosis	32047	not reported	0	825	33bb6f27-9eb6-5d4f-a83f-e3c89193ad47	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-B5-A11P_treatment	TCGA-B5-A11P_treatment_1	released	0ab65933-70af-536b-8007-a1b053b63419	no	Radiation Therapy, NOS	released	432c05d3-c1a2-5e2a-9aeb-dbf5075f0f96	no	Pharmaceutical Therapy, NOS	2dc90ef8-7ab7-47df-8f2f-181e2e0e897b
491298d4-e226-42dd-81a7-cedb7bb8b080.htseq.counts.gz	2bc51818-b63d-4adc-abf2-2c9aceac1af9	TCGA-A5-A0GW-01A-11R-A16W-07	TCGA-A5-A0GW-01A-11R	TCGA-A5-A0GW-01A-01-TSA	TCGA-A5-A0GW-01A-01-BSA		TCGA-A5-A0GW-01A-11	TCGA-A5-A0GW-01A	TCGA-A5-A0GW	5b6b9d0f-787c-4ae9-afd4-de7ce6c57a42	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	302	160.0	False	true	0EE4FD56-D0BA-43E8-A434-CD86B21F21BF	1.85	1e4969e5-6bf8-4b8d-970e-96f4424356a8	0.15	23	released	5d5a722a-2e4e-45ec-bd01-b0b63b813466	RNA	R	0.15	UV Spec	released	False	eebc10d2-0017-4837-920a-f778eace12c2	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	90.0	TOP	590452d2-00cb-4ba6-b90c-cd0833ec6338	released	0.0	0.0	0.0	0.0	0.0	0.0	100.0	90.0	BOTTOM	08c77013-9fdf-466c-8b46-5d60134c5375	released									released	30.0	e84d0533-e892-4c1e-9415-99f92aa9a360	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A0GW_demographic	46	-17092		4b3d4da8-f22d-5391-8b1f-3dc0a47b2dcb	not hispanic or latino	female	asian	released	Alive	1963		TCGA-A5-A0GW_exposure	Not Reported	24.300733981352906	6a9538f2-5843-5b07-b4fe-312276bcfd66	142.0	released	49.0	TCGA-A5-A0GW_diagnosis	17092	not reported	0	706	6b3d9176-5493-57f8-b6b2-0326c5e54e8e	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-A5-A0GW_treatment	TCGA-A5-A0GW_treatment_1	released	bcfbb83b-3ec2-572b-8f1f-83df371c1c62	yes	Radiation Therapy, NOS	released	282c9f55-a907-5291-b34b-b81d61e31243	no	Pharmaceutical Therapy, NOS	2bc51818-b63d-4adc-abf2-2c9aceac1af9
5c44bb54-7526-460a-9998-e7b80f5c16ca.htseq.counts.gz	d78eb5c2-b3d9-4d2f-8e09-206571da5535	TCGA-EO-A2CH-01A-11R-A180-07	TCGA-EO-A2CH-01A-11R	TCGA-EO-A2CH-01A-01-TSA			TCGA-EO-A2CH-01A-11	TCGA-EO-A2CH-01A	TCGA-EO-A2CH	0cc9a11f-1ac4-431d-8f94-52a3bc02b572	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	802	80.0	False	false	B4A5577E-C043-4D25-8D53-77A43C5EC0CC	1.76	f9814b3c-60f3-4d83-885e-1e1a88e520a9	0.17	23	released	931fa953-a71d-4d26-ac5c-ba25bceb5254	RNA	R	0.17	UV Spec	released	False	89c245c9-69a2-4c31-b2b0-e70374098004	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	85.0	TOP	83da9bfc-01d3-4207-b89c-8d3d633b4a49	released																				released	20.0	f0906353-4c3b-4f71-9b0b-cb1477450013	Primary Tumor	01	released	Not Reported	released	TCGA-EO-A2CH_demographic	73	-26966	590	0941ebb2-1a6b-5219-84c0-ff018fe2668f	not reported	female	not reported	released	Dead	1936	2010	TCGA-EO-A2CH_exposure	Not Reported	28.566481994459835	27d5dc16-87d0-5b6f-b708-e697b47c17d7	152.0	released	66.0	TCGA-EO-A2CH_diagnosis	26966	not reported	0		70b51cda-35f6-5d26-b3cf-78d6593f9bca	Stage IVB	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-EO-A2CH_treatment_1	TCGA-EO-A2CH_treatment	released	bb8bbc84-1bd5-5286-b08e-27d7e372717d	yes	Pharmaceutical Therapy, NOS	released	9f59d7e7-2c25-5d39-95c9-ebebeb98ee6b	yes	Radiation Therapy, NOS	d78eb5c2-b3d9-4d2f-8e09-206571da5535
69dccbbf-11bf-441a-81ec-79b92407ea77.htseq.counts.gz	cfa4f253-0203-4b98-9cb5-8d70ca7490d6	TCGA-A5-A3LO-01A-11R-A22K-07	TCGA-A5-A3LO-01A-11R	TCGA-A5-A3LO-01A-01-TS1			TCGA-A5-A3LO-01A-11	TCGA-A5-A3LO-01A	TCGA-A5-A3LO	2a2bc155-ca7c-48b2-bb77-ccfd6313710a	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	182	160.0	False	true	2AB1F28D-151D-4AFE-807A-9F98B48C51CE	1.77	70a9e739-6f24-44b7-97cc-7197097a4f83	0.16	23	released	58d96e0c-f5f4-4f22-8b0c-e5e398dd4bb0	RNA	R	0.16	UV Spec	released	False	1a07b773-354d-4d65-b390-41e4eb7d3904	11	0.0	0.0	0.0	0.0	0.0	15.0	85.0	75.0	TOP	115cccfd-8398-4fdc-b63b-06facab374a4	released																				released	30.0	3bf209df-55b0-4f3f-b98e-9a13fe5e8955	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A3LO_demographic	64	-23401		a86dfa2e-5d13-51d3-bf8e-cad075653a3d	not hispanic or latino	female	white	released	Alive	1947		TCGA-A5-A3LO_exposure	Not Reported	36.4937641723356	166fe51d-f5e5-54d4-8d0d-f457d2efbff6	168.0	released	103.0	TCGA-A5-A3LO_diagnosis	23401	not reported	0	776	2baac3d4-74dd-5577-af66-fc9044528a99	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-A5-A3LO_treatment	TCGA-A5-A3LO_treatment_1	released	033a2cd6-0b64-5a43-ad81-91b705778d83	yes	Radiation Therapy, NOS	released	3d1887cc-5805-5b11-b193-1b4dc36de92c	yes	Pharmaceutical Therapy, NOS	cfa4f253-0203-4b98-9cb5-8d70ca7490d6
9fe92e91-376a-4d8e-a34c-37e4a3c00f32.htseq.counts.gz	0cc5065e-a36f-4232-b7fc-ad031d5e2613	TCGA-EO-A3B1-01A-12R-A19W-07	TCGA-EO-A3B1-01A-12R	TCGA-EO-A3B1-01A-01-TSA			TCGA-EO-A3B1-01A-12	TCGA-EO-A3B1-01A	TCGA-EO-A3B1	2cf8de9f-b305-4d98-bfd4-33377bf6138f	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	163	90.0	False	false	D3309430-5427-4FAD-BDD6-A6E9BABE29D2	1.79	2b0670d8-a2b4-4e1b-a3b3-4ec277e0078f	0.15	23	released	ad00956a-3274-4ce1-a55f-a8caa7e2b3cb	RNA	R	0.15	UV Spec	released	False	89ad22ab-e48e-442f-aedf-959538892860	12	60.0	20.0	0.0	20.0	0.0	10.0	90.0	90.0	TOP	81b9161e-3271-4f85-bbb7-0612926e14fe	released																				released	10.0	7407e162-9e38-49d0-9957-6e98775f5475	Primary Tumor	01	released	Not Reported	released	TCGA-EO-A3B1_demographic	63	-23162		6f899329-75a0-56df-99c2-e4cc79c2a1c4	not reported	female	not reported	released	Alive	1948		TCGA-EO-A3B1_exposure	Not Reported	32.17993079584775	36d80709-11f7-5660-b71b-12487da44b23	170.0	released	93.0	TCGA-EO-A3B1_diagnosis	23162	not reported	0	820	fa7982cc-0b59-5be3-807e-b2dafcb02b85	Stage IB	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-EO-A3B1_treatment	TCGA-EO-A3B1_treatment_1	released	4ee400d4-e725-523a-bcbc-69b3cdb89b08	yes	Radiation Therapy, NOS	released	cb93749c-075d-5f3b-8ed9-45abe13358ac	yes	Pharmaceutical Therapy, NOS	0cc5065e-a36f-4232-b7fc-ad031d5e2613
788465ed-def3-4d72-ac49-6d2f0c19759e.htseq.counts.gz	2a3622f2-2936-4a65-8a4e-bf47f8e923d4	TCGA-AJ-A3NC-01A-11R-A22K-07	TCGA-AJ-A3NC-01A-11R	TCGA-AJ-A3NC-01A-01-TSA			TCGA-AJ-A3NC-01A-11	TCGA-AJ-A3NC-01A	TCGA-AJ-A3NC	c8fb94dd-c535-48f4-9419-aac2bf47bbb4	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	282	300.0	False	false	B6DB87F4-E88A-4209-92E2-75ADB364FB28	1.8	e6dbc0a5-b610-406a-9c7a-43eb8b6b6b53	0.16	23	released	5508fe64-f4b7-4d5b-b0e2-0f9265ec237a	RNA	R	0.16	UV Spec	released	False	04bd1e8a-6fb5-49f2-814a-8b1d87e71d06	11	1.0	1.0	5.0	1.0	0.0	0.0	95.0	95.0	TOP	cdb70b96-0425-4593-8052-1c5a87a855ec	released																				released	30.0	2398c565-2432-4fe9-bf9a-13ed877badea	Primary Tumor	01	released	Not Reported	released	TCGA-AJ-A3NC_demographic	63	-23353		af950860-01d9-57e3-a223-7ae401b8c798	not reported	female	white	released	Alive	1948		TCGA-AJ-A3NC_exposure	Not Reported	38.97392290249433	aaeea8bd-b083-526c-9941-e37eb1f1508c	168.0	released	110.0	TCGA-AJ-A3NC_diagnosis	23353	not reported	0	1125	53218018-d835-5878-a24c-d303aede851f	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-AJ-A3NC_treatment	TCGA-AJ-A3NC_treatment_1	released	0bfff125-be0b-51b9-a1b6-c3be59e73898	no	Radiation Therapy, NOS	released	0d89d31e-efaf-57e6-8b73-96f44d04b02c	no	Pharmaceutical Therapy, NOS	2a3622f2-2936-4a65-8a4e-bf47f8e923d4
7c366536-e6c8-4f06-908d-32a89408dc5a.htseq.counts.gz	9ea2cbe5-c59a-4ba9-8c2a-016981c65307	TCGA-B5-A11U-01A-11R-A118-07	TCGA-B5-A11U-01A-11R	TCGA-B5-A11U-01A-01-TSA	TCGA-B5-A11U-01A-01-MSA		TCGA-B5-A11U-01A-11	TCGA-B5-A11U-01A	TCGA-B5-A11U	0b672aa4-fc13-476f-b61e-5f2c3a615c23	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	371	220.0	False	true	1EF2CB28-A515-4E9D-9148-CC1A2DF77F60	1.86	714254dd-834a-4b70-8f88-c48bc7b4fdb8	0.17	23	released	4dac50b4-2009-4e64-b1a0-6d97210fef67	RNA	R	0.17	UV Spec	released	False	a6725c0d-3e12-467b-bdaf-e75d6492f246	11	10.0	0.0	20.0	10.0	0.0	30.0	50.0	70.0	TOP	e4ef60a3-41c0-4117-9e9e-6ab34eb43ea8	released	35.0	4.0	4.0	3.0	0.0	60.0	36.0	40.0	BOTTOM	0e174eee-6e4b-4a58-83e4-7cfbfce8e8f6	released									released	30.0	52265b60-6f79-4e28-92a9-f4f5bee5a95e	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A11U_demographic	74	-27160		c0fa632c-0f09-59bd-9e43-fb1211bd54cb	not reported	female	black or african american	released	Alive	1935		TCGA-B5-A11U_exposure	Not Reported	26.40235457063712	b5ac85f0-3b75-50ce-925d-40898d003acc	152.0	released	61.0	TCGA-B5-A11U_diagnosis	27160	not reported	0	509	99639fd2-381e-57f3-8de0-6e9f3dd7f6fc	Stage IVB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-B5-A11U_treatment	TCGA-B5-A11U_treatment_1	released	a9964f6a-2edd-5200-9d60-f08d94beb79a	yes	Radiation Therapy, NOS	released	8294de65-d0b7-57b1-89a7-9d9e56ed123e	no	Pharmaceutical Therapy, NOS	9ea2cbe5-c59a-4ba9-8c2a-016981c65307
4f320b74-5590-434e-88aa-8e9fd04db4f1.htseq.counts.gz	4ef1f602-a464-474e-a618-fd71aa9bbe74	TCGA-D1-A168-01A-31R-A12I-07	TCGA-D1-A168-01A-31R	TCGA-D1-A168-01A-03-TSC			TCGA-D1-A168-01A-31	TCGA-D1-A168-01A	TCGA-D1-A168	41893e97-7e90-4b03-b738-260f288ade4c	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	821	120.0	False	false	B9D9D808-17B1-415F-9E58-4FDBC1BF30C0	1.84	9ca7ed26-2a2c-47cd-8423-f9b100beccc3	0.16	23	released	c0a13869-3777-49d2-b2dc-5f600394db50	RNA	R	0.16	UV Spec	released	False	84a93681-3ae8-4056-8a98-db24a436c460	31	0.0	0.0	5.0	0.0	0.0	5.0	90.0	95.0	TOP	4593601c-0515-4fd9-b602-535be165a090	released																				released	20.0	b44c673e-9560-4b59-9ff3-34ce230cad1c	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A168_demographic	67	-24586		877d24ed-dd52-5247-95aa-d023b682a6dd	not hispanic or latino	female	white	released	Alive	1941		TCGA-D1-A168_exposure	Not Reported	28.95900015241579	4880dd0e-c6a3-59cc-a796-22b6c0e428b3	162.0	released	76.0	TCGA-D1-A168_diagnosis	24586	not reported	0	1098	a6f898ce-d3bf-5b6a-bf29-7a86fb211048	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-D1-A168_treatment_1	TCGA-D1-A168_treatment	released	549d415c-5742-571f-9db0-a6fef5c2a229	no	Pharmaceutical Therapy, NOS	released	21bac08b-e29c-5198-ae5c-4eea3bb311b6	yes	Radiation Therapy, NOS	4ef1f602-a464-474e-a618-fd71aa9bbe74
08ec676c-8ea3-40ed-b579-8ba863af6102.htseq.counts.gz	75e37138-6eb8-4440-8596-627a212f6078	TCGA-AP-A0LV-01A-11R-A040-07	TCGA-AP-A0LV-01A-11R	TCGA-AP-A0LV-01A-01-BSA	TCGA-AP-A0LV-01A-01-TSA		TCGA-AP-A0LV-01A-11	TCGA-AP-A0LV-01A	TCGA-AP-A0LV	5dfdfcfc-72cc-4e33-aa3f-0d744eb94330	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	341	280.0	False	true	75767B04-9FDF-4EE9-8DFF-350B60AF281C	1.91	0d04e718-95ff-4eb9-b56f-99c0ee5970d2	0.13	23	released	9ae0d691-536f-4d92-8ec4-d2252c4a2928	RNA	R	0.13	UV Spec	released	False	f507ccf5-9729-4679-87eb-e9f1cd21cd22	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	90.0	BOTTOM	07ca5dcb-d6d3-4142-9a8f-e791eedfb0a5	released	0.0	0.0	0.0	0.0	0.0	0.0	100.0	85.0	TOP	bcaf0eda-e74e-4575-81e6-58727b7f7c1d	released									released	30.0	f5c82191-3e5a-479a-b0e4-77f6ac14b3cc	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A0LV_demographic	39	-14556		5b89e6af-bc94-5d29-9aae-508edc9f7ae2	not reported	female	white	released	Alive	1970		TCGA-AP-A0LV_exposure	Not Reported	32.89473684210526	e9f8bc3d-30f9-5857-9037-8a9943fe5747	152.0	released	76.0	TCGA-AP-A0LV_diagnosis	14556	not reported	0	763	3d9dedea-6420-562b-96e0-30befcd1d44f	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-AP-A0LV_treatment_1	TCGA-AP-A0LV_treatment	released	a233f64b-e481-5012-b857-a936f056ecdf	no	Pharmaceutical Therapy, NOS	released	3344f8fb-070c-5e93-baaf-dd4901d6976d	no	Radiation Therapy, NOS	75e37138-6eb8-4440-8596-627a212f6078
538b497d-98a2-4e5b-afd6-e5dfe63d098a.htseq.counts.gz	3c1fad81-04dc-4dd2-a0b5-b711dfb3e7e0	TCGA-A5-A0VP-01A-21R-A104-07	TCGA-A5-A0VP-01A-21R	TCGA-A5-A0VP-01A-02-TSB	TCGA-A5-A0VP-01A-02-BSB		TCGA-A5-A0VP-01A-21	TCGA-A5-A0VP-01A	TCGA-A5-A0VP	2db0fb62-64ce-457c-9e22-dd05ef59f684	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	930	210.0	False	true	960B26D6-F9BA-4099-B6F4-6D1DEA6C0F0F	1.83	65e557db-24de-47df-827c-d8336cb099eb	0.14	23	released	7baaba1e-ffff-4427-b357-e7ae29e6d850	RNA	R	0.14	UV Spec	released	False	01e32eb2-846e-4cda-b5a4-4aaff5b0a017	21	20.0	0.0	20.0	20.0	0.0	0.0	80.0	100.0	TOP	abdeff57-30c9-4dbb-8cae-3fa75f69985a	released	10.0	0.0	10.0	10.0	0.0	0.0	90.0	100.0	BOTTOM	c26c680b-9d2a-4184-9f1a-5d37e003fec2	released									released	30.0	f1fbe4ac-f3fd-4609-9a2b-507820abe77e	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A0VP_demographic	74	-27335		ad5dab9e-da95-57a2-aee7-1d0708b16f05	not hispanic or latino	female	white	released	Alive	1934		TCGA-A5-A0VP_exposure	Not Reported	21.82995219993225	4ca458f8-e709-5c31-8435-d938e8b0e5d8	163.0	released	58.0	TCGA-A5-A0VP_diagnosis	27335	not reported	0	1288	956c0fb2-eb4d-52ce-9e44-b01eaab459fb	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-A5-A0VP_treatment_1	TCGA-A5-A0VP_treatment	released	0f3609ac-7602-5079-a04b-e36bfe02b33d	no	Pharmaceutical Therapy, NOS	released	a3666392-744d-5d18-800e-443e3171d222	yes	Radiation Therapy, NOS	3c1fad81-04dc-4dd2-a0b5-b711dfb3e7e0
6d7f5731-e599-4e3f-b80b-1f0ac2f68111.htseq.counts.gz	da9b145b-3276-42b6-a497-cbf5352507c2	TCGA-BK-A0C9-01A-11R-A00V-07	TCGA-BK-A0C9-01A-11R	TCGA-BK-A0C9-01A-01-TS1	TCGA-BK-A0C9-01A-01-BS1		TCGA-BK-A0C9-01A-11	TCGA-BK-A0C9-01A	TCGA-BK-A0C9	92a2cae3-b8ee-4ebb-ac5c-01e58749448f	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	192	490.0	False	false	3E14F5F3-2C40-403F-A499-BE64857E8559	1.8	71ef8bce-4b04-4fba-9ae6-8c8f2b18b2c7	0.14	23	released	25abd606-1648-4d4a-b302-631809546623	RNA	R	0.14	UV Spec	released	False	2333f095-4d71-45ed-9778-9b1c14faa5b4	11	0.0	0.0	0.0	0.0	0.0	25.0	75.0	75.0	TOP	beca33f8-0591-4830-800f-0713f8278648	released	0.0	0.0	0.0	0.0	0.0	15.0	85.0	85.0	BOTTOM	a3e6d573-95d8-470a-9fd5-303bbb08a40f	released									released	30.0	155181e3-7733-44be-8ef8-7e24cebb59a4	Primary Tumor	01	released	Not Reported	released	TCGA-BK-A0C9_demographic	57	-20876		dbc9ef72-8377-52a7-b0cc-6a29c0c1c174	not hispanic or latino	female	white	released	Alive	1952		TCGA-BK-A0C9_exposure	Not Reported	44.99716553287982	ee2e38b8-a7a3-5129-861c-989087ff4f2a	168.0	released	127.0	TCGA-BK-A0C9_diagnosis	20876	not reported	0	1092	69aaab7d-9b61-55a8-b617-f1ed370f06c3	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-BK-A0C9_treatment_1	TCGA-BK-A0C9_treatment	released	2a0db852-977a-5cde-989b-044b31b32bfa	no	Pharmaceutical Therapy, NOS	released	fbf028c5-5bd5-503a-8f53-a097d431b239	no	Radiation Therapy, NOS	da9b145b-3276-42b6-a497-cbf5352507c2
9bbe408c-e2fb-4485-ad73-618ca57da131.htseq.counts.gz	97b14803-64a9-451c-8d67-1f9e07a2a7bf	TCGA-D1-A16N-01A-11R-A12I-07	TCGA-D1-A16N-01A-11R	TCGA-D1-A16N-01A-01-TS1			TCGA-D1-A16N-01A-11	TCGA-D1-A16N-01A	TCGA-D1-A16N	dbbbddae-d711-40f5-bd10-863735885b1f	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	629	240.0	False	false	81CFA07C-5FCE-41F3-88D1-FFD17840B293	1.91	55b006ca-aacf-4ed5-a0bc-7238eacfb23e	0.16	23	released	54cb48d0-0449-4248-8861-33d47c18a205	RNA	R	0.16	UV Spec	released	False	33c64495-a359-4b09-9c5a-6e1c7bcb5061	11	0.0	0.0	3.0	0.0	0.0	2.0	95.0	95.0	TOP	a74c1a37-d6a5-4eb8-9917-ebf450457805	released																				released	30.0	6d916a47-dcff-4c98-9e88-348aaa353f98	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A16N_demographic	51	-18787		f0036ae7-4205-5040-8e3e-a693f85e34ec	not hispanic or latino	female	white	released	Alive	1958		TCGA-D1-A16N_exposure	Not Reported	37.04474505723204	c93fb777-88bb-5c1c-8e8a-57d2cbdf7467	155.0	released	89.0	TCGA-D1-A16N_diagnosis	18787	not reported	0	945	5fd69136-43be-59b2-8e31-a625adbfba40	Stage IIIA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-D1-A16N_treatment_1	TCGA-D1-A16N_treatment	released	188d6bb5-c6e1-5006-accf-d5952a9a23b3	yes	Pharmaceutical Therapy, NOS	released	b957ae85-6a97-54ff-85af-bf337f8f225f	yes	Radiation Therapy, NOS	97b14803-64a9-451c-8d67-1f9e07a2a7bf
ecbd08be-c930-47c6-bc1c-0b97c3cc8814.htseq.counts.gz	8e965fb7-434b-447b-acbe-83364d6c8eac	TCGA-D1-A17Q-01A-11R-A12I-07	TCGA-D1-A17Q-01A-11R	TCGA-D1-A17Q-01A-01-TSA			TCGA-D1-A17Q-01A-11	TCGA-D1-A17Q-01A	TCGA-D1-A17Q	ca8dbbfd-8928-4e25-94c6-b875de631bbd	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	434	130.0	False	false	698079B6-EB07-4491-9672-4BDE4E5DAC49	1.8	85b22bad-9b11-474f-9c87-5ddb98c76ccb	0.17	23	released	504a935f-44c6-4fe7-8f62-cd94276e103c	RNA	R	0.17	UV Spec	released	False	bfde1087-8a1a-4341-a1f2-48a0c7ff7b8c	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	65.0	TOP	08b233d1-b90a-401a-b29f-b500f62168af	released																				released	30.0	b6abeb01-b6ea-4ab4-aa00-ae16cfc88b7c	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A17Q_demographic	54	-20015		105fd313-edc4-545d-b653-07fd87c0f017	not hispanic or latino	female	white	released	Alive	1955		TCGA-D1-A17Q_exposure	Not Reported	23.808690171912748	78c2c0a9-6fd1-52d4-ae83-eb3a32f07b75	169.0	released	68.0	TCGA-D1-A17Q_diagnosis	20015	not reported	0	54	3f107814-8eeb-5e24-9e5a-5a9abc94546f	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-D1-A17Q_treatment	TCGA-D1-A17Q_treatment_1	released	e38e41c4-7639-565f-b930-b00d395a01d6	no	Radiation Therapy, NOS	released	764d184b-eb23-5ac5-aab8-3c4dca414dd0	no	Pharmaceutical Therapy, NOS	8e965fb7-434b-447b-acbe-83364d6c8eac
0297aa11-ec36-489f-a9a7-05ce96a55874.htseq.counts.gz	141c92e2-592f-4973-b250-f989b798f8a5	TCGA-SJ-A6ZJ-01A-12R-A34R-07	TCGA-SJ-A6ZJ-01A-12R	TCGA-SJ-A6ZJ-01A-01-TSA			TCGA-SJ-A6ZJ-01A-12	TCGA-SJ-A6ZJ-01A	TCGA-SJ-A6ZJ	fbfed398-2a44-44a9-83cf-657c29cb7d28	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	216	580.0	False	false	B7C3C4EC-E494-4290-AFDA-FEFEBA8A3BA5	1.84	d3473471-b625-4f56-8300-590324d48002	0.16	23	released	644b5730-19d5-4f58-9a80-cf8e2efae3ef	RNA	R	0.16	UV Spec	released	False	e53d542e-b707-4f92-9825-de496c6b48cd	12	1.0	1.0	0.0	1.0	20.0	10.0	70.0	70.0	TOP	c83e38ed-f883-4679-9dcb-e36f4e5586db	released																				released	30.0	c3064816-c2c1-4af0-8f0e-89d900e47d20	Primary Tumor	01	released	Not Reported	released	TCGA-SJ-A6ZJ_demographic	61	-22597		921580f9-9167-5eb6-86ee-2c4f16954e7c	not hispanic or latino	female	black or african american	released	Alive	1951		TCGA-SJ-A6ZJ_exposure	Not Reported	46.7687074829932	8c95d798-3ac2-52ef-a771-115ac6ee89f9	168.0	released	132.0	TCGA-SJ-A6ZJ_diagnosis	22597	not reported	0	556	aa82239a-6f37-5408-9bce-46d482a3c695	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2012	TCGA-SJ-A6ZJ_treatment_1	TCGA-SJ-A6ZJ_treatment	released	55d48517-9c33-5a98-a77a-a00d9ab21ab0	no	Pharmaceutical Therapy, NOS	released	cdf0c22b-fcc0-5ec8-8e54-02d949cd4822	yes	Radiation Therapy, NOS	141c92e2-592f-4973-b250-f989b798f8a5
22c7a99a-b192-486a-bd53-aede0ed73c75.htseq.counts.gz	e1aea9c7-4418-44f5-bcb9-fe244bcdacbe	TCGA-AX-A06D-01A-11R-A118-07	TCGA-AX-A06D-01A-11R	TCGA-AX-A06D-01A-01-TSA	TCGA-AX-A06D-01A-01-BSA		TCGA-AX-A06D-01A-11	TCGA-AX-A06D-01A	TCGA-AX-A06D	905291b0-f077-48f7-9c14-5cfa9d8a3e6e	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1066	190.0	False	false	B523C3E8-6FE7-4D6A-B6CE-7DEA1C32D33F	1.85	f29cd33b-c1eb-4c17-b2b0-5cf553beb2a9	0.16	23	released	b8775f7d-2b20-4a32-b024-cf9fab019252	RNA	R	0.16	UV Spec	released	False	dab01b45-bcac-4ff0-bc00-62313a267f92	11	3.0	0.0	25.0	0.0	15.0	5.0	55.0	60.0	TOP	1612207f-d9f1-4f39-812c-5b6f3e3ac570	released	1.0	0.0	10.0	0.0	30.0	10.0	50.0	60.0	BOTTOM	f1cbae87-7c7d-449e-adb0-5359fc0ff3e4	released									released	30.0	f97bb30a-759e-44b9-889a-b5bde9855b29	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A06D_demographic	82	-30024	373	0ba9baaa-8ead-50b7-a9e2-669532e9a138	not reported	female	white	released	Dead	1925	2008	TCGA-AX-A06D_exposure	Not Reported	35.546875	99f35939-f252-562a-a5c1-9642339d4d53	160.0	released	91.0	TCGA-AX-A06D_diagnosis	30024	not reported	0		0eafcbcd-deec-577e-a9bb-31bfdb6a3b2b	Stage IIIA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2007	TCGA-AX-A06D_treatment	TCGA-AX-A06D_treatment_1	released	d9dad5fc-bea9-5b35-bb49-ebd3974f9f05	no	Radiation Therapy, NOS	released	eee79523-feab-597c-b5f8-7fff1a9faa18	yes	Pharmaceutical Therapy, NOS	e1aea9c7-4418-44f5-bcb9-fe244bcdacbe
8f769163-f20b-4331-a415-3b49813c6a3a.htseq.counts.gz	d1628533-b61c-41d3-918e-f96d3d5e29da	TCGA-BG-A0MS-01A-11R-A104-07	TCGA-BG-A0MS-01A-11R	TCGA-BG-A0MS-01A-01-BSA	TCGA-BG-A0MS-01A-01-TSA		TCGA-BG-A0MS-01A-11	TCGA-BG-A0MS-01A	TCGA-BG-A0MS	a798a8cc-4e72-4a8c-9e20-74a14deafd12	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	420	560.0	False	true	7BE89F2D-74E5-4D9E-8270-A216D79ADCD7	1.95	09b4aa83-d8e7-4615-bfad-da877df4fe7d	0.13	23	released	711a4927-ba06-47ff-b56e-fd3ffb1ece5d	RNA	R	0.13	UV Spec	released	False	49245adc-3fe1-419b-b757-fc0e091a26a0	11	7.0	0.0	1.0	0.0	0.0	10.0	89.0	85.0	BOTTOM	a2fb1a5e-885f-4eea-9753-77d2afc91b19	released	15.0	1.0	1.0	3.0	30.0	5.0	64.0	60.0	TOP	7c5e3a35-55f3-445b-83aa-f19d6b99e672	released									released	30.0	ef7f78eb-314b-4cf2-b45b-810c84c6aa7b	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A0MS_demographic	53	-19547		eb111509-466e-5511-a767-c881fb9375e6	not hispanic or latino	female	white	released	Alive	1956		TCGA-BG-A0MS_exposure	Not Reported	25.390625	315d1c24-b925-5ebd-842c-dfe6958b2d68	160.0	released	65.0	TCGA-BG-A0MS_diagnosis	19547	not reported	0	1882	439da3e5-75e8-5825-a748-010655b6fe25	Stage IIIC1	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2009	TCGA-BG-A0MS_treatment_1	TCGA-BG-A0MS_treatment	released	687fb40f-fc6c-5a73-8c28-dad23074668a	yes	Pharmaceutical Therapy, NOS	released	9314546a-c286-59b2-970d-7b55c7672991	yes	Radiation Therapy, NOS	d1628533-b61c-41d3-918e-f96d3d5e29da
0d649941-c94d-45ad-b063-1bdeff2e675c.htseq.counts.gz	aa881a3b-fcb2-4659-bb5d-33619419a4da	TCGA-AX-A2IO-01A-11R-A180-07	TCGA-AX-A2IO-01A-11R	TCGA-AX-A2IO-01A-01-TSA			TCGA-AX-A2IO-01A-11	TCGA-AX-A2IO-01A	TCGA-AX-A2IO	8a235d4d-5ee1-4d6b-839e-e71cadcd8c39	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	1262	40.0	False	false	5482CC06-7854-459E-8A23-81ABC45DD076	1.68	e216a53d-5300-45af-985d-9d397e990acf	0.16	23	released	8a136768-0928-41c4-a0b9-e90f32d1989c	RNA	R	0.16	UV Spec	released	False	0b4c6c0f-c31c-47aa-b8e4-f03b90eeed6a	11	10.0	0.0	2.0	0.0	38.0	10.0	50.0	60.0	TOP	b934d163-edd2-4fa6-a6a7-b9ba833f327e	released																				released	30.0	4873bdca-1153-4187-95b8-30ee31880ddf	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A2IO_demographic	83	-30539		a3d8b15e-c949-5b84-8dfa-e04e6ef92814	not reported	female	white	released	Alive	1925		TCGA-AX-A2IO_exposure	Not Reported	24.386526444139612	6f497245-c25e-59a8-af38-b53f81cd2e37	162.0	released	64.0	TCGA-AX-A2IO_diagnosis	30539	not reported	0	1975	f9192a59-62b1-59d0-8feb-bf2e9ec37371	Stage IIA	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-AX-A2IO_treatment_1	TCGA-AX-A2IO_treatment	released	3094a64d-cdf0-55be-91f5-7675fbe50e6b	yes	Pharmaceutical Therapy, NOS	released	bced907c-b54c-570b-9717-e6de5a6a3360	yes	Radiation Therapy, NOS	aa881a3b-fcb2-4659-bb5d-33619419a4da
893b3d26-863d-4b30-8ed5-a3174e7eb334.htseq.counts.gz	2226fbdf-a620-4904-8608-436a09fb3b6a	TCGA-A5-A0GH-01A-21R-A16W-07	TCGA-A5-A0GH-01A-21R	TCGA-A5-A0GH-01A-02-BSB	TCGA-A5-A0GH-01A-02-TSB		TCGA-A5-A0GH-01A-21	TCGA-A5-A0GH-01A	TCGA-A5-A0GH	32e33897-29c8-48f2-b833-98f37204e0e7	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	2256	230.0	False	true	8E29A939-5581-4176-B19E-14076F17726B	1.81	ec3e03af-251e-497f-8cb4-b05816df2e12	0.15	23	released	153ccaee-b4d7-4c6e-8b0d-69c068404957	RNA	R	0.15	UV Spec	released	False	62685856-c69b-498e-84db-50425157bec2	21	20.0	0.0	20.0	10.0	5.0	0.0	75.0	95.0	BOTTOM	6cac7f11-4e15-4e16-b0c5-e55776aa78cd	released	20.0	0.0	10.0	10.0	10.0	0.0	80.0	90.0	TOP	84333999-23ec-45d3-a566-fc6f14d430b1	released									released	30.0	853196b6-8c1d-462f-af8f-acf2551f633d	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A0GH_demographic	57	-21090		d5ecc0c8-b648-567c-bef5-093fbf06a6cf	not hispanic or latino	female	white	released	Alive	1947		TCGA-A5-A0GH_exposure	Not Reported	20.700816741315066	0857e489-8b2a-5a2d-8a29-3f890aacc8c7	163.0	released	55.0	TCGA-A5-A0GH_diagnosis	21090	not reported	0	2254	e572117a-2fb1-5066-8813-9a18c7f4fe90	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2004	TCGA-A5-A0GH_treatment_1	TCGA-A5-A0GH_treatment	released	31bec311-9b87-5a4e-becb-d8a9fb567801	no	Pharmaceutical Therapy, NOS	released	c86ccec8-f08c-5efd-8ccd-c80ec68500b4	no	Radiation Therapy, NOS	2226fbdf-a620-4904-8608-436a09fb3b6a
e877622c-ef3c-447b-9496-cd1d2ab1a678.htseq.counts.gz	d1357e5a-9a6e-4fd9-9e00-a78573002330	TCGA-AX-A2HJ-01A-11R-A17B-07	TCGA-AX-A2HJ-01A-11R	TCGA-AX-A2HJ-01A-01-TSA			TCGA-AX-A2HJ-01A-11	TCGA-AX-A2HJ-01A	TCGA-AX-A2HJ	32398808-c46a-41bf-a0a8-e08723b40ea2	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	779	140.0	False	false	84FF1AB9-47F4-4884-9345-43878BDEF379	2.4	b3b47f11-3e7c-475e-8f39-cefb8db8fa35	0.16	23	released	4dedf641-dd4c-41f9-aac1-14a451f23cc7	RNA	R	0.16	UV Spec	released	False	f42eaa74-6e93-4c42-b970-4bb92b1b9249	11	1.0	0.0	5.0	0.0	0.0	25.0	70.0	90.0	TOP	2581d097-54c6-43ad-9f20-d06b2a1be069	released																				released	30.0	cced4976-8c11-4910-b5d4-6279be4851be	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A2HJ_demographic	35	-13112		5a34c9fd-6e43-566b-8e12-af41e66ca002	not hispanic or latino	female	asian	released	Alive	1974		TCGA-AX-A2HJ_exposure	Not Reported	24.238227146814403	d77ef2f2-abd6-523c-b9ab-ad6bbf65b167	152.0	released	56.0	TCGA-AX-A2HJ_diagnosis	13112	not reported	0	935	4af5b840-400a-5d19-820c-3b9fd60ba6e3	Stage IC	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-AX-A2HJ_treatment	TCGA-AX-A2HJ_treatment_1	released	4ec967a9-ecd8-5df2-a50d-46f9f46f0731	yes	Radiation Therapy, NOS	released	e93aa405-e49f-5e9f-9b58-b9fd8389f2c0	yes	Pharmaceutical Therapy, NOS	d1357e5a-9a6e-4fd9-9e00-a78573002330
33eb8dac-67ee-4ab4-bf70-e81dbec1bf29.htseq.counts.gz	cdec9313-d3bf-492d-9ead-86de702bc9cc	TCGA-QF-A5YS-01A-11R-A31O-07	TCGA-QF-A5YS-01A-11R	TCGA-QF-A5YS-01A-01-TSA			TCGA-QF-A5YS-01A-11	TCGA-QF-A5YS-01A	TCGA-QF-A5YS	df15901c-2508-42c9-bf06-026efd89e51f	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	158	120.0	False	false	2608B03E-0D29-49EF-BC3D-A26D5017C265	1.92	646422f2-97e3-43e4-bb4f-260277cff6f4	0.16	23	released	00479065-042b-453f-9d16-1eb8615c1d8e	RNA	R	0.16	UV Spec	released	False	837ce606-28e7-4a85-b578-cd14c9948fe7	11	1.0	1.0	0.0	1.0	0.0	10.0	90.0	90.0	TOP	ecc2619e-9e42-4b7a-8b5f-db7faca978c7	released																				released	30.0	a7646717-9292-4321-9ea1-259573d8a1f0	Primary Tumor	01	released	Not Reported	released	TCGA-QF-A5YS_demographic	57	-20841		07f2d324-0079-5388-a28a-e7b6a3c00f3d	not hispanic or latino	female	black or african american	released	Alive	1955		TCGA-QF-A5YS_exposure	Not Reported	30.102118579484834	254a1a54-f2df-50df-91e3-ac8a2dd7483d	162.0	released	79.0	TCGA-QF-A5YS_diagnosis	20841	not reported	0	689	7ef8e2f1-5575-5c40-9462-fbfc52077346	Stage II	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Isthmus uteri	released	No	Isthmus uteri	not reported	not reported	2012	TCGA-QF-A5YS_treatment_1	TCGA-QF-A5YS_treatment	released	21c41dfa-dcf3-54b4-961f-382fae73116b	yes	Pharmaceutical Therapy, NOS	released	e12441b5-1346-533a-b2d2-679afc1d2711	yes	Radiation Therapy, NOS	cdec9313-d3bf-492d-9ead-86de702bc9cc
bb9206ea-b2a3-4f20-b22c-cc6589e01af6.htseq.counts.gz	49ce186a-765d-4bfd-bc35-d3ace06e4aaf	TCGA-AX-A3G4-01A-11R-A213-07	TCGA-AX-A3G4-01A-11R	TCGA-AX-A3G4-01A-01-TS1			TCGA-AX-A3G4-01A-11	TCGA-AX-A3G4-01A	TCGA-AX-A3G4	83f2cd11-0dd7-47a6-b4b3-8212faac94bb	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	463	130.0	False	false	7E8857D6-4347-4BC5-8655-40AAD7197789	1.84	a598aef0-10a2-41bb-b755-4b2788b32e10	0.16	23	released	6406235e-cbd9-479e-851f-a8de5eedb05d	RNA	R	0.16	UV Spec	released	False	c75328a8-3829-4468-a282-502a37d68331	11	1.0	0.0	4.0	1.0	3.0	3.0	90.0	94.0	TOP	db36c5ff-d254-406d-8d8e-4f73817ce863	released																				released	30.0	bb0d2369-9133-4189-a386-25feaa78c6e9	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A3G4_demographic	60	-22099		f3e4184b-0452-5930-98c5-ac8023f647f4	not hispanic or latino	female	native hawaiian or other pacific islander	released	Alive	1950		TCGA-AX-A3G4_exposure	Not Reported	38.366381010434225	77e80186-716e-5804-ba31-8375b7e1eaeb	167.0	released	107.0	TCGA-AX-A3G4_diagnosis	22099	not reported	0	9	72611320-df20-5a36-8dde-6c5856557583	Stage IIIC	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-AX-A3G4_treatment_1	TCGA-AX-A3G4_treatment	released	edd4576b-1b68-5a30-9ef9-3e0bf78131df	not reported	Pharmaceutical Therapy, NOS	released	1633b899-ede4-541a-978e-6ff2d595cb9f	not reported	Radiation Therapy, NOS	49ce186a-765d-4bfd-bc35-d3ace06e4aaf
d2b1cf88-1050-4da4-a507-0e026987b6f8.htseq.counts.gz	5c1f7153-71a2-4332-8fb3-1bdabdffdad3	TCGA-B5-A0K3-01A-11R-A040-07	TCGA-B5-A0K3-01A-11R	TCGA-B5-A0K3-01A-01-TSA	TCGA-B5-A0K3-01A-01-BSA		TCGA-B5-A0K3-01A-11	TCGA-B5-A0K3-01A	TCGA-B5-A0K3	79ecc142-8f6e-4260-a7ce-c8e2a6212c35	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	523	390.0	False	true	2D78431C-7385-4BD3-B597-85E613D89BF6	1.85	a2d46b53-d9bd-4c19-9a0a-fecb48d3c06a	0.15	23	released	1a4d6db6-a0d4-4d42-bf09-b433c6475743	RNA	R	0.15	UV Spec	released	False	430088ab-f5da-42af-a0a7-464e191bb47d	11	0.0	0.0	5.0	0.0	0.0	0.0	95.0	90.0	TOP	08df3c15-bb0b-46d3-9a1b-fcf18a8b39aa	released	0.0	0.0	5.0	0.0	0.0	10.0	85.0	85.0	BOTTOM	109f079c-5142-4478-847a-955e9ae53da1	released									released	30.0	ed31ddc2-feda-496e-a642-0c4b5dce014d	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A0K3_demographic	62	-22664	830	8827821d-7097-5450-b0fb-239fd48ffac4	not reported	female	black or african american	released	Dead	1947		TCGA-B5-A0K3_exposure	Not Reported	32.71861986912552	c903f959-8f20-5281-9212-00f005551ee8	164.0	released	88.0	TCGA-B5-A0K3_diagnosis	22664	not reported	0	700	cccb49d5-f5a6-516f-aa16-e4095ee4c579	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-B5-A0K3_treatment	TCGA-B5-A0K3_treatment_1	released	4ffa9f48-e839-5b6a-9cff-92d0321c588a	no	Radiation Therapy, NOS	released	c6541fbe-833d-596a-8b77-a3916bd71eca	yes	Pharmaceutical Therapy, NOS	5c1f7153-71a2-4332-8fb3-1bdabdffdad3
6c29406b-2b71-4cee-894d-3bdab460f490.htseq.counts.gz	b90d27e9-7294-4c20-a8cd-77fa97af3283	TCGA-B5-A11R-01A-11R-A118-07	TCGA-B5-A11R-01A-11R	TCGA-B5-A11R-01A-01-TS1	TCGA-B5-A11R-01A-01-BS1		TCGA-B5-A11R-01A-11	TCGA-B5-A11R-01A	TCGA-B5-A11R	f04befed-6c81-4676-8715-b8c6a33cb9d1	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	734	100.0	False	true	0AC5670B-7EA6-438C-9326-843BB7A6A81C	1.86	6152d141-ed7d-4c03-9af9-4647dc455c4f	0.15	23	released	179dfc19-8aac-4793-bbd4-6de85c6250e5	RNA	R	0.15	UV Spec	released	False	02618944-a1ef-42fc-9fe0-c9c20265a1f0	11	8.0	3.0	4.0	0.0	0.0	30.0	66.0	70.0	TOP	7535a431-eddb-40b1-a721-045e13cfa540	released	5.0	3.0	2.0	0.0	0.0	5.0	93.0	95.0	BOTTOM	953abe32-70fa-4cd3-81c9-c86a31050111	released									released	30.0	1583391d-1489-4489-9cb8-30cd6529b307	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A11R_demographic	51	-18878		e331981e-7b68-53b7-95c2-5cf15949c2ea	not reported	female	black or african american	released	Alive	1957		TCGA-B5-A11R_exposure	Not Reported	31.53344671201814	a207a331-1040-54ce-9dc0-665bd6f79829	168.0	released	89.0	TCGA-B5-A11R_diagnosis	18878	not reported	0	2349	f675bdd0-9c39-5e2b-8e82-80ff3efeaba3	Stage II	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-B5-A11R_treatment_1	TCGA-B5-A11R_treatment	released	6633efae-5f7a-54f6-a9d0-d8502eb4c9e9	yes	Pharmaceutical Therapy, NOS	released	6e9c26cf-668b-5358-8c88-ba394d7eb615	yes	Radiation Therapy, NOS	b90d27e9-7294-4c20-a8cd-77fa97af3283
937ee998-d548-42d8-a9f1-c369d76b1246.htseq.counts.gz	86cc368d-5157-43e2-920c-3e4d26dda0e2	TCGA-D1-A17K-01A-11R-A12I-07	TCGA-D1-A17K-01A-11R	TCGA-D1-A17K-01A-01-TS1			TCGA-D1-A17K-01A-11	TCGA-D1-A17K-01A	TCGA-D1-A17K	5c22c8d6-5805-455c-8e1c-e6b8006738e4	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	513	140.0	False	false	C9E1B85A-8637-4421-A8CD-2E4BB28B3A73	1.78	de485b7d-cd88-4889-aff4-e290027f26bb	0.16	23	released	42fb2faf-f405-4efb-9e7e-daf2ec274798	RNA	R	0.16	UV Spec	released	False	db0d5721-ec22-4275-9a1f-22ee25a6a345	11	3.0	10.0	5.0	2.0	0.0	5.0	90.0	95.0	TOP	c4ec0e82-40ad-4eaf-9eca-bf4d0fc2ce3b	released																				released	30.0	ca213835-efc5-4216-a762-a6b320b516bf	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A17K_demographic	74	-27283		68902cda-85a5-5b5d-8aa5-69a8fc3b7da5	not hispanic or latino	female	white	released	Alive	1935		TCGA-D1-A17K_exposure	Not Reported	37.42139577948381	28ade17d-5cde-5a32-bd06-2771b0cd59c6	161.0	released	97.0	TCGA-D1-A17K_diagnosis	27283	not reported	0	854	8924b9e4-ba8b-5514-ae8f-634829d050f5	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-D1-A17K_treatment	TCGA-D1-A17K_treatment_1	released	e478cef9-e92d-5b9b-a744-f744825d6cff	no	Radiation Therapy, NOS	released	9d1fcf00-fd83-51b7-8629-5f13b04f1206	no	Pharmaceutical Therapy, NOS	86cc368d-5157-43e2-920c-3e4d26dda0e2
ceb45712-475b-454a-baa2-6fa6bd561745.htseq.counts.gz	16502386-d743-42ab-ad26-1e052d26db7e	TCGA-D1-A17T-01A-11R-A12I-07	TCGA-D1-A17T-01A-11R	TCGA-D1-A17T-01A-01-TSA			TCGA-D1-A17T-01A-11	TCGA-D1-A17T-01A	TCGA-D1-A17T	efa4c675-e35e-4f48-8d12-a40f30b63ddb	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	318	130.0	False	false	D5927418-5A2B-477D-9917-7CE912628CA4	1.84	2ede539e-5856-4781-bb6f-b1c6efbdf23d	0.15	23	released	32215674-2be3-4fed-af3f-fc47c48e53f5	RNA	R	0.15	UV Spec	released	False	16453ed6-8956-4b78-b7f7-1bb010735368	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	85.0	TOP	e0812390-895c-4233-8228-01c91a133c91	released																				released	30.0	179bdb8c-c4fd-4949-8aca-eca735a5320f	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A17T_demographic	67	-24652		e2b366b5-54d4-52ab-9057-e2a3f7755781	not hispanic or latino	female	white	released	Alive	1943		TCGA-D1-A17T_exposure	Not Reported	32.83097978719196	e5107392-faf2-5049-930f-6a2803e52dc7	159.0	released	83.0	TCGA-D1-A17T_diagnosis	24652	not reported	0	71	972ab98a-5ddf-54b4-8cf5-dc9bc4ebfad9	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-D1-A17T_treatment	TCGA-D1-A17T_treatment_1	released	862ff2bc-ac37-531b-b997-11f108a392c9	no	Radiation Therapy, NOS	released	b6fdf276-53f0-5f64-a76d-2dc9f9805e8b	no	Pharmaceutical Therapy, NOS	16502386-d743-42ab-ad26-1e052d26db7e
4e9719d5-6602-499d-baf7-4232fb719581.htseq.counts.gz	93808de1-8d1f-4911-997a-7b4f0463435f	TCGA-5B-A90C-01A-11R-A37O-07	TCGA-5B-A90C-01A-11R	TCGA-5B-A90C-01A-01-TS1			TCGA-5B-A90C-01A-11	TCGA-5B-A90C-01A	TCGA-5B-A90C	16ac4341-cf8f-45e2-b90b-2d12d5f74a59	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	811	50.0	False	false	608E2698-6A3A-4673-89D2-3BE98A74EBE5	1.86	4a299385-e7a5-4a82-940b-ff6e36c596c2	0.17	23	released	68e7e413-c5ba-4c5e-8c73-f7886b7d59ce	RNA	R	0.17	UV Spec	released	False	34f42fdd-9eb7-4f33-9deb-724c5acabfa2	11	60.0	20.0	10.0	20.0	0.0	10.0	80.0	80.0	TOP	ed0ddb75-4627-42f4-96d4-cdeffe02e0aa	released																				released	30.0	f1fb39e5-8275-4f45-a349-af82d6cd6ff7	Primary Tumor	01	released	Not Reported	released	TCGA-5B-A90C_demographic	69	-25518		554b34de-9690-5845-a36e-4302ca06a99b	not hispanic or latino	female	black or african american	released	Alive	1942		TCGA-5B-A90C_exposure	Not Reported	39.25652940233937	f03fa1fc-f318-52e9-95d4-29f1fa68d4dd	158.0	released	98.0	TCGA-5B-A90C_diagnosis	25518	not reported	0	1202	db9169d0-b9bd-544f-990f-924e37e052ae	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-5B-A90C_treatment_1	TCGA-5B-A90C_treatment	released	5fcf1dee-9b8e-5790-bc80-e057d179af7b	yes	Pharmaceutical Therapy, NOS	released	d263a3e8-8229-540b-a6fa-44d003157433	yes	Radiation Therapy, NOS	93808de1-8d1f-4911-997a-7b4f0463435f
ff1d5ef6-0f9d-408c-9feb-b03380c8ab9c.htseq.counts.gz	f5f18baf-803d-4434-a973-a327c302b771	TCGA-A5-A0G1-01A-11R-A118-07	TCGA-A5-A0G1-01A-11R	TCGA-A5-A0G1-01A-01-BS1	TCGA-A5-A0G1-01A-01-TS1		TCGA-A5-A0G1-01A-11	TCGA-A5-A0G1-01A	TCGA-A5-A0G1	53707bb3-426a-43cb-830f-3eeed930295f	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	5015	190.0	False	true	A2EB7E85-E836-462E-ABBA-65D5110CEB1C	1.87	c4bc1759-7de2-427c-a936-431f343ea929	0.16	23	released	f3789bc7-913b-427b-9885-64a51007de61	RNA	R	0.16	UV Spec	released	False	fdbdb704-3dba-43b6-85e6-38f9a686aa18	11	90.0	0.0	5.0	0.0	10.0	25.0	60.0	60.0	BOTTOM	d4eae68d-4714-4eb3-a179-cf2860555943	released	90.0	0.0	5.0	0.0	10.0	25.0	60.0	60.0	TOP	68d08dd9-34ee-4b40-a1e1-e056dcf37de6	released									released	30.0	b7fb82ee-0219-4fd0-b656-0509b9eda5f2	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A0G1_demographic	67	-24477	3251	8520fd69-3ed2-5152-961f-02319d643e56	not hispanic or latino	female	white	released	Dead	1929	2004	TCGA-A5-A0G1_exposure	Not Reported	20.90419501133787	c161256e-3e59-5442-b8e6-05d300a7bd00	168.0	released	59.0	TCGA-A5-A0G1_diagnosis	24477	not reported	0		f504f44e-78b2-5166-bdd0-c3af786879ef	Stage IA	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	1996	TCGA-A5-A0G1_treatment	TCGA-A5-A0G1_treatment_1	released	80033256-0bb7-53b5-a5d8-3a946ca42d16	yes	Radiation Therapy, NOS	released	cad785db-9221-54b2-b60b-9c527a28ea08	no	Pharmaceutical Therapy, NOS	f5f18baf-803d-4434-a973-a327c302b771
1965d764-3107-47a4-93b6-465720be0c6b.htseq.counts.gz	7b0b68bf-4a6c-4184-b204-6b653ff3da11	TCGA-EY-A549-01A-11R-A27V-07	TCGA-EY-A549-01A-11R	TCGA-EY-A549-01A-01-TS1			TCGA-EY-A549-01A-11	TCGA-EY-A549-01A	TCGA-EY-A549	3d9828ae-eb65-4d0a-8d7a-cc09e98b5e99	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	191	370.0	False	false	F6D1F090-C601-4212-951E-BEE086DDD24F	1.87	4cbce4ad-3208-4463-a06d-75edce32ed3f	0.17	23	released	2e0d3c55-be2d-46bb-a135-fc44f74d4946	RNA	R	0.17	UV Spec	released	False	d7642abc-1e4a-4001-9b67-2f91c8b100b2	11	3.0	2.0	5.0	0.0	0.0	0.0	95.0	80.0	TOP	1a4b17bb-3ce5-4a06-8ef2-8b60c5d7e39a	released																				released	30.0	2b096dd7-4d46-4c71-91c3-fa084ade57cb	Primary Tumor	01	released	Not Reported	released	TCGA-EY-A549_demographic	78	-28570		48c62578-8e2e-5d1a-a37a-f971a6d5b7f2	not hispanic or latino	female	black or african american	released	Alive	1934		TCGA-EY-A549_exposure	Not Reported	27.180899908172634	435d73c9-1b70-5694-9b0a-dbbf7b810af5	165.0	released	74.0	TCGA-EY-A549_diagnosis	28570	not reported	0	605	5c7588e5-e56e-597d-8aa3-3822164e4464	Stage IA	C54.9	not reported	8380/3	Endometrioid adenocarcinoma, NOS	yes	No	not reported	Corpus uteri	released	Not Reported	Corpus uteri	not reported	not reported	2012	TCGA-EY-A549_treatment_1	TCGA-EY-A549_treatment	released	310fd4f3-023a-53aa-9891-13a7c23c3603	no	Pharmaceutical Therapy, NOS	released	f6fe67bd-fdcd-50af-b5f7-66f286c11193	yes	Radiation Therapy, NOS	7b0b68bf-4a6c-4184-b204-6b653ff3da11
684b31a3-a8d8-4730-aac0-33367152f30a.htseq.counts.gz	5073733a-3c56-402d-9622-53d4553bafee	TCGA-FI-A2D0-01A-11R-A17B-07	TCGA-FI-A2D0-01A-11R	TCGA-FI-A2D0-01A-01-TSA			TCGA-FI-A2D0-01A-11	TCGA-FI-A2D0-01A	TCGA-FI-A2D0	1b35d083-f7c9-47d2-9a9e-718788f9e39a	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	945	80.0	False	true	DCA05B9F-A09D-459F-AAB3-63020E15069D	1.92	e8736e4d-6e9b-49b0-a321-0e42740a11c1	0.18	23	released	88d7e67d-49d2-4e1c-9dbc-5e40e62b944b	RNA	R	0.18	UV Spec	released	False	a0203b43-e5ca-486e-9c86-d3c938540739	11	3.0	6.0	3.0	8.0	0.0	40.0	57.0	60.0	TOP	ab0d3e9a-a497-4a70-961b-c2650a5325e3	released																				released	30.0	a2d2a29a-5abc-48c3-ac17-76b8b9ee1717	Primary Tumor	01	released	Not Reported	released	TCGA-FI-A2D0_demographic	55	-20393		7fe5583a-aa8c-5ce8-896a-0397ead74a1a	not hispanic or latino	female	white	released	Alive	1953		TCGA-FI-A2D0_exposure	Not Reported	54.07787213587566	c6616d67-57dc-5737-8e7e-c2cd866ef0e0	158.0	released	135.0	TCGA-FI-A2D0_diagnosis	20393	not reported	0	1213	2942c9b3-ec72-5212-9a2b-cffefc5e8d1d	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-FI-A2D0_treatment	TCGA-FI-A2D0_treatment_1	released	ef840ec7-a121-5fdf-ac01-541c3728ec9a	no	Radiation Therapy, NOS	released	20757def-1205-5ee6-b575-8951dc6873c5	no	Pharmaceutical Therapy, NOS	5073733a-3c56-402d-9622-53d4553bafee
3ca87ae7-bb82-486c-9030-d9331efd6b67.htseq.counts.gz	718198ab-ae03-4095-8cae-d0d80abca528	TCGA-BS-A0V7-01A-21R-A118-07	TCGA-BS-A0V7-01A-21R	TCGA-BS-A0V7-01A-01-BS1	TCGA-BS-A0V7-01A-02-MS2		TCGA-BS-A0V7-01A-21	TCGA-BS-A0V7-01A	TCGA-BS-A0V7	ca858743-1f06-40e3-accf-395d08375b63	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1455	130.0	False	false	A4515806-9888-48E8-8F9E-491527FFC29C	1.84	0fcc0aec-5ef8-4284-a7b5-eb8b328ef02c	0.16	23	released	d6499dd3-2a20-475f-bb04-74486725ac56	RNA	R	0.16	UV Spec	released	False	a6eb1a45-9bdf-4250-a5aa-347e9721b4ec	21	10.0	0.0	20.0	10.0	20.0	0.0	60.0	80.0	TOP	9d67b83e-9c43-4820-a480-1ca0e7f15afd	released	20.0	2.0	2.0	1.0	15.0	47.0	30.0	35.0	BOTTOM	442ecb7f-6800-419e-9cdd-e79ee1426201	released									released	30.0	a772ab94-cb06-464c-9a5a-fa4978510f9b	Primary Tumor	01	released	Not Reported	released	TCGA-BS-A0V7_demographic	48	-17810		358c1776-769f-553f-9b5b-edaa92da5a9a	not hispanic or latino	female	native hawaiian or other pacific islander	released	Alive	1958		TCGA-BS-A0V7_exposure	Not Reported	35.29411764705882	1d9f3764-9fc4-5ddf-b399-f81330512ce6	170.0	released	102.0	TCGA-BS-A0V7_diagnosis	17810	not reported	0	1934	c33af881-6611-57b2-a417-aa419c4974d7	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2006	TCGA-BS-A0V7_treatment	TCGA-BS-A0V7_treatment_1	released	615da570-874a-5d63-b27b-a5b5d7f92d9e	no	Radiation Therapy, NOS	released	49ad8f83-7029-5bbe-adb5-bdb07847a250	no	Pharmaceutical Therapy, NOS	718198ab-ae03-4095-8cae-d0d80abca528
7ab6c455-c4ef-4dc6-9b17-efdbebd8a18c.htseq.counts.gz	6940c3aa-ffc8-4aca-a490-c22a021d287b	TCGA-B5-A1MW-01A-11R-A32Y-07	TCGA-B5-A1MW-01A-11R	TCGA-B5-A1MW-01A-01-TSA			TCGA-B5-A1MW-01A-11	TCGA-B5-A1MW-01A	TCGA-B5-A1MW	e2b48d0d-57ca-400b-8598-55ef132e350e	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	148	340.0	False	true	870882D8-D89A-4A89-B516-DADAB95BE285	1.7	7ad9720d-18e2-472f-a267-525f191a23ca	0.15	23	released	9b2d9af5-e2c7-4e64-903c-586ee32bacf6	RNA	R	0.15	UV Spec	released	False	5878de67-8c83-4d7c-92b6-cd6af3dfdd1e	11	10.0	0.0	3.0	5.0	0.0	10.0	87.0	90.0	TOP	92feb8bd-20cc-427d-a955-9fec7b1b6757	released																				released	30.0	f886aacc-64f9-4f9e-8123-8ad25ce54d0c	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A1MW_demographic	55	-20183		cb02881c-ab1f-5acf-ac66-56e28fae03c7	not reported	female	white	released	Alive	1955		TCGA-B5-A1MW_exposure	Not Reported	23.335466144755163	7f8e7cc8-58ed-5ab8-b3b6-2192fe2bde93	163.0	released	62.0	TCGA-B5-A1MW_diagnosis	20183	not reported	0	447	ccc0b1d6-bd6c-541a-bdd1-8c304132dc99	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-B5-A1MW_treatment	TCGA-B5-A1MW_treatment_1	released	4a1f4fbb-1ca4-50f7-84ec-4ef35f6c15ea	yes	Radiation Therapy, NOS	released	71b4f124-cc0d-5635-a32b-00c5fba3011f	no	Pharmaceutical Therapy, NOS	6940c3aa-ffc8-4aca-a490-c22a021d287b
fbef38b2-454d-44e6-b27f-5a790c6f8c17.htseq.counts.gz	90299ada-28e8-4e75-8dce-f0a402699fce	TCGA-D1-A17D-01A-12R-A12I-07	TCGA-D1-A17D-01A-12R	TCGA-D1-A17D-01A-01-TSA			TCGA-D1-A17D-01A-12	TCGA-D1-A17D-01A	TCGA-D1-A17D	7ddeddd1-b2ad-425f-94a2-9c476b959f2a	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	541	160.0	False	false	1042404C-E963-4620-BC02-E33751FDB96C	1.82	ceaaf6e4-8f99-4fe0-8d2e-8d5aee22ebb9	0.16	23	released	37aeb0a7-aba6-4e3b-b81b-b3ca4a6ee062	RNA	R	0.16	UV Spec	released	False	357beb71-520f-4bc8-b446-2fd553d3ee21	12	5.0	5.0	10.0	5.0	0.0	20.0	70.0	80.0	TOP	3cddfd25-9705-4dd7-9666-ae5092c5d9f7	released																				released	30.0	9ec5a25b-9ce1-4fde-9341-13da39bc74b0	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A17D_demographic	58	-21441		b13e3c60-a675-5a8c-a335-12e65a23a310	not hispanic or latino	female	white	released	Alive	1951		TCGA-D1-A17D_exposure	Not Reported	28.303850156087407	0354a4b5-baff-5e7c-97af-b8803b3aa158	155.0	released	68.0	TCGA-D1-A17D_diagnosis	21441	not reported	0	926	ada11ac6-b450-5feb-ad99-5631e0845094	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-D1-A17D_treatment_1	TCGA-D1-A17D_treatment	released	471289a1-110e-54d4-bcd2-a12d0f570ce8	yes	Pharmaceutical Therapy, NOS	released	8935759e-cc41-5b31-8138-5db438299830	yes	Radiation Therapy, NOS	90299ada-28e8-4e75-8dce-f0a402699fce
6702de4e-a6f0-4ffb-83e7-6f8ed97c98b4.htseq.counts.gz	e89109f0-60d6-447a-a779-b445eb952b80	TCGA-BS-A0TA-01A-11R-A104-07	TCGA-BS-A0TA-01A-11R	TCGA-BS-A0TA-01A-01-TS1	TCGA-BS-A0TA-01A-01-BS1		TCGA-BS-A0TA-01A-11	TCGA-BS-A0TA-01A	TCGA-BS-A0TA	ad3d8420-f562-4cbe-ac82-c968bd4f782d	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1788	300.0	False	false	5F009A9A-549F-4EEB-BB6D-C67353C7A292	1.77	c1621135-fa9b-4043-8168-356402d45f01	0.16	23	released	63586f5a-7f6a-4ec5-b03d-bb707f2dfbf3	RNA	R	0.16	UV Spec	released	False	2dda202d-5041-4019-9b1e-acb3d4e1c63d	11	50.0	30.0	5.0	40.0	0.0	10.0	85.0	85.0	TOP	97560966-7c77-4e09-9cf8-294de46441cf	released	40.0	20.0	5.0	30.0	0.0	5.0	90.0	90.0	BOTTOM	96942cd0-80f0-40e3-803f-656755cb1a47	released									released	30.0	b6a042b6-f94a-4acc-98cb-a1a2fe72b9ad	Primary Tumor	01	released	Not Reported	released	TCGA-BS-A0TA_demographic	58	-21505	740	55d1f392-d699-5dd4-9831-47cdcdf35006	hispanic or latino	female	native hawaiian or other pacific islander	released	Dead	1947		TCGA-BS-A0TA_exposure	Not Reported	38.95429362880886	d7a28285-1d52-5eaf-a4bb-6a9ffbb2d7b8	152.0	released	90.0	TCGA-BS-A0TA_diagnosis	21505	not reported	0	714	fae06394-6c46-5ec5-8f41-1b53fbb65203	Stage IVB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2005	TCGA-BS-A0TA_treatment	TCGA-BS-A0TA_treatment_1	released	f85e4c69-fc08-5296-a038-1a34c2b7569c	yes	Radiation Therapy, NOS	released	6c7b540e-e28c-55d2-bac3-c5f8abbb15b3	yes	Pharmaceutical Therapy, NOS	e89109f0-60d6-447a-a779-b445eb952b80
36728930-730c-4406-bcee-7d1fdecca34d.htseq.counts.gz	8eaa49f1-ad03-46b1-b8de-25a6a23924e6	TCGA-PG-A917-01A-31R-A37O-07	TCGA-PG-A917-01A-31R	TCGA-PG-A917-01A-03-TSC			TCGA-PG-A917-01A-31	TCGA-PG-A917-01A	TCGA-PG-A917	b1b9173c-b370-4fe5-a263-c807e8a9709c	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	583	390.0	False	true	9836008F-81F7-4029-9A28-10AB6021DFEA	1.91	2dc0d41b-72fa-4514-889f-3c46507fd5e8	0.18	23	released	026139a8-b3ea-4cb3-932a-74b3e7b4956b	RNA	R	0.18	UV Spec	released	False	aa03eb18-162f-45cc-a93e-1b1b7aa82636	31	0.0	0.0	0.0	0.0	20.0	10.0	70.0	80.0	TOP	6a473512-d381-4bad-a7b0-7cd23065649a	released																				released	30.0	4f849148-48bb-4e89-b0b9-f7ec6e85e0b9	Primary Tumor	01	released	Not Reported	released	TCGA-PG-A917_demographic	74	-27104		6a5c27c8-b7e0-5ef7-8113-fd24e5e1a494	not hispanic or latino	female	black or african american	released	Alive	1938		TCGA-PG-A917_exposure	Not Reported		4f720239-2d8e-54fd-a678-659a332953b9		released		TCGA-PG-A917_diagnosis	27104	not reported	0	212	b57f13c5-0feb-5c26-b363-ea4811c9f398	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2012	TCGA-PG-A917_treatment	TCGA-PG-A917_treatment_1	released	1a4bcd82-3c46-554a-a446-15b5ff91cec3	no	Radiation Therapy, NOS	released	3762e1a0-4f16-5c10-8737-fb55808e11bb	no	Pharmaceutical Therapy, NOS	8eaa49f1-ad03-46b1-b8de-25a6a23924e6
4ba3930e-c69b-461e-964f-2735263ed235.htseq.counts.gz	b1af0d0f-d28b-4516-9a1e-c4b59c00cd19	TCGA-AX-A3FS-01A-11R-A22K-07	TCGA-AX-A3FS-01A-11R	TCGA-AX-A3FS-01A-01-TS1			TCGA-AX-A3FS-01A-11	TCGA-AX-A3FS-01A	TCGA-AX-A3FS	8c6b9b54-58eb-4d5f-b8a9-8007163db457	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	609	80.0	False	false	1AEA9AC0-3B22-4819-9542-1F6A6AD474BC	1.8	2db9f19e-4614-44f9-a9f5-7541d6a20369	0.16	23	released	1a352048-fd56-4559-bc97-0705454937c9	RNA	R	0.16	UV Spec	released	False	b6acf7ab-b2d4-4e33-9755-338900ad0415	11	1.0	0.0	10.0	0.0	10.0	5.0	75.0	95.0	TOP	27ae39d9-679d-42d4-ad3a-2e4342d5243f	released																				released	20.0	272d64f9-0b4b-4136-adff-66c5401fc1d2	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A3FS_demographic	82	-30102		75c88efc-df2b-5dc9-8f26-0a8826fc80c5	not hispanic or latino	female	white	released	Alive	1928		TCGA-AX-A3FS_exposure	Not Reported	50.722012318202985	485ba7d5-fb8a-5a33-bbc9-8f1d9c9022b3	139.0	released	98.0	TCGA-AX-A3FS_diagnosis	30102	not reported	0	7	aab6e5c3-dc5a-5f48-9bc6-9ab2ea1b7235	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-AX-A3FS_treatment_1	TCGA-AX-A3FS_treatment	released	918cebbf-03fe-54c7-bbff-22c8c8054d9e	not reported	Pharmaceutical Therapy, NOS	released	0bbc2e25-f483-5390-9aec-edd9531f8305	not reported	Radiation Therapy, NOS	b1af0d0f-d28b-4516-9a1e-c4b59c00cd19
2a962923-bbca-4fa9-a68c-da7c59297e02.htseq.counts.gz	c423d6d0-23d6-4797-b799-f3c3dd85c775	TCGA-A5-A2K4-01A-11R-A18M-07	TCGA-A5-A2K4-01A-11R	TCGA-A5-A2K4-01A-01-TSA			TCGA-A5-A2K4-01A-11	TCGA-A5-A2K4-01A	TCGA-A5-A2K4	c4f8f33f-a07c-4dfb-be24-c52d577bd640	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	849	140.0	False	true	CB29CD1C-584B-42EA-BF1D-11B6DF8EA756	1.79	586c18a6-7278-4200-9d64-20b2c7ccbc60	0.17	23	released	4ff86eeb-1be8-4519-8815-dbecbb2523f8	RNA	R	0.17	UV Spec	released	False	b4591d03-7d0a-4ff9-a780-b31ab13e34f9	11	10.0	4.0	5.0	1.0	0.0	10.0	85.0	75.0	TOP	09eeb44b-5743-47c4-9453-d4635b2b663a	released																				released	30.0	825524a8-ede8-44b2-9c4a-8375ac14387a	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A2K4_demographic	69	-25270	871	50869b7a-55b7-59d1-913e-a177d11580ff	not reported	female	white	released	Dead	1940	2011	TCGA-A5-A2K4_exposure	Not Reported	18.06972789115646	44a2d83e-bcb9-593a-a47c-71a694219d2c	168.0	released	51.0	TCGA-A5-A2K4_diagnosis	25270	not reported	0		2b092884-4975-5b4f-a839-d6fe0ff71e1f	Stage IIIA	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-A5-A2K4_treatment	TCGA-A5-A2K4_treatment_1	released	40491dc3-a7da-5038-8cfd-206a8a5cb312	no	Radiation Therapy, NOS	released	c6796838-6855-5f6d-bd6f-cb519b6ebb2b	yes	Pharmaceutical Therapy, NOS	c423d6d0-23d6-4797-b799-f3c3dd85c775
d5c5db61-77d0-48c7-b669-da590752f179.htseq.counts.gz	77b2614b-90c7-4969-936d-cad1c6d71ff4	TCGA-D1-A1O0-01A-11R-A17B-07	TCGA-D1-A1O0-01A-11R	TCGA-D1-A1O0-01A-01-TS1			TCGA-D1-A1O0-01A-11	TCGA-D1-A1O0-01A	TCGA-D1-A1O0	a98bbe29-8817-4380-a738-3c1bf9f8e0cc	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	195	50.0	False	false	2F5CADA5-176C-4B9D-9660-53BE86B1CD39	1.89	6eefe77a-d312-44fc-9b9e-7c3b439a7e23	0.17	23	released	7c7f29c1-2d3e-4052-8e16-b73dd13b5b0c	RNA	R	0.17	UV Spec	released	False	8846d84c-364a-4541-aa90-3eac33807648	11	5.0	8.0	5.0	1.0	0.0	5.0	90.0	95.0	TOP	8e429057-8273-4ea4-bf0c-fcf04d60d448	released																				released	30.0	e113e0f0-3ae5-48a3-a226-ad920f41259e	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A1O0_demographic	77	-28162		d4ecc93c-481d-5d2e-a1be-cadcc9a73cb8	not hispanic or latino	female	white	released	Alive	1933		TCGA-D1-A1O0_exposure	Not Reported	47.46642865836342	956583d0-2cda-594e-8ccd-45e0b5193435	157.0	released	117.0	TCGA-D1-A1O0_diagnosis	28162	not reported	0	63	f4d89a7e-b70c-5e08-9a4b-b87165d3122a	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-D1-A1O0_treatment	TCGA-D1-A1O0_treatment_1	released	83988d55-554c-54bc-b133-4faa168d9592	no	Radiation Therapy, NOS	released	1715ea84-3db6-5547-91f8-ad658901e88e	no	Pharmaceutical Therapy, NOS	77b2614b-90c7-4969-936d-cad1c6d71ff4
d89648f6-9138-46e3-8e07-2a49565f09f5.htseq.counts.gz	c62a8d38-c3a5-4dd7-8c57-4f8f87b695d2	TCGA-B5-A0JS-01A-11R-A104-07	TCGA-B5-A0JS-01A-11R	TCGA-B5-A0JS-01A-01-BSA	TCGA-B5-A0JS-01A-01-TSA		TCGA-B5-A0JS-01A-11	TCGA-B5-A0JS-01A	TCGA-B5-A0JS	0da7bbd4-ed8d-474b-b494-cb93c5fa811e	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1183	140.0	False	true	56BA86BF-9345-4956-952A-8EBA8C05926A	1.78	a18fa5ae-5c28-426a-a7ae-d0c0b223991f	0.15	23	released	23550e55-6a3f-41d0-a881-bc58199bfd63	RNA	R	0.15	UV Spec	released	False	e7cdfb87-dc65-4b3a-9380-5b0ba87e9bda	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	85.0	BOTTOM	5015e127-ad75-491f-afe9-d331532e701c	released	0.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	TOP	fb0ef224-c1c6-4c7e-be5a-c304128d1263	released									released	30.0	d0b88b1c-150d-4abc-9f9e-8c51cb208efa	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A0JS_demographic	54	-19995		9a587a49-7e43-57b6-9599-0dfd29696ad7	not reported	female	white	released	Alive	1953		TCGA-B5-A0JS_exposure	Not Reported	38.06228373702422	0d6e2c5e-0f9c-5bde-8386-15f4accb414f	170.0	released	110.0	TCGA-B5-A0JS_diagnosis	19995	not reported	0	2627	3046aeb0-f512-5573-88e3-35b4dd8c25bd	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2007	TCGA-B5-A0JS_treatment	TCGA-B5-A0JS_treatment_1	released	96cf4c75-104b-516c-be24-5c709faaa2cc	no	Radiation Therapy, NOS	released	bfb14e12-ab5a-5e53-a472-d1a908c45af1	no	Pharmaceutical Therapy, NOS	c62a8d38-c3a5-4dd7-8c57-4f8f87b695d2
47eeaa0c-f297-4686-b746-036b731d4a34.htseq.counts.gz	0dc1f33e-8f87-4667-8458-9929c231bd96	TCGA-AX-A05T-01A-11R-A00V-07	TCGA-AX-A05T-01A-11R	TCGA-AX-A05T-01A-01-BS1	TCGA-AX-A05T-01A-01-TS1		TCGA-AX-A05T-01A-11	TCGA-AX-A05T-01A	TCGA-AX-A05T	0119eab6-00e7-4346-aa52-cbbeeba3621d	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	310	160.0	False	false	85F75553-6E10-4AF5-9BDF-DAB52D00615B	1.71	8cfdaa7a-34fe-4b0f-9916-60e7158c893e	0.16	23	released	ef614467-7ef9-4fa0-9fd1-798d5086b037	RNA	R	0.16	UV Spec	released	False	2937f423-d0a4-412b-a0ed-bd6b1e293789	11	1.0	3.0	10.0	1.0	2.0	5.0	83.0	85.0	BOTTOM	6de3101f-6d2a-4a5a-b5c5-0e3ad9d70c70	released	1.0	1.0	10.0	1.0	2.0	5.0	83.0	85.0	TOP	c0be94a0-c678-476f-8260-b5b260838036	released									released	30.0	bc2885b5-c7cd-4467-88a3-a32cf602b3d5	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A05T_demographic	82	-30137		52e346ab-59e4-5cfc-97c1-ea275e8769a6	not reported	female	white	released	Alive	1927		TCGA-AX-A05T_exposure	Not Reported	23.533042706685695	0a6b5095-5e84-5f75-89f8-ae2f8682027b	161.0	released	61.0	TCGA-AX-A05T_diagnosis	30137	not reported	0	1010	9d060ff9-8e33-5477-b0d0-9bc80e8b207a	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-AX-A05T_treatment_1	TCGA-AX-A05T_treatment	released	b2dc2f65-00ed-57f1-a082-6c17efc5630d	no	Pharmaceutical Therapy, NOS	released	035425d3-a234-51cb-990e-cacf2f6d8a49	no	Radiation Therapy, NOS	0dc1f33e-8f87-4667-8458-9929c231bd96
c934f993-b10f-4ee0-a508-4b95722232e5.htseq.counts.gz	3a82161e-633a-4355-ae0c-5408ba3bf3c8	TCGA-AP-A0LI-01A-11R-A040-07	TCGA-AP-A0LI-01A-11R	TCGA-AP-A0LI-01A-01-TSA	TCGA-AP-A0LI-01A-01-BSA		TCGA-AP-A0LI-01A-11	TCGA-AP-A0LI-01A	TCGA-AP-A0LI	e1e8dc66-467c-48a5-be56-3db4f665b9f1	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	2567	180.0	False	true	EFEA05D7-E720-4FE4-977C-6A6369B1BA2E	1.94	0fd52e18-275a-4c3d-8c8d-9e27859a5482	0.15	23	released	b24824f3-d109-4e65-a85c-034f6adb7518	RNA	R	0.15	UV Spec	released	False	02a2899d-dbdf-4e6d-8cf6-b5b58449e656	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	85.0	TOP	21760092-2270-4e17-be41-aaa4e9acad69	released	0.0	0.0	0.0	0.0	0.0	0.0	100.0	90.0	BOTTOM	7141eb6f-43db-482c-8a60-6c07e290b964	released									released	30.0	981d9e3b-63c5-41e9-827f-7f1d268d62f4	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A0LI_demographic	67	-24573		1e9d614e-a709-5368-ad16-6a95d293e547	not reported	female	black or african american	released	Alive	1936		TCGA-AP-A0LI_exposure	Not Reported	33.17773234057328	3136dde9-508c-5fca-93b7-c7f77e482162	161.0	released	86.0	TCGA-AP-A0LI_diagnosis	24573	not reported	0	2972	6b3033f1-7849-5ed0-b1c1-abb61ba6d85b	Stage IIIC2	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2003	TCGA-AP-A0LI_treatment	TCGA-AP-A0LI_treatment_1	released	45dce2a1-41d9-5f94-8652-e9cb0b0c05eb	yes	Radiation Therapy, NOS	released	a56653f5-bf8e-5714-a186-8c47c1dc15c8	yes	Pharmaceutical Therapy, NOS	3a82161e-633a-4355-ae0c-5408ba3bf3c8
146ec029-21fe-4f5c-bca1-b1af900787e9.htseq.counts.gz	089ca769-7b2d-4c8a-a137-c88c7693fea2	TCGA-D1-A0ZS-01A-11R-A118-07	TCGA-D1-A0ZS-01A-11R	TCGA-D1-A0ZS-01A-01-MS1	TCGA-D1-A0ZS-01A-01-TS1		TCGA-D1-A0ZS-01A-11	TCGA-D1-A0ZS-01A	TCGA-D1-A0ZS	80105773-372e-4552-a10b-5df188b15b16	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	308	120.0	False	false	313BCAEC-965D-4FF4-BAAA-3CAF48C739C6	1.89	f35db751-0250-4045-9faf-2c0f1158b354	0.16	23	released	e62c8400-2b45-4adc-98ba-aa83cdbbb05a	RNA	R	0.16	UV Spec	released	False	cbf235bb-55a4-4f58-b5a2-845f23cec37c	11	40.0	20.0	10.0	30.0	0.0	20.0	70.0	70.0	BOTTOM	28d10901-23db-4a0e-884b-ff838e408be2	released	10.0	0.0	10.0	10.0	10.0	0.0	80.0	90.0	TOP	3bc66ffb-b6ce-478f-ac39-597260a1aa3c	released									released	30.0	e914e3db-e907-495a-9b59-43e07132052a	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A0ZS_demographic	54	-19821		7e3c3954-9e54-5294-be2e-0761ef69da77	not hispanic or latino	female	white	released	Alive	1955		TCGA-D1-A0ZS_exposure	Not Reported	23.05175490779298	a0f30146-c20d-5164-917d-5fac4c9ab7c3	164.0	released	62.0	TCGA-D1-A0ZS_diagnosis	19821	not reported	0	148	61c62350-18f6-5bdd-9eb5-447cef6c4df1	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-D1-A0ZS_treatment_1	TCGA-D1-A0ZS_treatment	released	a2bdc8dc-af6a-5911-aa76-4e50615ff563	no	Pharmaceutical Therapy, NOS	released	92545594-0cb0-5a9f-9019-a716304b9586	yes	Radiation Therapy, NOS	089ca769-7b2d-4c8a-a137-c88c7693fea2
e015598e-fb42-426c-ad01-c4fbfc0dfe88.htseq.counts.gz	6a42cc8e-0ea7-4c20-b6f4-4de376c1dedc	TCGA-AX-A1CF-01A-11R-A137-07	TCGA-AX-A1CF-01A-11R	TCGA-AX-A1CF-01A-01-TS1			TCGA-AX-A1CF-01A-11	TCGA-AX-A1CF-01A	TCGA-AX-A1CF	20dcf91a-0529-4e96-99a2-362a41fbe4a4	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	2284	130.0	False	false	CB16E769-AFE1-4555-A65D-691266C4898E	1.87	ee60f261-392f-4583-8ddb-b29f07f20e6e	0.16	23	released	9b47c263-d8a5-4a1f-88fb-64e9441c966c	RNA	R	0.16	UV Spec	released	False	4e8cca5c-71ae-45f3-be82-10565c36256f	11	1.0	0.0	2.0	0.0	20.0	5.0	73.0	75.0	TOP	bba8185b-535c-4671-bb73-3fca1bfb9066	released																				released	30.0	4c219685-44e4-489b-a72f-cfcba405588c	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A1CF_demographic	69	-25300		349f3d0a-a11d-5b87-9dd2-13ac1f4b68c2	not hispanic or latino	female	white	released	Alive	1935		TCGA-AX-A1CF_exposure	Not Reported	35.111111111111114	2508b214-bc0e-5d24-8bb4-1ccaee13fd7f	150.0	released	79.0	TCGA-AX-A1CF_diagnosis	25300	not reported	0	2337	151e2065-1540-58b5-b88a-fb97d6841ad8	Stage IVB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2004	TCGA-AX-A1CF_treatment	TCGA-AX-A1CF_treatment_1	released	c2f051d1-56b2-5b7d-8906-c5c26e591706	yes	Radiation Therapy, NOS	released	d526f076-1eca-57aa-9318-b582ec100739	yes	Pharmaceutical Therapy, NOS	6a42cc8e-0ea7-4c20-b6f4-4de376c1dedc
10414d34-f048-4a23-9ab6-055e0dd469ce.htseq.counts.gz	526bd2c6-a002-476e-adf3-4f77b3061be6	TCGA-B5-A0JZ-01A-11R-A040-07	TCGA-B5-A0JZ-01A-11R	TCGA-B5-A0JZ-01A-01-TSA	TCGA-B5-A0JZ-01A-01-BSA		TCGA-B5-A0JZ-01A-11	TCGA-B5-A0JZ-01A	TCGA-B5-A0JZ	d129ebb4-db21-4342-8d9b-318a67aefa56	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	642	400.0	False	true	B275A085-067D-42ED-8E41-8461D5183A6E	1.89	3bc43656-d16a-4ec6-9fde-aab0446c6e50	0.13	23	released	573ca4a5-9a80-4dbf-b2ea-1af6c39c0261	RNA	R	0.13	UV Spec	released	False	5dd9a30a-9e06-4585-9437-e273064a409c	11	20.0	0.0	10.0	10.0	0.0	30.0	60.0	70.0	TOP	02beb8b3-2a16-443c-a321-9bd0e2971ecc	released	20.0	0.0	10.0	10.0	0.0	30.0	60.0	70.0	BOTTOM	2f69e130-1709-486b-9a69-83b920a9fbd6	released									released	30.0	5e55ac8b-23b4-4cde-825a-753ed8c9208c	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A0JZ_demographic	60	-22106		3fccce6d-e7af-5ff7-9246-31b7c387040d	not reported	female	white	released	Alive	1948		TCGA-B5-A0JZ_exposure	Not Reported	33.150434385002285	8b83e1ec-a0be-557a-8fc0-3aa3a49688ae	162.0	released	87.0	TCGA-B5-A0JZ_diagnosis	22106	not reported	0	2173	8cc6e20a-f170-5433-bbca-2537c70c226f	Stage IIIC1	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-B5-A0JZ_treatment	TCGA-B5-A0JZ_treatment_1	released	52942e59-628b-5748-a05a-4cbe3aea5d2b	yes	Radiation Therapy, NOS	released	efecd461-e321-5e50-8a37-9da1c25d5b30	yes	Pharmaceutical Therapy, NOS	526bd2c6-a002-476e-adf3-4f77b3061be6
fcd8ddd5-d44b-4792-9fb1-f254916a1556.htseq.counts.gz	a5f12b5b-3703-45cc-952b-96d67feeaa22	TCGA-A5-A0GA-01A-11R-A040-07	TCGA-A5-A0GA-01A-11R	TCGA-A5-A0GA-01A-01-BSA	TCGA-A5-A0GA-01A-01-TSA		TCGA-A5-A0GA-01A-11	TCGA-A5-A0GA-01A	TCGA-A5-A0GA	71fed998-8fac-4e6b-b38a-22c83e05e958	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1312	320.0	False	true	36A4F391-2F46-4896-8E53-223202E42A38	1.85	e2aee7fd-1c60-471a-931d-878805f4a443	0.16	23	released	7f1d06d7-0081-4aa7-a1b5-d0007ee6bde2	RNA	R	0.16	UV Spec	released	False	d9fd6b09-8433-4697-a016-df0dee27ee99	11	0.0	0.0	0.0	0.0	0.0	10.0	90.0	85.0	BOTTOM	6074334a-089d-41ec-870e-99a99f7cf87b	released	0.0	0.0	0.0	0.0	0.0	20.0	80.0	75.0	TOP	ccc5cffb-765f-4598-9843-6888c43713ba	released									released	30.0	5a40330f-9307-4584-9557-5d19f2357fcc	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A0GA_demographic	67	-24659	543	e2c8cc50-bd74-513f-b812-c01b1b9600c2	not hispanic or latino	female	white	released	Dead	1939	2007	TCGA-A5-A0GA_exposure	Not Reported	31.141868512110726	57c9a56a-67a1-5ab7-9982-2a578db11fdb	170.0	released	90.0	TCGA-A5-A0GA_diagnosis	24659	not reported	0		7f059916-7f28-518d-b3d2-39ba89ce94e7	Stage IIIC2	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2006	TCGA-A5-A0GA_treatment	TCGA-A5-A0GA_treatment_1	released	ac03b65f-d0a6-58ea-94c5-b90bfb3cf6aa	no	Radiation Therapy, NOS	released	6800d3ca-7360-516f-b096-8f940d648dd1	yes	Pharmaceutical Therapy, NOS	a5f12b5b-3703-45cc-952b-96d67feeaa22
135d3378-fcae-4059-83e9-0887cf516313.htseq.counts.gz	0baf0d12-6457-411f-a327-5544a84921f6	TCGA-AJ-A23N-01A-11R-A22K-07	TCGA-AJ-A23N-01A-11R	TCGA-AJ-A23N-01A-01-MS1			TCGA-AJ-A23N-01A-11	TCGA-AJ-A23N-01A	TCGA-AJ-A23N	5d39e9a2-1073-4db2-b02e-db05d59563a7	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	84	130.0	False	false	38EB6233-9777-4640-A896-26D16A9DBD8E	1.82	fefa50dc-29a7-4c27-a735-ab6eb500a5d5	0.16	23	released	5ca965ca-7f3e-411f-9e9e-1e33d86af762	RNA	R	0.16	UV Spec	released	False	65ac3881-f174-4b1a-9425-9fed22e06d0c	11	5.0	1.0	5.0	1.0	0.0	0.0	95.0	65.0	TOP	d723a1dd-17b6-463d-8349-748bbeb66e02	released																				released	30.0	4a5f2624-4f86-44cd-84a3-cd1403e093b6	Primary Tumor	01	released	Not Reported	released	TCGA-AJ-A23N_demographic	70	-25772	439	22f3b2a8-466f-59e5-a3f7-03c1a8beee4b	not reported	female	white	released	Dead	1941		TCGA-AJ-A23N_exposure	Not Reported		40feab89-a434-504b-a7bb-f733ffb8153e		released		TCGA-AJ-A23N_diagnosis	25772	not reported	0	33	6c98a7d8-ead1-5662-9673-613cbaa8c99b	Stage IIIA	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-AJ-A23N_treatment	TCGA-AJ-A23N_treatment_1	released	172b4f09-46e1-5474-89df-c355b61adacf	yes	Radiation Therapy, NOS	released	30c650dd-4c8a-5f63-a5cf-c83a5dcb2f4a	yes	Pharmaceutical Therapy, NOS	0baf0d12-6457-411f-a327-5544a84921f6
53a9dbe8-a1b1-416b-8e7e-43f4862f7de0.htseq.counts.gz	402448c5-f41d-461d-b6ca-f09c8f89c77e	TCGA-A5-A0GP-01A-11R-A040-07	TCGA-A5-A0GP-01A-11R	TCGA-A5-A0GP-01A-01-BSA	TCGA-A5-A0GP-01A-01-TSA		TCGA-A5-A0GP-01A-11	TCGA-A5-A0GP-01A	TCGA-A5-A0GP	0547cdfa-c488-4da0-9bb5-4cc63a637179	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1030	160.0	False	true	A730192C-227E-4A86-96B9-8670D3F5EF59	1.87	0ac50ce8-8c72-4b83-98c3-6efdb138d7a1	0.16	23	released	b6e47841-861a-454f-852c-1723863e02c7	RNA	R	0.16	UV Spec	released	False	463d7fcd-90f1-4538-a648-98660c285c16	11	1.0	0.0	0.0	0.0	0.0	0.0	100.0	90.0	BOTTOM	73838b4c-68eb-4058-879e-67edaf12bee3	released	1.0	0.0	0.0	0.0	0.0	0.0	100.0	90.0	TOP	468dd530-f978-41ef-abb9-b9a61c83a5f8	released									released	30.0	1797c4d9-1677-4ff6-ba71-98331d53f6c6	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A0GP_demographic	58	-21365		15dac957-20b9-50f8-8f86-a1d216f696d3	not hispanic or latino	female	asian	released	Alive	1949		TCGA-A5-A0GP_exposure	Not Reported	23.4375	08df5808-4a2c-58d9-b265-baa39fe40f5d	160.0	released	60.0	TCGA-A5-A0GP_diagnosis	21365	not reported	0	1416	d22e87fc-a446-5e6f-8544-18705a43a8e7	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2007	TCGA-A5-A0GP_treatment	TCGA-A5-A0GP_treatment_1	released	2682baa7-0d1d-5ec3-94ba-6653052f3a15	no	Radiation Therapy, NOS	released	29ef3264-88ac-59af-a9c9-e5a02dc63f2c	no	Pharmaceutical Therapy, NOS	402448c5-f41d-461d-b6ca-f09c8f89c77e
fcaaa288-34cb-4597-b2c9-20b1eb027ebf.htseq.counts.gz	2c378864-d10d-40bc-b704-9e5cc689b4be	TCGA-AX-A1CP-01A-11R-A137-07	TCGA-AX-A1CP-01A-11R	TCGA-AX-A1CP-01A-01-TS1			TCGA-AX-A1CP-01A-11	TCGA-AX-A1CP-01A	TCGA-AX-A1CP	e297551c-a662-4677-b00d-0d9be232adca	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	1080	110.0	False	false	E2F94D2B-C53B-4112-AFBB-06A6751CAE4B	180.0	da204d4a-922e-4501-9db6-8034ae6b8177	0.15	23	released	3323dcb1-4c13-4a3a-acd7-fbebf45aeefe	RNA	R	0.15	UV Spec	released	False	18108555-481d-43de-b457-9ef0eb3c8395	11	5.0	0.0	1.0	0.0	35.0	4.0	60.0	70.0	TOP	f3e587e4-1a55-4678-8477-d798018f15aa	released																				released	30.0	28542436-6afd-4198-9efe-2b69768277b0	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A1CP_demographic	84	-30737		5693261a-fc8a-5ba2-b87a-1fbb44a72372	not hispanic or latino	female	white	released	Alive	1924		TCGA-AX-A1CP_exposure	Not Reported	22.600262984878366	abd2bfd3-a8ec-560c-9ee6-f79c109b979d	156.0	released	55.0	TCGA-AX-A1CP_diagnosis	30737	not reported	0	1107	58a8b660-b3a8-53f3-822f-00a2ffdd5ee5	Stage IA	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2008	TCGA-AX-A1CP_treatment	TCGA-AX-A1CP_treatment_1	released	58439707-19bc-5397-bbb4-68af79ec6be2	no	Radiation Therapy, NOS	released	ee5603c0-2eb8-54a8-906e-9125227a4fdb	yes	Pharmaceutical Therapy, NOS	2c378864-d10d-40bc-b704-9e5cc689b4be
a9191fde-9363-48b6-9750-72ad32c22596.htseq.counts.gz	84f611ee-128b-4e74-897c-037744f4b388	TCGA-BS-A0UV-01A-11R-A16W-07	TCGA-BS-A0UV-01A-11R	TCGA-BS-A0UV-01A-01-BS1	TCGA-BS-A0UV-01A-01-TS1		TCGA-BS-A0UV-01A-11	TCGA-BS-A0UV-01A	TCGA-BS-A0UV	b19425ab-a82f-4c2a-bf58-d1bd30511d74	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1902	80.0	False	false	9414D0B9-3126-42E9-8189-7C1EC38B2AAB	1.72	08890bb3-7ad1-41c2-8774-b10bf86ee047	0.15	23	released	28200f72-f54e-4f2d-832c-4ba6bfb7ef8e	RNA	R	0.15	UV Spec	released	False	c1037aad-376b-4776-b6c2-b7ccb591a1ec	11	40.0	0.0	15.0	57.0	0.0	10.0	75.0	90.0	BOTTOM	10d845c3-8b4f-4caf-8619-c4d7193afc35	released	40.0	0.0	20.0	57.0	0.0	10.0	70.0	90.0	TOP	0dfa1eda-9c93-4df0-86ec-124acff65398	released									released	30.0	30945527-528a-448e-8db4-2e0c31c9016d	Primary Tumor	01	released	Not Reported	released	TCGA-BS-A0UV_demographic	55	-20266		04f8eb46-e4c3-5074-ae25-c74e2facb1df	not hispanic or latino	female	native hawaiian or other pacific islander	released	Alive	1950		TCGA-BS-A0UV_exposure	Not Reported	39.682539682539684	ea8a1054-64e3-5cf9-85e0-abafaee6e9ce	168.0	released	112.0	TCGA-BS-A0UV_diagnosis	20266	not reported	0	2228	299e7afb-cff2-535a-ad6f-7a13d7a1bd44	Stage IIIC	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2005	TCGA-BS-A0UV_treatment	TCGA-BS-A0UV_treatment_1	released	9cb639e3-877c-5a07-a5a9-95b265b15172	no	Radiation Therapy, NOS	released	372d402f-e76f-54fa-b08f-26f27fa10928	no	Pharmaceutical Therapy, NOS	84f611ee-128b-4e74-897c-037744f4b388
7367d5b5-af64-42ca-b67b-d54796e8f980.htseq.counts.gz	f7b55c2c-998e-4974-8423-1abbb09331c0	TCGA-DF-A2KS-01A-11R-A18M-07	TCGA-DF-A2KS-01A-11R	TCGA-DF-A2KS-01A-01-TS1			TCGA-DF-A2KS-01A-11	TCGA-DF-A2KS-01A	TCGA-DF-A2KS	46e064cc-933b-444b-9e15-80fadbc53487	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC		120.0	False	false	C6638C17-4F05-491F-86ED-6D7DDB1B8FDE	1.79	05a3cad5-b1a2-481d-a2b7-f0e80ec78ed2	0.17	23	released	df0adcb3-d2b1-40e4-9a0d-996dd3ce6789	RNA	R	0.17	UV Spec	released	False	2035248e-fabb-4943-99bf-707e6bde1091	11	5.0	3.0	20.0	8.0	0.0	5.0	75.0	95.0	TOP	6b888cc3-daeb-4320-a03a-e7b2c9eb047e	released																				released	30.0	0e438d6a-52a7-473f-bb85-7805d63df150	Primary Tumor	01	released	Not Reported	released	TCGA-DF-A2KS_demographic	69	-25313		e6364172-46ac-520d-af07-f1d3d5bedeb9	not reported	female	not reported	released	Alive			TCGA-DF-A2KS_exposure	Not Reported		cca6be82-44f2-52e1-9eb5-7fba21d3e957		released	66.0	TCGA-DF-A2KS_diagnosis	25313	not reported		3318	ab2d1531-0ac6-5197-9585-ee8cd6beb3b6	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported		TCGA-DF-A2KS_treatment_1	TCGA-DF-A2KS_treatment	released	663f12f7-7918-52dd-b85c-ede15e48cbaf	no	Pharmaceutical Therapy, NOS	released	e69b49da-4c68-5663-bc0e-a86af502a5ef	yes	Radiation Therapy, NOS	f7b55c2c-998e-4974-8423-1abbb09331c0
7134aa37-37e9-4241-a0db-df4afd44d9cb.htseq.counts.gz	6440604d-c0a8-45e6-8324-6e18a15a2957	TCGA-AP-A05J-01A-11R-A00V-07	TCGA-AP-A05J-01A-11R	TCGA-AP-A05J-01A-01-BSA	TCGA-AP-A05J-01A-01-TSA		TCGA-AP-A05J-01A-11	TCGA-AP-A05J-01A	TCGA-AP-A05J	38f9fe64-de79-498c-b3ca-1c83af0ed72a	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	566	170.0	False	true	C6426DA0-86C5-49CC-9983-A0002DA0D4F2	1.76	dbe07c69-fd67-4dcd-b69d-6bdc4a85110c	0.17	23	released	0ab885f2-df5b-4236-98c5-8fe234bf6cdb	RNA	R	0.17	UV Spec	released	False	ea79f9cd-5812-47fe-b022-b9ed694c8b14	11	0.0	0.0	10.0	0.0	0.0	5.0	85.0	95.0	BOTTOM	9658ed08-b17d-472b-8a1f-38d957e4e6ce	released	0.0	1.0	5.0	0.0	0.0	5.0	90.0	95.0	TOP	c7360473-2dac-4bad-a794-36ca8e4c7bba	released									released	30.0	203c6ed3-2e18-400d-83ee-69a8fd9bb386	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A05J_demographic	66	-24119		ffb5b981-6cb5-5f4e-b50f-0fd3b4d6dcea	not reported	female	white	released	Alive	1942		TCGA-AP-A05J_exposure	Not Reported	27.990362811791382	0b697c65-bbce-5a15-b6c8-51f80b075019	168.0	released	79.0	TCGA-AP-A05J_diagnosis	24119	not reported	0	1122	ba11f1ed-4646-5adf-b91e-6b8562dbf59d	Stage II	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-AP-A05J_treatment	TCGA-AP-A05J_treatment_1	released	7a3dfec1-6e94-5740-a56f-17dae998b581	yes	Radiation Therapy, NOS	released	ededbc12-b3a4-5573-8147-4944c94e1d7f	yes	Pharmaceutical Therapy, NOS	6440604d-c0a8-45e6-8324-6e18a15a2957
cfd9d31b-3321-4424-9a95-5c5cdcfab1ab.htseq.counts.gz	8c73cba6-23d5-4479-bf52-39995f83bdbc	TCGA-AJ-A8CW-01A-11R-A37O-07	TCGA-AJ-A8CW-01A-11R	TCGA-AJ-A8CW-01A-01-TS1			TCGA-AJ-A8CW-01A-11	TCGA-AJ-A8CW-01A	TCGA-AJ-A8CW	43e08773-767e-4b81-94e4-8848565c23e9	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	840	90.0	False	false	146E0540-B6F0-495F-ADD5-90F7564C14CA	1.89	409104d7-db15-448e-96c6-e50fb7e5d67b	0.18	23	released	037b7dd5-ca6b-4722-ae89-af708edfa631	RNA	R	0.18	UV Spec	released	False	d59dd77e-d094-4d46-97e9-7651604344f8	11	3.0	0.0	2.0	0.0	5.0	8.0	85.0	85.0	TOP	2af40cb3-2f71-449b-8482-70748e30d1f2	released																				released	30.0	ca2da155-5ce0-4fe9-b82e-877295e4ad5e	Primary Tumor	01	released	Not Reported	released	TCGA-AJ-A8CW_demographic	64	-23554		6890a0be-464d-57fe-a1e4-40299008de2c	not hispanic or latino	female	black or african american	released	Alive	1947		TCGA-AJ-A8CW_exposure	Not Reported	47.47732426303855	e28268bd-20d6-53a3-bc2e-94c09f11dcc6	168.0	released	134.0	TCGA-AJ-A8CW_diagnosis	23554	not reported	0	4	65763f7d-c3f8-5db5-a71e-f921edcc96e4	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-AJ-A8CW_treatment_1	TCGA-AJ-A8CW_treatment	released	a84abc8d-2cf2-5528-a5f0-fe62a83b67dd	not reported	Pharmaceutical Therapy, NOS	released	8621a323-0eec-5454-be3a-119e8eabd5a3	not reported	Radiation Therapy, NOS	8c73cba6-23d5-4479-bf52-39995f83bdbc
e03c58cc-b1d3-4935-87b5-92dea1ce86f5.htseq.counts.gz	b211de16-6fa3-40e0-8200-b41da3d6e544	TCGA-A5-A1OF-01A-11R-A14D-07	TCGA-A5-A1OF-01A-11R	TCGA-A5-A1OF-01A-01-TS1			TCGA-A5-A1OF-01A-11	TCGA-A5-A1OF-01A	TCGA-A5-A1OF	286c112d-7b73-40a1-b23c-99911388fdef	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	128	210.0	False	true	C0A753A3-5202-4DD2-948E-2921AFBCB3BC	1.79	56fa9065-a4cd-435b-941b-d4507aef815b	0.17	23	released	0fe4da29-648e-4f66-8b85-cf817360ecc3	RNA	R	0.17	UV Spec	released	False	d597d39e-0392-465a-abdc-2c5b582e6a70	11	30.0	0.0	20.0	10.0	0.0	10.0	70.0	90.0	TOP	50ac8957-bfc0-44e4-b78c-d9e320d7d24e	released																				released	30.0	68c51551-232a-4adc-a0a0-fcecd7125f59	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A1OF_demographic	47	-17308		914f33d3-f471-5217-ab80-a340b1a61a93	hispanic or latino	female	not reported	released	Alive	1963		TCGA-A5-A1OF_exposure	Not Reported	29.1363163371488	6032a121-a8ac-597b-9f1e-a30b6ae41c99	155.0	released	70.0	TCGA-A5-A1OF_diagnosis	17308	not reported	0	973	650ef48f-88b9-5e34-a7e6-b86c220ce3d0	Stage IA	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-A5-A1OF_treatment_1	TCGA-A5-A1OF_treatment	released	2d151d71-9400-5866-b94d-b47f026f531f	no	Pharmaceutical Therapy, NOS	released	5c56574b-b9b5-5411-9463-bd91887e65d0	yes	Radiation Therapy, NOS	b211de16-6fa3-40e0-8200-b41da3d6e544
35c4cc14-5096-4da8-9190-359338fdb365.htseq.counts.gz	70bd3273-e57a-4bc0-b0d6-f5b5f681f71f	TCGA-AX-A1C5-01A-11R-A137-07	TCGA-AX-A1C5-01A-11R	TCGA-AX-A1C5-01A-01-TS1			TCGA-AX-A1C5-01A-11	TCGA-AX-A1C5-01A	TCGA-AX-A1C5	caebdce0-f954-471a-ac63-5daaa2e76d97	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	517	130.0	False	false	6F79B83A-90B4-45DF-8542-A6BC2F93470D	2.23	1bce2d6c-cbe9-4191-b23c-a3bb815ec5e1	0.18	23	released	24909727-4d69-44ef-ba40-a40a2be492f6	RNA	R	0.18	UV Spec	released	False	882dd5b9-7138-4a09-a312-9f973f600d48	11	5.0	1.0	1.0	1.0	5.0	34.0	60.0	70.0	TOP	80d815c6-0f04-40a6-838c-71cec774532a	released																				released	30.0	cb8bc1f7-c7a2-4378-9f91-a4d76a70435b	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A1C5_demographic	47	-17383		94140e88-a9fa-5519-947c-1960dd16a2cd	not hispanic or latino	female	white	released	Alive	1962		TCGA-AX-A1C5_exposure	Not Reported	41.796875	17c87eaf-e16b-55de-9f9c-c3ae4f383fb9	160.0	released	107.0	TCGA-AX-A1C5_diagnosis	17383	not reported	0	1001	523b2dd3-21d7-51f5-840a-98c0c584d53b	Stage IIIC	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-AX-A1C5_treatment_1	TCGA-AX-A1C5_treatment	released	4d527fed-b773-56b2-8322-5f1a13edbc75	yes	Pharmaceutical Therapy, NOS	released	7c8a22d1-d380-5319-9440-b69bdc7d9fa5	yes	Radiation Therapy, NOS	70bd3273-e57a-4bc0-b0d6-f5b5f681f71f
cf7616fa-d5c6-4430-b644-aaa63bbf2704.htseq.counts.gz	d1d871b2-d2d3-4c74-9850-9a0c4221d4a4	TCGA-SL-A6JA-01A-11R-A31O-07	TCGA-SL-A6JA-01A-11R	TCGA-SL-A6JA-01A-01-TSA			TCGA-SL-A6JA-01A-11	TCGA-SL-A6JA-01A	TCGA-SL-A6JA	2a19051e-3ad1-444a-9d02-f895c26ac02c	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	45	200.0	False	true	60CDA761-5DF1-4580-AD84-1CE9A15F31F8	1.9	1be5c0c6-8645-4894-8573-05ece1839689	0.16	23	released	f9b6e31e-c3e7-43dd-a623-c2edc0bd4539	RNA	R	0.16	UV Spec	released	False	45b054d7-def5-4e29-9588-ed01e9179edd	11	1.0	1.0	5.0	1.0	5.0	5.0	85.0	85.0	TOP	be66cc07-4fad-4c4a-9fca-33a80f4fe0a7	released																				released	30.0	691fc8b9-2221-444b-8de6-960aabd0cddd	Primary Tumor	01	released	Not Reported	released	TCGA-SL-A6JA_demographic	77	-28401		ab0425be-3d1c-5564-b557-614a4080be6a	not hispanic or latino	female	black or african american	released	Alive	1936		TCGA-SL-A6JA_exposure	Not Reported	46.25479579762631	39e9b646-4d53-5b93-8c60-db9621bd2d9e	167.0	released	129.0	TCGA-SL-A6JA_diagnosis	28401	not reported	0	7	e78ab9fc-8c16-5b13-a3a6-592314fe0141	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2013	TCGA-SL-A6JA_treatment_1	TCGA-SL-A6JA_treatment	released	75acad81-6d6a-5cb6-8446-56703ae52f4d	no	Pharmaceutical Therapy, NOS	released	fff63bc4-5160-5d59-b261-a47fba285a1c	no	Radiation Therapy, NOS	d1d871b2-d2d3-4c74-9850-9a0c4221d4a4
0abdff51-3e12-492e-bf51-fe302318d8c7.htseq.counts.gz	391a4641-eaee-4e38-b0e8-e410e8256b56	TCGA-EO-A22T-01A-21R-A18M-07	TCGA-EO-A22T-01A-21R	TCGA-EO-A22T-01A-02-TSB			TCGA-EO-A22T-01A-21	TCGA-EO-A22T-01A	TCGA-EO-A22T	63170b0e-78cf-45d9-af9d-ce986ac66991	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	916	140.0	False	false	1D5567D9-3015-452E-9888-2E67F91D6B20	1.92	fe8a344f-fc0b-415c-b388-c71e82b64703	0.16	23	released	f43bf8d6-fb30-4001-bd67-bba1eb1d0a8f	RNA	R	0.16	UV Spec	released	False	38170aa4-a0ac-4289-8d79-16cd25e52573	21	40.0	20.0	5.0	20.0	0.0	15.0	80.0	80.0	TOP	fe0d201a-41b3-4d5f-94d5-c7fdc88a1c35	released																				released	30.0	bf5a963a-4aa7-428b-acd6-606093a0ff2a	Primary Tumor	01	released	Not Reported	released	TCGA-EO-A22T_demographic	56	-20608		255807e2-d413-5f0e-8244-0047a41ee5fe	not hispanic or latino	female	asian	released	Alive	1952		TCGA-EO-A22T_exposure	Not Reported	22.939750692520775	dca0fd6a-fbde-5f2b-a219-de2b89a0dc9c	152.0	released	53.0	TCGA-EO-A22T_diagnosis	20608	not reported	0	2035	ac541daa-1255-51ea-add1-8b6374d98e66	Stage II	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-EO-A22T_treatment	TCGA-EO-A22T_treatment_1	released	fb692730-85bf-5ac6-ad3e-318b0eb96063	yes	Radiation Therapy, NOS	released	5c71a802-d5bc-5802-8810-d7e3509385bd	no	Pharmaceutical Therapy, NOS	391a4641-eaee-4e38-b0e8-e410e8256b56
64b5cc13-137b-49a3-8783-11febcc3a961.htseq.counts.gz	23c82e63-3e26-431b-8984-4276d75c38d0	TCGA-B5-A11V-01A-11R-A10J-07	TCGA-B5-A11V-01A-11R	TCGA-B5-A11V-01A-01-BS1	TCGA-B5-A11V-01A-01-TS1		TCGA-B5-A11V-01A-11	TCGA-B5-A11V-01A	TCGA-B5-A11V	d3c83c5e-acb1-4cb0-8f56-96341822582f	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	294	760.0	False	true	E1B5A941-5EEB-4207-84DC-F3BF22D5FC29	1.86	986bddf6-4dde-4bfb-94c3-123674a4ca45	0.15	23	released	18d36986-b058-47d9-83bc-2f7213dbc9ee	RNA	R	0.15	UV Spec	released	False	bed44600-2d48-46f8-ab6f-515987008f18	11	10.0	0.0	10.0	0.0	0.0	30.0	60.0	70.0	BOTTOM	c0a9546e-6a4e-487a-844c-ed11acf1ab7e	released	10.0	0.0	10.0	0.0	10.0	10.0	70.0	80.0	TOP	53cda3f8-4272-4447-93b4-5a2b72c4466d	released									released	30.0	1eb9c43a-17d8-4fa7-b779-9277ff828cb1	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A11V_demographic	64	-23630		a0d7577a-1868-535e-b229-e0ea205cd267	not reported	female	black or african american	released	Alive	1946		TCGA-B5-A11V_exposure	Not Reported	28.804413972169254	8e526b43-7688-57d1-a8c1-33587061fa59	157.0	released	71.0	TCGA-B5-A11V_diagnosis	23630	not reported	0	595	09b79b21-54c9-57a2-a6bc-fb02f236f79a	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-B5-A11V_treatment	TCGA-B5-A11V_treatment_1	released	45d01c6b-7ac8-58e1-b687-b2d440fac32b	no	Radiation Therapy, NOS	released	02746174-8cf1-5a4e-a797-2521c3af3b09	no	Pharmaceutical Therapy, NOS	23c82e63-3e26-431b-8984-4276d75c38d0
bc5738b1-7d71-4c40-969f-68616ed01345.htseq.counts.gz	4cee7895-a0e3-4b14-9212-d0aad28e18a4	TCGA-AP-A051-01A-21R-A00V-07	TCGA-AP-A051-01A-21R	TCGA-AP-A051-01A-02-BSB	TCGA-AP-A051-01A-02-TSB		TCGA-AP-A051-01A-21	TCGA-AP-A051-01A	TCGA-AP-A051	b045f24b-f822-4df9-9ffa-47308edcec8c	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	2475	430.0	False	true	2146A2FC-99EE-4939-AD9F-086BB77D2B21	1.83	520ac0a0-a49f-4990-8a49-dfe312361e30	0.14	23	released	104303d4-3dfe-478d-95ca-d664b69c3881	RNA	R	0.14	UV Spec	released	False	30ba55bb-39ae-405e-9efc-6d76b9f00c3d	21	0.0	0.0	4.0	0.0	0.0	6.0	90.0	98.0	BOTTOM	a0ef9cff-0cba-4cd7-aa0e-380626f0eae6	released	0.0	0.0	4.0	0.0	0.0	4.0	92.0	98.0	TOP	8a6c5124-ceeb-4199-a1ff-0d6bb3d1d7f9	released									released	30.0	417cff62-b034-4197-9cfd-e640d55f3094	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A051_demographic	69	-25269		ce7f54a2-f817-5fdc-8f8e-56e5ea202cc7	not reported	female	white	released	Alive	1934		TCGA-AP-A051_exposure	Not Reported	38.36873541394723	0e777688-64df-53c3-8e2e-37c2261c2d9a	159.0	released	97.0	TCGA-AP-A051_diagnosis	25269	not reported	0	3948	04b7b6ca-6e8a-5702-b1e2-0bdd145d546c	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2003	TCGA-AP-A051_treatment_1	TCGA-AP-A051_treatment	released	c0d288be-fd7c-5c7a-89f7-78af27dd68b8	no	Pharmaceutical Therapy, NOS	released	dcefc2e5-fa75-54a4-b60f-34b5b44f0ee1	yes	Radiation Therapy, NOS	4cee7895-a0e3-4b14-9212-d0aad28e18a4
3ba5d6ec-dcce-49bb-82e5-85d3903a2aa1.htseq.counts.gz	c247b168-3b4b-40ae-8e1a-32dda1b34397	TCGA-AJ-A2QL-11A-11R-A18M-07	TCGA-AJ-A2QL-11A-11R	TCGA-AJ-A2QL-11A-01-TSA			TCGA-AJ-A2QL-11A-11	TCGA-AJ-A2QL-11A	TCGA-AJ-A2QL	9002fc6c-26de-4b8f-8985-a4814cd3daf7	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	138	100.0	False	false		1.82	59022898-5d0a-4109-90fa-9f8ad89b9758	0.17	23	released	f232cadd-4774-4e2a-94ae-ed87240a9f25	RNA	R	0.17	UV Spec	released	False	b7bd7cd8-7f60-4791-8446-d86dba36201e	11	8.0	0.0	0.0	0.0	5.0	95.0	0.0	0.0	TOP	48e63c18-6022-48fd-8a19-9f0a6b45481b	released																				released	30.0	635f5364-1934-4130-9641-a1a6caff2e59	Solid Tissue Normal	11	released	Not Reported	released	TCGA-AJ-A2QL_demographic	60	-22057		ea1129e7-d64f-5806-8611-03a0818e92fc	not hispanic or latino	female	white	released	Alive	1951		TCGA-AJ-A2QL_exposure	Not Reported	42.154390455041586	4251ca27-a376-5d7e-825a-9b693b335278	163.0	released	112.0	TCGA-AJ-A2QL_diagnosis	22057	not reported	0	602	7b4cfed7-6fbc-51b1-8b33-e05317244f31	Stage IIIC1	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-AJ-A2QL_treatment	TCGA-AJ-A2QL_treatment_1	released	4f97ab32-906a-5607-a8e1-30b37a12a264	no	Radiation Therapy, NOS	released	e218b1cf-29c0-5021-8b2f-c6108b4ec008	yes	Pharmaceutical Therapy, NOS	c247b168-3b4b-40ae-8e1a-32dda1b34397
bd4fc579-105e-41c4-afe4-fd676f55977e.htseq.counts.gz	f2705d21-5d18-4614-b63d-2fcb6d743a0e	TCGA-DI-A2QY-11A-11R-A19W-07	TCGA-DI-A2QY-11A-11R	TCGA-DI-A2QY-11A-01-TS1			TCGA-DI-A2QY-11A-11	TCGA-DI-A2QY-11A	TCGA-DI-A2QY	6524a6d3-a9f0-4a46-ac0b-7beb0cd1b915	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	2957	110.0	False	false		1.81	9ba4d4d3-4640-40b7-8a67-72f384858b93	0.16	23	released	9490e6b4-f208-4b4c-be44-0fc2ca58928c	RNA	R	0.16	UV Spec	released	False	35aacc90-3b62-471c-b650-6640a0a54c67	11	30.0	30.0	0.0	10.0	90.0	10.0	0.0	0.0	TOP	9dea9504-6cf4-4fd2-a919-638517991b3e	released																				released	30.0	dd23fc95-047a-46eb-858f-c411bc337aa0	Solid Tissue Normal	11	released	Not Reported	released	TCGA-DI-A2QY_demographic	64	-23398	3349	1bf3a85e-3bba-5f86-bdac-e4b82c02dbf6	not hispanic or latino	female	white	released	Dead	1939		TCGA-DI-A2QY_exposure	Not Reported	33.203125	03abc5eb-1514-5a39-8ba9-2b04141c412d	160.0	released	85.0	TCGA-DI-A2QY_diagnosis	23398	not reported	0	2797	16ba3979-eeba-5a99-a3e4-50daa96f30cd	Stage IIB	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2003	TCGA-DI-A2QY_treatment	TCGA-DI-A2QY_treatment_1	released	80c89912-4642-58ff-9420-bcf75d9bb5a7	yes	Radiation Therapy, NOS	released	b96031fa-5e06-59d7-9021-f30999cfc018	yes	Pharmaceutical Therapy, NOS	f2705d21-5d18-4614-b63d-2fcb6d743a0e
bc0241d5-d781-4877-9366-d0fab0393638.htseq.counts.gz	fd2daf3c-8027-4df9-adeb-3ffb768c08fd	TCGA-AJ-A2QL-01A-11R-A18M-07	TCGA-AJ-A2QL-01A-11R	TCGA-AJ-A2QL-01A-01-TSA			TCGA-AJ-A2QL-01A-11	TCGA-AJ-A2QL-01A	TCGA-AJ-A2QL	9002fc6c-26de-4b8f-8985-a4814cd3daf7	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	138	170.0	False	false	4AD4E8D1-5DA7-4134-A0C0-0AF1C3A8BCD4	1.82	575c927a-b846-4ef3-9644-7879d522a2cb	0.16	23	released	8517610f-c48e-4c88-9189-f216f898d8af	RNA	R	0.16	UV Spec	released	False	20201732-98eb-4f63-a1d0-94926f27c834	11	8.0	5.0	0.0	3.0	0.0	20.0	80.0	80.0	TOP	0fa67bbc-0a8e-4173-b314-6e3797b5421e	released																				released	30.0	9884f8d6-3a49-4613-aa45-855be115e01b	Primary Tumor	01	released	Not Reported	released	TCGA-AJ-A2QL_demographic	60	-22057		ea1129e7-d64f-5806-8611-03a0818e92fc	not hispanic or latino	female	white	released	Alive	1951		TCGA-AJ-A2QL_exposure	Not Reported	42.154390455041586	4251ca27-a376-5d7e-825a-9b693b335278	163.0	released	112.0	TCGA-AJ-A2QL_diagnosis	22057	not reported	0	602	7b4cfed7-6fbc-51b1-8b33-e05317244f31	Stage IIIC1	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-AJ-A2QL_treatment	TCGA-AJ-A2QL_treatment_1	released	4f97ab32-906a-5607-a8e1-30b37a12a264	no	Radiation Therapy, NOS	released	e218b1cf-29c0-5021-8b2f-c6108b4ec008	yes	Pharmaceutical Therapy, NOS	fd2daf3c-8027-4df9-adeb-3ffb768c08fd
f3742353-056e-41ac-8a43-f73ee7594861.htseq.counts.gz	3b55e0ea-0217-44ac-9acd-1a6e2cd18a33	TCGA-A5-A1OK-01A-11R-A14M-07	TCGA-A5-A1OK-01A-11R	TCGA-A5-A1OK-01A-01-TSA			TCGA-A5-A1OK-01A-11	TCGA-A5-A1OK-01A	TCGA-A5-A1OK	2fe46394-cfc5-44bb-81a9-e438a0126f5b	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	113	250.0	False	true	1B0C95FC-7AA7-4F82-807D-85C579B6BF74	1.92	f26a449d-f3c6-4968-a2f7-4708a5686707	0.16	23	released	2f9b747a-2227-4414-8473-46faebcfb8a2	RNA	R	0.16	UV Spec	released	False	69bbd232-5c94-4874-972e-def4f9e494a4	11	40.0	20.0	5.0	20.0	0.0	15.0	80.0	80.0	TOP	0c3d307c-8019-4790-b303-42aa5d30ccb8	released																				released	30.0	0eaf63cf-3cf6-4049-b0ab-aedb65db648d	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A1OK_demographic	63	-23179		b346824d-c961-5a69-978a-f04452f8b1f0	not hispanic or latino	female	white	released	Alive	1947		TCGA-A5-A1OK_exposure	Not Reported	31.955922865013772	2093f8b4-d6c1-5c15-ba5a-53d89e5b372c	165.0	released	87.0	TCGA-A5-A1OK_diagnosis	23179	not reported	0	917	e73b3dc2-47fc-5c48-8b85-fa0416bad555	Stage IIIA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2010	TCGA-A5-A1OK_treatment_1	TCGA-A5-A1OK_treatment	released	5bc4acba-a824-5553-8889-6694f82f393b	yes	Pharmaceutical Therapy, NOS	released	59b1d10b-6e11-599b-b664-f48e0bf1bc14	yes	Radiation Therapy, NOS	3b55e0ea-0217-44ac-9acd-1a6e2cd18a33
6ce53ab9-7320-4a5a-8284-bf3021e29e24.htseq.counts.gz	687e27d1-b068-4c80-8b91-9bde0855bc42	TCGA-AX-A2HC-11A-11R-A32Y-07	TCGA-AX-A2HC-11A-11R	TCGA-AX-A2HC-11A-01-TSA			TCGA-AX-A2HC-11A-11	TCGA-AX-A2HC-11A	TCGA-AX-A2HC	53e8e07e-18f9-4c9b-9783-a5b67ceddcf7	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1786	120.0	False	false		1.82	0959be20-00aa-4736-9cf1-41b3c1d5c5b4	0.15	23	released	4f3babc3-780b-410f-8b1c-e5f8fe269b95	RNA	R	0.15	UV Spec	released	False	d3b02fa7-c857-46b3-a74b-2bc75eb9c5bc	11	5.0	0.0	0.0	0.0	100.0	0.0	0.0	0.0	TOP	95b41504-359a-4c6c-a45a-715cee6caa0f	released																				released	30.0	82851d79-abe1-4fa0-8f28-86b2a9656dc6	Solid Tissue Normal	11	released	Not Reported	released	TCGA-AX-A2HC_demographic	53	-19485		baa2500b-d4c9-5e0f-bc4a-41390e221f01	not hispanic or latino	female	black or african american	released	Alive	1953		TCGA-AX-A2HC_exposure	Not Reported	47.26806601506169	6308ecf6-0bd6-5496-9db7-67a1943c1fc2	158.0	released	118.0	TCGA-AX-A2HC_diagnosis	19485	not reported	0	1044	338fe46f-b6a4-50ed-8fc2-2ff30bca40e1	Stage IIIC	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2006	TCGA-AX-A2HC_treatment	TCGA-AX-A2HC_treatment_1	released	e28a8158-7cf7-535b-86c4-451eaa12d50a	yes	Radiation Therapy, NOS	released	7f3baa41-8e8f-5026-bda1-e93c874fb76f	yes	Pharmaceutical Therapy, NOS	687e27d1-b068-4c80-8b91-9bde0855bc42
1ace5c51-6a84-4e61-92c1-b7a846a4bfa6.htseq.counts.gz	2c2a78d4-8441-4c3b-82df-d9571dff5964	TCGA-B5-A11W-01A-12R-A118-07	TCGA-B5-A11W-01A-12R	TCGA-B5-A11W-01A-01-BSA	TCGA-B5-A11W-01A-01-TSA		TCGA-B5-A11W-01A-12	TCGA-B5-A11W-01A	TCGA-B5-A11W	f5bd3902-ff7f-4233-8f74-beef3676af9a	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	258	310.0	False	true	C5762F7C-AB69-40D0-A9D0-71A6281F30AF	1.85	168116db-99c5-4d7a-9e9f-3858e1824298	0.15	23	released	1995b32c-362f-459d-a7ce-43931c68b2c8	RNA	R	0.15	UV Spec	released	False	838c73c3-7464-4427-8859-66e68bb913a5	12	10.0	0.0	10.0	0.0	10.0	0.0	80.0	90.0	BOTTOM	3be033f7-3527-4807-9ce3-20cf08db176f	released	10.0	0.0	30.0	20.0	0.0	10.0	60.0	90.0	TOP	dac6580a-83b6-4f8f-8d94-9358862397a5	released									released	30.0	ac3c028c-d36b-489b-a3d9-a7f4783de5eb	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A11W_demographic	61	-22365		5a99a5f6-68c6-5de3-97e6-d1990afc1648	not reported	female	white	released	Alive	1949		TCGA-B5-A11W_exposure	Not Reported	38.3906055929843	c0c1cab2-2aed-526b-a4e8-f386e1db07ec	163.0	released	102.0	TCGA-B5-A11W_diagnosis	22365	not reported	0	593	86b131a8-df1c-5e14-b809-1f0ff6bd3306	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-B5-A11W_treatment_1	TCGA-B5-A11W_treatment	released	173b84aa-6570-5313-97b8-0fbeaea72636	no	Pharmaceutical Therapy, NOS	released	b0f777ba-d81d-502e-bc54-1018f82cfc98	yes	Radiation Therapy, NOS	2c2a78d4-8441-4c3b-82df-d9571dff5964
77035676-a6bf-4e20-ad0e-9abec766ab0a.htseq.counts.gz	09d6e6c6-3607-4fc8-91e0-83b9be8e9f2b	TCGA-D1-A0ZQ-01A-11R-A118-07	TCGA-D1-A0ZQ-01A-11R	TCGA-D1-A0ZQ-01A-01-BS1	TCGA-D1-A0ZQ-01A-01-MS1		TCGA-D1-A0ZQ-01A-11	TCGA-D1-A0ZQ-01A	TCGA-D1-A0ZQ	38243a33-073a-479b-8cf6-c8847aeb5a48	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	540	120.0	False	false	BAC6E925-0499-41AD-9F58-2CB8E3EE058E	1.88	650687c0-616b-41a5-ae29-322ba9cfc462	0.14	23	released	5043f07b-28c5-4bed-8356-2b65b6fb71a1	RNA	R	0.14	UV Spec	released	False	6ad4fb52-e988-4bf3-960e-91ff8e04aece	11	20.0	0.0	20.0	20.0	20.0	10.0	50.0	70.0	BOTTOM	5a63eca8-461b-419b-bc1a-d19223f33170	released	8.0	0.0	3.0	2.0	0.0	67.0	30.0	30.0	TOP	33217517-811e-4a56-944d-ff357667ea75	released									released	30.0	e20471d5-a261-448b-9a6f-fd3be8ed5c04	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A0ZQ_demographic	90	-32872		94dfa136-8422-58f4-a7c3-0856703cb127	not hispanic or latino	female	white	released	Alive	1919		TCGA-D1-A0ZQ_exposure	Not Reported	28.720083246618103	6f3567eb-401a-560f-bc9e-3eacb32d62fc	155.0	released	69.0	TCGA-D1-A0ZQ_diagnosis	32872	not reported	0	0	25abd952-109e-5bdf-95e0-cac38a8354c0	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-D1-A0ZQ_treatment	TCGA-D1-A0ZQ_treatment_1	released	b2eda5ce-233a-53a7-9b16-0e87b8918ed3	no	Radiation Therapy, NOS	released	72391147-14ba-5ea1-a827-240e06a3589e	no	Pharmaceutical Therapy, NOS	09d6e6c6-3607-4fc8-91e0-83b9be8e9f2b
a3cc902b-3b03-4025-a06e-8c6ff3357b66.htseq.counts.gz	03576ece-7979-403e-85d8-715a2370acac	TCGA-DF-A2L0-01A-11R-A180-07	TCGA-DF-A2L0-01A-11R	TCGA-DF-A2L0-01A-01-TSA			TCGA-DF-A2L0-01A-11	TCGA-DF-A2L0-01A	TCGA-DF-A2L0	7adaf608-19a5-4184-8b79-bbc6f9cf24ae	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC		520.0	False	false	1679CA2C-86BF-41D1-96E1-62FC89D9AAA7	1.76	60fc2e50-f36c-4074-879b-b5773d75a466	0.17	23	released	0ac14a36-d3d4-4157-89d8-bd808560cebe	RNA	R	0.17	UV Spec	released	False	2a2156c8-e7e2-45ff-bae9-cbaeba3f48e1	11	5.0	5.0	5.0	10.0	0.0	20.0	75.0	80.0	TOP	aa85eeaf-3a18-4572-b338-e33b4ec16fa8	released																				released	30.0	e3f9c326-544d-46e2-a58e-fc95e5ecd702	Primary Tumor	01	released	Not Reported	released	TCGA-DF-A2L0_demographic	60	-22200	788	e7e96bee-ac74-59ef-bb8f-80dcfcd1df95	not reported	female	not reported	released	Dead			TCGA-DF-A2L0_exposure	Not Reported	33.659297052154194	577b8e08-5415-5aaf-b372-7c9e70c19c55	168.0	released	95.0	TCGA-DF-A2L0_diagnosis	22200	not reported			40f97b80-edac-5aea-ac69-928d372f2a80	Stage IIIC	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported		TCGA-DF-A2L0_treatment_1	TCGA-DF-A2L0_treatment	released	f81005bd-863b-5789-a34b-4673f41b4475	yes	Pharmaceutical Therapy, NOS	released	ca5efbea-4f5d-57b2-9571-57100bd95bc2	yes	Radiation Therapy, NOS	03576ece-7979-403e-85d8-715a2370acac
ee8ef096-f606-4f7b-bf45-fc505d9e5648.htseq.counts.gz	970e8047-ad99-4327-b076-d348d353c330	TCGA-B5-A11N-01A-11R-A118-07	TCGA-B5-A11N-01A-11R	TCGA-B5-A11N-01A-01-TSA	TCGA-B5-A11N-01A-01-BSA		TCGA-B5-A11N-01A-11	TCGA-B5-A11N-01A	TCGA-B5-A11N	ca594f56-9c68-4b7e-84b2-669f1004e3a4	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1140	370.0	False	true	A4C1DE15-A45A-4D31-B363-C6652370C09C	1.83	823aed7c-3bf3-4ace-b17d-dc4f8a4e0e2f	0.16	23	released	fbcaeda7-ec48-4a6a-a304-50c1e89171fa	RNA	R	0.16	UV Spec	released	False	32b044a9-06bb-4194-a05a-5895942e7800	11	35.0	0.0	5.0	0.0	0.0	30.0	65.0	70.0	TOP	235c492f-dc54-413f-b00b-9651aca15076	released	30.0	2.0	5.0	0.0	0.0	25.0	70.0	75.0	BOTTOM	3742add6-0e00-4b8e-a5bf-7465f034496c	released									released	30.0	d3222a2c-6715-4eea-88b0-4006f61c736b	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A11N_demographic	69	-25442		ef38b762-6e65-5a5f-985e-ae40bec376aa	not reported	female	white	released	Alive	1938		TCGA-B5-A11N_exposure	Not Reported	29.72651605231867	276d0a4b-0086-5139-ba87-11369514f219	174.0	released	90.0	TCGA-B5-A11N_diagnosis	25442	not reported	0	1876	d6158568-3774-5c50-aaa7-671bf85d5032	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2007	TCGA-B5-A11N_treatment	TCGA-B5-A11N_treatment_1	released	b573c252-049a-5aa8-9ba9-258f89313a21	no	Radiation Therapy, NOS	released	7b1f84de-9f7e-5439-8422-81d4e2d451f7	no	Pharmaceutical Therapy, NOS	970e8047-ad99-4327-b076-d348d353c330
403f8d67-ffe2-466a-93ce-5bcefd609040.htseq.counts.gz	04a74558-bdd2-41e9-89fd-e06ddcc3257b	TCGA-EY-A2OM-01A-11R-A18M-07	TCGA-EY-A2OM-01A-11R	TCGA-EY-A2OM-01A-01-TS1			TCGA-EY-A2OM-01A-11	TCGA-EY-A2OM-01A	TCGA-EY-A2OM	2b60ef45-336c-42e0-aa3f-577069310d1f	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	176	640.0	False	false	7C46CE28-FC96-47FD-A133-B95EA93E1D8B	1.79	0c622763-f905-4eaa-a05b-ea27dbd49888	0.17	23	released	c7277159-d6ac-41b5-829b-2a034209bb35	RNA	R	0.17	UV Spec	released	False	55dbf8c7-b7f1-4253-875e-55b68b09180b	11	40.0	20.0	10.0	20.0	0.0	20.0	70.0	70.0	TOP	92d727ec-d04e-4421-8c65-a4dbaa27f86d	released																				released	30.0	2d9888f8-fa53-44a3-8e1c-20479cee4584	Primary Tumor	01	released	Not Reported	released	TCGA-EY-A2OM_demographic	55	-20398		913d2af6-77a5-5410-a188-fe74d2567774	not hispanic or latino	female	white	released	Alive	1956		TCGA-EY-A2OM_exposure	Not Reported	47.61080332409972	84aa203b-21cb-5150-bfab-32dda360a4f0	152.0	released	110.0	TCGA-EY-A2OM_diagnosis	20398	not reported	0	694	3b3e60e4-d5c1-5cf1-9ead-8a675165db70	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-EY-A2OM_treatment_1	TCGA-EY-A2OM_treatment	released	8b06b829-8a7f-51be-a830-09ba375184b6	yes	Pharmaceutical Therapy, NOS	released	1f4cc020-97aa-5d2d-b98f-66837d8741e8	yes	Radiation Therapy, NOS	04a74558-bdd2-41e9-89fd-e06ddcc3257b
c5e8f287-a5d7-4d69-ba74-39baf871f1a7.htseq.counts.gz	cb07ea11-11a2-4aa0-8b6d-0a9230b81ca2	TCGA-D1-A16I-01A-11R-A12I-07	TCGA-D1-A16I-01A-11R	TCGA-D1-A16I-01A-01-TS1			TCGA-D1-A16I-01A-11	TCGA-D1-A16I-01A	TCGA-D1-A16I	548ec160-4183-459f-8393-f4b4672a3251	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	763	190.0	False	false	3D30B053-444A-4F4D-B451-EB8746A157A2	1.89	21e840d7-f768-45b3-8a3a-bf228f7227e7	0.14	23	released	f80dd196-31ab-4391-bf7b-a053e8b1e8af	RNA	R	0.14	UV Spec	released	False	b8f3a04e-4b58-40b8-b53a-0dae9ad0a5c2	11	0.0	0.0	5.0	0.0	0.0	15.0	80.0	90.0	TOP	bd72b5e6-c9e2-466c-91aa-d5b8b34666d1	released																				released	30.0	62a1ff9f-f730-4703-8271-89e1a123da65	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A16I_demographic	62	-22836	350	83564807-d14e-5322-865d-4869b93fc86d	not hispanic or latino	female	white	released	Dead	1946	2008	TCGA-D1-A16I_exposure	Not Reported	31.615792841281188	a2082423-f611-5d19-84fd-2b195e9dd8e7	163.0	released	84.0	TCGA-D1-A16I_diagnosis	22836	not reported	0		1e7f4048-0130-582a-9efb-c35579987389	Stage IC	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-D1-A16I_treatment_1	TCGA-D1-A16I_treatment	released	56f0f157-f423-5d33-8edd-ffb6463df51c	yes	Pharmaceutical Therapy, NOS	released	ae66f263-4856-52b2-bc3d-702c88df34b3	yes	Radiation Therapy, NOS	cb07ea11-11a2-4aa0-8b6d-0a9230b81ca2
013dc5b4-cf78-4a1a-90f0-2bc3fe230a5a.htseq.counts.gz	19473a0f-ca4c-4793-bc69-60c380d71b7d	TCGA-AJ-A8CT-01A-11R-A37O-07	TCGA-AJ-A8CT-01A-11R	TCGA-AJ-A8CT-01A-01-TS1			TCGA-AJ-A8CT-01A-11	TCGA-AJ-A8CT-01A	TCGA-AJ-A8CT	6c2232b2-80ce-4156-a0b4-ffa411b0963e	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	587	60.0	False	false	67EF8128-8F99-4B19-9B64-9C5E5BD0786F	1.86	4c56a6cc-f912-4b2f-b301-d6a64f211d31	0.18	23	released	8175c453-7d3c-40f7-b097-c8854e00a08a	RNA	R	0.18	UV Spec	released	False	5ec40098-b09f-454b-9273-a827f433e048	11	5.0	5.0	0.0	0.0	20.0	20.0	60.0	60.0	TOP	8c79095b-35c3-40c8-a08a-c624290a3fd1	released																				released	30.0	bfe80d89-f6e6-4ec9-9d0a-8a46ed80082c	Primary Tumor	01	released	Not Reported	released	TCGA-AJ-A8CT_demographic	58	-21515		dac92b16-78e8-5599-94e2-bf73feae8378	not reported	female	black or african american	released	Alive	1954		TCGA-AJ-A8CT_exposure	Not Reported	42.24058769513315	08099bbe-9e3f-56f9-923e-e5a72e2eca8c	165.0	released	115.0	TCGA-AJ-A8CT_diagnosis	21515	not reported	0	82	2e7d9194-0cb7-5ba2-912c-90ac968c8b4d	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2012	TCGA-AJ-A8CT_treatment	TCGA-AJ-A8CT_treatment_1	released	b0ad9250-bf04-544e-9cd7-b662617d7bc3	not reported	Radiation Therapy, NOS	released	3709f5c3-8bce-56c2-9c55-2756e4ced30d	not reported	Pharmaceutical Therapy, NOS	19473a0f-ca4c-4793-bc69-60c380d71b7d
9fa303d7-d89d-4524-99fa-88999b042994.htseq.counts.gz	98c15a14-a0b8-4a54-bedc-dc6b96bac5fc	TCGA-AX-A06B-01A-11R-A00V-07	TCGA-AX-A06B-01A-11R	TCGA-AX-A06B-01A-01-BS1	TCGA-AX-A06B-01A-01-TS1		TCGA-AX-A06B-01A-11	TCGA-AX-A06B-01A	TCGA-AX-A06B	95e6d327-9ab7-45de-9527-f5634b3995c3	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1563	210.0	False	false	394E8BCD-1BE6-44C4-BDAC-D251A6C08E2B	1.76	e62793b0-8fb2-4c91-9f64-c0eae21571a7	0.16	23	released	a970fd10-ff56-4b1c-8847-a9b78596241a	RNA	R	0.16	UV Spec	released	False	5ad4b637-9b81-4885-91b7-b6647e5f3feb	11	5.0	0.0	2.0	0.0	36.0	2.0	60.0	72.0	BOTTOM	3f60ba31-1a26-4eff-8b2d-5e35f6802f40	released	7.0	0.0	2.0	0.0	18.0	2.0	78.0	85.0	TOP	088c195d-ea53-4630-a24b-07aa8d975e1b	released									released	30.0	a43f90b7-4a6c-423c-82de-ad2c330ae0fb	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A06B_demographic	72	-26348		26a37a66-829e-5cad-b2d4-c18ad2b5d28f	not hispanic or latino	female	white	released	Alive	1933		TCGA-AX-A06B_exposure	Not Reported	40.78768475066883	f49ae067-0c1b-5f64-9e09-3bcc404c8411	151.0	released	93.0	TCGA-AX-A06B_diagnosis	26348	not reported	0	2058	181824f3-502b-50d8-a5a6-1308d7c7fed1	Stage IIA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2005	TCGA-AX-A06B_treatment	TCGA-AX-A06B_treatment_1	released	2c0edc5d-dd45-5c1f-b9e1-854580e3588c	yes	Radiation Therapy, NOS	released	230b2a57-9530-52a9-9064-01268181f7d1	no	Pharmaceutical Therapy, NOS	98c15a14-a0b8-4a54-bedc-dc6b96bac5fc
983f1e8e-9c59-403d-b424-84aae2bca034.htseq.counts.gz	0fbcbdd5-c351-4063-980b-bebc6196d463	TCGA-E6-A2P9-01A-11R-A19W-07	TCGA-E6-A2P9-01A-11R	TCGA-E6-A2P9-01A-01-TSA			TCGA-E6-A2P9-01A-11	TCGA-E6-A2P9-01A	TCGA-E6-A2P9	077bdc90-1bbd-49ec-93a5-729b1ac1ba8d	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	189	230.0	False	true	EF7B01C4-0952-4FE8-B128-2A43FA31E6F5	1.86	08576085-2f37-41fc-82f6-39d396d75862	0.17	23	released	f801ec7c-c5d2-46b1-bae8-bf564e59087e	RNA	R	0.17	UV Spec	released	False	ac1f6b84-e195-46f2-a9ec-ab75565ce486	11	3.0	0.0	0.0	0.0	0.0	5.0	95.0	96.0	TOP	9774fa25-45d4-4d09-9c0c-69f2aee08602	released																				released	30.0	9c35e13b-87fc-4dc4-a847-dba192079ec1	Primary Tumor	01	released	Not Reported	released	TCGA-E6-A2P9_demographic	65	-24088		f4b4d94a-2b7d-53bd-8d10-811b893eed5d	not hispanic or latino	female	white	released	Alive	1946		TCGA-E6-A2P9_exposure	Not Reported	41.765511711049484	939c26c6-a93e-5caa-989b-16e875224c8f	173.0	released	125.0	TCGA-E6-A2P9_diagnosis	24088	not reported	0	1386	659e3007-fec4-561b-a424-41c0e035dc24	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-E6-A2P9_treatment	TCGA-E6-A2P9_treatment_1	released	5c509bb2-9e60-5357-b17b-4706277ea7e5	yes	Radiation Therapy, NOS	released	4f3204f9-4457-5947-aa41-c820c5e13e37	no	Pharmaceutical Therapy, NOS	0fbcbdd5-c351-4063-980b-bebc6196d463
e8caa240-51e5-41c2-8340-32613692be11.htseq.counts.gz	8ee7bc0a-351a-4c51-98b8-8aa83cfa34e5	TCGA-AJ-A3NC-11A-11R-A22K-07	TCGA-AJ-A3NC-11A-11R	TCGA-AJ-A3NC-11A-01-TS1			TCGA-AJ-A3NC-11A-11	TCGA-AJ-A3NC-11A	TCGA-AJ-A3NC	c8fb94dd-c535-48f4-9419-aac2bf47bbb4	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	282	70.0	False	false		1.8	cd0ccc13-2ce8-408e-aceb-1b363e98584f	0.16	23	released	511e9231-c091-4bb6-8630-6a563f93c7c9	RNA	R	0.16	UV Spec	released	False	43e24494-ce16-4816-9abf-f6687c53bfd8	11	1.0	0.0	0.0	0.0	100.0	0.0	0.0	0.0	TOP	3af0e14c-7ce0-448a-9de4-ae154f299c7f	released																				released	30.0	df404299-c2eb-4edd-9a9a-c20619b0f7c6	Solid Tissue Normal	11	released	Not Reported	released	TCGA-AJ-A3NC_demographic	63	-23353		af950860-01d9-57e3-a223-7ae401b8c798	not reported	female	white	released	Alive	1948		TCGA-AJ-A3NC_exposure	Not Reported	38.97392290249433	aaeea8bd-b083-526c-9941-e37eb1f1508c	168.0	released	110.0	TCGA-AJ-A3NC_diagnosis	23353	not reported	0	1125	53218018-d835-5878-a24c-d303aede851f	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-AJ-A3NC_treatment	TCGA-AJ-A3NC_treatment_1	released	0bfff125-be0b-51b9-a1b6-c3be59e73898	no	Radiation Therapy, NOS	released	0d89d31e-efaf-57e6-8b73-96f44d04b02c	no	Pharmaceutical Therapy, NOS	8ee7bc0a-351a-4c51-98b8-8aa83cfa34e5
138f223a-bca0-4ea0-9e04-e5a0b8c7c7c9.htseq.counts.gz	79f96970-5ee0-4667-b1c2-fe9807e9bcd9	TCGA-BK-A56F-01A-32R-A27V-07	TCGA-BK-A56F-01A-32R	TCGA-BK-A56F-01A-03-TS3			TCGA-BK-A56F-01A-32	TCGA-BK-A56F-01A	TCGA-BK-A56F	2d166dc0-8890-4b00-ab73-9e2dbb6c530d	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	93	360.0	False	false	2778F3EE-0211-4B51-8FBE-050FC7A4D0FF	1.9	5d83ceb3-a3f0-419e-945a-a5cf49d439e9	0.16	23	released	cd92de77-749b-4bcf-ae15-05d048ba7db6	RNA	R	0.16	UV Spec	released	False	9e0ce335-1b3c-40e3-8766-94bf707a33c0	32	3.0	0.0	10.0	0.0	0.0	0.0	90.0	60.0	TOP	5a054b42-a230-4735-ac43-5db1376d3b02	released																				released	30.0	ef8e84ff-3e1b-4543-99ee-56ee8687795c	Primary Tumor	01	released	Not Reported	released	TCGA-BK-A56F_demographic	75	-27523		eb35520c-df45-5f2c-a0c9-e8edc9832a81	not hispanic or latino	female	black or african american	released	Alive	1937		TCGA-BK-A56F_exposure	Not Reported	31.615792841281188	19430dbe-c729-5990-96d3-f2c22aa354ab	163.0	released	84.0	TCGA-BK-A56F_diagnosis	27523	not reported	0	401	8121aad3-2741-5b93-a575-16463d2f87f1	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2012	TCGA-BK-A56F_treatment	TCGA-BK-A56F_treatment_1	released	e8ca6047-6cfd-5ff0-9bb0-29364dff36a7	yes	Radiation Therapy, NOS	released	f696ebef-3673-5382-8e0f-a270338019e9	no	Pharmaceutical Therapy, NOS	79f96970-5ee0-4667-b1c2-fe9807e9bcd9
f18bc0a2-c3f6-4738-aae7-5e5e8276d848.htseq.counts.gz	c4d6416a-4a5c-43a0-8df5-63c11b56d448	TCGA-B5-A0K7-01A-11R-A104-07	TCGA-B5-A0K7-01A-11R	TCGA-B5-A0K7-01A-01-BSA	TCGA-B5-A0K7-01A-01-TSA		TCGA-B5-A0K7-01A-11	TCGA-B5-A0K7-01A	TCGA-B5-A0K7	2f0640bc-598c-4714-9e9b-7e0f2ca4567f	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	184	1160.0	False	true	5C3818CE-5DA9-403E-B895-61DEA4BBFA57	1.72	444a9114-2e40-4e7c-979a-624bc95d4c47	0.13	23	released	4f755ee1-c93b-407d-b8d0-cecbe9dcc033	RNA	R	0.13	UV Spec	released	False	e7178389-6e08-43eb-be9f-64668d92d56f	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	85.0	BOTTOM	b8636a59-070b-4875-9692-4d7b6c74a799	released	0.0	0.0	0.0	0.0	0.0	0.0	100.0	85.0	TOP	3c196ee4-4510-4904-a038-94a81ac1c9b9	released									released	30.0	51e8577d-6849-422e-8f37-2ea8c400bbe5	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A0K7_demographic	64	-23429		a7d688f5-0410-5408-8e94-f4d5621df1df	not reported	female	white	released	Alive	1945		TCGA-B5-A0K7_exposure	Not Reported	21.61281179138322	1c2dd909-f3cc-53db-8dd5-44b2b72cbf49	168.0	released	61.0	TCGA-B5-A0K7_diagnosis	23429	not reported	0	1933	2db53c86-27d4-5a81-a2a0-6ac0e682102b	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-B5-A0K7_treatment_1	TCGA-B5-A0K7_treatment	released	0bfff8c2-2a88-5852-8287-2802f55b5357	no	Pharmaceutical Therapy, NOS	released	3e5c4e8d-5a8a-55ea-bd1b-7b7f72c11076	yes	Radiation Therapy, NOS	c4d6416a-4a5c-43a0-8df5-63c11b56d448
47640d00-0eb4-443d-bb17-e7ae15af37e9.htseq.counts.gz	c6e038d7-fc1b-4358-89fc-dfe69edbcef0	TCGA-AX-A0J1-01A-11R-A040-07	TCGA-AX-A0J1-01A-11R	TCGA-AX-A0J1-01A-01-TS1	TCGA-AX-A0J1-01A-01-BS1		TCGA-AX-A0J1-01A-11	TCGA-AX-A0J1-01A	TCGA-AX-A0J1	ec7a9d74-8b3f-4747-8926-1739a016ab2b	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1721	220.0	False	false	38FCBC4A-2CAB-46EF-805D-121BEF85912E	1.91	20b8dd9b-c6b1-4a16-aeeb-e5aa49e62247	0.16	23	released	a67b79e6-b062-408d-ad85-9b0a7237cdd1	RNA	R	0.16	UV Spec	released	False	c994a987-bf7e-4fe7-8625-43d8b4fe5f0c	11	0.0	0.0	1.0	0.0	30.0	5.0	64.0	70.0	TOP	0708f648-98cb-4826-a6c7-5008795669c5	released	0.0	0.0	10.0	1.0	13.0	2.0	75.0	80.0	BOTTOM	f85a049e-045d-43ab-857d-66d8f8939ea8	released									released	30.0	ac14e378-2de1-458a-b8cd-7c60131aa927	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A0J1_demographic	80	-29501		e75c880e-40b7-5369-8760-575774b83938	not hispanic or latino	female	white	released	Alive	1925		TCGA-AX-A0J1_exposure	Not Reported	22.265625	bde33b39-a469-5426-af54-8ac0c1df3b42	160.0	released	57.0	TCGA-AX-A0J1_diagnosis	29501	not reported	0	2354	d6b774d2-1612-538f-a4b2-ffa96238483a	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2005	TCGA-AX-A0J1_treatment_1	TCGA-AX-A0J1_treatment	released	14c9dbd9-ed6d-54c4-b499-c38b825a0c15	no	Pharmaceutical Therapy, NOS	released	46084428-8366-5730-95d0-4857216622bb	no	Radiation Therapy, NOS	c6e038d7-fc1b-4358-89fc-dfe69edbcef0
7b6228be-5c4f-417a-b0bc-49be4169293b.htseq.counts.gz	4d37535c-cd46-46e2-97a0-0b45e40516b4	TCGA-EY-A1GV-01A-11R-A13S-07	TCGA-EY-A1GV-01A-11R	TCGA-EY-A1GV-01A-01-TSA			TCGA-EY-A1GV-01A-11	TCGA-EY-A1GV-01A	TCGA-EY-A1GV	e3e39474-c2b0-45af-bbe1-4c24f17cc284	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	156	300.0	False	false	87A6A698-71B7-41D8-AE28-C2FCC92F9A94	1.62	2b56219d-b0d0-4107-acdf-b2ad9c18f090	0.15	23	released	13b0027f-75d8-475c-b5e7-b22793e64f58	RNA	R	0.15	UV Spec	released	False	ebd800fa-627c-4a95-a960-60fa807d5d91	11	40.0	20.0	10.0	20.0	0.0	10.0	80.0	80.0	TOP	97922e37-799e-4339-a49b-82fa59c0877b	released																				released	30.0	8e9dd4fb-3de9-4bce-bf90-1692904088ca	Primary Tumor	01	released	Not Reported	released	TCGA-EY-A1GV_demographic	75	-27581		f7a149e5-b25a-58e3-8ad4-4457ffb83a89	not hispanic or latino	female	white	released	Alive	1935		TCGA-EY-A1GV_exposure	Not Reported	29.01744719926538	606cc6f6-7ef5-583f-b4ad-0698f592dd30	165.0	released	79.0	TCGA-EY-A1GV_diagnosis	27581	not reported	0	481	0e70f82d-667f-5df8-a3d6-5dbbd3ab01e2	Stage IIIC1	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-EY-A1GV_treatment	TCGA-EY-A1GV_treatment_1	released	b46d9d81-0276-5a48-8320-45c712937ffd	yes	Radiation Therapy, NOS	released	4fa3fe24-d5cc-5db6-a49e-080d72e596d9	yes	Pharmaceutical Therapy, NOS	4d37535c-cd46-46e2-97a0-0b45e40516b4
37b92ed0-5d5e-4851-b36a-dbb08ba49111.htseq.counts.gz	94372522-4e88-4d18-94a0-4d25002f29d2	TCGA-D1-A175-01A-11R-A12I-07	TCGA-D1-A175-01A-11R	TCGA-D1-A175-01A-01-TS1			TCGA-D1-A175-01A-11	TCGA-D1-A175-01A	TCGA-D1-A175	f0b3ab10-43f8-48a8-b460-66ceaaf637db	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	566	200.0	False	false	4A0D74F3-74A0-4CAE-960B-71D37DF4F4DE	1.33	5ff09a0f-1deb-41fe-9cad-4ed6556f2bf8	0.16	23	released	9843af05-b29f-4301-80ee-b52a266ea787	RNA	R	0.16	UV Spec	released	False	a197a64a-63f6-46ea-9c5e-338f1fa713d3	11	40.0	20.0	10.0	20.0	0.0	30.0	60.0	60.0	TOP	ff05a4a2-2849-474d-b4ce-601bc8265ce6	released																				released	30.0	07bfbb0c-b58b-4364-b12e-dca462c5b43e	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A175_demographic	48	-17802		5adae4ab-9d4c-5380-ba44-2fc49810993d	not hispanic or latino	female	white	released	Alive	1961		TCGA-D1-A175_exposure	Not Reported	24.690405462752206	d1aca2e9-2c87-5f53-a742-ce1e44a59000	161.0	released	64.0	TCGA-D1-A175_diagnosis	17802	not reported	0	202	5a78079f-1378-5ba1-be36-e3047a837778	Stage IC	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-D1-A175_treatment	TCGA-D1-A175_treatment_1	released	504387e3-8483-54d6-930b-87ed3e89ac8b	yes	Radiation Therapy, NOS	released	8c59e5d0-addc-508c-8c1b-b3fe11b06f28	yes	Pharmaceutical Therapy, NOS	94372522-4e88-4d18-94a0-4d25002f29d2
ccdfb795-0b81-4050-b83e-cef9caf05713.htseq.counts.gz	54405551-0f35-42b2-8d5e-89d0143b3358	TCGA-AX-A2H5-01A-11R-A17B-07	TCGA-AX-A2H5-01A-11R	TCGA-AX-A2H5-01A-01-TSA			TCGA-AX-A2H5-01A-11	TCGA-AX-A2H5-01A	TCGA-AX-A2H5	c88e3901-f3ee-436a-ba80-143c8eab7d69	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	2206	100.0	False	false	BF4BE7F8-7D37-4CB2-B340-FAE14155F257	2.08	2f712e62-f400-4922-bdc5-d5d06276101d	0.17	23	released	901ff01d-4e37-44af-b3fd-ed4d1b4226e6	RNA	R	0.17	UV Spec	released	False	18c05333-77bc-4488-a35c-9cbb2ea842a5	11	1.0	1.0	2.0	0.0	0.0	4.0	94.0	97.0	TOP	d840ca6e-8c30-4292-8b89-035e3a72788d	released																				released	30.0	44eb96b4-5e4f-460b-bc51-add38cbc76a1	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A2H5_demographic	67	-24757		e0765893-2c2e-50ce-a4c7-ac3526a8746e	not hispanic or latino	female	black or african american	released	Alive	1938		TCGA-AX-A2H5_exposure	Not Reported	33.56351992592878	53f71c9b-db2a-52d3-9637-6e9637de8750	161.0	released	87.0	TCGA-AX-A2H5_diagnosis	24757	not reported	0	2167	a2c8a8c5-431a-528b-b5d2-e077796b783d	Stage IIIC	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2005	TCGA-AX-A2H5_treatment	TCGA-AX-A2H5_treatment_1	released	95a7a730-476b-5069-9f63-3652c25c345f	yes	Radiation Therapy, NOS	released	57c6e796-a4e8-56ce-9a7d-1c6fe208cb9f	yes	Pharmaceutical Therapy, NOS	54405551-0f35-42b2-8d5e-89d0143b3358
f58a5c4d-a655-483b-a8f8-6919052eb6d4.htseq.counts.gz	7ac2632d-781c-4725-a024-1778bdaff58c	TCGA-B5-A3FC-01A-11R-A22K-07	TCGA-B5-A3FC-01A-11R	TCGA-B5-A3FC-01A-01-TSA			TCGA-B5-A3FC-01A-11	TCGA-B5-A3FC-01A	TCGA-B5-A3FC	ec2040a3-788b-4f2c-a093-c5c4b3dc4b6c	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1814	150.0	False	true	4A63436E-BBC1-4F02-9B72-7ED4CC2AC1CD	1.83	cfc3065f-652c-458b-926f-24092edb803f	0.17	23	released	38455dcc-32dc-4d6e-ba5c-801a650a5d01	RNA	R	0.17	UV Spec	released	False	9446f713-5dba-49bd-8327-1fc3bd0ef7a6	11	1.0	2.0	5.0	0.0	0.0	0.0	95.0	95.0	TOP	6a897a5d-dc69-4b74-bc89-13ff3a7502df	released																				released	30.0	cb538aff-c08c-455d-8dd8-e3cd0d404e00	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A3FC_demographic	53	-19422		17832a39-9b9c-59f2-a313-ab23798e31fa	not hispanic or latino	female	black or african american	released	Alive	1953		TCGA-B5-A3FC_exposure	Not Reported	26.609712545078953	15ac7684-3a9e-5e8f-928e-a644158063df	169.0	released	76.0	TCGA-B5-A3FC_diagnosis	19422	not reported	0	2185	8f92a82c-7e5e-5769-ad9a-c8226ae6c174	Stage II	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2006	TCGA-B5-A3FC_treatment_1	TCGA-B5-A3FC_treatment	released	9cdb9604-d03b-5b83-89a5-dcf3bb540db6	no	Pharmaceutical Therapy, NOS	released	f3176092-333e-52ee-8d52-6f340ed83f29	no	Radiation Therapy, NOS	7ac2632d-781c-4725-a024-1778bdaff58c
65609104-efd1-4527-aafa-1c59d76876a6.htseq.counts.gz	64a5f5ce-d7f6-42ba-9f12-4c041d97d0e1	TCGA-BS-A0UA-01A-11R-A118-07	TCGA-BS-A0UA-01A-11R	TCGA-BS-A0UA-01A-01-MS1	TCGA-BS-A0UA-01A-01-TS1		TCGA-BS-A0UA-01A-11	TCGA-BS-A0UA-01A	TCGA-BS-A0UA	a1a0177d-e670-4f2f-a99d-6f668a2f9e8a	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	2361	50.0	False	false	58DC7332-5100-408B-9A1E-F0282B013648	1.82	97ffaeb2-3ff9-41ff-9552-27f622469460	0.14	23	released	0d7b5a13-853e-41d0-a0dc-a43a4f78c0a3	RNA	R	0.14	UV Spec	released	False	0f8eeb71-7011-4e42-8d70-cb0d10fd6688	11	0.0	0.0	0.0	0.0	10.0	40.0	50.0	50.0	BOTTOM	8b842815-0a31-444f-84af-44ba42fd2488	released	0.0	20.0	0.0	0.0	0.0	10.0	90.0	100.0	TOP	612653f3-1d4d-4ec1-873a-750e661f3e49	released									released	30.0	c72da85c-c6dc-4567-9db6-f15b044328dc	Primary Tumor	01	released	Not Reported	released	TCGA-BS-A0UA_demographic	68	-24872		344d426f-68fd-5ffe-8808-4716cab3c3c5	not hispanic or latino	female	white	released	Alive	1936		TCGA-BS-A0UA_exposure	Not Reported	27.700831024930746	0b21253a-2093-5bec-beb4-b04f3a37a2f8	152.0	released	64.0	TCGA-BS-A0UA_diagnosis	24872	not reported	0	3495	2f04a3a1-b00b-5cfc-87b4-d4bd9b401c23	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2004	TCGA-BS-A0UA_treatment	TCGA-BS-A0UA_treatment_1	released	223ec108-3a8d-593c-9628-338927ee526d	yes	Radiation Therapy, NOS	released	fabd1354-6b0f-5413-9488-bb25397aea3a	no	Pharmaceutical Therapy, NOS	64a5f5ce-d7f6-42ba-9f12-4c041d97d0e1
51d9ffed-23ce-4e3e-afec-5ac0b189b113.htseq.counts.gz	9746938a-56c9-4a1b-9164-e8a20e570a2a	TCGA-AP-A0L8-01A-11R-A040-07	TCGA-AP-A0L8-01A-11R	TCGA-AP-A0L8-01A-01-BSA	TCGA-AP-A0L8-01A-01-TSA		TCGA-AP-A0L8-01A-11	TCGA-AP-A0L8-01A	TCGA-AP-A0L8	9aa8c2b4-db32-4899-bf0c-d578cb175e90	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	3510	110.0	False	true	A708C154-A635-4423-A1A0-BB1FC23D3613	1.7	ca1e32b0-7daf-403e-a3b2-7cfd3948cedf	0.14	23	released	ac56ffa1-aacf-4ca5-97eb-6a7b7834ae55	RNA	R	0.14	UV Spec	released	False	f6a521ef-9222-4b0b-8362-5412cf98d788	11	10.0	0.0	10.0	10.0	30.0	0.0	60.0	70.0	BOTTOM	3bd0b305-fc91-4904-bb40-dc57f95ee394	released	10.0	0.0	10.0	10.0	30.0	0.0	60.0	70.0	TOP	e7ff33de-2622-4476-a2df-4240b06b8342	released									released	30.0	d1a7a58f-7a35-4a94-a337-051ae56ded00	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A0L8_demographic	70	-25733	1484	dc7a4a86-4e5d-5763-939f-1ef9f9df5bf5	not reported	female	black or african american	released	Dead	1930	2004	TCGA-AP-A0L8_exposure	Not Reported		183b7693-81b6-5a19-b7df-4f681073eff7		released	61.0	TCGA-AP-A0L8_diagnosis	25733	not reported	0		45d8de3a-d52a-5566-8697-68775330fbba	Stage IIIC2	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2000	TCGA-AP-A0L8_treatment_1	TCGA-AP-A0L8_treatment	released	250dcdf9-601d-5a12-a9b3-04a45ab42968	no	Pharmaceutical Therapy, NOS	released	d602a5df-060d-5d39-b2af-cd35f774b133	yes	Radiation Therapy, NOS	9746938a-56c9-4a1b-9164-e8a20e570a2a
fd08f7a8-683a-44de-add7-5936e6c0617d.htseq.counts.gz	0d94181a-3858-445b-a86f-0dea61004317	TCGA-D1-A161-01A-11R-A118-07	TCGA-D1-A161-01A-11R	TCGA-D1-A161-01A-01-TS1			TCGA-D1-A161-01A-11	TCGA-D1-A161-01A	TCGA-D1-A161	0305db4a-62ee-4ecb-bede-032981298732	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	864	170.0	False	false	E68A0ED2-CBE3-40A9-8DBF-A3BBC49204DD	1.85	9336e8ea-7afe-45b3-b9e7-add7141ecca0	0.16	23	released	8c5dc308-4728-440f-8041-c910df7e0e17	RNA	R	0.16	UV Spec	released	False	bdf0e0e8-d1e5-4822-8c3e-d77c72e1bb52	11	0.0	0.0	0.0	0.0	25.0	0.0	75.0	60.0	TOP	42f8d0d2-50e6-4583-80e7-5f1732ba48ce	released																				released	30.0	94ad0779-7342-4f52-a6da-aed090129cd1	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A161_demographic	78	-28695		3c625a1d-559a-5c1f-a2ac-a798cda8da14	not hispanic or latino	female	white	released	Alive	1930		TCGA-D1-A161_exposure	Not Reported	28.084332107116012	7e4283df-2ac2-50d7-b858-b1a9ac7f8d38	159.0	released	71.0	TCGA-D1-A161_diagnosis	28695	not reported	0	892	e0980a3b-3670-52a5-ad47-b6f1b4467acc	Stage IC	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-D1-A161_treatment_1	TCGA-D1-A161_treatment	released	b27f6bfe-e5c0-54fd-b6df-7ea269981002	no	Pharmaceutical Therapy, NOS	released	2b6b0ec2-b4fd-5d34-b117-87d3a3ac016d	no	Radiation Therapy, NOS	0d94181a-3858-445b-a86f-0dea61004317
0214a707-de46-4b7b-899b-89390ad86b60.htseq.counts.gz	07adf2dd-5e01-4928-9d05-5077257249be	TCGA-BK-A139-01A-11R-A277-07	TCGA-BK-A139-01A-11R	TCGA-BK-A139-01A-01-BSA	TCGA-BK-A139-01A-01-TSA		TCGA-BK-A139-01A-11	TCGA-BK-A139-01A	TCGA-BK-A139	8d9e4917-334b-4c76-aee1-1e22be772db0	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	175	770.0	False	false	5F8C376B-31F8-4566-8EBF-21E7F4E6499D	1.84	8e901591-a236-4208-899b-f1bde1e5f841	0.15	23	released	e8da3efa-c60c-43a1-af72-3772da62d2b2	RNA	R	0.15	UV Spec	released	False	4e7f7eeb-0b1c-4f53-842c-229ea461c6d8	11	50.0	20.0	60.0	50.0	0.0	10.0	30.0	90.0	BOTTOM	08b415f6-1a0a-4b55-96a1-3a26b26e7c0b	released	20.0	10.0	20.0	20.0	0.0	20.0	60.0	80.0	TOP	18724d00-97cf-48c0-b7bb-638a80ef5e39	released									released	30.0	d777e49b-cb47-44f3-ad42-4d23af7e296c	Primary Tumor	01	released	Not Reported	released	TCGA-BK-A139_demographic	74	-27077	943	283a931a-a653-50c4-992a-c69e21c6af1c	not hispanic or latino	female	white	released	Dead	1936		TCGA-BK-A139_exposure	Not Reported	24.87771968291449	8155bfc1-1c5f-5642-9a14-8b020eeb7bf3	154.0	released	59.0	TCGA-BK-A139_diagnosis	27077	not reported	0	309	fff68755-ed35-52d0-9a4f-86a4b19bc82e	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-BK-A139_treatment	TCGA-BK-A139_treatment_1	released	6c775c6a-d5bf-5bd8-8b8c-3a27635d6c8e	no	Radiation Therapy, NOS	released	de6d0cd2-02d1-51e0-9e71-feb4f4d24986	no	Pharmaceutical Therapy, NOS	07adf2dd-5e01-4928-9d05-5077257249be
abb0a6a3-4a2f-4686-b9d0-41c40b94d170.htseq.counts.gz	edbbee47-5b60-46ac-adf2-2cf217d8f69e	TCGA-D1-A17U-01A-21R-A12I-07	TCGA-D1-A17U-01A-21R	TCGA-D1-A17U-01A-02-TS2			TCGA-D1-A17U-01A-21	TCGA-D1-A17U-01A	TCGA-D1-A17U	6397c4a1-0a29-4c2c-b8cb-ce73af93dd0b	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	314	210.0	False	false	A0A4164D-FD8D-4472-BAFA-A036469E22CC	1.88	07508c27-8f79-414e-af9d-e78240df5c48	0.17	23	released	f8554b65-fecf-4570-ac11-a52ca3a118c7	RNA	R	0.17	UV Spec	released	False	d0c9d545-e1e6-446a-b1b0-a7ae8dc5a2d4	21	0.0	0.0	0.0	0.0	0.0	0.0	100.0	65.0	BOTTOM	dde736f1-b204-43c9-b43f-52cd95e5fe7a	released																				released	20.0	1f1945ee-4cf3-43a3-9998-1c4528c7a511	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A17U_demographic	53	-19544		eada4ab5-d648-5c4f-9f46-ea31cebd6457	not hispanic or latino	female	white	released	Alive	1957		TCGA-D1-A17U_exposure	Not Reported	30.82482993197279	918a068f-b3f6-5d96-9f0e-aa9fe0296146	168.0	released	87.0	TCGA-D1-A17U_diagnosis	19544	not reported	0	697	0e51088d-0e30-5949-82fe-36db6f57ac16	Stage IIIC2	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-D1-A17U_treatment	TCGA-D1-A17U_treatment_1	released	df41d07b-14db-5a29-bfa5-c1eaa22cb4aa	yes	Radiation Therapy, NOS	released	3024d0f7-2147-561a-9ca3-51ccb99736ff	yes	Pharmaceutical Therapy, NOS	edbbee47-5b60-46ac-adf2-2cf217d8f69e
6c85fe07-e17c-4450-b4d9-f20d24924d8b.htseq.counts.gz	8968a7cd-0194-4d74-b1d6-deabc43310fe	TCGA-BS-A0V6-01A-11R-A118-07	TCGA-BS-A0V6-01A-11R	TCGA-BS-A0V6-01A-01-TS1	TCGA-BS-A0V6-01A-01-MS1		TCGA-BS-A0V6-01A-11	TCGA-BS-A0V6-01A	TCGA-BS-A0V6	a9b6cd65-f042-4073-9000-4143a2c55373	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1462	80.0	False	false	657466BC-3CA2-4568-BF64-2905571C3666	1.84	a7efbfc2-48f4-44ec-a8a6-7e565cfe2b6a	0.16	23	released	76d9d53a-f046-4d2e-87b8-6e3b4e3423c2	RNA	R	0.16	UV Spec	released	False	64c2137a-10e4-4cd7-b7e4-efecd09702b3	11	30.0	0.0	20.0	20.0	0.0	10.0	70.0	90.0	TOP	935ddf91-06b4-4553-930a-41605aa2548f	released	40.0	2.0	5.0	2.0	25.0	30.0	40.0	30.0	BOTTOM	2ed39e1a-3670-47f2-bafb-7f87ed4da19d	released									released	20.0	1c337d11-f2ac-48cf-9c8f-ec27550876ea	Primary Tumor	01	released	Not Reported	released	TCGA-BS-A0V6_demographic	55	-20369		118bb2cb-a544-5ce7-9eba-f989bd4f48f0	not hispanic or latino	female	asian	released	Alive	1951		TCGA-BS-A0V6_exposure	Not Reported	33.6727656294373	30700f2f-dec9-5942-9ef2-88c96f520b82	157.0	released	83.0	TCGA-BS-A0V6_diagnosis	20369	not reported	0	2725	f9e16061-74b2-560a-844c-561de6ed91ab	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2006	TCGA-BS-A0V6_treatment	TCGA-BS-A0V6_treatment_1	released	a29ed7c9-472f-5e82-aa48-b3ce4b8057bd	no	Radiation Therapy, NOS	released	37347f9c-ef2d-5dd8-80ca-5ce0b6e7470c	no	Pharmaceutical Therapy, NOS	8968a7cd-0194-4d74-b1d6-deabc43310fe
22bdcfae-7b41-434f-81e0-3867cd30b3c2.htseq.counts.gz	3aa77df8-733d-4646-b518-b429c10c348d	TCGA-EY-A1GU-01A-11R-A13S-07	TCGA-EY-A1GU-01A-11R	TCGA-EY-A1GU-01A-01-TSA			TCGA-EY-A1GU-01A-11	TCGA-EY-A1GU-01A	TCGA-EY-A1GU	5dd28537-d24f-4a6d-a454-6f64cf37e16a	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	189	380.0	False	false	7A06A8F8-416F-41CD-B546-95DEA06996D0	1.67	02302c44-fe54-4b39-9bef-c56db229c2ac	0.15	23	released	f4dde49c-e9a2-465b-9be8-73177c9b21dd	RNA	R	0.15	UV Spec	released	False	6448a84b-23ec-4e59-9483-4aa94ebd059e	11	40.0	10.0	5.0	40.0	0.0	15.0	80.0	80.0	TOP	687bddc2-4ed6-4f56-bbad-84bf72ab618f	released																				released	30.0	ef348984-8c78-46a3-8e76-d5d974819d1b	Primary Tumor	01	released	Not Reported	released	TCGA-EY-A1GU_demographic	66	-24304	997	fc12f5c0-916b-58cd-adf6-ffd5a2316196	not hispanic or latino	female	black or african american	released	Dead	1944		TCGA-EY-A1GU_exposure	Not Reported	35.15625	8af56266-28ad-56d8-a31a-6f75b263a63c	160.0	released	90.0	TCGA-EY-A1GU_diagnosis	24304	not reported	0	378	b9931a2c-2e4f-5dc9-a4b5-6d30be3fd97d	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-EY-A1GU_treatment_1	TCGA-EY-A1GU_treatment	released	2640887f-849c-5782-b050-33c207e9c2e8	no	Pharmaceutical Therapy, NOS	released	81fcac9b-cdd5-51cf-be43-8e65f8cb3379	yes	Radiation Therapy, NOS	3aa77df8-733d-4646-b518-b429c10c348d
f8001c8a-39b5-4ff9-b607-cf91ad696494.htseq.counts.gz	d346b232-8e08-4116-850a-71bfd1a79921	TCGA-EO-A2CG-01A-12R-A180-07	TCGA-EO-A2CG-01A-12R	TCGA-EO-A2CG-01A-01-TS1			TCGA-EO-A2CG-01A-12	TCGA-EO-A2CG-01A	TCGA-EO-A2CG	af363cec-bec9-4de3-8cc2-e98b0eed2858	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	643	60.0	False	false	CAF671DB-2DD1-43D5-99C8-185253775B37	1.87	5f65a8b5-2460-4544-be71-5e7b7347b0fa	0.16	23	released	07881191-f7a0-4275-800c-2c855b50af02	RNA	R	0.16	UV Spec	released	False	9510c1d0-3512-4080-b667-face7e065147	12	0.0	0.0	0.0	0.0	20.0	0.0	80.0	75.0	TOP	8fdad480-24ea-485a-8087-877cd5143349	released																				released	30.0	cf894594-77cc-471e-b112-5eae1829c415	Primary Tumor	01	released	Not Reported	released	TCGA-EO-A2CG_demographic	69	-25279		07c36ef4-9831-5e46-a1af-0458dd1703c6	not hispanic or latino	female	asian	released	Alive	1940		TCGA-EO-A2CG_exposure	Not Reported	29.43213296398892	10ada757-7957-52ba-9d8a-23d6fa925270	152.0	released	68.0	TCGA-EO-A2CG_diagnosis	25279	not reported	0	1564	8f4ffe4f-967f-5d0a-876b-1bc00c13b80d	Stage IA	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-EO-A2CG_treatment_1	TCGA-EO-A2CG_treatment	released	5f6c3462-b98b-589d-af5c-7f1e22c399d6	yes	Pharmaceutical Therapy, NOS	released	1488e994-e459-5daf-ba2e-e37bba5831c0	yes	Radiation Therapy, NOS	d346b232-8e08-4116-850a-71bfd1a79921
e7a29167-b58f-4fec-9b5e-cfd6b7c922a9.htseq.counts.gz	6e6b0294-ed2b-495b-bab6-053cd2ac8073	TCGA-AJ-A2QM-01A-11R-A18M-07	TCGA-AJ-A2QM-01A-11R	TCGA-AJ-A2QM-01A-01-TSA			TCGA-AJ-A2QM-01A-11	TCGA-AJ-A2QM-01A	TCGA-AJ-A2QM	d9f4a2c1-ac6d-48c6-95fe-ffbc2fa08268	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	108	210.0	False	false	282D10FF-370D-4252-B1CB-3410A43C8F82	1.81	2bd4aa66-5a09-4bac-bfd0-fc3519d398a1	0.18	23	released	12fe7b63-34a5-4674-ab2a-bee8371594d9	RNA	R	0.18	UV Spec	released	False	3f996f67-17d3-489e-9611-7557c74a0837	11	3.0	8.0	4.0	5.0	0.0	10.0	86.0	90.0	TOP	a7357359-de36-4ab7-991c-8a0a08feb731	released																				released	30.0	f2748bad-0575-4258-9186-118bbd471325	Primary Tumor	01	released	Not Reported	released	TCGA-AJ-A2QM_demographic	67	-24776		e636331b-e748-57b6-8d24-32106af64cdf	not hispanic or latino	female	white	released	Alive	1944		TCGA-AJ-A2QM_exposure	Not Reported	25.60553633217993	280ff0e1-7698-53b7-8443-e8d26cac5bba	170.0	released	74.0	TCGA-AJ-A2QM_diagnosis	24776	not reported	0	894	dde0f5b7-2211-5416-ac11-5766a2b0cf8d	Stage II	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2011	TCGA-AJ-A2QM_treatment	TCGA-AJ-A2QM_treatment_1	released	4df372b1-60ba-52b0-93b7-48970232bb46	yes	Radiation Therapy, NOS	released	e39fe0b1-f37d-5291-a51b-fb1072416dcc	yes	Pharmaceutical Therapy, NOS	6e6b0294-ed2b-495b-bab6-053cd2ac8073
686d388d-92b0-43c7-a68b-71c6a26d19d3.htseq.counts.gz	48df1ee5-f7fe-4b3f-a7ca-5f61b03efa1d	TCGA-AP-A0LF-01A-11R-A118-07	TCGA-AP-A0LF-01A-11R	TCGA-AP-A0LF-01A-01-BSA	TCGA-AP-A0LF-01A-01-TSA		TCGA-AP-A0LF-01A-11	TCGA-AP-A0LF-01A	TCGA-AP-A0LF	748e38b1-2ead-4a0a-8881-d640617b856b	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	2891	240.0	False	true	7112CE75-9EFD-4989-9F2A-4D0F517B8EDE	1.86	2c5d86e0-2e3d-4259-97e9-023df54c8c56	0.17	23	released	3b7a90dd-db50-4cec-9e96-5a2472fcddb0	RNA	R	0.17	UV Spec	released	False	900d67db-959b-4415-9680-c5eb717ae09d	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	60.0	BOTTOM	8e902213-2e30-454a-ab73-99a4a4ece6e0	released	0.0	0.0	0.0	0.0	0.0	0.0	100.0	60.0	TOP	7e71c711-fc0e-4a85-b54d-3334a88ba5ed	released									released	30.0	902e2dd8-81e5-4949-a57b-92b3efd86c63	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A0LF_demographic	82	-30027		157a0de8-9a60-547a-92df-8b04e55b9482	not hispanic or latino	female	white	released	Alive	1920		TCGA-AP-A0LF_exposure	Not Reported	27.776706145596233	9181fcd6-8106-512e-a88e-498f332aa9d5	161.0	released	72.0	TCGA-AP-A0LF_diagnosis	30027	not reported	0	2845	e09759b2-7f3c-5e76-b034-8b15aebd184d	Stage IVB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2002	TCGA-AP-A0LF_treatment_1	TCGA-AP-A0LF_treatment	released	001c8597-a3cd-52d3-bc75-f0b78f2a47fe	no	Pharmaceutical Therapy, NOS	released	071b4f71-ac6c-510a-97c4-4fa5c83397a4	no	Radiation Therapy, NOS	48df1ee5-f7fe-4b3f-a7ca-5f61b03efa1d
80ba6169-1f5a-415b-a1b0-e16ac6427e18.htseq.counts.gz	bac893dd-512d-4405-8597-57098fdf46d7	TCGA-D1-A17M-01A-21R-A12I-07	TCGA-D1-A17M-01A-21R	TCGA-D1-A17M-01A-02-TS2			TCGA-D1-A17M-01A-21	TCGA-D1-A17M-01A	TCGA-D1-A17M	02b2cd50-221f-437c-a1ce-6da1467ec809	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	454	140.0	False	false	E69EF984-AF58-4EB0-93D2-CADE53DF0A6D	1.8	7e8a4ecc-07b0-4765-a8da-5868523736f5	0.16	23	released	0a8fd77b-6e5a-4be2-b6ed-1b28110bcc94	RNA	R	0.16	UV Spec	released	False	b6919532-ca53-4c16-a4d5-403f77ae73a7	21	10.0	2.0	0.0	3.0	0.0	35.0	65.0	65.0	BOTTOM	2258ba92-6aa3-411b-afad-91ee27b5fd06	released																				released	30.0	027f53c8-0687-495f-917a-4dc6894216a6	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A17M_demographic	56	-20685		196b8cc4-bb1e-5790-9ba1-218e0a0309a2	not hispanic or latino	female	white	released	Alive	1953		TCGA-D1-A17M_exposure	Not Reported	53.44574504121344	0efc3a6b-6582-5a6b-9790-9b52cb0addec	163.0	released	142.0	TCGA-D1-A17M_diagnosis	20685	not reported	0	311	20b0d629-74ae-5329-b423-57586cbea3b1	Stage II	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-D1-A17M_treatment_1	TCGA-D1-A17M_treatment	released	149d8bd2-4578-5e0a-af56-0a5873dcb7b7	no	Pharmaceutical Therapy, NOS	released	c76664c7-f9f7-5ddc-b6c1-509eac7499a1	yes	Radiation Therapy, NOS	bac893dd-512d-4405-8597-57098fdf46d7
ee5cf540-f7c4-4cbb-89f6-41bf2583981b.htseq.counts.gz	fd75b433-530f-4e41-bb39-29e7430316f6	TCGA-A5-A0R9-01A-11R-A104-07	TCGA-A5-A0R9-01A-11R	TCGA-A5-A0R9-01A-01-BSA	TCGA-A5-A0R9-01A-01-TSA		TCGA-A5-A0R9-01A-11	TCGA-A5-A0R9-01A	TCGA-A5-A0R9	284174fd-1320-4617-9e99-75bd75df9bf3	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	471	270.0	False	true	0AAD58D4-7865-4235-AE18-8685DC5F4FE1	1.81	d4ab800e-e0c4-40ae-8256-7271d22d1470	0.16	23	released	005001c8-0bd5-49ed-8c86-30b8a3765ed0	RNA	R	0.16	UV Spec	released	False	1436aff8-872d-459c-bf4e-a3349130331b	11	0.0	0.0	0.0	0.0	0.0	5.0	95.0	95.0	BOTTOM	726730b2-c031-484f-983f-31459814b896	released	0.0	0.0	0.0	0.0	0.0	0.0	100.0	98.0	TOP	0e41ca6e-6334-4f76-819b-400649cbaf08	released									released	30.0	986ac6ac-087f-412b-bb0c-9be10d104989	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A0R9_demographic	51	-18982		e1dc80db-4a53-5b1c-9d21-5577d2a116db	not hispanic or latino	female	white	released	Alive	1958		TCGA-A5-A0R9_exposure	Not Reported	54.57488049983063	0d99fb9b-4664-57eb-ac00-ed3f48bf8905	163.0	released	145.0	TCGA-A5-A0R9_diagnosis	18982	not reported	0	749	c1a50eaf-8bbe-5be7-b81e-efb5e1921af2	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-A5-A0R9_treatment	TCGA-A5-A0R9_treatment_1	released	339de67c-c87f-5567-8418-61f2d754ece7	yes	Radiation Therapy, NOS	released	dd60a236-7b80-5637-a800-5786fdbaefe3	no	Pharmaceutical Therapy, NOS	fd75b433-530f-4e41-bb39-29e7430316f6
74d699e7-e9f5-4bf7-a939-c32493016921.htseq.counts.gz	e80cdddd-0af6-408e-94a0-48960716c623	TCGA-A5-A0GV-01A-31R-A16W-07	TCGA-A5-A0GV-01A-31R	TCGA-A5-A0GV-01A-03-TSC	TCGA-A5-A0GV-01A-03-BSC		TCGA-A5-A0GV-01A-31	TCGA-A5-A0GV-01A	TCGA-A5-A0GV	5e3b981e-73fe-4cc9-8c89-b420e8e2f426	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	454	330.0	False	true	0E6417D3-6E95-4EEF-AE93-40D69D4F6525	1.81	e1c80dfd-3db5-4005-9bb5-245124d4dc0f	0.14	23	released	630eced3-4a14-4e3d-978d-f229a3e6edff	RNA	R	0.14	UV Spec	released	False	a76405f0-50c4-41e7-9690-70d304b3a579	31	1.0	1.0	5.0	0.0	0.0	3.0	92.0	95.0	TOP	657bc432-8053-44f3-b484-357aa6901915	released	0.0	0.0	5.0	0.0	0.0	3.0	92.0	98.0	BOTTOM	0130f61b-ff0a-48aa-b04f-36ddcb673a8e	released									released	30.0	339926e1-61e6-4256-a808-f931aa2c17d2	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A0GV_demographic	67	-24540		42b773b4-de7e-563d-b394-022955a80a1b	not hispanic or latino	female	white	released	Alive	1942		TCGA-A5-A0GV_exposure	Not Reported	25.236340330075308	63456843-86ba-5082-93e7-00bab5612ab1	158.0	released	63.0	TCGA-A5-A0GV_diagnosis	24540	not reported	0	1643	e71ae858-ef0c-5ca2-a931-dbf8abbb0e7b	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-A5-A0GV_treatment_1	TCGA-A5-A0GV_treatment	released	90acf6df-574c-56f1-b240-cbc33f46c2d3	no	Pharmaceutical Therapy, NOS	released	a20ab2ad-87d8-51ff-948f-ca3415f53cd6	yes	Radiation Therapy, NOS	e80cdddd-0af6-408e-94a0-48960716c623
bdc49eae-31d4-425b-b7d1-49f1cf14df44.htseq.counts.gz	f7b1dcfd-1cb8-4e03-8c23-cab7beb38888	TCGA-B5-A1MZ-01A-11R-A144-07	TCGA-B5-A1MZ-01A-11R	TCGA-B5-A1MZ-01A-01-TSA			TCGA-B5-A1MZ-01A-11	TCGA-B5-A1MZ-01A	TCGA-B5-A1MZ	838fcc2b-48b4-49dd-b8fc-ff27bbd16b17	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	114	130.0	False	true	071A53F9-6E40-4402-8353-BB963AFE5C33	1.85	770fd2b7-24cf-432b-829d-39364a11277d	0.15	23	released	242f3c70-da92-464d-ad32-ee0b248326f7	RNA	R	0.15	UV Spec	released	False	08baddd1-51b6-4800-b5f7-30ca4acc22bc	11	20.0	3.0	0.0	5.0	0.0	15.0	85.0	85.0	TOP	0bfcc6bd-5d49-476b-9866-b342d9f2574a	released																				released	30.0	cba2dcfb-5988-435c-99c1-445a36c6082f	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A1MZ_demographic	54	-19955		d0725cda-50ff-56dc-a9bd-64f4ae186931	not reported	female	white	released	Alive	1956		TCGA-B5-A1MZ_exposure	Not Reported	41.37030047902453	dcd65c55-1006-55e9-a1f7-b0fdd38403a9	166.0	released	114.0	TCGA-B5-A1MZ_diagnosis	19955	not reported	0	1598	474dca13-43a1-5c7a-8fa9-21dfd1a79d7b	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-B5-A1MZ_treatment_1	TCGA-B5-A1MZ_treatment	released	4ed38f78-56f5-58a6-aa3f-fbb6bc159cfa	no	Pharmaceutical Therapy, NOS	released	b187910f-eff1-59c2-ad9a-0b9551241194	yes	Radiation Therapy, NOS	f7b1dcfd-1cb8-4e03-8c23-cab7beb38888
0011596d-cfa3-48f7-b182-b1e5765209fc.htseq.counts.gz	e381ac7f-46b4-419a-86cf-73d6e858807e	TCGA-D1-A1NW-01A-11R-A14M-07	TCGA-D1-A1NW-01A-11R	TCGA-D1-A1NW-01A-01-TS1			TCGA-D1-A1NW-01A-11	TCGA-D1-A1NW-01A	TCGA-D1-A1NW	d7258a64-3ea0-40fc-b3f4-b581a1725fff	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	199	80.0	False	false	10E1E872-408C-458D-9438-00F5ECA3083A	1.82	35759844-0020-4b37-bd5a-ede870b7f0ab	0.16	23	released	476109fe-9d56-4162-bbc2-f8aafc17e3e9	RNA	R	0.16	UV Spec	released	False	4840796f-9972-48d4-84d7-97c431d81a09	11	40.0	20.0	5.0	20.0	0.0	5.0	90.0	90.0	TOP	6c1e3c0a-2c0e-4ca4-a088-8f6c6d2715d8	released																				released	30.0	b79a1d9c-02ef-4192-beb3-bca8b362eb2e	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A1NW_demographic	72	-26556		694e78fe-7a46-5958-8551-9345298fe4ba	not hispanic or latino	female	white	released	Alive	1938		TCGA-D1-A1NW_exposure	Not Reported	38.28125	248a0f69-967e-5d4c-acbb-715c3c04cc74	160.0	released	98.0	TCGA-D1-A1NW_diagnosis	26556	not reported	0	22	5d5d849c-052c-5063-ade9-20bd9e3e4943	Stage IVB	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-D1-A1NW_treatment_1	TCGA-D1-A1NW_treatment	released	c5fc2054-6e39-55e6-b1e1-df513c98bfa2	no	Pharmaceutical Therapy, NOS	released	683c480b-caa4-509d-9f18-23dbd20d4781	no	Radiation Therapy, NOS	e381ac7f-46b4-419a-86cf-73d6e858807e
b7f1ca65-f09f-4eba-9e59-73d308266e0c.htseq.counts.gz	7ecd6357-c628-4e0b-9434-d8d838955b10	TCGA-AJ-A3BD-01A-11R-A19W-07	TCGA-AJ-A3BD-01A-11R	TCGA-AJ-A3BD-01A-01-TSA			TCGA-AJ-A3BD-01A-11	TCGA-AJ-A3BD-01A	TCGA-AJ-A3BD	ab68cd1b-5075-4b30-a829-d6d0f95871cb	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	170	200.0	False	false	8B7CB7C6-86B5-41EA-A6CB-FC496C311888	1.86	b38f9ed4-266f-4b44-b42f-48396fb0be68	0.17	23	released	792a6656-0729-47c1-ba48-df0e22ddb575	RNA	R	0.17	UV Spec	released	False	686d429b-667c-4fa6-800b-d6b9641fe1b1	11	2.0	0.0	3.0	0.0	5.0	2.0	90.0	95.0	TOP	34c01987-fbf9-4d64-bacf-1281380926c0	released																				released	30.0	a41beebe-3c3a-41fc-a611-0e9b322f638b	Primary Tumor	01	released	Not Reported	released	TCGA-AJ-A3BD_demographic	57	-20998		8c2d24f1-cb1d-5b13-84a0-dcccefd1655c	not hispanic or latino	female	white	released	Alive	1954		TCGA-AJ-A3BD_exposure	Not Reported	36.79016620498615	4e9a5fbc-2830-535c-bfb4-413693b6e698	152.0	released	85.0	TCGA-AJ-A3BD_diagnosis	20998	not reported	0	1039	a1b1c6cb-6499-5b68-a141-e465b688c84f	Stage IIIC2	C54.1	not reported	8460/3	Papillary serous cystadenocarcinoma	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-AJ-A3BD_treatment_1	TCGA-AJ-A3BD_treatment	released	63ac8123-6bc2-56c4-9e8d-9ea1c4bbfad7	yes	Pharmaceutical Therapy, NOS	released	0f11beca-c742-5020-8e34-25c01a756d48	yes	Radiation Therapy, NOS	7ecd6357-c628-4e0b-9434-d8d838955b10
d15c3f00-7cfd-4058-9276-13b25f1d065c.htseq.counts.gz	1b6587ec-32a8-41db-a86a-ff15c32600a2	TCGA-AJ-A23O-01A-11R-A157-07	TCGA-AJ-A23O-01A-11R	TCGA-AJ-A23O-01A-01-TSA			TCGA-AJ-A23O-01A-11	TCGA-AJ-A23O-01A	TCGA-AJ-A23O	70b4b353-10d4-49d0-bcc1-855616d8c8cc	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	165	120.0	False	false	4D477218-A4D1-4940-AEF5-D8F46931594C	1.93	aaece63d-8d6f-4048-81e3-d4e7e3706948	0.17	23	released	1aea1578-1b26-4f11-a832-b1f5a1fb9108	RNA	R	0.17	UV Spec	released	False	c154364f-593f-444a-a485-1058043f9cec	11	40.0	20.0	10.0	20.0	0.0	20.0	70.0	70.0	TOP	972cfefd-a013-47c2-a77e-661421b5059d	released																				released	30.0	b8e857f7-25b5-481d-b374-075138925fb8	Primary Tumor	01	released	Not Reported	released	TCGA-AJ-A23O_demographic	69	-25433	312	b0f4f234-03f6-5629-b12d-ec4154d1c2b5	not hispanic or latino	female	white	released	Dead	1941		TCGA-AJ-A23O_exposure	Not Reported	24.341758286340216	b982828e-e89f-575e-b18c-022a27010534	157.0	released	60.0	TCGA-AJ-A23O_diagnosis	25433	not reported	0	60	e017d64b-fd53-5fa0-8344-3a17671f49aa	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Fundus uteri	released	No	Fundus uteri	not reported	not reported	2010	TCGA-AJ-A23O_treatment	TCGA-AJ-A23O_treatment_1	released	70502229-873b-5d58-bc64-a2e57732f9d1	no	Radiation Therapy, NOS	released	87df5930-b274-58d8-940a-757afd5de79c	no	Pharmaceutical Therapy, NOS	1b6587ec-32a8-41db-a86a-ff15c32600a2
f6533844-15b4-4f2f-bc6a-6d1658c54406.htseq.counts.gz	f4f80a02-9e14-4014-b334-88f8c50baa0d	TCGA-DF-A2KR-01A-11R-A180-07	TCGA-DF-A2KR-01A-11R	TCGA-DF-A2KR-01A-01-TSA			TCGA-DF-A2KR-01A-11	TCGA-DF-A2KR-01A	TCGA-DF-A2KR	30b62630-fc6d-4620-874a-1e15fd4f40ea	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC		80.0	False	false	7252DF0D-0D16-48DD-9484-9C4B83012927	1.79	b8e18fd7-ff5d-44b9-b977-945622d2a59e	0.16	23	released	01a5d05c-425c-4f1f-bd6b-76ed815f8658	RNA	R	0.16	UV Spec	released	False	d8d00dbf-4727-4c86-81f3-e3452b84711c	11	25.0	15.0	2.0	5.0	0.0	5.0	93.0	95.0	TOP	97d82fa3-b458-4ecc-9e59-52ec294951b6	released																				released	30.0	acdc8a17-c1b8-4f45-a1af-7c7953c346a4	Primary Tumor	01	released	Not Reported	released	TCGA-DF-A2KR_demographic	84	-31007		1db96901-2fe2-55cd-84fa-dc1d0da97ede	not reported	female	not reported	released	Alive			TCGA-DF-A2KR_exposure	Not Reported		50cf868d-febd-59e4-9df6-365194e7c4af		released		TCGA-DF-A2KR_diagnosis	31007	not reported		1865	483b7756-5065-5f57-adc2-4cb2e906d3f9	Stage IIIC	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported		TCGA-DF-A2KR_treatment_1	TCGA-DF-A2KR_treatment	released	2250d5f3-bf65-5592-ae9f-502f202b48e4	no	Pharmaceutical Therapy, NOS	released	155a92d0-f44a-58c0-9d49-33190002e34c	yes	Radiation Therapy, NOS	f4f80a02-9e14-4014-b334-88f8c50baa0d
11c0bd94-1621-4d51-8886-ccd77f6c04c3.htseq.counts.gz	5106bdf1-1a63-4cc7-9221-3bd3668a38a3	TCGA-KP-A3W1-01A-11R-A22K-07	TCGA-KP-A3W1-01A-11R	TCGA-KP-A3W1-01A-01-TS1			TCGA-KP-A3W1-01A-11	TCGA-KP-A3W1-01A	TCGA-KP-A3W1	3bce9803-e74c-462e-bd40-8ec337a66f3a	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	198	710.0	False	true	58145248-B111-463A-A1CC-32DA993F0B26	1.87	b1ee7148-ddae-404a-b796-004539c02aa7	0.15	23	released	29b243bb-1db4-4821-bad5-e77cc08fffa7	RNA	R	0.15	UV Spec	released	False	fa733adc-358d-4c12-b78a-c283504c9e4e	11	60.0	20.0	5.0	10.0	0.0	5.0	90.0	90.0	TOP	9f0c6ab0-95ac-482b-8121-af2c88ec6f17	released																				released	30.0	1ad2a1ca-75e0-4f9f-808d-768cb14bdff3	Primary Tumor	01	released	Not Reported	released	TCGA-KP-A3W1_demographic	76	-27902		877f9a19-9723-5331-bde9-2b6313f89de2	not reported	female	not reported	released	Alive	1935		TCGA-KP-A3W1_exposure	Not Reported	22.837370242214533	3482948f-557a-524b-aaa6-4af5b5f79fda	170.0	released	66.0	TCGA-KP-A3W1_diagnosis	27902	not reported	0	288	08dc5ad6-6bd9-5771-b249-46fa848dc1e8	Stage IA	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-KP-A3W1_treatment	TCGA-KP-A3W1_treatment_1	released	99fd35f6-5cc5-5425-baf3-1c742b048649	yes	Radiation Therapy, NOS	released	5fb68338-f060-5745-b05e-d1e22e8dce57	yes	Pharmaceutical Therapy, NOS	5106bdf1-1a63-4cc7-9221-3bd3668a38a3
f5f94b57-3a13-4898-a57a-941a31e976c4.htseq.counts.gz	b579bdce-3e66-4ee2-8d13-5487c95b6ef3	TCGA-D1-A2G6-01A-11R-A17B-07	TCGA-D1-A2G6-01A-11R	TCGA-D1-A2G6-01A-01-TS1			TCGA-D1-A2G6-01A-11	TCGA-D1-A2G6-01A	TCGA-D1-A2G6	46cd8ded-f8a1-4f8c-a4c2-2d5b51c04f18	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1350	130.0	False	true	3375E2AF-173B-4263-84A8-8535DF33BA69	1.8	ccc7b7d6-f3a1-48b7-a266-73080858257d	0.15	23	released	bd7efc50-541d-499a-89f6-5bc76f411369	RNA	R	0.15	UV Spec	released	False	c14edc09-79e5-456f-a048-fdefe0180d10	11	10.0	0.0	10.0	10.0	30.0	0.0	60.0	70.0	TOP	215923b8-b7c5-4bcf-8600-4d9dd61d7b97	released																				released	30.0	2127e58b-bd7b-490e-b34b-4f626b2a4053	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A2G6_demographic	53	-19547	258	4c66146b-bcc2-5139-8bbc-91f38bf58f48	not hispanic or latino	female	white	released	Dead	1954	2007	TCGA-D1-A2G6_exposure	Not Reported	28.34467120181406	d308cdee-e455-5c2b-80b7-053e98af3ecd	168.0	released	80.0	TCGA-D1-A2G6_diagnosis	19547	not reported	0		8035dae0-412a-51c1-86a1-7a159431ace3	Stage IIIC	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2007	TCGA-D1-A2G6_treatment	TCGA-D1-A2G6_treatment_1	released	6a8afad1-f9b7-5be2-9bee-ef63deb26c03	not reported	Radiation Therapy, NOS	released	16cfc3b2-ae9c-5eb9-9c3b-558762cf49ea	not reported	Pharmaceutical Therapy, NOS	b579bdce-3e66-4ee2-8d13-5487c95b6ef3
d7980ec2-4100-4528-a929-e43873de14ab.htseq.counts.gz	1b9537a4-7135-483c-86d5-ff4dd7af8e9a	TCGA-B5-A0K4-01A-11R-A040-07	TCGA-B5-A0K4-01A-11R	TCGA-B5-A0K4-01A-01-TS1	TCGA-B5-A0K4-01A-01-BS1		TCGA-B5-A0K4-01A-11	TCGA-B5-A0K4-01A	TCGA-B5-A0K4	a8f38e37-978b-4435-b676-e8d4c34da909	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	264	280.0	False	true	80DE2981-089A-47A2-B221-F7C28ECAF3F2	1.77	73e01a38-164c-44ce-ab36-ed429af8af44	0.14	23	released	8c76c396-a566-4a1f-b8a3-5b64ded3e20d	RNA	R	0.14	UV Spec	released	False	4fd4eaec-f023-4f55-95e0-baa21436a3a3	11	0.0	0.0	20.0	0.0	0.0	20.0	60.0	70.0	TOP	7d5daf5a-f9d5-43ec-b4a0-1c935d7af49a	released	0.0	0.0	15.0	0.0	0.0	15.0	70.0	80.0	BOTTOM	c716946c-3e2e-4d05-b569-770d6f5023a5	released									released	30.0	a4ac1f6e-3411-47ae-9592-513b3d32223f	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A0K4_demographic	51	-18631		9234f877-58d0-540d-89b1-9666a42bbfc4	not reported	female	not reported	released	Alive	1958		TCGA-B5-A0K4_exposure	Not Reported	28.577960676726107	2da882ba-e841-5e22-abdc-806a990c0209	162.0	released	75.0	TCGA-B5-A0K4_diagnosis	18631	not reported	0	1757	d54c375d-f9ef-5698-8f4d-af8872247cee	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-B5-A0K4_treatment_1	TCGA-B5-A0K4_treatment	released	3bd25fce-0b26-5005-8964-eb8fe3e90ae1	yes	Pharmaceutical Therapy, NOS	released	a93d1176-b083-536f-b90c-0b99e4578474	yes	Radiation Therapy, NOS	1b9537a4-7135-483c-86d5-ff4dd7af8e9a
3fcc7b8e-9124-4840-b070-d0ae42d8e1dd.htseq.counts.gz	8f41e9af-37eb-4f49-9693-7f7ee5ed305f	TCGA-PG-A7D5-01A-11R-A34R-07	TCGA-PG-A7D5-01A-11R	TCGA-PG-A7D5-01A-01-TSA			TCGA-PG-A7D5-01A-11	TCGA-PG-A7D5-01A	TCGA-PG-A7D5	4adc20d7-5af1-4126-9073-c7d7ae465d92	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	618	100.0	False	true	2E996CFE-9F6E-432F-9B09-6FBC2A920B24	1.92	460f0df0-00fb-43bf-9143-782a45ca490c	0.17	23	released	77ceca33-e35d-428d-ad3b-96050a0629ad	RNA	R	0.17	UV Spec	released	False	c566bd7a-6a64-4bdf-9e1d-1edd3bf84024	11	40.0	20.0	10.0	20.0	0.0	30.0	60.0	60.0	TOP	1523ca04-a243-45a0-a525-b5e856cd14d5	released																				released	30.0	f408c11a-cbc3-4d31-8cf3-c204423e798f	Primary Tumor	01	released	Not Reported	released	TCGA-PG-A7D5_demographic	62	-23006		b18085fa-a9fc-591d-97c2-4ca241b9bc92	not hispanic or latino	female	black or african american	released	Alive	1949		TCGA-PG-A7D5_exposure	Not Reported	31.645569620253166	4b216d14-e4a7-569e-a85c-585afbb46bd4	158.0	released	79.0	TCGA-PG-A7D5_diagnosis	23006	not reported	0	1177	eee42fb5-89c1-530d-952e-d9c333442c28	Stage IA	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-PG-A7D5_treatment_1	TCGA-PG-A7D5_treatment	released	9fcb569a-8851-555d-a1ec-6821c3877ec9	yes	Pharmaceutical Therapy, NOS	released	556eafb4-eeb5-5301-bed7-28236be7be40	yes	Radiation Therapy, NOS	8f41e9af-37eb-4f49-9693-7f7ee5ed305f
6b0cf425-7863-4edd-bc2d-0a05dfc7fc75.htseq.counts.gz	aabc1dc0-8fb5-4cd8-89b4-b30778bac27e	TCGA-SJ-A6ZI-01A-12R-A34R-07	TCGA-SJ-A6ZI-01A-12R	TCGA-SJ-A6ZI-01A-01-TS1			TCGA-SJ-A6ZI-01A-12	TCGA-SJ-A6ZI-01A	TCGA-SJ-A6ZI	3c2a6e30-a507-49f6-8b1f-36eb3aa41e60	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	88	880.0	False	false	2CA0FD3F-7635-4395-A13B-C3BB9D3FF0D8	1.85	0d5a9a1e-e473-4b9a-bc27-60147dca9fe6	0.18	23	released	879c12bd-740f-4233-a596-1359f92d5a31	RNA	R	0.18	UV Spec	released	False	26014226-b5e9-422d-b062-4b5da6b6a990	12	5.0	0.0	0.0	0.0	0.0	20.0	80.0	80.0	TOP	f9ce9e77-0ef0-491f-aeaa-e1f8a90fa7e8	released																				released	30.0	629770a3-4982-480b-a066-e85c609dfa3f	Primary Tumor	01	released	Not Reported	released	TCGA-SJ-A6ZI_demographic	64	-23653		9414ed5c-c3bf-5195-b220-09297a960ba8	not hispanic or latino	female	black or african american	released	Alive	1949		TCGA-SJ-A6ZI_exposure	Not Reported	213.49862258953166	d28b637f-e6a8-5bbb-bec1-67fed0cea4de	66.0	released	93.0	TCGA-SJ-A6ZI_diagnosis	23653	not reported	0	631	fc4ddf2e-0c66-5936-8e76-4dd8e54823a2	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2013	TCGA-SJ-A6ZI_treatment	TCGA-SJ-A6ZI_treatment_1	released	cb2eb786-9ad0-5af7-8361-153e87ed660d	yes	Radiation Therapy, NOS	released	8df5752a-89d1-5aff-8277-7806bdf7e879	no	Pharmaceutical Therapy, NOS	aabc1dc0-8fb5-4cd8-89b4-b30778bac27e
3b8d3271-6803-4f67-ae0f-2c0f26fce27a.htseq.counts.gz	f5aa19cd-8f1f-4165-8b04-e803e3308a44	TCGA-FI-A2F9-01A-11R-A17B-07	TCGA-FI-A2F9-01A-11R	TCGA-FI-A2F9-01A-01-TS1			TCGA-FI-A2F9-01A-11	TCGA-FI-A2F9-01A	TCGA-FI-A2F9	25e7d9d6-7381-40e1-b7ed-1d8c936b7c5c	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	709	60.0	False	true	5D03E085-0588-47A8-8B1C-E243D8127325	1.78	2aef2acc-a065-4196-a278-1c1ce689e689	0.16	23	released	e21a71b2-6b4e-4104-bfe1-0db9db29e8f2	RNA	R	0.16	UV Spec	released	False	a8ce39e3-f15c-42b9-8984-7bdd1aa6549c	11	40.0	20.0	5.0	20.0	0.0	5.0	90.0	90.0	TOP	0a372772-5768-4f60-8f3b-31d785317358	released																				released	30.0	d62280fd-4b51-4ec9-9ddc-1aa04f6578f3	Primary Tumor	01	released	Not Reported	released	TCGA-FI-A2F9_demographic	79	-28886		b66db2b7-1f4f-5998-bc30-50af2b0a5309	not hispanic or latino	female	white	released	Alive	1930		TCGA-FI-A2F9_exposure	Not Reported	32.326530612244895	5c30bd44-6542-5a9a-8576-3ceb40638f69	175.0	released	99.0	TCGA-FI-A2F9_diagnosis	28886	not reported	0	1803	ff559877-2c95-5ed7-822e-73243281e99f	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-FI-A2F9_treatment_1	TCGA-FI-A2F9_treatment	released	13b886b6-31ad-598f-9fd7-608bfd2a1e77	no	Pharmaceutical Therapy, NOS	released	5403b64c-e62d-582b-be76-64325085a36d	yes	Radiation Therapy, NOS	f5aa19cd-8f1f-4165-8b04-e803e3308a44
c625ddd0-ae64-4ed6-b19d-439ed2f0dca9.htseq.counts.gz	cf680a96-70d2-410e-b0f4-f46ca8e84e9d	TCGA-B5-A0JY-01A-11R-A104-07	TCGA-B5-A0JY-01A-11R	TCGA-B5-A0JY-01A-01-TSA	TCGA-B5-A0JY-01A-01-BSA		TCGA-B5-A0JY-01A-11	TCGA-B5-A0JY-01A	TCGA-B5-A0JY	61935424-44d0-4211-81c1-c925e436eac5	Epithelial Neoplasms, NOS	Corpus uteri	TCGA-UCEC	632	1170.0	False	true	9708BE95-175D-458B-8BA1-02D9C488225D	1.6	bbc76639-b9f4-4e9f-afa2-e319eee91b48	0.15	23	released	eb058127-7cec-4744-8332-5e0c3fc5f346	RNA	R	0.15	UV Spec	released	False	76b12a32-9d3c-4cea-bff9-227cf1e79193	11	20.0	0.0	30.0	10.0	30.0	0.0	40.0	70.0	TOP	702749b2-ce04-407d-980b-50b1260c87bb	released	20.0	0.0	10.0	10.0	20.0	0.0	70.0	80.0	BOTTOM	71d96c32-bf0d-4f7e-bf8b-701e45ffbb5b	released									released	30.0	95f418ce-fcd9-4402-bc24-1520f45cb6b7	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A0JY_demographic	50	-18475		afd12a04-a61b-56c0-b7fc-bd90db975abb	not reported	female	white	released	Alive	1958		TCGA-B5-A0JY_exposure	Not Reported	23.738662131519273	17350fb5-14c2-5152-9441-3f71c26a3ee9	168.0	released	67.0	TCGA-B5-A0JY_diagnosis	18475	not reported	0	2107	2a69024b-1be6-586d-9895-f3cdc6062d14	Stage IIIC1	C54.1	not reported	8020/3	Carcinoma, undifferentiated, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-B5-A0JY_treatment	TCGA-B5-A0JY_treatment_1	released	95c875fd-1ad1-59e8-8ae0-213498c177db	no	Radiation Therapy, NOS	released	d14fcf6e-a034-51d1-b2ee-ebe610657b5d	yes	Pharmaceutical Therapy, NOS	cf680a96-70d2-410e-b0f4-f46ca8e84e9d
53a74c26-a067-4e66-901d-d825f8f292c8.htseq.counts.gz	7789ed75-76d6-4167-b2eb-385a21a8487e	TCGA-EO-A22Y-01A-11R-A180-07	TCGA-EO-A22Y-01A-11R	TCGA-EO-A22Y-01A-01-TSA			TCGA-EO-A22Y-01A-11	TCGA-EO-A22Y-01A	TCGA-EO-A22Y	e6183a43-24b9-4fe1-95c3-4cff67e6c1ed	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	692	110.0	False	false	44F2A17C-265B-4C2A-9AA0-42C55A23B592	1.82	24ee58d3-60c9-4808-b35a-2767594b83f8	0.16	23	released	4d67df35-b0b6-430b-af85-57210f825c48	RNA	R	0.16	UV Spec	released	False	b2e826df-ceac-49f9-8474-f270360b1c2e	11	40.0	20.0	5.0	20.0	0.0	15.0	80.0	80.0	TOP	0612aa32-3071-4cca-8081-000b85e065d4	released																				released	30.0	1fcdc9c7-5448-4a87-9ad5-cfb60837c296	Primary Tumor	01	released	Not Reported	released	TCGA-EO-A22Y_demographic	68	-25127		5e0bfc08-50a0-56fd-b8fe-6dbdde64fd2e	not hispanic or latino	female	white	released	Alive	1941		TCGA-EO-A22Y_exposure	Not Reported		30620e1d-2232-5827-9558-9cd84f67aadd		released		TCGA-EO-A22Y_diagnosis	25127	not reported	0	1567	c6501557-57ac-5799-85ec-44e4c15ae22b	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-EO-A22Y_treatment_1	TCGA-EO-A22Y_treatment	released	978dd27a-5047-5bba-8d5c-936dde124785	no	Pharmaceutical Therapy, NOS	released	f8b5bb6c-83ad-5344-827a-dc977d0cd9d7	yes	Radiation Therapy, NOS	7789ed75-76d6-4167-b2eb-385a21a8487e
2256ef51-c589-4c08-b17f-b3242c44680f.htseq.counts.gz	701ee133-8cfe-47e3-9d73-2693d1f7eb3d	TCGA-B5-A1MX-01A-11R-A144-07	TCGA-B5-A1MX-01A-11R	TCGA-B5-A1MX-01A-01-TSA			TCGA-B5-A1MX-01A-11	TCGA-B5-A1MX-01A	TCGA-B5-A1MX	37bac6ba-be93-42cc-892b-efd0bdb850bd	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	103	560.0	False	true	C8962646-1A09-4EAA-8864-2539A0CCEC4C	1.72	1cb61aae-c6d4-4afc-889e-4060d109c83e	0.16	23	released	0c15a0ee-34db-4b1b-b148-7152df624d73	RNA	R	0.16	UV Spec	released	False	184a6b11-ce6b-48bc-80a0-0c06b5b84db3	11	5.0	2.0	2.0	2.0	0.0	3.0	95.0	97.0	TOP	fcb3e3cf-f205-433b-ba60-005001e43f01	released																				released	30.0	68e7d2d6-3313-4ffc-bb4f-ba9167a7b669	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A1MX_demographic	47	-17320		9c2b69c8-d692-58c7-aa43-f7ed2aaa6dc7	not reported	female	white	released	Alive	1963		TCGA-B5-A1MX_exposure	Not Reported	25.10387811634349	93a59612-d60a-53cf-b284-a1154720a04d	152.0	released	58.0	TCGA-B5-A1MX_diagnosis	17320	not reported	0	1473	2c4fc6a9-529d-59ce-8ea1-4e4dadf8380c	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-B5-A1MX_treatment_1	TCGA-B5-A1MX_treatment	released	6d931b5b-d0f1-5114-93a5-3b66ac68683c	yes	Pharmaceutical Therapy, NOS	released	e8d186bb-8b17-5f60-95ef-9caced8d79f1	yes	Radiation Therapy, NOS	701ee133-8cfe-47e3-9d73-2693d1f7eb3d
b2697c28-f5f4-4af9-901a-c322f59e7aec.htseq.counts.gz	642ea490-7acd-4946-8db5-54dddaba4b5c	TCGA-FI-A2F8-01A-12R-A17B-07	TCGA-FI-A2F8-01A-12R	TCGA-FI-A2F8-01A-01-TS1			TCGA-FI-A2F8-01A-12	TCGA-FI-A2F8-01A	TCGA-FI-A2F8	601734da-2d11-4745-a260-0965f58aadea	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	679	70.0	False	true	9445945A-A7AC-4C36-889B-68A50644D556	1.83	1b38dbc6-5830-4514-9317-9dcb23e36b98	0.17	23	released	50848127-ca56-41e4-bc07-1295d77aca3c	RNA	R	0.17	UV Spec	released	False	9f4a5b99-a326-4c55-a7b3-bcabf48f4abf	12	40.0	20.0	10.0	20.0	0.0	20.0	70.0	70.0	TOP	8e154304-4c97-44b3-88a2-b71e5cbb7900	released																				released	20.0	500c427b-db2c-4ca4-8bad-9f573e99c32a	Primary Tumor	01	released	Not Reported	released	TCGA-FI-A2F8_demographic	64	-23649		a4323184-d6f7-50dc-85ae-1b9adbf70349	not hispanic or latino	female	white	released	Alive	1945		TCGA-FI-A2F8_exposure	Not Reported	33.07828527515119	1d0b0d91-9493-5718-9b0b-958305c1c0ed	173.0	released	99.0	TCGA-FI-A2F8_diagnosis	23649	not reported	0	933	8e61edf0-cbe0-5a74-8ae9-1082dff20b6e	Stage II	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-FI-A2F8_treatment_1	TCGA-FI-A2F8_treatment	released	66daaace-97e8-52c8-85e4-566fcc68ed88	yes	Pharmaceutical Therapy, NOS	released	9c78a99b-1815-50dd-83a8-07ae7223d2fd	no	Radiation Therapy, NOS	642ea490-7acd-4946-8db5-54dddaba4b5c
403b1855-51e5-4136-8e76-17ceba12046d.htseq.counts.gz	72452c3e-445a-4876-89d0-a08a5f6b2186	TCGA-AX-A1CA-01A-12R-A137-07	TCGA-AX-A1CA-01A-12R	TCGA-AX-A1CA-01A-01-TS1			TCGA-AX-A1CA-01A-12	TCGA-AX-A1CA-01A	TCGA-AX-A1CA	3ede5dff-8cf5-43e8-bf4b-e8ad75bf68ee	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	591	110.0	False	false	5906346F-CB34-421F-BBC3-3B6D2239AA7F	1.85	cadf8449-cd8e-4581-ad35-37a0aa2f7a9b	0.18	23	released	3090e3bc-3701-402a-b69f-d2c91b0a7b6d	RNA	R	0.18	UV Spec	released	False	ec8bd7a6-131e-4dbf-a0a8-438e0ea49c3c	12	1.0	0.0	1.0	0.0	30.0	10.0	59.0	60.0	TOP	ebb49626-ca18-44b1-b56b-8811f228d278	released																				released	30.0	b627e715-006f-45ac-a168-85d37e9dc6e1	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A1CA_demographic	70	-25817		ce12f12d-6909-5e15-b949-98cea3d19440	not hispanic or latino	female	black or african american	released	Alive	1939		TCGA-AX-A1CA_exposure	Not Reported	31.238589800803275	9354678d-05c4-53ec-9bb3-306f2a9732e5	157.0	released	77.0	TCGA-AX-A1CA_diagnosis	25817	not reported	0	974	c05fa32f-6e1d-5526-ab18-4df2d3d31107	Stage IB	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-AX-A1CA_treatment	TCGA-AX-A1CA_treatment_1	released	e421e734-144e-5e2c-ae81-2b6908b7e337	no	Radiation Therapy, NOS	released	51719bd9-e751-5a53-ae66-fdc988535629	yes	Pharmaceutical Therapy, NOS	72452c3e-445a-4876-89d0-a08a5f6b2186
d04f3046-4497-4cac-837b-dae18c57b298.htseq.counts.gz	62946d27-e6de-415a-b1c1-175498c2cf64	TCGA-EY-A1GQ-01A-21R-A13S-07	TCGA-EY-A1GQ-01A-21R	TCGA-EY-A1GQ-01A-02-TSB			TCGA-EY-A1GQ-01A-21	TCGA-EY-A1GQ-01A	TCGA-EY-A1GQ	8636db4d-a67b-4d8a-b02f-15fce553cf17	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	274	160.0	False	false	9A8D1D19-18D8-483B-BD87-B686D25C617F	1.9	afceaea6-337b-4ac4-a7fb-773c98d95547	0.15	23	released	c8725946-e4b3-4439-8fca-bc37cd7c9f17	RNA	R	0.15	UV Spec	released	False	3b92755b-913e-4828-b0ad-49aa7622c3a5	21	40.0	20.0	10.0	20.0	0.0	30.0	60.0	60.0	TOP	9b72acda-452c-42e1-931d-ff3165be1358	released																				released	30.0	2ce5197d-0239-4df1-85fc-47ae27324028	Primary Tumor	01	released	Not Reported	released	TCGA-EY-A1GQ_demographic	76	-27905		823c38c3-da83-5448-a724-54b825439b21	not hispanic or latino	female	white	released	Alive	1934		TCGA-EY-A1GQ_exposure	Not Reported	29.752066115702476	98946abd-7fdd-5947-b44d-1e9a2e9699ce	165.0	released	81.0	TCGA-EY-A1GQ_diagnosis	27905	not reported	0	544	26cd1b0f-a731-52ee-b6f8-1b4d226a267d	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2010	TCGA-EY-A1GQ_treatment_1	TCGA-EY-A1GQ_treatment	released	127c8ad3-bc6f-5c71-9702-a1a72486120f	yes	Pharmaceutical Therapy, NOS	released	dd963ed0-4dbe-591b-9106-f46e58b4808e	yes	Radiation Therapy, NOS	62946d27-e6de-415a-b1c1-175498c2cf64
c8640e96-2450-4a0f-a0f3-017f5ae9a3b9.htseq.counts.gz	912ef0f0-0258-47ef-9856-05272fbc8ba4	TCGA-DI-A1BY-01A-21R-A137-07	TCGA-DI-A1BY-01A-21R	TCGA-DI-A1BY-01A-02-TSB			TCGA-DI-A1BY-01A-21	TCGA-DI-A1BY-01A	TCGA-DI-A1BY	e46b6434-ee88-4630-9fc3-441afc431745	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	989	140.0	False	false	8B96371D-5E42-461B-B7A2-AB9641D842CD	1.84	4d54cfbb-2bb7-4a45-b870-7ac7c87cae5e	0.16	23	released	79329cbf-f670-4cb2-bd9d-4849b1cd0539	RNA	R	0.16	UV Spec	released	False	3d6bf099-fb3a-4bb1-bada-e09b6ca21e78	21	40.0	20.0	10.0	20.0	0.0	30.0	60.0	60.0	TOP	963f1f32-b356-474d-a59f-49fdf57aa502	released																				released	30.0	7a5cf7c9-1b05-4de9-af5d-a859171049d6	Primary Tumor	01	released	Not Reported	released	TCGA-DI-A1BY_demographic	63	-23113		73986089-8e5f-5a89-8e84-674c67d66ce7	not hispanic or latino	female	white	released	Alive	1945		TCGA-DI-A1BY_exposure	Not Reported	52.029136316337144	a5f3f76e-b161-50a9-a3a3-e99c63378b9e	155.0	released	125.0	TCGA-DI-A1BY_diagnosis	23113	not reported	0	1114	a439ad3c-44d7-5d10-ae48-718f94201a2b	Stage IIB	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-DI-A1BY_treatment	TCGA-DI-A1BY_treatment_1	released	35ae15d7-a300-558e-b83b-8d9362dd3dce	yes	Radiation Therapy, NOS	released	f200b505-2aca-5fea-a12b-439a054714dd	no	Pharmaceutical Therapy, NOS	912ef0f0-0258-47ef-9856-05272fbc8ba4
6c005bee-d65c-4a91-b210-5da5d98d7a5e.htseq.counts.gz	2fa1eae6-453c-45d0-9967-cfda039dff1b	TCGA-BG-A2AD-01A-21R-A16F-07	TCGA-BG-A2AD-01A-21R	TCGA-BG-A2AD-01A-02-TSB			TCGA-BG-A2AD-01A-21	TCGA-BG-A2AD-01A	TCGA-BG-A2AD	49adc60f-211b-4547-84f6-094257767409	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	45	770.0	False	true	E3FBF856-C09F-4F3A-975E-A1D07286A0EB	1.91	a6ed9981-f7df-4f36-be2e-da4c96722680	0.17	23	released	84c21683-723c-42b2-8c45-d94f7c63b83a	RNA	R	0.17	UV Spec	released	False	56db1a09-6978-4a32-b4be-8bffe1b67788	21	40.0	20.0	10.0	20.0	0.0	30.0	60.0	60.0	TOP	b5caff99-4c14-47da-9b77-104660462ca9	released																				released	30.0	d07bb656-7b30-4d4c-a804-e3336c881a20	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A2AD_demographic	63	-23064		89d21b25-7c06-5b8c-b35c-4ae66fd0aa6d	not hispanic or latino	female	white	released	Alive	1948		TCGA-BG-A2AD_exposure	Not Reported	31.25	c6931bad-ae18-5a74-b5a5-bd4838e3ff01	160.0	released	80.0	TCGA-BG-A2AD_diagnosis	23064	not reported	0	609	4ae53ec5-18e1-548f-bc61-82359ef2e1f8	Stage IIIB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-BG-A2AD_treatment	TCGA-BG-A2AD_treatment_1	released	8c0ef4a5-2f57-5167-b4fb-6c811871c8ad	no	Radiation Therapy, NOS	released	a32d23ad-7cfa-5bdd-bb76-801a6eae45e6	yes	Pharmaceutical Therapy, NOS	2fa1eae6-453c-45d0-9967-cfda039dff1b
39f87aff-f96b-4f2d-a36d-10558054657a.htseq.counts.gz	055f703c-1963-4723-bb9a-f015e5e593c2	TCGA-EO-A3B0-01A-12R-A19W-07	TCGA-EO-A3B0-01A-12R	TCGA-EO-A3B0-01A-01-TSA			TCGA-EO-A3B0-01A-12	TCGA-EO-A3B0-01A	TCGA-EO-A3B0	4c2e6abf-02e1-4ef7-a0be-6a6d4069581d	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	196	160.0	False	false	5B8CD9C0-148B-4421-AA68-C1F2DF7F9B28	1.85	cad7a685-cb28-44bf-ad8e-e4528a73f0b6	0.17	23	released	d945be03-3ad7-45a9-81e7-3692036fad78	RNA	R	0.17	UV Spec	released	False	4864b645-7e80-43ce-bba4-da5fd2d4f926	12	0.0	0.0	10.0	0.0	0.0	20.0	70.0	70.0	TOP	7c3b79ea-b874-4692-bf9a-4906cbc72868	released																				released	30.0	87a5c4d3-9aa2-4a86-9cc9-f99a4b67feae	Primary Tumor	01	released	Not Reported	released	TCGA-EO-A3B0_demographic	43	-15954		3b813f30-d519-5c0e-9aa7-ce07c2780822	not reported	female	asian	released	Alive	1968		TCGA-EO-A3B0_exposure	Not Reported	22.939750692520775	13186b2d-211b-5489-88d5-ce7a891827a1	152.0	released	53.0	TCGA-EO-A3B0_diagnosis	15954	not reported	0	1412	3381b937-de4b-527c-ad36-5984ddcc6bb2	Stage IIIC2	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-EO-A3B0_treatment	TCGA-EO-A3B0_treatment_1	released	3871232a-c174-5f4d-9cbd-9d74d3cc9124	no	Radiation Therapy, NOS	released	01158cb0-2d20-5560-99db-a9ab3310ac2f	no	Pharmaceutical Therapy, NOS	055f703c-1963-4723-bb9a-f015e5e593c2
f3ef32dc-5c02-414d-af11-92064cc4dc1d.htseq.counts.gz	0abfebd4-c541-4164-a51c-b615ff0858c4	TCGA-D1-A16X-01A-11R-A12I-07	TCGA-D1-A16X-01A-11R	TCGA-D1-A16X-01A-01-TS1			TCGA-D1-A16X-01A-11	TCGA-D1-A16X-01A	TCGA-D1-A16X	22618073-4ef0-4c3a-97b9-90ba1caa1d72	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	618	230.0	False	false	0C395D2C-1864-448E-8FB7-09BFE5FF4C50	2.04	4468bb31-bb94-4353-9d13-556d4b8a892a	0.17	23	released	b5f6b397-6ab9-4620-980b-3f1337f5dc95	RNA	R	0.17	UV Spec	released	False	0f03c16f-84b8-4777-a327-8d923daf9ec4	11	3.0	10.0	1.0	15.0	0.0	5.0	94.0	95.0	TOP	3a60b134-2b7d-486f-8623-b5ea0555868a	released																				released	30.0	6421d807-9bec-4ad4-8b75-8f9dd594a977	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A16X_demographic	54	-19799		21211a7f-bfde-54df-8a7d-c139cb0922c9	not hispanic or latino	female	white	released	Alive	1955		TCGA-D1-A16X_exposure	Not Reported	39.453125	e380828d-919b-588a-aadb-fc5ee42607f1	160.0	released	101.0	TCGA-D1-A16X_diagnosis	19799	not reported	0	111	2adb3bfe-3072-512c-ae66-781ce266d5eb	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-D1-A16X_treatment_1	TCGA-D1-A16X_treatment	released	0e302d2a-8d7f-5e07-971e-199bbe29cf53	no	Pharmaceutical Therapy, NOS	released	25bc91ad-9658-5359-aa17-6e1072c35894	no	Radiation Therapy, NOS	0abfebd4-c541-4164-a51c-b615ff0858c4
4a80d459-f8a8-4d82-b728-3ee91d469e3c.htseq.counts.gz	63165796-78ad-48b4-ba89-6ec0be3e1b50	TCGA-EY-A1H0-01A-11R-A13S-07	TCGA-EY-A1H0-01A-11R	TCGA-EY-A1H0-01A-01-TSA			TCGA-EY-A1H0-01A-11	TCGA-EY-A1H0-01A	TCGA-EY-A1H0	c71e0986-56c0-45f4-be8d-2236e4418604	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	262	330.0	False	false	CE7F1184-9FFC-4A30-926B-0008915893F2	1.81	8b72e6e7-cac5-4b7f-8f6a-7abef8b24e01	0.15	23	released	543da982-d5cb-4452-a6bf-e2939b5b7084	RNA	R	0.15	UV Spec	released	False	92fda1b6-fe02-417d-82a9-06600885d055	11	30.0	20.0	5.0	30.0	0.0	25.0	70.0	70.0	TOP	0600e93e-8c34-4173-9158-6fe3bf6a2dd6	released																				released	30.0	3e1472fb-a882-4bb1-b4c0-c0ff3c9e6e25	Primary Tumor	01	released	Not Reported	released	TCGA-EY-A1H0_demographic	57	-20937		0fe639d2-e36c-5dd9-bed0-8e11e1d36a61	not hispanic or latino	female	black or african american	released	Alive	1953		TCGA-EY-A1H0_exposure	Not Reported	33.87406375851556	77377d91-2f23-502d-a2fd-dfe6d944c6de	163.0	released	90.0	TCGA-EY-A1H0_diagnosis	20937	not reported	0	588	850391fc-3536-5ce9-b8ad-2fc1b06b5eab	Stage IIIC2	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-EY-A1H0_treatment_1	TCGA-EY-A1H0_treatment	released	ca29138c-2c11-5fb3-8604-d250b93c5c82	yes	Pharmaceutical Therapy, NOS	released	6106b9c8-845e-5722-aa46-0c0a637644a2	yes	Radiation Therapy, NOS	63165796-78ad-48b4-ba89-6ec0be3e1b50
6e787323-b1b0-40fc-879b-d8fec6b6ce59.htseq.counts.gz	f39f38c9-682e-4531-9cf7-fed2d826ff99	TCGA-B5-A3FD-01A-11R-A19W-07	TCGA-B5-A3FD-01A-11R	TCGA-B5-A3FD-01A-01-TSA			TCGA-B5-A3FD-01A-11	TCGA-B5-A3FD-01A	TCGA-B5-A3FD	eeb327b4-b705-4161-ba94-647f0e14f5b4	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	679	370.0	False	true	7AC30D60-097A-4FED-A928-7A4BCAFB6C8D	1.81	6fbe6214-bdfd-4688-bae3-d12a931f9989	0.17	23	released	58180b99-1908-49e1-aa5a-19e3a162e449	RNA	R	0.17	UV Spec	released	False	1683058f-3d1a-4d3f-98c0-78caa9faa50e	11	2.0	2.0	5.0	1.0	0.0	5.0	90.0	90.0	TOP	1b6d7840-d3b4-4a71-9a87-baa784731419	released																				released	30.0	d496dc3a-fc5b-4177-8570-e8725778d186	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A3FD_demographic	70	-25813	1197	e94319b4-e027-5ad2-aa86-d68b64ecca13	not reported	female	black or african american	released	Dead	1939		TCGA-B5-A3FD_exposure	Not Reported	37.98388162240719	dc750726-9202-558c-8bc8-e0e961d284e2	174.0	released	115.0	TCGA-B5-A3FD_diagnosis	25813	not reported	0	1007	7a2f53e6-61d9-50c5-b44e-1f576b14fbd5	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-B5-A3FD_treatment_1	TCGA-B5-A3FD_treatment	released	c70af701-4ee1-504a-8b31-ae9f6ce69bde	yes	Pharmaceutical Therapy, NOS	released	57be0f53-06e3-5939-a196-52352520324b	no	Radiation Therapy, NOS	f39f38c9-682e-4531-9cf7-fed2d826ff99
5d09a214-1894-4ab5-b103-fddb9b1cf590.htseq.counts.gz	1964485c-18f9-4ec5-86ca-abacd9e62500	TCGA-BG-A0YU-01A-21R-A10J-07	TCGA-BG-A0YU-01A-21R	TCGA-BG-A0YU-01A-02-BSB	TCGA-BG-A0YU-01A-02-TSB		TCGA-BG-A0YU-01A-21	TCGA-BG-A0YU-01A	TCGA-BG-A0YU	957ac10a-7365-47b1-bbed-47e5d42fbfdf	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	166	310.0	False	true	5E3AA4BA-20F6-4241-AD70-8E5DEDA9D129	1.89	6e00c57a-69e5-4b00-9e5e-97aa1d4933c7	0.17	23	released	149495ad-fcf4-4d18-977e-3ca11db7f326	RNA	R	0.17	UV Spec	released	False	7e3aebd5-9384-467f-83e1-851784773e14	21	20.0	0.0	20.0	10.0	0.0	20.0	60.0	80.0	BOTTOM	8d1f9efc-9ddc-4a6f-a53c-464c157d8bd0	released	20.0	0.0	10.0	10.0	0.0	10.0	80.0	90.0	TOP	532f2d2b-50e6-421a-9001-10d5e0f35f43	released									released	30.0	61a80dcf-f83b-4b4f-806f-8ad3882ecfe4	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A0YU_demographic	37	-13644		33a85b3a-5efc-559a-958b-e7cc12adaff4	not hispanic or latino	female	white	released	Alive	1973		TCGA-BG-A0YU_exposure	Not Reported	43.40946894397339	eff04177-e895-599d-874b-b37a31de3d82	157.0	released	107.0	TCGA-BG-A0YU_diagnosis	13644	not reported	0	451	fb3780be-6dfa-56b2-981a-762ea0de6733	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-BG-A0YU_treatment	TCGA-BG-A0YU_treatment_1	released	b1082cf6-f173-5473-8cbf-f4b7931b6341	no	Radiation Therapy, NOS	released	c488d165-0f54-5350-8aea-2ffc0ea8ac7d	no	Pharmaceutical Therapy, NOS	1964485c-18f9-4ec5-86ca-abacd9e62500
d6729d70-9495-487c-857c-8ff2f0765877.htseq.counts.gz	27c15892-d77e-496e-b7b4-8127b81f1f97	TCGA-EO-A3AY-01A-12R-A19W-07	TCGA-EO-A3AY-01A-12R	TCGA-EO-A3AY-01A-01-TSA			TCGA-EO-A3AY-01A-12	TCGA-EO-A3AY-01A	TCGA-EO-A3AY	0878e44d-bdc8-4d5f-9bf4-31101f14f797	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	227	150.0	False	false	330AEFE0-D564-4799-8928-B05280BACA91	1.84	8025c2b5-a137-4c88-9ac4-cc4be43e4f25	0.16	23	released	026f6965-6363-417e-b4a8-1c8c57de1fca	RNA	R	0.16	UV Spec	released	False	346e1b39-e960-4f14-805d-5c1c14fc5ff1	12	0.0	0.0	2.0	0.0	0.0	8.0	90.0	90.0	TOP	faa2afb3-619a-41e0-ac2d-13b910845187	released																				released	20.0	47bf70a1-6738-495f-9e61-92feaf33c28c	Primary Tumor	01	released	Not Reported	released	TCGA-EO-A3AY_demographic	58	-21291		6fd6df70-ae97-57fd-97f6-997004450695	not reported	female	not reported	released	Alive	1953		TCGA-EO-A3AY_exposure	Not Reported	28.25698988697204	f4db310b-c3ac-5116-af33-3bfb83aa14db	164.0	released	76.0	TCGA-EO-A3AY_diagnosis	21291	not reported	0	1158	063e134c-a2d4-54d2-ab38-c1a92c528dc1	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-EO-A3AY_treatment_1	TCGA-EO-A3AY_treatment	released	75f0791d-3b7c-5396-b531-351ae7721a14	no	Pharmaceutical Therapy, NOS	released	ab0cdeb3-034c-5006-afe9-3964d0eda6f7	no	Radiation Therapy, NOS	27c15892-d77e-496e-b7b4-8127b81f1f97
418eab89-5e78-4be3-ba93-c9dc2a7d1c68.htseq.counts.gz	e591901c-2d45-4485-8c15-25786b403453	TCGA-EY-A548-01A-11R-A27V-07	TCGA-EY-A548-01A-11R	TCGA-EY-A548-01A-01-TS1			TCGA-EY-A548-01A-11	TCGA-EY-A548-01A	TCGA-EY-A548	56bdb68c-a647-4aba-94ac-9cd52bb5344a	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	169	850.0	False	false	A9ACF7BF-BB91-4B56-A398-C7A0FD473FC5	1.85	32b29d34-5d28-4b68-9d64-61290448fca5	0.18	23	released	ecc65cc6-d279-4311-a80f-35160037546c	RNA	R	0.18	UV Spec	released	False	8f761f81-0771-4236-8c48-a0a956743cd0	11	3.0	2.0	0.0	0.0	0.0	0.0	100.0	80.0	TOP	29c8bf41-5ab3-4ffb-94ce-9c968fef67dd	released																				released	30.0	081ac69b-8390-42b1-917a-d7cd231c0156	Primary Tumor	01	released	Not Reported	released	TCGA-EY-A548_demographic	83	-30544		2842e7d2-131b-560d-9b81-97d97647ff8a	not hispanic or latino	female	black or african american	released	Alive	1929		TCGA-EY-A548_exposure	Not Reported	27.18163008641324	8f520e23-09e2-51d3-b7fc-db30b2990ba5	157.0	released	67.0	TCGA-EY-A548_diagnosis	30544	not reported	0	430	8f6aaac5-a59d-5d94-ba34-e90593e47aec	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2012	TCGA-EY-A548_treatment_1	TCGA-EY-A548_treatment	released	466e083e-273c-5254-973c-9e647ee558a1	no	Pharmaceutical Therapy, NOS	released	777d2841-457c-5ff1-8176-3de8bc70bc8e	no	Radiation Therapy, NOS	e591901c-2d45-4485-8c15-25786b403453
c6cbdff4-b55c-4e33-984a-3e016ce6622f.htseq.counts.gz	b4f8ca6f-b11b-4243-82af-63fa1808a3f0	TCGA-D1-A16E-01A-22R-A12I-07	TCGA-D1-A16E-01A-22R	TCGA-D1-A16E-01A-02-TSB			TCGA-D1-A16E-01A-22	TCGA-D1-A16E-01A	TCGA-D1-A16E	e70465f6-1922-4eb7-b646-8b01ad3ce77b	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	790	170.0	False	false	DF926973-D344-48AE-A6F6-5901A4A8C846	1.83	abe099ed-caea-4903-aa4a-2729d2b28da2	0.15	23	released	ca8f7b2f-8ae6-489c-87d3-b5482afb1d99	RNA	R	0.15	UV Spec	released	False	9938f00f-ec24-4fd9-94ca-b20e6d159919	22	5.0	4.0	0.0	12.0	0.0	20.0	80.0	80.0	TOP	0d3cd7be-8add-4d9b-b147-7a9e3c7fe00f	released																				released	20.0	58fc1e66-39c4-44d1-bdd3-338e0d833792	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A16E_demographic	73	-26859		ee615383-004f-552b-b4bb-3ec74433dfa9	not hispanic or latino	female	white	released	Alive	1935		TCGA-D1-A16E_exposure	Not Reported	25.2993759487266	aeaec965-9093-51ac-b32b-c0bd1c6af66e	154.0	released	60.0	TCGA-D1-A16E_diagnosis	26859	not reported	0	1119	3a94f159-3a38-550d-86eb-65f6b65800a6	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-D1-A16E_treatment	TCGA-D1-A16E_treatment_1	released	d832fbd1-f20c-5ded-8321-bc80a7b81d63	no	Radiation Therapy, NOS	released	8bd7e5b7-6bc2-5119-9e0b-bb058b9423e1	no	Pharmaceutical Therapy, NOS	b4f8ca6f-b11b-4243-82af-63fa1808a3f0
2207de29-e1c5-43b0-97c9-a2b323dcca78.htseq.counts.gz	1cb24081-219d-41cf-9027-3a71f071bd2c	TCGA-AJ-A3NE-01A-11R-A22K-07	TCGA-AJ-A3NE-01A-11R	TCGA-AJ-A3NE-01A-01-TS1	TCGA-AJ-A3NE-01A-01-BS1		TCGA-AJ-A3NE-01A-11	TCGA-AJ-A3NE-01A	TCGA-AJ-A3NE	1dcf33e9-4c9b-4b2b-914e-15e6be5dcd07	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	134	23.0	False	false	4618A1F6-B969-4746-8190-7D856A21C25F	1.76	a133035a-7076-4fe7-b260-f866b409aba4	0.18	23	released	02084bcc-967d-49b4-8d32-e5b2d2c73d0b	RNA	R	0.18	UV Spec	released	False	6e9b4037-da5a-4429-9b25-7570ff433ef5	11	0.0	0.0	5.0	0.0	0.0	15.0	80.0	60.0	TOP	6f2b775a-26f6-42ac-a9b1-9daf1c4be9fe	released	0.0	0.0	5.0	0.0	0.0	15.0	80.0	65.0	BOTTOM	9390be15-d93a-4e83-9f8e-9ca10592e95e	released									released	30.0	a1ec8680-c144-4a99-8d51-ae9a68f15d67	Primary Tumor	01	released	Not Reported	released	TCGA-AJ-A3NE_demographic	46	-16957		7cd0bfbb-89d6-5f79-8bee-d7a676d2e60d	not hispanic or latino	female	white	released	Alive	1965		TCGA-AJ-A3NE_exposure	Not Reported	31.25	b060a9fc-e273-5591-ac58-29e05312788e	160.0	released	80.0	TCGA-AJ-A3NE_diagnosis	16957	not reported	0	628	18780bc0-1bba-5cd3-8b89-1ad711411545	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-AJ-A3NE_treatment_1	TCGA-AJ-A3NE_treatment	released	7b26b77a-cff4-5353-82e8-06e49c19e026	no	Pharmaceutical Therapy, NOS	released	2e5afb49-8cc8-53c3-8444-1b285a628db9	no	Radiation Therapy, NOS	1cb24081-219d-41cf-9027-3a71f071bd2c
bb1160fd-9f7e-48a7-b9d1-4bdfa6e26588.htseq.counts.gz	083df11e-8c68-4b0c-8976-e4b7a974034b	TCGA-FL-A1YQ-11A-11R-A32Y-07	TCGA-FL-A1YQ-11A-11R	TCGA-FL-A1YQ-11A-01-TSA			TCGA-FL-A1YQ-11A-11	TCGA-FL-A1YQ-11A	TCGA-FL-A1YQ	545ba049-b7c1-4b46-9ec2-9331dccd6c60	Not Reported	Uterus, NOS	TCGA-UCEC		130.0	False	false	A183E852-81EF-413C-85F0-122FB8F22DE2	2.15	21a04fd6-500e-4d42-846b-b6b7783098fb	0.18	23	released	c0d6e758-9354-4bf4-a681-32787db1723b	RNA	R	0.18	UV Spec	released	False	3ec6ad54-4714-464f-9e7b-7aef4c5ebb50	11					100.0		0.0		TOP	f93bc494-a7ba-4c52-a71b-434458a2ca4b	released																				released	30.0	f6c7db6c-cf42-4e24-8ff9-aece36ee1842	Solid Tissue Normal	11	released	Not Reported	released																																																			083df11e-8c68-4b0c-8976-e4b7a974034b
08834b43-87fd-4759-9350-964457f879bb.htseq.counts.gz	05f15623-de75-46b2-ae4d-a8ee6b3d664e	TCGA-B5-A1MR-01A-31R-A14D-07	TCGA-B5-A1MR-01A-31R	TCGA-B5-A1MR-01A-03-TSC			TCGA-B5-A1MR-01A-31	TCGA-B5-A1MR-01A	TCGA-B5-A1MR	02af18ee-ab8e-4ac3-b22e-dec80c201058	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	5556	240.0	False	true	BA4793F4-FBB3-4953-8204-A9C360D32D76	1.54	a644742b-ae08-41e3-810e-800bf0eef8fe	0.16	23	released	0595bd19-925f-49dc-9491-a79e908def49	RNA	R	0.16	UV Spec	released	False	41014d52-529f-403d-b41e-63b77de683f2	31	40.0	20.0	20.0	20.0	0.0	20.0	60.0	60.0	TOP	1c52c4b0-b214-4121-bc0c-b974fb2af770	released																				released	30.0	f2d9d82b-aa3f-44f8-b882-1381704f6cc5	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A1MR_demographic	65	-24017		f3f20b72-0419-5862-a8ab-db01ed67c608	not reported	female	white	released	Alive	1930		TCGA-B5-A1MR_exposure	Not Reported		c7be8bfb-1658-574f-afc8-bf5f3b73067b		released	58.0	TCGA-B5-A1MR_diagnosis	24017	not reported	0	6859	a21fbabe-e875-5677-9e68-6b37282186d6	Stage IIIA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	1995	TCGA-B5-A1MR_treatment_1	TCGA-B5-A1MR_treatment	released	5962c91f-0733-59dd-8080-468fc279d953	no	Pharmaceutical Therapy, NOS	released	332578c7-1409-5142-8456-ef31512df5d6	yes	Radiation Therapy, NOS	05f15623-de75-46b2-ae4d-a8ee6b3d664e
13bcca7a-0ef9-436f-82c4-01abf32f510e.htseq.counts.gz	ffaa88c8-687f-4af1-833c-4ab619815cfc	TCGA-B5-A11X-01A-11R-A10J-07	TCGA-B5-A11X-01A-11R	TCGA-B5-A11X-01A-01-TSA	TCGA-B5-A11X-01A-01-BSA		TCGA-B5-A11X-01A-11	TCGA-B5-A11X-01A	TCGA-B5-A11X	f70a64a8-3faa-468a-a6f3-4815eb01e5a3	Epithelial Neoplasms, NOS	Corpus uteri	TCGA-UCEC	246	530.0	False	true	89C9704E-F43C-440C-970F-872835910268	1.84	bca7a3e6-57e9-44e6-b33f-a5e62011884d	0.14	23	released	5b6f5101-778f-4235-aaf8-84b98b03b9d0	RNA	R	0.14	UV Spec	released	False	83c3fd26-9f3c-4874-8beb-58aa892e8033	11	20.0	0.0	10.0	10.0	20.0	0.0	70.0	80.0	TOP	96957922-fd59-46c5-a6af-6b409327ac65	released	20.0	0.0	10.0	10.0	20.0	0.0	70.0	80.0	BOTTOM	77fdc43a-b8cb-45e2-9ff4-ca487dbe1f04	released									released	30.0	0a9e02d6-62db-4b0e-ac92-677db018ec9c	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A11X_demographic	66	-24217		b77ca676-a31b-51be-bf22-fc4de05b5d1c	not reported	female	black or african american	released	Alive	1944		TCGA-B5-A11X_exposure	Not Reported	27.734375	4ca76d7b-6324-56b1-a042-4525a1d322eb	160.0	released	71.0	TCGA-B5-A11X_diagnosis	24217	not reported	0	596	350ce20b-915b-5926-8869-acbce9450a98	Stage IIIC2	C54.1	not reported	8020/3	Carcinoma, undifferentiated, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-B5-A11X_treatment_1	TCGA-B5-A11X_treatment	released	cf8429a4-6848-527f-b3f8-915414b8c938	yes	Pharmaceutical Therapy, NOS	released	b8017e12-f0d8-57f3-aa71-e8d91c8bab64	no	Radiation Therapy, NOS	ffaa88c8-687f-4af1-833c-4ab619815cfc
6d60eab2-3b0a-4c35-9fc2-f4c8b7c5b894.htseq.counts.gz	808c70fb-1d07-4ae8-86cb-77e456cbcfe1	TCGA-AX-A3GI-01A-11R-A213-07	TCGA-AX-A3GI-01A-11R	TCGA-AX-A3GI-01A-01-TSA			TCGA-AX-A3GI-01A-11	TCGA-AX-A3GI-01A	TCGA-AX-A3GI	e4787c7b-40e7-483c-98c0-38da03e26b56	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	300	110.0	False	false	A803E376-399C-4841-A6AE-E82B99CD57B7	1.86	9d42a9c4-305b-4e25-a260-82805d6b059a	0.18	23	released	2e416718-3f6c-4c8a-b436-52520469f38b	RNA	R	0.18	UV Spec	released	False	ffe36ec9-c51e-45b3-a992-b06e344ac66a	11	0.0	0.0	4.0	0.0	0.0	2.0	94.0	98.0	TOP	beb03e92-2a77-4b41-a987-7464894843f1	released																				released	30.0	c5cdb056-0de5-496f-a301-87f11ce50dde	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A3GI_demographic	66	-24388		2d2bd541-cbc4-5496-ae3e-ce02fb8ca17d	not hispanic or latino	female	black or african american	released	Alive	1945		TCGA-AX-A3GI_exposure	Not Reported	31.1950948402596	1dfaa55e-f989-56e3-90d1-00c6b23ef2a7	167.0	released	87.0	TCGA-AX-A3GI_diagnosis	24388	not reported	0	12	4a075418-2792-5db0-9e64-396cb2c93fd8	Stage IIIC	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-AX-A3GI_treatment_1	TCGA-AX-A3GI_treatment	released	10fa240c-9ae6-552a-a99a-cd6253be85f2	not reported	Pharmaceutical Therapy, NOS	released	d8556c08-7ea4-54c6-88c7-b65f9a87e923	not reported	Radiation Therapy, NOS	808c70fb-1d07-4ae8-86cb-77e456cbcfe1
9882f530-c5b1-4306-ac6e-aafe915ac56f.htseq.counts.gz	f068b5b5-abca-45eb-9a2d-27ddd7781cd7	TCGA-BG-A3EW-11A-22R-A22K-07	TCGA-BG-A3EW-11A-22R	TCGA-BG-A3EW-11A-02-TSB			TCGA-BG-A3EW-11A-22	TCGA-BG-A3EW-11A	TCGA-BG-A3EW	a31554af-d77a-4862-8aed-4581fb2bd877	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	24	220.0	False	true		1.76	a75c4597-041a-44ad-88e1-0466278f621c	0.18	23	released	74b0d078-8d4c-449d-adb7-09385b3d79dc	RNA	R	0.18	UV Spec	released	False	ad6bebd4-14ec-4657-900a-4e5da79c8046	22	1.0	0.0	0.0	0.0	100.0	0.0	0.0	0.0	TOP	5d0cf041-bd1c-416a-aaa5-035b622d3c2e	released																				released	20.0	44dcbef9-4ff8-425d-895e-127f7f5c4d4d	Solid Tissue Normal	11	released	Not Reported	released	TCGA-BG-A3EW_demographic	62	-22705		d1af4708-62fe-5624-9a61-f1542621ba4b	not hispanic or latino	female	white	released	Alive	1949		TCGA-BG-A3EW_exposure	Not Reported	45.72506895050079	fce2e002-ab7f-5878-b97e-cab6552407b6	166.0	released	126.0	TCGA-BG-A3EW_diagnosis	22705	not reported	0	344	e43255c0-7939-5711-9902-2c989fe7a847	Stage III	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-BG-A3EW_treatment_1	TCGA-BG-A3EW_treatment	released	767ce000-1aca-5b64-8590-d5f4f52bed49	no	Pharmaceutical Therapy, NOS	released	5a52d132-8e17-587a-adba-b3fa180144f6	yes	Radiation Therapy, NOS	f068b5b5-abca-45eb-9a2d-27ddd7781cd7
9e0bba8c-ee44-41f6-8b09-7688fe4192a1.htseq.counts.gz	6dff219f-3120-454b-8434-01e56e326345	TCGA-BG-A3PP-11A-11R-A22K-07	TCGA-BG-A3PP-11A-11R	TCGA-BG-A3PP-11A-01-TSA			TCGA-BG-A3PP-11A-11	TCGA-BG-A3PP-11A	TCGA-BG-A3PP	9f92080f-f6e0-42db-a02b-b3069664f6d0	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	143	190.0	False	true		2.04	02446b95-1e3f-474b-8123-f49117f58893	0.16	23	released	9216a218-3da2-469d-b2c0-7f18fc97ef1b	RNA	R	0.16	UV Spec	released	False	8af9fefa-90ba-414c-a77f-eb3ffeb7caa7	11	1.0	0.0	0.0	0.0	100.0	0.0	0.0	0.0	TOP	d8c90564-c3a9-4505-89f8-dbfde985884d	released																				released	30.0	65b6c8b0-ae4a-410a-8e35-f7d8abeecfc6	Solid Tissue Normal	11	released	Not Reported	released	TCGA-BG-A3PP_demographic	82	-30227		190653c3-b629-5caf-8cad-8a6dfc4b62f9	not hispanic or latino	female	white	released	Alive	1929		TCGA-BG-A3PP_exposure	Not Reported		bbd5e0eb-5769-510a-ba7f-0a38d9fea1da		released		TCGA-BG-A3PP_diagnosis	30227	not reported	0	681	0facab6a-307d-5b57-af33-9afebf96a986	Stage II	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-BG-A3PP_treatment	TCGA-BG-A3PP_treatment_1	released	b7e48094-6fa6-509e-b289-82ec1f865547	yes	Radiation Therapy, NOS	released	1b785a2b-d020-5e7f-a5b1-e963b7d53daf	yes	Pharmaceutical Therapy, NOS	6dff219f-3120-454b-8434-01e56e326345
cfc97eda-9c6e-4636-8103-74d6798c8e58.htseq.counts.gz	9e4daefd-53e7-4712-8b98-8e652c2130f7	TCGA-AP-A0LL-01A-12R-A104-07	TCGA-AP-A0LL-01A-12R	TCGA-AP-A0LL-01A-01-TSA	TCGA-AP-A0LL-01A-01-BSA		TCGA-AP-A0LL-01A-12	TCGA-AP-A0LL-01A	TCGA-AP-A0LL	d17668c4-5d66-4e16-8b70-b54616581aae	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	2066	160.0	False	true	B4A6F5DE-E477-48FD-ADA1-EAE436FBC576	1.86	96756b4d-0e43-404d-a819-dc6da126eef8	0.17	23	released	4a218ecf-5cbf-46fa-a06e-dbfca03b612e	RNA	R	0.17	UV Spec	released	False	76353c8d-9d97-48c7-ad8f-0fe2470c0c09	12	0.0	0.0	0.0	0.0	0.0	0.0	100.0	95.0	TOP	0c989325-952b-43bd-9c5e-685a04daf2b7	released	0.0	0.0	0.0	0.0	0.0	0.0	100.0	90.0	BOTTOM	78948b84-4b2f-4898-9697-628e3dbd4a5d	released									released	30.0	488a7462-8348-422c-91d3-7d9f0c39d25e	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A0LL_demographic	56	-20700		08c435d5-dcc2-53eb-b1bc-64e9ff9fdb60	not reported	female	white	released	Alive	1948		TCGA-AP-A0LL_exposure	Not Reported	27.776706145596233	9101d280-d44f-544e-91bb-ea775ca37dc1	161.0	released	72.0	TCGA-AP-A0LL_diagnosis	20700	not reported	0	2554	f06b7f7a-a842-5716-a603-cc32d3f20ba4	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2004	TCGA-AP-A0LL_treatment_1	TCGA-AP-A0LL_treatment	released	dd87bb90-17c4-50db-8dfb-1429fa3080b0	yes	Pharmaceutical Therapy, NOS	released	897e754a-2682-5790-952a-90ecf5096aef	yes	Radiation Therapy, NOS	9e4daefd-53e7-4712-8b98-8e652c2130f7
4462a8af-5371-475c-94a5-2e23c15d4479.htseq.counts.gz	4c48363c-2178-4303-9091-e8293366a535	TCGA-BG-A18B-01A-11R-A12I-07	TCGA-BG-A18B-01A-11R	TCGA-BG-A18B-01A-01-TSA			TCGA-BG-A18B-01A-11	TCGA-BG-A18B-01A	TCGA-BG-A18B	62ae3bb1-8102-4693-aee6-4d8d0d2bc515	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	56	480.0	False	true	E7006FF4-33D9-4369-A4E0-42D124EAE1E0	1.84	5e981b2d-fef0-44c2-8228-8f5f7e9e3026	0.16	23	released	2ea67e75-a9d1-4b2f-a62f-d2e3d2c78a10	RNA	R	0.16	UV Spec	released	False	994ce471-152f-4e18-8822-6fbf09b082b0	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	75.0	TOP	5a681584-bbb6-4b8c-85e9-38b522cecd8e	released																				released	30.0	2a3bc803-54c4-4544-a72d-7077dbb0b93e	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A18B_demographic	53	-19550		5c40ea92-1293-5e14-96bf-5e39c5875c25	not hispanic or latino	female	white	released	Alive	1957		TCGA-BG-A18B_exposure	Not Reported	43.6599043998645	ebe78ab2-28eb-56d1-bb01-559c13d9b07d	163.0	released	116.0	TCGA-BG-A18B_diagnosis	19550	not reported	0	470	4cb8a266-6605-5f34-95c2-b3dcee52e93e	Stage I	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-BG-A18B_treatment	TCGA-BG-A18B_treatment_1	released	a8f65561-fd60-50f9-876f-40b137c56808	no	Radiation Therapy, NOS	released	4183f104-a809-5c6f-883c-305923457040	no	Pharmaceutical Therapy, NOS	4c48363c-2178-4303-9091-e8293366a535
0e656bc2-412d-4866-9201-fb2d0daeac97.htseq.counts.gz	0eba867e-e48e-48cb-826f-9db2a746c814	TCGA-EY-A1GF-01A-11R-A13S-07	TCGA-EY-A1GF-01A-11R	TCGA-EY-A1GF-01A-01-TSA			TCGA-EY-A1GF-01A-11	TCGA-EY-A1GF-01A	TCGA-EY-A1GF	615ea37d-6302-4d68-b253-d24efd947c3e	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	504	160.0	False	false	0C63BAC2-FD3E-49CB-A352-0B1653B78BDD	1.83	e8d79b43-6ed3-40f4-854e-5fd23204381f	0.15	23	released	e2c95738-efa2-4294-94ad-842b8b956ac5	RNA	R	0.15	UV Spec	released	False	2d718463-9edc-4007-ba74-969464ee826b	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	TOP	53943c4d-af3b-432f-9340-f8f4e79553bc	released																				released	30.0	f6e156ad-3e24-4e44-94c0-bcf731ad7c80	Primary Tumor	01	released	Not Reported	released	TCGA-EY-A1GF_demographic	75	-27450		0ecfa5bf-9458-5c6b-9ed8-3f37ef209fee	not hispanic or latino	female	black or african american	released	Alive	1934		TCGA-EY-A1GF_exposure	Not Reported	26.078971533516988	531a14d1-e5f0-53bf-88fa-d648c4f4b453	165.0	released	71.0	TCGA-EY-A1GF_diagnosis	27450	not reported	0	826	da1d2ce6-d1fa-59e2-bfc0-cf6ab085c864	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-EY-A1GF_treatment_1	TCGA-EY-A1GF_treatment	released	94a6859c-6e08-5f4b-83cc-133ed7f12163	no	Pharmaceutical Therapy, NOS	released	16dd6398-da72-5801-8dd2-007510d0c0f4	no	Radiation Therapy, NOS	0eba867e-e48e-48cb-826f-9db2a746c814
5bdcda4a-5fd1-4545-8c15-ace50ee3c836.htseq.counts.gz	2c146e2a-4209-41c2-914c-cad6bdd2b74e	TCGA-EY-A1GD-01A-11R-A13S-07	TCGA-EY-A1GD-01A-11R	TCGA-EY-A1GD-01A-01-TS1			TCGA-EY-A1GD-01A-11	TCGA-EY-A1GD-01A	TCGA-EY-A1GD	33efe6c6-9159-48e8-b759-fba9ddbde761	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	511	230.0	False	false	65C636F7-B24D-479C-A607-FEFEE7D7E30D	1.82	5d109d0e-7bc8-4d3e-898b-a48ab288a5ee	0.16	23	released	4d8cf0c6-804f-4d0a-bc9e-0380eb83be02	RNA	R	0.16	UV Spec	released	False	7d6ac060-782c-49dc-91a1-ed5c6e1455d1	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	TOP	e77980d3-cfdf-4540-8a9e-8ff44d28d121	released																				released	30.0	486403dc-c250-4088-9eed-a4032391d9d8	Primary Tumor	01	released	Not Reported	released	TCGA-EY-A1GD_demographic	51	-18638		20432a64-7226-55a6-bc3f-2c6dd69a4572	not hispanic or latino	female	black or african american	released	Alive	1958		TCGA-EY-A1GD_exposure	Not Reported	32.049981743681286	e4a2989a-aafc-5560-96e7-5e7b98fac1de	157.0	released	79.0	TCGA-EY-A1GD_diagnosis	18638	not reported	0	1639	b6287040-362f-59f2-b7a3-a5fef7595c2f	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-EY-A1GD_treatment	TCGA-EY-A1GD_treatment_1	released	1370eb32-cec4-518f-bf6d-6686ab485217	no	Radiation Therapy, NOS	released	05658fd2-1ae4-5837-9768-468f177ea853	no	Pharmaceutical Therapy, NOS	2c146e2a-4209-41c2-914c-cad6bdd2b74e
d717df43-bc62-449d-a4e2-e30f95b10e8b.htseq.counts.gz	121856d9-285f-4664-b5e9-824b0890bf3a	TCGA-AP-A1DH-01A-31R-A137-07	TCGA-AP-A1DH-01A-31R	TCGA-AP-A1DH-01A-03-TSC			TCGA-AP-A1DH-01A-31	TCGA-AP-A1DH-01A	TCGA-AP-A1DH	07d1aef3-31c7-4c44-a078-16a9eb096d58	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1843	150.0	False	true	B77EE1CD-716C-4441-B4A9-CCCC37BD1379	1.95	c5d7f9d3-70d3-469d-8588-5a125a24efa3	0.17	23	released	66fed9ce-e05b-462c-91bb-4b756a0f6f8a	RNA	R	0.17	UV Spec	released	False	f1e0f761-a45b-48a0-bed6-9861369c50b4	31	0.0	0.0	15.0	0.0	0.0	0.0	85.0	80.0	TOP	406241a4-f5e7-404a-99b6-a2cab4029025	released																				released	30.0	da4b6bf2-0e9d-495a-8220-93359d2afa67	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A1DH_demographic	62	-22652		a0172345-d345-5bd2-b785-7f054781a0fe	not reported	female	white	released	Alive	1943		TCGA-AP-A1DH_exposure	Not Reported	44.99716553287982	69e79316-783f-5c93-92a6-2fd795d7937a	168.0	released	127.0	TCGA-AP-A1DH_diagnosis	22652	not reported	0	2180	8cbd7dd9-f707-56af-ac1b-85833817d15f	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2005	TCGA-AP-A1DH_treatment	TCGA-AP-A1DH_treatment_1	released	88d7374c-c7c5-592f-8902-6d0c75bdcdcd	yes	Radiation Therapy, NOS	released	bc3f0fcf-4ba7-5aa4-b86e-ec0f6972cf04	no	Pharmaceutical Therapy, NOS	121856d9-285f-4664-b5e9-824b0890bf3a
1a6947d9-21f3-4d78-bb00-a854314bb7d2.htseq.counts.gz	8a742f5f-a314-4ec4-ab4f-6c2ae3b8bc7a	TCGA-B5-A11J-01A-11R-A118-07	TCGA-B5-A11J-01A-11R	TCGA-B5-A11J-01A-01-BS1	TCGA-B5-A11J-01A-01-TS1		TCGA-B5-A11J-01A-11	TCGA-B5-A11J-01A	TCGA-B5-A11J	027b2a29-2fad-4ca8-a7cd-eb913d0205f8	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1536	90.0	False	true	1F9E7FAB-ADA0-4EFF-8A86-F5344357ADED	1.9	4f3e68ae-cf3c-491d-a3ed-0fc30261ead3	0.16	23	released	517cb1de-d507-4f4d-9c79-b3b4eff9666c	RNA	R	0.16	UV Spec	released	False	7b6ebf9f-de36-40e7-aa77-4c53fe5f9abd	11	8.0	10.0	1.0	1.0	0.0	7.0	92.0	92.0	BOTTOM	e16173f1-c773-4fd0-b996-b07d8e7fcf9c	released	5.0	8.0	1.0	1.0	0.0	4.0	95.0	95.0	TOP	8184df9b-39c0-45ae-a0b1-75b949872115	released									released	30.0	1eccac56-e4de-4ffd-a0d8-f93d7b8b63f7	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A11J_demographic	64	-23485		95491576-be63-50fd-a69a-453ec41714bb	not reported	female	white	released	Alive	1942		TCGA-B5-A11J_exposure	Not Reported		d774d67f-cdd0-54b7-a25a-504e057adf07		released	134.0	TCGA-B5-A11J_diagnosis	23485	not reported	0	1656	e611e793-17c5-5251-ac80-d2947a148d81	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2006	TCGA-B5-A11J_treatment	TCGA-B5-A11J_treatment_1	released	171dd5bf-4e87-53f0-a4ce-adbe5478f20d	no	Radiation Therapy, NOS	released	c792b410-bef5-5f4a-8cf0-38b9e12b3432	no	Pharmaceutical Therapy, NOS	8a742f5f-a314-4ec4-ab4f-6c2ae3b8bc7a
45a5a115-c0b7-4c26-aab2-c24cc69a1345.htseq.counts.gz	6c0c3011-56d8-490c-8411-aafb3531a2a7	TCGA-EO-A22S-01A-11R-A18M-07	TCGA-EO-A22S-01A-11R	TCGA-EO-A22S-01A-01-TSA			TCGA-EO-A22S-01A-11	TCGA-EO-A22S-01A	TCGA-EO-A22S	8f2d3495-8ce7-4f6e-a41d-8cfae5750937	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	919	100.0	False	false	DB26485C-BE5C-4874-B79D-7FCFFFF70C4E	1.93	b8177a01-9ec3-47dc-a776-1794f693d9e7	0.17	23	released	bdad030a-3a89-4e4b-9462-304de7608b75	RNA	R	0.17	UV Spec	released	False	251b7a17-25c6-4a31-8f94-1d58562565ef	11	40.0	20.0	5.0	20.0	0.0	15.0	80.0	80.0	TOP	5324ea1e-59de-4d69-9441-f39244beda3b	released																				released	30.0	745f2cc5-f0f1-49d1-899e-72b823802b08	Primary Tumor	01	released	Not Reported	released	TCGA-EO-A22S_demographic	58	-21328		3d97f2b9-778a-5826-8aa7-ddc7402c36c2	not reported	female	not reported	released	Alive	1950		TCGA-EO-A22S_exposure	Not Reported	34.51676528599605	9ec07980-e64c-5cc6-99d0-e75b54a9d57d	156.0	released	84.0	TCGA-EO-A22S_diagnosis	21328	not reported	0	1872	dde5c9f9-6cd7-5b32-b160-a711fc93b1f7	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-EO-A22S_treatment	TCGA-EO-A22S_treatment_1	released	6c44fbd4-5976-5484-9e81-2817197df8de	yes	Radiation Therapy, NOS	released	654d80b8-017c-5e00-8c16-3c549dffbcc2	no	Pharmaceutical Therapy, NOS	6c0c3011-56d8-490c-8411-aafb3531a2a7
0e92cbf2-ac17-4227-a54d-1c8877b2db8f.htseq.counts.gz	ab7c859d-f6e0-4a3c-938b-a0538b126bd8	TCGA-BG-A0VX-01A-11R-A118-07	TCGA-BG-A0VX-01A-11R	TCGA-BG-A0VX-01A-01-MS1	TCGA-BG-A0VX-01A-01-BS1		TCGA-BG-A0VX-01A-11	TCGA-BG-A0VX-01A	TCGA-BG-A0VX	6c2a0f37-49cd-4fd0-b126-58b35f9121df	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	729	90.0	False	true	D0131F13-2BA5-4B20-8D3D-25743A258C06	1.88	e6322f79-edd2-48f2-9712-82f7153b6e1e	0.15	23	released	6233b0cd-2cb4-4950-90c9-d7daa89f5902	RNA	R	0.15	UV Spec	released	False	fed382a9-bfab-467d-97e7-b190819f617c	11	60.0	15.0	5.0	20.0	10.0	35.0	50.0	50.0	TOP	a9f524cf-2ac3-40fb-8d24-61224aea7dc6	released	40.0	25.0	10.0	30.0	0.0	20.0	70.0	70.0	BOTTOM	7750c886-9e1f-4d9b-96f4-2e11d4297c41	released									released	30.0	5797d32b-e482-4af3-b043-ad84c84e0296	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A0VX_demographic	58	-21425		3eafb5fd-b307-50ba-838d-d8a4921cce6d	not hispanic or latino	female	white	released	Alive	1950		TCGA-BG-A0VX_exposure	Not Reported	67.95360110803324	5c62e486-871b-59cb-95bf-a9c874aaee5e	152.0	released	157.0	TCGA-BG-A0VX_diagnosis	21425	not reported	0	1043	d48fb6b3-bc0c-54d1-8b6b-ddcf57e9798e	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-BG-A0VX_treatment_1	TCGA-BG-A0VX_treatment	released	3324174b-2ec3-5bca-99dc-a6c1b0a53a2b	no	Pharmaceutical Therapy, NOS	released	647fc589-2820-52fb-a2d1-f38ccc26aa32	yes	Radiation Therapy, NOS	ab7c859d-f6e0-4a3c-938b-a0538b126bd8
15de6a8e-f6bb-49c1-abd6-5c6519f56fa8.htseq.counts.gz	9af56723-49a0-4c71-8e59-617662b790b7	TCGA-E6-A1LX-01A-11R-A14D-07	TCGA-E6-A1LX-01A-11R	TCGA-E6-A1LX-01A-01-TSA			TCGA-E6-A1LX-01A-11	TCGA-E6-A1LX-01A	TCGA-E6-A1LX	435b57e7-5cd4-486a-b3d4-ccb1ef160d52	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1539	190.0	False	false	73CEBF93-0E7C-4EF9-A695-AF489AF3F0F0	1.8	ca056af5-cdea-498c-adaf-9550e8fb4336	0.17	23	released	f8b21df2-d0f0-4ca7-b69c-cc4affa33ff6	RNA	R	0.17	UV Spec	released	False	22a4a7a9-c043-4f1f-8472-fb9d5735912a	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	75.0	TOP	704380e2-d0bd-4d9c-b948-b193b0d105df	released																				released	30.0	840ff7bf-7acc-400b-8395-d048e38674ee	Primary Tumor	01	released	Not Reported	released	TCGA-E6-A1LX_demographic	40	-14731		9c57e3d8-61cf-58c5-a4ff-386c7d91c6d4	not hispanic or latino	female	white	released	Alive	1966		TCGA-E6-A1LX_exposure	Not Reported		a365b8c0-858a-5223-ae7d-12ab2820ad14	163.0	released		TCGA-E6-A1LX_diagnosis	14731	not reported	0	711	99c53e20-d513-55c3-bacf-ec514441fea5	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2006	TCGA-E6-A1LX_treatment	TCGA-E6-A1LX_treatment_1	released	ebf951ca-aefc-568b-9f87-6d13e7cda3e5	yes	Radiation Therapy, NOS	released	983b3c1a-e094-5753-95f5-b91eb0156132	no	Pharmaceutical Therapy, NOS	9af56723-49a0-4c71-8e59-617662b790b7
dcf356c8-93f1-47e4-a143-9931305b4ded.htseq.counts.gz	18b3b90d-1cfa-47c4-b6bc-27a81b83abb9	TCGA-A5-A0GD-01A-11R-A16W-07	TCGA-A5-A0GD-01A-11R	TCGA-A5-A0GD-01A-01-BSA	TCGA-A5-A0GD-01A-01-TSA		TCGA-A5-A0GD-01A-11	TCGA-A5-A0GD-01A	TCGA-A5-A0GD	1486a031-b74d-4976-8b0b-4569e6978f49	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	4119	170.0	False	true	44561792-F2F8-42F7-B697-5D7752F8430E	1.88	7e36dab1-7cb0-42df-acfc-615f7c0bba2c	0.17	23	released	e6dd4417-7688-4dd2-aecf-5c99de5750a9	RNA	R	0.17	UV Spec	released	False	21d2b089-0712-4b8f-bbb8-fca83097f098	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	85.0	BOTTOM	a2cb73af-073c-41e4-abae-c8d04a0aae3a	released	0.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	TOP	5e6779bc-1ac5-4dd3-9ac6-ad375f7a5d79	released									released	30.0	f449f50a-7664-4ddc-87aa-6a061ee7190c	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A0GD_demographic	75	-27399	3423	46557fd9-7911-588f-a680-4f45ad150016	not reported	female	white	released	Dead	1924		TCGA-A5-A0GD_exposure	Not Reported	27.852007979223906	7d108e66-179e-588e-aa96-216b4e546186	163.0	released	74.0	TCGA-A5-A0GD_diagnosis	27399	not reported	0	98	90623af9-2c1f-599e-9e2c-f2079e4715d6	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	1999	TCGA-A5-A0GD_treatment	TCGA-A5-A0GD_treatment_1	released	dffa6065-3577-52b2-90a9-5d28505c6d5e	no	Radiation Therapy, NOS	released	61d4d334-fbb5-59d8-9d8d-f5b05fb80849	no	Pharmaceutical Therapy, NOS	18b3b90d-1cfa-47c4-b6bc-27a81b83abb9
30696f32-59bd-4be3-84bb-8856485483a8.htseq.counts.gz	cc0c02ec-bbbc-427f-b764-1545e258d505	TCGA-D1-A17H-01A-11R-A12I-07	TCGA-D1-A17H-01A-11R	TCGA-D1-A17H-01A-01-TS1			TCGA-D1-A17H-01A-11	TCGA-D1-A17H-01A	TCGA-D1-A17H	6c526c42-2fb2-4dfa-8a3d-5651dd600ac7	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	531	230.0	False	false	E2EBC803-BE77-4936-9B6A-9E6E7E6B8FA4	1.85	e9e9ace8-7686-48a6-9e1b-91899268bd11	0.16	23	released	a7c5153f-6cb9-4c4d-8016-1fc451e58a39	RNA	R	0.16	UV Spec	released	False	fd6a31e2-8218-4841-bb8c-d14e1a2d9b18	11	5.0	0.0	0.0	0.0	0.0	40.0	60.0	60.0	TOP	41e683a7-63df-4fd4-8688-c3d4e61b9bcb	released																				released	30.0	bf526d65-b323-418f-926a-6a0acd8f68e3	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A17H_demographic	61	-22389		d6a3f6e0-9fcc-5add-a7b0-77050a978c56	not hispanic or latino	female	white	released	Alive	1948		TCGA-D1-A17H_exposure	Not Reported	34.42217361683818	bafb79de-8390-5e91-8b2f-4bf53575f0b2	167.0	released	96.0	TCGA-D1-A17H_diagnosis	22389	not reported	0	852	b69f14a4-a7d5-5835-9968-652acdce5769	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-D1-A17H_treatment_1	TCGA-D1-A17H_treatment	released	28bb8bda-d471-53ab-8d58-31720d3a0e32	no	Pharmaceutical Therapy, NOS	released	cc6b1ba9-a429-537b-ac64-afef83990274	no	Radiation Therapy, NOS	cc0c02ec-bbbc-427f-b764-1545e258d505
ef7fb70d-b9aa-4722-9162-c859e00ed132.htseq.counts.gz	9813923c-9d24-4f23-8282-24c54224f22d	TCGA-AX-A2H8-01A-11R-A17B-07	TCGA-AX-A2H8-01A-11R	TCGA-AX-A2H8-01A-01-TSA			TCGA-AX-A2H8-01A-11	TCGA-AX-A2H8-01A	TCGA-AX-A2H8	da0474b3-48ab-4398-ae4b-f15e27e99b2d	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1974	150.0	False	false	1D1AF737-8A5A-4274-B9AD-2F4BA3127DDD	2.02	99d5ea34-d803-41f1-a7bc-3d9e0fb3dbda	0.16	23	released	0f829573-c934-4fe7-97a7-7dc236811a6c	RNA	R	0.16	UV Spec	released	False	27a77645-6138-4c3e-84f1-4066b2175846	11	1.0	0.0	1.0	0.0	0.0	5.0	94.0	96.0	TOP	2aed6dc8-ed88-4ebb-922f-aa0cb71ea818	released																				released	30.0	5b39cf2f-3ada-4c86-aab1-05734e817664	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A2H8_demographic	64	-23448		abe07506-82c6-5605-8235-f6792943c654	not hispanic or latino	female	white	released	Alive	1942		TCGA-AX-A2H8_exposure	Not Reported	44.140625	c1b39e28-562f-5b2b-a6d4-e20bfcfe5d27	160.0	released	113.0	TCGA-AX-A2H8_diagnosis	23448	not reported	0	1861	f34ddcc1-6f19-596f-ac77-2fdf5ddf1507	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2006	TCGA-AX-A2H8_treatment_1	TCGA-AX-A2H8_treatment	released	e56d9121-28b4-568f-8869-45f20d539c36	no	Pharmaceutical Therapy, NOS	released	a405c0db-a0a9-5eb9-a91d-da06b48951d4	yes	Radiation Therapy, NOS	9813923c-9d24-4f23-8282-24c54224f22d
339d2f52-4b6a-44d3-ac6f-3517dd466986.htseq.counts.gz	5cb7d509-5de1-4a0e-bfe4-c27f1ce33666	TCGA-AX-A05W-01A-21R-A466-07	TCGA-AX-A05W-01A-21R	TCGA-AX-A05W-01A-02-TSB	TCGA-AX-A05W-01A-02-BSB		TCGA-AX-A05W-01A-21	TCGA-AX-A05W-01A	TCGA-AX-A05W	87e44856-eb9a-475f-96b1-047b7f77b0da	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1935	210.0	False	false	4C960E79-D109-4C4C-B99F-F73D4DD73B40	1.8	ceba19ee-6da0-4917-a4ba-e9bd20ad7f10	0.16	23	released	4c7b6670-9aa1-46b9-a6a1-bb90d58d3ba2	RNA	R	0.16	UV Spec	released	False	91549966-8c2f-448f-898c-56bbc6000b1c	21	3.0	0.0	10.0	0.0	3.0	2.0	85.0	95.0	TOP	7504484a-e663-47da-845b-a7aa648a4717	released	3.0	0.0	5.0	2.0	6.0	4.0	85.0	90.0	BOTTOM	8073e8ab-2786-472c-944b-e92ce36e7bc5	released									released	30.0	dbdf67e1-e4c2-499c-b701-f1f322242e84	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A05W_demographic	60	-22200		2a3c98a5-a5b9-56cc-9247-093e90862409	not hispanic or latino	female	white	released	Alive	1944		TCGA-AX-A05W_exposure	Not Reported	28.54828131630724	a536f19d-3e30-5535-becc-cd43aa95d393	161.0	released	74.0	TCGA-AX-A05W_diagnosis	22200	not reported	0	2450	b7d4f74c-12af-5445-b73d-84769ca2e86c	Stage IIB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2004	TCGA-AX-A05W_treatment_1	TCGA-AX-A05W_treatment	released	9c3acc2f-b852-5345-876b-4559f9c22245	no	Pharmaceutical Therapy, NOS	released	be3c981b-54f6-5287-9e05-aad09e92a735	no	Radiation Therapy, NOS	5cb7d509-5de1-4a0e-bfe4-c27f1ce33666
68b5552c-677f-4416-b7a0-3ecec3137082.htseq.counts.gz	944bbb2a-f544-42b6-a6d2-5474b69633fd	TCGA-D1-A1O7-01A-11R-A14D-07	TCGA-D1-A1O7-01A-11R	TCGA-D1-A1O7-01A-01-TS1			TCGA-D1-A1O7-01A-11	TCGA-D1-A1O7-01A	TCGA-D1-A1O7	01ed791e-3187-4e24-a5ff-afff0778c152	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	154	50.0	False	false	37C25226-AD56-487E-969B-1538E6E00A5D	1.76	00ea54c2-1043-4a7f-ae62-e2851eb94ba1	0.16	23	released	c4aa25a7-efaa-4386-ab9c-d4711eef27ae	RNA	R	0.16	UV Spec	released	False	5bc8aae4-7ddc-45f5-8f70-39b8a04f7d2b	11	40.0	10.0	5.0	40.0	10.0	15.0	70.0	70.0	TOP	1e4723c7-83af-4d56-8903-de7d2cc5fa6e	released																				released	30.0	c38210f9-bb16-471c-91e1-2cdebfe23345	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A1O7_demographic	60	-22037		cb0d8efa-9f52-5939-9cb2-bc1759bf7fdf	not hispanic or latino	female	white	released	Alive	1950		TCGA-D1-A1O7_exposure	Not Reported	43.82761139517896	3d2140bf-eb5d-5bdb-b454-65e0c043eacd	148.0	released	96.0	TCGA-D1-A1O7_diagnosis	22037	not reported	0	32	2e4c434e-b8e7-5db1-ac83-907d844bcf30	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-D1-A1O7_treatment_1	TCGA-D1-A1O7_treatment	released	6ba8558a-6098-5e37-a4fc-77b928bb5387	no	Pharmaceutical Therapy, NOS	released	235fafd2-6cc7-5be6-a1be-e11fd76f1a84	no	Radiation Therapy, NOS	944bbb2a-f544-42b6-a6d2-5474b69633fd
ab245571-87c5-4759-a529-8250074160d1.htseq.counts.gz	dd556318-7382-4d65-89d4-f038605b19b8	TCGA-B5-A5OD-01A-11R-A31O-07	TCGA-B5-A5OD-01A-11R	TCGA-B5-A5OD-01A-01-TS1			TCGA-B5-A5OD-01A-11	TCGA-B5-A5OD-01A	TCGA-B5-A5OD	3e240dc0-80b7-41ea-81b3-33ece2753c2b	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	662	370.0	False	true	8A0B9737-98D2-4A61-95FF-18842056A6DE	1.9	0dfc3298-73ab-4c7b-b4f5-1314a5713c92	0.16	23	released	411e8d74-17c9-44c5-982d-2e5cd63ce9c2	RNA	R	0.16	UV Spec	released	False	70846809-7a93-491a-a328-d1004da4cdc3	11	2.0	2.0	5.0	2.0	0.0	15.0	80.0	85.0	TOP	3220b10f-e059-4d82-bc74-fad9910ac8ea	released																				released	30.0	71994580-4a7f-433d-80d3-71e408d44eb3	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A5OD_demographic	67	-24775		8a10febd-d599-50a1-a42c-6dee0e428a6a	not reported	female	black or african american	released	Alive	1944		TCGA-B5-A5OD_exposure	Not Reported		14fc2263-ab01-58ae-860b-da570cd43ae2		released		TCGA-B5-A5OD_diagnosis	24775	not reported	0	1038	396a29cc-f50f-56bd-85ee-8fbb80e73e3c	Stage IIIC	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-B5-A5OD_treatment_1	TCGA-B5-A5OD_treatment	released	9725ad32-fd3c-50be-8099-3dc0b2cb2f78	yes	Pharmaceutical Therapy, NOS	released	89c32f7a-7690-546f-b303-d1a69c53ad64	yes	Radiation Therapy, NOS	dd556318-7382-4d65-89d4-f038605b19b8
4b9c4397-d2c4-45e4-abed-842392ab40f9.htseq.counts.gz	ffd421dd-0d99-4284-b347-9e96a55678f4	TCGA-QS-A5YR-01A-31R-A31O-07	TCGA-QS-A5YR-01A-31R	TCGA-QS-A5YR-01A-03-TS3			TCGA-QS-A5YR-01A-31	TCGA-QS-A5YR-01A	TCGA-QS-A5YR	6696cf88-3c43-482c-aabb-f1ea5cf565aa	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	118	280.0	False	false	D9417AEE-FD30-42FA-986E-26C98E29C428	1.82	0c0e6adb-5f3b-429c-bbc4-5d3d74e9ef63	0.16	23	released	8c31b35e-3c44-4b5c-85c4-7d5ca2887d85	RNA	R	0.16	UV Spec	released	False	8a4788e4-00fb-4488-b50e-fd0a93b7f5c6	31	40.0	20.0	10.0	20.0	0.0	20.0	70.0	70.0	TOP	41a0f2d6-2866-4cea-9395-a33d327efdcb	released																				released	30.0	ff0189ba-f127-4093-b92c-5e37388c7a54	Primary Tumor	01	released	Not Reported	released	TCGA-QS-A5YR_demographic	61	-22372		32525c21-d012-5d48-add2-322fb2132125	not hispanic or latino	female	black or african american	released	Alive	1951		TCGA-QS-A5YR_exposure	Not Reported	35.430839002267575	8d8d7f0c-0274-540b-8131-721c30eb5b23	168.0	released	100.0	TCGA-QS-A5YR_diagnosis	22372	not reported	0	719	933be2c9-e498-54b3-97d2-99f70124dba0	Stage IIIB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2012	TCGA-QS-A5YR_treatment_1	TCGA-QS-A5YR_treatment	released	cb8d3e78-00d3-5003-9c42-9dcaf7ad1060	no	Pharmaceutical Therapy, NOS	released	73d3ee91-14e0-51ca-b7f3-fb82fb08309c	no	Radiation Therapy, NOS	ffd421dd-0d99-4284-b347-9e96a55678f4
bd0da177-9dad-4f37-9e6a-202b5fd2139e.htseq.counts.gz	c820f3b7-77b8-4ec3-ab81-a25b9009ac82	TCGA-B5-A0JN-01A-11R-A104-07	TCGA-B5-A0JN-01A-11R	TCGA-B5-A0JN-01A-01-BS1	TCGA-B5-A0JN-01A-01-TS1		TCGA-B5-A0JN-01A-11	TCGA-B5-A0JN-01A	TCGA-B5-A0JN	b60f22ac-a659-4f33-b01d-820e86a9a5c9	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	2164	440.0	False	true	A22F4C33-7630-4595-8415-24C87949B211	1.7	cbd18c2a-4544-4a90-904e-533c3f776f32	0.15	23	released	a09e5a77-fa03-474d-925d-6b6e491430be	RNA	R	0.15	UV Spec	released	False	13ce4847-064c-4e9a-9d49-6ce705d67d0f	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	90.0	BOTTOM	19bbff7a-2913-4963-8bbe-2a632dc04e82	released	0.0	0.0	0.0	0.0	0.0	0.0	100.0	90.0	TOP	1ada5fe5-accb-4872-a5b9-19545a359e21	released									released	30.0	684c6894-fd49-4934-8962-9628ece734fb	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A0JN_demographic	84	-30933		803b97ad-544f-5652-a79b-7dc4f1df6e1c	not reported	female	black or african american	released	Alive	1920		TCGA-B5-A0JN_exposure	Not Reported	24.456063417102378	54349de0-3234-5aa9-bd95-5e4700382947	154.0	released	58.0	TCGA-B5-A0JN_diagnosis	30933	not reported	0	1939	4c735ac3-31b0-59a6-9214-c58a003e4c8f	Stage IVB	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	yes	Yes	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2004	TCGA-B5-A0JN_treatment_1	TCGA-B5-A0JN_treatment	released	7543f14c-9eac-5ba2-97ae-badefb4c3e29	yes	Pharmaceutical Therapy, NOS	released	03baf715-289a-5971-9525-3be0eca9a7f5	no	Radiation Therapy, NOS	c820f3b7-77b8-4ec3-ab81-a25b9009ac82
a63f03fe-8d15-426d-b41f-88d30aebe774.htseq.counts.gz	f40eb4ab-33cc-452a-bd50-bfe8d294117f	TCGA-D1-A17A-01A-11R-A12I-07	TCGA-D1-A17A-01A-11R	TCGA-D1-A17A-01A-01-TS1			TCGA-D1-A17A-01A-11	TCGA-D1-A17A-01A	TCGA-D1-A17A	c68dd983-b199-4f53-ac0c-b2d8dd6a7931	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	553	60.0	False	false	9E0E5CDA-AE46-4ABC-8AF7-C89FE86B7472	1.86	88aec124-1462-4fd5-b209-b0dadf1138bc	0.17	23	released	504aebe6-7441-4d44-a625-3dd6b8db2e26	RNA	R	0.17	UV Spec	released	False	7afc9762-1860-4ae7-abc3-9dd5a8898431	11	30.0	10.0	10.0	50.0	0.0	10.0	80.0	80.0	TOP	602734e5-9cc2-4682-b4db-903744434568	released																				released	30.0	a0083336-5187-4969-85bb-993fa72fbd75	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A17A_demographic	59	-21560		34a4b0c0-cafa-5ade-9250-9a33891abdf0	not hispanic or latino	female	white	released	Alive	1950		TCGA-D1-A17A_exposure	Not Reported	32.92871900826446	126788c8-8bea-584c-ad9c-43c050709f55	176.0	released	102.0	TCGA-D1-A17A_diagnosis	21560	not reported	0	48	65afd97d-49f3-57ce-aef3-e0393aa0b85d	Stage IIA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-D1-A17A_treatment_1	TCGA-D1-A17A_treatment	released	625ec38d-fbf6-5564-84bb-ad79f0e51c01	no	Pharmaceutical Therapy, NOS	released	9522a52c-1ca1-5b97-b212-33b0b26519fe	no	Radiation Therapy, NOS	f40eb4ab-33cc-452a-bd50-bfe8d294117f
afc7a95d-cab9-4416-a3d0-ce13cbae8918.htseq.counts.gz	25a7f764-dc57-457c-9065-3c13c55b1d64	TCGA-BG-A0VW-01A-11R-A118-07	TCGA-BG-A0VW-01A-11R	TCGA-BG-A0VW-01A-01-BS1	TCGA-BG-A0VW-01A-01-TS1		TCGA-BG-A0VW-01A-11	TCGA-BG-A0VW-01A	TCGA-BG-A0VW	62d71839-4fba-42e9-9929-8d937f0fe287	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	246	90.0	False	true	7663D410-13EC-4A5B-B655-F7DCCC9C8E8D	1.88	818368c5-a7b6-40d2-a24f-39604ea80303	0.15	23	released	b87ca17d-8a2c-439c-a71c-3e2a1dd84324	RNA	R	0.15	UV Spec	released	False	68fca334-a7ad-4e28-bf00-8754a40e1134	11	40.0	20.0	0.0	30.0	0.0	40.0	60.0	60.0	BOTTOM	55ce56a0-b2e0-4625-9d75-e48b2f0d416f	released	40.0	30.0	5.0	30.0	10.0	25.0	60.0	60.0	TOP	9f154f06-61ab-4645-8ec5-5a7ce1149f46	released									released	30.0	e5e61331-4cca-4742-83ab-87e9dddafaca	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A0VW_demographic	77	-28383		540f6a1a-88ee-5303-8612-f84ac47bc183	not hispanic or latino	female	white	released	Alive	1933		TCGA-BG-A0VW_exposure	Not Reported	37.72972534382733	3a1bed2c-dce9-51f9-945b-872fb61ff4c6	157.0	released	93.0	TCGA-BG-A0VW_diagnosis	28383	not reported	0	1582	2c1907ca-c957-5798-9ce9-23fbcc276ab9	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-BG-A0VW_treatment_1	TCGA-BG-A0VW_treatment	released	6bf12f53-51d0-5efd-8e56-843debf1850e	no	Pharmaceutical Therapy, NOS	released	e4c508a0-2edf-5f8b-974b-1652d00c1d88	no	Radiation Therapy, NOS	25a7f764-dc57-457c-9065-3c13c55b1d64
bc23d1e2-f73e-49b4-be5b-6a4fc915c6b6.htseq.counts.gz	84deedf3-ad8c-4dec-b3db-b5adbf9844f8	TCGA-BG-A0MC-01A-21R-A040-07	TCGA-BG-A0MC-01A-21R	TCGA-BG-A0MC-01A-02-TSB	TCGA-BG-A0MC-01A-02-BSB		TCGA-BG-A0MC-01A-21	TCGA-BG-A0MC-01A	TCGA-BG-A0MC	884fd57d-bd8e-40e7-82f6-0ba1c71101a9	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	779	630.0	False	true	100F4900-491A-438B-9704-51D4E016B325	1.94	1ad1a4dc-b34a-4f34-990b-05c2c14fb4c9	0.15	23	released	f084272e-7a5d-42ef-ba7a-950ad591e5d8	RNA	R	0.15	UV Spec	released	False	7a317648-c8d5-4996-8322-717b17f27ed9	21	0.0	0.0	0.0	0.0	0.0	0.0	100.0	75.0	TOP	a62cbfb6-1ee0-4f71-93bd-ba89a3329b81	released	0.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	BOTTOM	1da708b6-4e12-4d86-8c15-6e768f2103c8	released									released	30.0	46b48bf8-346b-4f25-916e-26a3cddfa00d	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A0MC_demographic	74	-27136		42b3c01b-def5-5cb2-be54-586665f83089	not hispanic or latino	female	white	released	Alive	1934		TCGA-BG-A0MC_exposure	Not Reported	56.19146722164411	afc80ae7-c13d-5667-9466-39c1c6aba358	155.0	released	135.0	TCGA-BG-A0MC_diagnosis	27136	not reported	0	1263	6489843e-939f-5f39-badf-ccab378a3ad6	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-BG-A0MC_treatment	TCGA-BG-A0MC_treatment_1	released	6d91b950-ac08-5e7e-95f1-27820d5c7083	no	Radiation Therapy, NOS	released	321d5fa3-73a7-55cf-8d9e-be6ae758f8f1	no	Pharmaceutical Therapy, NOS	84deedf3-ad8c-4dec-b3db-b5adbf9844f8
59118944-d135-4b7d-8ce4-438fcaa4fcf4.htseq.counts.gz	ad1802fc-2f54-45c7-b6fe-c6ba55a1b7da	TCGA-D1-A2G0-01A-11R-A32Y-07	TCGA-D1-A2G0-01A-11R	TCGA-D1-A2G0-01A-01-TSA			TCGA-D1-A2G0-01A-11	TCGA-D1-A2G0-01A	TCGA-D1-A2G0	6f661f0d-f08b-486e-8bd7-4306e1593eb9	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	1416	90.0	False	true	02872006-6F7E-4FB7-B1C2-1C5DD3199FE3	1.79	ca1b7ca7-5c8b-442d-ab3d-29bd16de1229	0.17	23	released	a8b9f8ec-e248-4ab6-9bb4-6fd1d240d723	RNA	R	0.17	UV Spec	released	False	b8209aee-0c7e-48bd-8936-3f1719c868cd	11	20.0	0.0	20.0	10.0	10.0	0.0	70.0	90.0	TOP	597a1c04-57f6-499a-af5f-4b72214aff21	released																				released	30.0	134cd317-cbeb-4633-b540-b639454615f7	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A2G0_demographic	70	-25573		d45a801b-a1cd-51a8-abd6-5b5f4ad4f091	not hispanic or latino	female	white	released	Alive	1937		TCGA-D1-A2G0_exposure	Not Reported	24.964946479258575	a98c4a0a-1da4-5a07-a022-2e1bc468b73f	171.0	released	73.0	TCGA-D1-A2G0_diagnosis	25573	not reported	0	1484	3b9ea115-6fd4-5ead-91ad-38a0290e8a50	Stage IB	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2007	TCGA-D1-A2G0_treatment_1	TCGA-D1-A2G0_treatment	released	ce98e0a4-9a7e-5d93-82f7-899ecaeaf42d	not reported	Pharmaceutical Therapy, NOS	released	02674f23-c7f6-5daf-818a-f167d8575e44	not reported	Radiation Therapy, NOS	ad1802fc-2f54-45c7-b6fe-c6ba55a1b7da
758b4472-0993-4e40-b3f0-36c1e9e86994.htseq.counts.gz	969b1c04-85a6-4ace-a732-b267e0908692	TCGA-BG-A0M7-01A-11R-A040-07	TCGA-BG-A0M7-01A-11R	TCGA-BG-A0M7-01A-01-BSA	TCGA-BG-A0M7-01A-01-TSA		TCGA-BG-A0M7-01A-11	TCGA-BG-A0M7-01A	TCGA-BG-A0M7	1d9c2113-ddcb-4440-89c3-cd21cee6d401	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	659	260.0	False	true	F9128DAE-F3D0-4738-AC20-E665F22DDC63	1.9	a832a6a6-1998-41c2-9dab-87076a1f11cf	0.15	23	released	700a9d82-11b0-473e-8ae4-0419c41550b2	RNA	R	0.15	UV Spec	released	False	9dba01e9-2702-4ef1-910c-ebd9f5ac430c	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	75.0	BOTTOM	05ade59e-bee2-465b-b1c1-68ee5d03607a	released	0.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	TOP	6e229e68-dfd1-458e-aaa8-bcd622a3c6d2	released									released	30.0	d053fa9e-5d19-4940-8915-4a03cb479263	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A0M7_demographic	60	-22096		a5a0d889-9d31-55c0-80a8-9c3eb31ed85d	not hispanic or latino	female	white	released	Alive	1948		TCGA-BG-A0M7_exposure	Not Reported	39.84375	7ba83248-6954-5f93-b34f-1c416bdd7a23	160.0	released	102.0	TCGA-BG-A0M7_diagnosis	22096	not reported	0	1937	ca893451-6c23-52c1-86ed-65da0df32661	Stage IIIC1	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-BG-A0M7_treatment_1	TCGA-BG-A0M7_treatment	released	d9973988-a655-5272-8789-e2aacdf5edf7	yes	Pharmaceutical Therapy, NOS	released	1d000dea-f4e2-5d05-9167-287fd41901f8	yes	Radiation Therapy, NOS	969b1c04-85a6-4ace-a732-b267e0908692
e916087d-f531-4130-9823-1019ee7a7dd9.htseq.counts.gz	8cf9024a-2b9b-466e-873b-9cc96954ce73	TCGA-D1-A177-01A-21R-A12I-07	TCGA-D1-A177-01A-21R	TCGA-D1-A177-01A-02-TS2			TCGA-D1-A177-01A-21	TCGA-D1-A177-01A	TCGA-D1-A177	e8c58d8b-51d7-4599-af79-469ee6f269db	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	227	190.0	False	false	28FF1BEE-6F93-4BCA-A6DC-56A1EA8EA337	1.32	75b0fdbd-9670-468e-b426-410c95d84426	0.17	23	released	34fa4406-bc22-4467-acdc-fda440db931a	RNA	R	0.17	UV Spec	released	False	80ee4a64-0c0a-4344-8a48-8d241b2e347a	21	40.0	20.0	10.0	20.0	0.0	30.0	60.0	60.0	TOP	21ac5ebe-b9cb-4c6b-9618-dda4b8baa06d	released																				released	30.0	97587fd4-0f6f-4af5-ac0a-7328abb40e9c	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A177_demographic	70	-25602		dd1d384b-f3e5-53cb-b3e1-cff1a4d84850	not hispanic or latino	female	white	released	Alive	1940		TCGA-D1-A177_exposure	Not Reported	22.939750692520775	5b9d01f1-6ff2-5183-ac55-f84e14e4619a	152.0	released	53.0	TCGA-D1-A177_diagnosis	25602	not reported	0	548	2e0e272b-4997-507a-b791-0d1d28ed2cfd	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-D1-A177_treatment_1	TCGA-D1-A177_treatment	released	6c6439c1-efed-586c-900f-bcee6e3bd0a0	no	Pharmaceutical Therapy, NOS	released	5b69be75-99d1-5c22-bb7f-f3f7fe51088a	yes	Radiation Therapy, NOS	8cf9024a-2b9b-466e-873b-9cc96954ce73
ddb3fd2f-1481-4dba-8b0e-db3eb12ebae1.htseq.counts.gz	ad5ec58a-a0eb-420c-8d02-42f7b2713596	TCGA-B5-A3FH-01A-11R-A19W-07	TCGA-B5-A3FH-01A-11R	TCGA-B5-A3FH-01A-01-TSA			TCGA-B5-A3FH-01A-11	TCGA-B5-A3FH-01A	TCGA-B5-A3FH	139e2c5a-cc0c-43a2-b30e-b8ac17c0b5f2	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	97	480.0	False	true	05AD8EE1-E2F8-42F7-8E6A-380A8EE4770E	1.78	2bb3a670-627e-4aa7-8dfc-88f6cc06d1a7	0.17	23	released	53852682-4845-47aa-abb9-d5e667df072f	RNA	R	0.17	UV Spec	released	False	22937cfe-0834-433f-96a3-e9c87b35542c	11	1.0	5.0	15.0	2.0	0.0	0.0	85.0	80.0	TOP	b669c243-7a48-4b1f-8224-b01c34ce7b75	released																				released	30.0	f7c02f75-ca0a-4d2d-bd45-d40e77fe74fc	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A3FH_demographic	74	-27221		deb86788-08c6-59ba-9c5d-5637dd170b6e	not reported	female	black or african american	released	Alive	1937		TCGA-B5-A3FH_exposure	Not Reported	33.203125	3d9772e1-9dfd-5ad8-afdf-e378219ddd6d	160.0	released	85.0	TCGA-B5-A3FH_diagnosis	27221	not reported	0	841	600b71c3-44e0-59ff-b7b7-997e8563788c	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-B5-A3FH_treatment	TCGA-B5-A3FH_treatment_1	released	bf84eb09-d3e2-50f8-a63c-9292ae243dee	no	Radiation Therapy, NOS	released	ae7cb3be-ba87-597f-982a-6cf51a0604a4	no	Pharmaceutical Therapy, NOS	ad5ec58a-a0eb-420c-8d02-42f7b2713596
42dc44c3-e041-48eb-92bb-0d12bcd4ae58.htseq.counts.gz	781691d0-809f-4d95-b7a7-1f75ff6aed1a	TCGA-KJ-A3U4-01A-11R-A22K-07	TCGA-KJ-A3U4-01A-11R	TCGA-KJ-A3U4-01A-01-TS1			TCGA-KJ-A3U4-01A-11	TCGA-KJ-A3U4-01A	TCGA-KJ-A3U4	1a36d5de-a097-4323-90e9-f1b924a8a5d8	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	56	420.0	False	true	F0B04416-21FE-4DBC-84BB-7188131399B6	1.83	ad229cea-5cac-422d-a773-370ed37152e9	0.17	23	released	825f8eb5-4da1-45fd-a2de-2f9dac894bb1	RNA	R	0.17	UV Spec	released	False	4909aed3-a030-40d5-9ec1-7d200d119011	11	2.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	TOP	1fb56eb4-61b8-4656-a22c-07410e9ef641	released																				released	30.0	7fcbd3e2-4a71-4ef2-96df-d4be66352d9e	Primary Tumor	01	released	Not Reported	released	TCGA-KJ-A3U4_demographic	55	-20392		fdbce5bb-88bb-572b-8b58-e3f94a340c33	hispanic or latino	female	white	released	Alive	1957		TCGA-KJ-A3U4_exposure	Not Reported	35.26170798898072	19cf3c90-19d8-5055-bce8-3a2ee8d532a9	165.0	released	96.0	TCGA-KJ-A3U4_diagnosis	20392	not reported	0	1095	9f60a2c7-9963-59e1-8563-8e4da64db571	Stage IA	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2012	TCGA-KJ-A3U4_treatment_1	TCGA-KJ-A3U4_treatment	released	a0056717-f4b8-51ad-91d3-4ac111417a87	yes	Pharmaceutical Therapy, NOS	released	0d132b73-1dfe-5233-9592-6d9194d74605	no	Radiation Therapy, NOS	781691d0-809f-4d95-b7a7-1f75ff6aed1a
9fa9c576-3593-43e4-b0c6-102fcb9c0774.htseq.counts.gz	ae07a413-3a5a-423a-bb5a-20a07fc6d0b9	TCGA-B5-A3FB-01A-11R-A19W-07	TCGA-B5-A3FB-01A-11R	TCGA-B5-A3FB-01A-01-TSA			TCGA-B5-A3FB-01A-11	TCGA-B5-A3FB-01A	TCGA-B5-A3FB	0c1946a8-ee54-4b9b-8054-9a7bece74d33	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	2066	350.0	False	true	FA278AFC-C294-48A5-BE7B-B26F4AE3FC5B	1.8	0421d738-8236-46c5-8b98-6b261defb294	0.17	23	released	2251d71c-d3fc-483d-abd2-2c5b3b1abcad	RNA	R	0.17	UV Spec	released	False	8bdfbd16-52aa-4b9d-8020-a479efc00be3	11	1.0	5.0	15.0	5.0	0.0	0.0	85.0	80.0	TOP	02567037-92cb-4e4a-9b7c-a7618aa2201b	released																				released	30.0	0cea1bde-18ed-4e42-b5f6-3d4ff182b0c0	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A3FB_demographic	73	-26779		9f7d00ec-c32d-54a4-b535-29f67966f7b6	not reported	female	black or african american	released	Alive	1933		TCGA-B5-A3FB_exposure	Not Reported	39.792387543252595	5867147e-8b9e-5d2f-9597-3f071ac84e40	170.0	released	115.0	TCGA-B5-A3FB_diagnosis	26779	not reported	0	2844	a6abf562-401d-58f2-9205-ef490b917966	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2006	TCGA-B5-A3FB_treatment	TCGA-B5-A3FB_treatment_1	released	597ee7fc-bf02-5e62-9081-33f15bc255fa	no	Radiation Therapy, NOS	released	5b19df24-b2b2-55ae-b69c-06bddd6e22aa	no	Pharmaceutical Therapy, NOS	ae07a413-3a5a-423a-bb5a-20a07fc6d0b9
0fcb64a3-76ac-405a-baa9-7919fc32cd6e.htseq.counts.gz	602636b1-892e-4992-ad07-47c7ad13ac9b	TCGA-B5-A11I-01A-11R-A10J-07	TCGA-B5-A11I-01A-11R	TCGA-B5-A11I-01A-01-BSA	TCGA-B5-A11I-01A-01-TSA		TCGA-B5-A11I-01A-11	TCGA-B5-A11I-01A	TCGA-B5-A11I	f6d136c7-c250-4361-9fed-50f513959a40	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1974	970.0	False	true	850EFCC5-484B-4E09-801A-2FAFB4CFD72B	1.92	5706f1b9-2c2c-4906-a9fb-64ba5a57d47e	0.15	23	released	ed154bf0-f433-4d04-9a65-eb3a76044c7e	RNA	R	0.15	UV Spec	released	False	15eacd2a-cf7e-4486-ad4a-7874ba1efc91	11	30.0	30.0	5.0	3.0	0.0	3.0	92.0	92.0	BOTTOM	eb31fc61-7f1d-4e98-ad19-17842f2024c3	released	30.0	25.0	7.0	2.0	0.0	3.0	90.0	90.0	TOP	1242e86f-9fc8-4774-be96-fd33b8886123	released									released	30.0	56652dde-33da-451e-a1c2-6e9884f9915a	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A11I_demographic	65	-23857		bbb417a3-02c2-56b4-b115-92346aa6216f	not reported	female	black or african american	released	Alive	1940		TCGA-B5-A11I_exposure	Not Reported	49.04869269411811	84717fa6-8c46-51e1-8ad3-f63221b231ad	159.0	released	124.0	TCGA-B5-A11I_diagnosis	23857	not reported	0	2303	0a88bce6-1fc7-5b47-b586-c3f60a39ed68	Stage IVB	C54.1	not reported	8140/3	Adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2005	TCGA-B5-A11I_treatment	TCGA-B5-A11I_treatment_1	released	1e269e8b-584c-5dbe-ad4d-2c5b8358bd59	yes	Radiation Therapy, NOS	released	e5c3b949-f6a9-508e-bd0b-b2108f426a4b	yes	Pharmaceutical Therapy, NOS	602636b1-892e-4992-ad07-47c7ad13ac9b
632d317d-e0fd-4af3-865e-1d87bc4423bb.htseq.counts.gz	a49d52c2-23b0-4286-85fa-6faf06c4ba5c	TCGA-EO-A3AZ-01A-12R-A19W-07	TCGA-EO-A3AZ-01A-12R	TCGA-EO-A3AZ-01A-01-TSA			TCGA-EO-A3AZ-01A-12	TCGA-EO-A3AZ-01A	TCGA-EO-A3AZ	38bf8476-fde7-423b-bbaa-15483207de39	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	241	120.0	False	false	EA5D2C1C-703B-46BE-8B16-C40CE4BA0B46	1.79	78ab0c5d-29cf-4660-bd1f-1a0eb5edaf2f	0.17	23	released	486115fa-86c7-4201-b3e3-53ea07455e98	RNA	R	0.17	UV Spec	released	False	9f08642a-4681-446c-919a-90d4dafd248b	12	70.0	10.0	5.0	10.0	0.0	15.0	80.0	80.0	TOP	7eafe5b3-1fc6-4495-9dae-4d33a9f8c31e	released																				released	20.0	de7f0a98-8365-4dfc-856f-138eae9cef16	Primary Tumor	01	released	Not Reported	released	TCGA-EO-A3AZ_demographic	80	-29234		4d5a76c9-3887-5675-bb43-b0fb50bc0d49	not reported	female	not reported	released	Alive	1931		TCGA-EO-A3AZ_exposure	Not Reported	39.795918367346935	723116d3-1dfd-53e0-844f-5e68c7bdb32d	140.0	released	78.0	TCGA-EO-A3AZ_diagnosis	29234	not reported	0	826	6a15561f-5eee-51c1-81ef-a8c63d313591	Stage IB	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-EO-A3AZ_treatment_1	TCGA-EO-A3AZ_treatment	released	5ae24240-f17d-5be1-8583-dc6bc23df23b	no	Pharmaceutical Therapy, NOS	released	6f41146a-6ec2-5aca-b679-e2554e0fea90	no	Radiation Therapy, NOS	a49d52c2-23b0-4286-85fa-6faf06c4ba5c
8aa824c9-cda6-4a30-a92e-66d50c3b221d.htseq.counts.gz	3be439d4-14bc-4271-ab18-f1a98381b437	TCGA-BG-A0YV-01A-11R-A10J-07	TCGA-BG-A0YV-01A-11R	TCGA-BG-A0YV-01A-01-TSA	TCGA-BG-A0YV-01A-01-BSA		TCGA-BG-A0YV-01A-11	TCGA-BG-A0YV-01A	TCGA-BG-A0YV	d8e57746-37a1-482a-a3d3-a11bd00cdc11	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	62	330.0	False	true	D037EFD1-22CB-43FE-BE0A-F2189C5FB202	1.9	9b120d0b-5e47-4428-8116-557fcb7edf8a	0.16	23	released	301f3fff-5315-4749-bf76-f180d5716b70	RNA	R	0.16	UV Spec	released	False	eaabf134-57bc-4073-8c6d-62097ba34336	11	10.0	10.0	20.0	10.0	0.0	20.0	60.0	80.0	TOP	00b115d7-c396-41dd-ae34-05f0eccd40b6	released	10.0	10.0	20.0	20.0	0.0	20.0	60.0	80.0	BOTTOM	381aa5ac-a1d2-4ddf-893d-3f32a07817fa	released									released	30.0	13db3af5-5f71-49b8-95f6-d452062c7ea4	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A0YV_demographic	67	-24567		a725b8c8-1661-5ee3-8187-e4cb2286b6ed	not hispanic or latino	female	white	released	Alive	1943		TCGA-BG-A0YV_exposure	Not Reported	22.476586888657646	2ac0cf15-c3cb-5c1c-af00-6dfcffd580ed	155.0	released	54.0	TCGA-BG-A0YV_diagnosis	24567	not reported	0	382	6e2eb9bb-87c9-5622-99ea-211fba71718e	Stage IIIA	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2010	TCGA-BG-A0YV_treatment_1	TCGA-BG-A0YV_treatment	released	67ea746a-e0d7-5b2c-856d-28b2bcbcf127	yes	Pharmaceutical Therapy, NOS	released	1c1cda1f-b8d3-5f9b-9eb2-ef8ebed93596	yes	Radiation Therapy, NOS	3be439d4-14bc-4271-ab18-f1a98381b437
b775000b-5f07-4730-9b31-d4cab53309ab.htseq.counts.gz	c0f9199b-e69c-4490-9cba-a9465a8b5ec4	TCGA-EY-A3L3-01A-11R-A22K-07	TCGA-EY-A3L3-01A-11R	TCGA-EY-A3L3-01A-01-TSA			TCGA-EY-A3L3-01A-11	TCGA-EY-A3L3-01A	TCGA-EY-A3L3	06728b1b-6b69-4467-8e10-a8a4e6328ac8	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	198	1020.0	False	false	DBCC8E6F-3AB9-41B2-8266-341509A9FDB3	1.83	eacfdc9c-b044-4dd5-a153-1ed9b62b0fb8	0.15	23	released	247f573c-f013-468d-a5f2-8b0c0c4ec829	RNA	R	0.15	UV Spec	released	False	f1052d2e-cc51-4d1d-bbf5-e0ef19ca7bc5	11	2.0	0.0	0.0	0.0	0.0	0.0	100.0	90.0	TOP	0c120c7b-6dd1-4e15-831d-cd00762d823d	released																				released	30.0	9895a2ad-1c08-4e2e-acca-88a3927a2c2d	Primary Tumor	01	released	Not Reported	released	TCGA-EY-A3L3_demographic	82	-30138		cc57dcd7-5e85-5e52-b35b-4adf130b31d7	not hispanic or latino	female	black or african american	released	Alive	1929		TCGA-EY-A3L3_exposure	Not Reported	35.492457852706295	f4e1aa59-e9c8-5a53-82f8-c5ad1ccde310	161.0	released	92.0	TCGA-EY-A3L3_diagnosis	30138	not reported	0	832	03da229e-75bb-588f-90bf-84d998331fe1	Stage IA	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-EY-A3L3_treatment	TCGA-EY-A3L3_treatment_1	released	cad43da4-7e03-5555-87a4-121b24947e13	yes	Radiation Therapy, NOS	released	e3ca0d69-45b9-5088-bc79-394be6707385	yes	Pharmaceutical Therapy, NOS	c0f9199b-e69c-4490-9cba-a9465a8b5ec4
0e114891-8315-49a0-92a6-171f233f7638.htseq.counts.gz	fa22b57c-6ac2-4a90-b96b-7b0beac0287f	TCGA-BK-A6W4-01A-12R-A34R-07	TCGA-BK-A6W4-01A-12R	TCGA-BK-A6W4-01A-01-TS1			TCGA-BK-A6W4-01A-12	TCGA-BK-A6W4-01A	TCGA-BK-A6W4	8e7792b3-2b6c-47ac-acbe-3da7462a8321	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	118	180.0	False	false	5F25185F-4F80-4137-A07C-230FB3ACE3AE	1.89	1073a603-5546-48b8-b6aa-9a16f909547b	0.15	23	released	2737de9e-1ed5-43ae-8177-d11fe850a49f	RNA	R	0.15	UV Spec	released	False	519a54df-c5dc-4a43-80f6-72fff1e0b814	12	5.0	2.0	0.0	2.0	15.0	10.0	75.0	75.0	TOP	9e10af3c-0004-4315-bf06-e9f05f613a2b	released																				released	30.0	780bb0ac-d5dd-447f-a280-3ff49d7849f2	Primary Tumor	01	released	Not Reported	released	TCGA-BK-A6W4_demographic	62	-22766		13527a4f-c30d-54d3-87c3-f2e6883445da	not hispanic or latino	female	black or african american	released	Alive	1951		TCGA-BK-A6W4_exposure	Not Reported	43.40946894397339	63ba4be2-1e1c-5661-ab87-525f4b944b56	157.0	released	107.0	TCGA-BK-A6W4_diagnosis	22766	not reported	0	300	796e258f-42f2-5fdb-8f39-750511699f03	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2013	TCGA-BK-A6W4_treatment	TCGA-BK-A6W4_treatment_1	released	728d30c7-200c-50c1-85c6-d80f08642e0c	yes	Radiation Therapy, NOS	released	043fa2b8-7ebe-55db-b06b-3c22d412ef54	no	Pharmaceutical Therapy, NOS	fa22b57c-6ac2-4a90-b96b-7b0beac0287f
beac152e-13ba-4510-a259-ba04e3f33857.htseq.counts.gz	aea96580-7317-4163-a889-7d46e912831a	TCGA-AX-A05Y-01A-11R-A00V-07	TCGA-AX-A05Y-01A-11R	TCGA-AX-A05Y-01A-01-TS1	TCGA-AX-A05Y-01A-01-BS1		TCGA-AX-A05Y-01A-11	TCGA-AX-A05Y-01A	TCGA-AX-A05Y	cbe0bd4a-02b7-43e7-b08e-2b0f13560eaf	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1967	230.0	False	false	7E7D9403-AA77-4F14-9017-3B69F66D8EBC	1.83	153cecfe-8963-4b96-8cc3-d2870ce8e584	0.15	23	released	f11f0bc6-a6fd-4bee-97ce-8b067a16fbfa	RNA	R	0.15	UV Spec	released	False	f31f3dcf-ab1a-4a11-a9d2-e950d4774efb	11	0.0	0.0	3.0	5.0	0.0	5.0	92.0	92.0	TOP	9a336ebb-191b-408d-be0a-901386e9c59b	released	0.0	0.0	2.0	2.0	0.0	2.0	96.0	96.0	BOTTOM	3d803842-442e-4429-9669-f6e405eb3cb7	released									released	30.0	60e1de46-8c8f-4fa9-bc51-ce975d02d5ac	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A05Y_demographic	57	-20904		d62cdfef-4a5d-51b3-90a0-369c60216423	not hispanic or latino	female	white	released	Alive	1947		TCGA-AX-A05Y_exposure	Not Reported	33.38655828131804	693d99bb-5af1-5412-915b-467c061fe43c	166.0	released	92.0	TCGA-AX-A05Y_diagnosis	20904	not reported	0	2684	a122877f-69ee-5e1e-975d-3ece1c4e4684	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2004	TCGA-AX-A05Y_treatment_1	TCGA-AX-A05Y_treatment	released	1917c6c3-0e9f-5905-9067-4116d6638e67	no	Pharmaceutical Therapy, NOS	released	722a709c-684a-5209-9163-28a3e8b6d946	no	Radiation Therapy, NOS	aea96580-7317-4163-a889-7d46e912831a
98a789b7-f52a-412d-87ca-019f7caee237.htseq.counts.gz	a9c5aa3d-b93d-4729-8bcb-6d5cf277538b	TCGA-DF-A2KY-01A-21R-A213-07	TCGA-DF-A2KY-01A-21R	TCGA-DF-A2KY-01A-02-TS2			TCGA-DF-A2KY-01A-21	TCGA-DF-A2KY-01A	TCGA-DF-A2KY	5bf97d66-cdc6-47d0-ac74-5c6280b31072	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC		960.0	False	false	8A35F74A-AFA4-4B2D-931B-FA2DE895F010	1.81	872ef409-1ec0-4856-859c-37be70ebce35	0.15	23	released	a24a04af-d49a-46e9-a31e-123b88d35121	RNA	R	0.15	UV Spec	released	False	8a407e04-c72d-4c8b-87b2-7658225605ab	21	0.0	0.0	0.0	0.0	0.0	0.0	100.0	90.0	TOP	53786177-eb62-4b9f-8c9f-a7056baaa8d8	released																				released	30.0	5c46962c-67dc-45cd-842a-d0f71c747bbd	Primary Tumor	01	released	Not Reported	released	TCGA-DF-A2KY_demographic	49	-18086		176c0a99-0302-5a6a-b9ad-30ff04e3360c	not reported	female	not reported	released	Alive			TCGA-DF-A2KY_exposure	Not Reported		d078f55d-b119-5767-955a-d6f46d6135e5		released		TCGA-DF-A2KY_diagnosis	18086	not reported	0	332	f5b6b0dd-46c1-5d14-bd23-e714eefaf0d4	Stage IVA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported		TCGA-DF-A2KY_treatment	TCGA-DF-A2KY_treatment_1	released	7f87c4f0-912b-53c6-84c5-9e51629bc7d5	no	Radiation Therapy, NOS	released	275997ef-df5e-509c-91bd-e3b1df5a95c4	yes	Pharmaceutical Therapy, NOS	a9c5aa3d-b93d-4729-8bcb-6d5cf277538b
61ce076e-eb53-47d1-a930-0ca2e70407c6.htseq.counts.gz	4a0e1c89-2308-4ca4-9da3-fca85e8305fe	TCGA-BG-A3EW-01A-11R-A22K-07	TCGA-BG-A3EW-01A-11R	TCGA-BG-A3EW-01A-01-TSA			TCGA-BG-A3EW-01A-11	TCGA-BG-A3EW-01A	TCGA-BG-A3EW	a31554af-d77a-4862-8aed-4581fb2bd877	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	24	130.0	False	true	0463CA05-339C-4AB9-A236-CEAE733AD5F6	1.82	8b8048b4-fe60-45f4-97c5-662c45169334	0.16	23	released	fb87078d-e3f6-4310-a47b-1843a9896163	RNA	R	0.16	UV Spec	released	False	d31adce8-de3a-4259-99ed-bd4b668d69d2	11	2.0	0.0	0.0	0.0	5.0	15.0	80.0	85.0	TOP	5f8074f6-b42b-4ecf-a051-a37f9b9be555	released																				released	30.0	be387236-f691-4303-aa47-be1d67cbdd5e	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A3EW_demographic	62	-22705		d1af4708-62fe-5624-9a61-f1542621ba4b	not hispanic or latino	female	white	released	Alive	1949		TCGA-BG-A3EW_exposure	Not Reported	45.72506895050079	fce2e002-ab7f-5878-b97e-cab6552407b6	166.0	released	126.0	TCGA-BG-A3EW_diagnosis	22705	not reported	0	344	e43255c0-7939-5711-9902-2c989fe7a847	Stage III	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-BG-A3EW_treatment_1	TCGA-BG-A3EW_treatment	released	767ce000-1aca-5b64-8590-d5f4f52bed49	no	Pharmaceutical Therapy, NOS	released	5a52d132-8e17-587a-adba-b3fa180144f6	yes	Radiation Therapy, NOS	4a0e1c89-2308-4ca4-9da3-fca85e8305fe
10495d8f-e54e-49ff-a034-645a4e7b5354.htseq.counts.gz	370bf815-0e77-44ff-af8d-c5d34005709a	TCGA-AX-A2HD-01A-21R-A17B-07	TCGA-AX-A2HD-01A-21R	TCGA-AX-A2HD-01A-02-TSB			TCGA-AX-A2HD-01A-21	TCGA-AX-A2HD-01A	TCGA-AX-A2HD	a8def1a0-a136-47f4-9ad9-60ebcf9b726b	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1175	100.0	False	false	83BDA3FE-254F-4F99-B41E-FC1F8C128906	1.85	03141105-bc66-4e89-ad97-c54fcf189468	0.17	23	released	0cb9da84-99d2-4e46-a1a4-57520616a55c	RNA	R	0.17	UV Spec	released	False	f15a4f70-8cc3-4b21-b5f3-37a46fd9ac21	21	1.0	0.0	2.0	0.0	0.0	2.0	96.0	96.0	TOP	e8562f08-560d-4bd2-8c4e-015837b6bc91	released																				released	30.0	5a2ede97-0cf7-44d7-a789-92ee9bda3d6c	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A2HD_demographic	69	-25499		0cbf6c30-6909-56ac-9390-67b1bba5eaac	not hispanic or latino	female	white	released	Alive	1939		TCGA-AX-A2HD_exposure	Not Reported	22.97193820098194	9c6b1c0f-6943-5a5f-be42-039f5d5fb4ee	149.0	released	51.0	TCGA-AX-A2HD_diagnosis	25499	not reported	0	1414	c3080851-f81c-5b94-b205-562399603585	Stage IIIA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-AX-A2HD_treatment	TCGA-AX-A2HD_treatment_1	released	61f8a04d-cded-5f19-aa28-ea114d0f140d	no	Radiation Therapy, NOS	released	335e6652-9cdb-5121-b941-fb07f550b61f	no	Pharmaceutical Therapy, NOS	370bf815-0e77-44ff-af8d-c5d34005709a
d123ae50-704e-4782-9822-609111fda11d.htseq.counts.gz	18d42722-ce77-47ff-b28a-9be38c7d7426	TCGA-AJ-A3TW-01A-11R-A22K-07	TCGA-AJ-A3TW-01A-11R	TCGA-AJ-A3TW-01A-01-TS1			TCGA-AJ-A3TW-01A-11	TCGA-AJ-A3TW-01A	TCGA-AJ-A3TW	9ee944ef-4293-4228-b750-cc34ab388eb3	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	71	230.0	False	false	1271A645-AF29-453E-BEA8-420ECCD0DFDC	2.02	a1ba7666-0fb4-4fa6-8530-242d32ca3708	0.17	23	released	a3998157-26d8-4a18-818f-861694cd3ffb	RNA	R	0.17	UV Spec	released	False	0112d354-393a-47bb-8a41-1b0e944cea94	11	3.0	1.0	5.0	0.0	0.0	0.0	95.0	90.0	TOP	6e3b83cf-8516-46bf-a922-2b9a0bb5308f	released																				released	20.0	25c226fa-c084-4128-8b49-62f1d5538aa0	Primary Tumor	01	released	Not Reported	released	TCGA-AJ-A3TW_demographic	78	-28559		561d660f-959e-5ee1-8989-14eebe9c71a9	not hispanic or latino	female	white	released	Alive	1934		TCGA-AJ-A3TW_exposure	Not Reported	21.484375	d35d8a96-7e57-5400-a455-a2f5e91b03cf	160.0	released	55.0	TCGA-AJ-A3TW_diagnosis	28559	not reported	0	513	2c526212-4581-593b-b288-6315a6fdab8f	Stage IB	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2012	TCGA-AJ-A3TW_treatment	TCGA-AJ-A3TW_treatment_1	released	23229ee4-af8d-5d34-8678-19aeb85322f8	yes	Radiation Therapy, NOS	released	8386ff0e-9d6e-5d9d-a0ff-b0b95385c4bb	no	Pharmaceutical Therapy, NOS	18d42722-ce77-47ff-b28a-9be38c7d7426
ae5bea01-148d-4559-9327-2f926e93bb6e.htseq.counts.gz	c2a7105a-e8de-43aa-9622-e4f078f0831f	TCGA-D1-A16O-01A-11R-A12I-07	TCGA-D1-A16O-01A-11R	TCGA-D1-A16O-01A-01-TS1			TCGA-D1-A16O-01A-11	TCGA-D1-A16O-01A	TCGA-D1-A16O	8f508b78-cdc6-4a3d-b86e-520746d78653	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	756	120.0	False	false	B4EFFDB8-CB4C-46D7-96AD-9D33DF7163C0	2.13	3581b34d-0e76-4feb-a872-b510effff12a	0.15	23	released	ed08d1d1-9a8a-46bf-828d-5ceaaee815fc	RNA	R	0.15	UV Spec	released	False	3eaaed5c-3d51-4109-a61b-974655194b6d	11	10.0	0.0	20.0	0.0	10.0	10.0	60.0	80.0	TOP	4cae4d24-d0c5-48d0-820b-947f5c1ed0f8	released																				released	30.0	a2befa03-27ec-4d5a-bf12-6ded95a4dd18	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A16O_demographic	44	-16114		992e1ed5-04f1-53ff-9084-e6594408070b	not hispanic or latino	female	white	released	Alive	1964		TCGA-D1-A16O_exposure	Not Reported	35.71303525786912	1e54903b-19d3-55b7-b511-a417f21ad6e2	169.0	released	102.0	TCGA-D1-A16O_diagnosis	16114	not reported	0	1023	ee91774f-4d7a-537f-89de-fb5655fa7819	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-D1-A16O_treatment_1	TCGA-D1-A16O_treatment	released	cdd898c9-c824-5c8c-a89d-2dabdd694ff3	no	Pharmaceutical Therapy, NOS	released	a2438fdc-5246-5b10-8e25-58542cb1c948	no	Radiation Therapy, NOS	c2a7105a-e8de-43aa-9622-e4f078f0831f
db7dfd9d-a11d-4a13-b80b-b23632fdd564.htseq.counts.gz	40b9c879-9f39-4e0a-b5cc-b435e8a4130b	TCGA-FI-A2D5-01A-11R-A17B-07	TCGA-FI-A2D5-01A-11R	TCGA-FI-A2D5-01A-01-TSA			TCGA-FI-A2D5-01A-11	TCGA-FI-A2D5-01A	TCGA-FI-A2D5	dcfbe781-a92a-45b5-b80a-e3bb3bdc0d9a	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	702	60.0	False	true	A8F4B3DC-7B7D-4F1F-A909-E23DAE23E52C	1.95	33655926-ef2e-4e77-8be7-3f9c921db77c	0.18	23	released	14aaeb65-a0cf-4d2b-9f69-b89def63dff0	RNA	R	0.18	UV Spec	released	False	507f2c98-1aeb-4fcc-bfc9-764fe7722b0d	11	15.0	5.0	15.0	3.0	0.0	2.0	83.0	98.0	TOP	0176e005-01be-44da-81fa-8dbe508526be	released																				released	30.0	d5f6444e-c388-42e9-8b20-7b3a4db8e0db	Primary Tumor	01	released	Not Reported	released	TCGA-FI-A2D5_demographic	56	-20666	421	e289b51f-d0b4-53a0-b413-30c24ce2f776	not hispanic or latino	female	white	released	Dead	1953	2010	TCGA-FI-A2D5_exposure	Not Reported	35.9375	8913283d-14b2-5ca1-87e7-f9c907ba689e	160.0	released	92.0	TCGA-FI-A2D5_diagnosis	20666	not reported	0		c3f99001-ee1d-5f72-b8f7-416690803ed2	Stage IVB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2009	TCGA-FI-A2D5_treatment	TCGA-FI-A2D5_treatment_1	released	04c3a52f-064d-5e78-9d54-dbcacd9140c7	yes	Radiation Therapy, NOS	released	8f0ae61c-8d77-5780-a711-4cae1180eca2	yes	Pharmaceutical Therapy, NOS	40b9c879-9f39-4e0a-b5cc-b435e8a4130b
448111f8-187f-47b3-8198-94d351253cf0.htseq.counts.gz	960dea5e-bdb9-48b4-ad1e-9c8dc01e7d0e	TCGA-A5-A0GR-01A-11R-A118-07	TCGA-A5-A0GR-01A-11R	TCGA-A5-A0GR-01A-01-MSA	TCGA-A5-A0GR-01A-01-TSA		TCGA-A5-A0GR-01A-11	TCGA-A5-A0GR-01A	TCGA-A5-A0GR	82c51af5-4ba2-48fe-b5e2-a0f1c9d68f34	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	632	160.0	False	true	009B5049-74B7-49B8-8B64-28184A3ACA2B	2.0	10b2b797-1ddd-4ef8-b0e7-38f96fb06f57	0.16	23	released	0500da3c-ce40-4f0b-a7e9-9a3f46b6c9fb	RNA	R	0.16	UV Spec	released	False	6abb44a2-aaa9-4a50-a228-9e09c23530a8	11	40.0	2.0	10.0	2.0	0.0	75.0	15.0	8.0	BOTTOM	ac22b37c-7c54-4055-b3c6-52e332ec9dfe	released	35.0	20.0	10.0	25.0	0.0	30.0	60.0	70.0	TOP	4701ffe6-35eb-4376-a141-a7b34dc982e9	released									released	30.0	1c8de102-85f6-47d5-87ce-50b6fe24bb7a	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A0GR_demographic	69	-25353		4507d83f-2738-5679-abb2-92367a2ac213	not hispanic or latino	female	black or african american	released	Alive	1939		TCGA-A5-A0GR_exposure	Not Reported	28.088991030674453	f9744e32-0223-5afe-b0db-69bd117b6916	177.0	released	88.0	TCGA-A5-A0GR_diagnosis	25353	not reported	0	1120	4a331b84-3e37-57fc-b8ba-74480f256522	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-A5-A0GR_treatment	TCGA-A5-A0GR_treatment_1	released	302c22c2-e905-5abb-8d21-80b12d60607c	no	Radiation Therapy, NOS	released	b8f159ae-fae9-5d56-b27a-491467b3fdc1	no	Pharmaceutical Therapy, NOS	960dea5e-bdb9-48b4-ad1e-9c8dc01e7d0e
a535f377-4f7e-46b0-adbe-9433a5c1f269.htseq.counts.gz	66a3e1d3-4e2d-4ce8-ae84-a4d53d58a91c	TCGA-D1-A0ZN-01A-11R-A118-07	TCGA-D1-A0ZN-01A-11R	TCGA-D1-A0ZN-01A-01-TS1	TCGA-D1-A0ZN-01A-01-MS1		TCGA-D1-A0ZN-01A-11	TCGA-D1-A0ZN-01A	TCGA-D1-A0ZN	916ccf0d-02ef-4ccb-824b-6b4294095a08	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	567	120.0	False	false	53DB2270-9308-47F5-BD1F-4D4C737F98AC	1.87	2d12622b-f828-43b0-a63f-fc542af894db	0.14	23	released	7b3ec4a1-850c-4a29-89d8-e3dfb3bd58fd	RNA	R	0.14	UV Spec	released	False	744b50cd-f41d-4c05-a1c1-2f2eda8c2783	11	20.0	0.0	10.0	10.0	20.0	10.0	60.0	70.0	TOP	3cdc79ef-c829-472e-b22e-01174ed0e21c	released	8.0	0.0	0.0	1.0	2.0	38.0	60.0	60.0	BOTTOM	a3f086e1-a55b-43ae-a442-3698c43b3a97	released									released	30.0	87d4a16c-1a19-4234-b946-aea11d70169b	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A0ZN_demographic	60	-22026		820573ea-7bc9-59dd-aca0-e4e712597461	not hispanic or latino	female	white	released	Alive	1949		TCGA-D1-A0ZN_exposure	Not Reported	29.05328798185941	73e7bdbb-7c14-5e83-b300-06ace5938d5b	168.0	released	82.0	TCGA-D1-A0ZN_diagnosis	22026	not reported	0	512	ca0a7de2-265c-56df-8221-83cdff52a52c	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-D1-A0ZN_treatment	TCGA-D1-A0ZN_treatment_1	released	8126ce2b-b1e3-51db-a428-e1152951871c	yes	Radiation Therapy, NOS	released	e8ee0e93-7801-523d-8d9c-e862d9aa0cdf	no	Pharmaceutical Therapy, NOS	66a3e1d3-4e2d-4ce8-ae84-a4d53d58a91c
53d514bb-4b81-474f-ae58-b58b1436c459.htseq.counts.gz	637ffe86-0bf5-4680-aeb4-c41bc06e3a36	TCGA-BS-A0TG-01A-32R-A16W-07	TCGA-BS-A0TG-01A-32R	TCGA-BS-A0TG-01A-03-TSC	TCGA-BS-A0TG-01A-03-MSC		TCGA-BS-A0TG-01A-32	TCGA-BS-A0TG-01A	TCGA-BS-A0TG	13f31bcb-befd-4ed2-adc0-dc9e9ce52b75	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1996	270.0	False	false	7A7B4B4B-5EE2-4D8D-A90A-DDFB96AE49A8	1.68	5fcefe73-6ed0-42f2-beda-3afc67aba867	0.17	23	released	e9f19ecc-948b-4eeb-b144-55c8674cea03	RNA	R	0.17	UV Spec	released	False	1f1a7386-bffd-483d-860e-0f1eabe0f04d	32	0.0	0.0	0.0	0.0	0.0	20.0	80.0	70.0	TOP	935c776c-6ec2-4a67-892d-b1756b3ea029	released	10.0	0.0	20.0	0.0	10.0	0.0	70.0	100.0	BOTTOM	5660dd6f-fb70-4a95-9307-f1571363d3e6	released									released	10.0	36e44603-a1ee-4a5b-9506-49a9358bf8d0	Primary Tumor	01	released	Not Reported	released	TCGA-BS-A0TG_demographic	60	-22043		a761f58b-17f5-5a95-9d10-299a4fbf98e7	not hispanic or latino	female	white	released	Alive	1945		TCGA-BS-A0TG_exposure	Not Reported	24.08822311716662	3dc8bc0a-c45f-556a-988e-46bfb67f0de9	163.0	released	64.0	TCGA-BS-A0TG_diagnosis	22043	not reported	0	2371	6473de9e-e3af-5f99-975c-a8373c55a391	Stage IIIA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2005	TCGA-BS-A0TG_treatment_1	TCGA-BS-A0TG_treatment	released	fe057a36-b9da-53bc-a206-9ef944b063fb	no	Pharmaceutical Therapy, NOS	released	a0fd16e3-f175-5918-9b7f-dca383e84e83	yes	Radiation Therapy, NOS	637ffe86-0bf5-4680-aeb4-c41bc06e3a36
afdee3d2-e728-4230-8cd4-e0a19c587c5a.htseq.counts.gz	c3af9b29-1904-4c2b-85e7-792c00593f7c	TCGA-BG-A0MO-01A-11R-A040-07	TCGA-BG-A0MO-01A-11R	TCGA-BG-A0MO-01A-01-BSA	TCGA-BG-A0MO-01A-01-TSA		TCGA-BG-A0MO-01A-11	TCGA-BG-A0MO-01A	TCGA-BG-A0MO	734ef97f-807c-480e-8df9-feaf041032d2	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	854	100.0	False	true	C120AC98-36D2-49AD-84A1-6EA168D2A2BA	1.82	7fc96ce5-b529-4d89-8b27-5f8ba4e301e9	0.13	23	released	b3f6d7dc-2218-4458-876b-8e48478f438b	RNA	R	0.13	UV Spec	released	False	da7a3351-4324-49d7-95a2-c9cf0a47860d	11	2.0	0.0	4.0	0.0	0.0	6.0	90.0	96.0	BOTTOM	933efb7e-8d38-4641-94a3-66af9061b625	released	1.0	0.0	1.0	0.0	0.0	3.0	96.0	97.0	TOP	733bb672-8d01-40d9-acac-a6cffeef158c	released									released	30.0	7582cbb9-42d3-496c-991d-d76bea4c434c	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A0MO_demographic	63	-23287		ca39bf6f-6549-5d17-ae60-15dde3f5a32d	not hispanic or latino	female	white	released	Alive	1945		TCGA-BG-A0MO_exposure	Not Reported	32.421875	39b5cde9-6df1-52b6-b23b-f7226152baa2	160.0	released	83.0	TCGA-BG-A0MO_diagnosis	23287	not reported	0	1309	b05be386-4150-55a8-870e-6501f1517364	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-BG-A0MO_treatment_1	TCGA-BG-A0MO_treatment	released	016ad5f9-b42d-57d1-a484-9ca1fe1d355f	no	Pharmaceutical Therapy, NOS	released	1b233bee-34f2-552a-b0e1-5eb8ce1e039f	yes	Radiation Therapy, NOS	c3af9b29-1904-4c2b-85e7-792c00593f7c
3b650844-9475-45c2-932d-6804ab8ea2ec.htseq.counts.gz	f8985d0b-d352-49b9-9bb5-6c0b58e4d2e3	TCGA-D1-A15X-01A-11R-A118-07	TCGA-D1-A15X-01A-11R	TCGA-D1-A15X-01A-01-TSA			TCGA-D1-A15X-01A-11	TCGA-D1-A15X-01A	TCGA-D1-A15X	14c03068-8930-472a-9fd1-49c9fd4db47d	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	897	130.0	False	false	F32EB1C9-4802-4873-8F0E-E10724DA9C15	1.88	51f60923-90f4-4bf7-9cc4-0bcdd9ed50e1	0.17	23	released	f9c21e2d-74ef-4e3f-8417-499b3fa7a386	RNA	R	0.17	UV Spec	released	False	1a23bd8c-d6b9-43a5-84ff-e0625b00d50c	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	70.0	TOP	a499993c-96cd-4517-ad4c-0a4bb86f8e8b	released																				released	30.0	c81d521c-70f9-4299-87d2-02173751efc8	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A15X_demographic	45	-16532		94e5d21e-5343-553f-80b3-79fb4e38d0ba	not hispanic or latino	female	white	released	Alive	1963		TCGA-D1-A15X_exposure	Not Reported	25.20920135849585	fe7af538-d2aa-51db-99b6-0106e7685ea8	169.0	released	72.0	TCGA-D1-A15X_diagnosis	16532	not reported	0	909	b4a0d69d-3c39-5956-b8c4-c05c4d083263	Stage IA	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-D1-A15X_treatment_1	TCGA-D1-A15X_treatment	released	5ef82aa3-0a03-53cc-bb75-49c73cd80a2e	no	Pharmaceutical Therapy, NOS	released	9c4236e1-86dc-5ef7-84c0-1e6fc2893d99	yes	Radiation Therapy, NOS	f8985d0b-d352-49b9-9bb5-6c0b58e4d2e3
549a08ff-7895-4697-bb4f-a16104710057.htseq.counts.gz	6921f20e-7a7b-4fbc-b199-3374415691c4	TCGA-B5-A0K8-01A-11R-A14M-07	TCGA-B5-A0K8-01A-11R	TCGA-B5-A0K8-01A-01-TSA	TCGA-B5-A0K8-01A-01-BSA		TCGA-B5-A0K8-01A-11	TCGA-B5-A0K8-01A	TCGA-B5-A0K8	24118b8f-59fe-482a-aed3-7b1bde1571b7	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	191	260.0	False	true	1E7C9CA2-73AA-4443-A125-D5588F93BEF9	1.78	71cdc7a1-4bbb-461c-ab98-34cad8c3a767	0.13	23	released	b8317b8c-892e-470e-97b6-45fabb957157	RNA	R	0.13	UV Spec	released	False	b0c32eec-6008-4dd4-94a8-8e3309085a4f	11	10.0	0.0	10.0	0.0	0.0	30.0	60.0	70.0	TOP	195413a2-6bad-4766-94e6-de0efeabb0c3	released	10.0	0.0	10.0	0.0	0.0	10.0	80.0	90.0	BOTTOM	de390c6e-0914-4d9e-8819-f2b80a8262f4	released									released	30.0	66184035-af3e-4c2b-901a-0709c49dc54e	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A0K8_demographic	71	-25992		a44ec5e7-b90f-5892-bdaa-19fe891d1b50	not reported	female	white	released	Alive	1938		TCGA-B5-A0K8_exposure	Not Reported	23.828125	3f246748-70da-5b1b-a340-9fd2a322aa18	160.0	released	61.0	TCGA-B5-A0K8_diagnosis	25992	not reported	0	847	47d73528-9f12-5d55-9afb-eb467c56f0bb	Stage IB	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-B5-A0K8_treatment_1	TCGA-B5-A0K8_treatment	released	2ced5e83-7a23-5470-90ce-bf1a17eb6d8a	yes	Pharmaceutical Therapy, NOS	released	5d24a41d-346a-50e7-bbf8-65e21c19272c	no	Radiation Therapy, NOS	6921f20e-7a7b-4fbc-b199-3374415691c4
b689bc2b-5e52-4244-afd3-499254cedeef.htseq.counts.gz	12d2085c-e9e0-42e7-beb8-e959844dbcff	TCGA-DI-A1BU-01A-11R-A137-07	TCGA-DI-A1BU-01A-11R	TCGA-DI-A1BU-01A-01-TS1			TCGA-DI-A1BU-01A-11	TCGA-DI-A1BU-01A	TCGA-DI-A1BU	53245616-e095-4616-89bb-6062669122da	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	903	140.0	False	false	18A286FD-E85B-48FC-B193-456AB10D24B9	1.86	60728ff8-1098-4ed9-9cc0-b3d5523736d3	0.16	23	released	557ddaab-ab7d-430b-a125-608efc1a5ee1	RNA	R	0.16	UV Spec	released	False	7f3adc76-2802-467d-9ee3-cb0d45d0b62c	11	40.0	20.0	10.0	20.0	0.0	10.0	80.0	80.0	TOP	6b7a8d1d-fe89-4aaf-ab70-15ae1f2c8196	released																				released	30.0	241bfb1f-5cf8-458d-b335-18babf507e85	Primary Tumor	01	released	Not Reported	released	TCGA-DI-A1BU_demographic	55	-20114		5e7522d0-0e5d-5ca7-84c7-e0ae4e82dfee	not hispanic or latino	female	white	released	Alive	1953		TCGA-DI-A1BU_exposure	Not Reported	31.804657843439006	bc3e44bb-535b-5cf3-a227-42686d835588	171.0	released	93.0	TCGA-DI-A1BU_diagnosis	20114	not reported	0	1195	0322cb67-0295-5910-8351-7749a26fb857	Stage IIB	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-DI-A1BU_treatment	TCGA-DI-A1BU_treatment_1	released	31eafe0e-20ad-5676-b50e-a44dd52a62b3	yes	Radiation Therapy, NOS	released	c71e727e-6361-589e-be9c-b15fe56817bd	yes	Pharmaceutical Therapy, NOS	12d2085c-e9e0-42e7-beb8-e959844dbcff
c3e0e0bf-cef2-4dcd-9a44-7cafb4cbb6f1.htseq.counts.gz	8a6fa603-c102-4329-9e04-39bfa558b31f	TCGA-EY-A1GI-01A-11R-A13S-07	TCGA-EY-A1GI-01A-11R	TCGA-EY-A1GI-01A-01-TSA			TCGA-EY-A1GI-01A-11	TCGA-EY-A1GI-01A	TCGA-EY-A1GI	16bde24f-61b8-458d-aca3-df4806abbd1b	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	444	150.0	False	false	1D56F7CA-A3F0-4078-B8E3-A10CD97873D4	1.83	e505cac9-a568-42db-bc67-d90af57e5265	0.17	23	released	66e7c24b-7511-4333-932b-43c9342a9373	RNA	R	0.17	UV Spec	released	False	c2b44ff4-894e-4f9e-b1cb-9d9ab72f2a77	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	85.0	TOP	3f4486b1-11c5-4b46-be64-696584cf1eea	released																				released	30.0	9618747c-19fc-4243-ab49-d277992544e5	Primary Tumor	01	released	Not Reported	released	TCGA-EY-A1GI_demographic	52	-19117		15b9957d-8c31-5525-b249-cb4e25a082fd	not hispanic or latino	female	white	released	Alive	1957		TCGA-EY-A1GI_exposure	Not Reported	25.34435261707989	841d200b-8a8b-5e41-97fe-b7e3d4ba9cf6	165.0	released	69.0	TCGA-EY-A1GI_diagnosis	19117	not reported	0	710	a6b29f73-2887-5de1-88ea-25441a3379e9	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-EY-A1GI_treatment	TCGA-EY-A1GI_treatment_1	released	aae9d72c-f9dd-50d1-9ebf-f0c2b3c5860c	yes	Radiation Therapy, NOS	released	9dd3c55a-7f72-5238-92b5-be2735f9d3e6	no	Pharmaceutical Therapy, NOS	8a6fa603-c102-4329-9e04-39bfa558b31f
86769aff-fbef-40f2-9485-63454be3bad6.htseq.counts.gz	eaef2218-f134-41d3-abae-60e20faba863	TCGA-EY-A215-01A-11R-A14M-07	TCGA-EY-A215-01A-11R	TCGA-EY-A215-01A-01-TS1			TCGA-EY-A215-01A-11	TCGA-EY-A215-01A	TCGA-EY-A215	48ab48a5-30e7-4f2e-8d0f-9bad7b8dc7db	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	293	210.0	False	false	C0F970E3-E534-4A34-B87A-4383FD261B53	1.77	9ea0e44d-a6c8-4e54-9e1f-ebdb82d0c5ab	0.16	23	released	32add62d-9842-4da5-8158-1d61b8bb45db	RNA	R	0.16	UV Spec	released	False	35dd2b5b-80fe-4f41-9bf1-e3878cd4cfbe	11	40.0	40.0	10.0	10.0	0.0	10.0	80.0	80.0	TOP	514d2f15-a2b6-4a9b-82a0-91905bab780a	released																				released	30.0	4d692dbb-bbd7-429b-894e-ccb215ca41cc	Primary Tumor	01	released	Not Reported	released	TCGA-EY-A215_demographic	60	-22076		42256e3f-852f-5914-8b38-744378ef0cac	not hispanic or latino	female	white	released	Alive	1950		TCGA-EY-A215_exposure	Not Reported	17.36111111111111	8a8b311e-b801-5651-b8a5-e00d87bfd032	168.0	released	49.0	TCGA-EY-A215_diagnosis	22076	not reported	0	574	c0ab32b5-4c54-544a-9657-6efd97264221	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2010	TCGA-EY-A215_treatment	TCGA-EY-A215_treatment_1	released	ed0a5ef1-8e27-595b-b379-323f7ea2c86b	yes	Radiation Therapy, NOS	released	cf2d2856-e544-52a9-b6ae-0cfb24dd90be	no	Pharmaceutical Therapy, NOS	eaef2218-f134-41d3-abae-60e20faba863
f4cee707-9cb6-406d-b9da-8a9eb27e42c6.htseq.counts.gz	709a053b-845f-4a42-8ac3-75567bdd99b2	TCGA-D1-A3DG-01A-11R-A19W-07	TCGA-D1-A3DG-01A-11R	TCGA-D1-A3DG-01A-01-TSA			TCGA-D1-A3DG-01A-11	TCGA-D1-A3DG-01A	TCGA-D1-A3DG	7890628d-7120-4dbc-85ae-1f895b6660c2	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	49	140.0	False	true	97C44FFC-8D88-43DC-BCC9-F634151C7098	1.79	11a0e295-f45e-4979-8317-10429d515d34	0.18	23	released	b4371fb2-dff3-452a-9ff4-4e228f426b51	RNA	R	0.18	UV Spec	released	False	90ddb87c-d172-415c-9bb8-6188cddd8fef	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	75.0	TOP	db67f64d-84c6-40ab-86fa-45fdad212016	released																				released	30.0	ad26154d-5587-4af9-975f-367d712a5749	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A3DG_demographic	81	-29771	130	4e318d3b-5faf-5302-b744-2aaf8d6fb33b	not hispanic or latino	female	white	released	Dead	1930		TCGA-D1-A3DG_exposure	Not Reported	30.470521541950113	85cfee60-717d-5709-9abf-fcaa5892d786	168.0	released	86.0	TCGA-D1-A3DG_diagnosis	29771	not reported	0	130	0f8d3a22-1d15-53f5-980b-63ebe2380b58	Stage IVB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-D1-A3DG_treatment_1	TCGA-D1-A3DG_treatment	released	5e372c3f-a63c-5eba-a549-6a82f4264378	no	Pharmaceutical Therapy, NOS	released	b17f86ce-7b1c-5122-9bbb-c8055aba484e	no	Radiation Therapy, NOS	709a053b-845f-4a42-8ac3-75567bdd99b2
0e11a8a9-81a9-44a2-95ee-a062750ee9ae.htseq.counts.gz	aee601e0-73f6-4250-bfd3-c3c28f68b0ab	TCGA-EO-A22U-01A-11R-A180-07	TCGA-EO-A22U-01A-11R	TCGA-EO-A22U-01A-01-TSA			TCGA-EO-A22U-01A-11	TCGA-EO-A22U-01A	TCGA-EO-A22U	30bc72d5-07b5-48d2-b025-bba9bcf2f09f	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	758	110.0	False	false	DB7D72BC-F9C7-4726-98F4-A4F642B125C6	1.93	3513c95d-9ea0-4c3b-9e8e-0f148231bc83	0.17	23	released	a95ea16d-5f34-44b9-8347-aa5e279376a2	RNA	R	0.17	UV Spec	released	False	1e53b284-8163-4788-a1fc-c50ab76c2543	11	40.0	20.0	5.0	20.0	0.0	15.0	80.0	80.0	TOP	213b24d5-572d-4622-ae8c-1d95667cc82b	released																				released	30.0	4eb2e033-34f4-4a2d-837e-c927c1e52359	Primary Tumor	01	released	Not Reported	released	TCGA-EO-A22U_demographic	83	-30557		e8d75a74-9bea-5427-ac4c-e20566531835	not reported	female	white	released	Alive	1926		TCGA-EO-A22U_exposure	Not Reported	26.22222222222222	602ddb15-e1ed-5e7e-82dc-7d725ff0727c	150.0	released	59.0	TCGA-EO-A22U_diagnosis	30557	not reported	0	1407	36f0913f-9b70-5403-9b6d-d8e3cced5f58	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-EO-A22U_treatment	TCGA-EO-A22U_treatment_1	released	782a304e-53c4-5a39-b015-8b7f6eaf353b	yes	Radiation Therapy, NOS	released	cb7adb2a-2b3e-5f96-9dcb-e084d856cf75	no	Pharmaceutical Therapy, NOS	aee601e0-73f6-4250-bfd3-c3c28f68b0ab
fee74585-07a7-4901-90d3-a1abae2e7382.htseq.counts.gz	f5908823-0340-4e7e-b35a-53ebac121df4	TCGA-AX-A3FW-01A-11R-A22K-07	TCGA-AX-A3FW-01A-11R	TCGA-AX-A3FW-01A-01-TS1			TCGA-AX-A3FW-01A-11	TCGA-AX-A3FW-01A	TCGA-AX-A3FW	3052065a-b8b1-48d3-971d-9d605292249c	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	723	90.0	False	false	AAB4F0FC-D6D5-4D5F-B36C-E4D4869E1A15	1.89	bbf7786d-0996-47fc-8af9-482d2087ccb1	0.18	23	released	b6360f85-7f3f-47e8-b867-3ca159514662	RNA	R	0.18	UV Spec	released	False	d509477d-a220-4470-a7d9-f82f12d64238	11	2.0	1.0	2.0	0.0	0.0	2.0	96.0	95.0	TOP	d08631c4-0f25-42e5-a0d5-ac2003c49207	released																				released	30.0	d3deb563-5420-4890-b763-01ca855b4b61	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A3FW_demographic	66	-24419		7150706f-be8d-5f53-8882-93c479869817	not hispanic or latino	female	white	released	Alive	1943		TCGA-AX-A3FW_exposure	Not Reported	30.11940191473341	d236da69-c009-5d64-8704-74c62edad450	167.0	released	84.0	TCGA-AX-A3FW_diagnosis	24419	not reported	0	17	6c0615cd-0061-5fca-8bef-3ca10ce6383a	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-AX-A3FW_treatment	TCGA-AX-A3FW_treatment_1	released	fbbc28cf-2e15-50bb-8b1e-a9ee98107e79	not reported	Radiation Therapy, NOS	released	52b90767-0dc9-5975-b524-b1197ed75e93	not reported	Pharmaceutical Therapy, NOS	f5908823-0340-4e7e-b35a-53ebac121df4
be23bb2f-67c3-4a76-a4ab-a80ef1178ceb.htseq.counts.gz	d8aacdb6-fedf-4030-add5-08ebcab8393c	TCGA-AP-A1DP-01A-11R-A137-07	TCGA-AP-A1DP-01A-11R	TCGA-AP-A1DP-01A-01-TSA			TCGA-AP-A1DP-01A-11	TCGA-AP-A1DP-01A	TCGA-AP-A1DP	a93c47a9-65b5-4785-af4f-a2078db4514e	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1105	230.0	False	true	20EEB047-0185-4B65-9A6A-43D6C97307C8	1.79	97b9cac2-2c23-4759-b558-24f7b90fe787	0.16	23	released	01010c21-8a0c-4b39-9501-5e866f1ec03c	RNA	R	0.16	UV Spec	released	False	93c2da90-ed4e-408d-bfb9-1aec33bf06d5	11	5.0	0.0	0.0	2.0	0.0	10.0	90.0	90.0	TOP	50c3ed02-e9b5-4e2a-a210-b422ceecdb2b	released																				released	30.0	b5206087-88de-4963-9239-189d159f7b35	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A1DP_demographic	70	-25601	1081	4a9cbf57-5459-5e8b-8fda-2a5dd5a9e2f5	not reported	female	white	released	Dead	1938	2010	TCGA-AP-A1DP_exposure	Not Reported	33.24787694279763	77875cc2-334a-55c0-8d2c-e72c8b15e127	158.0	released	83.0	TCGA-AP-A1DP_diagnosis	25601	not reported	0		c96495d3-47a4-5cd1-8e8b-cc70f395057c	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-AP-A1DP_treatment_1	TCGA-AP-A1DP_treatment	released	1168dd58-4d30-5eae-99b5-1936e213435e	yes	Pharmaceutical Therapy, NOS	released	fd8f072a-5782-5bf8-bf2e-dc5f6faebb5f	yes	Radiation Therapy, NOS	d8aacdb6-fedf-4030-add5-08ebcab8393c
6aced1e7-3d02-4fbf-8209-12406dcfd20f.htseq.counts.gz	59347779-3cdd-4a04-bf7c-b9d4922151f7	TCGA-BK-A4ZD-11A-12R-A27V-07	TCGA-BK-A4ZD-11A-12R	TCGA-BK-A4ZD-11A-01-TS1			TCGA-BK-A4ZD-11A-12	TCGA-BK-A4ZD-11A	TCGA-BK-A4ZD	1c4d225e-e065-4e26-9413-78f54a7e0cf5	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	92	210.0	False	false		1.77	babe74ee-b0dc-41c3-9968-2faac94addf2	0.15	23	released	4034814b-4f0e-47ac-81cd-b47e1b2c6edf	RNA	R	0.15	UV Spec	released	False	23e95626-647a-4dea-91e1-ac0c8e6c3946	12	2.0	0.0	0.0	0.0	100.0	0.0	0.0	0.0	TOP	245899f6-aa6a-409e-928e-aa87c2467c6a	released																				released	20.0	a24e32e7-0ac4-481f-a69f-f42b1f1e3eef	Solid Tissue Normal	11	released	Not Reported	released	TCGA-BK-A4ZD_demographic	42	-15536		932b5f34-279f-58a1-b7ea-5ac264c68f39	not hispanic or latino	female	black or african american	released	Alive	1970		TCGA-BK-A4ZD_exposure	Not Reported	53.44574504121344	fa681863-042a-56d1-bae9-ace2cce9c4f7	163.0	released	142.0	TCGA-BK-A4ZD_diagnosis	15536	not reported	0	506	52ef00ac-cc39-502a-9e36-18076721f0be	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2012	TCGA-BK-A4ZD_treatment_1	TCGA-BK-A4ZD_treatment	released	9ef670d7-1bdf-5138-89c9-41ecea75db1e	no	Pharmaceutical Therapy, NOS	released	8b8b5ac1-2427-574c-aad5-0051111ddbf0	no	Radiation Therapy, NOS	59347779-3cdd-4a04-bf7c-b9d4922151f7
ea161735-6a52-43dd-a665-3674046ef96c.htseq.counts.gz	be4a13c3-3e69-479f-bbcb-d239a8a6bef2	TCGA-AX-A05Y-11A-11R-A27V-07	TCGA-AX-A05Y-11A-11R	TCGA-AX-A05Y-11A-01-TSA			TCGA-AX-A05Y-11A-11	TCGA-AX-A05Y-11A	TCGA-AX-A05Y	cbe0bd4a-02b7-43e7-b08e-2b0f13560eaf	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	2391	140.0	False	false		1.89	1011cb92-17a6-48b0-95ab-da22acddfb5a	0.15	23	released	e14e2802-fcda-444e-9857-8644033f0014	RNA	R	0.15	UV Spec	released	False	7f488fea-22f5-4c9e-9b73-348c67d1b7ba	11	0.0	0.0	0.0	0.0	100.0	0.0	0.0	0.0	TOP	0c20881c-9561-4130-816d-bb28e3d48ec7	released																				released	30.0	82790b63-1c88-49b8-b09f-8b42f0a93c2b	Solid Tissue Normal	11	released	Not Reported	released	TCGA-AX-A05Y_demographic	57	-20904		d62cdfef-4a5d-51b3-90a0-369c60216423	not hispanic or latino	female	white	released	Alive	1947		TCGA-AX-A05Y_exposure	Not Reported	33.38655828131804	693d99bb-5af1-5412-915b-467c061fe43c	166.0	released	92.0	TCGA-AX-A05Y_diagnosis	20904	not reported	0	2684	a122877f-69ee-5e1e-975d-3ece1c4e4684	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2004	TCGA-AX-A05Y_treatment_1	TCGA-AX-A05Y_treatment	released	1917c6c3-0e9f-5905-9067-4116d6638e67	no	Pharmaceutical Therapy, NOS	released	722a709c-684a-5209-9163-28a3e8b6d946	no	Radiation Therapy, NOS	be4a13c3-3e69-479f-bbcb-d239a8a6bef2
e99d5a8f-e0ba-4c12-a715-404be2c30113.htseq.counts.gz	f44b8188-3409-47e6-b8f5-564d398b85b8	TCGA-AX-A0J0-11A-11R-A27V-07	TCGA-AX-A0J0-11A-11R	TCGA-AX-A0J0-11A-01-TSA			TCGA-AX-A0J0-11A-11	TCGA-AX-A0J0-11A	TCGA-AX-A0J0	1c7b41fc-daa7-4a6e-b553-aff73e8ebac6	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1952	110.0	False	false		1.87	bdb31196-8bc4-4c2a-bbcf-641e1916733f	0.17	23	released	14265853-5d27-412e-bea6-bd817d94683c	RNA	R	0.17	UV Spec	released	False	d109341e-3e6d-44a0-9870-c0d794168352	11	0.0	0.0	0.0	0.0	100.0	0.0	0.0	0.0	TOP	8ce25dca-40dc-4a86-a816-f80140d6bad2	released																				released	30.0	06731fda-e0ba-49d4-9d61-9c6cab663097	Solid Tissue Normal	11	released	Not Reported	released	TCGA-AX-A0J0_demographic	47	-17466		0740835f-f4ed-5dc5-8ff0-d9df87dbd640	not hispanic or latino	female	white	released	Alive	1959		TCGA-AX-A0J0_exposure	Not Reported	19.948059768903608	aed00cc4-a090-5c04-a038-bd3cbc563952	163.0	released	53.0	TCGA-AX-A0J0_diagnosis	17466	not reported	0	1220	316a64b1-581c-573b-95c0-487c977868d8	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2006	TCGA-AX-A0J0_treatment	TCGA-AX-A0J0_treatment_1	released	3b53d30b-df55-5124-bb8e-b2b07424b9df	no	Radiation Therapy, NOS	released	2835bf70-cfb3-5fd1-b16f-4beb3d0afb40	no	Pharmaceutical Therapy, NOS	f44b8188-3409-47e6-b8f5-564d398b85b8
9106b138-472d-4fa5-a1c7-ca09fe73774a.htseq.counts.gz	131ac913-a57f-4c5e-879f-4dd8ce01b782	TCGA-A5-A0GG-01A-11R-A118-07	TCGA-A5-A0GG-01A-11R	TCGA-A5-A0GG-01A-01-TSA	TCGA-A5-A0GG-01A-01-BSA		TCGA-A5-A0GG-01A-11	TCGA-A5-A0GG-01A	TCGA-A5-A0GG	a8614c49-c7f1-4de9-bd2f-4764b094d604	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	2369	220.0	False	true	6867E576-1020-41D7-BC18-25160FE17F81	1.81	88e9cdc4-bcf1-49e9-8965-7dc6b3688585	0.15	23	released	a0e9b3f2-70cc-40ab-b39f-637d50f8347e	RNA	R	0.15	UV Spec	released	False	f704fb02-9c9a-46ff-9291-4112433333e4	11	0.0	0.0	0.0	0.0	20.0	0.0	80.0	70.0	TOP	129ee9f0-ade1-4f92-800c-9be7c2500b78	released	0.0	0.0	0.0	0.0	30.0	10.0	60.0	50.0	BOTTOM	6e03d58b-727d-4a60-a7ab-726183eae29d	released									released	30.0	b5b941e3-f828-4091-b9b1-6b38d1493847	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A0GG_demographic	76	-27809		ffaff7f1-1d96-5720-9231-587e03833f53	not hispanic or latino	female	black or african american	released	Alive	1927		TCGA-A5-A0GG_exposure	Not Reported	25.0	4e2f60a6-7e94-5a2f-982d-8ecf3caf95f7	160.0	released	64.0	TCGA-A5-A0GG_diagnosis	27809	not reported	0	3762	1e3e2d09-526a-5154-a63e-32946e37e91b	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2003	TCGA-A5-A0GG_treatment_1	TCGA-A5-A0GG_treatment	released	19d885f4-6fac-5704-b9c2-0bb8de64112a	no	Pharmaceutical Therapy, NOS	released	80b36487-b93d-5818-b76c-37a327462440	yes	Radiation Therapy, NOS	131ac913-a57f-4c5e-879f-4dd8ce01b782
60890e58-8718-49c2-bee0-e6823dabcbc5.htseq.counts.gz	ba11ebcf-4251-459b-b276-06ebcc99e6df	TCGA-AP-A05D-01A-11R-A00V-07	TCGA-AP-A05D-01A-11R	TCGA-AP-A05D-01A-01-BS1	TCGA-AP-A05D-01A-01-TS1		TCGA-AP-A05D-01A-11	TCGA-AP-A05D-01A	TCGA-AP-A05D	f7e06a10-74ca-4f52-a944-b3f22c016998	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	1063	190.0	False	true	3312F531-00A3-4104-8C9C-8734C32C89C0	1.75	c60df680-5bd6-48cc-a112-985f73d9092c	0.14	23	released	40474521-f3ed-46ae-b500-cbe7b06f7677	RNA	R	0.14	UV Spec	released	False	c6284b85-c0e8-4413-8812-d308262f2e0c	11	8.0	0.0	1.0	0.0	0.0	15.0	84.0	80.0	BOTTOM	4279a3ff-06ff-4d47-9790-3457391e1a0d	released	10.0	0.0	1.0	0.0	0.0	20.0	79.0	70.0	TOP	a67301a2-467c-40ce-916f-3029c65d15dd	released									released	30.0	5b19af28-1179-42cb-a474-856ef2048d5b	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A05D_demographic	67	-24597		b9fe82c2-4fea-502e-9d7d-7bd0b98acde3	not reported	female	white	released	Alive	1940		TCGA-AP-A05D_exposure	Not Reported	37.80718336483932	3b4a3909-cac6-5612-8d54-eb48c2c59548	161.0	released	98.0	TCGA-AP-A05D_diagnosis	24597	not reported	0	1758	8e296ccc-66ee-5507-883a-618483a5d16b	Stage IIIC2	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2007	TCGA-AP-A05D_treatment_1	TCGA-AP-A05D_treatment	released	36c4c5cd-0858-5640-ac78-fa7409287255	yes	Pharmaceutical Therapy, NOS	released	aaf0e00f-c511-5b67-bd52-a587e3ca359c	yes	Radiation Therapy, NOS	ba11ebcf-4251-459b-b276-06ebcc99e6df
68d81a0c-10b7-4417-8fca-b0a9d645683f.htseq.counts.gz	34023a85-f588-47b4-a074-e9bec08fab0e	TCGA-KP-A3W3-01A-11R-A22K-07	TCGA-KP-A3W3-01A-11R	TCGA-KP-A3W3-01A-01-TS1			TCGA-KP-A3W3-01A-11	TCGA-KP-A3W3-01A	TCGA-KP-A3W3	0264c9c2-6b6a-485c-98f5-aed4f52ed0ca	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	739	680.0	False	true	9D8F170A-A4B1-463A-B92C-357870762EAD	1.83	b2d5d73b-6669-438a-b6fd-0e29b7bce645	0.15	23	released	5cfda0bd-c9f8-4980-b556-02a1769213bf	RNA	R	0.15	UV Spec	released	False	5a71f937-2d46-4083-99f1-1441ca54e010	11	60.0	20.0	5.0	10.0	0.0	5.0	90.0	90.0	TOP	d8ebc5eb-9f64-4146-bce2-018338e5c447	released																				released	30.0	d54f4476-7191-4a52-a310-8392f62404cb	Primary Tumor	01	released	Not Reported	released	TCGA-KP-A3W3_demographic	72	-26310		2e5d8b2d-f3a4-5ebd-a612-2fd511f12455	not hispanic or latino	female	white	released	Alive	1938		TCGA-KP-A3W3_exposure	Not Reported	46.847114812611544	2ba473f0-9d61-52b3-8674-bbaa7b27d4df	164.0	released	126.0	TCGA-KP-A3W3_diagnosis	26310	not reported	0	794	5bb79aec-bb1a-5619-a006-0cf8edcb82f4	Stage IB	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-KP-A3W3_treatment	TCGA-KP-A3W3_treatment_1	released	f68f37cc-4f05-5ca2-b716-52f6a66f169a	yes	Radiation Therapy, NOS	released	b16fb506-fb87-5411-9bfd-0ea0253156ab	yes	Pharmaceutical Therapy, NOS	34023a85-f588-47b4-a074-e9bec08fab0e
69ee0de8-763d-49de-8410-b8d564cd7afe.htseq.counts.gz	00e47883-c7a7-4504-9413-e0014b41caf8	TCGA-B5-A5OC-01A-21R-A27V-07	TCGA-B5-A5OC-01A-21R	TCGA-B5-A5OC-01A-02-TSB			TCGA-B5-A5OC-01A-21	TCGA-B5-A5OC-01A	TCGA-B5-A5OC	ae8a4958-5407-4c01-93c3-8090862533ae	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	732	750.0	False	true	2B1515A6-001A-46AF-952C-D393944DE57F	1.88	12be39a5-bbae-439a-84a9-28b790e89aa9	0.16	23	released	f274d7ac-057a-4053-8881-0d25b299b5fc	RNA	R	0.16	UV Spec	released	False	280dbbfb-b37e-4ec0-a892-e79d50296c7e	21	20.0	40.0	0.0	20.0	0.0	40.0	60.0	60.0	TOP	15d25a6a-f0e7-4ad1-8b42-10faa46ed62e	released																				released	30.0	69ac12c0-a986-44ac-8687-134ccb12ac21	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A5OC_demographic	71	-26109		7d93421a-71dc-502a-9c1a-8d3d30104edf	not reported	female	black or african american	released	Alive	1940		TCGA-B5-A5OC_exposure	Not Reported		d1f77a82-9999-537c-b1bb-50128a7ef8ee		released		TCGA-B5-A5OC_diagnosis	26109	not reported	0	1249	d0efbe59-a540-5d2d-83db-f1e2c8d18b8e	Stage IIIB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-B5-A5OC_treatment	TCGA-B5-A5OC_treatment_1	released	480b91ab-910b-5bac-ad43-dca37c364126	yes	Radiation Therapy, NOS	released	fb1f947b-da02-5759-8e79-b9e190527071	yes	Pharmaceutical Therapy, NOS	00e47883-c7a7-4504-9413-e0014b41caf8
186b160e-ab23-40df-9dd3-fba8031f7023.htseq.counts.gz	c96862f3-65c0-4570-b9f2-d8fca7bd3998	TCGA-BG-A0MU-01A-11R-A104-07	TCGA-BG-A0MU-01A-11R	TCGA-BG-A0MU-01A-01-BSA	TCGA-BG-A0MU-01A-01-TSA		TCGA-BG-A0MU-01A-11	TCGA-BG-A0MU-01A	TCGA-BG-A0MU	a7329910-b1c7-4a18-b28e-8fad79121339	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	121	860.0	False	true	7162F7A7-7295-4736-B721-B13DAE006092	1.78	06c39fc6-9167-4913-bf84-4fde036869a2	0.15	23	released	8a2bd51a-13ae-43b6-94e4-9fb6e5bd2997	RNA	R	0.15	UV Spec	released	False	05f82e60-6b95-4ea4-b035-7122eb450141	11	1.0	1.0	3.0	1.0	0.0	7.0	90.0	94.0	BOTTOM	84f88171-4dfe-4ef7-920d-79674fbf8b55	released	2.0	1.0	2.0	1.0	0.0	6.0	92.0	94.0	TOP	93aeefe4-33bd-42e5-a05b-891899da1ed7	released									released	30.0	f0af3f30-3d64-4bd8-9a8f-7ff7ab9bb7b0	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A0MU_demographic	78	-28621		ad41e1ef-c12d-539c-936a-66be05ef82b6	not hispanic or latino	female	white	released	Alive	1932		TCGA-BG-A0MU_exposure	Not Reported	29.43213296398892	0a471f35-4e1d-5c94-9dca-3d9e81a87bb8	152.0	released	68.0	TCGA-BG-A0MU_diagnosis	28621	not reported	0	617	a87f99dd-5401-5644-83c3-bd101864d91b	Stage IIIA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-BG-A0MU_treatment	TCGA-BG-A0MU_treatment_1	released	f920c410-cea7-5309-970b-8bc5adb439a5	yes	Radiation Therapy, NOS	released	5663d573-fa1c-5751-8b0d-6b95eb3011d8	yes	Pharmaceutical Therapy, NOS	c96862f3-65c0-4570-b9f2-d8fca7bd3998
3e940a49-f192-435a-9533-dd5a99e619e3.htseq.counts.gz	8ea574a0-a18f-41b3-a4b8-7315fa8c0635	TCGA-D1-A0ZV-01A-11R-A10J-07	TCGA-D1-A0ZV-01A-11R	TCGA-D1-A0ZV-01A-01-TS1	TCGA-D1-A0ZV-01A-01-BS1		TCGA-D1-A0ZV-01A-11	TCGA-D1-A0ZV-01A	TCGA-D1-A0ZV	0c01c673-e396-47b2-9562-4144d7705ebf	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	324	110.0	False	false	C9AE2762-705F-4061-B3B6-325426D0C0C8	1.86	45676252-677e-45f6-a1e3-3052d3615472	0.17	23	released	0af87a76-6e98-4afe-a6c2-431c17d92bd7	RNA	R	0.17	UV Spec	released	False	c3856358-55c6-4e69-aa82-9f6b8e22758b	11	20.0	0.0	10.0	20.0	0.0	20.0	70.0	80.0	TOP	8cfb7bc6-3f83-45e5-b5a4-b4ea43acdc7a	released	20.0	0.0	10.0	20.0	0.0	20.0	70.0	80.0	BOTTOM	991664d7-c175-4508-8217-a47ece7ba41f	released									released	30.0	a1cb5589-26dd-4d0e-9447-375ebeca6b78	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A0ZV_demographic	58	-21374		c172bc97-df3f-59ab-b64c-63529d29ba3d	not hispanic or latino	female	white	released	Alive	1951		TCGA-D1-A0ZV_exposure	Not Reported	26.643598615916954	674c54c8-3196-5b89-a6cc-c8d7b869f842	170.0	released	77.0	TCGA-D1-A0ZV_diagnosis	21374	not reported	0	728	54abed21-c1a1-55fb-95a4-1018adbd0293	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-D1-A0ZV_treatment_1	TCGA-D1-A0ZV_treatment	released	d2cb5aa4-81a1-5ccc-8243-bfb7c9baf831	no	Pharmaceutical Therapy, NOS	released	9847d6e2-f1f8-5c53-a200-8ea26e33ecf5	no	Radiation Therapy, NOS	8ea574a0-a18f-41b3-a4b8-7315fa8c0635
04314b36-c636-4419-b8e2-df532e58b8b6.htseq.counts.gz	a2f68b21-4a8f-42e3-a825-ead324a52ed4	TCGA-EO-A22X-01A-11R-A180-07	TCGA-EO-A22X-01A-11R	TCGA-EO-A22X-01A-01-TSA			TCGA-EO-A22X-01A-11	TCGA-EO-A22X-01A	TCGA-EO-A22X	10eb7dfa-d43d-479f-8c46-c0424207f958	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	842	110.0	False	false	4D919902-FBCE-4AAC-ACD2-38A2F1D8E901	1.81	ca6bff3c-e95e-42e6-8eff-76d66e8031b0	0.17	23	released	dd80fb08-6e32-4906-a34c-01f9c0c22094	RNA	R	0.17	UV Spec	released	False	716977a4-761c-48b8-a3f8-6281f3b989b2	11	40.0	20.0	0.0	20.0	0.0	30.0	70.0	70.0	TOP	ad9e3dc0-0129-4966-a0fc-aaa97d8fcff3	released																				released	30.0	0c6fd9ef-cffe-4b5b-b2fb-8136285da058	Primary Tumor	01	released	Not Reported	released	TCGA-EO-A22X_demographic	36	-13245		692609e2-c553-550a-ac55-c875089ec9f1	not reported	female	not reported	released	Alive	1972		TCGA-EO-A22X_exposure	Not Reported	24.238227146814403	67ccad95-5f1b-5ac3-9a9d-4bbb7c28fe1f	152.0	released	56.0	TCGA-EO-A22X_diagnosis	13245	not reported	0	1752	ba89b860-0f53-5836-9e61-24f89de6f90c	Stage IIIA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-EO-A22X_treatment_1	TCGA-EO-A22X_treatment	released	09a1f203-98e9-5dd7-8548-f0557e9c6aaf	yes	Pharmaceutical Therapy, NOS	released	7f11a2ae-e375-59b4-b31d-a96df7b1d6e5	no	Radiation Therapy, NOS	a2f68b21-4a8f-42e3-a825-ead324a52ed4
30036430-f24a-49d9-b35e-233f67f11b3f.htseq.counts.gz	acae3854-f0c7-4414-983e-58d6b0cda85b	TCGA-B5-A11O-01A-11R-A118-07	TCGA-B5-A11O-01A-11R	TCGA-B5-A11O-01A-01-BS1	TCGA-B5-A11O-01A-01-TS1		TCGA-B5-A11O-01A-11	TCGA-B5-A11O-01A	TCGA-B5-A11O	a59a79fd-433d-44dc-9601-4c63d599ab28	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	993	130.0	False	true	078AA8A2-E812-4603-9084-8414937B88E1	1.8	7e3666db-df81-4413-b742-c475e786772e	0.14	23	released	dec99650-a2c8-4ece-b9b2-9ca33d77c155	RNA	R	0.14	UV Spec	released	False	cd5fc1b5-09ba-4394-a718-f2289ea5abfb	11	20.0	8.0	10.0	8.0	0.0	5.0	85.0	95.0	BOTTOM	164cda41-b90e-42d0-9851-8c98137d09d0	released	20.0	8.0	8.0	5.0	0.0	10.0	82.0	90.0	TOP	4f87ebf7-49e5-4f9d-bfd0-c8bf651be2ce	released									released	30.0	f3d85f05-bd2c-46fc-ac6a-0e2a7248c630	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A11O_demographic	62	-22720		b0e6de39-ab28-5b60-90a2-2ae8485c99d9	not reported	female	white	released	Alive	1946		TCGA-B5-A11O_exposure	Not Reported	36.388011107919176	5e0f52ff-49b2-597e-9637-680d466885dd	177.0	released	114.0	TCGA-B5-A11O_diagnosis	22720	not reported	0	2609	4528c73f-e558-5634-8ad1-76154e43a209	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-B5-A11O_treatment_1	TCGA-B5-A11O_treatment	released	ef5a4abb-5f9a-5785-bdbc-45ef5f3325a7	yes	Pharmaceutical Therapy, NOS	released	f166c518-fa80-528e-9ad3-a9bb7367e827	yes	Radiation Therapy, NOS	acae3854-f0c7-4414-983e-58d6b0cda85b
2bca719d-0f0a-4ccf-959c-0babe2fe2455.htseq.counts.gz	8cc8fd20-a7df-4396-90db-9e40a5a6bf39	TCGA-QS-A5YQ-01A-11R-A31O-07	TCGA-QS-A5YQ-01A-11R	TCGA-QS-A5YQ-01A-01-TS1			TCGA-QS-A5YQ-01A-11	TCGA-QS-A5YQ-01A	TCGA-QS-A5YQ	03381d49-e25f-4376-8e36-f47063a7d3fb	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	43	370.0	False	false	D1631D6F-F055-4D35-A6DD-FE7A251BD4C2	1.88	618b52e3-9797-4c61-a0dd-1ffa8ea6d321	0.16	23	released	e2920509-ba32-4e21-93fb-e9414ded2fc4	RNA	R	0.16	UV Spec	released	False	0149346e-899b-4ee5-bcdd-5803743f741d	11	20.0	0.0	0.0	0.0	0.0	30.0	70.0	70.0	TOP	bac674d2-c637-4b09-80ee-3a629b812233	released																				released	30.0	c38114c8-744b-4919-8f2a-c8f30fba38b3	Primary Tumor	01	released	Not Reported	released	TCGA-QS-A5YQ_demographic	55	-20425		e2e24506-9147-5af7-abf8-8e974293db26	not hispanic or latino	female	black or african american	released	Alive	1958		TCGA-QS-A5YQ_exposure	Not Reported	32.421875	a0e17bf8-c36e-530a-ab8d-e5923a933b83	160.0	released	83.0	TCGA-QS-A5YQ_diagnosis	20425	not reported	0	759	c086b653-e209-5155-bd29-8da62fd7ec9a	Stage IIIA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2013	TCGA-QS-A5YQ_treatment_1	TCGA-QS-A5YQ_treatment	released	809ddc45-a597-54bf-b854-d36f3deb9cd6	yes	Pharmaceutical Therapy, NOS	released	0fb5dc43-a72f-5993-929a-3ef1486249cb	yes	Radiation Therapy, NOS	8cc8fd20-a7df-4396-90db-9e40a5a6bf39
f37ffd3e-defe-4e0f-bbd6-f3257a78a4eb.htseq.counts.gz	c0d5a43b-85e6-415f-88ae-f64cb5f15127	TCGA-EY-A54A-01A-11R-A27V-07	TCGA-EY-A54A-01A-11R	TCGA-EY-A54A-01A-01-TS1			TCGA-EY-A54A-01A-11	TCGA-EY-A54A-01A	TCGA-EY-A54A	75783dbe-e18c-4535-b9eb-2affd320e098	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	105	500.0	False	false	E3C3D3B8-550A-4652-9B17-122BC64A437A	1.88	a7c691a2-a91d-44d0-8e91-0234cddb1e92	0.17	23	released	e056a7b9-9392-498f-8b76-6772a72e2fec	RNA	R	0.17	UV Spec	released	False	67c3b59a-6690-4bf2-ac4e-a7dd63c04d01	11	5.0	3.0	0.0	0.0	0.0	0.0	100.0	65.0	TOP	3296f85a-b33f-4658-bf59-c9cb1e366030	released																				released	30.0	6d890026-4221-471a-afa6-1118ed804f08	Primary Tumor	01	released	Not Reported	released	TCGA-EY-A54A_demographic	67	-24822		be31e54c-a3d3-5eb6-8d3f-25c7b2e63f8c	not hispanic or latino	female	black or african american	released	Alive	1945		TCGA-EY-A54A_exposure	Not Reported	27.005130974885226	766d1f1d-8f0e-580b-a55a-3a9840139306	161.0	released	70.0	TCGA-EY-A54A_diagnosis	24822	not reported	0	447	b0351059-8e11-5467-97c2-a451c3438893	Stage IIIC2	C54.9	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Corpus uteri	released	No	Corpus uteri	not reported	not reported	2012	TCGA-EY-A54A_treatment	TCGA-EY-A54A_treatment_1	released	71705968-3a24-5db0-8a48-2f04c84bc90c	yes	Radiation Therapy, NOS	released	696de390-33ae-5ab0-9d47-08c88bb73183	yes	Pharmaceutical Therapy, NOS	c0d5a43b-85e6-415f-88ae-f64cb5f15127
2f4228ea-16a0-48d8-9d36-d52ba70d0e67.htseq.counts.gz	5f3b438b-96e4-4b1e-9102-eec1616d3024	TCGA-D1-A3DH-01A-11R-A19W-07	TCGA-D1-A3DH-01A-11R	TCGA-D1-A3DH-01A-01-TSA			TCGA-D1-A3DH-01A-11	TCGA-D1-A3DH-01A	TCGA-D1-A3DH	7d22ff96-9249-46b3-9cfa-e40dc4ecebd6	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	43	150.0	False	true	C63CF985-CF78-42EE-A7A2-22083FED571D	1.78	8576f260-e8fb-4fbf-81ad-34fb4af302fd	0.17	23	released	ed4c2af6-a12a-4741-8c1a-9c2b3c8f7501	RNA	R	0.17	UV Spec	released	False	46236498-c503-43d8-bda3-a32bac4cc5b9	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	85.0	TOP	64be6a8f-6309-4492-b858-57c814070948	released																				released	30.0	5d130578-de0c-4336-92e6-02c6f11add92	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A3DH_demographic	71	-25935		0b11fb4d-52a2-56e1-9cef-35568e1a2c19	not hispanic or latino	female	white	released	Alive	1940		TCGA-D1-A3DH_exposure	Not Reported	26.927437641723355	0e3a954a-529c-5281-b836-51aea8bc1753	168.0	released	76.0	TCGA-D1-A3DH_diagnosis	25935	not reported	0	573	4016a029-9a7a-5557-9078-8876bf570a60	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-D1-A3DH_treatment	TCGA-D1-A3DH_treatment_1	released	2275e016-0860-5fd9-a236-4fe8d14ed7ea	yes	Radiation Therapy, NOS	released	220c598f-dc6c-51a9-9af0-a425354c824c	no	Pharmaceutical Therapy, NOS	5f3b438b-96e4-4b1e-9102-eec1616d3024
ead4c59e-2719-4bf8-a44e-5cc966c42f94.htseq.counts.gz	7fad48c7-7bd7-4a5c-9843-37231e3399aa	TCGA-B5-A0JX-01A-21R-A14M-07	TCGA-B5-A0JX-01A-21R	TCGA-B5-A0JX-01A-02-TSB	TCGA-B5-A0JX-01A-02-BSB		TCGA-B5-A0JX-01A-21	TCGA-B5-A0JX-01A	TCGA-B5-A0JX	586d7b3f-67a8-4a22-862f-cf50de3c1598	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	952	170.0	False	true	E511CFF9-9687-4134-B85D-37C037B71643	1.7	093be209-e5ac-4129-83b2-5f79f6a5c15f	0.15	23	released	99e9bfc2-372d-46db-9b7c-e502255138ba	RNA	R	0.15	UV Spec	released	False	ebba647c-371d-492f-95cc-a0baaa329c82	21	20.0	0.0	10.0	10.0	10.0	0.0	90.0	90.0	TOP	15084d96-0391-46de-95df-fe514cec6093	released	20.0	0.0	20.0	10.0	30.0	0.0	50.0	70.0	BOTTOM	863f5e29-c989-4cd5-b65f-2c21c6f97b01	released									released	30.0	f4c448e1-8415-42a4-b8d4-b71bf57ad00b	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A0JX_demographic	62	-22834		6014440f-b492-52dc-a262-f14f49e88341	not reported	female	white	released	Alive	1945		TCGA-B5-A0JX_exposure	Not Reported	40.03684807256236	647bc5a5-316b-5300-a8b5-0db38783e259	168.0	released	113.0	TCGA-B5-A0JX_diagnosis	22834	not reported	0	1787	a401e5ac-82c4-54b0-976e-fa86731953d1	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2007	TCGA-B5-A0JX_treatment_1	TCGA-B5-A0JX_treatment	released	eaf1675c-65a4-5577-b837-3b2581fc08dd	no	Pharmaceutical Therapy, NOS	released	40ee69f8-a8b5-569e-882d-41a9614b7a93	no	Radiation Therapy, NOS	7fad48c7-7bd7-4a5c-9843-37231e3399aa
2dad895e-fde7-4526-9af8-e69c23df9afa.htseq.counts.gz	50a8131c-1d91-4986-b8bb-fdb9719fc804	TCGA-B5-A0JT-01A-21R-A118-07	TCGA-B5-A0JT-01A-21R	TCGA-B5-A0JT-01A-02-BSB	TCGA-B5-A0JT-01A-02-TSB		TCGA-B5-A0JT-01A-21	TCGA-B5-A0JT-01A	TCGA-B5-A0JT	d5f2bae1-7cd1-49bf-ae41-12d2aa44408e	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1128	750.0	False	true	CC6EE5B1-5548-4DE7-873F-332DBF81710F	1.73	b3e039bf-945c-4974-a4ec-8e3b177aef8d	0.17	23	released	05903202-0bf3-41e0-8132-cb79843b50f8	RNA	R	0.17	UV Spec	released	False	f0663ac1-9d86-4576-ac94-aa1f66b554ac	21	0.0	0.0	0.0	0.0	20.0	0.0	80.0	65.0	BOTTOM	f3f9c95a-a557-469d-8521-8d2705976f89	released	0.0	0.0	0.0	0.0	50.0	0.0	50.0	40.0	TOP	c4c62b77-f331-4101-8fe5-5794ef695407	released									released	30.0	4188c8ea-fe84-4c30-a390-0bd9a6b10c7b	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A0JT_demographic	63	-23041		d5d00d70-77b9-5443-bd30-112211cf1f36	not reported	female	white	released	Alive	1944		TCGA-B5-A0JT_exposure	Not Reported	42.16269841269841	c7f8aa1d-a411-5467-ab5c-ae89e4953919	168.0	released	119.0	TCGA-B5-A0JT_diagnosis	23041	not reported	0	1682	1f791e55-9d7d-5124-93cb-f158cbaf8e8e	Stage IIIA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2007	TCGA-B5-A0JT_treatment	TCGA-B5-A0JT_treatment_1	released	45c03b7b-783e-5995-9fdb-aeaf67737262	no	Radiation Therapy, NOS	released	6016075b-070a-5f3c-83c3-6d6d46f646a0	yes	Pharmaceutical Therapy, NOS	50a8131c-1d91-4986-b8bb-fdb9719fc804
c8fd69b8-365d-4802-aed6-619956545feb.htseq.counts.gz	b0f9b72b-d64d-41f8-9cab-b201a3dc4dce	TCGA-A5-A0GJ-01A-11R-A040-07	TCGA-A5-A0GJ-01A-11R	TCGA-A5-A0GJ-01A-01-BS1	TCGA-A5-A0GJ-01A-01-TS1		TCGA-A5-A0GJ-01A-11	TCGA-A5-A0GJ-01A	TCGA-A5-A0GJ	94817e78-78f5-4556-9394-610df65605e2	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1708	220.0	False	true	83743C19-A9FF-42F0-947E-5697709151C5	2.04	2b483617-1fc6-4809-b15c-d48d687ca3b8	0.16	23	released	3667ad27-d2f4-4322-bf7e-8670e7514314	RNA	R	0.16	UV Spec	released	False	1ab2ed43-67ab-4cd7-8fc6-94e8aa7b08b8	11	10.0	0.0	30.0	15.0	0.0	0.0	70.0	100.0	BOTTOM	514abe88-06d3-4c49-9426-9e5cf3ab0858	released	10.0	0.0	10.0	5.0	30.0	0.0	60.0	70.0	TOP	2f2d238d-1607-4d7a-98a1-76e995cf8bc2	released									released	30.0	48fa5b7d-e488-4743-a7ce-aceb9945f00b	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A0GJ_demographic	44	-16421		bb77659e-237f-5a94-8538-2fb5d2a1797f	not hispanic or latino	female	white	released	Alive	1961		TCGA-A5-A0GJ_exposure	Not Reported	43.28352591365877	d551f2d8-155a-5ff2-8a7a-bb3036b01c25	163.0	released	115.0	TCGA-A5-A0GJ_diagnosis	16421	not reported	0	2000	b6fb24ef-56f2-58fe-9500-478b07397a71	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2005	TCGA-A5-A0GJ_treatment_1	TCGA-A5-A0GJ_treatment	released	a9697f93-8864-577a-b05a-40b24976ad83	yes	Pharmaceutical Therapy, NOS	released	aea681f6-5801-52ce-b126-a79682dce318	no	Radiation Therapy, NOS	b0f9b72b-d64d-41f8-9cab-b201a3dc4dce
9be93e32-5549-49b7-9a9d-b425871a765d.htseq.counts.gz	d38ac171-5938-4117-a60e-35ccdd973761	TCGA-BG-A220-01A-11R-A157-07	TCGA-BG-A220-01A-11R	TCGA-BG-A220-01A-01-TSA			TCGA-BG-A220-01A-11	TCGA-BG-A220-01A	TCGA-BG-A220	41dcafa0-b196-46dd-ab07-58cb747c9ebc	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	110	190.0	False	true	59CD459F-FB2B-4B0E-9E16-3E26BDF252E1	1.77	f26378d3-9f18-4367-a553-1a6c02e72575	0.18	23	released	53a065fe-0af3-4c95-9d42-f20f8ea774b1	RNA	R	0.18	UV Spec	released	False	d76503af-7002-472a-af3c-cf02a9276039	11	40.0	10.0	5.0	30.0	0.0	5.0	90.0	90.0	TOP	75475254-532d-45ac-ac0d-ac4b260b1d3b	released																				released	30.0	b88002d7-76cb-4ea7-b894-8572d49411ab	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A220_demographic	69	-25346		fbd9da68-0278-5568-957d-94cbc2f6de8a	not hispanic or latino	female	white	released	Alive	1941		TCGA-BG-A220_exposure	Not Reported		2172194b-1f36-5e20-a58a-92884ccc2d8e		released	127.0	TCGA-BG-A220_diagnosis	25346	not reported	0	434	cbe109ac-6baf-5aed-92d5-45aa7db3e8fe	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2010	TCGA-BG-A220_treatment_1	TCGA-BG-A220_treatment	released	3dbf65d0-939e-57f4-bf21-beb814d5d388	no	Pharmaceutical Therapy, NOS	released	04c547cc-072b-57a6-b4d3-5d996fb47dfe	yes	Radiation Therapy, NOS	d38ac171-5938-4117-a60e-35ccdd973761
f0910dd0-5170-4222-a5ea-bfcc93ed1766.htseq.counts.gz	ff9df0ea-610d-4478-b401-63876bb9a97a	TCGA-EY-A1GP-01A-11R-A13S-07	TCGA-EY-A1GP-01A-11R	TCGA-EY-A1GP-01A-01-TSA			TCGA-EY-A1GP-01A-11	TCGA-EY-A1GP-01A	TCGA-EY-A1GP	75fb484d-cd12-4cf0-a99d-faf27aead118	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	262	90.0	False	false	D9933BA3-3D3B-4B93-AD6C-22ED47C4DBB1	1.78	c3740105-aee5-42ef-94e9-50f6b242b7c8	0.15	23	released	de8342ab-8fe5-42a2-aa7d-66e6afd11e13	RNA	R	0.15	UV Spec	released	False	053730cc-968f-4936-a60b-407c3da2b988	11	40.0	20.0	10.0	20.0	0.0	10.0	80.0	80.0	TOP	f44b05b6-51ee-474e-9baa-3a86cdf7e65f	released																				released	30.0	13c41beb-c86d-423f-97a4-8f18bff149be	Primary Tumor	01	released	Not Reported	released	TCGA-EY-A1GP_demographic	54	-20011		ce96d3e6-6f9d-54ec-8173-e7af52159c07	not hispanic or latino	female	black or african american	released	Alive	1956		TCGA-EY-A1GP_exposure	Not Reported	28.841531805800354	49e62e21-2c9d-5e2f-853f-5fca173db285	158.0	released	72.0	TCGA-EY-A1GP_diagnosis	20011	not reported	0	573	9d18e30f-2e1e-511a-8941-81743f8b9cf7	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-EY-A1GP_treatment_1	TCGA-EY-A1GP_treatment	released	abc3728a-2f51-5a65-89c1-7d7c301bcc20	no	Pharmaceutical Therapy, NOS	released	2ac31c35-3472-5389-818d-f067f899b839	no	Radiation Therapy, NOS	ff9df0ea-610d-4478-b401-63876bb9a97a
2650ece4-ac6b-4fcd-86b3-f8e3d75695a1.htseq.counts.gz	adf41362-3f20-4999-aa5d-86707f41e4ea	TCGA-D1-A102-01A-11R-A10J-07	TCGA-D1-A102-01A-11R	TCGA-D1-A102-01A-01-BSA	TCGA-D1-A102-01A-01-TSA		TCGA-D1-A102-01A-11	TCGA-D1-A102-01A	TCGA-D1-A102	f9cf4125-0db3-4b66-b51b-bc2f0240c9ef	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	380	200.0	False	false	9983D576-706A-48D2-93EE-70EABB3BD77C	1.8	120e984a-ef3b-4240-8990-20aeadce8226	0.17	23	released	75ab77a1-bbf1-45a1-ae2a-0c877998dece	RNA	R	0.17	UV Spec	released	False	623f44d2-f3b4-4977-8fea-6862d2b7bd14	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	75.0	BOTTOM	dcf1de88-b781-41f0-9f63-6eb1eb0be454	released	0.0	0.0	0.0	0.0	0.0	5.0	95.0	75.0	TOP	22d0b59a-ca62-4fbb-a34b-50544a5761eb	released									released	30.0	eef5bd16-dc47-47da-baa9-295b8c28361b	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A102_demographic	49	-17991		24d81207-6d0e-56d6-9cff-9d05306baef1	not hispanic or latino	female	white	released	Alive	1960		TCGA-D1-A102_exposure	Not Reported	38.505239237470015	b0c06667-6a23-5317-8054-358ae113c515	178.0	released	122.0	TCGA-D1-A102_diagnosis	17991	not reported	0	135	8392456e-f5ba-5589-8e27-985d34a4d90b	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2009	TCGA-D1-A102_treatment_1	TCGA-D1-A102_treatment	released	a32d810d-412c-5bd1-bd83-21ea59fba3b7	no	Pharmaceutical Therapy, NOS	released	3d8bf7b7-1423-5bb3-ae68-af654337e0b9	no	Radiation Therapy, NOS	adf41362-3f20-4999-aa5d-86707f41e4ea
d8219bec-aec9-4cc3-8864-be208897fdd1.htseq.counts.gz	23cffb86-6d9c-4c31-a25c-1dd55d6394cd	TCGA-BS-A0UL-01A-11R-A109-07	TCGA-BS-A0UL-01A-11R	TCGA-BS-A0UL-01A-01-TS1	TCGA-BS-A0UL-01A-01-MS1		TCGA-BS-A0UL-01A-11	TCGA-BS-A0UL-01A	TCGA-BS-A0UL	5428c4b2-37c2-4f8c-a474-39fe1aacb26b	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	2155	70.0	False	false	323FC36E-D8E3-4F6B-A8FE-2040F3E44BB9	1.89	954c9805-885f-481a-9dac-024d4481256b	0.16	23	released	c723696b-4198-4ea5-913b-eb9e6f1088a0	RNA	R	0.16	UV Spec	released	False	e6c8ab51-28e1-4bf6-aa72-8128fc22bf72	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	75.0	TOP	93630db7-6ffa-4627-8fe2-a5f9c8a3f564	released	0.0	0.0	0.0	0.0	0.0	25.0	75.0	70.0	BOTTOM	4b59c747-82cb-4898-aac9-ba0f1627f14d	released									released	20.0	d9a2756b-472f-4eee-9d76-91f4320f8a1a	Primary Tumor	01	released	Not Reported	released	TCGA-BS-A0UL_demographic	54	-19982		c2e76a4c-ddb2-55de-baa7-c7067c1259f4	not hispanic or latino	female	native hawaiian or other pacific islander	released	Alive	1950		TCGA-BS-A0UL_exposure	Not Reported	39.44636678200692	08bcfcd4-d0f2-5c36-80df-7667025ca9f7	170.0	released	114.0	TCGA-BS-A0UL_diagnosis	19982	not reported	0	2481	0209538e-826c-5cc3-92de-c19f17737c3f	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2004	TCGA-BS-A0UL_treatment_1	TCGA-BS-A0UL_treatment	released	68545713-71ca-5a6e-af82-79a6edab5fbd	no	Pharmaceutical Therapy, NOS	released	77c46c07-7ce3-57e1-9ad5-c49955c8340f	no	Radiation Therapy, NOS	23cffb86-6d9c-4c31-a25c-1dd55d6394cd
43b91db3-cd6b-402d-8f92-00439350fc18.htseq.counts.gz	9c9849f4-0dc2-4649-bb66-1cd4e36fa236	TCGA-BG-A0MA-01A-11R-A17B-07	TCGA-BG-A0MA-01A-11R	TCGA-BG-A0MA-01A-01-TSA	TCGA-BG-A0MA-01A-01-MSA		TCGA-BG-A0MA-01A-11	TCGA-BG-A0MA-01A	TCGA-BG-A0MA	f85bc60b-ab07-4b24-820b-6860b198e910	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	805	130.0	False	true	E5908692-5B04-407B-818A-D202756DD880	1.82	e93ac169-2fab-4312-9239-a9141d347763	0.16	23	released	ed640361-de54-4d44-89f8-e8521be3fe72	RNA	R	0.16	UV Spec	released	False	ac3d950c-c43c-4abe-a105-b4c2f3dc7649	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	85.0	TOP	4b53b2b4-525c-4ec7-baf6-976ac947707c	released	20.0	0.0	20.0	20.0	20.0	0.0	60.0	80.0	BOTTOM	bc079aac-396b-40b6-92ad-110baf836a6c	released									released	30.0	8b7459ed-d1d7-4499-b057-12bc9a5bc488	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A0MA_demographic	60	-22036	326	5d06e636-7e27-5d5a-8bc0-dce45ba5fa01	not hispanic or latino	female	white	released	Dead	1948	2008	TCGA-BG-A0MA_exposure	Not Reported	38.40830449826989	026328b3-8085-5a51-af6a-f112b22c732c	170.0	released	111.0	TCGA-BG-A0MA_diagnosis	22036	not reported	0		34eb0cae-e80a-5584-92dc-60f9673dac69	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-BG-A0MA_treatment	TCGA-BG-A0MA_treatment_1	released	0df877e1-4db1-558c-8841-3d961fc9c5f1	no	Radiation Therapy, NOS	released	1eccd229-359d-53f4-bafd-0b86f5c981a4	no	Pharmaceutical Therapy, NOS	9c9849f4-0dc2-4649-bb66-1cd4e36fa236
9b8e7043-9daf-4969-b13e-93f29b8f4b9a.htseq.counts.gz	dd15509f-d674-4e73-b83a-8b8c1a5f3761	TCGA-EO-A1Y5-01A-11R-A157-07	TCGA-EO-A1Y5-01A-11R	TCGA-EO-A1Y5-01A-01-TSA			TCGA-EO-A1Y5-01A-11	TCGA-EO-A1Y5-01A	TCGA-EO-A1Y5	5f2f2e7a-8aec-4011-b261-0c5bc68da840	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	223	110.0	False	false	B3A96371-1CD6-4B08-BDA5-C8CD7C7DE81F	1.88	fd13e02a-4bfb-4aaa-bbf7-488660106a31	0.15	23	released	ec3154b2-15fa-4a62-a1ce-a46e522626a8	RNA	R	0.15	UV Spec	released	False	8f22001a-6fe2-4a3f-9a6a-58048716145c	11	0.0	0.0	0.0	0.0	0.0	20.0	80.0	80.0	TOP	bd409406-8451-4980-8914-e4df8fc23af3	released																				released	30.0	9bed3aea-1f78-4567-bb7b-016753a9bd0b	Primary Tumor	01	released	Not Reported	released	TCGA-EO-A1Y5_demographic	63	-23251		fd594d66-0c40-5b02-9262-afbc6549a207	not reported	female	not reported	released	Alive	1947		TCGA-EO-A1Y5_exposure	Not Reported	30.477219243084754	e95d407e-ec1d-5865-ad8d-f640f72f2363	161.0	released	79.0	TCGA-EO-A1Y5_diagnosis	23251	not reported	0	332	a52f4e96-efca-5354-ac1f-d5e4600af48f	Stage IIIC2	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-EO-A1Y5_treatment	TCGA-EO-A1Y5_treatment_1	released	e7870fa8-d744-59c3-97d4-6ea0b3f51420	yes	Radiation Therapy, NOS	released	81bbed92-ce6a-5f9b-b0f2-73a5411bbd97	yes	Pharmaceutical Therapy, NOS	dd15509f-d674-4e73-b83a-8b8c1a5f3761
ad190495-86c3-4c04-bb23-6619606577d2.htseq.counts.gz	a6b74fff-8c82-40a8-847c-315a126e4c3b	TCGA-EY-A1GL-01A-11R-A13S-07	TCGA-EY-A1GL-01A-11R	TCGA-EY-A1GL-01A-01-TSA			TCGA-EY-A1GL-01A-11	TCGA-EY-A1GL-01A	TCGA-EY-A1GL	d46d5af5-62ae-43eb-a885-4c078e0c956e	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	366	300.0	False	false	449C1D9F-6A1F-4523-8C86-AFED911D95D4	1.9	94120972-002e-4dbd-8bb1-7f41f05f2b0f	0.16	23	released	09f8fc57-db83-4fcb-8b0c-42639e9f5311	RNA	R	0.16	UV Spec	released	False	16200664-274a-4d51-b1f1-0c28290d2778	11	40.0	20.0	5.0	20.0	0.0	25.0	70.0	70.0	TOP	0c4ab12b-f8d8-4e51-b815-284720767ad1	released																				released	30.0	4032607d-6cf1-4b53-941e-0c50cb3d0f10	Primary Tumor	01	released	Not Reported	released	TCGA-EY-A1GL_demographic	51	-18761		51e0a502-6a75-5175-89d6-43421041fff7	not reported	female	white	released	Alive	1959		TCGA-EY-A1GL_exposure	Not Reported	24.3910588392529	e24c7895-fd05-50a1-b458-a8c80e68686a	173.0	released	73.0	TCGA-EY-A1GL_diagnosis	18761	not reported	0	1014	12d48312-efdd-529e-abdf-822efda92984	Stage II	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-EY-A1GL_treatment_1	TCGA-EY-A1GL_treatment	released	729b0ba4-eec9-5f8d-abd6-1d84c6f1099c	no	Pharmaceutical Therapy, NOS	released	40f1eca8-b298-578e-81fa-6f9d0e263ce7	yes	Radiation Therapy, NOS	a6b74fff-8c82-40a8-847c-315a126e4c3b
0d8cefef-c6ce-4483-9a6d-8ba42febce4d.htseq.counts.gz	6ef31911-1494-4080-bb31-0128207a4e78	TCGA-A5-A2K7-01A-11R-A180-07	TCGA-A5-A2K7-01A-11R	TCGA-A5-A2K7-01A-01-TSA			TCGA-A5-A2K7-01A-11	TCGA-A5-A2K7-01A	TCGA-A5-A2K7	f42868c0-ff59-438b-90a7-489aea678de9	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	195	170.0	False	true	1880F604-34C9-4B58-92DC-D67C7E656E3B	1.8	7f9fd176-6826-4472-bf00-89632783b629	0.16	23	released	91ce03a7-5002-44f4-9763-e0f830201662	RNA	R	0.16	UV Spec	released	False	0b3ca650-6326-4286-918a-7ac746b82c04	11	1.0	0.0	0.0	0.0	0.0	25.0	75.0	85.0	TOP	f70793ef-32f7-4bf5-b4d6-aed487bcec8a	released																				released	30.0	b19b35dd-9431-4040-bbf1-e7490b037de7	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A2K7_demographic	41	-14980		0dc5ba75-646a-5fac-be58-86ae178ea9a3	hispanic or latino	female	not reported	released	Alive	1970		TCGA-A5-A2K7_exposure	Not Reported	29.21010994360826	8a56bb29-f43a-584f-b3ff-7dd56ff8a064	157.0	released	72.0	TCGA-A5-A2K7_diagnosis	14980	not reported	0	1063	9eb35cf2-e1d7-5a6c-abdd-5f04c5a7b1dd	Stage II	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-A5-A2K7_treatment	TCGA-A5-A2K7_treatment_1	released	25d41f28-b73e-50dc-aa15-c234be932e6d	yes	Radiation Therapy, NOS	released	c99515cd-3aa0-59dc-b93b-b9da399b1297	yes	Pharmaceutical Therapy, NOS	6ef31911-1494-4080-bb31-0128207a4e78
c216afb1-a48a-4ab9-9885-a301f2992d50.htseq.counts.gz	ceb349e0-be04-4003-a92b-d3293d831375	TCGA-DI-A2QT-01A-12R-A19W-07	TCGA-DI-A2QT-01A-12R	TCGA-DI-A2QT-01A-01-TS1			TCGA-DI-A2QT-01A-12	TCGA-DI-A2QT-01A	TCGA-DI-A2QT	ee932b34-0114-41dc-b119-210c0ed84bcb	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	1186	280.0	False	false	416DF035-67B0-4461-9523-EB4A4A1FBA5B	1.87	859fec54-ae79-44fa-8021-b6dd66d529da	0.17	23	released	c1b928f7-8a7b-433c-9657-b9740eda46da	RNA	R	0.17	UV Spec	released	False	d8f7ebaa-f67c-41ca-b9b6-56791189524c	12	20.0	5.0	0.0	5.0	0.0	40.0	60.0	60.0	TOP	0063bb23-983f-4fbd-9a79-d0083805d579	released																				released	20.0	41ee0d15-a55b-47a4-9f5a-02a29e89e8dd	Primary Tumor	01	released	Not Reported	released	TCGA-DI-A2QT_demographic	51	-18835	377	8ab85fd8-bf9d-5f86-942f-60383f958f5b	hispanic or latino	female	american indian or alaska native	released	Dead	1957	2009	TCGA-DI-A2QT_exposure	Not Reported	25.476660092044707	b91e4f10-fb11-56ee-9141-6d537d6069d6	156.0	released	62.0	TCGA-DI-A2QT_diagnosis	18835	not reported	0		06f7b4e5-837b-5466-9916-77470ee9e884	Stage IIIC	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-DI-A2QT_treatment_1	TCGA-DI-A2QT_treatment	released	e2366ea4-7525-56a1-a416-c0402295c794	not reported	Pharmaceutical Therapy, NOS	released	d7bb4b46-3f72-5749-aef0-54d592a446e6	not reported	Radiation Therapy, NOS	ceb349e0-be04-4003-a92b-d3293d831375
245898d6-05ac-4e6a-b8e7-39aafeb98c71.htseq.counts.gz	549cef9a-b0b8-400d-99c7-98628765a26c	TCGA-AJ-A5DW-01A-11R-A27V-07	TCGA-AJ-A5DW-01A-11R	TCGA-AJ-A5DW-01A-01-TS1			TCGA-AJ-A5DW-01A-11	TCGA-AJ-A5DW-01A	TCGA-AJ-A5DW	c0b684d1-b96c-4420-9285-172402b7b123	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	133	80.0	False	false	8B641F9B-ACF5-448B-9AC3-8C8E6B1F0724	1.89	25b2c2d1-38b6-4fa7-ab1c-c2de3b6fb2fd	0.18	23	released	649fc253-aae2-40f5-b91d-0accfbbc155c	RNA	R	0.18	UV Spec	released	False	9cc40a73-24f5-45e8-960e-8df749e0c3f9	11	2.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	TOP	d3be5fb2-efde-44da-8b73-8147588f0bde	released																				released	30.0	ae83512d-3739-4e4d-9f27-8b01e6400479	Primary Tumor	01	released	Not Reported	released	TCGA-AJ-A5DW_demographic	56	-20711		e0c51d2e-2739-5a27-ad54-25d14c00f90a	not hispanic or latino	female	black or african american	released	Alive	1956		TCGA-AJ-A5DW_exposure	Not Reported	39.08350962745168	adc55366-0db9-55ca-a01f-b1cf55917a6d	167.0	released	109.0	TCGA-AJ-A5DW_diagnosis	20711	not reported	0	390	0f80c564-ea46-5654-a562-53c10686392d	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2012	TCGA-AJ-A5DW_treatment	TCGA-AJ-A5DW_treatment_1	released	d2bfeef2-549f-5886-ad2a-5761a5d1f908	no	Radiation Therapy, NOS	released	0ad8b192-dff7-5abb-b7fb-c27e0ff926e2	no	Pharmaceutical Therapy, NOS	549cef9a-b0b8-400d-99c7-98628765a26c
f567c8ad-73b1-4206-8aa1-ef6dcff378c5.htseq.counts.gz	3a323dbd-2e34-423c-bf1a-9be915e56cbe	TCGA-AP-A052-01A-11R-A00V-07	TCGA-AP-A052-01A-11R	TCGA-AP-A052-01A-01-TSA	TCGA-AP-A052-01A-01-BSA		TCGA-AP-A052-01A-11	TCGA-AP-A052-01A	TCGA-AP-A052	bd4284a7-260d-48b3-9b48-a1c578c30d27	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	2211	500.0	False	true	830EF496-4672-4E9A-B662-DCB4678E99B0	1.76	2b64fee1-6e95-417d-b9b7-25bad9db4dc3	0.15	23	released	367368c4-c762-4d02-a7ee-b25d1fdd7dd5	RNA	R	0.15	UV Spec	released	False	6acc7044-e1f7-4d28-a785-70cb588e0112	11	3.0	1.0	2.0	0.0	0.0	15.0	83.0	85.0	TOP	8355f3c9-6aff-4f3b-8ac5-ab0684156bbe	released	1.0	1.0	5.0	0.0	0.0	20.0	75.0	90.0	BOTTOM	e0d3e061-5fac-4c79-9cc7-d456b1f5933b	released									released	30.0	33c21dca-f3b3-48cd-9fc5-ad316598f23e	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A052_demographic	59	-21721	669	85eec076-18a5-5b0e-a276-1c95815c60c8	not reported	female	black or african american	released	Dead	1945	2005	TCGA-AP-A052_exposure	Not Reported	46.280991735537185	b8538893-9082-5a20-95b5-5eed462ec69d	165.0	released	126.0	TCGA-AP-A052_diagnosis	21721	not reported	0		38131fdb-27ab-55c1-96eb-d8d1577b4764	Stage IVB	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2004	TCGA-AP-A052_treatment	TCGA-AP-A052_treatment_1	released	4c91f2d1-dbf7-58dd-95ca-6db6c735f694	no	Radiation Therapy, NOS	released	d49aff5a-3cdb-588e-b460-5857cb142ecf	yes	Pharmaceutical Therapy, NOS	3a323dbd-2e34-423c-bf1a-9be915e56cbe
bc25991e-4835-42e6-b898-87df2434d7c5.htseq.counts.gz	449f255a-1a79-4cf3-b606-f13fa6572222	TCGA-AJ-A3BH-01A-11R-A19W-07	TCGA-AJ-A3BH-01A-11R	TCGA-AJ-A3BH-01A-01-TSA			TCGA-AJ-A3BH-01A-11	TCGA-AJ-A3BH-01A	TCGA-AJ-A3BH	a7d07151-5fc8-4c2a-a1cd-e7c7a2a9a7a7	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC		100.0	False	false	469A2D52-09E6-4B67-B8D0-D6292AC22285	1.34	9f7b98f9-86c1-4c0c-8727-b8ecfb7b5e4e	0.18	23	released	b994deb3-938c-493d-8f80-f8fc6cc6f558	RNA	R	0.18	UV Spec	released	False	069f69f8-f9b9-4861-a7a7-4968e748205e	11	2.0	1.0	2.0	0.0	6.0	2.0	90.0	90.0	TOP	13a3c30d-32ac-4982-859a-4100a29dbbe2	released																				released	30.0	5f692f2b-3736-4b1f-8ffe-a0ee085975df	Primary Tumor	01	released	Not Reported	released	TCGA-AJ-A3BH_demographic				1974fb64-2bf1-5ae4-a1d3-549373310899	not hispanic or latino	female	white	released	Alive			TCGA-AJ-A3BH_exposure	Not Reported	28.804413972169254	3f9f336f-1876-5ebf-b865-9bdfaefb2be4	157.0	released	71.0	TCGA-AJ-A3BH_diagnosis		not reported			42feafc4-47c7-5f07-938b-cab59277e396	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-AJ-A3BH_treatment	TCGA-AJ-A3BH_treatment_1	released	712d6c72-03e3-563c-a608-66fac6735f30	not reported	Radiation Therapy, NOS	released	3f0aeb62-af22-5068-8b8c-ecaa102689eb	not reported	Pharmaceutical Therapy, NOS	449f255a-1a79-4cf3-b606-f13fa6572222
4734e515-f478-481c-b3e6-81f755331a47.htseq.counts.gz	65015c27-5357-4831-a8c5-0296d3abb570	TCGA-B5-A11G-01A-13R-A118-07	TCGA-B5-A11G-01A-13R	TCGA-B5-A11G-01A-01-BSA	TCGA-B5-A11G-01A-01-TSA		TCGA-B5-A11G-01A-13	TCGA-B5-A11G-01A	TCGA-B5-A11G	d2aa7d70-a25f-4a9e-9d52-37e372461824	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	3248	180.0	False	true	7021DC28-67C3-4BB6-9C8B-0FE7EFBCA1E1	1.88	b213f9e2-4253-41db-9a05-e91791f4ec7e	0.17	23	released	0ed4029a-d942-45f7-993e-d787200e483a	RNA	R	0.17	UV Spec	released	False	44a18c8c-f485-4ada-8702-b6a8966de960	13	4.0	4.0	0.0	0.0	0.0	5.0	95.0	95.0	BOTTOM	8ffb147a-8145-435d-83ff-d630fd0bbc15	released	4.0	4.0	1.0	0.0	0.0	4.0	95.0	95.0	TOP	a0533411-2cfa-4f6b-9971-b380beaea8c2	released									released	20.0	fe5d8e64-98b1-4ea7-adda-f28d12349a7e	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A11G_demographic	71	-25995		f42df73b-0462-5a66-b2da-39969fa1bcb0	not reported	female	black or african american	released	Alive	1930		TCGA-B5-A11G_exposure	Not Reported	30.078125	9f7acdeb-54fd-5ec8-ba42-72fc6f01bbda	160.0	released	77.0	TCGA-B5-A11G_diagnosis	25995	not reported	0	3448	69dd2f41-a209-50cc-88a1-5baa38da839e	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2001	TCGA-B5-A11G_treatment	TCGA-B5-A11G_treatment_1	released	3c9f4783-73f1-5b34-abbd-878387de2a34	no	Radiation Therapy, NOS	released	bb1fd701-a354-5145-9bc9-333f84801e7d	no	Pharmaceutical Therapy, NOS	65015c27-5357-4831-a8c5-0296d3abb570
555ab898-bcca-4b58-b7d3-a96bf1f6f851.htseq.counts.gz	3da6f39d-cd89-47eb-9356-5ba2df77120c	TCGA-B5-A1MV-01A-31R-A14D-07	TCGA-B5-A1MV-01A-31R	TCGA-B5-A1MV-01A-03-TSC			TCGA-B5-A1MV-01A-31	TCGA-B5-A1MV-01A	TCGA-B5-A1MV	0f36c3a2-0ba5-4c43-a3f0-78d125e5d0ac	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	226	470.0	False	true	E536759E-F47A-4EE9-B855-AFEC6BCF5EE0	1.79	ef62242e-872b-4bd3-ac3d-a6645f771020	0.15	23	released	2e2d3e01-5d0d-400c-893e-66af9ed5dd7c	RNA	R	0.15	UV Spec	released	False	3bd6644c-db72-4cc1-8af2-ff59bd4664e7	31	40.0	20.0	10.0	20.0	0.0	20.0	70.0	70.0	TOP	6cf0aa75-b7b7-4fb9-bb21-f7d50845fdb5	released																				released	30.0	efd221c1-8513-4129-99ba-43ab94d1a6b9	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A1MV_demographic	84	-30926		62e5753a-c900-5b22-b3ab-7d11afe47bdf	not reported	female	white	released	Alive	1926		TCGA-B5-A1MV_exposure	Not Reported	31.577562387614577	0e4fcdc3-82ce-5c03-8032-d6ee1b25dc39	151.0	released	72.0	TCGA-B5-A1MV_diagnosis	30926	not reported	0	1565	1dfe36df-e4de-5a59-83e4-d4b83ab864b4	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-B5-A1MV_treatment_1	TCGA-B5-A1MV_treatment	released	ec4d0045-02bd-5ea6-91c5-2736a0db696e	no	Pharmaceutical Therapy, NOS	released	81ad654f-04f2-5ca0-91c3-65fe8350599d	no	Radiation Therapy, NOS	3da6f39d-cd89-47eb-9356-5ba2df77120c
5837f785-a733-4641-a438-f3e5313fa6ef.htseq.counts.gz	884cb4ef-00d9-49f8-834d-973c576a27c2	TCGA-D1-A174-01A-11R-A12I-07	TCGA-D1-A174-01A-11R	TCGA-D1-A174-01A-01-TS1			TCGA-D1-A174-01A-11	TCGA-D1-A174-01A	TCGA-D1-A174	fc7315b0-9f48-4206-b197-2268c0518eb4	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	219	80.0	False	false	E45B2436-C0B2-44C3-B400-49C668114B01	1.3	67f6f0d9-6581-4946-a9c7-a6629da86888	0.16	23	released	1183f7c6-992d-4084-946e-adce7c52f9cc	RNA	R	0.16	UV Spec	released	False	6e55e6d9-902f-439b-b6f1-ca296c123fd3	11	40.0	10.0	0.0	20.0	30.0	30.0	40.0	60.0	TOP	7602727e-b46d-40fc-bd03-5ccf631041f8	released																				released	30.0	ad5a9cb6-b3f9-4651-b6d1-13c78010bd88	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A174_demographic	51	-18702		6cb2b392-7f9d-56ff-951f-50fa1961540e	not hispanic or latino	female	white	released	Alive	1959		TCGA-D1-A174_exposure	Not Reported	26.370238143535232	89d19aa0-c846-5449-9dbd-986f46df02bc	157.0	released	65.0	TCGA-D1-A174_diagnosis	18702	not reported	0	594	6d77a903-7e29-5b60-85e1-c20fcf1a0760	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-D1-A174_treatment	TCGA-D1-A174_treatment_1	released	1e006a92-c7dd-5a99-aa84-e7bee88b91f6	yes	Radiation Therapy, NOS	released	eefaed13-fc04-5511-bd0e-91822bdc9213	no	Pharmaceutical Therapy, NOS	884cb4ef-00d9-49f8-834d-973c576a27c2
5eb93550-2972-45ed-85a1-c37353f03544.htseq.counts.gz	29d88f67-a903-4118-9729-6eef834c3567	TCGA-D1-A2G5-01A-11R-A17B-07	TCGA-D1-A2G5-01A-11R	TCGA-D1-A2G5-01A-01-TS1			TCGA-D1-A2G5-01A-11	TCGA-D1-A2G5-01A	TCGA-D1-A2G5	016e515e-7f78-4997-9b97-3628464d9222	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1354	70.0	False	true	741AB1D9-493E-4659-BC2E-BF77A7E1CC14	1.83	c890843b-4712-4d9f-998d-8ddcb2c39c3c	0.16	23	released	db28909e-7365-435a-93bd-a3eed8ff59cd	RNA	R	0.16	UV Spec	released	False	6c40aed7-05c5-4356-bccd-09bcb3cd12e4	11	10.0	0.0	10.0	10.0	10.0	0.0	80.0	90.0	TOP	a8e51297-f320-497d-a450-a3e3460708e2	released																				released	30.0	7aafad6c-6329-41e5-ba2e-74ae104ddcb1	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A2G5_demographic	50	-18322		b2b94f43-6ae2-5741-a03e-9bd5b9d71433	not hispanic or latino	female	white	released	Alive	1957		TCGA-D1-A2G5_exposure	Not Reported	47.77974539744061	bd9b1ba4-d376-5ec7-b120-2c769eb4ba91	173.0	released	143.0	TCGA-D1-A2G5_diagnosis	18322	not reported	0	1455	c67e3e07-6dd1-5141-8c19-a1091989b5f2	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2007	TCGA-D1-A2G5_treatment	TCGA-D1-A2G5_treatment_1	released	1a5f6f8a-873c-56fe-968d-810328798059	yes	Radiation Therapy, NOS	released	5d60145f-6e8d-5f2e-8b98-842d5c1f511f	yes	Pharmaceutical Therapy, NOS	29d88f67-a903-4118-9729-6eef834c3567
20914368-5aac-4081-ba98-696ebb3cae15.htseq.counts.gz	701c7ecb-f908-483f-8760-520500144ff7	TCGA-FI-A2EX-01A-11R-A17B-07	TCGA-FI-A2EX-01A-11R	TCGA-FI-A2EX-01A-01-TSA			TCGA-FI-A2EX-01A-11	TCGA-FI-A2EX-01A	TCGA-FI-A2EX	3878f58e-76ba-4480-a784-88505bd464d0	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	2201	110.0	False	true	68355069-2D77-4C5C-9AA9-E93A0C3CFD94	1.77	06745c8c-5e2b-4131-93a5-9023c32665ac	0.15	23	released	30b80c51-db89-4ced-8ed7-5b3ccdbe206d	RNA	R	0.15	UV Spec	released	False	c59ee5a8-7481-4464-b7a2-21b171e39e6e	11	40.0	20.0	5.0	20.0	0.0	5.0	90.0	90.0	TOP	22a21910-624d-4a3c-acdb-ce30e6c97235	released																				released	30.0	0a2eaf88-6c98-409f-bf63-4d62c844193c	Primary Tumor	01	released	Not Reported	released	TCGA-FI-A2EX_demographic	58	-21489		62496790-a6d7-551d-98e3-2cccd01e73d2	not hispanic or latino	female	white	released	Alive	1947		TCGA-FI-A2EX_exposure	Not Reported	37.52740765727779	229570c0-3a7a-5b12-9c12-ae3fd9ce3587	154.0	released	89.0	TCGA-FI-A2EX_diagnosis	21489	not reported	0	284	a4feb6ed-8fc3-5bcb-bd28-bedc292581a5	Stage IIIA	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2005	TCGA-FI-A2EX_treatment	TCGA-FI-A2EX_treatment_1	released	f14ce906-d403-51e4-bf63-21aee21356b9	no	Radiation Therapy, NOS	released	6d67896e-62db-55d5-9b58-684b6cab980b	yes	Pharmaceutical Therapy, NOS	701c7ecb-f908-483f-8760-520500144ff7
580e6dcf-235d-4629-9d70-91bc86795b26.htseq.counts.gz	52e562d9-2368-41ab-8605-2d23369be500	TCGA-AP-A05A-01A-11R-A00V-07	TCGA-AP-A05A-01A-11R	TCGA-AP-A05A-01A-01-BSA	TCGA-AP-A05A-01A-01-TSA		TCGA-AP-A05A-01A-11	TCGA-AP-A05A-01A	TCGA-AP-A05A	c350b53b-3c27-4b9e-8b57-d7b6a1205a1f	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	1479	260.0	False	true	1DAE9968-7D20-45A9-B2BC-5F32F6EC7A08	1.75	02528092-3a7a-4ddf-8801-e47a48fdeafe	0.16	23	released	1ac07cb7-088c-4366-baf7-4c08657d2c97	RNA	R	0.16	UV Spec	released	False	5620503a-d61f-482b-859f-72adb0085101	11	2.0	0.0	3.0	0.0	10.0	5.0	82.0	90.0	BOTTOM	4f7e22ff-a721-45dd-bc3a-ebd416ad6349	released	0.0	0.0	2.0	0.0	0.0	5.0	93.0	96.0	TOP	4fbf18dc-8d25-4cd6-af8c-8447642d1d0c	released									released	30.0	482153fb-e69d-4748-9cf4-e281ec141518	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A05A_demographic	81	-29914	1944	e2c969a6-33f1-5950-af29-6b93725ec9c0	not reported	female	white	released	Dead	1925		TCGA-AP-A05A_exposure	Not Reported		13477ffa-4243-5520-a3df-b488c413436a		released		TCGA-AP-A05A_diagnosis	29914	not reported	0	1199	96c1048b-6aae-5406-9ec5-44b1e2b5807b	Stage II	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2006	TCGA-AP-A05A_treatment	TCGA-AP-A05A_treatment_1	released	2ef259b3-b982-5425-9c29-aed7393b1800	yes	Radiation Therapy, NOS	released	4933367b-9c09-5a61-a131-ca2177460440	yes	Pharmaceutical Therapy, NOS	52e562d9-2368-41ab-8605-2d23369be500
62bab023-adee-4ab7-a99a-196d6e0365e4.htseq.counts.gz	4dde3662-e32e-472d-9471-c87c1163816f	TCGA-EY-A1GE-01A-11R-A13S-07	TCGA-EY-A1GE-01A-11R	TCGA-EY-A1GE-01A-01-TSA			TCGA-EY-A1GE-01A-11	TCGA-EY-A1GE-01A	TCGA-EY-A1GE	a28beb70-d309-45b8-a2ba-40558f3c8f4f	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	506	410.0	False	false	432813D0-4B52-4941-940C-5725BCE4211A	1.83	d2a5585a-76fe-4e69-bf8a-36553bf282fb	0.15	23	released	0aa8a6be-52f8-46d9-b241-ac8c1037c541	RNA	R	0.15	UV Spec	released	False	c989af12-0f87-4ee7-bbfa-05c465ed48e2	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	65.0	TOP	dccc2cec-5058-49ab-ab08-1f05534b3682	released																				released	30.0	8673d69f-530e-4c33-ba96-25cd44adea7b	Primary Tumor	01	released	Not Reported	released	TCGA-EY-A1GE_demographic	67	-24667		06154713-6fc5-589b-8799-e904a7d3ebd6	not hispanic or latino	female	white	released	Alive	1942		TCGA-EY-A1GE_exposure	Not Reported	37.83287419651056	f7e83fbd-79bb-568a-a87e-a013b168994d	165.0	released	103.0	TCGA-EY-A1GE_diagnosis	24667	not reported	0	741	d67270f5-331a-59d8-bb5d-52d08dd818b2	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-EY-A1GE_treatment_1	TCGA-EY-A1GE_treatment	released	16fba6c0-2e12-599b-b807-b811c2666eda	no	Pharmaceutical Therapy, NOS	released	db85fdb2-ef42-5d45-9d98-f3bb3ffccbb5	no	Radiation Therapy, NOS	4dde3662-e32e-472d-9471-c87c1163816f
bd6e216f-1420-4869-b3e4-d6166e838c74.htseq.counts.gz	c0e7c7f5-f232-413b-87d8-88cc938d8817	TCGA-A5-A7WJ-01A-12R-A34R-07	TCGA-A5-A7WJ-01A-12R	TCGA-A5-A7WJ-01A-01-TSA			TCGA-A5-A7WJ-01A-12	TCGA-A5-A7WJ-01A	TCGA-A5-A7WJ	a3e728ce-0874-4f4b-a83d-8c679f4bd938	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	439	140.0	False	true	402A6ED4-B9EC-43A0-B47C-A0B95282678D	1.82	382f8e3e-6414-4bfd-81de-fa4260be7ede	0.18	23	released	86e90f23-0549-4bd2-8061-2e01fa5c7941	RNA	R	0.18	UV Spec	released	False	3ae83a34-ee45-47d9-bf8c-cdbe2e9db75f	12	40.0	20.0	10.0	20.0	0.0	20.0	70.0	70.0	TOP	bc04c484-4974-4f86-b084-260a5ed2cffd	released																				released	10.0	6595c691-70d1-4b5f-a8c3-ed0167e07249	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A7WJ_demographic	64	-23723		9251d9f1-be21-5e38-9822-eede8d5cc51c	not hispanic or latino	female	black or african american	released	Alive	1948		TCGA-A5-A7WJ_exposure	Not Reported	22.14532871972318	edefd70e-3f10-5f74-b0d4-a2627bae7b7a	170.0	released	64.0	TCGA-A5-A7WJ_diagnosis	23723	not reported	0	341	b66be01d-91aa-5e6d-91a2-76c1c5729a52	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2012	TCGA-A5-A7WJ_treatment_1	TCGA-A5-A7WJ_treatment	released	97dc1fa8-2101-5c6a-a8c4-06bf0f9d1dc3	no	Pharmaceutical Therapy, NOS	released	cca169e6-85f5-5896-a2b2-1a7fa4f8b2ae	no	Radiation Therapy, NOS	c0e7c7f5-f232-413b-87d8-88cc938d8817
471c6daf-5ccd-4278-8a7b-ea5acd56731d.htseq.counts.gz	83703c6a-e946-4652-88e0-d9b2f247f05b	TCGA-A5-A1OH-01A-21R-A22K-07	TCGA-A5-A1OH-01A-21R	TCGA-A5-A1OH-01A-02-MSB			TCGA-A5-A1OH-01A-21	TCGA-A5-A1OH-01A	TCGA-A5-A1OH	9bce44a2-dcee-4d1a-a522-c2bcb9a8e025	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	358	200.0	False	true	AAF1B591-1A0D-48D2-BF59-95B0D605950A	1.86	303036f4-8c7a-484d-8458-8db4803ad6b5	0.16	23	released	8b489c1e-4f51-4915-bae3-0c21171ad69c	RNA	R	0.16	UV Spec	released	False	541448d3-09b6-415b-b37a-c5ce1d52aa89	21	1.0	1.0	10.0	0.0	0.0	0.0	90.0	95.0	TOP	04cdda6d-14a0-4d93-91f0-0f22fad9d006	released																				released	30.0	8bf78dab-9910-48eb-ab6a-fc92502a71a3	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A1OH_demographic	86	-31451		fa79ab3e-3e6a-53f8-8f85-fe4c34052427	not reported	female	white	released	Alive	1924		TCGA-A5-A1OH_exposure	Not Reported	24.55775234131113	0e1b9cf2-08f2-5a07-ae12-4286ce860f30	155.0	released	59.0	TCGA-A5-A1OH_diagnosis	31451	not reported	0	1105	bf3d0dd5-2dd5-5d34-b02c-d776a26745ec	Stage IIIA	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-A5-A1OH_treatment	TCGA-A5-A1OH_treatment_1	released	3c9754da-2a89-52e4-bf33-cd1610f9c400	yes	Radiation Therapy, NOS	released	23c8064e-dcf6-541d-aee1-838c0c225565	yes	Pharmaceutical Therapy, NOS	83703c6a-e946-4652-88e0-d9b2f247f05b
417295dd-1247-40f0-9988-36fe8814dd70.htseq.counts.gz	697ca638-9383-4133-9348-5e1d4b10fc37	TCGA-B5-A0JU-01B-11R-A14D-07	TCGA-B5-A0JU-01B-11R	TCGA-B5-A0JU-01B-01-TS1			TCGA-B5-A0JU-01B-11	TCGA-B5-A0JU-01B	TCGA-B5-A0JU	65ef7168-69c6-4910-a141-d7558d0027c9	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1345	300.0	False	true	1EB80878-50FF-4E79-AF16-E809E6EE7DEC	1.8	26ef4a16-ddf1-4585-949b-14057cc8a5bf	0.16	23	released	ec132fe9-3aa9-4efc-915c-49367b808fec	RNA	R	0.16	UV Spec	released	False	3d113161-9475-4010-a378-41165550acfb	11	3.0	0.0	0.0	0.0	0.0	10.0	90.0	90.0	TOP	2dec1f0c-b7e9-42cb-b79e-61dd91df97fe	released																				released	30.0	a4e7601a-9828-453a-8616-17f19de6f997	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A0JU_demographic	57	-21159		152431b8-e214-5341-b373-68135dc22afb	not reported	female	black or african american	released	Alive	1950		TCGA-B5-A0JU_exposure	Not Reported	54.8790257971479	dccacf7b-9f88-5460-bf11-62b44e59ffb6	158.0	released	137.0	TCGA-B5-A0JU_diagnosis	21159	not reported	0	1802	49971867-9281-589f-86d7-068279f8956c	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2007	TCGA-B5-A0JU_treatment_1	TCGA-B5-A0JU_treatment	released	be3d891f-2bb1-5be4-9495-44d08e769dce	no	Pharmaceutical Therapy, NOS	released	fd84a4f0-a0dc-5c60-bcf0-e634d7bad2b4	no	Radiation Therapy, NOS	697ca638-9383-4133-9348-5e1d4b10fc37
95bb05e3-2995-4cef-be79-060b0cc841ac.htseq.counts.gz	f9fd413c-19a8-4555-bd42-a4fadf47c702	TCGA-AX-A3FX-01A-11R-A22K-07	TCGA-AX-A3FX-01A-11R	TCGA-AX-A3FX-01A-01-TS1			TCGA-AX-A3FX-01A-11	TCGA-AX-A3FX-01A	TCGA-AX-A3FX	6f45a2e9-1ca5-438c-b06f-1cd8eb845465	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	736	100.0	False	false	B3326BA1-71E3-4207-9727-B157A3E195E7	1.87	73d3142f-9060-488c-9108-3b1abd12f323	0.17	23	released	8b55d7d6-b206-40c4-a7ca-1775e06f7477	RNA	R	0.17	UV Spec	released	False	d49772ce-4577-43c4-977a-339b1b1c53e5	11	1.0	1.0	2.0	0.0	5.0	1.0	92.0	96.0	TOP	e1d48480-d8f9-461f-8243-68a123363bfc	released																				released	30.0	375bec4c-5e9b-4bc0-9f28-5854a159d655	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A3FX_demographic	69	-25260	1333	42ecb87e-7e52-5296-aa28-bafa3f80d30a	not hispanic or latino	female	white	released	Dead	1940		TCGA-AX-A3FX_exposure	Not Reported	38.28656366830323	83655193-bc62-51f5-b94d-cb045bb883e4	149.0	released	85.0	TCGA-AX-A3FX_diagnosis	25260	not reported	0	4	a1c3f997-b0ef-589d-8be2-28d44d1e2a26	Stage IIB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-AX-A3FX_treatment_1	TCGA-AX-A3FX_treatment	released	4706a7d9-c0c1-545b-bac1-932a4851a26c	yes	Pharmaceutical Therapy, NOS	released	c14178c7-2c26-5cc4-8279-a98e9aa27017	no	Radiation Therapy, NOS	f9fd413c-19a8-4555-bd42-a4fadf47c702
1a766cb4-eb5e-44a1-ac95-2f3f87992cd0.htseq.counts.gz	09495756-ee52-4154-81e0-933705d1b959	TCGA-D1-A163-01A-11R-A12I-07	TCGA-D1-A163-01A-11R	TCGA-D1-A163-01A-01-TSA			TCGA-D1-A163-01A-11	TCGA-D1-A163-01A	TCGA-D1-A163	a438dce7-6592-4ea6-a401-57f5a8fe8ba6	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	854	170.0	False	false	993B9CE9-7D25-4B2B-B246-F642550C70CD	1.89	b9d45e58-d758-4aa0-a282-1366dc00f833	0.16	23	released	ecc53abc-b0a2-4e44-b95d-57c9b97cf7c4	RNA	R	0.16	UV Spec	released	False	39121036-acf8-487f-8989-9f7f5082efc6	11	0.0	0.0	0.0	0.0	10.0	0.0	90.0	60.0	TOP	bd20600a-f798-4fa0-bb32-f78be6a5f29c	released																				released	30.0	8e3afec6-eb01-404f-ae76-08590b3c0ad0	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A163_demographic	50	-18604		3706c952-17d0-5829-9624-26ed35ce61c6	not hispanic or latino	female	white	released	Alive	1958		TCGA-D1-A163_exposure	Not Reported	38.16392983438955	8736d299-95aa-5149-92c9-31aa172bf96c	169.0	released	109.0	TCGA-D1-A163_diagnosis	18604	not reported	0	991	76162bb9-f138-5dde-9b50-b697cd6328cb	Stage IIIC	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-D1-A163_treatment_1	TCGA-D1-A163_treatment	released	0d7b81ff-e322-5712-a0e6-fd86edb4d0c6	yes	Pharmaceutical Therapy, NOS	released	7281bfd0-c3df-5071-9c27-4df40e1b39cc	yes	Radiation Therapy, NOS	09495756-ee52-4154-81e0-933705d1b959
0dd129d5-46d3-4229-b16e-c6a1e92b42e4.htseq.counts.gz	18a80d27-6068-44e8-bf8d-e07fd8c871d6	TCGA-B5-A3FA-01A-11R-A19W-07	TCGA-B5-A3FA-01A-11R	TCGA-B5-A3FA-01A-01-TSA			TCGA-B5-A3FA-01A-11	TCGA-B5-A3FA-01A	TCGA-B5-A3FA	ac9ec63a-c3b6-4d0c-b1a9-7c72dbad456c	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	2679	510.0	False	true	1CA1DEC3-AD70-40F7-859B-24A27F47C904	1.82	ae424bbe-6970-4afc-aa3b-7ae842f9a9d9	0.16	23	released	038b647b-2287-4f46-bc49-05f90f06277a	RNA	R	0.16	UV Spec	released	False	f1640f9c-4947-4efc-8eed-b1b1778759f7	11	1.0	2.0	0.0	0.0	30.0	0.0	70.0	75.0	TOP	4047ce05-c5cd-4141-9d7f-5770e2d70270	released																				released	30.0	6ba7181f-0fd1-4158-ad8d-2ce4513ab53f	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A3FA_demographic	73	-26850		03dbbfce-a850-50b1-a52b-10a4bda28aaa	not reported	female	white	released	Alive	1931		TCGA-B5-A3FA_exposure	Not Reported	29.642685467072585	4852fa36-e90a-559f-939e-89648ab2ef78	158.0	released	74.0	TCGA-B5-A3FA_diagnosis	26850	not reported	0	2929	c99b7ccb-7e94-5dc8-9192-5d3d7a6f8708	Stage IC	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2004	TCGA-B5-A3FA_treatment	TCGA-B5-A3FA_treatment_1	released	8352456b-9961-58af-a2df-092254af1008	no	Radiation Therapy, NOS	released	2176d6d4-66de-550d-8825-c9875f6900de	no	Pharmaceutical Therapy, NOS	18a80d27-6068-44e8-bf8d-e07fd8c871d6
737ad078-c85c-4359-b548-283146bc3046.htseq.counts.gz	f3c7d513-62bc-4710-a675-3f8cd3c9349c	TCGA-AP-A1DV-01A-21R-A137-07	TCGA-AP-A1DV-01A-21R	TCGA-AP-A1DV-01A-02-TSB			TCGA-AP-A1DV-01A-21	TCGA-AP-A1DV-01A	TCGA-AP-A1DV	1b685c46-57b3-4052-b5b9-1f704809bf04	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	876	170.0	False	true	F3163501-DD37-4C13-A921-3C2A74928BA7	1.83	ca0261c0-0935-450b-9e9c-db02f92ecb0e	0.16	23	released	db24b079-abdd-4ede-95cd-025eecc06fd6	RNA	R	0.16	UV Spec	released	False	f43d132c-e33b-44c2-9b51-cd7285287fc0	21	2.0	4.0	5.0	2.0	0.0	10.0	85.0	90.0	TOP	a24d2925-7d50-4c42-8b11-7ead4d8d2454	released																				released	30.0	a03f9020-3ded-4c1c-bf7e-1fa3a47e76de	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A1DV_demographic	59	-21901		48e7f835-6a07-549a-8f3e-d1ccdfb2ae3a	not hispanic or latino	female	white	released	Alive	1949		TCGA-AP-A1DV_exposure	Not Reported	21.287426535239945	d5da959d-fe14-5422-8d4a-5bcd9304353c	147.0	released	46.0	TCGA-AP-A1DV_diagnosis	21901	not reported	0	204	516469f0-fecc-5018-8591-11518519030a	Stage II	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-AP-A1DV_treatment_1	TCGA-AP-A1DV_treatment	released	7d1868d8-9161-584e-a6ee-c5086a9c2402	no	Pharmaceutical Therapy, NOS	released	5006618c-9c08-561a-b3b6-e5ae6d803668	yes	Radiation Therapy, NOS	f3c7d513-62bc-4710-a675-3f8cd3c9349c
666424f9-3547-452d-8dc5-1b126a70a619.htseq.counts.gz	97a25658-9062-4d07-87e8-b75d64cfc899	TCGA-BG-A0MT-01A-11R-A104-07	TCGA-BG-A0MT-01A-11R	TCGA-BG-A0MT-01A-01-TSA	TCGA-BG-A0MT-01A-01-BSA		TCGA-BG-A0MT-01A-11	TCGA-BG-A0MT-01A	TCGA-BG-A0MT	082e32c5-7f82-466a-b52d-a3293a8f8e57	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	344	820.0	False	true	89610F48-AC0D-431D-8A9E-FC9E51CF8FC0	1.91	578f3ec4-17e0-4cf9-bfa8-56624d174374	0.14	23	released	90d8cc09-2030-4722-a297-86c0b21a9374	RNA	R	0.14	UV Spec	released	False	e425c3fc-14c3-411b-8c37-c88c81e18af9	11	6.0	3.0	1.0	0.0	0.0	3.0	96.0	85.0	TOP	8c5de964-11ad-45c0-8934-e0ea8709cc6e	released	7.0	5.0	1.0	1.0	0.0	9.0	90.0	85.0	BOTTOM	70501f20-6431-488c-a5c3-b8c6204c3815	released									released	30.0	91f629f5-6938-4f5c-ba2e-1f519ce6b255	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A0MT_demographic	64	-23574		4d444b66-2a61-5097-8234-82701fa74420	not hispanic or latino	female	white	released	Alive	1945		TCGA-BG-A0MT_exposure	Not Reported	25.864512471655328	1734a103-cfca-587e-9438-f68d00dbb2ee	168.0	released	73.0	TCGA-BG-A0MT_diagnosis	23574	not reported	0	644	c00a7e30-e559-5fe1-afb0-4c86b798c6f3	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-BG-A0MT_treatment_1	TCGA-BG-A0MT_treatment	released	9c471085-ad96-53a4-92c6-bd2b29b44bfb	no	Pharmaceutical Therapy, NOS	released	01012744-f996-5de6-92e4-8b7a2748ae4e	yes	Radiation Therapy, NOS	97a25658-9062-4d07-87e8-b75d64cfc899
33721d7a-398c-42f8-8d8a-d18ae4aa0fdc.htseq.counts.gz	d69172af-d05b-4883-a41b-cd8dfcdede05	TCGA-FL-A1YT-11A-12R-A32Y-07	TCGA-FL-A1YT-11A-12R	TCGA-FL-A1YT-11A-01-TSA			TCGA-FL-A1YT-11A-12	TCGA-FL-A1YT-11A	TCGA-FL-A1YT	1e5053ae-9a78-41ed-81cd-1a43756fca09	Not Reported	Uterus, NOS	TCGA-UCEC		70.0	False	false	4E2E650A-F057-4B4E-84FD-2ECFC6D13C4D	1.86	2532b16b-1217-43df-aa69-cdbb5f9c3778	0.12	23	released	63cd901b-709b-4d17-9ed9-bbfb3d4796d4	RNA	R	0.12	UV Spec	released	False	73f47bf4-fe72-45df-a3f1-7f0606087892	12					100.0		0.0		TOP	35602b14-252e-4483-b163-64ca8793da18	released																				released	10.0	b67349d0-bc63-43e0-9b52-13095e184b94	Solid Tissue Normal	11	released	Not Reported	released																																																			d69172af-d05b-4883-a41b-cd8dfcdede05
4a0acc32-acf8-4720-b6c1-59fb6cdda3de.htseq.counts.gz	643a13b8-abd9-46ff-96c6-59a6fb74166f	TCGA-E6-A2P8-01A-11R-A19W-07	TCGA-E6-A2P8-01A-11R	TCGA-E6-A2P8-01A-01-TSA			TCGA-E6-A2P8-01A-11	TCGA-E6-A2P8-01A	TCGA-E6-A2P8	d213da3a-ff1c-4fbd-8d4e-7f9e6a2318d0	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	254	100.0	False	true	B67CD692-73B4-4A61-A65B-65964AA3ACF4	1.86	db3429ba-32b0-40ef-bc81-ad0a8b097610	0.16	23	released	58f151ce-20b0-4b1d-a86b-e7b7cf934c93	RNA	R	0.16	UV Spec	released	False	4876b99c-9727-4afa-a8ca-91af844500ef	11	1.0	0.0	0.0	0.0	0.0	10.0	90.0	85.0	TOP	754e84db-2c31-438f-87ee-751524443e21	released																				released	30.0	04dea046-32c8-4bd8-a5b2-944957072bdc	Primary Tumor	01	released	Not Reported	released	TCGA-E6-A2P8_demographic	53	-19448	72	a51a6a0a-d4c4-54ec-97a9-ce55baea0d0f	not hispanic or latino	female	black or african american	released	Dead	1957	2010	TCGA-E6-A2P8_exposure	Not Reported	31.22945430637738	a53cd3d2-3db2-58a3-9c64-14b93b8ac606	156.0	released	76.0	TCGA-E6-A2P8_diagnosis	19448	not reported	0		ac55b2e9-7e56-5d7f-acd8-d576ae60066c	Stage IV	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-E6-A2P8_treatment	TCGA-E6-A2P8_treatment_1	released	1ace1606-ee88-5554-8696-63819b2606aa	no	Radiation Therapy, NOS	released	7fc67d33-4b33-5615-a5de-93374f71a600	no	Pharmaceutical Therapy, NOS	643a13b8-abd9-46ff-96c6-59a6fb74166f
404d4937-4038-41eb-a4cc-47820d4a2d3f.htseq.counts.gz	552d5a73-c12a-4ba0-910e-258b4f527de3	TCGA-AJ-A3OK-01A-12R-A22K-07	TCGA-AJ-A3OK-01A-12R	TCGA-AJ-A3OK-01A-01-TSA			TCGA-AJ-A3OK-01A-12	TCGA-AJ-A3OK-01A	TCGA-AJ-A3OK	12df24c6-1229-4777-ad90-7dd66259b65f	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	162	80.0	False	false	54D4BBBE-D458-44B2-8F7C-0185DD16D961	1.83	33dc8709-5c3e-4944-8e41-2bc36b26fced	0.15	23	released	557bc021-6d3e-440f-8b0a-99237317d000	RNA	R	0.15	UV Spec	released	False	6ce8f692-8ed6-474e-8465-e5b455cfd4b3	12	3.0	0.0	3.0	1.0	5.0	0.0	92.0	85.0	TOP	9af2da7a-d0ae-4925-96d6-05819d0c3093	released																				released	10.0	d349d257-56da-4693-815e-9b90aee59b23	Primary Tumor	01	released	Not Reported	released	TCGA-AJ-A3OK_demographic	73	-26851		44ebf565-e6c0-59c5-a3d6-7e355683c90a	not reported	female	white	released	Alive	1938		TCGA-AJ-A3OK_exposure	Not Reported	29.296875	7ed8aaa5-9712-5f2a-8c31-492883af953b	160.0	released	75.0	TCGA-AJ-A3OK_diagnosis	26851	not reported	0	485	07254dcb-569e-5834-90ca-0fa36cd3db19	Stage IA	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-AJ-A3OK_treatment_1	TCGA-AJ-A3OK_treatment	released	0503fdd8-eefc-51f8-a34c-e7a2c88d9b85	yes	Pharmaceutical Therapy, NOS	released	d6d44d5d-f1f6-5a2e-bc44-823d5dfe6d98	yes	Radiation Therapy, NOS	552d5a73-c12a-4ba0-910e-258b4f527de3
8301fe5c-c7c9-4def-ac1c-edeee5b8a424.htseq.counts.gz	5503f013-2bf9-404a-b40c-4d3763918d8b	TCGA-E6-A1M0-11A-11R-A144-07	TCGA-E6-A1M0-11A-11R	TCGA-E6-A1M0-11A-01-TSA			TCGA-E6-A1M0-11A-11	TCGA-E6-A1M0-11A	TCGA-E6-A1M0	e3dcde4e-5def-4b89-97b4-047b8288919b	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	360	130.0	False	false		1.74	a0c84298-852b-454f-aab8-fb64656834dc	0.16	23	released	de046d5a-3fa2-4ae8-821d-f61b0d0f5858	RNA	R	0.16	UV Spec	released	False	c6832cfa-f38b-4688-9136-6b7325ad8302	11	0.0	0.0	0.0	0.0	100.0	0.0	0.0	0.0	TOP	6e6920df-cb08-474a-a1d4-cceeb22352e4	released																				released	30.0	abcd9bfe-3511-46e3-97fe-cb0c068fb491	Solid Tissue Normal	11	released	Not Reported	released	TCGA-E6-A1M0_demographic	56	-20629		11bbbb3d-ec5c-5cb7-885c-50576834f378	not hispanic or latino	female	white	released	Alive	1954		TCGA-E6-A1M0_exposure	Not Reported	37.65358699960365	9627ae8c-07b0-5e1a-bd74-10bd95ef3272	174.0	released	114.0	TCGA-E6-A1M0_diagnosis	20629	not reported	0	1793	2613f1af-c343-5333-bf51-3cc30b0e4996	Stage IIIC	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-E6-A1M0_treatment_1	TCGA-E6-A1M0_treatment	released	68bd4957-9fcd-52d8-9b4f-aac0187085ec	yes	Pharmaceutical Therapy, NOS	released	1669c85b-f008-5ec1-aa37-a5811767f345	no	Radiation Therapy, NOS	5503f013-2bf9-404a-b40c-4d3763918d8b
f124f06e-7d63-4b9a-88db-ca21b4be4cf9.htseq.counts.gz	1734d586-026e-477a-99e3-ceb2e139e233	TCGA-FI-A2EW-01A-11R-A17B-07	TCGA-FI-A2EW-01A-11R	TCGA-FI-A2EW-01A-01-TSA			TCGA-FI-A2EW-01A-11	TCGA-FI-A2EW-01A	TCGA-FI-A2EW	93d6df4a-aea2-48c2-8b6a-4b3eca0bf26f	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	2321	120.0	False	true	3DED6690-5A21-4EDC-B9D4-5E1F2F5A9CC1	1.79	e3abb7cf-945d-496f-8bf0-828ddfef6538	0.15	23	released	6a20e426-b5fa-4c88-8220-8fcf569b2b1d	RNA	R	0.15	UV Spec	released	False	ac6bb6fd-d3bc-41fb-ae56-d4f1a841f7f6	11	40.0	20.0	5.0	20.0	0.0	10.0	85.0	85.0	TOP	3c90e1b7-c496-4c98-b729-0173657f4488	released																				released	30.0	c10f91bf-385f-4e50-a9ef-67cf43b279b1	Primary Tumor	01	released	Not Reported	released	TCGA-FI-A2EW_demographic	71	-26267		6576c375-63ee-5f39-8eba-d41859b9dc27	not reported	female	black or african american	released	Alive	1934		TCGA-FI-A2EW_exposure	Not Reported	32.421875	9ee99747-d0f7-5b74-a5f1-0c7dd2e0726e	160.0	released	83.0	TCGA-FI-A2EW_diagnosis	26267	not reported	0	1795	be321182-f652-5312-9819-ffd9509fa760	Stage IIB	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2005	TCGA-FI-A2EW_treatment	TCGA-FI-A2EW_treatment_1	released	3dc0ea35-e22f-5639-b0e4-5fb7fbc8e19d	no	Radiation Therapy, NOS	released	4f90e1a2-5ddf-55d2-bd23-376da548d0f4	yes	Pharmaceutical Therapy, NOS	1734d586-026e-477a-99e3-ceb2e139e233
ccfa60a7-6a2c-442a-a6ad-baac2705283a.htseq.counts.gz	5fa3d78d-5970-4c2b-8c04-aeac7178a542	TCGA-D1-A165-01A-11R-A12I-07	TCGA-D1-A165-01A-11R	TCGA-D1-A165-01A-01-TS1			TCGA-D1-A165-01A-11	TCGA-D1-A165-01A	TCGA-D1-A165	9bc2f33f-3067-4000-bc8a-1c5bb671d101	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	848	90.0	False	false	476F8219-DAAE-4DB3-BA31-C64AC24ACF65	1.83	6d1d9284-004e-4ed7-91dd-71f4fa919632	0.16	23	released	569484fe-f7d0-47a9-babe-821255c84e9a	RNA	R	0.16	UV Spec	released	False	2ac57c15-170f-4001-8e25-24e2cd12d578	11	4.0	1.0	0.0	0.0	0.0	40.0	60.0	60.0	TOP	8d25db67-52cf-429e-9559-7753348377a0	released																				released	30.0	ba3d9cb2-0d1c-4f3b-b1b8-a6dd4ac9adef	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A165_demographic	64	-23526		23755925-6968-50a9-b660-040e517fa61c	not hispanic or latino	female	white	released	Alive	1944		TCGA-D1-A165_exposure	Not Reported	26.555965935105768	9f540e38-64dd-56bb-8055-6d0aa6644ec9	181.0	released	87.0	TCGA-D1-A165_diagnosis	23526	not reported	0	20	faceeab7-76af-541e-a04d-6cfdbfa8b23f	Stage IIIA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-D1-A165_treatment_1	TCGA-D1-A165_treatment	released	716f4483-5982-5ad9-bb4e-e84176946e67	no	Pharmaceutical Therapy, NOS	released	302c56de-3836-5d29-9e73-f4532f4af26d	no	Radiation Therapy, NOS	5fa3d78d-5970-4c2b-8c04-aeac7178a542
7f63d097-d3b0-484f-84ed-985718c4af7f.htseq.counts.gz	cc93aa54-981d-4dbb-938e-9dec49d488ae	TCGA-BG-A222-01A-11R-A157-07	TCGA-BG-A222-01A-11R	TCGA-BG-A222-01A-01-TSA			TCGA-BG-A222-01A-11	TCGA-BG-A222-01A	TCGA-BG-A222	397b2672-d014-4b57-88dd-17e66ff8be4d	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	50	630.0	False	true	32837D2C-0D2B-4A47-9E42-1A809CB4A25A	1.71	0e8881cf-4745-4fb5-9842-dface6532da3	0.16	23	released	acba69fd-53bb-48ed-ab56-5d32fa5a3a66	RNA	R	0.16	UV Spec	released	False	3e71a9de-b5fb-464b-b382-d544d8147691	11	40.0	20.0	10.0	20.0	0.0	10.0	80.0	80.0	TOP	846fe31d-2c0e-4bd6-a101-6fda03c00e2a	released																				released	30.0	002eb27d-18c4-49d0-a977-8d2717e7ee42	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A222_demographic	49	-18220		7fa24ac1-267b-525f-8deb-3a2b9b0e64a9	not hispanic or latino	female	white	released	Alive	1962		TCGA-BG-A222_exposure	Not Reported	47.3304887231525	f08c6cf3-534a-5ea6-9899-31c80648f197	167.0	released	132.0	TCGA-BG-A222_diagnosis	18220	not reported	0	291	0e900d10-ce62-519e-aa93-27cd4b5ab78c	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-BG-A222_treatment_1	TCGA-BG-A222_treatment	released	bd2eb633-c69a-5624-9d04-f24bb0e7ff1f	yes	Pharmaceutical Therapy, NOS	released	05449b6f-5ed0-5476-9414-33013a97f947	yes	Radiation Therapy, NOS	cc93aa54-981d-4dbb-938e-9dec49d488ae
a8187969-0610-479a-8d12-2c8e61c07a80.htseq.counts.gz	f01b8e67-352c-4a0b-8c5d-cafbe3938d5a	TCGA-PG-A914-01A-11R-A37O-07	TCGA-PG-A914-01A-11R	TCGA-PG-A914-01A-01-TS1			TCGA-PG-A914-01A-11	TCGA-PG-A914-01A	TCGA-PG-A914	ff6b5fc8-0572-4b58-b3a5-bcda41badbc8	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	263	260.0	False	true	B073614D-A6E3-4A83-96C4-1F189F8D16B4	1.85	6e5ab8c9-03de-4a9d-ac92-37f28170c0a0	0.17	23	released	d9a0b4ad-66f2-4efc-ae82-0cde360a969d	RNA	R	0.17	UV Spec	released	False	646da843-d54b-4f25-a29b-5ab873348d2d	11	0.0	0.0	0.0	0.0	0.0	20.0	80.0	90.0	TOP	93ebb8f5-491e-4f5b-b8a9-03cb4d9423a3	released																				released	30.0	6086978b-8f73-458e-9624-b99bcd6b50c8	Primary Tumor	01	released	Not Reported	released	TCGA-PG-A914_demographic	73	-26992		16d35689-c5a4-50b8-b9ee-af408c742373	not hispanic or latino	female	black or african american	released	Alive	1940		TCGA-PG-A914_exposure	Not Reported		cf65b541-26e3-53f5-9587-9d1437a5d81c		released		TCGA-PG-A914_diagnosis	26992	not reported	0	687	8e9682d1-d9d5-5299-8107-abc7b9e9c8b0	Stage IA	C54.1	not reported	8461/3	Serous surface papillary carcinoma	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2013	TCGA-PG-A914_treatment_1	TCGA-PG-A914_treatment	released	74c1d7b2-6f44-56eb-8103-82b72c794065	no	Pharmaceutical Therapy, NOS	released	f948624f-f941-5342-ba97-f1f3d18780c8	yes	Radiation Therapy, NOS	f01b8e67-352c-4a0b-8c5d-cafbe3938d5a
e311f76b-2b7f-487d-9dbf-a6d9552fdd88.htseq.counts.gz	8c15aa1c-79a0-4bbb-bc54-b43e144e7406	TCGA-AX-A1CE-01A-11R-A137-07	TCGA-AX-A1CE-01A-11R	TCGA-AX-A1CE-01A-01-TS1			TCGA-AX-A1CE-01A-11	TCGA-AX-A1CE-01A	TCGA-AX-A1CE	4db38349-28d2-4af5-a12f-3d861937b0e0	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	504	130.0	False	false	79482353-F9A0-4A36-97B3-F270241B2B50	1.85	2a9c8cdb-71bc-480d-b9d5-c6b8c0198daf	0.16	23	released	f0ec1790-690e-4b85-b9d8-176fb5874cc4	RNA	R	0.16	UV Spec	released	False	804ccaed-bec2-4ab7-aa0b-28b5112a033b	11	10.0	0.0	8.0	0.0	8.0	2.0	82.0	80.0	TOP	3daccc03-2c90-4e1e-94e1-a5d432baa1d7	released																				released	30.0	cb0ceff2-34e2-420e-8924-51bb5872c6c5	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A1CE_demographic	60	-21969		5bdd67ed-7c28-56a7-84b4-89f703283c5c	not hispanic or latino	female	white	released	Alive	1949		TCGA-AX-A1CE_exposure	Not Reported	22.65625	66c4a6fe-7b6e-5eb5-88df-cd2a39175fb1	160.0	released	58.0	TCGA-AX-A1CE_diagnosis	21969	not reported	0	1037	7460dd75-3445-5805-b2f8-d49dcdcca843	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-AX-A1CE_treatment	TCGA-AX-A1CE_treatment_1	released	25afc6f3-e19c-5de7-87c6-6cf7db53f79a	yes	Radiation Therapy, NOS	released	0772c2c5-f6e3-5f23-bc13-e77da523a86b	yes	Pharmaceutical Therapy, NOS	8c15aa1c-79a0-4bbb-bc54-b43e144e7406
61ed5ca1-343a-42aa-9d54-73ddd3f6b484.htseq.counts.gz	d05a35e0-8d21-479f-a0b9-798cb39c8232	TCGA-D1-A17F-01A-11R-A12I-07	TCGA-D1-A17F-01A-11R	TCGA-D1-A17F-01A-01-TSA			TCGA-D1-A17F-01A-11	TCGA-D1-A17F-01A	TCGA-D1-A17F	129a49d4-edb8-4a1d-aabb-51b9ad5a8dd1	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	269	200.0	False	false	62F464EA-9410-4511-8DE8-F0E62AB1E482	1.83	67a8a629-6001-48cb-99b1-588a69f49ecc	0.17	23	released	fd17a8e3-bbae-4a98-965c-8c38c9ec2878	RNA	R	0.17	UV Spec	released	False	4240aa7a-4d1b-4f3e-85b8-678ec68715cf	11	3.0	5.0	0.0	2.0	2.0	35.0	63.0	65.0	TOP	299baf41-4137-4574-b0d9-59b6e2e18be3	released																				released	30.0	9592e87f-f3e4-49e9-919c-6f679a4b9110	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A17F_demographic	68	-25116		484728d0-24db-5eb6-af3c-0702a2907055	not hispanic or latino	female	white	released	Alive	1942		TCGA-D1-A17F_exposure	Not Reported	31.645569620253166	61614981-5411-546c-873f-aab3edc2cd21	158.0	released	79.0	TCGA-D1-A17F_diagnosis	25116	not reported	0	39	56b0f462-b736-5a75-9c4d-a1fe4352c8fd	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-D1-A17F_treatment	TCGA-D1-A17F_treatment_1	released	b5f7e265-6cd5-5b61-9322-faa8e910a3c6	no	Radiation Therapy, NOS	released	a3383f8f-96db-5e40-b948-641695a97e08	no	Pharmaceutical Therapy, NOS	d05a35e0-8d21-479f-a0b9-798cb39c8232
b502ccb3-36fc-4e58-944d-56b217fe7ad8.htseq.counts.gz	5a80b5da-60c1-43df-bce9-798cb89063a5	TCGA-EO-A3AV-01A-12R-A19W-07	TCGA-EO-A3AV-01A-12R	TCGA-EO-A3AV-01A-01-TSA			TCGA-EO-A3AV-01A-12	TCGA-EO-A3AV-01A	TCGA-EO-A3AV	d383008a-a1bf-4689-b243-3c464c79b818	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	407	130.0	False	false	9FF6FADC-4F38-41A2-8B96-24CB1EB2010E	1.82	ec7693cf-c6ec-4fff-9d18-d1fd165a1a6f	0.16	23	released	25eb8a73-bf84-468d-a760-ba96391c5b05	RNA	R	0.16	UV Spec	released	False	c9e15897-713c-4989-b6d5-8a82af76317b	12	70.0	10.0	5.0	10.0	0.0	5.0	90.0	90.0	TOP	c65920a1-68cb-4b9d-8f39-7e20cdf5eadf	released																				released	20.0	c3beeb0b-07f7-44e6-ab4b-8015472b0dd1	Primary Tumor	01	released	Not Reported	released	TCGA-EO-A3AV_demographic	51	-18713		f558be12-2a1f-5506-b7a5-39ae58109415	not reported	female	not reported	released	Alive	1959		TCGA-EO-A3AV_exposure	Not Reported	18.025957378625222	bbf781ad-2708-57a1-a541-93eb65d01bd7	158.0	released	45.0	TCGA-EO-A3AV_diagnosis	18713	not reported	0	1069	b4428283-5286-527f-97ff-74c7988b7d01	Stage IIIC1	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-EO-A3AV_treatment_1	TCGA-EO-A3AV_treatment	released	5893966a-a0ec-5e21-ab19-d66f9fa5d99c	yes	Pharmaceutical Therapy, NOS	released	c6b3a35f-f5c9-5c8e-8e97-baca09dd2367	yes	Radiation Therapy, NOS	5a80b5da-60c1-43df-bce9-798cb89063a5
a10b47a9-d9c4-495a-95b8-606c2551fe58.htseq.counts.gz	1fe6780a-7b1e-44b0-839c-45bd94de0711	TCGA-D1-A17B-01A-22R-A12I-07	TCGA-D1-A17B-01A-22R	TCGA-D1-A17B-01A-02-TS2			TCGA-D1-A17B-01A-22	TCGA-D1-A17B-01A	TCGA-D1-A17B	e55dd65a-c75e-4a3c-bb24-8b3af4d65321	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	685	140.0	False	false	FBE330EA-52BC-4B16-A046-3858318348F5	1.88	7dc8574f-d39c-4a7d-be83-e326a577b5bb	0.17	23	released	147c6696-408c-4cde-bab9-7abc80544513	RNA	R	0.17	UV Spec	released	False	599db78f-1bd2-45e3-b48d-6d3ac69a8454	22	30.0	10.0	10.0	50.0	0.0	20.0	70.0	70.0	TOP	cbf11380-bdba-4a0c-b0f1-fe418b05cfba	released																				released	30.0	37c92c44-320d-4881-8cb3-357cc8bace5c	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A17B_demographic	69	-25504		ecf70e7a-8b2e-57a7-82e6-a3ba6cf2ac80	not hispanic or latino	female	white	released	Alive	1940		TCGA-D1-A17B_exposure	Not Reported	41.91434232586496	6c11b8fe-575c-5d76-b9c8-9ec8c1fd81c5	162.0	released	110.0	TCGA-D1-A17B_diagnosis	25504	not reported	0	213	adcf1940-b352-5c45-8993-318a66c3902e	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-D1-A17B_treatment_1	TCGA-D1-A17B_treatment	released	09790e88-02a7-52cf-8f3b-2fc5cb358fe1	no	Pharmaceutical Therapy, NOS	released	e5846de8-424b-5e80-ab3c-0a1e668c8f94	no	Radiation Therapy, NOS	1fe6780a-7b1e-44b0-839c-45bd94de0711
c04981bc-b64c-4a1f-a4ac-e7489932c834.htseq.counts.gz	3060d960-3d9a-45ab-864f-60d2d0509fe3	TCGA-E6-A8L9-01A-21R-A37O-07	TCGA-E6-A8L9-01A-21R	TCGA-E6-A8L9-01A-02-TSB			TCGA-E6-A8L9-01A-21	TCGA-E6-A8L9-01A	TCGA-E6-A8L9	eb642568-30d4-4805-a295-bda314ccaaaf	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	657	200.0	False	true	40CB57C1-7E8C-45B0-BEDD-DFE531C9201E	1.92	916cf47a-0100-4e01-a912-2e884777186f	0.17	23	released	8b57eed4-ec7a-4cd4-b037-803acfeee916	RNA	R	0.17	UV Spec	released	False	bf8de433-036b-41fa-bd8c-312cd8136c90	21	5.0	1.0	0.0	1.0	10.0	20.0	70.0	70.0	TOP	00af22b5-6c5a-4ead-af04-d7b43d6c333b	released																				released	30.0	04225ab6-5a39-4694-bab3-423f95d60421	Primary Tumor	01	released	Not Reported	released	TCGA-E6-A8L9_demographic	61	-22333		f0e29733-ab34-52ea-8d38-1c603eda8865	not hispanic or latino	female	black or african american	released	Alive	1951		TCGA-E6-A8L9_exposure	Not Reported	29.72107910379515	bae38ce8-a6dc-5552-a7a5-16ef70237e9f	162.0	released	78.0	TCGA-E6-A8L9_diagnosis	22333	not reported	0	1013	bee9e07c-de76-5588-8add-332436e717e2	Stage IB	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2012	TCGA-E6-A8L9_treatment_1	TCGA-E6-A8L9_treatment	released	18e1ace4-5060-5dbf-a7f8-2ad8c28ea672	yes	Pharmaceutical Therapy, NOS	released	cfdb0473-ab2f-5c6b-856f-3843aa400c27	yes	Radiation Therapy, NOS	3060d960-3d9a-45ab-864f-60d2d0509fe3
4225530c-5f18-4e9f-b3b5-33c3db05be4d.htseq.counts.gz	d6a6f36f-091a-4ef7-85c2-93af6e9db2bb	TCGA-4E-A92E-01A-11R-A37O-07	TCGA-4E-A92E-01A-11R	TCGA-4E-A92E-01A-01-TS1			TCGA-4E-A92E-01A-11	TCGA-4E-A92E-01A	TCGA-4E-A92E	b43de98d-4bb1-41a1-91f2-ce4e7ea4d0ca	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	90	140.0	False	false	BC43D6CA-235C-4217-BF72-F33B089C532B	1.84	87087b2e-a589-4a75-a005-2c61cb44b414	0.16	23	released	49ffad67-4577-498d-ba56-e19f16ce1038	RNA	R	0.16	UV Spec	released	False	4b3123cc-488f-46b3-97e6-30317ab76e87	11	40.0	20.0	5.0	20.0	0.0	15.0	80.0	80.0	TOP	54bd2abd-0a11-4c82-8d1e-dfe242bda516	released																				released	30.0	3043a6c9-3dce-4a5b-bbb1-9ad5a07f21e8	Primary Tumor	01	released	Not Reported	released	TCGA-4E-A92E_demographic	54	-19818		0599478f-7f76-560c-a1c0-93972e0d41da	not hispanic or latino	female	black or african american	released	Alive	1959		TCGA-4E-A92E_exposure	Not Reported	28.95900015241579	d5c4d745-ae0a-5a59-a4f3-74b051e6322a	162.0	released	76.0	TCGA-4E-A92E_diagnosis	19818	not reported	0	13	2db9e566-967e-5b4b-8b14-9ecb2d7ee2ab	Stage I	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2013	TCGA-4E-A92E_treatment	TCGA-4E-A92E_treatment_1	released	05b9fb1e-52f1-5acd-9b36-559e012d02de	no	Radiation Therapy, NOS	released	77994ccf-925b-5aff-b2dd-99cd52583d5d	no	Pharmaceutical Therapy, NOS	d6a6f36f-091a-4ef7-85c2-93af6e9db2bb
ff66393b-2c09-4471-8347-515269c0519c.htseq.counts.gz	683a9290-d1bb-45a9-956c-d0382e57d200	TCGA-AP-A1DK-01A-11R-A137-07	TCGA-AP-A1DK-01A-11R	TCGA-AP-A1DK-01A-01-TSA			TCGA-AP-A1DK-01A-11	TCGA-AP-A1DK-01A	TCGA-AP-A1DK	51de7e94-e2fa-420b-9aa2-3637d17fc6ea	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1541	70.0	False	true	9A3BB88B-F16F-4773-8912-CF519B847354	1.93	13096ff9-ae2d-4ccb-8127-8e4238cef4d3	0.18	23	released	862f823c-0cc8-4b4f-a143-8eabf01c6996	RNA	R	0.18	UV Spec	released	False	8b4cac80-ad26-467c-b021-daf2ac15e1f3	11	20.0	0.0	20.0	20.0	0.0	20.0	60.0	80.0	TOP	63ee7863-ddca-436d-9282-72b8b54de736	released																				released	30.0	1cb12a0f-0081-441f-a86e-71d76ef5b8d0	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A1DK_demographic	53	-19509		2f3cfe29-af4d-5dcd-84a6-304a3717051a	not reported	female	white	released	Alive	1953		TCGA-AP-A1DK_exposure	Not Reported	21.875	9aff286b-26c6-58b1-b52a-7058e7f2c1a1	160.0	released	56.0	TCGA-AP-A1DK_diagnosis	19509	not reported	0	2767	8d4d021a-930e-59f9-a84e-62cca254ea07	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2006	TCGA-AP-A1DK_treatment_1	TCGA-AP-A1DK_treatment	released	cade30f7-823d-5dc5-8b5c-9ac25fb692c4	no	Pharmaceutical Therapy, NOS	released	3f4425e9-8e50-5558-9a49-80680266ae7e	yes	Radiation Therapy, NOS	683a9290-d1bb-45a9-956c-d0382e57d200
20985140-36fe-4ff1-9f81-55d0579fa920.htseq.counts.gz	6f89c493-9c2b-4a61-8cf6-b765f457f87f	TCGA-AP-A05P-01A-11R-A16W-07	TCGA-AP-A05P-01A-11R	TCGA-AP-A05P-01A-01-BS1	TCGA-AP-A05P-01A-01-MS1		TCGA-AP-A05P-01A-11	TCGA-AP-A05P-01A	TCGA-AP-A05P	3cb83517-78a4-47b8-8b1e-57e765dbdd2e	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	203	170.0	False	true	5BA23C70-805A-4356-B739-AFBAFD29D7FC	1.75	167b2ac1-034d-4eac-982e-b96f65bedfb2	0.14	23	released	825e518b-8e14-45df-b2a6-3cc7c9d6f3a6	RNA	R	0.14	UV Spec	released	False	8ab8bf7d-6c02-4524-adfd-7a22fac01eb0	11	10.0	5.0	0.0	10.0	0.0	10.0	90.0	90.0	BOTTOM	0cd19382-d4d6-4cf8-861e-616d6a8b105d	released	5.0	5.0	5.0	10.0	0.0	10.0	85.0	85.0	TOP	630bd0d2-60e8-41e9-adfc-7adf9b41a2fc	released									released	20.0	f51f7b0e-3ea6-4232-9de4-a4dd63b23bb5	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A05P_demographic	54	-20017		34b18611-fa05-568a-8e4c-358e8525c1ef	not hispanic or latino	female	asian	released	Alive	1955		TCGA-AP-A05P_exposure	Not Reported	28.54828131630724	94c5b31d-18e4-517d-8676-96c5ce9b7e9e	161.0	released	74.0	TCGA-AP-A05P_diagnosis	20017	not reported	0	636	638ceddb-6bcf-511d-a998-b487df53824f	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-AP-A05P_treatment_1	TCGA-AP-A05P_treatment	released	99169b6f-d00c-509d-88e1-4b8f86a8ef39	no	Pharmaceutical Therapy, NOS	released	c8b1c095-7106-5184-b148-62f9893d35b1	no	Radiation Therapy, NOS	6f89c493-9c2b-4a61-8cf6-b765f457f87f
17e8f188-45e4-4ed2-8953-2d5f0760f244.htseq.counts.gz	9025df01-ed8c-4016-a501-b4161c9b6c2c	TCGA-EO-A3KW-01A-11R-A22K-07	TCGA-EO-A3KW-01A-11R	TCGA-EO-A3KW-01A-01-TS1			TCGA-EO-A3KW-01A-11	TCGA-EO-A3KW-01A	TCGA-EO-A3KW	5f764ac1-3de7-4cfd-a77a-d21baa418834	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	205	150.0	False	false	C1CFE3DE-628B-4C0F-881B-588C613498DA	1.8	eb279337-8251-4442-905c-8a4be743f057	0.17	23	released	5721f4d8-b8d1-4d96-948a-1376a4036ece	RNA	R	0.17	UV Spec	released	False	a017cef2-8567-4dd1-8851-bc10599ab8f3	11	1.0	0.0	0.0	0.0	20.0	0.0	80.0	90.0	TOP	8fcde58f-d538-46f2-9b5f-356c6a416c1e	released																				released	30.0	ac5073ea-51cf-466c-9b31-1d4fbb86f998	Primary Tumor	01	released	Not Reported	released	TCGA-EO-A3KW_demographic	72	-26492		2892198e-6c40-564b-b111-52a3797e9f8c	not reported	female	not reported	released	Alive	1939		TCGA-EO-A3KW_exposure	Not Reported	26.48553974966893	4aadd2f4-c495-5ea3-a408-873fce16aa07	153.0	released	62.0	TCGA-EO-A3KW_diagnosis	26492	not reported	0	497	4d741fd5-b1bb-59fe-a569-74158159de1e	Stage IA	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-EO-A3KW_treatment	TCGA-EO-A3KW_treatment_1	released	ef755f5e-2676-5747-b307-7eb36c72e6fb	yes	Radiation Therapy, NOS	released	e04827fb-269e-56a8-b2b0-3d199d03235d	yes	Pharmaceutical Therapy, NOS	9025df01-ed8c-4016-a501-b4161c9b6c2c
6cbf61b6-bf95-4997-b8e8-591a1db9d52d.htseq.counts.gz	0cd87e91-c8aa-4edb-9dc4-a631043442eb	TCGA-B5-A0K0-01A-11R-A16W-07	TCGA-B5-A0K0-01A-11R	TCGA-B5-A0K0-01A-01-BSA	TCGA-B5-A0K0-01A-01-TSA		TCGA-B5-A0K0-01A-11	TCGA-B5-A0K0-01A	TCGA-B5-A0K0	29c8f468-5ac1-4d6c-8376-e36e6d246926	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	615	440.0	False	true	6284E0A9-FACB-4297-ABC6-308715ABAFCD	1.93	2df1abb0-b25b-4486-a5ed-728964eb0a1b	0.14	23	released	ad89ea44-203c-4ce8-a648-3a0e58fa986b	RNA	R	0.14	UV Spec	released	False	5da0bd98-9e70-4ff5-8c9c-4b144baadd48	11	30.0	0.0	10.0	10.0	10.0	10.0	70.0	80.0	BOTTOM	269b2160-8e78-4c6c-af9a-e1b81724c74e	released									TOP	c773ec96-62bc-46ef-a329-6d2cdbf59b6c	released									released	30.0	11c43948-e7c9-4436-a654-82fa8033b625	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A0K0_demographic	48	-17810		c4dacc00-24ae-5643-ba9f-f81668f7fc01	not reported	female	white	released	Alive	1960		TCGA-B5-A0K0_exposure	Not Reported	49.6031746031746	d1d589bf-9b98-5d44-ba6e-7f6760f085ad	168.0	released	140.0	TCGA-B5-A0K0_diagnosis	17810	not reported	0	1478	0e1b6dbb-ed50-5171-9dc6-383802394d94	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-B5-A0K0_treatment	TCGA-B5-A0K0_treatment_1	released	a4192721-05db-5d1a-8ae2-248c038bb76b	no	Radiation Therapy, NOS	released	3e75bcaf-7d97-583a-abf0-2f7533965c5f	no	Pharmaceutical Therapy, NOS	0cd87e91-c8aa-4edb-9dc4-a631043442eb
1c76c6df-dcb3-41fb-9972-ddfdc3121f63.htseq.counts.gz	39c9c3a8-6c5c-4398-a656-535b90f132d3	TCGA-A5-A1OG-01A-11R-A14D-07	TCGA-A5-A1OG-01A-11R	TCGA-A5-A1OG-01A-01-TSA			TCGA-A5-A1OG-01A-11	TCGA-A5-A1OG-01A	TCGA-A5-A1OG	5c3f826c-b447-457d-a90e-715bad3c7118	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	223	190.0	False	true	7BE01FDF-C4CF-471E-B395-8D7C4531CD6F	1.83	f501c084-03d5-48ad-b365-085773a7bd2d	0.18	23	released	3359a3db-2dbb-4dd8-a2db-0bcaa598b81b	RNA	R	0.18	UV Spec	released	False	9e0a171b-69a9-43cf-9c24-e9ee59502eb8	11	10.0	0.0	20.0	10.0	0.0	30.0	50.0	70.0	TOP	58ae39e5-f5ae-44ad-8d4a-cc442b18c5c3	released																				released	30.0	4cbc8fb7-9de4-4e17-8fb2-8571a224fb8d	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A1OG_demographic	65	-23956	973	0083a218-06f6-5278-ac8e-1bc4f0cf5124	not hispanic or latino	female	asian	released	Dead	1945		TCGA-A5-A1OG_exposure	Not Reported	25.636917160711423	f62f4c93-7a49-5216-ad9e-fd98d58316a6	158.0	released	64.0	TCGA-A5-A1OG_diagnosis	23956	not reported	0	348	f853a784-588f-507c-9f83-400ecd132330	Stage IIIC2	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-A5-A1OG_treatment	TCGA-A5-A1OG_treatment_1	released	d835223b-c175-5c78-bffa-0d96ffdc85a7	yes	Radiation Therapy, NOS	released	f38e343f-60f1-5e48-b394-cd519b3f5340	yes	Pharmaceutical Therapy, NOS	39c9c3a8-6c5c-4398-a656-535b90f132d3
c9b6ca16-44ea-4173-83ff-ead3fd987937.htseq.counts.gz	7e8ddfd6-4169-40a1-a292-064fde245cec	TCGA-AJ-A2QN-01A-11R-A18M-07	TCGA-AJ-A2QN-01A-11R	TCGA-AJ-A2QN-01A-01-TS1			TCGA-AJ-A2QN-01A-11	TCGA-AJ-A2QN-01A	TCGA-AJ-A2QN	e00f6dc5-bc8b-472d-bac3-c7823364f01e	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	289	25.0	False	false	F92EF591-695A-4E48-9ACF-67497880AC20	1.8	13a499dd-2bb6-4750-b24a-1c76993f5b97	0.17	23	released	c7ba0111-9c80-4c8b-bbd9-795ad49afa5f	RNA	R	0.17	UV Spec	released	False	a916e232-ba04-4d1e-af15-3177e8b9401c	11	0.0	0.0	10.0	0.0	0.0	15.0	75.0	75.0	TOP	57ea32bd-84da-4ef1-b1eb-6b82135e9677	released																				released	25.0	3fd07879-b069-4595-a704-cd7d11733f01	Primary Tumor	01	released	Not Reported	released	TCGA-AJ-A2QN_demographic	60	-21915		715f8a44-a741-5bf0-977f-2d443c2c098d	not reported	female	white	released	Alive	1950		TCGA-AJ-A2QN_exposure	Not Reported	45.674740484429066	5ed191a7-54d8-5bf9-9d49-43dda89dd33f	170.0	released	132.0	TCGA-AJ-A2QN_diagnosis	21915	not reported	0	1069	42bb44bc-d039-5d7d-9b18-e9d123743198	Stage II	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-AJ-A2QN_treatment_1	TCGA-AJ-A2QN_treatment	released	bba86fe0-bfb5-5c65-90fc-60aa3a77429e	no	Pharmaceutical Therapy, NOS	released	0e34cc70-9e6d-5096-8ef4-7033a91c848d	no	Radiation Therapy, NOS	7e8ddfd6-4169-40a1-a292-064fde245cec
656900ef-bf75-4cc8-a73f-80b4a88a97fd.htseq.counts.gz	422f1c44-30ac-4c52-86d6-c19aa679353c	TCGA-AX-A1CK-01A-11R-A137-07	TCGA-AX-A1CK-01A-11R	TCGA-AX-A1CK-01A-01-TS1			TCGA-AX-A1CK-01A-11	TCGA-AX-A1CK-01A	TCGA-AX-A1CK	45effb44-0b5f-4081-a202-d85969c72f2b	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	2115	100.0	False	false	5810919B-7778-4566-A024-2D70BDE9A4F5	1.91	5755caa5-b187-498f-a7a9-22e8ddcd2830	0.16	23	released	e7d9c764-f0f0-4969-b7d4-a6140e45d028	RNA	R	0.16	UV Spec	released	False	45f5690f-5a93-4afe-bacb-118b70d51df5	11	8.0	1.0	2.0	1.0	1.0	8.0	89.0	85.0	TOP	d0423494-b1e4-40f4-a49f-fb5941dd5557	released																				released	30.0	7028ec96-26a1-4ec7-a044-9b263e50ca8d	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A1CK_demographic	58	-21200		64bf5f32-7f0d-5ea2-80c1-8fc679a3de3b	not hispanic or latino	female	white	released	Alive	1947		TCGA-AX-A1CK_exposure	Not Reported	27.099251006812448	fd7c70eb-a52b-5f34-83f0-777da3cb5c2b	163.0	released	72.0	TCGA-AX-A1CK_diagnosis	21200	not reported	0	2441	5c32ec46-1a26-57af-ae73-42b96cd3a53d	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2005	TCGA-AX-A1CK_treatment	TCGA-AX-A1CK_treatment_1	released	84d4a50f-57d8-543e-96de-b14d52a21af7	no	Radiation Therapy, NOS	released	96416453-a6f3-5ab5-9731-ab31a7791c16	yes	Pharmaceutical Therapy, NOS	422f1c44-30ac-4c52-86d6-c19aa679353c
b91d49a7-086e-4617-ba5e-9369268c13c6.htseq.counts.gz	6d8ae300-694c-44c1-a4a4-5221998782fe	TCGA-BG-A0LW-01A-11R-A16W-07	TCGA-BG-A0LW-01A-11R	TCGA-BG-A0LW-01A-01-TSA	TCGA-BG-A0LW-01A-01-BSA		TCGA-BG-A0LW-01A-11	TCGA-BG-A0LW-01A	TCGA-BG-A0LW	68181bc9-aa8b-44ec-8601-564b30ea0561	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	107	190.0	False	true	75A97BED-AB64-46CC-AE6B-59860673D53E	1.91	e91d204d-8790-4438-add0-52f520fa532b	0.13	23	released	784aa2a1-4074-4a61-9986-64f884e2044d	RNA	R	0.13	UV Spec	released	False	ccdaf387-f4b9-4a03-8fa6-dd29b1a62dfd	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	90.0	TOP	1cd44382-0c7e-4ab1-af3e-05e589cb33d9	released	0.0	0.0	0.0	0.0	0.0	0.0	100.0	90.0	BOTTOM	095d6c24-e044-4e9e-a863-d0fde9d2dacd	released									released	30.0	6527ec31-1d41-49c2-93ff-11615a6cba8b	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A0LW_demographic	47	-17369		d8c4248b-3e80-5a02-bf28-aff20c54f0dc	not hispanic or latino	female	white	released	Alive	1963		TCGA-BG-A0LW_exposure	Not Reported	57.203131972899506	c2adc86a-6fd1-56e1-bc7e-56e4d3581bca	157.0	released	141.0	TCGA-BG-A0LW_diagnosis	17369	not reported	0	566	565c2697-e6db-5c22-be88-bbc3f88f1424	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-BG-A0LW_treatment_1	TCGA-BG-A0LW_treatment	released	8bdbe7b5-265d-5352-9df6-4734cf6f1198	no	Pharmaceutical Therapy, NOS	released	4278df68-abfe-558c-9aea-4848666f3327	no	Radiation Therapy, NOS	6d8ae300-694c-44c1-a4a4-5221998782fe
99adb4be-c350-4965-873a-d8a0086f6815.htseq.counts.gz	4891ef92-743a-49b2-bc18-27edf38586fc	TCGA-B5-A11H-01A-11R-A118-07	TCGA-B5-A11H-01A-11R	TCGA-B5-A11H-01A-01-BSA	TCGA-B5-A11H-01A-01-TSA		TCGA-B5-A11H-01A-11	TCGA-B5-A11H-01A	TCGA-B5-A11H	dee43082-4aa7-4650-981c-a779e9fe7b55	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	2324	620.0	False	true	40813C61-4B78-4677-89A4-4B9488613F57	1.87	c0294497-87d4-481f-864a-e4fa9baab8c5	0.16	23	released	719c3f43-47f2-4018-9322-ab09f7a46e11	RNA	R	0.16	UV Spec	released	False	0c13a866-403d-4fd0-96a5-a7662e651f59	11	5.0	10.0	10.0	5.0	0.0	5.0	85.0	85.0	BOTTOM	a6d3cbbf-266d-4ae7-adab-c9f34fb75361	released	5.0	10.0	10.0	2.0	0.0	5.0	85.0	85.0	TOP	9fc6dc5a-b11d-409d-a8c5-74d6b5a128cc	released									released	30.0	d78d2f6b-3eb3-4082-a7ea-f7b6202cdc58	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A11H_demographic	67	-24556		8c9e16d5-74cd-58a5-87ae-aa6dd8a31bff	not reported	female	white	released	Alive	1937		TCGA-B5-A11H_exposure	Not Reported		5477aabf-1d89-5a52-bfad-fba2c2a3dace		released	101.0	TCGA-B5-A11H_diagnosis	24556	not reported	0	2687	85535d33-70d5-53e0-b4f9-738a62b34432	Stage IIIA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2004	TCGA-B5-A11H_treatment	TCGA-B5-A11H_treatment_1	released	f8ae1bf0-ec07-529d-8d7d-1f9be209aee6	no	Radiation Therapy, NOS	released	7b9e9fce-7f4c-5ef6-b175-dc004e617630	yes	Pharmaceutical Therapy, NOS	4891ef92-743a-49b2-bc18-27edf38586fc
dd337cd0-fa4b-4a16-a7bb-5301a0dba980.htseq.counts.gz	2862db86-0f4d-4741-ae29-e5d61d6a810b	TCGA-AX-A2HH-01A-11R-A32Y-07	TCGA-AX-A2HH-01A-11R	TCGA-AX-A2HH-01A-01-TSA			TCGA-AX-A2HH-01A-11	TCGA-AX-A2HH-01A	TCGA-AX-A2HH	52fef8a9-6860-48bd-b992-a56ccad1243c	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	462	150.0	False	false	2EE7245F-7069-456A-A215-41E59D9FE606	1.75	9cfe7287-c1aa-4fc0-8d4f-dc72655b2810	0.15	23	released	4bdc122e-3872-4eb8-8fc7-af8a872e9682	RNA	R	0.15	UV Spec	released	False	5fcef1d5-3dfa-44bb-8333-a90bf2abb63b	11	1.0	0.0	18.0	0.0	0.0	2.0	80.0	96.0	TOP	5810b3f2-6657-4383-a153-7a619f5650c7	released																				released	30.0	0e73eeac-251a-43fa-9141-636262ee3129	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A2HH_demographic	60	-21924		5155c521-35ee-5ea9-be34-9912fa0d736b	not hispanic or latino	female	white	released	Alive	1950		TCGA-AX-A2HH_exposure	Not Reported	27.055150884495315	e15ec8c4-139a-5a3f-9d00-9d1932038f6b	155.0	released	65.0	TCGA-AX-A2HH_diagnosis	21924	not reported	0	540	f32ae4a0-f573-5a9b-b3dc-97ac5ff847e5	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-AX-A2HH_treatment_1	TCGA-AX-A2HH_treatment	released	667b911a-497b-5365-acb6-1e20e8d03571	no	Pharmaceutical Therapy, NOS	released	b7522251-1f1c-5103-ac45-92e2008a62a9	no	Radiation Therapy, NOS	2862db86-0f4d-4741-ae29-e5d61d6a810b
f570f256-5698-4d33-b115-811f0663aeac.htseq.counts.gz	c1c03260-4179-4609-86a3-8f8314ab5ac8	TCGA-B5-A5OE-01A-11R-A31O-07	TCGA-B5-A5OE-01A-11R	TCGA-B5-A5OE-01A-01-TSA			TCGA-B5-A5OE-01A-11	TCGA-B5-A5OE-01A	TCGA-B5-A5OE	d5ee39e8-a1d2-4244-9c38-07d7c5c1baba	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	609	1540.0	False	true	82A668E5-6B89-4C94-BEED-F4FF227BD0B1	1.9	0595a9e2-f382-4f97-8d0e-69af86b9fb78	0.16	23	released	10335946-6ec2-45cd-bf6d-93788ed8341b	RNA	R	0.16	UV Spec	released	False	e723f328-5597-4606-9ce8-fba9bf987501	11	2.0	2.0	10.0	2.0	0.0	10.0	80.0	80.0	TOP	88d0713a-7553-405a-958b-d234a21bb537	released																				released	30.0	df9184ec-0a56-4227-a0f7-ce92e5e6203e	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A5OE_demographic	68	-24905		efdecf34-f346-53d8-9aab-eefc419d4463	not reported	female	black or african american	released	Alive	1943		TCGA-B5-A5OE_exposure	Not Reported		73048860-d819-5808-80e1-461490925fb0		released		TCGA-B5-A5OE_diagnosis	24905	not reported	0	1063	4c34818d-6290-52a5-a4d4-29ab9ec64c52	Stage IIIC2	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-B5-A5OE_treatment	TCGA-B5-A5OE_treatment_1	released	a1de606d-210d-5d88-ab82-eff7e6b4ab75	no	Radiation Therapy, NOS	released	ff7dc17e-8b3e-5eca-9135-4ed468fa4d58	yes	Pharmaceutical Therapy, NOS	c1c03260-4179-4609-86a3-8f8314ab5ac8
c21ed2cb-ddd8-4f27-b5d8-f237e6fa4d21.htseq.counts.gz	5522fcfc-6d2f-4a38-9036-0117efcb458b	TCGA-BG-A0M6-01A-31R-A104-07	TCGA-BG-A0M6-01A-31R	TCGA-BG-A0M6-01A-03-BSC	TCGA-BG-A0M6-01A-03-TSC		TCGA-BG-A0M6-01A-31	TCGA-BG-A0M6-01A	TCGA-BG-A0M6	002724fa-7051-49fa-9c58-4bcb7eba4ac6	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	618	320.0	False	true	39EC3673-5B31-403B-8328-9DEA5FF7CD1A	1.69	989bcd83-f8c2-4027-a10c-19ce3b67e348	0.14	23	released	39bec55d-8c08-43e3-af07-06eb84289a12	RNA	R	0.14	UV Spec	released	False	5d8398d3-dd49-4589-87a1-02ef9db420c1	31	10.0	0.0	10.0	0.0	40.0	0.0	50.0	60.0	BOTTOM	a3099859-7626-46c3-bb96-d58499e20eed	released	10.0	0.0	10.0	0.0	20.0	0.0	70.0	80.0	TOP	5ccd474e-0a7c-49c5-94e2-bc967d66b018	released									released	30.0	66e4b080-e6ef-4531-9b69-1b27f15c5669	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A0M6_demographic	73	-26666	671	3e7266d1-dce3-556c-ab45-4ed485d16350	not hispanic or latino	female	white	released	Dead	1935		TCGA-BG-A0M6_exposure	Not Reported	23.80540166204986	9f90326d-c8de-5788-99f6-7ea88ef9781a	152.0	released	55.0	TCGA-BG-A0M6_diagnosis	26666	not reported	0	241	1d9b02ad-e4a7-5861-8f48-040a0b558207	Stage IIIC2	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2008	TCGA-BG-A0M6_treatment	TCGA-BG-A0M6_treatment_1	released	80930add-59eb-55a4-907e-75b402c24473	yes	Radiation Therapy, NOS	released	4650e484-ae66-5144-9a53-b7f7841b086d	yes	Pharmaceutical Therapy, NOS	5522fcfc-6d2f-4a38-9036-0117efcb458b
9e8b0d08-5be1-44c5-8dda-bd4d4ba3a88d.htseq.counts.gz	a8202485-02b1-4573-910d-68c54a95040d	TCGA-B5-A11Y-01A-21R-A10J-07	TCGA-B5-A11Y-01A-21R	TCGA-B5-A11Y-01A-02-TSB	TCGA-B5-A11Y-01A-02-BSB		TCGA-B5-A11Y-01A-21	TCGA-B5-A11Y-01A	TCGA-B5-A11Y	c0db966b-1024-4ee3-899a-f12e3c71a42c	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	244	580.0	False	true	4FA7876E-EF1B-4EBA-99F9-1D26099B2CA1	1.8	f192adcd-d613-400e-9737-725083638ee4	0.16	23	released	1f402838-540c-4bb1-9164-af68a76823e5	RNA	R	0.16	UV Spec	released	False	7ce830c4-8738-4f44-98bc-86d6cc5e9762	21	0.0	0.0	0.0	0.0	0.0	0.0	100.0	75.0	TOP	3fa72e73-ebf0-43f3-8673-5fddc1fa8855	released	0.0	0.0	0.0	0.0	0.0	0.0	100.0	70.0	BOTTOM	947a3803-7406-4234-ba7c-ca6a17a2d6de	released									released	30.0	24ddff8e-237c-47a0-acde-ce602cd70739	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A11Y_demographic	59	-21860		0ac0360f-5df5-52b5-a219-49f145a7e2ba	not reported	female	white	released	Alive	1951		TCGA-B5-A11Y_exposure	Not Reported	24.00548696844993	dee837c1-5a9a-5b76-be3b-8c5da8965adf	162.0	released	63.0	TCGA-B5-A11Y_diagnosis	21860	not reported	0	560	f93b188b-6244-59fe-9580-e068f8f319dd	Stage IB	C54.1	not reported	8382/3	Endometrioid adenocarcinoma, secretory variant	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-B5-A11Y_treatment_1	TCGA-B5-A11Y_treatment	released	b24ec926-72e4-5c7c-ba95-b14d918ad752	no	Pharmaceutical Therapy, NOS	released	beed18da-4b8e-51ce-af0a-eb8102903543	no	Radiation Therapy, NOS	a8202485-02b1-4573-910d-68c54a95040d
eb8067e5-1e8b-4994-9a28-f512c20502d4.htseq.counts.gz	e45c9dfa-efd2-41e4-8b57-f5b302d6c8a9	TCGA-AJ-A3IA-01A-11R-A213-07	TCGA-AJ-A3IA-01A-11R	TCGA-AJ-A3IA-01A-01-TS1			TCGA-AJ-A3IA-01A-11	TCGA-AJ-A3IA-01A	TCGA-AJ-A3IA	8a0a58a0-5c12-4366-af43-4fd25f8ff454	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	66	35.0	False	false	883486F6-0EDF-4BBC-8412-67F31351427B	1.73	c32dabac-90ce-4b8c-b08c-85a1a2fe8ccf	0.15	23	released	1cb03957-b716-4d6f-9190-ebea2edbe3ec	RNA	R	0.15	UV Spec	released	False	bcd1928a-1b55-4eab-aae7-6c243db67778	11	0.0	0.0	0.0	0.0	0.0	10.0	90.0	75.0	TOP	58b1e9f4-4ccf-4590-a481-eceefd0541b3	released																				released	35.0	0fb7ceae-cf5d-4e98-8ad8-114947b6e7e3	Primary Tumor	01	released	Not Reported	released	TCGA-AJ-A3IA_demographic	77	-28470		7d424c52-15ea-5d54-9fc8-3bdfb035d686	not hispanic or latino	female	white	released	Alive	1934		TCGA-AJ-A3IA_exposure	Not Reported	23.53036634346221	96f1dafe-b560-5350-8c4e-e6a36276b72c	157.0	released	58.0	TCGA-AJ-A3IA_diagnosis	28470	not reported	0	633	15536478-e5fd-539a-9ce0-3beb75abd69f	Stage IB	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2011	TCGA-AJ-A3IA_treatment	TCGA-AJ-A3IA_treatment_1	released	b774bff9-6bb0-5134-8bbe-161997a63981	no	Radiation Therapy, NOS	released	e48b4dce-333c-5863-a705-8dd028cd06f7	no	Pharmaceutical Therapy, NOS	e45c9dfa-efd2-41e4-8b57-f5b302d6c8a9
cccd4262-87e3-4c9e-8ba2-661d3ec22cda.htseq.counts.gz	d7f7de73-d041-4d82-9550-30b8034eaa8e	TCGA-D1-A1NS-01A-11R-A14D-07	TCGA-D1-A1NS-01A-11R	TCGA-D1-A1NS-01A-01-TSA			TCGA-D1-A1NS-01A-11	TCGA-D1-A1NS-01A	TCGA-D1-A1NS	a79a4e56-09bf-4691-b7e0-81a9c2620d0f	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	92	220.0	False	false	FE397385-B600-4450-AE73-3CB62D5FEA3B	1.81	48ade293-84c9-41cf-97aa-c28bb4ac4ca6	0.17	23	released	e6704de6-897e-4594-bda2-fedbe9b99c2f	RNA	R	0.17	UV Spec	released	False	dd430f7d-8cab-440d-9481-de8d5c04bbd5	11	40.0	20.0	10.0	20.0	0.0	20.0	70.0	70.0	TOP	c94d0f93-0e68-4149-9c0f-86311c5d0d39	released																				released	30.0	88b09e18-049d-4cbe-b7cb-42f0add220bb	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A1NS_demographic	53	-19638		9c7ebc91-28c8-5947-adb5-8a59ce7a93c4	not hispanic or latino	female	white	released	Alive	1957		TCGA-D1-A1NS_exposure	Not Reported	39.767706097714935	5fc51d01-4ac8-53c6-885d-fe3101fae088	178.0	released	126.0	TCGA-D1-A1NS_diagnosis	19638	not reported	0	43	aab4e05f-3644-56c4-b7f7-af9d5e1b8adc	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-D1-A1NS_treatment_1	TCGA-D1-A1NS_treatment	released	58ac48dc-eb73-5970-bca7-25580da42c93	no	Pharmaceutical Therapy, NOS	released	10cd44cc-c7cc-5dff-b589-04115adc19a0	no	Radiation Therapy, NOS	d7f7de73-d041-4d82-9550-30b8034eaa8e
65703426-dbb6-4591-ad7f-53663cc3aeae.htseq.counts.gz	c431cd25-633b-4d67-80fe-e95811cf87d4	TCGA-AX-A2H2-01A-11R-A180-07	TCGA-AX-A2H2-01A-11R	TCGA-AX-A2H2-01A-01-TSA			TCGA-AX-A2H2-01A-11	TCGA-AX-A2H2-01A	TCGA-AX-A2H2	e4510c66-a60b-4b09-a4e8-74ec5b26a3a5	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	1079	160.0	False	false	1BDF6880-A5E1-4DD8-A7E5-1E91BBCF8F60	2.36	245e65eb-ec7a-4a85-a524-194afbdf67ef	0.17	23	released	793f4ac9-457e-40fe-91ca-9ae2e29896dd	RNA	R	0.17	UV Spec	released	False	c3c2036b-9921-420b-a04c-84850761fb86	11	1.0	0.0	2.0	0.0	0.0	1.0	97.0	96.0	TOP	9ba08d6f-56b8-4a64-8f77-9aa202165679	released																				released	30.0	6d3fb251-74e8-40d5-8262-f265a5a3395a	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A2H2_demographic	86	-31524	145	f245ea87-05fb-51a2-b9fd-288a61e2424c	not hispanic or latino	female	black or african american	released	Dead	1922	2008	TCGA-AX-A2H2_exposure	Not Reported	24.767565919829295	d3d44258-462f-5a62-86a4-c75987339852	162.0	released	65.0	TCGA-AX-A2H2_diagnosis	31524	not reported	0		9c2e8300-e809-535d-a98f-3380cc8b409a	Stage IIA	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-AX-A2H2_treatment_1	TCGA-AX-A2H2_treatment	released	a824de28-1788-519d-9a7d-9f4448bcda6a	no	Pharmaceutical Therapy, NOS	released	1aa150f8-865a-5e73-a0cb-61fd3cafaeec	no	Radiation Therapy, NOS	c431cd25-633b-4d67-80fe-e95811cf87d4
f9153720-86f1-4d70-b2a9-7b88dd365514.htseq.counts.gz	e0f22946-51bc-4c1a-aa10-333d3ac2e97c	TCGA-D1-A162-01A-11R-A118-07	TCGA-D1-A162-01A-11R	TCGA-D1-A162-01A-01-TSA			TCGA-D1-A162-01A-11	TCGA-D1-A162-01A	TCGA-D1-A162	3f96b142-77b6-40a1-8e16-6581b964583b	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	874	180.0	False	false	CB5E7FA1-33EE-492F-B2B0-F4C9332640A9	1.82	4f440484-1605-442b-b1e5-b3534277b9c2	0.16	23	released	c6fb62c3-0d2c-45b5-8624-7d07a46c2a73	RNA	R	0.16	UV Spec	released	False	484b363f-7a38-44ab-b2fa-7869546aa877	11	0.0	0.0	0.0	0.0	25.0	0.0	75.0	70.0	TOP	ba165261-a11f-4442-9550-6f5d48e6c506	released																				released	30.0	4357a0dc-7d05-4c36-949f-8b30e91e208a	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A162_demographic	69	-25543		a9871d31-b21f-58cf-99c9-c43961029a80	not hispanic or latino	female	white	released	Alive	1939		TCGA-D1-A162_exposure	Not Reported	34.602076124567475	77bc2efa-4279-55e9-9cca-732994f31c53	170.0	released	100.0	TCGA-D1-A162_diagnosis	25543	not reported	0	1145	02aed327-1439-5bbf-b166-8638931a8e41	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-D1-A162_treatment	TCGA-D1-A162_treatment_1	released	3c3c641d-bca9-52cd-8ce6-a091443e8692	no	Radiation Therapy, NOS	released	05fbac43-0b1f-5b1b-a1e1-b5d3b0c7d347	no	Pharmaceutical Therapy, NOS	e0f22946-51bc-4c1a-aa10-333d3ac2e97c
450fcc03-f10a-45a9-8dae-e22a81439975.htseq.counts.gz	66146563-3e39-4446-a7f3-0b55e454b5e9	TCGA-AP-A0LG-01A-11R-A16W-07	TCGA-AP-A0LG-01A-11R	TCGA-AP-A0LG-01A-01-TSA	TCGA-AP-A0LG-01A-01-BSA		TCGA-AP-A0LG-01A-11	TCGA-AP-A0LG-01A	TCGA-AP-A0LG	cca5717d-226d-4390-a99b-c7aed6d9d70e	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	2833	360.0	False	true	7343A9B5-276E-4EE1-AC06-27835D63B0E2	1.81	e4db21b5-9a76-47c1-b838-10f49d2696d0	0.17	23	released	dae0c39d-947b-4c11-b518-dfefe267661a	RNA	R	0.17	UV Spec	released	False	0435bafb-f1e8-4413-b25a-9af52e9f88c7	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	90.0	TOP	baf8495c-f210-4bd6-99bd-3f6d558aea44	released	0.0	0.0	20.0	0.0	0.0	0.0	80.0	90.0	BOTTOM	a7e14a9a-8172-4e41-b6bd-de60f3c1330d	released									released	30.0	031667f8-38d9-4df3-a18e-32cc426d234b	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A0LG_demographic	54	-20047		dc97087e-e474-5a4a-ae55-9df2cd584547	not reported	female	white	released	Alive	1948		TCGA-AP-A0LG_exposure	Not Reported	28.60476495163536	416c1d18-dfc9-582b-b5e9-69aa3615deef	163.0	released	76.0	TCGA-AP-A0LG_diagnosis	20047	not reported	0	2015	6ce71ba2-cd75-57ee-af14-db1e0b405777	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2002	TCGA-AP-A0LG_treatment	TCGA-AP-A0LG_treatment_1	released	695886f4-309d-58ac-aefc-e2c3eb137fae	yes	Radiation Therapy, NOS	released	43137e75-90d0-50c2-9d61-d0df7efe29d1	no	Pharmaceutical Therapy, NOS	66146563-3e39-4446-a7f3-0b55e454b5e9
9a258d14-23ec-4d25-902d-a2839d76a809.htseq.counts.gz	940c09a6-a685-4b07-910a-a4c1db8b05a4	TCGA-DF-A2KN-01A-11R-A180-07	TCGA-DF-A2KN-01A-11R	TCGA-DF-A2KN-01A-01-TS1			TCGA-DF-A2KN-01A-11	TCGA-DF-A2KN-01A	TCGA-DF-A2KN	d438c58e-f038-47a3-8e62-485a5aca9695	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC		200.0	False	false	A61CE064-B18B-429E-93F1-BA0FC06AB310	1.8	291167cc-8f00-47e1-abe2-72388c98170d	0.18	23	released	d19e8fb1-142e-4ca6-a109-08be2e20b21b	RNA	R	0.18	UV Spec	released	False	37c58b0c-175e-4328-b400-b322d1894362	11	20.0	6.0	0.0	3.0	0.0	10.0	90.0	90.0	TOP	29d8a8b6-0104-4756-986d-2ef7e3d18da8	released																				released	30.0	4ad23a52-bceb-4b12-88aa-272153e01b01	Primary Tumor	01	released	Not Reported	released	TCGA-DF-A2KN_demographic				9e21e02c-b227-5e1f-8ed6-c145c7713145	not reported	female	not reported	released	Alive			TCGA-DF-A2KN_exposure	Not Reported	33.3275623268698	2826093c-4900-5aa8-9338-8effb5b12e0d	152.0	released	77.0	TCGA-DF-A2KN_diagnosis		not reported		67	f0c22945-90d0-568d-a3ab-dfed57db05fc	Stage IC	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported		TCGA-DF-A2KN_treatment	TCGA-DF-A2KN_treatment_1	released	bd3d7d6a-606f-5bcc-83d2-9de0d36e2971	not reported	Radiation Therapy, NOS	released	075d1b78-14dd-5469-b5b3-d46dd30295a1	no	Pharmaceutical Therapy, NOS	940c09a6-a685-4b07-910a-a4c1db8b05a4
7960f154-6b52-41c7-9426-ee3eb72fe470.htseq.counts.gz	db1d9595-8e8b-415e-907b-5ff5259fc7a3	TCGA-AX-A1C4-01A-11R-A137-07	TCGA-AX-A1C4-01A-11R	TCGA-AX-A1C4-01A-01-TS1			TCGA-AX-A1C4-01A-11	TCGA-AX-A1C4-01A	TCGA-AX-A1C4	40ce24c6-b331-4be2-baf9-2fa7dc855f9b	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	575	120.0	False	false	81C6DDE6-ACC3-4659-91EC-D986671B592A	1.91	58623d8a-f51b-470a-bde3-f31e91f9bd80	0.17	23	released	5fc924b9-ad0d-4f8d-a8e9-9821ce9696f1	RNA	R	0.17	UV Spec	released	False	6712d9df-c213-43e8-803b-5dd3808941bd	11	1.0	0.0	1.0	0.0	6.0	2.0	91.0	95.0	TOP	df686b3d-f729-495e-9fd3-bd34f945a4b9	released																				released	30.0	48977d80-9f8f-488d-9292-661d7487e089	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A1C4_demographic	52	-19209		f5abb0b7-7d51-5bf3-87e8-b27e9cba66c3	not hispanic or latino	female	white	released	Alive	1957		TCGA-AX-A1C4_exposure	Not Reported	36.295922232041406	559b1575-8ecf-5fa1-8782-bc2b5dcc88d7	178.0	released	115.0	TCGA-AX-A1C4_diagnosis	19209	not reported	0	404	d13c3b46-984f-5d2f-b490-90fc9053caea	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-AX-A1C4_treatment	TCGA-AX-A1C4_treatment_1	released	71b7f65b-6e7b-5617-811c-65652dccc1b8	yes	Radiation Therapy, NOS	released	860c26f2-9f9e-5801-bcb8-58410eb48469	no	Pharmaceutical Therapy, NOS	db1d9595-8e8b-415e-907b-5ff5259fc7a3
5c1c7971-4ea2-4569-8c26-cebccde268d2.htseq.counts.gz	916eb615-a839-4705-9f73-39ac71d32e3c	TCGA-BK-A139-01C-08R-A277-07	TCGA-BK-A139-01C-08R	TCGA-BK-A139-01C-07-BS7	TCGA-BK-A139-01C-08-BS8		TCGA-BK-A139-01C-08	TCGA-BK-A139-01C	TCGA-BK-A139	8d9e4917-334b-4c76-aee1-1e22be772db0	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	551		True	false	5F8C376B-31F8-4566-8EBF-21E7F4E6499D	1.83	470f2bb9-1dd8-4e57-a8a5-e6b7c8de78dd	0.15	23	released	1645eb95-adb9-419d-961f-0039936d6ad5	RNA	R	0.15	UV Spec	released	True	a0e08019-4220-470f-b3b9-4e556f1d6bf8	08	20.0	40.0	0.0	20.0	0.0	40.0	60.0	60.0	TOP	ca999e4a-352f-4af7-bc49-71c9fea4c18c	released	2.0	40.0	0.0	20.0	0.0	30.0	70.0	70.0	BOTTOM	a52ed78b-2752-43d5-a185-c329b9b38b74	released									released	1.0	0c2e9ba3-0e50-41e0-bfcd-9c221383df4c	Primary Tumor	01	released	Not Reported	released	TCGA-BK-A139_demographic	74	-27077	943	283a931a-a653-50c4-992a-c69e21c6af1c	not hispanic or latino	female	white	released	Dead	1936		TCGA-BK-A139_exposure	Not Reported	24.87771968291449	8155bfc1-1c5f-5642-9a14-8b020eeb7bf3	154.0	released	59.0	TCGA-BK-A139_diagnosis	27077	not reported	0	309	fff68755-ed35-52d0-9a4f-86a4b19bc82e	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-BK-A139_treatment	TCGA-BK-A139_treatment_1	released	6c775c6a-d5bf-5bd8-8b8c-3a27635d6c8e	no	Radiation Therapy, NOS	released	de6d0cd2-02d1-51e0-9e71-feb4f4d24986	no	Pharmaceutical Therapy, NOS	916eb615-a839-4705-9f73-39ac71d32e3c
537fc2c1-ec0f-472a-88ad-6aeb4e77d0bb.htseq.counts.gz	6de1c24c-40a1-4cca-ad27-7f99b61f5d64	TCGA-AX-A3G9-01A-11R-A22K-07	TCGA-AX-A3G9-01A-11R	TCGA-AX-A3G9-01A-01-TS1			TCGA-AX-A3G9-01A-11	TCGA-AX-A3G9-01A	TCGA-AX-A3G9	f7527b5e-5330-49ea-82ce-f6f2cdccbadc	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	560	110.0	False	false	FADFF649-7518-4EFB-B96C-9390DD308DBD	1.85	f31b5e70-af25-4f1a-b7e3-13f17998e7e2	0.16	23	released	dd68d29d-2772-4328-95a5-1083dcde9139	RNA	R	0.16	UV Spec	released	False	96b698a8-9ba6-4437-b6be-fa6d38a73466	11	1.0	0.0	2.0	0.0	10.0	5.0	83.0	90.0	TOP	cfdd8b54-73d9-4e70-a5fd-852c0fe3ac11	released																				released	30.0	739cf2f3-e9eb-4f4a-8310-2d7413e323e4	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A3G9_demographic	63	-23361		3085459e-dcc9-5589-b8de-cd5e8529769b	not hispanic or latino	female	white	released	Alive	1947		TCGA-AX-A3G9_exposure	Not Reported	25.2993759487266	1a20acf7-462f-5190-9aae-8287ce168f62	154.0	released	60.0	TCGA-AX-A3G9_diagnosis	23361	not reported	0	558	40bdafb9-bf8b-55fd-8ef5-1560d7588e65	Stage IIIC	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-AX-A3G9_treatment_1	TCGA-AX-A3G9_treatment	released	f024d7ea-1923-5a24-9e35-13e968eb4ddb	yes	Pharmaceutical Therapy, NOS	released	97e1cb75-6659-5045-b7fe-ceef7634f7ea	yes	Radiation Therapy, NOS	6de1c24c-40a1-4cca-ad27-7f99b61f5d64
18c907bb-5ea1-40ff-9d5c-a93c9129d104.htseq.counts.gz	03b46312-c582-4cc6-96fd-911e617e1cef	TCGA-B5-A0JR-01A-13R-A466-07	TCGA-B5-A0JR-01A-13R	TCGA-B5-A0JR-01A-01-BSA	TCGA-B5-A0JR-01A-01-TSA		TCGA-B5-A0JR-01A-13	TCGA-B5-A0JR-01A	TCGA-B5-A0JR	a766d113-bc3f-4448-a4e5-f391fb0c0e22	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1407	100.0	False	true	B3CF4DE2-8755-4585-92C5-F8EE350C1C50	1.98	a67adcd5-7f63-44f2-a127-568569c9a357	0.17	23	released	8ee063d2-aa96-4631-8bfe-af66a43eba15	RNA	R	0.17	UV Spec	released	False	fe5c1a15-4677-4f53-9475-79dacea622f5	13	0.0	0.0	0.0	0.0	0.0	50.0	50.0	65.0	BOTTOM	a1c2fa30-471a-42c5-91fc-f4d9430153e2	released	0.0	0.0	0.0	0.0	0.0	15.0	85.0	80.0	TOP	973f9b75-2d49-4be1-9b46-4e1857d0f33e	released									released	20.0	07381a09-5cbd-4744-86ec-41a81e470204	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A0JR_demographic	73	-26814		ac45a829-3a9a-5711-953f-829b2fec2583	not reported	female	white	released	Alive	1933		TCGA-B5-A0JR_exposure	Not Reported	40.507696462327836	5cdf5e5c-f91a-5d80-8ef7-ef253e62de2d	161.0	released	105.0	TCGA-B5-A0JR_diagnosis	26814	not reported	0	1731	938f9cea-823b-5d31-be57-89661c35ca40	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2006	TCGA-B5-A0JR_treatment_1	TCGA-B5-A0JR_treatment	released	c71ed997-6f9d-52fa-9da6-8ead75c82d5e	no	Pharmaceutical Therapy, NOS	released	d525ff07-ba20-515e-a548-eba05bd605cc	no	Radiation Therapy, NOS	03b46312-c582-4cc6-96fd-911e617e1cef
7b5ff8ec-8e07-4810-95a3-171623340f88.htseq.counts.gz	c59de53e-a8eb-4636-bcc6-dda0e8d689c7	TCGA-BK-A13C-11A-11R-A118-07	TCGA-BK-A13C-11A-11R	TCGA-BK-A13C-11A-01-TS1			TCGA-BK-A13C-11A-11	TCGA-BK-A13C-11A	TCGA-BK-A13C	ce73d0aa-bb3d-4aa3-8ed3-e9912cf25d38	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	146	270.0	False	false		1.8	a6ba27cf-7e06-4a44-a948-8575593272cb	0.16	23	released	5e832945-e5ab-4021-9ea1-40fcc2f71f48	RNA	R	0.16	UV Spec	released	False	a5a694f1-916c-4332-8e88-a1711886867e	11	10.0	0.0	0.0	0.0	100.0	0.0	0.0	0.0	TOP	d2bde2c5-6261-41c4-8d13-60cd839647f2	released																				released	30.0	badde2a2-91b8-4f92-9993-a854f408c887	Solid Tissue Normal	11	released	Not Reported	released	TCGA-BK-A13C_demographic	47	-17317		51289bbf-8cc2-5022-bfdd-b1377b17ce22	not hispanic or latino	female	black or african american	released	Alive	1963		TCGA-BK-A13C_exposure	Not Reported	33.74945565394106	cc6f1bed-847c-5811-a3bc-2e3f40b3ba70	166.0	released	93.0	TCGA-BK-A13C_diagnosis	17317	not reported	0	760	609011ba-d2fd-5a6c-a353-3959ab108622	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-BK-A13C_treatment	TCGA-BK-A13C_treatment_1	released	ae363043-0668-5e9f-82b7-125cf2d2d6cc	no	Radiation Therapy, NOS	released	6ceb7a98-17df-53e0-a3b2-b49f1bfbecb4	no	Pharmaceutical Therapy, NOS	c59de53e-a8eb-4636-bcc6-dda0e8d689c7
f40521e6-c30d-45d2-ab6d-61edf96edf89.htseq.counts.gz	276cbf7b-d7a4-4001-9373-b53107cf6549	TCGA-BG-A221-01A-21R-A157-07	TCGA-BG-A221-01A-21R	TCGA-BG-A221-01A-02-TSB			TCGA-BG-A221-01A-21	TCGA-BG-A221-01A	TCGA-BG-A221	e7e667be-9b31-4870-9c38-740098f37213	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	99	240.0	False	true	58D68577-9022-4EF3-82E9-6EE159D41947	1.69	58957940-d71f-4ad5-98a8-c8f2913801c5	0.18	23	released	6be63c48-3be9-4dab-be2b-19fa15eb20f3	RNA	R	0.18	UV Spec	released	False	9c4f7dc8-0d95-4911-a3a2-d7efa1c2c8a3	21	40.0	20.0	10.0	20.0	0.0	10.0	80.0	80.0	TOP	c3b6fa5c-49f8-41da-87bf-ab3ab1a7a9f3	released																				released	30.0	d96882db-9a46-493a-a26b-efb7bddf34ff	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A221_demographic	84	-30960		6a80fd66-a580-51bd-b9f9-c954eb173de6	not hispanic or latino	female	white	released	Alive	1926		TCGA-BG-A221_exposure	Not Reported	25.153150229218223	4de3392f-10d1-5129-a1e5-9f3d19efdbdd	157.0	released	62.0	TCGA-BG-A221_diagnosis	30960	not reported	0	55	234059ae-74aa-52aa-9851-674d03cf8d59	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2010	TCGA-BG-A221_treatment	TCGA-BG-A221_treatment_1	released	54302cd4-2071-5dda-a850-0217ad6ea790	no	Radiation Therapy, NOS	released	46830e0c-e0aa-582a-b41c-af0ccaec9133	no	Pharmaceutical Therapy, NOS	276cbf7b-d7a4-4001-9373-b53107cf6549
92939250-d58f-4167-bf73-52f8fb89992e.htseq.counts.gz	ae108c31-c3e7-43e2-a593-b2e49a9138a8	TCGA-FI-A2EU-01A-11R-A17B-07	TCGA-FI-A2EU-01A-11R	TCGA-FI-A2EU-01A-01-TSA			TCGA-FI-A2EU-01A-11	TCGA-FI-A2EU-01A	TCGA-FI-A2EU	4284a85d-d9b6-40ee-aac4-c2c03554528e	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	2779	110.0	False	true	95F8FB60-A533-4A37-8B4B-FC6811A77636	1.81	1d3ec463-a3c0-4aa5-8fc0-d221be3a0700	0.16	23	released	f619aa64-8e20-4eed-8423-b369fca5f23a	RNA	R	0.16	UV Spec	released	False	d3bdad06-62c7-4a52-94b2-5b5866051a17	11	40.0	20.0	5.0	20.0	0.0	5.0	90.0	90.0	TOP	3c2579f4-c41f-455b-9347-695267902624	released																				released	30.0	af843246-e00f-40f4-849f-3c5ba74a7479	Primary Tumor	01	released	Not Reported	released	TCGA-FI-A2EU_demographic	68	-24837		ae46540d-b520-585f-941d-5492c9ae03bb	not hispanic or latino	female	not reported	released	Alive	1935		TCGA-FI-A2EU_exposure	Not Reported	32.95068027210884	e4a3672c-0ba4-52a2-97c6-3b10e635bf19	168.0	released	93.0	TCGA-FI-A2EU_diagnosis	24837	not reported	0	2941	57b6e82a-baa3-5a30-90e5-787f6f2b905e	Stage IA	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2003	TCGA-FI-A2EU_treatment	TCGA-FI-A2EU_treatment_1	released	5ff0ab24-6512-58c4-b147-2a0aad2850be	no	Radiation Therapy, NOS	released	e8da3386-253c-50a7-be00-de53c9d70318	yes	Pharmaceutical Therapy, NOS	ae108c31-c3e7-43e2-a593-b2e49a9138a8
a73e37eb-a9a3-4494-8cc8-3ae37acede20.htseq.counts.gz	07306132-5eee-4e33-93f6-9fd233f4ccab	TCGA-A5-AB3J-01A-11R-A40A-07	TCGA-A5-AB3J-01A-11R	TCGA-A5-AB3J-01A-01-TS1			TCGA-A5-AB3J-01A-11	TCGA-A5-AB3J-01A	TCGA-A5-AB3J	8a67ed86-156f-4b45-b460-000fe33da26b	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	126	210.0	False	true	41CDFB48-33A6-4FCD-97CA-30C73A9E6FED	1.86	8cda2390-3a6c-422e-b827-5c62c015f020	0.17	23	released	56d7021e-21e7-45ec-a626-5ce001005b3b	RNA	R	0.17	UV Spec	released	False	2b7f26c0-60c9-4b32-b03b-e88001ba6102	11	5.0	0.0	0.0	0.0	30.0	10.0	60.0	60.0	TOP	a55d457e-1df1-4007-8f97-4a849f453371	released																				released	30.0	396753d3-fae0-4a1a-b193-4121a47746d2	Primary Tumor	01	released	Not Reported	released	TCGA-A5-AB3J_demographic	52	-19020		a4c89303-0bac-562f-bd1a-207d4fd60680	not hispanic or latino	female	black or african american	released	Alive	1961		TCGA-A5-AB3J_exposure	Not Reported	23.046875	b08b910e-0926-518c-9c2a-40c832005267	160.0	released	59.0	TCGA-A5-AB3J_diagnosis	19020	not reported	0	512	81c22851-9367-5247-96b9-934f8a458523	Stage II	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2013	TCGA-A5-AB3J_treatment_1	TCGA-A5-AB3J_treatment	released	7f4e2af1-5d4c-5c4b-91d6-af0589fb9faf	yes	Pharmaceutical Therapy, NOS	released	5cffb7dc-c095-5a07-a445-89bceb62fcf2	yes	Radiation Therapy, NOS	07306132-5eee-4e33-93f6-9fd233f4ccab
05ac38d7-29f0-46ae-b4d2-a908a4a9599b.htseq.counts.gz	0369aff7-f987-4322-8ff7-78c2e4207555	TCGA-A5-A0G2-01A-11R-A16W-07	TCGA-A5-A0G2-01A-11R	TCGA-A5-A0G2-01A-01-BS1	TCGA-A5-A0G2-01A-01-TS1		TCGA-A5-A0G2-01A-11	TCGA-A5-A0G2-01A	TCGA-A5-A0G2	4abbd258-0f0c-4428-901d-625d47ad363a	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	4825	200.0	False	true	A3CD42AF-D356-415B-958D-D14D7AC52693	1.82	4b998fee-a0c6-4039-824f-e5f43d5a3dbc	0.16	23	released	b8bfdc23-4a54-42d0-b5ef-1c453bdafd04	RNA	R	0.16	UV Spec	released	False	09ec609b-ee52-4b9e-8ae0-7ebe5d306d29	11	20.0	0.0	10.0	10.0	5.0	0.0	85.0	90.0	BOTTOM	9a87a97c-740b-4df5-8a5e-1c97188b511d	released	20.0	0.0	5.0	5.0	10.0	0.0	85.0	90.0	TOP	ac44810a-1366-4bc5-aa98-7d98ef8b6329	released									released	30.0	771811e3-740e-42fe-be9c-fd485997eaae	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A0G2_demographic	57	-20953		9d0e2902-bcba-53ff-bd4b-7c5d4e29e3ac	not hispanic or latino	female	asian	released	Alive	1940		TCGA-A5-A0G2_exposure	Not Reported	25.969529085872576	2d4ab07d-5569-586c-a6f5-c31fb4f41718	152.0	released	60.0	TCGA-A5-A0G2_diagnosis	20953	not reported	0	4549	e6730fe7-a340-5923-b5aa-9f29e1b840e5	Stage IIIB	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	1997	TCGA-A5-A0G2_treatment	TCGA-A5-A0G2_treatment_1	released	f807d385-a797-5faa-ab2f-89396c895cba	yes	Radiation Therapy, NOS	released	a1be7e6f-327b-5c5d-a093-b322ea54089b	no	Pharmaceutical Therapy, NOS	0369aff7-f987-4322-8ff7-78c2e4207555
43716956-aa57-46fb-afd7-0d244f21af00.htseq.counts.gz	91501ee4-54a7-4a19-86d7-6fbf1db61153	TCGA-FL-A1YU-11A-11R-A32Y-07	TCGA-FL-A1YU-11A-11R	TCGA-FL-A1YU-11A-01-TSA			TCGA-FL-A1YU-11A-11	TCGA-FL-A1YU-11A	TCGA-FL-A1YU	a94de778-9c21-410d-8b9d-0f9240036bb8	Not Reported	Uterus, NOS	TCGA-UCEC		50.0	False	false	50EB1015-2B54-4B28-B581-1F0707604595	1.6	f0d6b561-bfd2-41b7-a43c-1006370eec8f	0.16	23	released	7ea5bfa4-fc82-42cc-905e-4cc6eed54332	RNA	R	0.16	UV Spec	released	False	f5b0baf6-c7b1-4dda-846c-6f7a885169f7	11					100.0		0.0		TOP	2c88512b-6a11-47f8-9904-6ce354bcf8e4	released																				released	20.0	b28c3b96-d5a6-4209-831f-5e1f0277d825	Solid Tissue Normal	11	released	Not Reported	released																																																			91501ee4-54a7-4a19-86d7-6fbf1db61153
6698a82c-ebeb-406f-bc7a-5afa09b29e11.htseq.counts.gz	13560de5-f020-49c0-aa82-2df9b228eb4b	TCGA-FI-A2D2-01A-11R-A17B-07	TCGA-FI-A2D2-01A-11R	TCGA-FI-A2D2-01A-01-TS1			TCGA-FI-A2D2-01A-11	TCGA-FI-A2D2-01A	TCGA-FI-A2D2	46a1fdb9-548d-44d1-ab77-d51d44ac8198	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	975	70.0	False	true	75FB8F31-5C30-48C2-B4A5-2DA184DC039C	1.95	941d70e7-2ac8-4809-baa4-7752df3c2ee3	0.16	23	released	c9233516-26d9-4230-9b72-2512aedc6ca3	RNA	R	0.16	UV Spec	released	False	fb6cd920-0c8b-4726-b271-725cce48d973	11	5.0	5.0	2.0	5.0	0.0	2.0	96.0	98.0	TOP	20aa144e-37b9-4758-86e8-5ea6e409ce1d	released																				released	30.0	88f8998f-3d6a-4f9d-8b82-3250d26f5065	Primary Tumor	01	released	Not Reported	released	TCGA-FI-A2D2_demographic	66	-24260	2352	eba1519c-68e7-55ca-b7cb-8d2133a25108	not hispanic or latino	female	white	released	Dead	1942		TCGA-FI-A2D2_exposure	Not Reported	58.81519274376417	cceaba09-e187-5318-9464-f2d37f675654	168.0	released	166.0	TCGA-FI-A2D2_diagnosis	24260	not reported	0	1215	d4f21a6a-c973-5e3b-8577-7ae13dc8940b	Stage IB	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-FI-A2D2_treatment_1	TCGA-FI-A2D2_treatment	released	09fecd14-df07-5796-afde-06bd727bb3a3	yes	Pharmaceutical Therapy, NOS	released	6bbd9db0-e25d-5db8-b5a1-3fa7aa9c898b	no	Radiation Therapy, NOS	13560de5-f020-49c0-aa82-2df9b228eb4b
7b91ee01-c8c0-45f3-9654-e911a2a73fab.htseq.counts.gz	d461302f-84ca-46fb-a6e0-f670dd47b1c8	TCGA-AP-A056-01A-11R-A00V-07	TCGA-AP-A056-01A-11R	TCGA-AP-A056-01A-01-BSA	TCGA-AP-A056-01A-01-TSA		TCGA-AP-A056-01A-11	TCGA-AP-A056-01A	TCGA-AP-A056	585a1f31-3804-43ca-81e9-4e571fe03642	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	2017	400.0	False	true	008786AD-6CA8-488D-A5AC-BA558985E765	1.81	833990d5-5a6c-4d68-b15b-f2cc2309c611	0.15	23	released	64dbaa92-b80b-4c31-91f3-f955a1847324	RNA	R	0.15	UV Spec	released	False	8976fb33-0aaf-434f-ab18-4b0ac4509e13	11	14.0	0.0	6.0	0.0	0.0	40.0	54.0	60.0	BOTTOM	ac762006-4ba4-4016-add7-a502e2ba45cd	released	1.0	0.0	3.0	0.0	0.0	25.0	72.0	88.0	TOP	e03de89a-1175-4559-99be-b79e4c014e70	released									released	30.0	1d811231-b972-4977-890d-1fbb9109d61d	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A056_demographic	64	-23707		e8476897-909b-57ac-abe1-14a9f79e2a3a	not reported	female	white	released	Alive	1940		TCGA-AP-A056_exposure	Not Reported	24.560326301478007	73c2882c-5903-5d51-9ac9-2d83cff2197a	151.0	released	56.0	TCGA-AP-A056_diagnosis	23707	not reported	0	2618	dca335c4-c79c-5c18-8bac-7e8070caebd4	Stage II	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2004	TCGA-AP-A056_treatment_1	TCGA-AP-A056_treatment	released	f54698ec-b9dc-5d01-9a16-f55b8e6101da	no	Pharmaceutical Therapy, NOS	released	5c8b1d8c-39b7-5624-8cd9-93f44f9220bc	yes	Radiation Therapy, NOS	d461302f-84ca-46fb-a6e0-f670dd47b1c8
e5b7fd98-9b6f-4bbe-b8dc-c92de129a86c.htseq.counts.gz	f0516a16-9029-4683-a75b-e93872283c2c	TCGA-D1-A17R-01A-11R-A12I-07	TCGA-D1-A17R-01A-11R	TCGA-D1-A17R-01A-01-TSA			TCGA-D1-A17R-01A-11	TCGA-D1-A17R-01A	TCGA-D1-A17R	73a0dd38-115d-48fb-b683-04aa5d612f2a	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	443	150.0	False	false	51598364-A609-4EBC-8500-53042C9E79E9	1.76	e500f620-089f-4e15-ba8c-25c91e88e7e2	0.17	23	released	718bd3a2-73ba-431b-8839-21ae908383d9	RNA	R	0.17	UV Spec	released	False	bbf8f7ac-bebb-4104-919e-c26b7afab238	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	TOP	d292545c-33f3-4a6c-8733-9ad31ee5b43d	released																				released	30.0	205de3e7-b078-4904-82c3-3d0f757d94a8	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A17R_demographic	58	-21382	339	19d4a3c9-de61-5c42-b9fa-c1f83f34a08c	not hispanic or latino	female	white	released	Dead	1951	2009	TCGA-D1-A17R_exposure	Not Reported	46.280991735537185	894c1492-59af-526b-9cdd-08fd4188f1b1	165.0	released	126.0	TCGA-D1-A17R_diagnosis	21382	not reported	0		38409ad3-77ba-53f6-951c-92fc23d78067	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-D1-A17R_treatment_1	TCGA-D1-A17R_treatment	released	963c26af-280a-5ef2-9fec-70c2e18dcf3d	no	Pharmaceutical Therapy, NOS	released	5c57bd8f-8573-569b-81a6-b92af2efa9b8	no	Radiation Therapy, NOS	f0516a16-9029-4683-a75b-e93872283c2c
4131e0c9-7757-444c-9c1d-996a80f156f1.htseq.counts.gz	99ced843-779d-42e3-bfb3-3082696cf3aa	TCGA-AX-A060-01A-11R-A00V-07	TCGA-AX-A060-01A-11R	TCGA-AX-A060-01A-01-BS1	TCGA-AX-A060-01A-01-TS1		TCGA-AX-A060-01A-11	TCGA-AX-A060-01A	TCGA-AX-A060	d1b615f4-50c9-497b-8a69-8de78aa17e09	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1033	170.0	False	false	9086A79B-F764-42D4-BD9A-4C4F9F65C92B	1.77	3289fb8a-7268-4669-8d0c-471fc24a8607	0.15	23	released	04853f6b-883a-44de-aa34-f3a40f3ab02e	RNA	R	0.15	UV Spec	released	False	c594df1d-ac4c-40a5-9561-fe3fe4110033	11	0.0	0.0	11.0	2.0	4.0	4.0	81.0	96.0	BOTTOM	0bb77d77-b5c6-43d2-a2ad-c57ea2effd11	released	1.0	0.0	15.0	0.0	3.0	2.0	80.0	95.0	TOP	ec8525f0-2d81-426e-8fc8-814988e22a70	released									released	20.0	7b7fd42b-451a-40d8-8b00-cbf745493115	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A060_demographic	77	-28472		19a24b4b-1b54-5c06-ae56-8d3dde47aadd	not hispanic or latino	female	american indian or alaska native	released	Alive	1930		TCGA-AX-A060_exposure	Not Reported	32.744928299898376	e6432995-20a1-527d-89a5-87927bc855ae	163.0	released	87.0	TCGA-AX-A060_diagnosis	28472	not reported	0	1075	f7ad81f2-cea4-5e5f-8da3-33ec4c74256b	Stage IC	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2007	TCGA-AX-A060_treatment	TCGA-AX-A060_treatment_1	released	8d747551-451b-5b61-8052-319604eba5dd	yes	Radiation Therapy, NOS	released	360282af-35d5-56da-8d28-a126b0eb6aa4	yes	Pharmaceutical Therapy, NOS	99ced843-779d-42e3-bfb3-3082696cf3aa
6c4b016e-c2dc-4a85-97fb-65ea8b4d0603.htseq.counts.gz	d8a2954e-19c2-4db5-ba50-542c546c389a	TCGA-BS-A0UT-01A-11R-A104-07	TCGA-BS-A0UT-01A-11R	TCGA-BS-A0UT-01A-01-MS1	TCGA-BS-A0UT-01A-01-BS1		TCGA-BS-A0UT-01A-11	TCGA-BS-A0UT-01A	TCGA-BS-A0UT	e2b1d0de-5221-44a1-8fad-9708a3cada14	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1886	90.0	False	false	326838B8-D069-4F9C-9353-F806B56DCA48	1.96	ece7dac4-4f09-45c9-8a63-e4375ebf4c88	0.15	23	released	f1e37c6e-1d50-407d-a171-185a5cde86b7	RNA	R	0.15	UV Spec	released	False	bf01b704-9b64-43c2-89f7-a848ef0ec454	11	0.0	0.0	0.0	0.0	0.0	5.0	95.0	80.0	TOP	02478d6c-0328-4ee3-b083-1151dd8e0c62	released	80.0	0.0	5.0	20.0	0.0	25.0	70.0	70.0	BOTTOM	127548ac-fad7-4f4b-a142-9e3a7558159d	released									released	20.0	824d0dbc-293f-4893-a68c-24dedd437ea5	Primary Tumor	01	released	Not Reported	released	TCGA-BS-A0UT_demographic	62	-22775		4483f9f3-4e11-52f5-bdd7-074f47cde40d	not hispanic or latino	female	asian	released	Alive	1943		TCGA-BS-A0UT_exposure	Not Reported	28.133656509695292	1d16e31a-179d-5e78-b92e-4e8bb3607b7c	152.0	released	65.0	TCGA-BS-A0UT_diagnosis	22775	not reported	0	2212	c8e7cb30-8811-5468-920d-1c0643a8a7ed	Stage IIB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2005	TCGA-BS-A0UT_treatment	TCGA-BS-A0UT_treatment_1	released	c84b6211-ff3a-5f74-a2c2-a3f49115c195	no	Radiation Therapy, NOS	released	29186fb6-45f3-5483-8932-aa5d44e38dda	no	Pharmaceutical Therapy, NOS	d8a2954e-19c2-4db5-ba50-542c546c389a
1e6c7c12-a08f-459a-b583-0e80637f10cd.htseq.counts.gz	9ea9c3a4-caed-41af-9db5-204b4d860b2b	TCGA-AX-A2H7-01A-12R-A18M-07	TCGA-AX-A2H7-01A-12R	TCGA-AX-A2H7-01A-01-TSA			TCGA-AX-A2H7-01A-12	TCGA-AX-A2H7-01A	TCGA-AX-A2H7	a1780432-860e-4bff-9b66-a1e25c0076fe	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	951	160.0	False	false	76630DF8-2D08-4CF8-8B07-ACCE872B3ED1	1.8	25dd0765-735c-4146-9551-cdfdd9213593	0.15	23	released	b7857b18-8f2d-457b-b1c0-058c9c987b17	RNA	R	0.15	UV Spec	released	False	873200a2-04af-4fc5-a386-389aee4092ad	12	0.0	1.0	2.0	0.0	0.0	5.0	93.0	97.0	TOP	d5b7be92-43c9-408e-a25c-3aa2d9d5c4e0	released																				released	30.0	7077ce1b-d224-4313-9d71-1a3eee54ffaf	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A2H7_demographic	87	-32100	772	c44cf1de-5a77-5fad-b61a-6878e3bdb55c	not hispanic or latino	female	white	released	Dead	1921		TCGA-AX-A2H7_exposure	Not Reported	26.314635323012148	f3a96c85-baf7-5004-a921-1030ea0f6e49	151.0	released	60.0	TCGA-AX-A2H7_diagnosis	32100	not reported	0	772	bebfb9f5-f3ef-5aa7-a11f-2616dfdee4a0	Stage IC	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-AX-A2H7_treatment_1	TCGA-AX-A2H7_treatment	released	4aff596f-5bba-566b-9f7b-c597e18c154a	no	Pharmaceutical Therapy, NOS	released	315b14aa-f4e7-5df3-9968-9be063f71479	yes	Radiation Therapy, NOS	9ea9c3a4-caed-41af-9db5-204b4d860b2b
65961154-aacc-4c6e-a87c-145c0b5ac55d.htseq.counts.gz	e50d2352-dfa9-4c06-b070-91f526e17f79	TCGA-A5-A2K3-01A-11R-A32Y-07	TCGA-A5-A2K3-01A-11R	TCGA-A5-A2K3-01A-01-TSA			TCGA-A5-A2K3-01A-11	TCGA-A5-A2K3-01A	TCGA-A5-A2K3	c3096984-bd11-44a0-8ee0-47f07ad04d81	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	1431	120.0	False	true	D38D2FD4-78EF-4F49-976E-529055A6D9A9	1.79	ef76bd16-f313-4d92-8040-44e7068958a7	0.17	23	released	dd3794f2-4bea-49de-8286-86760c291d2c	RNA	R	0.17	UV Spec	released	False	f1fe2759-7cc4-494e-8b91-546f78e42f74	11	3.0	1.0	5.0	0.0	0.0	5.0	90.0	85.0	TOP	3955dfaf-9ccf-4946-b662-bfbb11f7089d	released																				released	30.0	b6e6722f-cefe-4eb7-8545-94383659db9a	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A2K3_demographic	68	-24907		018043c6-bd82-5183-8d98-7b422d6d321c	not hispanic or latino	female	white	released	Alive	1939		TCGA-A5-A2K3_exposure	Not Reported	31.25	d7b1c567-84eb-57ac-ba1d-fc5be9dc4c1e	160.0	released	80.0	TCGA-A5-A2K3_diagnosis	24907	not reported	0	2012	18dc7277-755f-57f0-adad-d98b47ecb6d1	Stage IA	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2007	TCGA-A5-A2K3_treatment_1	TCGA-A5-A2K3_treatment	released	538fdc1e-e7d0-5284-8368-f0c43a33be73	yes	Pharmaceutical Therapy, NOS	released	3accfced-92be-5249-8170-f255470aad79	no	Radiation Therapy, NOS	e50d2352-dfa9-4c06-b070-91f526e17f79
0f2e7130-fc3e-4e65-a369-38d4ed1c6fe4.htseq.counts.gz	aa4126c7-d788-43ba-94ea-a4939e5b5d2f	TCGA-AP-A05H-01A-11R-A00V-07	TCGA-AP-A05H-01A-11R	TCGA-AP-A05H-01A-01-TS1	TCGA-AP-A05H-01A-01-BS1		TCGA-AP-A05H-01A-11	TCGA-AP-A05H-01A	TCGA-AP-A05H	fe5f4822-37a3-4f9e-8d33-8b9f36bf6895	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	706	210.0	False	true	805B997D-9755-4AC1-8695-294806148F25	1.74	b3516570-4a66-418f-87e1-32829d67ec1c	0.16	23	released	33d80d70-4e03-441a-b407-c6b02a5ffae1	RNA	R	0.16	UV Spec	released	False	74b9930e-1b76-4659-907e-24c440576eff	11	3.0	0.0	10.0	0.0	15.0	10.0	65.0	75.0	TOP	268e0275-f970-496b-8ae7-276499fea6d7	released	1.0	0.0	5.0	0.0	10.0	5.0	80.0	90.0	BOTTOM	a9b54b34-76e2-4a74-b319-2eecd84aaba5	released									released	40.0	e417cb26-f6e8-4a31-b7e0-5bb43fd587b1	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A05H_demographic	75	-27744		73f1bca1-fc2b-5767-899a-8ff467a68d62	not reported	female	white	released	Alive	1933		TCGA-AP-A05H_exposure	Not Reported	38.01956512452475	e67bd6f4-8e38-52c7-9e2f-4c929dca598c	153.0	released	89.0	TCGA-AP-A05H_diagnosis	27744	not reported	0	1385	5814746b-6afc-5eda-90ad-4e03e226a6dc	Stage IB	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-AP-A05H_treatment	TCGA-AP-A05H_treatment_1	released	64c69722-979e-5ecd-8ce1-c3e6c4394bcb	yes	Radiation Therapy, NOS	released	9ccec149-c224-5bcf-b6bf-42e6d9b6b6d0	yes	Pharmaceutical Therapy, NOS	aa4126c7-d788-43ba-94ea-a4939e5b5d2f
5d72242b-938d-43cc-ba30-015ffaca9986.htseq.counts.gz	dbb30cde-07f5-4cc7-a8a2-ea14cbf385b4	TCGA-AX-A3FV-01A-11R-A22K-07	TCGA-AX-A3FV-01A-11R	TCGA-AX-A3FV-01A-01-TS1			TCGA-AX-A3FV-01A-11	TCGA-AX-A3FV-01A	TCGA-AX-A3FV	a033fbea-7cd0-4e65-94c4-b54f2f80b895	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	799	100.0	False	false	0D1601D0-E0F4-4DBA-91EA-62092FE8621F	1.86	3f24dcf1-9ec6-4ec4-9379-f9051151c639	0.17	23	released	15a8b76e-17b4-4d5a-9602-1f5b7bd806dd	RNA	R	0.17	UV Spec	released	False	d5d650d9-74f9-409d-882d-3697b716be27	11	0.0	0.0	5.0	0.0	0.0	5.0	90.0	97.0	TOP	ab1337a9-1fa9-433a-9b1a-73963cf61f32	released																				released	30.0	1661922c-cd0a-4b1e-a9bf-4aefe10654a6	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A3FV_demographic	62	-22752		68eeb680-0c16-5cd2-ad66-077e1551696c	not hispanic or latino	female	white	released	Alive	1947		TCGA-AX-A3FV_exposure	Not Reported	48.909279778393355	a405c9ed-a2fe-52ee-9dd3-fe6c3c7fbeb8	152.0	released	113.0	TCGA-AX-A3FV_diagnosis	22752	not reported	0	-6	29e797a7-4a65-573e-b3a7-8650ffca6ed2	Stage IIIA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-AX-A3FV_treatment_1	TCGA-AX-A3FV_treatment	released	825bcf89-04f6-5d73-b31f-537a3f43b279	not reported	Pharmaceutical Therapy, NOS	released	521523e4-353b-5e8d-bf02-62daef0086d1	not reported	Radiation Therapy, NOS	dbb30cde-07f5-4cc7-a8a2-ea14cbf385b4
f4dc779b-628d-443d-9dc5-de478efff865.htseq.counts.gz	51e3c862-90ba-4bd1-9b2c-e894259bdc65	TCGA-D1-A16F-01A-11R-A12I-07	TCGA-D1-A16F-01A-11R	TCGA-D1-A16F-01A-01-TS1			TCGA-D1-A16F-01A-11	TCGA-D1-A16F-01A	TCGA-D1-A16F	60c65e5e-57a4-4f15-8b95-30bd2dbd9010	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	783	280.0	False	false	E89C4CBF-45D5-405D-A673-F67186C206B3	2.06	7eab3a7a-c66e-4289-8fb4-ae751b2103e6	0.16	23	released	73b79b06-1325-44b2-90ff-f88538108f69	RNA	R	0.16	UV Spec	released	False	efe393cb-bd3a-40dc-9a3a-50568bcf9479	11	0.0	0.0	0.0	0.0	0.0	34.0	66.0	66.0	TOP	086af72a-e40c-4556-ba18-4e9d03959230	released																				released	30.0	25b73036-0cd7-43e1-b40e-b2e01c1b7247	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A16F_demographic	60	-22242		6ce087d0-d4e5-5568-a73d-d12df1aba4d9	not hispanic or latino	female	white	released	Alive	1948		TCGA-D1-A16F_exposure	Not Reported	36.51263742951032	7a07d5ed-f44d-5740-ba0c-33040e723b46	157.0	released	90.0	TCGA-D1-A16F_diagnosis	22242	not reported	0	80	f14db50e-6bd3-55e2-9bc0-0a71a28eae56	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-D1-A16F_treatment_1	TCGA-D1-A16F_treatment	released	bed42bf0-934d-537e-8dcb-b84efb137ab9	no	Pharmaceutical Therapy, NOS	released	37a24e06-4f5f-5676-8e4f-9c28fe0910f1	no	Radiation Therapy, NOS	51e3c862-90ba-4bd1-9b2c-e894259bdc65
fc56bcfb-cda6-421a-847d-2adcaf6c5fa2.htseq.counts.gz	9d08dab0-14fd-4e50-bb33-ff801fb3c090	TCGA-JU-AAVI-01A-11R-A40A-07	TCGA-JU-AAVI-01A-11R	TCGA-JU-AAVI-01A-01-TS1			TCGA-JU-AAVI-01A-11	TCGA-JU-AAVI-01A	TCGA-JU-AAVI	3e41cf2f-3de9-44c1-a819-bce693baf67d	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	139	20.0	False	true	8639CE54-3D67-4E2E-BECB-26755EE726C5	1.89	e860c29e-5d8d-4aee-b631-f55664403bdc	0.17	23	released	31ec5057-1917-42bd-99d9-3b0566ab73f7	RNA	R	0.17	UV Spec	released	False	46ed15de-e90c-4e4a-ae47-f0e69c6fc60e	11	40.0	20.0	5.0	20.0	0.0	25.0	70.0	70.0	TOP	10379d62-7652-49df-a79e-5ea5309dce09	released																				released	20.0	1b186f8e-06a6-488b-b4ce-f59cb0318034	Primary Tumor	01	released	Not Reported	released	TCGA-JU-AAVI_demographic	61	-22289	540	f907a2a5-22a2-58dd-866e-d9feb0d7969f	not hispanic or latino	female	black or african american	released	Dead	1952		TCGA-JU-AAVI_exposure	Not Reported	53.77777777777778	2fda767d-3b7e-5a8f-8783-ac99625a5402	150.0	released	121.0	TCGA-JU-AAVI_diagnosis	22289	not reported	0	236	f3001592-e8ec-56a5-8d72-3d58846fe180	Stage IIIC1	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2013	TCGA-JU-AAVI_treatment_1	TCGA-JU-AAVI_treatment	released	5ff486e6-081d-5227-bded-e56c5d6b5f87	yes	Pharmaceutical Therapy, NOS	released	b3f73560-67d6-545c-9828-aa622d764e30	yes	Radiation Therapy, NOS	9d08dab0-14fd-4e50-bb33-ff801fb3c090
5e7058fb-cdb8-49c1-9272-7bf43a03b192.htseq.counts.gz	63bb9680-51f5-40de-92e5-6013e03d27dd	TCGA-AX-A06L-01A-11R-A118-07	TCGA-AX-A06L-01A-11R	TCGA-AX-A06L-01A-01-TS1	TCGA-AX-A06L-01A-01-BS1		TCGA-AX-A06L-01A-11	TCGA-AX-A06L-01A	TCGA-AX-A06L	f4a7f2ff-be76-48d3-9f59-9223db33680e	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1499	250.0	False	false	926937F8-6057-4D39-BB3B-0115B0ACFE1A	1.89	06ee29fc-036c-4c36-b62b-f304c6ccad50	0.16	23	released	31d6e8a6-2a9c-4157-9b4d-0f26f1e8c27f	RNA	R	0.16	UV Spec	released	False	64d6aa68-f337-4991-8fd5-7ae7b177e89e	11	12.0	0.0	8.0	1.0	25.0	2.0	65.0	60.0	TOP	ca0dcaa3-74fa-46fe-910d-0d6557fc269e	released	2.0	0.0	10.0	0.0	30.0	0.0	60.0	60.0	BOTTOM	8e604aa5-2798-4d40-9b45-d521e460119e	released									released	30.0	cacec107-78de-47c7-9386-dbefcfc1f07a	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A06L_demographic	63	-23294		316d7ad8-9075-5bbb-b4b3-a38a05ae77c3	not reported	female	white	released	Alive	1943		TCGA-AX-A06L_exposure	Not Reported	43.20820955981636	85a52fcc-f951-51f5-a7b8-240c2adde653	161.0	released	112.0	TCGA-AX-A06L_diagnosis	23294	not reported	0	1845	5ade4692-b9f4-5130-802d-4408788d54fe	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2006	TCGA-AX-A06L_treatment_1	TCGA-AX-A06L_treatment	released	a70c725b-b893-5790-ad07-933ed2f11072	no	Pharmaceutical Therapy, NOS	released	5cfbda68-70ae-50f0-9817-479a5ed5d894	no	Radiation Therapy, NOS	63bb9680-51f5-40de-92e5-6013e03d27dd
34cf0edc-ba30-466b-a52a-f9dd7f1b146f.htseq.counts.gz	3952e1a0-0dec-4be3-a636-9d2aff9dcb3b	TCGA-BG-A3PP-01A-11R-A22K-07	TCGA-BG-A3PP-01A-11R	TCGA-BG-A3PP-01A-01-TSA			TCGA-BG-A3PP-01A-11	TCGA-BG-A3PP-01A	TCGA-BG-A3PP	9f92080f-f6e0-42db-a02b-b3069664f6d0	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	143	320.0	False	true	728D12CF-B846-49B7-8B16-463460CAD5C0	2.07	5ece050b-b22d-44b9-b920-257a351b5602	0.17	23	released	4ec9612e-dcdf-4613-becc-162daaac0756	RNA	R	0.17	UV Spec	released	False	40ee0b33-13ad-41e2-a083-174ce0ecd125	11	2.0	0.0	5.0	0.0	15.0	0.0	80.0	70.0	TOP	2e4ac653-5b8b-4fc1-ae25-82542db00b02	released																				released	30.0	b3533e99-9a5d-46a5-8d7e-d1b6192d5edd	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A3PP_demographic	82	-30227		190653c3-b629-5caf-8cad-8a6dfc4b62f9	not hispanic or latino	female	white	released	Alive	1929		TCGA-BG-A3PP_exposure	Not Reported		bbd5e0eb-5769-510a-ba7f-0a38d9fea1da		released		TCGA-BG-A3PP_diagnosis	30227	not reported	0	681	0facab6a-307d-5b57-af33-9afebf96a986	Stage II	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-BG-A3PP_treatment	TCGA-BG-A3PP_treatment_1	released	b7e48094-6fa6-509e-b289-82ec1f865547	yes	Radiation Therapy, NOS	released	1b785a2b-d020-5e7f-a5b1-e963b7d53daf	yes	Pharmaceutical Therapy, NOS	3952e1a0-0dec-4be3-a636-9d2aff9dcb3b
10a0aa68-3dda-4fe7-8fe8-57d42208fd3b.htseq.counts.gz	e619dd2e-aeb2-4911-b87a-93aea2ea3439	TCGA-B5-A1MU-01A-11R-A13S-07	TCGA-B5-A1MU-01A-11R	TCGA-B5-A1MU-01A-01-TSA			TCGA-B5-A1MU-01A-11	TCGA-B5-A1MU-01A	TCGA-B5-A1MU	f5261330-596e-4632-a5a3-8d3a2aa5de38	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	1834	260.0	False	true	FC3D9B79-4CAD-4F62-892C-C830B24E50DD	2.01	5afaa343-65f0-4499-a44d-c3c87106443a	0.16	23	released	d8b424e2-38c4-45e1-8a61-1795833490d2	RNA	R	0.16	UV Spec	released	False	4e509b6d-76f8-41a4-ad71-03b0eecdecad	11	8.0	3.0	0.0	3.0	0.0	15.0	85.0	85.0	TOP	c5dd96b2-fa10-4e66-96ec-eb7356560d4f	released																				released	30.0	bb3bdc38-8011-4427-a863-eba7a6cfff69	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A1MU_demographic	79	-29027	1548	202c205f-99be-54e1-b30f-7cc2d63ef130	not reported	female	white	released	Dead	1927	2010	TCGA-B5-A1MU_exposure	Not Reported	20.361886251099076	b6f82407-1bc9-566e-8db9-414c2becd5aa	147.0	released	44.0	TCGA-B5-A1MU_diagnosis	29027	not reported	0		13c28c27-513b-56ac-9f50-4a80d1dd06b2	Stage IVB	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2006	TCGA-B5-A1MU_treatment	TCGA-B5-A1MU_treatment_1	released	c8387477-25d3-53c1-b867-4a69dc0cb943	no	Radiation Therapy, NOS	released	bd99e4b0-d6e0-5668-acf5-1ad44f11685f	no	Pharmaceutical Therapy, NOS	e619dd2e-aeb2-4911-b87a-93aea2ea3439
3f4ffd99-d1b2-4f56-8ba8-071f59503c8a.htseq.counts.gz	03f168e7-5508-4117-add6-e8e1c0f3966a	TCGA-A5-A0RA-01A-21R-A104-07	TCGA-A5-A0RA-01A-21R	TCGA-A5-A0RA-01A-02-BS2	TCGA-A5-A0RA-01A-01-BS1		TCGA-A5-A0RA-01A-21	TCGA-A5-A0RA-01A	TCGA-A5-A0RA	afd710b8-d172-4ac4-9973-e969db1ed231	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	492	270.0	False	true	EB6E4309-9CE1-468A-A94B-907874BDE9DE	1.87	7a051ecb-ad2d-4c98-8b91-96b66110a46e	0.14	23	released	f02c5538-7df2-450e-9ca9-6e4f486b3a33	RNA	R	0.14	UV Spec	released	False	7257e875-f62e-4a96-b706-08d202267e81	21	20.0	20.0	10.0	40.0	0.0	5.0	85.0	80.0	BOTTOM	39e37d9a-6328-4504-985d-52199e42f1fb	released	30.0	20.0	5.0	30.0	5.0	20.0	70.0	70.0	TOP	da7de47e-22bd-4c64-9141-0c0c18bd5188	released									released	30.0	4ed231ee-0e54-4ac5-8278-1061ad3972a2	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A0RA_demographic	68	-25060		0c86e026-26be-5c46-b41c-fa8aaaf5668b	not hispanic or latino	female	white	released	Alive	1941		TCGA-A5-A0RA_exposure	Not Reported	47.03433922996878	aaaca63f-90b0-5526-88c9-b08163906748	155.0	released	113.0	TCGA-A5-A0RA_diagnosis	25060	not reported	0	884	b4cac064-3445-58c8-8349-dbf25cf9fe3d	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-A5-A0RA_treatment_1	TCGA-A5-A0RA_treatment	released	9638559e-52a6-5423-abef-153337732e62	no	Pharmaceutical Therapy, NOS	released	778d9f52-fdff-5736-b77a-bd0338744023	yes	Radiation Therapy, NOS	03f168e7-5508-4117-add6-e8e1c0f3966a
d90b08ef-512b-41b3-a329-45b0fd741587.htseq.counts.gz	c1de8534-362b-48dc-a32f-aa2c1cc4e8e3	TCGA-BG-A0MK-01A-51R-A19W-07	TCGA-BG-A0MK-01A-51R	TCGA-BG-A0MK-01A-05-TS5			TCGA-BG-A0MK-01A-51	TCGA-BG-A0MK-01A	TCGA-BG-A0MK	1f9b1b71-8753-4cd5-a585-708bea8ff1fa	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1399	1100.0	False	true	9D631FCB-78A9-4CA9-A033-D66CB78D8CA3	1.79	1f577d0a-ab0b-4464-b75d-4d3dc2b80cd3	0.18	23	released	fe6f1bc1-3e94-47ae-be64-b1bd3fd3c4ff	RNA	R	0.18	UV Spec	released	False	079c2833-c221-4766-9eff-1761441a1427	51	0.0	0.0	15.0	0.0	0.0	15.0	70.0	60.0	TOP	cedc4148-a29a-4a96-8862-6db908805e6c	released																				released	26.0	24678d73-94e1-49b4-a772-bda6a02d6075	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A0MK_demographic	52	-19034	1317	a4b71057-d927-5959-83ac-9a5e77c626eb	not hispanic or latino	female	black or african american	released	Dead	1954	2009	TCGA-BG-A0MK_exposure	Not Reported		fdbdaae8-8c77-515c-9825-dbe9990a51bf		released		TCGA-BG-A0MK_diagnosis	19034	not reported	0		d4f3ce8c-2851-5c83-b8ab-35ab88dbe5ed	Stage IIB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2006	TCGA-BG-A0MK_treatment_1	TCGA-BG-A0MK_treatment	released	d47a9609-4f1f-5aff-835b-5fba0d30095e	no	Pharmaceutical Therapy, NOS	released	a73bdb4d-be63-5b60-86b5-2ae334cd5c9c	yes	Radiation Therapy, NOS	c1de8534-362b-48dc-a32f-aa2c1cc4e8e3
09c3eb98-12e5-4dd9-8866-36e9fecf857e.htseq.counts.gz	5e2a12e5-9258-46a4-a157-553ed57bcdbe	TCGA-A5-A0GB-01A-11R-A040-07	TCGA-A5-A0GB-01A-11R	TCGA-A5-A0GB-01A-01-TSA	TCGA-A5-A0GB-01A-01-BSA		TCGA-A5-A0GB-01A-11	TCGA-A5-A0GB-01A	TCGA-A5-A0GB	2f4458b6-3caf-4e33-890e-a04722badd1b	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	583	190.0	False	true	8AC80DBE-46DE-46D5-B900-C807CBE941A6	1.86	12960b87-9d83-41e5-8980-a1ebe955fd73	0.16	23	released	b60870d7-218a-4a10-8a7f-e1431632918d	RNA	R	0.16	UV Spec	released	False	15061268-90ca-45a4-a72f-b88b5f81d52a	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	90.0	TOP	25405f52-e599-41e8-82e7-248e9f2a2fc6	released	0.0	0.0	0.0	0.0	0.0	0.0	100.0	90.0	BOTTOM	53aac88b-c777-4c27-ba31-97d351b51b80	released									released	30.0	130744ca-a9a2-4c99-8abb-20fe76e0a955	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A0GB_demographic	65	-23883		b6988514-2f1c-5264-b604-412054c5d4ec	not reported	female	white	released	Alive	1943		TCGA-A5-A0GB_exposure	Not Reported	44.81175390266299	e4415b90-5857-57a7-a438-acd9c9e531b6	165.0	released	122.0	TCGA-A5-A0GB_diagnosis	23883	not reported	0	997	aafd3d0a-9b88-5dbe-8e83-18aaccc30289	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-A5-A0GB_treatment_1	TCGA-A5-A0GB_treatment	released	f4e1b5dc-961a-52a2-b73d-fe8495c12bcf	no	Pharmaceutical Therapy, NOS	released	7197d523-7793-5e75-9fc6-af3694d40210	yes	Radiation Therapy, NOS	5e2a12e5-9258-46a4-a157-553ed57bcdbe
7a54b4d7-c87d-4f53-92e0-90c317f3e225.htseq.counts.gz	fe718908-1673-4aa0-8dfa-dd35d476d23d	TCGA-AX-A2HA-01A-12R-A18M-07	TCGA-AX-A2HA-01A-12R	TCGA-AX-A2HA-01A-01-TSA			TCGA-AX-A2HA-01A-12	TCGA-AX-A2HA-01A	TCGA-AX-A2HA	9d84dff8-6c19-4881-93c6-56c98a3049b5	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	2188	100.0	False	false	E44408C9-53DE-4FF7-8D8E-6BFAB24302C3	1.84	3df718d2-9089-4055-8190-adc218fd3216	0.16	23	released	c06ffb0f-4e7b-405b-beca-d44c8ebd5f55	RNA	R	0.16	UV Spec	released	False	5ac36dca-91c2-4259-aa72-2c34be3e056a	12	6.0	0.0	3.0	0.0	10.0	7.0	80.0	85.0	TOP	a2f0b4e7-4910-4be1-863e-32340ba709a0	released																				released	20.0	76742cf8-a932-47bd-acf9-c507184e02c3	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A2HA_demographic	35	-13142		dbd03450-1805-5569-9589-3d0455324e64	not reported	female	white	released	Alive	1970		TCGA-AX-A2HA_exposure	Not Reported	21.513858510523864	6b0affe5-8f9e-57cc-814d-5edb7d7d1245	167.0	released	60.0	TCGA-AX-A2HA_diagnosis	13142	not reported	0	2475	daae28ec-ef21-5f4d-9d8f-201866caca25	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2005	TCGA-AX-A2HA_treatment	TCGA-AX-A2HA_treatment_1	released	9fc2141a-cb1f-52c6-a705-83396cfe0c7b	no	Radiation Therapy, NOS	released	e3b3df41-6297-5045-b26d-fa07f07bb858	no	Pharmaceutical Therapy, NOS	fe718908-1673-4aa0-8dfa-dd35d476d23d
32321d7e-aeb9-4e0f-9653-e70e1f3b432a.htseq.counts.gz	d4556185-08ff-40de-a3a4-fcd38cfd2f09	TCGA-EY-A1GH-01A-11R-A13S-07	TCGA-EY-A1GH-01A-11R	TCGA-EY-A1GH-01A-01-TSA			TCGA-EY-A1GH-01A-11	TCGA-EY-A1GH-01A	TCGA-EY-A1GH	a45a2343-f425-4e62-9049-7782733b6234	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	452	280.0	False	false	29D738E9-2F8D-4909-A427-7C056859B89A	1.82	55f89e0e-bb6b-40e0-bc85-602a011c764b	0.15	23	released	ef84c144-3d07-471b-88cb-2a2ecf61c67c	RNA	R	0.15	UV Spec	released	False	cdb787bf-b97c-44d0-8be3-0fd4677e95f2	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	75.0	TOP	37a2f139-dd85-4660-9712-11fd5a006507	released																				released	30.0	b32b07ac-a84d-4b1d-89c9-ffe2e91ee037	Primary Tumor	01	released	Not Reported	released	TCGA-EY-A1GH_demographic	70	-25802		ea34983c-8abf-5e0e-b795-731c3baf565e	not hispanic or latino	female	white	released	Alive	1939		TCGA-EY-A1GH_exposure	Not Reported	40.484429065743946	9ef75f65-f805-509d-9a48-cd1a25a72a50	170.0	released	117.0	TCGA-EY-A1GH_diagnosis	25802	not reported	0	710	989578c6-378e-573e-9073-63846c0150e4	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-EY-A1GH_treatment	TCGA-EY-A1GH_treatment_1	released	f5d65e17-9e74-5109-b5a8-16f07cafdc9a	yes	Radiation Therapy, NOS	released	de48ecc3-ccb3-5277-a6bc-17c88e6b4b55	no	Pharmaceutical Therapy, NOS	d4556185-08ff-40de-a3a4-fcd38cfd2f09
94ca26b4-6673-4dba-a7d0-8e6a8c4b03ee.htseq.counts.gz	42102471-0891-4ca7-b9ad-d2647345624b	TCGA-AJ-A3EL-01A-11R-A213-07	TCGA-AJ-A3EL-01A-11R	TCGA-AJ-A3EL-01A-01-TS1			TCGA-AJ-A3EL-01A-11	TCGA-AJ-A3EL-01A	TCGA-AJ-A3EL	23e1d96e-6175-4145-8267-8f0a88f54c4d	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	317	20.0	False	false	CB5EF343-EDD4-46B1-82DD-48C49FF7E778	1.75	a7a5bc3b-d82d-447d-8679-47b48612834a	0.18	23	released	f6308920-b4d8-4dd5-a458-7c533232a365	RNA	R	0.18	UV Spec	released	False	79f3be31-a1fb-4eb1-a2ad-701b51a9b8ce	11	0.0	0.0	0.0	0.0	0.0	10.0	90.0	85.0	TOP	0cc3718e-f67a-46cc-9926-5ac056631340	released																				released	20.0	f82eeaf4-aa1a-422b-b16e-790241eea904	Primary Tumor	01	released	Not Reported	released	TCGA-AJ-A3EL_demographic	47	-17442		0427721e-1969-585e-96ef-584f2d46f0fc	not reported	female	native hawaiian or other pacific islander	released	Alive	1963		TCGA-AJ-A3EL_exposure	Not Reported	23.725286160249738	473a3a15-c909-5680-be4a-1f72b3b0f9cc	155.0	released	57.0	TCGA-AJ-A3EL_diagnosis	17442	not reported	0	684	99f23a7d-b458-552a-b214-67ede6224c8f	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-AJ-A3EL_treatment	TCGA-AJ-A3EL_treatment_1	released	e805f4ce-753c-5b66-9c83-4f12fba5debc	no	Radiation Therapy, NOS	released	d12f7316-7ab9-5b4f-8563-fdbcf8c02953	no	Pharmaceutical Therapy, NOS	42102471-0891-4ca7-b9ad-d2647345624b
c0401b43-aca6-49ef-90fa-1d4ec7cc2c1d.htseq.counts.gz	98af0447-c96d-491a-a385-7a5a0e83dc05	TCGA-EY-A3QX-01A-11R-A22K-07	TCGA-EY-A3QX-01A-11R	TCGA-EY-A3QX-01A-01-TS1			TCGA-EY-A3QX-01A-11	TCGA-EY-A3QX-01A	TCGA-EY-A3QX	8bb89c0f-0f04-485e-8e08-801042dfcba9	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	112	659.0	False	false	8AED036E-FB86-42D1-B840-FB4AD6E8D0EF	1.84	cdb9c4a5-81e3-4718-bb7e-ace2bc04b7c3	0.16	23	released	aafb0027-06fa-4d0a-8177-29fd04ddb7dd	RNA	R	0.16	UV Spec	released	False	a5d18bd4-0f54-4fd1-b2d6-09230a57836c	11	5.0	1.0	10.0	0.0	0.0	0.0	90.0	75.0	TOP	d77f35e6-7b7a-4a9e-9c31-acf9395a356e	released																				released	30.0	8d1365a7-c67c-4073-8483-8693d4683ccd	Primary Tumor	01	released	Not Reported	released	TCGA-EY-A3QX_demographic	64	-23663	989	02f9c51a-865f-5292-9165-f7d4c7de2cd1	not hispanic or latino	female	white	released	Dead	1947		TCGA-EY-A3QX_exposure	Not Reported	22.321428571428573	c3a523e8-bbb4-550a-a627-09cbd5ddb198	168.0	released	63.0	TCGA-EY-A3QX_diagnosis	23663	not reported	0	421	848350aa-eb1a-54e2-9b71-f9584248ad9d	Stage IVB	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-EY-A3QX_treatment_1	TCGA-EY-A3QX_treatment	released	8df28490-bdfb-5835-8d4e-68c71fdb00c8	yes	Pharmaceutical Therapy, NOS	released	2af2ea6f-38c3-5a69-93d1-349a4598bb99	no	Radiation Therapy, NOS	98af0447-c96d-491a-a385-7a5a0e83dc05
923257c8-8013-4ad6-b65c-e12142aa4e9c.htseq.counts.gz	b4659e8a-e136-47ec-9306-08491f4eeae9	TCGA-B5-A11F-01A-11R-A10J-07	TCGA-B5-A11F-01A-11R	TCGA-B5-A11F-01A-01-BSA	TCGA-B5-A11F-01A-01-TSA		TCGA-B5-A11F-01A-11	TCGA-B5-A11F-01A	TCGA-B5-A11F	3ea53b15-37f0-446e-a130-6bb2dee56865	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	5482	380.0	False	true	228E437D-FB45-452B-A5A0-299C125F4CC4	1.89	fb1c341a-34f7-482c-a954-de07652990b1	0.16	23	released	63a780b1-e01b-4e82-a6f9-6cfd37bcaf6a	RNA	R	0.16	UV Spec	released	False	f113093d-c776-4255-b05f-24745ea2aeab	11	3.0	6.0	5.0	1.0	0.0	5.0	90.0	90.0	BOTTOM	8b6d2a81-402d-4e95-97c1-f30b11a3e4f7	released	2.0	6.0	1.0	1.0	0.0	0.0	99.0	99.0	TOP	e4d98993-6567-436f-b48e-ca52818693b2	released									released	30.0	a4dabdb5-4a72-4e31-981b-2c501c8dc7ab	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A11F_demographic	55	-20171		de77fb9d-02b5-5d16-994a-46fa5a3e323b	not reported	female	white	released	Alive	1940		TCGA-B5-A11F_exposure	Not Reported		f143835a-fdff-516a-95d2-0fb21e7d3efc		released		TCGA-B5-A11F_diagnosis	20171	not reported	0	5651	c1904f6f-f484-5afb-85e3-f1c6eace9af7	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	1995	TCGA-B5-A11F_treatment	TCGA-B5-A11F_treatment_1	released	0e128094-cd09-58df-ae15-7738a966ef59	yes	Radiation Therapy, NOS	released	ce53c4f9-9b2b-502b-a11c-01006033761f	yes	Pharmaceutical Therapy, NOS	b4659e8a-e136-47ec-9306-08491f4eeae9
7a5aed1d-3dcd-408e-bb86-a0c5a2dbb0af.htseq.counts.gz	2646c426-fa11-4342-9ee9-1d9fe9f379a4	TCGA-EY-A1GX-01A-12R-A13S-07	TCGA-EY-A1GX-01A-12R	TCGA-EY-A1GX-01A-01-TSA			TCGA-EY-A1GX-01A-12	TCGA-EY-A1GX-01A	TCGA-EY-A1GX	a7fd6522-8953-461f-9e5f-fdeb7d180d46	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	172	370.0	False	false	4AD600AE-7CE0-4BBA-B4FC-0EB8C460502B	1.89	253d79e4-6505-4704-8cd4-aafa5d36b4a4	0.15	23	released	cf6a97de-ef94-4dea-aa94-1cc026e86039	RNA	R	0.15	UV Spec	released	False	6676b287-4309-4924-a5e7-f45e598d8e03	12	40.0	20.0	10.0	20.0	0.0	30.0	60.0	60.0	TOP	ea199ce8-d342-4084-89be-818eedd0a4ab	released																				released	20.0	a6a446ff-6dcf-4311-ac05-afb34fcb19a7	Primary Tumor	01	released	Not Reported	released	TCGA-EY-A1GX_demographic	76	-27962	1127	f1aab7a0-5038-57c0-bbcd-a20644b292c6	not hispanic or latino	female	white	released	Dead	1934		TCGA-EY-A1GX_exposure	Not Reported	26.953125	ac42e896-1a9c-5755-8a71-a1b9714f3795	160.0	released	69.0	TCGA-EY-A1GX_diagnosis	27962	not reported	0	197	51442c7f-83e1-5dee-b60b-d7393a63ebf6	Stage IIIA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-EY-A1GX_treatment_1	TCGA-EY-A1GX_treatment	released	0e070553-66a4-57a2-83a2-7f790e72568a	no	Pharmaceutical Therapy, NOS	released	2e803209-934e-5057-ac22-b2e4f59b52c9	yes	Radiation Therapy, NOS	2646c426-fa11-4342-9ee9-1d9fe9f379a4
91a3f291-9335-409c-bdf1-f788cce9c4af.htseq.counts.gz	5c6c0b25-86a7-4c57-8d7a-35dd35867914	TCGA-AJ-A3NE-11A-11R-A22K-07	TCGA-AJ-A3NE-11A-11R	TCGA-AJ-A3NE-11A-01-TS1			TCGA-AJ-A3NE-11A-11	TCGA-AJ-A3NE-11A	TCGA-AJ-A3NE	1dcf33e9-4c9b-4b2b-914e-15e6be5dcd07	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	134	80.0	False	false		1.86	b4a85000-c0fd-4287-83f2-fc0757fe4a60	0.17	23	released	b814ac8a-7d7d-4007-bf95-28c4680a27a4	RNA	R	0.17	UV Spec	released	False	ab420324-a508-4e09-9be6-8a421be7a5d5	11	1.0	0.0	0.0	0.0	100.0	0.0	0.0	0.0	TOP	de5980fa-a4fd-43f7-a8cc-e20e18b890b8	released																				released	30.0	6436be59-08e6-4db6-9d8d-fbecfbc00b7c	Solid Tissue Normal	11	released	Not Reported	released	TCGA-AJ-A3NE_demographic	46	-16957		7cd0bfbb-89d6-5f79-8bee-d7a676d2e60d	not hispanic or latino	female	white	released	Alive	1965		TCGA-AJ-A3NE_exposure	Not Reported	31.25	b060a9fc-e273-5591-ac58-29e05312788e	160.0	released	80.0	TCGA-AJ-A3NE_diagnosis	16957	not reported	0	628	18780bc0-1bba-5cd3-8b89-1ad711411545	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-AJ-A3NE_treatment_1	TCGA-AJ-A3NE_treatment	released	7b26b77a-cff4-5353-82e8-06e49c19e026	no	Pharmaceutical Therapy, NOS	released	2e5afb49-8cc8-53c3-8444-1b285a628db9	no	Radiation Therapy, NOS	5c6c0b25-86a7-4c57-8d7a-35dd35867914
c3e569a6-ac60-471e-a438-0d08c733e3be.htseq.counts.gz	369b34f5-88f9-4485-b99b-2f5ecc366586	TCGA-D1-A15V-01A-11R-A118-07	TCGA-D1-A15V-01A-11R	TCGA-D1-A15V-01A-01-TSA			TCGA-D1-A15V-01A-11	TCGA-D1-A15V-01A	TCGA-D1-A15V	f7010b87-a559-4501-99f9-0fcca1e986e1	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	895	250.0	False	false	597F20F2-AE36-4A9F-A7AF-1647CB56B453	1.86	30f27799-c311-47c4-ad9e-6c80863a3cd2	0.16	23	released	dc71ea6c-5460-4726-b6c2-6ccc4ce4c4ae	RNA	R	0.16	UV Spec	released	False	7e4f7f0f-3462-49c4-9eb1-6e54b8b293a5	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	75.0	TOP	7c40e4cb-8342-42e8-8512-a15adde996a5	released																				released	30.0	8bf1146c-8442-47b5-83af-f7899d4a94a6	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A15V_demographic	68	-24886		5e0b5d34-f9df-502e-94e6-7bfeeb92a539	not hispanic or latino	female	white	released	Alive	1940		TCGA-D1-A15V_exposure	Not Reported	26.953125	efa0519e-fb97-500d-ab67-9a5912e70cb2	160.0	released	69.0	TCGA-D1-A15V_diagnosis	24886	not reported	0	1201	30f9ef49-9429-50d7-8a9d-1ba517fdc60a	Stage IB	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-D1-A15V_treatment_1	TCGA-D1-A15V_treatment	released	30a144db-a061-560f-8b25-ac5de0663151	yes	Pharmaceutical Therapy, NOS	released	b3442fbd-0bc6-5afc-bbbe-e5ebbacba46d	yes	Radiation Therapy, NOS	369b34f5-88f9-4485-b99b-2f5ecc366586
4aef4c57-4e39-4f1b-8955-2a7c25dafc32.htseq.counts.gz	35127d97-1e72-4e26-b693-f3fb2cd409b8	TCGA-AP-A0LO-01A-11R-A040-07	TCGA-AP-A0LO-01A-11R	TCGA-AP-A0LO-01A-01-BSA	TCGA-AP-A0LO-01A-01-TSA		TCGA-AP-A0LO-01A-11	TCGA-AP-A0LO-01A	TCGA-AP-A0LO	a081da6f-51f3-4555-a6b8-736f8c6cda39	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1894	140.0	False	true	DC0116C2-788E-46F5-A4AC-115D857C1F85	2.02	e563cfb5-6904-45c6-acbb-ac96bfb9770b	0.14	23	released	5caa3eb1-f9f7-42ee-b8e8-d36f3349a0ac	RNA	R	0.14	UV Spec	released	False	b14abbed-fbac-4a91-a2ee-6fc4391a91b1	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	BOTTOM	a6b2e6d7-e482-4aa7-8084-5e1f043412cf	released	0.0	0.0	0.0	0.0	0.0	0.0	100.0	90.0	TOP	6075d8de-0bbb-491f-aff0-27bcd61f9ee1	released									released	30.0	9846d8f3-5b22-48e9-b972-a0fe9f509fb4	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A0LO_demographic	45	-16493	1016	d07b1e85-ccc7-5cd4-9a87-b38f8ae021bb	not hispanic or latino	female	white	released	Dead	1960	2007	TCGA-AP-A0LO_exposure	Not Reported	26.171875	b26ac3c8-78a3-5358-8dfb-d59ec0b6b9c7	160.0	released	67.0	TCGA-AP-A0LO_diagnosis	16493	not reported	0		91213600-3f58-58a5-a12c-e90f4f1c9f90	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2005	TCGA-AP-A0LO_treatment_1	TCGA-AP-A0LO_treatment	released	c87aa114-38ac-5726-99d7-070550b8559a	no	Pharmaceutical Therapy, NOS	released	55c9dfc2-0933-5e78-9e9d-e719a12cafb9	yes	Radiation Therapy, NOS	35127d97-1e72-4e26-b693-f3fb2cd409b8
8de508c8-1e2d-4b83-81c2-39b3ba2c67a7.htseq.counts.gz	0a3808d9-d4d2-4bd8-a91c-e6158f83ab1d	TCGA-D1-A1NX-01A-11R-A16F-07	TCGA-D1-A1NX-01A-11R	TCGA-D1-A1NX-01A-01-TS1			TCGA-D1-A1NX-01A-11	TCGA-D1-A1NX-01A	TCGA-D1-A1NX	df01a5ee-e8b5-40b0-8a6a-b6b3faed9df9	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	204	50.0	False	false	C2A3FA63-63A1-4424-BD92-FAEC1C377C62	1.81	d04855a8-fdd2-464c-967d-1a58e530539f	0.18	23	released	97d9ce59-b06a-4ccb-883e-d129431bd07b	RNA	R	0.18	UV Spec	released	False	2576c181-88f8-444c-b0dc-60373839dd41	11	2.0	0.0	5.0	4.0	20.0	5.0	70.0	65.0	TOP	360b4a96-4637-44ff-b9fa-6215666be9bd	released																				released	30.0	1e016d9f-9fab-4191-8209-bc0a8ff0bacf	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A1NX_demographic	66	-24441		f0d1ed71-a6fc-526b-9a5a-8183ccd0229d	not hispanic or latino	female	white	released	Alive	1944		TCGA-D1-A1NX_exposure	Not Reported	34.41319568055061	4deda643-90ad-5a1c-837c-277e21245210	159.0	released	87.0	TCGA-D1-A1NX_diagnosis	24441	not reported	0	555	62fa317d-6ed7-5f82-8fd3-64caab7df675	Stage IIIC	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-D1-A1NX_treatment	TCGA-D1-A1NX_treatment_1	released	88869daa-0ef2-51f5-8ee6-4a5ac4435d10	yes	Radiation Therapy, NOS	released	98dc4683-40ad-52ae-9867-08c594ad081e	yes	Pharmaceutical Therapy, NOS	0a3808d9-d4d2-4bd8-a91c-e6158f83ab1d
a1f556b4-541c-418c-a0c1-6f33216702d8.htseq.counts.gz	30224803-edc1-47ab-b1be-881d1379f328	TCGA-B5-A0JV-01A-11R-A104-07	TCGA-B5-A0JV-01A-11R	TCGA-B5-A0JV-01A-01-TSA	TCGA-B5-A0JV-01A-01-BSA		TCGA-B5-A0JV-01A-11	TCGA-B5-A0JV-01A	TCGA-B5-A0JV	233e947a-d5e2-48e5-a8ce-5da1abb20681	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1001	40.0	False	true	71A1DE5B-7CE5-4884-A91E-3BE753036E4F	1.77	39b1ee4d-b57a-44d5-8b14-20b02f878123	0.15	23	released	f4fe664c-cb75-4568-9d4f-aa30d439ec73	RNA	R	0.15	UV Spec	released	False	a3b9e5ea-7f25-4cef-9d15-5ecc50d4c843	11	30.0	0.0	20.0	10.0	5.0	25.0	50.0	70.0	TOP	323cb82d-2a86-4366-b7de-78ca47c001bf	released	10.0	0.0	20.0	10.0	10.0	5.0	65.0	85.0	BOTTOM	9edda9a0-2d77-4a13-89b0-85acb7c165a7	released									released	30.0	42199e5a-9f4f-4445-9e6e-114d47ba67fa	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A0JV_demographic	63	-23295		e88ad5a0-3e91-5f6f-a2b5-19a6bc04e25a	not reported	female	black or african american	released	Alive	1944		TCGA-B5-A0JV_exposure	Not Reported	34.11235302656409	ba6cb989-30cf-5ad9-b46c-d98eea024943	166.0	released	94.0	TCGA-B5-A0JV_diagnosis	23295	not reported	0	2616	70a965e0-7f44-5ba2-9ae0-b5dbb74d7153	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2007	TCGA-B5-A0JV_treatment_1	TCGA-B5-A0JV_treatment	released	b2dc1980-3408-56c5-bc0d-8efaf4414a91	no	Pharmaceutical Therapy, NOS	released	7eaa452e-2be9-5498-865e-0275bd34a32c	yes	Radiation Therapy, NOS	30224803-edc1-47ab-b1be-881d1379f328
c09a5ffc-56b4-481b-a2a6-f8b08e31d60e.htseq.counts.gz	838139a6-b0a9-402a-a755-8a88a11abfea	TCGA-AP-A5FX-01A-11R-A27V-07	TCGA-AP-A5FX-01A-11R	TCGA-AP-A5FX-01A-01-TSA			TCGA-AP-A5FX-01A-11	TCGA-AP-A5FX-01A	TCGA-AP-A5FX	a633d316-59a4-45ae-8bf8-135cfbd27656	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	878	300.0	False	true	AF38CD86-2F5A-46A3-903A-81A8067F2456	1.91	e55857c5-0581-471c-ba7a-cd9b83afbc14	0.18	23	released	c8c70b18-c574-4152-b883-a5387924aeab	RNA	R	0.18	UV Spec	released	False	24df9d5e-20ba-4825-b90f-cf118928e8f6	11	1.0	0.0	2.0	0.0	0.0	0.0	98.0	80.0	TOP	7ea0b9d7-ac2e-4ba6-ab92-304bc4f0be2b	released																				released	30.0	b37ba34a-5f2e-46a9-9334-79e6782d40dc	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A5FX_demographic	68	-25063	1099	c54df739-8b8f-53d4-be3f-4bb048131e5d	not reported	female	black or african american	released	Dead	1942		TCGA-AP-A5FX_exposure	Not Reported	28.34467120181406	bb55f4d4-d6d1-5709-84b1-e4c1066d56e8	168.0	released	80.0	TCGA-AP-A5FX_diagnosis	25063	not reported	0	1026	0dcdbef2-95f1-5dbe-b7ed-98f7bacfe3e8	Stage IIIC1	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-AP-A5FX_treatment_1	TCGA-AP-A5FX_treatment	released	077ecaa8-a216-5b2e-bf4a-51460727e665	yes	Pharmaceutical Therapy, NOS	released	59d9ccb0-1130-5204-8080-95ad631ca47a	yes	Radiation Therapy, NOS	838139a6-b0a9-402a-a755-8a88a11abfea
2a1c76fa-8112-4233-b7d2-805481cdf37a.htseq.counts.gz	8c1d4c15-8790-48e2-ad81-5baf556c79bb	TCGA-AJ-A3EK-01A-11R-A19W-07	TCGA-AJ-A3EK-01A-11R	TCGA-AJ-A3EK-01A-01-TS1			TCGA-AJ-A3EK-01A-11	TCGA-AJ-A3EK-01A	TCGA-AJ-A3EK	14db56ef-ec5e-4775-a229-5d83e58e027c	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	127	220.0	False	false	F153EAC2-7347-4CEF-916A-995C7BB8B0F1	1.86	1ff9e0b8-b682-4da8-86f3-c510b7e6e1f4	0.16	23	released	7c03dc0f-2992-4185-ad84-72b61a9c1f53	RNA	R	0.16	UV Spec	released	False	32ba9ade-7638-4f78-9446-b092fe695a7b	11	4.0	0.0	5.0	0.0	5.0	0.0	90.0	85.0	TOP	97dd19e3-8852-4ae5-a7e2-92734ddb2cb7	released																				released	30.0	01747185-0d0d-4b27-b956-115df4d90bed	Primary Tumor	01	released	Not Reported	released	TCGA-AJ-A3EK_demographic	53	-19609		d53f1a50-e0f6-56cd-8d86-3f2c7fa50cd5	hispanic or latino	female	white	released	Alive	1958		TCGA-AJ-A3EK_exposure	Not Reported	24.341758286340216	9d1be268-1969-5e24-beac-7646f39b5c61	157.0	released	60.0	TCGA-AJ-A3EK_diagnosis	19609	not reported	0	446	7ae32546-37ad-563a-b07c-259612c7d3c2	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-AJ-A3EK_treatment_1	TCGA-AJ-A3EK_treatment	released	d56171f3-e0a2-5203-8049-854969a8c633	yes	Pharmaceutical Therapy, NOS	released	471a8465-9e03-5c43-ac81-aa90ee210f5e	yes	Radiation Therapy, NOS	8c1d4c15-8790-48e2-ad81-5baf556c79bb
1c6fd68e-4c01-4272-b3f1-89361420372e.htseq.counts.gz	62245ad4-96cc-4daa-aca5-601e59d68d3d	TCGA-AX-A1C8-01A-11R-A137-07	TCGA-AX-A1C8-01A-11R	TCGA-AX-A1C8-01A-01-TS1			TCGA-AX-A1C8-01A-11	TCGA-AX-A1C8-01A	TCGA-AX-A1C8	bad34c92-1e64-4187-a0b4-061105fd13ba	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	475	100.0	False	false	5F0E78BA-B827-4DB6-99EB-5FA3D3598793	1.89	34149234-2d6a-46ac-b7e0-52787cf2c49a	0.17	23	released	47c776c6-58b0-4ff2-9505-b529230c2fb0	RNA	R	0.17	UV Spec	released	False	ba4b4047-b61a-46eb-9018-bd4564770192	11	1.0	1.0	5.0	0.0	0.0	20.0	75.0	80.0	TOP	61e0c69d-6a8d-4674-a03d-217c5ea965aa	released																				released	30.0	83e4dfb0-f240-476b-bc25-f9f52c960af5	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A1C8_demographic	77	-28452		46ee949e-91ac-585a-b287-023dda00ab3d	not hispanic or latino	female	white	released	Alive	1932		TCGA-AX-A1C8_exposure	Not Reported	27.12031558185404	da890de9-6fd6-5967-80f4-50fa4012fcd0	156.0	released	66.0	TCGA-AX-A1C8_diagnosis	28452	not reported	0	776	2409cab7-cad6-57d6-8b56-732c17c0e990	Stage IIIC	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-AX-A1C8_treatment_1	TCGA-AX-A1C8_treatment	released	076571f0-ffb7-5a0b-be2b-94b336210741	yes	Pharmaceutical Therapy, NOS	released	0ed6b81a-29d4-591c-b16f-8c0a2196310d	no	Radiation Therapy, NOS	62245ad4-96cc-4daa-aca5-601e59d68d3d
1d5dbeb9-9d9f-4d28-bd9d-273899c0c6aa.htseq.counts.gz	6bf40ddc-0463-4c1c-b323-b254252cca36	TCGA-AX-A0IU-01A-11R-A16W-07	TCGA-AX-A0IU-01A-11R	TCGA-AX-A0IU-01A-01-BS1	TCGA-AX-A0IU-01A-01-MS1		TCGA-AX-A0IU-01A-11	TCGA-AX-A0IU-01A	TCGA-AX-A0IU	7e64ea6c-a3db-48eb-91be-131361510a92	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	636	240.0	False	false	454539FB-7B1B-43DF-87D1-E7E47C1776E7	1.85	fb355c45-282b-4eff-8d06-074d9acf1ea5	0.14	23	released	53904cdf-ecfa-4a1b-a41b-ed2666936ff3	RNA	R	0.14	UV Spec	released	False	65212f6f-ee67-41ad-afa6-0a9d3550907b	11	7.0	0.0	30.0	1.0	0.0	15.0	55.0	85.0	BOTTOM	ea8dcc0a-2081-43b5-a21b-fbf7dc1c275d	released	10.0	4.0	10.0	2.0	0.0	45.0	45.0	60.0	TOP	50434b51-2b9b-46f1-929e-5679835479b6	released									released	30.0	dc4b3695-ce62-48d5-9f1d-7dd70d049c97	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A0IU_demographic	79	-29063		337f449f-972e-5bc5-a434-fe6dfca3d407	not hispanic or latino	female	black or african american	released	Alive	1929		TCGA-AX-A0IU_exposure	Not Reported	30.443839128344816	aae18b61-0a6d-51fb-b2c5-ab11fa22cc0b	158.0	released	76.0	TCGA-AX-A0IU_diagnosis	29063	not reported	0	1087	cd91da4b-9f1c-590c-9b86-ae8be6b80640	Stage IIIC	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-AX-A0IU_treatment	TCGA-AX-A0IU_treatment_1	released	6a29e81c-0eaf-5629-82e9-8cc5da7b1f46	no	Radiation Therapy, NOS	released	670a828e-0fd5-5692-b5ff-6c75352c17ae	yes	Pharmaceutical Therapy, NOS	6bf40ddc-0463-4c1c-b323-b254252cca36
3d0557c9-73a8-4953-a5f0-bbdbd79189e6.htseq.counts.gz	daa2a621-ed84-4ac2-818a-12112a830dd8	TCGA-A5-A0R6-01A-11R-A104-07	TCGA-A5-A0R6-01A-11R	TCGA-A5-A0R6-01A-01-TS1	TCGA-A5-A0R6-01A-01-BS1		TCGA-A5-A0R6-01A-11	TCGA-A5-A0R6-01A	TCGA-A5-A0R6	39609d3c-f5d3-4bc4-b356-1403c6dd1cb5	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	259	200.0	False	true	2F8BAD18-8A37-4F1A-A1BA-31494035E05F	1.86	20977188-9019-4672-a435-760abd19ee5b	0.17	23	released	bc9073b0-38e4-48e8-9617-31049b887434	RNA	R	0.17	UV Spec	released	False	21216431-57f5-4250-9b00-a05df4790e26	11	30.0	15.0	10.0	35.0	0.0	20.0	70.0	70.0	TOP	8f6ba218-fba3-49b1-b830-da5b1509f9d9	released	30.0	15.0	10.0	25.0	10.0	5.0	75.0	75.0	BOTTOM	006d1ac4-db60-4b08-aaf4-c89494b8dbbd	released									released	30.0	836bd487-091b-4728-bcd7-8065e5b76465	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A0R6_demographic	64	-23449		ed7b2087-cf0f-5360-be88-97a509a5dcbf	hispanic or latino	female	white	released	Alive	1945		TCGA-A5-A0R6_exposure	Not Reported	27.587326057852245	a34dc1c3-35a9-596a-8427-f198544bccca	157.0	released	68.0	TCGA-A5-A0R6_diagnosis	23449	not reported	0	1153	34a9e020-9e90-5fd4-beca-55bb8f8e18bd	Stage IIIC1	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-A5-A0R6_treatment_1	TCGA-A5-A0R6_treatment	released	9964b218-3c4a-55da-ad7e-96d271b904a5	yes	Pharmaceutical Therapy, NOS	released	790f4370-75ac-582d-a918-aa5048071600	yes	Radiation Therapy, NOS	daa2a621-ed84-4ac2-818a-12112a830dd8
a28e48a6-da13-4a01-b513-48eef3c50956.htseq.counts.gz	9d47d566-03df-448e-8687-003b8a19adda	TCGA-AX-A0IZ-11A-11R-A27V-07	TCGA-AX-A0IZ-11A-11R	TCGA-AX-A0IZ-11A-01-TSA			TCGA-AX-A0IZ-11A-11	TCGA-AX-A0IZ-11A	TCGA-AX-A0IZ	11285dc5-8742-477a-8692-af1b6e2c1434	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1485	160.0	False	false		1.84	9d6c70ea-ec88-4b78-a495-cd31cc048ece	0.15	23	released	ced36f9c-58b0-405f-b4fe-944e7578d575	RNA	R	0.15	UV Spec	released	False	a9a423f7-da11-40d4-9aa1-fac02ce78966	11	0.0	0.0	0.0	0.0	100.0	0.0	0.0	0.0	TOP	2477ae69-3d24-4dbf-97ea-f911e1d70287	released																				released	30.0	e6ffcb81-f76d-40ee-ac9b-f71ed0c6c92d	Solid Tissue Normal	11	released	Not Reported	released	TCGA-AX-A0IZ_demographic	53	-19364		400b2e1e-7ebf-56da-a404-7bc683ec14ce	not hispanic or latino	female	white	released	Alive	1954		TCGA-AX-A0IZ_exposure	Not Reported	23.4375	37e36409-538a-5401-8e30-97f40c5c253e	160.0	released	60.0	TCGA-AX-A0IZ_diagnosis	19364	not reported	0	1333	fa08e52e-a08c-5dff-992d-48d8f2399ce4	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2007	TCGA-AX-A0IZ_treatment_1	TCGA-AX-A0IZ_treatment	released	4e7e3bc3-75fe-5ad4-817d-44fd076f05d2	no	Pharmaceutical Therapy, NOS	released	81d10302-589d-5a62-be62-0151793a6cea	no	Radiation Therapy, NOS	9d47d566-03df-448e-8687-003b8a19adda
24a7ea15-77e7-4396-9f97-4b420f62930e.htseq.counts.gz	7eb5952a-da66-49e5-907f-b9b517335360	TCGA-BG-A0LX-01A-11R-A16W-07	TCGA-BG-A0LX-01A-11R	TCGA-BG-A0LX-01A-01-BSA	TCGA-BG-A0LX-01A-01-TSA		TCGA-BG-A0LX-01A-11	TCGA-BG-A0LX-01A	TCGA-BG-A0LX	ac1d3946-fe6c-4bd8-b02c-638799cb0f67	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	120	250.0	False	true	4306E592-FA36-4AB9-BF84-7232CC599A64	1.74	7961370a-641d-4dc9-a530-99789e7d0036	0.14	23	released	bc892b57-8222-49ad-9354-89be22e7139a	RNA	R	0.14	UV Spec	released	False	27a12dec-2c9d-4404-bb84-00632f0e187f	11	0.0	0.0	30.0	0.0	0.0	0.0	70.0	90.0	BOTTOM	10ccc5d8-9f9a-4905-9302-bfb34cebc861	released	0.0	0.0	10.0	0.0	0.0	0.0	90.0	85.0	TOP	040f601d-497b-49c7-afb3-86e8aee102e2	released									released	30.0	99cdf3a0-90dc-4992-b75a-11dd41928d43	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A0LX_demographic	57	-20928		1bcc5a0d-6671-5861-b26d-b67afa80d667	not hispanic or latino	female	white	released	Alive	1953		TCGA-BG-A0LX_exposure	Not Reported	33.21799307958477	5d4cdf8a-e235-556e-8dcd-0bc4e5ae7172	170.0	released	96.0	TCGA-BG-A0LX_diagnosis	20928	not reported	0	614	64f9d868-5fb4-5a05-b777-196a4c569488	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-BG-A0LX_treatment	TCGA-BG-A0LX_treatment_1	released	29470147-1ea9-5cf9-b1d5-a422a62d321c	yes	Radiation Therapy, NOS	released	11195dd5-186d-5161-962e-04a47c1ac589	no	Pharmaceutical Therapy, NOS	7eb5952a-da66-49e5-907f-b9b517335360
df02af7a-ae3a-4836-848c-8c2957c51dfa.htseq.counts.gz	7f8fda48-24e3-4a8e-9fa6-dcf6719e49cf	TCGA-B5-A11E-01A-11R-A10J-07	TCGA-B5-A11E-01A-11R	TCGA-B5-A11E-01A-01-TSA	TCGA-B5-A11E-01A-01-BSA		TCGA-B5-A11E-01A-11	TCGA-B5-A11E-01A	TCGA-B5-A11E	38a3ea92-8965-4bda-9dbd-144832975cdd	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	198	890.0	False	true	2058131C-09EA-4DC7-A84A-EB055A68F1B6	1.86	7e923dc8-9920-4f06-a98b-085a5935b29c	0.15	23	released	7de87cac-7ea1-455c-b86b-ffceac3080c9	RNA	R	0.15	UV Spec	released	False	2af664be-61cb-4253-b242-3c018ad1ba37	11	4.0	0.0	2.0	1.0	0.0	3.0	95.0	95.0	TOP	6220bbcd-62ad-4215-8208-63341b6f8e2e	released	4.0	0.0	3.0	1.0	0.0	1.0	96.0	96.0	BOTTOM	1d1b836a-9771-4806-ba0d-fc09b4608cde	released									released	30.0	cd68a1a9-039f-4da5-9a53-3cd60a261f7f	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A11E_demographic	53	-19458		bac1495d-3338-556a-b9d6-93239b967de8	not reported	female	white	released	Alive	1957		TCGA-B5-A11E_exposure	Not Reported	19.100091827364555	66760adc-d607-5bb3-a2da-738c1d73ee46	165.0	released	52.0	TCGA-B5-A11E_diagnosis	19458	not reported	0	1820	1b2d6833-a1ee-5d20-9567-173f86e5af4d	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-B5-A11E_treatment	TCGA-B5-A11E_treatment_1	released	9a3d0025-acb8-59da-bf52-9c4bccdfcc24	no	Radiation Therapy, NOS	released	636f29bc-e16e-592e-beb8-41d911f7e1e3	no	Pharmaceutical Therapy, NOS	7f8fda48-24e3-4a8e-9fa6-dcf6719e49cf
61c5c0b5-c38b-489d-b0dd-3b42725f29b1.htseq.counts.gz	f1793ed0-b101-4254-8693-2575ef464dd2	TCGA-BG-A0W1-01A-12R-A109-07	TCGA-BG-A0W1-01A-12R	TCGA-BG-A0W1-01A-01-BSA	TCGA-BG-A0W1-01A-01-TSA		TCGA-BG-A0W1-01A-12	TCGA-BG-A0W1-01A	TCGA-BG-A0W1	2d750c67-24a2-4b12-b4f2-dbd65f2f27f0	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1014	100.0	False	true	BE7CC54D-8220-4AC6-9F8D-016DE4167B35	1.87	85dd6956-38ee-4f12-9210-ffe2a8964aef	0.16	23	released	5816c645-9360-4310-aec6-8c7e47a9b6f5	RNA	R	0.16	UV Spec	released	False	b0a10b30-eb19-4394-a58f-0ebe0e9d8840	12	40.0	20.0	5.0	30.0	0.0	25.0	70.0	70.0	BOTTOM	c7710ddc-5e2b-477c-b3b3-15288725879e	released	30.0	20.0	5.0	40.0	0.0	25.0	70.0	70.0	TOP	b9956c37-9819-452f-8801-060a34b6d8a2	released									released	30.0	13dec3d1-c7f8-4b95-bd54-2d3136cee001	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A0W1_demographic	89	-32750		2b410e4c-7ff6-5e08-9cd0-f4797aa28dc8	not hispanic or latino	female	white	released	Alive	1918		TCGA-BG-A0W1_exposure	Not Reported	33.13609467455621	2059e12b-1bdf-525d-8340-75d46aa61b61	130.0	released	56.0	TCGA-BG-A0W1_diagnosis	32750	not reported	0	122	2f57195e-be66-5f99-a9cf-800a9d022168	Stage II	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2007	TCGA-BG-A0W1_treatment_1	TCGA-BG-A0W1_treatment	released	d0d9ddc6-34e8-5f07-9659-910ac48bff44	no	Pharmaceutical Therapy, NOS	released	a93e2a76-3c1c-5b5e-86dc-a889d27ac599	no	Radiation Therapy, NOS	f1793ed0-b101-4254-8693-2575ef464dd2
046e8909-9b5f-42f3-8bd3-e206dc70927c.htseq.counts.gz	144f72b9-3d79-4619-826c-1c79d3b9108f	TCGA-AJ-A3NH-11A-11R-A22K-07	TCGA-AJ-A3NH-11A-11R	TCGA-AJ-A3NH-11A-01-TS1			TCGA-AJ-A3NH-11A-11	TCGA-AJ-A3NH-11A	TCGA-AJ-A3NH	7186180a-688a-4fcc-9a67-166eff032e4b	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	67	70.0	False	false		1.85	1b2609b8-8c1f-4407-aba5-e47f9e83ebb1	0.16	23	released	13646f9c-663b-425a-9ee4-6b98921a13f9	RNA	R	0.16	UV Spec	released	False	48ee9e7c-777d-4068-96ca-4a3d29d245ff	11	0.0	0.0	0.0	0.0	100.0	0.0	0.0	0.0	TOP	c924e0fb-d565-4405-9f30-7e62a679003b	released																				released	30.0	6985142f-a646-4b89-a60b-0801a3820bbd	Solid Tissue Normal	11	released	Not Reported	released	TCGA-AJ-A3NH_demographic	90	-32871	1	5260b2a3-c911-50eb-a9f3-7ab433a02860	not hispanic or latino	female	white	released	Dead	1921		TCGA-AJ-A3NH_exposure	Not Reported	24.767565919829295	c411984a-753e-5855-8855-2fbf4a442b32	162.0	released	65.0	TCGA-AJ-A3NH_diagnosis	32871	not reported	0	1	05fae6e0-105f-517a-8fc6-bcc404aeb97a	Stage IB	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2011	TCGA-AJ-A3NH_treatment_1	TCGA-AJ-A3NH_treatment	released	2e65be50-2ef3-5b89-be19-2dab9dfa97af	yes	Pharmaceutical Therapy, NOS	released	6bd33564-ffec-5150-a2aa-74bb98c49f6f	no	Radiation Therapy, NOS	144f72b9-3d79-4619-826c-1c79d3b9108f
38653f5f-fd47-477a-a2ff-6d7dfdcda9d6.htseq.counts.gz	e7474b4c-a1d0-4821-8f29-c391b276a045	TCGA-AP-A05N-01A-11R-A00V-07	TCGA-AP-A05N-01A-11R	TCGA-AP-A05N-01A-01-TS1	TCGA-AP-A05N-01A-01-BS1		TCGA-AP-A05N-01A-11	TCGA-AP-A05N-01A	TCGA-AP-A05N	08b11e0e-5b8e-45ea-9b6b-30e3185b03d7	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	232	350.0	False	true	E4FF43F2-5CBD-4B68-9CD5-BE4E84AD67D5	1.8	63ba785b-9345-4cc3-b0af-a1a1d45b59b3	0.14	23	released	5f722a1c-54bb-49da-a24f-a5aa6e020dc7	RNA	R	0.14	UV Spec	released	False	51bd6de3-87aa-4440-b64f-fcd6928bcf87	11	15.0	10.0	5.0	20.0	0.0	30.0	65.0	65.0	TOP	69e97962-4160-47d8-90ec-cabace0aa478	released	20.0	5.0	5.0	10.0	0.0	20.0	75.0	75.0	BOTTOM	c3c8530a-5143-4878-8077-2e00ab18e09e	released									released	30.0	67a90941-d6ec-4465-a727-7193504c8982	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A05N_demographic	58	-21254	726	04149f27-e7a1-546d-816b-906f65010536	not reported	female	white	released	Dead	1951		TCGA-AP-A05N_exposure	Not Reported	46.86785550983082	f33d9c15-8838-5df2-aaad-623ba88d7cbd	162.0	released	123.0	TCGA-AP-A05N_diagnosis	21254	not reported	0	239	0d8675f4-8c52-557b-a5c1-7e8f13b5e3e1	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-AP-A05N_treatment	TCGA-AP-A05N_treatment_1	released	753da8f8-9301-5718-a4ae-94f838f7f76c	yes	Radiation Therapy, NOS	released	34dadbd5-4704-5519-9b0f-4f56e8f497bd	no	Pharmaceutical Therapy, NOS	e7474b4c-a1d0-4821-8f29-c391b276a045
abb994fc-71fb-4ea3-9607-94ed78fcad3c.htseq.counts.gz	1cc87e96-e1b3-4ab4-87a6-ed9242c3a726	TCGA-BS-A0U5-01A-11R-A109-07	TCGA-BS-A0U5-01A-11R	TCGA-BS-A0U5-01A-01-BS1	TCGA-BS-A0U5-01A-01-MS1		TCGA-BS-A0U5-01A-11	TCGA-BS-A0U5-01A	TCGA-BS-A0U5	c306d7e8-5486-41d3-84dd-9311ce3e2069	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	2525	110.0	False	false	8024498D-449C-45C6-B57D-846DDBA3FF30	1.84	2bb7d230-0982-4ce5-908a-a04064cb7665	0.16	23	released	150721ea-0b2f-45e8-92d5-52190be5047d	RNA	R	0.16	UV Spec	released	False	6a17ee30-84ce-457c-97d4-6adc8bcbc86c	11	30.0	40.0	0.0	20.0	0.0	30.0	70.0	70.0	BOTTOM	dece34dc-5192-4142-968e-06be2bde0faf	released	0.0	0.0	0.0	0.0	0.0	10.0	90.0	80.0	TOP	57d20a48-afb8-4130-a4a2-351c51729c26	released									released	30.0	48a5e048-b35d-4207-b45b-e72ac51e041d	Primary Tumor	01	released	Not Reported	released	TCGA-BS-A0U5_demographic	76	-27945		ba99ed39-a94d-592d-ac4a-1ad8c93ba4d6	not hispanic or latino	female	white	released	Alive	1927		TCGA-BS-A0U5_exposure	Not Reported	21.671258034894397	e78cd5cb-a45c-56b9-b63b-a59c84358444	165.0	released	59.0	TCGA-BS-A0U5_diagnosis	27945	not reported	0	2935	1500a430-392c-5459-bbb2-de07e77900cb	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2003	TCGA-BS-A0U5_treatment_1	TCGA-BS-A0U5_treatment	released	47b6ee27-11c5-5021-a1b7-8cd3c077914e	no	Pharmaceutical Therapy, NOS	released	c8a1090d-555b-5b20-8083-3467e950f28d	no	Radiation Therapy, NOS	1cc87e96-e1b3-4ab4-87a6-ed9242c3a726
778ce259-40a8-48ff-8513-4921f3fe0760.htseq.counts.gz	598a2fd9-6aa1-4d3d-930b-f73f1b712c1f	TCGA-QF-A5YT-01A-11R-A31O-07	TCGA-QF-A5YT-01A-11R	TCGA-QF-A5YT-01A-01-TS1			TCGA-QF-A5YT-01A-11	TCGA-QF-A5YT-01A	TCGA-QF-A5YT	e4bccea0-0104-40c4-9e3c-2ad7262d918e	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	804	40.0	False	false	1CCA2D47-BA5D-46A9-89F9-681C58EFC10D	1.92	86ae75e5-6460-45a3-89f0-aaeba2462268	0.17	23	released	9239490a-614f-4826-936e-cecfa954b731	RNA	R	0.17	UV Spec	released	False	e2cda9df-fc5a-4f9d-8c54-c4f2da4acce8	11	0.0	0.0	0.0	0.0	10.0	10.0	80.0	90.0	TOP	704726e5-220d-456d-af0b-678cd1f4c86e	released																				released	30.0	e62ea0d8-61cb-41ed-9d15-a0c5add11249	Primary Tumor	01	released	Not Reported	released	TCGA-QF-A5YT_demographic	57	-20981		7593a65f-93eb-5143-a5a6-8e4c144e0880	not hispanic or latino	female	black or african american	released	Alive	1953		TCGA-QF-A5YT_exposure	Not Reported	50.51903114186851	4f2b0a87-8845-524d-a20d-2e0fac7c3bf1	170.0	released	146.0	TCGA-QF-A5YT_diagnosis	20981	not reported	0	1215	a6a42e4d-add8-57a7-8b60-f9f1f890df34	Stage II	C54.0	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Isthmus uteri	released	No	Isthmus uteri	not reported	not reported	2010	TCGA-QF-A5YT_treatment	TCGA-QF-A5YT_treatment_1	released	0610ab27-0a85-5962-817c-8c854d4d564e	yes	Radiation Therapy, NOS	released	167fe7b5-ed62-5ffb-b8ca-4e90b494e56a	yes	Pharmaceutical Therapy, NOS	598a2fd9-6aa1-4d3d-930b-f73f1b712c1f
82d4eabe-b54d-4d53-9347-79fb4c507629.htseq.counts.gz	a5e77359-d39a-49b7-af19-9be86b9c64d5	TCGA-AJ-A5DV-01A-11R-A27V-07	TCGA-AJ-A5DV-01A-11R	TCGA-AJ-A5DV-01A-01-TS1			TCGA-AJ-A5DV-01A-11	TCGA-AJ-A5DV-01A	TCGA-AJ-A5DV	c7b3ac87-5260-4042-895a-279cd8cda620	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	220	70.0	False	false	049C45D6-6FC6-42EE-BD51-AC344D1E3CD9	1.81	f9cc97ae-9b1a-46fa-ab38-c46bccf84380	0.17	23	released	52707cc5-9e8d-47ad-aab8-74522ddde533	RNA	R	0.17	UV Spec	released	False	ece80489-896e-41f4-a008-74b560037260	11	5.0	0.0	10.0	0.0	0.0	0.0	90.0	75.0	TOP	eb6105ef-8c73-4159-9125-72cb6ef88715	released																				released	30.0	0e933a81-858a-4a82-9ece-b56af448a510	Primary Tumor	01	released	Not Reported	released	TCGA-AJ-A5DV_demographic	65	-23892		f51e0306-5841-5740-83d5-43755b0b9f1e	not hispanic or latino	female	black or african american	released	Alive	1947		TCGA-AJ-A5DV_exposure	Not Reported	57.421875	4ac76f76-706a-5226-b0f8-d6c990278671	160.0	released	147.0	TCGA-AJ-A5DV_diagnosis	23892	not reported	0	679	96dfad91-dccc-59e3-9879-0bfd79b07218	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2012	TCGA-AJ-A5DV_treatment_1	TCGA-AJ-A5DV_treatment	released	63c1fdbd-8856-5d9c-bb21-0d924f86e087	no	Pharmaceutical Therapy, NOS	released	a87dbe9b-af61-5eec-b2f4-f6d40bb908fa	no	Radiation Therapy, NOS	a5e77359-d39a-49b7-af19-9be86b9c64d5
3d5eb5d4-79b4-44f9-8396-f0892e0971de.htseq.counts.gz	76c5ac01-5ce2-4370-9e2e-ba522d2ef752	TCGA-AX-A3G3-01A-11R-A213-07	TCGA-AX-A3G3-01A-11R	TCGA-AX-A3G3-01A-01-TS1			TCGA-AX-A3G3-01A-11	TCGA-AX-A3G3-01A	TCGA-AX-A3G3	16745dfb-8b28-4f5d-9ef1-2aa31ccb7293	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	713	140.0	False	false	3D86258F-2C9B-4DF2-86C5-E12B3FCB480D	1.83	11e82091-a9fb-4b7b-b0a2-7908e50e2c60	0.17	23	released	8298c48a-8f0e-451e-8af0-9725ec53e925	RNA	R	0.17	UV Spec	released	False	347e1242-0979-4b60-84c9-e4f2a333fe7e	11	0.0	0.0	15.0	0.0	0.0	3.0	82.0	97.0	TOP	279081b2-ed01-4949-bdef-2a72abca5131	released																				released	30.0	5efdace8-5790-4239-8e8a-6349f88b10dd	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A3G3_demographic	58	-21308		bfa17d93-143b-53bf-953e-b442f40b66da	not reported	female	white	released	Alive	1951		TCGA-AX-A3G3_exposure	Not Reported	19.721036967980208	f70826d8-a67f-53bc-9521-d690b78c711e	167.0	released	55.0	TCGA-AX-A3G3_diagnosis	21308	not reported	0	42	ffc1671e-9b30-5a81-b25f-0e651261e367	Stage IIIA	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2009	TCGA-AX-A3G3_treatment_1	TCGA-AX-A3G3_treatment	released	ec694fb2-c4f8-593f-a738-7126b58b9ddb	not reported	Pharmaceutical Therapy, NOS	released	f439094c-f8d9-583b-857a-dbe1c4f015c1	not reported	Radiation Therapy, NOS	76c5ac01-5ce2-4370-9e2e-ba522d2ef752
a717b697-d2cc-4edb-9742-d976aae5beae.htseq.counts.gz	4574744f-36f2-468c-a861-6c411e28e282	TCGA-EY-A210-01A-11R-A157-07	TCGA-EY-A210-01A-11R	TCGA-EY-A210-01A-01-TSA			TCGA-EY-A210-01A-11	TCGA-EY-A210-01A	TCGA-EY-A210	ea1c693d-490d-4816-b6e3-d12946ad7cc1	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	70	840.0	False	false	51A98C43-6A6A-4027-8E92-B3B9AA1A63D4	1.94	4547d0d6-21ed-4128-9be9-34555bff3b83	0.17	23	released	846f1496-827e-4cb0-8459-63a933f2da54	RNA	R	0.17	UV Spec	released	False	010f8ce1-fa47-45a2-a1fe-358229dbadc8	11	35.0	5.0	0.0	15.0	0.0	5.0	95.0	95.0	TOP	dda817ab-29c4-497c-9d8a-73e0a0225243	released																				released	30.0	3879caa4-a747-4879-8923-05232476730d	Primary Tumor	01	released	Not Reported	released	TCGA-EY-A210_demographic	82	-30095		63c1a62a-724b-537a-ae88-6845143841c9	not hispanic or latino	female	black or african american	released	Alive	1929		TCGA-EY-A210_exposure	Not Reported	26.22268470343392	8460df12-0130-5350-af7d-03a381ec9c02	155.0	released	63.0	TCGA-EY-A210_diagnosis	30095	not reported	0	383	166ebb1b-3acb-5af6-b800-00d5930c720c	Stage IIIC2	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-EY-A210_treatment	TCGA-EY-A210_treatment_1	released	04ef0a9b-f05f-570b-a62c-8c689c93eda4	no	Radiation Therapy, NOS	released	e193af62-ea66-5196-8317-13ad9958b5a2	no	Pharmaceutical Therapy, NOS	4574744f-36f2-468c-a861-6c411e28e282
ceaca530-f0eb-4b5c-9107-4f072a480000.htseq.counts.gz	12fc846e-a254-47fa-9a26-fa906d081894	TCGA-EY-A1GO-01A-11R-A14D-07	TCGA-EY-A1GO-01A-11R	TCGA-EY-A1GO-01A-01-TSA			TCGA-EY-A1GO-01A-11	TCGA-EY-A1GO-01A	TCGA-EY-A1GO	9370e189-8fb7-4bfa-8ef9-2220f3557188	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	259	100.0	False	false	82216372-E1EF-47F2-B57A-25C1DCB24E5E	1.8	8bf59d5d-e4e0-48c3-9ae7-16feeb2675e7	0.16	23	released	60b02e7b-db9d-4e40-abd3-9d4d71067c45	RNA	R	0.16	UV Spec	released	False	125682f6-1757-49ce-b371-7807d71a7093	11	40.0	20.0	10.0	20.0	0.0	10.0	80.0	80.0	TOP	a56e1e97-9298-4131-8c25-41fb19926214	released																				released	30.0	84c460ba-e8a0-43ea-a4c3-c838d5587f99	Primary Tumor	01	released	Not Reported	released	TCGA-EY-A1GO_demographic	65	-23853		bffaa34a-37f1-5822-ab31-7d17a1aca9e4	not hispanic or latino	female	white	released	Alive	1945		TCGA-EY-A1GO_exposure	Not Reported	31.22945430637738	a4f0ecef-c3c3-5e1c-9088-f506048dbe89	156.0	released	76.0	TCGA-EY-A1GO_diagnosis	23853	not reported	0	586	75a373fb-25bb-52a0-b7c5-a59f7de4a641	Stage IIIC1	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-EY-A1GO_treatment_1	TCGA-EY-A1GO_treatment	released	223e6b7e-50a5-5aac-8776-870c1b5ef5b9	yes	Pharmaceutical Therapy, NOS	released	1bf9e4d5-faeb-5ff7-8742-47defac8fd1c	yes	Radiation Therapy, NOS	12fc846e-a254-47fa-9a26-fa906d081894
1361dd18-8a88-428c-9576-d3a4a4265e68.htseq.counts.gz	7498cfdc-50c0-4c24-b424-eb1370392712	TCGA-QS-A8F1-01A-21R-A37O-07	TCGA-QS-A8F1-01A-21R	TCGA-QS-A8F1-01A-02-TS2			TCGA-QS-A8F1-01A-21	TCGA-QS-A8F1-01A	TCGA-QS-A8F1	54ac877a-52ff-450c-9df9-b7cd3fc8e2e2	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	29	250.0	False	false	563BDC27-AFA6-4DE0-AB17-8CFD93D1CA81	1.7	d05ea5d7-8d21-4fd6-9199-fdc606a9843c	0.15	23	released	a2c880fd-daf4-4006-a63f-8be70a1b101b	RNA	R	0.15	UV Spec	released	False	2f0bb5c7-f40c-4d69-a2a4-f6f82e5aca45	21	1.0	1.0	5.0	0.0	5.0	20.0	70.0	70.0	TOP	35c9f884-daff-45e8-8218-d3e3a6c3abd4	released																				released	30.0	7bc29acd-1306-4439-9042-27a9115eb563	Primary Tumor	01	released	Not Reported	released	TCGA-QS-A8F1_demographic	85	-31386	135	289d909f-5255-5016-8ff0-00454a0ca55a	not hispanic or latino	female	black or african american	released	Dead	1928		TCGA-QS-A8F1_exposure	Not Reported	26.57312925170068	d9f1e147-690e-5e93-a498-9588908311f9	168.0	released	75.0	TCGA-QS-A8F1_diagnosis	31386	not reported	0	125	cf4f8fc1-67e6-5fac-a933-4266cfd81299	Stage IIIA	C54.3	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Fundus uteri	released	No	Fundus uteri	not reported	not reported	2013	TCGA-QS-A8F1_treatment_1	TCGA-QS-A8F1_treatment	released	d147518c-61ff-5f14-a35a-a752983fea25	yes	Pharmaceutical Therapy, NOS	released	ddc7c63f-7d14-5418-9ede-7f7ca88f8d50	no	Radiation Therapy, NOS	7498cfdc-50c0-4c24-b424-eb1370392712
573b5b56-64cc-4b97-848f-2970163b86e9.htseq.counts.gz	c9c3e011-d492-4556-acc9-cea8fda67fab	TCGA-AJ-A2QK-01A-11R-A18M-07	TCGA-AJ-A2QK-01A-11R	TCGA-AJ-A2QK-01A-01-TS1			TCGA-AJ-A2QK-01A-11	TCGA-AJ-A2QK-01A	TCGA-AJ-A2QK	de5abe44-6d9d-4797-a57a-5adfd71383f0	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	146	170.0	False	false	01A114A2-098F-4AAD-9010-54910FB89B4A	1.82	3ec89fd3-b1fe-495c-99ef-122ab708e633	0.16	23	released	1bbed407-cd5d-4193-9d53-555a452d3cb8	RNA	R	0.16	UV Spec	released	False	d0c75dcc-a71d-47e8-abf4-fdd1ed6865da	11	40.0	20.0	10.0	20.0	0.0	30.0	60.0	60.0	TOP	d0afd31b-b16b-48b3-aff4-202a99eed78a	released																				released	30.0	0959f580-cc84-4702-81b8-d6ef96f5469f	Primary Tumor	01	released	Not Reported	released	TCGA-AJ-A2QK_demographic	65	-23945		8ab5b506-712f-54cc-95f5-082df9ea6660	hispanic or latino	female	white	released	Alive	1946		TCGA-AJ-A2QK_exposure	Not Reported	49.53173777315296	c30cab87-fca5-51b8-9a40-094d072b53eb	155.0	released	119.0	TCGA-AJ-A2QK_diagnosis	23945	not reported	0	643	5266f863-323d-5f28-b48b-8f121693eebe	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-AJ-A2QK_treatment_1	TCGA-AJ-A2QK_treatment	released	89a9ddbf-ac23-557e-81c0-67450079650e	yes	Pharmaceutical Therapy, NOS	released	ee6d2a2b-9030-5817-a44f-7a4abbfcdf01	yes	Radiation Therapy, NOS	c9c3e011-d492-4556-acc9-cea8fda67fab
3d8fc9be-b978-48b5-ac83-18a2e9209687.htseq.counts.gz	93fbb2c3-6b66-40c1-a5a8-760c4149b6f6	TCGA-AJ-A3BI-01A-11R-A213-07	TCGA-AJ-A3BI-01A-11R	TCGA-AJ-A3BI-01A-01-TS1			TCGA-AJ-A3BI-01A-11	TCGA-AJ-A3BI-01A	TCGA-AJ-A3BI	525fb4fc-2167-4506-b4fa-fb896bf64cd0	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	137	19.0	False	false	19B5518D-075F-40BE-A104-75C925F133A4	1.8	5dc20b99-8440-4d30-a803-1e10cdb29dbe	0.17	23	released	b80463e6-27e7-43b1-98f0-49b668250a51	RNA	R	0.17	UV Spec	released	False	3b3230c0-1d0c-4b66-ae79-da2a7c7ac62f	11	0.0	0.0	20.0	0.0	0.0	0.0	80.0	85.0	TOP	417a5b08-38ac-40c6-8774-2036aa15bdd5	released																				released	19.0	b4d093ec-48a4-4edd-a88c-de51130a368c	Primary Tumor	01	released	Not Reported	released	TCGA-AJ-A3BI_demographic	67	-24623		c5e55511-7437-599c-9032-552b66dedc28	not hispanic or latino	female	white	released	Alive	1944		TCGA-AJ-A3BI_exposure	Not Reported	40.56959714390036	fef3e0f2-340b-531a-b24f-a150ededc547	157.0	released	100.0	TCGA-AJ-A3BI_diagnosis	24623	not reported	0	575	76791262-f3b4-5bfc-85aa-0244e4b2ac0f	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-AJ-A3BI_treatment	TCGA-AJ-A3BI_treatment_1	released	19a961c6-bdb3-5294-afce-82e6ac0a525a	no	Radiation Therapy, NOS	released	71008791-010b-5a80-a159-ae6d3d31d11a	yes	Pharmaceutical Therapy, NOS	93fbb2c3-6b66-40c1-a5a8-760c4149b6f6
dc396277-cc20-4077-8ce7-229a61a92bd6.htseq.counts.gz	23d35e25-dd00-4262-9dab-1cc4c0cf754e	TCGA-BK-A0CA-01A-21R-A118-07	TCGA-BK-A0CA-01A-21R	TCGA-BK-A0CA-01A-02-BS2	TCGA-BK-A0CA-01A-01-BS1		TCGA-BK-A0CA-01A-21	TCGA-BK-A0CA-01A	TCGA-BK-A0CA	51bd85e2-2c60-4654-bfcb-83dccef8964b	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	86	300.0	False	false	883D4832-75FB-495C-B93F-904FCA1AB18C	1.85	20f433c2-0909-4b42-9429-215774b19604	0.15	23	released	0c2b324d-f151-4899-a15a-fcef11c4f15a	RNA	R	0.15	UV Spec	released	False	56df7696-d1f4-49e3-93d4-093c8c59ba2d	21	0.0	0.0	0.0	0.0	50.0	50.0	0.0	0.0	BOTTOM	f22571d6-ffc4-4152-aaa1-8b01eaa5e3c5	released	0.0	0.0	0.0	0.0	0.0	25.0	75.0	75.0	TOP	04c00d4c-a3f4-4231-ab05-67cda5847ca5	released									released	30.0	d836db96-83fb-4f25-a16c-aaaaf55d7b12	Primary Tumor	01	released	Not Reported	released	TCGA-BK-A0CA_demographic	61	-22378		3b6442dc-a44c-5d6d-91f4-9aabb0781977	not hispanic or latino	female	white	released	Alive	1949		TCGA-BK-A0CA_exposure	Not Reported		4feb395e-390e-5e3f-a5a0-52b36201e248	163.0	released		TCGA-BK-A0CA_diagnosis	22378	not reported	0	1064	1b042946-cb3e-57aa-8321-29375cbfaf8c	Stage IIIC	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-BK-A0CA_treatment	TCGA-BK-A0CA_treatment_1	released	86795392-d88c-5bbc-8ae3-67ede9060efc	no	Radiation Therapy, NOS	released	9e810137-bf8e-5eaa-b176-c2077477617c	yes	Pharmaceutical Therapy, NOS	23d35e25-dd00-4262-9dab-1cc4c0cf754e
0548ad5b-d44e-49bf-ba58-d6ad036b272b.htseq.counts.gz	ecc6018f-ff97-478e-95e6-9208ff1bdfc8	TCGA-AX-A064-01A-11R-A00V-07	TCGA-AX-A064-01A-11R	TCGA-AX-A064-01A-01-TSA	TCGA-AX-A064-01A-01-BSA		TCGA-AX-A064-01A-11	TCGA-AX-A064-01A	TCGA-AX-A064	633e6994-3e8b-4c0b-9b79-06cf4ab6f9bc	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1024	180.0	False	false	F760DFF2-7A11-4465-8581-397ABAA76BE4	1.84	91340f00-f5e1-496d-b7d5-08c2ccf57292	0.14	23	released	6a1a4913-a135-4d8e-9fc0-5f995e493813	RNA	R	0.14	UV Spec	released	False	db5309a8-cb9a-487f-9186-a01bcb0d1dd5	11	0.0	0.0	15.0	4.0	0.0	2.0	83.0	92.0	TOP	5268bead-7f4c-4d38-89bc-5fa684c93806	released	0.0	0.0	15.0	4.0	2.0	3.0	80.0	90.0	BOTTOM	6967f3dd-eed4-450c-b565-c3d60ffcbd9f	released									released	30.0	3d85e546-d9f4-49ba-adbd-301118cd1307	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A064_demographic	81	-29625		7a2e57b2-e19b-5407-967c-2f076d5ee7fc	not reported	female	white	released	Alive	1926		TCGA-AX-A064_exposure	Not Reported	20.23950075898128	7df6a162-82bf-5784-978b-e5676c071072	154.0	released	48.0	TCGA-AX-A064_diagnosis	29625	not reported	0	1517	8d97aefb-5fe0-5a3b-a87e-d9d0f992ceab	Stage IIA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2007	TCGA-AX-A064_treatment_1	TCGA-AX-A064_treatment	released	ba89ab19-5591-5c86-923d-b1977ab8e4d9	no	Pharmaceutical Therapy, NOS	released	14fae94d-544a-58d6-8461-1f3aaf95ce41	no	Radiation Therapy, NOS	ecc6018f-ff97-478e-95e6-9208ff1bdfc8
d19908e6-b664-4b4f-95ab-a00bd5106a3b.htseq.counts.gz	f64628b1-8f2f-4918-ab03-439a7f41dfe2	TCGA-AP-A053-01A-21R-A00V-07	TCGA-AP-A053-01A-21R	TCGA-AP-A053-01A-02-BS2	TCGA-AP-A053-01A-01-BS1		TCGA-AP-A053-01A-21	TCGA-AP-A053-01A	TCGA-AP-A053	af37d8f0-fea0-47f6-be0a-2fb55a5da5c4	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	2163	220.0	False	true	6179478F-93BE-4C03-9F65-D74E66AFE449	1.79	bd558781-2e3b-4fb0-aeb8-a8cefbf3272d	0.16	23	released	28ebda4e-94e7-45e1-8a67-d91afa0e979e	RNA	R	0.16	UV Spec	released	False	de85d9af-d956-4856-be0f-769bf80dbf16	21	0.0	0.0	15.0	0.0	0.0	2.0	83.0	98.0	BOTTOM	9770d67d-7a80-42c2-a9a8-9f23d9a881e1	released	0.0	0.0	8.0	0.0	30.0	2.0	60.0	70.0	TOP	0317dafc-0b86-43ac-847d-f1500ced3cd2	released									released	30.0	e1121a9e-bc27-44eb-a1ad-eb0ab10b7c3a	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A053_demographic	90	-32872	0	75602116-9f85-5987-8850-77008a821b05	not hispanic or latino	female	white	released	Dead	1914		TCGA-AP-A053_exposure	Not Reported	19.72386587771203	c6cc757c-e7b9-57c1-8be5-523e21d7a022	156.0	released	48.0	TCGA-AP-A053_diagnosis	32872	not reported	0	0	2e148196-8012-5792-9d48-74c104ac12a8	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2004	TCGA-AP-A053_treatment	TCGA-AP-A053_treatment_1	released	f2c07f84-a8ab-57ee-bbc9-3c579efeb595	yes	Radiation Therapy, NOS	released	ee2b668c-4755-57c2-a82e-ae080f38b4c4	no	Pharmaceutical Therapy, NOS	f64628b1-8f2f-4918-ab03-439a7f41dfe2
d225a442-a4f3-40cd-b80e-d4c3f4cb6b5f.htseq.counts.gz	8af4ecec-58b3-466d-afa9-bde68b124caa	TCGA-DI-A1NO-01A-31R-A157-07	TCGA-DI-A1NO-01A-31R	TCGA-DI-A1NO-01A-03-TSC			TCGA-DI-A1NO-01A-31	TCGA-DI-A1NO-01A	TCGA-DI-A1NO	d3e93d76-6565-454a-a085-4492024350e9	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	688	270.0	False	false	11CEAAB6-3853-48EB-94CE-1B11FEF45B4C	1.88	272f94bc-ce8b-46ff-b13f-827bba6071d5	0.18	23	released	932e56c1-931e-412f-a13f-6a4fd99204a2	RNA	R	0.18	UV Spec	released	False	e268a235-d038-4d1f-b655-2add842d1cf4	31	40.0	20.0	10.0	20.0	0.0	10.0	80.0	80.0	TOP	6555461b-cb50-4f06-a64a-49f6ba9fcccb	released																				released	30.0	002a3a28-71c7-4a8c-960a-14a239ffb433	Primary Tumor	01	released	Not Reported	released	TCGA-DI-A1NO_demographic	68	-24996	285	c538c930-b7ad-54d7-a79e-15aa04e38237	not hispanic or latino	female	black or african american	released	Dead	1941	2009	TCGA-DI-A1NO_exposure	Not Reported	44.27347946000871	b9c36527-91a9-53fd-9cc3-cbf25e0bfcfa	166.0	released	122.0	TCGA-DI-A1NO_diagnosis	24996	not reported	0		ab76fd83-0688-509b-a2f7-164e59ade853	Stage IIIA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-DI-A1NO_treatment_1	TCGA-DI-A1NO_treatment	released	17b2e08d-7ce3-5b8a-be40-26cb248c2958	no	Pharmaceutical Therapy, NOS	released	fd99f745-6d70-5394-a9c0-be334264d4ff	no	Radiation Therapy, NOS	8af4ecec-58b3-466d-afa9-bde68b124caa
6b1442d8-64b8-456a-b6ce-08c8f1fa9ce6.htseq.counts.gz	e3aa0a64-a535-4be7-8232-3f7f44d27d63	TCGA-FI-A3PX-01A-11R-A22K-07	TCGA-FI-A3PX-01A-11R	TCGA-FI-A3PX-01A-01-TS1			TCGA-FI-A3PX-01A-11	TCGA-FI-A3PX-01A	TCGA-FI-A3PX	3e8e34c8-766a-4514-97f4-8000b5350ab9	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	1280	130.0	False	true	5E3FD49D-DE9B-4A5B-B4FC-2825CCB48B46	1.96	773a978c-a52f-470b-b659-4c06de8a7e5b	0.17	23	released	bfeddf87-f72b-4afa-b7cb-1ef9c00d64a7	RNA	R	0.17	UV Spec	released	False	c50025c8-0973-4cd0-bc94-62c902e64f31	11	0.0	0.0	15.0	0.0	0.0	0.0	85.0	90.0	TOP	d9eb834b-e1f0-4e36-88cf-6f1bb076d994	released																				released	30.0	9a1614c1-0c60-4a98-ac4c-447bfdf26576	Primary Tumor	01	released	Not Reported	released	TCGA-FI-A3PX_demographic	57	-21063		42272efd-0292-5bdf-b4cc-8a767f9dfc7f	not hispanic or latino	female	white	released	Alive	1951		TCGA-FI-A3PX_exposure	Not Reported	31.141868512110726	b3c4d76a-96e3-55cb-aed5-d9847a2c3b9e	170.0	released	90.0	TCGA-FI-A3PX_diagnosis	21063	not reported	0	2384	e041e648-069c-5ebb-a0a2-d4c311ae000d	Stage IIIC2	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-FI-A3PX_treatment	TCGA-FI-A3PX_treatment_1	released	90a0fd69-2c28-5d6c-bf20-9ff6caa18cf1	no	Radiation Therapy, NOS	released	eb78b7e7-04c8-55d2-bb1a-0096881da26f	no	Pharmaceutical Therapy, NOS	e3aa0a64-a535-4be7-8232-3f7f44d27d63
41cbb3ce-cee2-4aca-a868-6a8e7a78860f.htseq.counts.gz	7ce9c5b0-381d-44dc-bb4c-2443665d33fb	TCGA-BS-A0V4-01A-11R-A14D-07	TCGA-BS-A0V4-01A-11R	TCGA-BS-A0V4-01A-01-TS1	TCGA-BS-A0V4-01A-01-BS1		TCGA-BS-A0V4-01A-11	TCGA-BS-A0V4-01A	TCGA-BS-A0V4	e3f515f8-a940-40d1-86b0-baed0f410f2c	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1576	310.0	False	false	AA0FFBF8-693C-484E-A29D-02F859E1E4C5	1.83	5deaf911-f777-4c38-95bf-19af647e7806	0.18	23	released	5709564c-ba3e-4e54-8721-4b503964af64	RNA	R	0.18	UV Spec	released	False	c22bf5a9-445a-4bb9-a095-459593365556	11	40.0	20.0	5.0	20.0	0.0	25.0	70.0	70.0	TOP	2d36e6bf-3582-4d6b-b9c2-4b3547ea7732	released	50.0	20.0	0.0	20.0	0.0	20.0	80.0	80.0	BOTTOM	2d72a7ff-7a6b-49b7-8e94-c424bd4a7235	released									released	30.0	dd12111e-9001-4d8d-b8f3-5801b4ab529b	Primary Tumor	01	released	Not Reported	released	TCGA-BS-A0V4_demographic	56	-20777		72351cbb-af0d-50ae-b476-edbb6706eadc	not hispanic or latino	female	white	released	Alive	1950		TCGA-BS-A0V4_exposure	Not Reported	35.26170798898072	936faab9-610e-5a94-83d3-b0621dcf6861	165.0	released	96.0	TCGA-BS-A0V4_diagnosis	20777	not reported	0	1810	a1b6fdf1-0714-573e-9903-953ce31f660f	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2006	TCGA-BS-A0V4_treatment	TCGA-BS-A0V4_treatment_1	released	a6b6e318-d64f-5f22-bf53-bdb8033d0902	no	Radiation Therapy, NOS	released	937db5d2-4dbc-5988-91e1-c6a0ab0775d3	no	Pharmaceutical Therapy, NOS	7ce9c5b0-381d-44dc-bb4c-2443665d33fb
d2713482-d0fb-495e-bb01-307369ef4ec7.htseq.counts.gz	549a267c-ce6b-40cc-95c0-f4a60aa4e63c	TCGA-AP-A1DQ-01A-11R-A137-07	TCGA-AP-A1DQ-01A-11R	TCGA-AP-A1DQ-01A-01-TSA			TCGA-AP-A1DQ-01A-11	TCGA-AP-A1DQ-01A	TCGA-AP-A1DQ	ad0806a5-df9e-48ea-bc8b-d4a3c9ea7ea0	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	1074	100.0	False	true	F5983E58-F466-42CF-8905-B942D2BDF702	1.88	19d3602e-79e6-467f-b49d-c2fa216418ed	0.18	23	released	67bb6dd0-e058-4d6a-a632-e15c82991849	RNA	R	0.18	UV Spec	released	False	0e2e0154-c083-406c-a8f7-fdad10e371ef	11	3.0	4.0	0.0	3.0	0.0	30.0	70.0	70.0	TOP	08c20bf9-6de9-4841-be39-f93381fc1cf1	released																				released	30.0	812485e9-fbb8-431b-8c49-d2f1a9391457	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A1DQ_demographic	76	-27815	1423	306dab98-cd1e-50f5-989a-70e8f5e5da76	not reported	female	white	released	Dead	1932		TCGA-AP-A1DQ_exposure	Not Reported	22.582709172343705	73a3d5ce-3b08-52c5-bfd0-90e3029ecd0c	163.0	released	60.0	TCGA-AP-A1DQ_diagnosis	27815	not reported	0	1276	42051a2d-4aa0-53ce-b7ec-e9dc8ba5aab3	Stage IIIC1	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-AP-A1DQ_treatment_1	TCGA-AP-A1DQ_treatment	released	f2e53561-249f-5281-8cab-f2bc9a0a4e80	yes	Pharmaceutical Therapy, NOS	released	bc799570-1022-5ad9-9c7d-96f05e735efe	yes	Radiation Therapy, NOS	549a267c-ce6b-40cc-95c0-f4a60aa4e63c
8adf8d6d-df8f-4bdb-8999-a25b9d9dea39.htseq.counts.gz	f64e4478-85da-4082-8be9-7e1171142d46	TCGA-AP-A1E0-01A-11R-A137-07	TCGA-AP-A1E0-01A-11R	TCGA-AP-A1E0-01A-01-TSA			TCGA-AP-A1E0-01A-11	TCGA-AP-A1E0-01A	TCGA-AP-A1E0	84b96f93-6273-4101-a259-9602000ae491	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	582	110.0	False	true	700FD29A-69DC-4B34-B841-FFFA7E76A5AF	1.8	d2b4e23b-6cfa-4831-b0ea-8d15f2a55e61	0.16	23	released	6a4278f3-47bd-4b4c-84c5-ce766ae1c587	RNA	R	0.16	UV Spec	released	False	4f644467-1a7b-4598-aaa0-0f6382305644	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	85.0	TOP	de8bfae6-cc2e-4b96-8794-60fb878957d1	released																				released	30.0	9862bae4-6ad0-4607-ab28-cc6bf73d77d0	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A1E0_demographic	40	-14653		27868555-f3af-59fb-ba00-4da9c14176e1	not reported	female	white	released	Alive	1969		TCGA-AP-A1E0_exposure	Not Reported	23.634033007530846	6686ea8c-0df1-5815-a294-b1a8ab449db5	158.0	released	59.0	TCGA-AP-A1E0_diagnosis	14653	not reported	0	1832	bcaeab42-ac51-534a-8007-c4de65e6c3d8	Stage IIIC2	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-AP-A1E0_treatment	TCGA-AP-A1E0_treatment_1	released	38b3b145-82e2-53a0-945e-553cb6414e36	no	Radiation Therapy, NOS	released	0f23d6f2-4f16-5117-bd9f-8436ea943bea	yes	Pharmaceutical Therapy, NOS	f64e4478-85da-4082-8be9-7e1171142d46
b529c21b-a6a7-4a2c-bc67-345aeb239c39.htseq.counts.gz	3cfae78f-ff70-42b0-b0b0-28df7e7ad069	TCGA-A5-A0GM-01A-11R-A040-07	TCGA-A5-A0GM-01A-11R	TCGA-A5-A0GM-01A-01-TSA	TCGA-A5-A0GM-01A-01-BSA		TCGA-A5-A0GM-01A-11	TCGA-A5-A0GM-01A	TCGA-A5-A0GM	976bb47a-d999-4e24-ad08-452fea73c846	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1518	360.0	False	true	4AAFF034-45D3-4F4F-A283-262BA641D03A	1.79	75da1901-49d7-4a96-b195-6e38625898e5	0.16	23	released	f30238a6-ff6b-4800-98f7-019a4eb596c0	RNA	R	0.16	UV Spec	released	False	a390c44f-ea7b-474b-a2cc-5e8e90161856	11	1.0	0.0	0.0	0.0	10.0	0.0	90.0	85.0	TOP	a5b795a0-0503-4fb6-af85-c632897dd867	released	1.0	0.0	0.0	0.0	5.0	0.0	95.0	90.0	BOTTOM	b94b737c-2623-4a9b-9fa0-d8d2aa5c337d	released									released	30.0	a0eccb29-0485-459a-a881-9bb5c59f4371	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A0GM_demographic	53	-19452		2bb9d677-ca90-5a3c-a8d6-6962e1ecaa7e	not hispanic or latino	female	white	released	Alive	1953		TCGA-A5-A0GM_exposure	Not Reported	37.890625	ec2c4d69-801b-5580-adab-94284a87cacc	160.0	released	97.0	TCGA-A5-A0GM_diagnosis	19452	not reported	0	1841	582dc06e-79d4-52fb-b0a2-11597a992790	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2006	TCGA-A5-A0GM_treatment_1	TCGA-A5-A0GM_treatment	released	36398500-9353-5583-99ad-f6f25bf08f19	no	Pharmaceutical Therapy, NOS	released	84cd1149-7f47-5e2c-a7b9-0d3946c006e8	no	Radiation Therapy, NOS	3cfae78f-ff70-42b0-b0b0-28df7e7ad069
2b5ca104-2a13-47e6-9fd5-13aee4c5190a.htseq.counts.gz	5b7cbea8-ce0a-4880-a118-2bc4b3749a14	TCGA-FL-A1YH-11A-11R-A16F-07	TCGA-FL-A1YH-11A-11R	TCGA-FL-A1YH-11A-01-TSA			TCGA-FL-A1YH-11A-11	TCGA-FL-A1YH-11A	TCGA-FL-A1YH	47c49c54-95f8-42c8-94e4-411280452512	Not Reported	Uterus, NOS	TCGA-UCEC		310.0	False	false	F49FD879-727C-4F5E-B4B8-6FE59B4C05FF	1.72	ba70deb1-e8c2-4f74-9883-46e7095f677d	0.16	23	released	7539db96-fcea-4ce0-a6f9-f732e249a973	RNA	R	0.16	UV Spec	released	False	32f8c84c-73c9-4301-9e1a-7add1fe13f3e	11					100.0		0.0		TOP	a2a056a5-8da6-45c1-b2fe-a8e3c8e0a4d0	released																				released	30.0	0e9c603f-5ec6-4fd7-87bb-bce23ca2c042	Solid Tissue Normal	11	released	Not Reported	released																																																			5b7cbea8-ce0a-4880-a118-2bc4b3749a14
face3e41-ea52-4a20-9809-12bde16e0685.htseq.counts.gz	6c22534f-32b9-4549-8255-dc26a8a7cf46	TCGA-AX-A0J0-01A-11R-A109-07	TCGA-AX-A0J0-01A-11R	TCGA-AX-A0J0-01A-01-BSA	TCGA-AX-A0J0-01A-01-TSA		TCGA-AX-A0J0-01A-11	TCGA-AX-A0J0-01A	TCGA-AX-A0J0	1c7b41fc-daa7-4a6e-b553-aff73e8ebac6	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1581	180.0	False	false	EC377A34-B219-4A4F-95DB-DF6E0050A63A	1.9	cb236783-68e6-4522-8618-ea19fd0b8ab5	0.16	23	released	1b498aef-2501-4b86-8c9f-2bce296b7422	RNA	R	0.16	UV Spec	released	False	a00efc1b-eaf5-4375-b5de-5be95e8b0f23	11	1.0	0.0	20.0	0.0	0.0	5.0	75.0	90.0	BOTTOM	4986bc48-d678-4373-98e8-d7e06c4a4914	released	0.0	0.0	10.0	0.0	0.0	5.0	85.0	90.0	TOP	f965c24e-d39f-4950-abd6-e914f3c64c5d	released									released	30.0	e5dea504-d715-4682-ab51-fc6f52fc39a3	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A0J0_demographic	47	-17466		0740835f-f4ed-5dc5-8ff0-d9df87dbd640	not hispanic or latino	female	white	released	Alive	1959		TCGA-AX-A0J0_exposure	Not Reported	19.948059768903608	aed00cc4-a090-5c04-a038-bd3cbc563952	163.0	released	53.0	TCGA-AX-A0J0_diagnosis	17466	not reported	0	1220	316a64b1-581c-573b-95c0-487c977868d8	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2006	TCGA-AX-A0J0_treatment	TCGA-AX-A0J0_treatment_1	released	3b53d30b-df55-5124-bb8e-b2b07424b9df	no	Radiation Therapy, NOS	released	2835bf70-cfb3-5fd1-b16f-4beb3d0afb40	no	Pharmaceutical Therapy, NOS	6c22534f-32b9-4549-8255-dc26a8a7cf46
77cf3117-a628-4642-8171-c99925195ac4.htseq.counts.gz	961900bf-d19b-437e-820a-d393e0b9b167	TCGA-FL-A1YF-11A-12R-A16F-07	TCGA-FL-A1YF-11A-12R	TCGA-FL-A1YF-11A-01-TSA			TCGA-FL-A1YF-11A-12	TCGA-FL-A1YF-11A	TCGA-FL-A1YF	0b0a54ac-bb74-40a4-b647-d067fb9de1ff	Not Reported	Uterus, NOS	TCGA-UCEC		130.0	False	false	77548105-E280-4614-A76D-0177207D77D2	1.75	b80bd803-b042-474e-864e-b2c6ee4708e5	0.17	23	released	8d0ce078-9c06-4d29-8f48-feb368a0b1fb	RNA	R	0.17	UV Spec	released	False	5fb1b16e-b4e2-4bdd-b3c6-ab9f5e7e9175	12					100.0		0.0		TOP	25cba401-385b-48f5-9123-5535b2c6c802	released																				released	30.0	2efbdfb5-99ec-4c46-af68-e10d7ea6f3ce	Solid Tissue Normal	11	released	Not Reported	released																																																			961900bf-d19b-437e-820a-d393e0b9b167
063a2ac5-3574-47b1-b42e-9d4817d7abc9.htseq.counts.gz	3e2d5e82-cdb2-454f-b473-dbad8d615efe	TCGA-AX-A3G8-01A-11R-A22K-07	TCGA-AX-A3G8-01A-11R	TCGA-AX-A3G8-01A-01-TS1			TCGA-AX-A3G8-01A-11	TCGA-AX-A3G8-01A	TCGA-AX-A3G8	6d3fdb58-fdc0-4937-ad38-3a455225ea51	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	350	110.0	False	false	FD22A233-9333-4DA2-A913-4DBA90600247	1.82	9c949f30-455e-48a6-ae31-73f26c609ffd	0.16	23	released	7a87e942-615c-457e-9aaa-8c0ec070adf7	RNA	R	0.16	UV Spec	released	False	bf25511d-d297-4fd3-badd-dd68bbce8c00	11	1.0	0.0	2.0	0.0	0.0	2.0	96.0	97.0	TOP	353f1c27-91b6-40bf-a5b3-e8b1abcc2d59	released																				released	20.0	dfe35835-d03e-4ce3-a76a-fdb15e601257	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A3G8_demographic	76	-27899		9f6ec603-0186-5e86-bd95-3ae3fe32682b	not reported	female	white	released	Alive	1934		TCGA-AX-A3G8_exposure	Not Reported	25.153150229218223	7d92eebf-0692-5756-bec1-00cd27226776	157.0	released	62.0	TCGA-AX-A3G8_diagnosis	27899	not reported	0	36	55334364-e942-507e-a788-e01c1651b279	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-AX-A3G8_treatment_1	TCGA-AX-A3G8_treatment	released	c31adf51-4c2c-5162-9eaf-7d34bbc9c4bb	not reported	Pharmaceutical Therapy, NOS	released	a244c19e-ccc7-5b22-a17c-57c6f4d3c426	not reported	Radiation Therapy, NOS	3e2d5e82-cdb2-454f-b473-dbad8d615efe
8cb6626b-4c3d-4db5-8930-0801535f884e.htseq.counts.gz	12583f10-72be-4a73-9fa4-0808b9e50a51	TCGA-A5-A0G9-01A-11R-A040-07	TCGA-A5-A0G9-01A-11R	TCGA-A5-A0G9-01A-01-BS1	TCGA-A5-A0G9-01A-01-TS1		TCGA-A5-A0G9-01A-11	TCGA-A5-A0G9-01A	TCGA-A5-A0G9	45d58088-d3f4-4eb0-b75c-bcb98c0981dc	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	2095	210.0	False	true	32FB682E-B73F-4525-A845-7F240F9F40CE	1.85	4575ca5e-968c-419d-9707-4e99d55dddb7	0.14	23	released	6d1b1d7e-ea19-4f29-a74c-d2dbf3532480	RNA	R	0.14	UV Spec	released	False	5f02dce1-c4fb-4f40-90a1-94302e9f36ca	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	85.0	BOTTOM	8c640a35-85a2-4b75-952e-90dc7bc16428	released	0.0	0.0	0.0	0.0	0.0	0.0	100.0	85.0	TOP	646ceca1-d91f-4d55-bc90-15eafb5ef0aa	released									released	30.0	117a5b33-42c5-4a52-babe-d9712f3e7472	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A0G9_demographic	79	-29122		22ddbd13-3b49-5a2d-a251-a5cbe4b96c39	not reported	female	white	released	Alive	1925		TCGA-A5-A0G9_exposure	Not Reported	27.7176852352623	e620f837-6883-519d-acc2-2cec62a42f3b	172.0	released	82.0	TCGA-A5-A0G9_diagnosis	29122	not reported	0	2540	9efcef0b-9ec0-570a-9836-92d8c0bb01e2	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2004	TCGA-A5-A0G9_treatment	TCGA-A5-A0G9_treatment_1	released	847742d4-328a-5ade-bbb9-b37c937bb5b7	no	Radiation Therapy, NOS	released	67fb7f36-cf7d-5a8b-8fbe-2ec67c8ac3e8	no	Pharmaceutical Therapy, NOS	12583f10-72be-4a73-9fa4-0808b9e50a51
f5f5f1ed-60e3-4370-a79a-69d3e871f54d.htseq.counts.gz	aceac354-8da8-4831-9c86-655d093d76f5	TCGA-BG-A0MG-01A-21R-A104-07	TCGA-BG-A0MG-01A-21R	TCGA-BG-A0MG-01A-02-TSB	TCGA-BG-A0MG-01A-02-BSB		TCGA-BG-A0MG-01A-21	TCGA-BG-A0MG-01A	TCGA-BG-A0MG	9cde90c8-2be0-4328-a032-ff1dc19e66fd	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	980	240.0	False	true	65A0B84A-72AD-42E2-B0DB-DA8D2BD54E9B	1.94	a21894d9-a459-4dbd-b9de-6c39f6fc61c2	0.15	23	released	0c97c8b8-a458-4423-8111-b2b3f64111d0	RNA	R	0.15	UV Spec	released	False	0115cd29-20f1-4f38-ac10-5238f6f0cf8d	21	2.0	1.0	10.0	7.0	0.0	5.0	85.0	85.0	TOP	b8cadd5d-2b2d-479f-ba56-36dddbc6786b	released	1.0	1.0	3.0	20.0	10.0	10.0	77.0	65.0	BOTTOM	37a03d5d-afc5-43a0-a6ab-132f9afc2e08	released									released	30.0	96b6826d-8a4c-45f5-8cd3-b5988aa5fd0e	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A0MG_demographic	73	-26957		d8ac2c9f-ad6c-5280-8b9b-2851dbd4af1c	not hispanic or latino	female	white	released	Alive	1934		TCGA-BG-A0MG_exposure	Not Reported	23.828125	a32bd207-a734-54b7-b7f4-a3ceeb6f8ff6	160.0	released	61.0	TCGA-BG-A0MG_diagnosis	26957	not reported	0	1477	c8e5a50b-7533-55fc-b7f9-c9d246d65b2a	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2007	TCGA-BG-A0MG_treatment_1	TCGA-BG-A0MG_treatment	released	aadfd0ed-c3cb-5f7e-8f34-efe90b8a1237	no	Pharmaceutical Therapy, NOS	released	72656f0e-d49d-5f08-82b1-99989496ddbe	no	Radiation Therapy, NOS	aceac354-8da8-4831-9c86-655d093d76f5
7b86351f-5a09-4aa3-8d4e-ea124f5fbe93.htseq.counts.gz	59b256c0-d93c-44db-bf3c-7bcd46e2964e	TCGA-FL-A1YM-11A-12R-A17B-07	TCGA-FL-A1YM-11A-12R	TCGA-FL-A1YM-11A-01-TS1			TCGA-FL-A1YM-11A-12	TCGA-FL-A1YM-11A	TCGA-FL-A1YM	f8360744-6bc8-4f53-b1fc-a133789455a8	Not Reported	Uterus, NOS	TCGA-UCEC		80.0	False	false	5FCF83F3-5851-476C-87F6-2DEDF2669A6C	1.92	3499b1ce-1d6d-423d-8509-77e3f6818b0c	0.15	23	released	379ac9ff-ac2f-4f3b-aadb-e203437550d9	RNA	R	0.15	UV Spec	released	False	d647f9eb-8474-4bc2-a152-4b1e2413d758	12					100.0		0.0		TOP	ca2318ff-f4d8-46b5-ab26-b8c1b43d262e	released																				released	30.0	c7add734-286a-4b4f-8d6c-1b30f6a2d1b0	Solid Tissue Normal	11	released	Not Reported	released																																																			59b256c0-d93c-44db-bf3c-7bcd46e2964e
ea77fe52-24ab-4bb7-88ac-8fa54af8d01c.htseq.counts.gz	d439cc58-4086-4893-be9e-810b1cdecb3a	TCGA-BG-A0M3-01A-11R-A104-07	TCGA-BG-A0M3-01A-11R	TCGA-BG-A0M3-01A-01-TSA	TCGA-BG-A0M3-01A-01-BSA		TCGA-BG-A0M3-01A-11	TCGA-BG-A0M3-01A	TCGA-BG-A0M3	8bdd4e0e-5bec-43f2-b9fa-d6e94a72fe05	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	597	100.0	False	true	19AABBD8-3DC5-418E-9B62-37CF7500F174	1.81	e5b97796-bf64-458e-8ed8-246c2b303ce7	0.16	23	released	3e652242-e504-458f-b385-008245431dbb	RNA	R	0.16	UV Spec	released	False	762cb09b-ad1e-4df5-8955-09d0a6e364ea	11	0.0	0.0	5.0	0.0	0.0	0.0	95.0	90.0	TOP	42bb9b1f-f16b-4a2b-b1ed-4bb317e5cc9e	released	0.0	0.0	0.0	0.0	0.0	0.0	100.0	90.0	BOTTOM	9255500f-76e1-4055-b698-b1c858a00f24	released									released	30.0	1802cd6b-4d4a-45fa-b839-7450071e41ee	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A0M3_demographic	74	-27183		fc98d37b-3159-5080-92f4-829f488879b6	not hispanic or latino	female	white	released	Alive	1934		TCGA-BG-A0M3_exposure	Not Reported	29.296875	bfa7b4c2-6ef2-57fa-97bb-2c72a03a0727	160.0	released	75.0	TCGA-BG-A0M3_diagnosis	27183	not reported	0	1071	1df0ea26-2081-5b79-a3dc-bbed3d057699	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-BG-A0M3_treatment	TCGA-BG-A0M3_treatment_1	released	8da9a0a6-d51c-513f-8ad2-4828fa6efb5e	yes	Radiation Therapy, NOS	released	2b8a8500-6f9a-53f3-8a19-307f83436619	no	Pharmaceutical Therapy, NOS	d439cc58-4086-4893-be9e-810b1cdecb3a
d43d8f86-1c94-4058-9569-f15023068ff3.htseq.counts.gz	1193aac3-a2a9-425b-8ab2-9deab7e74e74	TCGA-AX-A06J-01A-11R-A00V-07	TCGA-AX-A06J-01A-11R	TCGA-AX-A06J-01A-01-TS1	TCGA-AX-A06J-01A-01-BS1		TCGA-AX-A06J-01A-11	TCGA-AX-A06J-01A	TCGA-AX-A06J	b6819b52-6f01-4011-9bd3-a1a00397e0c9	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	662	200.0	False	false	553324CE-44B8-416F-B965-074CE5FF9834	1.78	3d4e6413-b717-45c2-8531-118ed3a593a0	0.14	23	released	a8ef6e23-1fe3-425c-869f-ee3996ad0a67	RNA	R	0.14	UV Spec	released	False	7ab839b8-df38-4cf5-b67d-7f32ccec757a	11	0.0	1.0	1.0	1.0	3.0	8.0	88.0	95.0	TOP	9c92618f-0e02-4ce8-a288-946f96276883	released	0.0	4.0	20.0	0.0	3.0	2.0	75.0	95.0	BOTTOM	ae5db9f1-f67c-4989-817a-1325ebff6d96	released									released	30.0	fa750459-78d8-4dd7-890b-45729bad112a	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A06J_demographic	71	-26000		96e572fd-b222-549c-969e-fd4cc8e894d3	not hispanic or latino	female	white	released	Alive	1937		TCGA-AX-A06J_exposure	Not Reported	45.908722657304885	53d69ff1-e5a9-576d-81e1-6bec9f4a5422	161.0	released	119.0	TCGA-AX-A06J_diagnosis	26000	not reported	0	913	86f02a51-8598-52f5-9385-2039491b5c30	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-AX-A06J_treatment	TCGA-AX-A06J_treatment_1	released	3d47647b-b5ab-5673-832f-36582f08741d	yes	Radiation Therapy, NOS	released	6e1e7672-6e95-50c4-aa0e-59773bd344db	yes	Pharmaceutical Therapy, NOS	1193aac3-a2a9-425b-8ab2-9deab7e74e74
67cfe653-e458-44cc-aa05-3e10e305b168.htseq.counts.gz	a5e72a6d-7893-4a2f-bc0d-db7edd61bfc9	TCGA-KP-A3W4-01A-11R-A22K-07	TCGA-KP-A3W4-01A-11R	TCGA-KP-A3W4-01A-01-TSA			TCGA-KP-A3W4-01A-11	TCGA-KP-A3W4-01A	TCGA-KP-A3W4	62df1bd8-23a8-4e52-a483-6895b2f02494	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	688	540.0	False	true	5B8C1B60-7046-4A3A-9D65-ECCB91BF9847	1.85	8488db37-440c-407d-a184-72ee19632c9f	0.15	23	released	989b93ff-767b-4775-87ed-2607221add6a	RNA	R	0.15	UV Spec	released	False	bf924e74-bd28-4560-958d-1cfbcc3f9d57	11	60.0	20.0	10.0	10.0	0.0	20.0	70.0	70.0	TOP	65b33d84-956f-47aa-bd5f-80912f580e45	released																				released	20.0	85363534-a7c9-481e-8d37-b961ce1ad7ae	Primary Tumor	01	released	Not Reported	released	TCGA-KP-A3W4_demographic	63	-23200	554	a8449130-b9ad-5bf1-94ef-5855cf4613e5	not hispanic or latino	female	white	released	Dead	1947	2011	TCGA-KP-A3W4_exposure	Not Reported	26.753212578395683	215ef57c-8150-582d-a45e-a3ce5e40f80d	151.0	released	61.0	TCGA-KP-A3W4_diagnosis	23200	not reported	0		a64b797a-6739-5be1-a4a8-9ee44b7570a5	Stage IIIA	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-KP-A3W4_treatment	TCGA-KP-A3W4_treatment_1	released	ed102a95-c140-572c-8132-cc949b135ae8	no	Radiation Therapy, NOS	released	51d54d31-2627-51c3-97b3-f931f30da97e	yes	Pharmaceutical Therapy, NOS	a5e72a6d-7893-4a2f-bc0d-db7edd61bfc9
50b266c7-525a-4b6c-ac66-7fbb96aa6da1.htseq.counts.gz	78cc5958-3682-4f75-96a8-f9dc26419330	TCGA-FI-A2D6-01A-11R-A17B-07	TCGA-FI-A2D6-01A-11R	TCGA-FI-A2D6-01A-01-TSA			TCGA-FI-A2D6-01A-11	TCGA-FI-A2D6-01A	TCGA-FI-A2D6	787d313f-9255-4b93-8ac2-0aa8febb7909	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	641	70.0	False	true	829C7791-3872-4EAC-BEC2-6B849056A4B7	2.0	fffc5da3-ed33-4f8d-982e-e75b2d707c4b	0.17	23	released	70386def-6c18-45f1-b3c1-14670ada9293	RNA	R	0.17	UV Spec	released	False	2330f1cf-fc65-417a-b7b2-1d9f4e75ec33	11	15.0	5.0	15.0	3.0	0.0	2.0	83.0	98.0	TOP	f53c9c47-0df9-4738-8ed0-a29cd1426224	released																				released	30.0	08f6f51f-9c99-4581-8cda-bec9a5208ee8	Primary Tumor	01	released	Not Reported	released	TCGA-FI-A2D6_demographic	74	-27060	767	64644953-9847-5512-ab46-7325c89519b5	not hispanic or latino	female	white	released	Dead	1935		TCGA-FI-A2D6_exposure	Not Reported	34.89439853076217	1f1e5e97-6e7f-5ca7-b2a8-cc847ef55f70	165.0	released	95.0	TCGA-FI-A2D6_diagnosis	27060	not reported	0	273	a5b33358-e477-5003-a61b-918ef585c326	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-FI-A2D6_treatment	TCGA-FI-A2D6_treatment_1	released	032537d8-6aed-5929-a8c7-0d4baaf8e538	no	Radiation Therapy, NOS	released	ee1d6116-a08b-5168-ab3f-5f7a712205b0	no	Pharmaceutical Therapy, NOS	78cc5958-3682-4f75-96a8-f9dc26419330
8f192531-1289-49a1-8453-b64b2818128b.htseq.counts.gz	91dec093-fd31-4e3a-83a7-7ac0d87dca74	TCGA-BG-A0MQ-01A-11R-A104-07	TCGA-BG-A0MQ-01A-11R	TCGA-BG-A0MQ-01A-01-TSA	TCGA-BG-A0MQ-01A-01-BSA		TCGA-BG-A0MQ-01A-11	TCGA-BG-A0MQ-01A	TCGA-BG-A0MQ	12d36a1d-9922-4311-bbda-71f32ac2c03b	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	692	120.0	False	true	3252AEB3-3B0D-4066-B18E-31096F928D63	1.79	37d2da87-d591-440d-87d3-a34a038bef5b	0.15	23	released	76053f6a-e79b-4cbc-b7b3-9e65c08c49a5	RNA	R	0.15	UV Spec	released	False	f3b41b53-0740-4933-8dc0-efa3f146f9e9	11	4.0	1.0	18.0	2.0	0.0	3.0	79.0	90.0	TOP	0c8a0211-b7ea-4e2b-a09c-36d9bc41bb8e	released	5.0	1.0	18.0	3.0	0.0	5.0	77.0	88.0	BOTTOM	7f714485-37ad-40a6-880d-c79f20d949bd	released									released	30.0	3d1fa321-d2e8-4460-ae87-356ab1ca6281	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A0MQ_demographic	71	-26284		1cfbb428-8eb0-51c0-ab30-92967445c79e	not hispanic or latino	female	white	released	Alive	1937		TCGA-BG-A0MQ_exposure	Not Reported	37.09825528007346	bf13eff6-5567-5374-9d44-e69975009781	165.0	released	101.0	TCGA-BG-A0MQ_diagnosis	26284	not reported	0	1817	2435de46-4c58-55df-94eb-1e49bf074da5	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-BG-A0MQ_treatment_1	TCGA-BG-A0MQ_treatment	released	8e109c6f-9371-54a9-ab59-163e7d560653	no	Pharmaceutical Therapy, NOS	released	85eb8154-5e49-5f0d-84fd-c80b6ee653b1	yes	Radiation Therapy, NOS	91dec093-fd31-4e3a-83a7-7ac0d87dca74
25c04d68-f867-4c8a-a597-2e30e13b9258.htseq.counts.gz	e3dc8324-6856-48a0-9522-1022b9106484	TCGA-BG-A0VV-01A-21R-A118-07	TCGA-BG-A0VV-01A-21R	TCGA-BG-A0VV-01A-02-BSB	TCGA-BG-A0VV-01A-02-TSB		TCGA-BG-A0VV-01A-21	TCGA-BG-A0VV-01A	TCGA-BG-A0VV	6164588a-d03a-46fc-82fb-a32cbaa54cac	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	217	130.0	False	true	42E7D5FF-18CD-4DEA-9518-9B9732BCA635	1.87	34a66e0d-169f-4e39-89a2-78376bf741ae	0.16	23	released	2c6e825f-7339-4865-8a12-14edebaf0fc7	RNA	R	0.16	UV Spec	released	False	de79e1e7-299a-4925-b609-c7f4e7afc49a	21	40.0	40.0	0.0	20.0	10.0	30.0	60.0	60.0	BOTTOM	da84e6f7-3adb-4449-b1e9-737c37f2a7a4	released	60.0	5.0	10.0	30.0	0.0	20.0	70.0	70.0	TOP	46ea817a-d652-4bef-b780-347f51e3a1c7	released									released	10.0	cf919557-13c9-4cf1-982c-a8d8ad3bf4ee	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A0VV_demographic	53	-19581		92763274-a8e2-5612-a776-b334b6ae5dbe	not hispanic or latino	female	white	released	Alive	1957		TCGA-BG-A0VV_exposure	Not Reported	56.01280292638317	e249c7fa-9f08-5f06-bf03-faa6197fc198	162.0	released	147.0	TCGA-BG-A0VV_diagnosis	19581	not reported	0	1553	753cacfd-1655-5069-814e-8960f01f0aca	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-BG-A0VV_treatment_1	TCGA-BG-A0VV_treatment	released	92be7b96-9c70-5cde-8553-90bdc6534fc9	no	Pharmaceutical Therapy, NOS	released	2105efad-c535-50fc-9b6c-1abc93a65c97	no	Radiation Therapy, NOS	e3dc8324-6856-48a0-9522-1022b9106484
e63ab3ed-47ef-4b58-9735-082709d2591c.htseq.counts.gz	506c8e90-c20d-419f-856f-2bf048c85f9a	TCGA-D1-A16V-01A-11R-A12I-07	TCGA-D1-A16V-01A-11R	TCGA-D1-A16V-01A-01-TS1			TCGA-D1-A16V-01A-11	TCGA-D1-A16V-01A	TCGA-D1-A16V	8b19c8ac-68e6-4dc8-aec9-1556e62ca20f	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	609	410.0	False	false	92EA83B6-8041-4449-BAE6-5060C32966D0	1.85	860613bc-72b2-47bb-90ac-2b272e549860	0.17	23	released	aaa6975f-c829-40a6-bc87-469c7676cf4c	RNA	R	0.17	UV Spec	released	False	cc688a6d-95de-4869-9b4d-55137caa6475	11	15.0	2.0	6.0	3.0	2.0	10.0	82.0	90.0	TOP	87b4a379-4103-4fdf-a182-5aa53bcf5bc0	released																				released	30.0	67d0886e-54be-4771-aee7-63adf4a475b7	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A16V_demographic	78	-28635	120	c70e4bfa-e599-54ca-91a6-d9088fab9f05	not hispanic or latino	female	white	released	Dead	1931		TCGA-D1-A16V_exposure	Not Reported	35.083029837281565	cc4cd264-a016-5827-81fb-14e0d849ddf6	173.0	released	105.0	TCGA-D1-A16V_diagnosis	28635	not reported	0	43	6f7e7f7a-d0fd-52fb-b263-c8678cbdfcbe	Stage IIIC	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-D1-A16V_treatment	TCGA-D1-A16V_treatment_1	released	0b5906f7-d802-5f84-813c-0e371f8ace82	no	Radiation Therapy, NOS	released	47242ef7-fa76-56e4-b010-83aeb7b84913	no	Pharmaceutical Therapy, NOS	506c8e90-c20d-419f-856f-2bf048c85f9a
f06cdde6-b92d-4825-938f-252a0054f338.htseq.counts.gz	86cfdc39-a589-478b-a135-4f2a0c686001	TCGA-EO-A22R-01A-11R-A18M-07	TCGA-EO-A22R-01A-11R	TCGA-EO-A22R-01A-01-TSA			TCGA-EO-A22R-01A-11	TCGA-EO-A22R-01A	TCGA-EO-A22R	508bf716-46f9-44dc-8e39-09261dfb073e	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	925	130.0	False	false	5B97D87A-5D28-417F-A942-21775156B46C	1.87	21aa44a9-e23e-4ab9-aa35-6942b118b066	0.16	23	released	6afc456b-ac70-4834-950b-60557cbee5fe	RNA	R	0.16	UV Spec	released	False	d9282b98-146f-41ff-a6b5-f3dd91ed2d8b	11	40.0	20.0	5.0	20.0	0.0	15.0	80.0	80.0	TOP	2f6d56ac-7e3b-4af8-a457-3a6995dcde26	released																				released	30.0	8f1f3c76-1cad-434e-b77a-bc17c7742e76	Primary Tumor	01	released	Not Reported	released	TCGA-EO-A22R_demographic	56	-20604		1c25671b-2d5d-5bb4-b022-6c8571ccc85f	not reported	female	not reported	released	Alive	1952		TCGA-EO-A22R_exposure	Not Reported	31.179138321995463	6c9a2d2c-b273-56d5-9796-5fff29ca49fd	168.0	released	88.0	TCGA-EO-A22R_diagnosis	20604	not reported	0	1878	262813f0-6ba0-5775-a7e9-cb37b50f78a1	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-EO-A22R_treatment	TCGA-EO-A22R_treatment_1	released	2f65a41f-081b-58b1-927c-29cb81517c29	yes	Radiation Therapy, NOS	released	ddb9a6b2-8181-56b9-9b1e-f6c9e433a0ef	no	Pharmaceutical Therapy, NOS	86cfdc39-a589-478b-a135-4f2a0c686001
16a67a95-996d-47d0-a311-6dfda6eba085.htseq.counts.gz	0a9c0939-d535-4be0-bb1a-0404cfa20787	TCGA-BG-A0MH-01A-11R-A118-07	TCGA-BG-A0MH-01A-11R	TCGA-BG-A0MH-01A-01-MSA	TCGA-BG-A0MH-01A-01-TSA		TCGA-BG-A0MH-01A-11	TCGA-BG-A0MH-01A	TCGA-BG-A0MH	bfac45a6-fa01-4edb-9807-6898ea82e80e	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1000	790.0	False	true	F641C526-7A0D-46C3-92EE-CD9CB0D13960	1.85	f73e7e5b-239b-4ac9-861e-c8f42e68188e	0.13	23	released	810dcff2-4428-4ba7-a1b0-3c12f9442956	RNA	R	0.13	UV Spec	released	False	d51efcd6-2f8a-417e-ac86-1907f5f14f45	11	20.0	0.0	20.0	20.0	30.0	50.0	20.0	20.0	BOTTOM	312fdc18-104e-464f-9e32-043e43fb86b0	released	2.0	3.0	2.0	8.0	0.0	20.0	78.0	80.0	TOP	1d841b27-12f3-462c-96be-feeb72f4b477	released									released	30.0	8ad77275-6034-4d01-832f-d8bf3668e6bb	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A0MH_demographic	61	-22475		b42bdb93-a0ce-5f19-9aba-f7c50bdd8f5e	not reported	female	white	released	Alive	1946		TCGA-BG-A0MH_exposure	Not Reported	57.34525215044696	a1b951b1-4c7f-55e8-9173-a3068b174deb	154.0	released	136.0	TCGA-BG-A0MH_diagnosis	22475	not reported	0	1930	1c708c57-cbf9-589f-85c1-c9979ed11899	Stage IC	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2007	TCGA-BG-A0MH_treatment_1	TCGA-BG-A0MH_treatment	released	d8dbd48e-b7aa-5997-8adf-8fc04c12d19c	no	Pharmaceutical Therapy, NOS	released	f7509265-bfe3-5212-ab86-ea1e3f36b03b	yes	Radiation Therapy, NOS	0a9c0939-d535-4be0-bb1a-0404cfa20787
8cd31f85-1d2e-4d90-bd8b-7ca7ebd9241b.htseq.counts.gz	472bdac0-5f51-4b54-a232-b750cc9a8c7b	TCGA-EY-A2OP-01A-11R-A19W-07	TCGA-EY-A2OP-01A-11R	TCGA-EY-A2OP-01A-01-TS1			TCGA-EY-A2OP-01A-11	TCGA-EY-A2OP-01A	TCGA-EY-A2OP	f7165dea-c528-44f3-954f-e111a3d77b4e	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	521	1.0	False	false	E16B08BE-7F2E-4F0E-9FC8-40FCC29F7BC7	1.82	48c88e05-4d0e-444a-8c57-8c9c0c3e7a1f	0.15	23	released	7225b59f-4b68-4fa4-946a-f052a0bc1c48	RNA	R	0.15	UV Spec	released	False	16c33832-d6ab-4e27-9314-36b899fe5b28	11	0.0	0.0	8.0	0.0	0.0	5.0	92.0	85.0	TOP	96a102dc-0814-4e7e-b211-e576f6dba031	released																				released	20.0	53076e0c-46b7-4b5a-8082-2c14fabbfa73	Primary Tumor	01	released	Not Reported	released	TCGA-EY-A2OP_demographic	63	-23090		1e0b3a28-6504-56ef-80e0-7c9db03689ee	not hispanic or latino	female	white	released	Alive	1947		TCGA-EY-A2OP_exposure	Not Reported	25.333333333333332	0be8c84b-36a8-51c8-9a8d-0505b621143d	150.0	released	57.0	TCGA-EY-A2OP_diagnosis	23090	not reported	0	944	798f6013-adc5-5d9f-b366-5d6749226b43	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-EY-A2OP_treatment_1	TCGA-EY-A2OP_treatment	released	c1f9616a-549e-5f50-a86e-42a932b2c5a4	no	Pharmaceutical Therapy, NOS	released	ef0fc883-1043-5e72-9912-967f0b552c99	no	Radiation Therapy, NOS	472bdac0-5f51-4b54-a232-b750cc9a8c7b
96ca4c22-f17f-4125-a3db-aeaff0d42660.htseq.counts.gz	6554e488-b398-4966-8c52-16981ebf9cd1	TCGA-FL-A1YG-11A-12R-A16F-07	TCGA-FL-A1YG-11A-12R	TCGA-FL-A1YG-11A-01-TSA			TCGA-FL-A1YG-11A-12	TCGA-FL-A1YG-11A	TCGA-FL-A1YG	7d8e6965-51ea-4864-968e-5cecfb7da48a	Not Reported	Uterus, NOS	TCGA-UCEC		170.0	False	false	5E88F0A0-6949-485D-89BA-9769A8847919	1.87	88802e34-7269-4b5e-b552-a969281ab241	0.16	23	released	7e850466-b1a1-48e0-83de-2c7238103749	RNA	R	0.16	UV Spec	released	False	34cd9a5c-ed54-4945-9a31-c2db260c215c	12					100.0		0.0		TOP	489186e6-19cf-4f65-859f-ac1b187a95af	released																				released	20.0	7ce9c6ea-2d0b-448e-9d5f-3ab19714d979	Solid Tissue Normal	11	released	Not Reported	released																																																			6554e488-b398-4966-8c52-16981ebf9cd1
e21157c9-e81c-4a5c-8e62-dffb9e51402f.htseq.counts.gz	e73c7c2f-f1c9-4380-adfe-fe5008fe27b9	TCGA-B5-A11L-01B-21R-A13S-07	TCGA-B5-A11L-01B-21R	TCGA-B5-A11L-01B-02-TSB			TCGA-B5-A11L-01B-21	TCGA-B5-A11L-01B	TCGA-B5-A11L	07b24a23-3d9f-4591-800f-8738cc232f9a	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1297	90.0	False	true	ABA26FE8-0C80-459A-9DF8-537D1A08A92E	1.95	d262b256-5452-4df1-9526-9a1b11da775f	0.16	23	released	2344201a-e4ba-4905-8599-00f4c5a0892f	RNA	R	0.16	UV Spec	released	False	1c0549c7-5b9a-404e-8831-bb38bf268b2e	21	15.0	3.0	3.0	3.0	0.0	30.0	67.0	70.0	TOP	3fa9d2d1-14f1-44fd-bcbb-0afd20eee75b	released																				released	20.0	790ace35-d090-4933-bd57-5efc61889c85	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A11L_demographic	71	-26120	2240	1ed66275-6c77-5a3c-9c2f-beae4c94d66f	not reported	female	white	released	Dead	1936		TCGA-B5-A11L_exposure	Not Reported	34.626820730927015	0b518b72-5dfa-5a37-a99c-a27a7a9d5b6d	163.0	released	92.0	TCGA-B5-A11L_diagnosis	26120	not reported	0	1396	708bf6ee-ba97-507f-b1b3-3b4a66d91444	Stage IC	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2007	TCGA-B5-A11L_treatment	TCGA-B5-A11L_treatment_1	released	fdc31081-01fe-5709-a770-61d7a84f6f05	yes	Radiation Therapy, NOS	released	79f43f37-1523-5785-8232-01f111d6ce1c	no	Pharmaceutical Therapy, NOS	e73c7c2f-f1c9-4380-adfe-fe5008fe27b9
0254436b-fef6-4a7c-9e9c-751c9dca66ca.htseq.counts.gz	aba28641-b135-4044-9f29-4672a1242bfa	TCGA-D1-A0ZR-01A-21R-A10J-07	TCGA-D1-A0ZR-01A-21R	TCGA-D1-A0ZR-01A-01-BS1	TCGA-D1-A0ZR-01A-02-BS2		TCGA-D1-A0ZR-01A-21	TCGA-D1-A0ZR-01A	TCGA-D1-A0ZR	0ce940f2-9eb1-4757-8f8f-147a4f3a1e67	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	537	240.0	False	false	ECC5B77F-7B6C-4C4A-A32C-1346DC3AF24D	1.82	41f4268d-a222-4d6b-b4aa-515bb8765c6c	0.16	23	released	49be2dbd-3142-40a8-8031-c605b5aeb4a2	RNA	R	0.16	UV Spec	released	False	48b63274-2f66-4501-abe1-625e161763ef	21	20.0	0.0	10.0	20.0	0.0	30.0	60.0	70.0	TOP	1dad6c1e-2f1a-4a06-86c3-a2572f486261	released	20.0	0.0	10.0	10.0	0.0	10.0	80.0	90.0	BOTTOM	660250c8-1893-4175-b6a6-e568732f263e	released									released	30.0	6647e6db-bba8-4e27-b24f-fc886d777906	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A0ZR_demographic	57	-21157		7013e283-d503-51f1-b15e-14770b692036	not hispanic or latino	female	white	released	Alive	1952		TCGA-D1-A0ZR_exposure	Not Reported	42.97520661157024	30bb3a9b-216e-5039-99c9-9780f7827b82	165.0	released	117.0	TCGA-D1-A0ZR_diagnosis	21157	not reported	0	17	dd662e50-f856-549e-b8c3-3d974418f62a	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-D1-A0ZR_treatment_1	TCGA-D1-A0ZR_treatment	released	184e1ed7-56e7-56f2-a803-d19d2282e3de	no	Pharmaceutical Therapy, NOS	released	1c79c103-84a2-5df3-a04c-23e6078fe081	no	Radiation Therapy, NOS	aba28641-b135-4044-9f29-4672a1242bfa
f0635afd-c734-4171-a687-8e40ba01d53e.htseq.counts.gz	5a9ae12a-de42-4bf1-b614-e893a9cc60ee	TCGA-EY-A72D-01A-12R-A34R-07	TCGA-EY-A72D-01A-12R	TCGA-EY-A72D-01A-01-TS1			TCGA-EY-A72D-01A-12	TCGA-EY-A72D-01A	TCGA-EY-A72D	a12df3d7-c560-4e7d-a482-1025a6e5b465	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	120	340.0	False	false	6F2C081B-8D36-4DB4-9846-67DC1D3964E0	1.9	051469db-cfa9-4907-ae54-13c060ad2958	0.17	23	released	4ea9fa37-e9c5-4f7b-a0e1-dbf4ade86bc5	RNA	R	0.17	UV Spec	released	False	77033bbb-7b69-45c4-8488-76657dba00eb	12	40.0	20.0	10.0	20.0	0.0	10.0	80.0	80.0	TOP	6290a65c-ceca-4c42-879f-a11519e88993	released																				released	30.0	f661c070-cff5-4fdc-bb26-9f1a3ef2592a	Primary Tumor	01	released	Not Reported	released	TCGA-EY-A72D_demographic	87	-31818		c8b4918b-961a-55ee-930c-51304d95033f	not hispanic or latino	female	black or african american	released	Alive	1926		TCGA-EY-A72D_exposure	Not Reported	40.390184423106234	1efc26d0-50e5-5bb4-9d83-bc80d36cf7df	162.0	released	106.0	TCGA-EY-A72D_diagnosis	31818	not reported	0	179	c584ec2e-e218-50e5-845f-eb874468128a	Stage II	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2013	TCGA-EY-A72D_treatment_1	TCGA-EY-A72D_treatment	released	9f7a76e3-a665-5365-8f96-984ec6966dee	no	Pharmaceutical Therapy, NOS	released	49732276-e5ab-5fea-98fe-dfc0c5f4d4cc	no	Radiation Therapy, NOS	5a9ae12a-de42-4bf1-b614-e893a9cc60ee
0622b0c0-ea47-44fb-8ea1-e150230648ad.htseq.counts.gz	4909e661-3121-49b8-8a71-44f01ada71c9	TCGA-B5-A11M-01A-11R-A118-07	TCGA-B5-A11M-01A-11R	TCGA-B5-A11M-01A-01-BS1	TCGA-B5-A11M-01A-01-TS1		TCGA-B5-A11M-01A-11	TCGA-B5-A11M-01A	TCGA-B5-A11M	fd370e9d-2719-45e0-b8f1-048ed1ee602f	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1085	40.0	False	true	3C00B510-8D9C-4DD4-9E7C-FC058230BE97	1.79	aefe6191-1196-4614-b319-4ce263d3cc90	0.15	23	released	e0cacc29-e1fd-4011-93dd-294bce61252f	RNA	R	0.15	UV Spec	released	False	b02990fb-1816-4f90-9d79-7e7873847b04	11	30.0	2.0	0.0	0.0	0.0	50.0	50.0	50.0	BOTTOM	6fa80b2e-6374-451c-8ac8-1a0a312e9340	released	30.0	2.0	0.0	0.0	0.0	30.0	70.0	70.0	TOP	a1d3f157-de01-434d-9973-379e425ffc8c	released									released	30.0	82f33c0d-f9dc-4463-8ab5-ae7283e85431	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A11M_demographic	43	-16063		2c8ee06f-8361-510d-816f-c0e4550cdbd7	not reported	female	white	released	Alive	1964		TCGA-B5-A11M_exposure	Not Reported	59.37887137425776	9d1d2e6e-5ff0-5442-98ab-8736c7b73be4	153.0	released	139.0	TCGA-B5-A11M_diagnosis	16063	not reported	0	1362	c2e77d56-7025-5ab5-919e-43b706b07a50	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2007	TCGA-B5-A11M_treatment_1	TCGA-B5-A11M_treatment	released	93a496e5-582e-526b-8b46-82a03de9ffe4	no	Pharmaceutical Therapy, NOS	released	3e4550eb-57c8-5930-870b-461edb575bdb	no	Radiation Therapy, NOS	4909e661-3121-49b8-8a71-44f01ada71c9
82e164f3-ce5d-4226-b338-e3d7a4fd8807.htseq.counts.gz	e3237ddc-f2ce-4497-bc7d-ce77afb274cf	TCGA-EY-A1GS-01A-11R-A13S-07	TCGA-EY-A1GS-01A-11R	TCGA-EY-A1GS-01A-01-TSA			TCGA-EY-A1GS-01A-11	TCGA-EY-A1GS-01A	TCGA-EY-A1GS	c10b2885-70ea-4d32-bc48-8b85530df702	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	211	270.0	False	false	3F953015-45DC-4678-A8B3-DC55339DE717	1.98	7348f1f9-8bcf-41e2-bcb0-743823cac926	0.15	23	released	ef6ba5c4-6376-4c27-ba92-379df193e68c	RNA	R	0.15	UV Spec	released	False	d52fffaa-5c45-4a46-a1e2-d6f68bfabcfc	11	40.0	20.0	10.0	20.0	0.0	10.0	80.0	80.0	TOP	89f78eaa-1840-432a-a384-53efc4e21889	released																				released	30.0	99540910-61a1-434b-9937-216dfac5f719	Primary Tumor	01	released	Not Reported	released	TCGA-EY-A1GS_demographic	71	-26012	670	d4070e0f-bae1-5bbc-920e-4c67a15f4736	not hispanic or latino	female	black or african american	released	Dead	1939		TCGA-EY-A1GS_exposure	Not Reported	23.9188302920412	e352b332-b45f-58b2-a355-4343af2f0585	161.0	released	62.0	TCGA-EY-A1GS_diagnosis	26012	not reported	0	459	884471a7-e889-56f7-a090-97fcb66320df	Stage IVB	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-EY-A1GS_treatment	TCGA-EY-A1GS_treatment_1	released	a7576901-6053-541e-b0b6-b53150db5aa8	no	Radiation Therapy, NOS	released	e44b5e05-f54a-58d2-8475-b71bc199220a	yes	Pharmaceutical Therapy, NOS	e3237ddc-f2ce-4497-bc7d-ce77afb274cf
48a1887e-e335-4897-95c9-043410e48fe7.htseq.counts.gz	ab09f5cf-d7a8-4de0-a868-68dd227394e5	TCGA-BK-A0CB-01A-32R-A104-07	TCGA-BK-A0CB-01A-32R	TCGA-BK-A0CB-01A-02-BS2	TCGA-BK-A0CB-01A-03-BS3		TCGA-BK-A0CB-01A-32	TCGA-BK-A0CB-01A	TCGA-BK-A0CB	59e9029a-8ddd-4447-b35a-72bc39f82a30	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	64	450.0	False	false	37923E3D-3CCB-41DB-8F30-C19FDE7407CB	1.77	6b8a0d03-6a82-49ed-b3ee-66937dc06201	0.16	23	released	c8a72928-a591-4c2b-9086-87be224099d1	RNA	R	0.16	UV Spec	released	False	ae54fa86-b9fc-4460-ac58-5b7e5af4684e	32	0.0	0.0	0.0	0.0	0.0	25.0	75.0	75.0	TOP	f3b81218-6651-4c2c-84bb-592a44ea3e63	released	5.0	1.0	1.0	0.0	15.0	14.0	70.0	70.0	BOTTOM	9d100a55-f190-49a0-ba18-0b4cadada132	released									released	30.0	7678c70d-a298-4472-89a0-427af1e93d28	Primary Tumor	01	released	Not Reported	released	TCGA-BK-A0CB_demographic	60	-21930		1f26523e-25cd-56bb-9040-3a6c41c9990a	not hispanic or latino	female	white	released	Alive	1950		TCGA-BK-A0CB_exposure	Not Reported	46.80384550514421	e7ee05d7-b87a-522e-b770-bb7f1b74a1ee	154.0	released	111.0	TCGA-BK-A0CB_diagnosis	21930	not reported	0	1092	5a486ede-eca5-51a6-bbec-2e5edf372fae	Stage IIIC	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-BK-A0CB_treatment_1	TCGA-BK-A0CB_treatment	released	88b56b49-9b27-5e70-945a-2635a0f0eb30	yes	Pharmaceutical Therapy, NOS	released	08300f38-dec3-5766-bc08-c806044a2990	no	Radiation Therapy, NOS	ab09f5cf-d7a8-4de0-a868-68dd227394e5
dc2c4dfc-d8e4-40c5-ab54-3cfa15f166cf.htseq.counts.gz	91b3b8dd-938a-418a-aaf0-737c0c551885	TCGA-KP-A3W0-01A-21R-A22K-07	TCGA-KP-A3W0-01A-21R	TCGA-KP-A3W0-01A-02-TSB			TCGA-KP-A3W0-01A-21	TCGA-KP-A3W0-01A	TCGA-KP-A3W0	c9ebaeff-6a27-4a6c-a34c-5337a3508a52	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	351	90.0	False	true	8623B627-C3E3-469B-A640-2F8BCFC0B711	1.85	0ed2207e-47d3-47aa-804f-abffb6f42e64	0.17	23	released	e5e443b8-031d-4fa6-b66f-d1dd86ac152f	RNA	R	0.17	UV Spec	released	False	246029f0-0e22-4f73-baa5-eb80d889d8e7	21	60.0	20.0	10.0	10.0	0.0	30.0	60.0	60.0	TOP	e56865fe-8c27-4dbb-8c65-4f35e433cb5f	released																				released	30.0	570bb596-bad8-4a83-a7d7-e9fa8c9e16aa	Primary Tumor	01	released	Not Reported	released	TCGA-KP-A3W0_demographic	72	-26378		59388de5-fd85-5e5e-9f59-87345330429b	not reported	female	not reported	released	Alive	1939		TCGA-KP-A3W0_exposure	Not Reported	35.817710714830056	84ca83c3-7077-535c-9fc3-7fe95c1049ea	162.0	released	94.0	TCGA-KP-A3W0_diagnosis	26378	not reported	0	404	27fb4d70-b5fe-515f-8dc1-b4d461322f31	Stage IB	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-KP-A3W0_treatment	TCGA-KP-A3W0_treatment_1	released	267ad052-a47f-566c-b65b-bf25b5550753	yes	Radiation Therapy, NOS	released	efacfcbd-c51e-520f-8901-fd4d7e6ab6e4	yes	Pharmaceutical Therapy, NOS	91b3b8dd-938a-418a-aaf0-737c0c551885
5b0571f1-a20a-4601-bc0b-901d32c4fb40.htseq.counts.gz	a25c2cf8-59ab-4f08-adbd-90cb1243ff24	TCGA-DF-A2KV-01A-11R-A180-07	TCGA-DF-A2KV-01A-11R	TCGA-DF-A2KV-01A-01-TSA			TCGA-DF-A2KV-01A-11	TCGA-DF-A2KV-01A	TCGA-DF-A2KV	59cebae6-632d-4632-b695-c48ae46b2e67	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC		580.0	False	false	5717937B-AC81-452E-9B4D-3301FDA7CD0B	1.8	5378bbbf-3ddf-43bf-824d-fcb46028f571	0.17	23	released	0daee1cd-9fb5-4462-a729-278bd58e4c8c	RNA	R	0.17	UV Spec	released	False	de51ecbb-c9a9-458b-adf6-f21f523b4b34	11	5.0	5.0	0.0	25.0	0.0	15.0	85.0	85.0	TOP	cdba507c-5dcb-4442-9f99-720917a0cdec	released																				released	30.0	0c713392-8713-40f2-93cf-4272be99427f	Primary Tumor	01	released	Not Reported	released	TCGA-DF-A2KV_demographic	55	-20160		65351b19-481f-5a72-9867-f1b3c0fad92d	not reported	female	not reported	released	Alive			TCGA-DF-A2KV_exposure	Not Reported		d05ba4b9-fcf3-5136-834f-89adef4209b4		released		TCGA-DF-A2KV_diagnosis	20160	not reported	0	2717	1a85d10b-785d-5992-9efa-17360d4f462a	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported		TCGA-DF-A2KV_treatment	TCGA-DF-A2KV_treatment_1	released	02be3f87-9cd1-581f-80c7-78100f58abf4	not reported	Radiation Therapy, NOS	released	7ac458ed-700a-5a49-8c54-4ab7d0ab1553	not reported	Pharmaceutical Therapy, NOS	a25c2cf8-59ab-4f08-adbd-90cb1243ff24
7b695fd1-d4be-40dc-856c-1e5fc6f33d3e.htseq.counts.gz	9680fa9b-ce88-42ae-b5f9-00396cdfb399	TCGA-D1-A17C-01A-11R-A12I-07	TCGA-D1-A17C-01A-11R	TCGA-D1-A17C-01A-01-TS1			TCGA-D1-A17C-01A-11	TCGA-D1-A17C-01A	TCGA-D1-A17C	6f4f0cdd-8387-45d0-a9e8-efce6260159d	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	249	130.0	False	false	213A073E-C5E1-4BA8-B4D5-23C92E539FA5	1.77	1f3910ae-d1c0-4815-836b-25f2926f9258	0.15	23	released	1a664ff5-a753-4401-bb7b-4f0419e1d529	RNA	R	0.15	UV Spec	released	False	d5a30152-40d4-40bc-b90d-c0430bb643bf	11	5.0	3.0	0.0	5.0	5.0	40.0	55.0	60.0	TOP	7377e706-2022-40a3-86e7-8d49a6a4219c	released																				released	30.0	2d5ac7fc-bed4-4c7f-927d-9b44846324c4	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A17C_demographic	78	-28571		7510a9b9-dfb5-55c4-98c3-cfbd60e2d6a9	not hispanic or latino	female	white	released	Alive	1932		TCGA-D1-A17C_exposure	Not Reported	31.24879441379576	7964cb46-e34f-5cbe-a801-52ce36710622	161.0	released	81.0	TCGA-D1-A17C_diagnosis	28571	not reported	0	30	c37a7f86-46a7-5a73-b85e-db7612e0f0e4	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-D1-A17C_treatment	TCGA-D1-A17C_treatment_1	released	2bf2e225-b089-5162-a321-f27fa348557f	no	Radiation Therapy, NOS	released	c5cd9d53-fc15-5469-b213-a17dca36b2d1	no	Pharmaceutical Therapy, NOS	9680fa9b-ce88-42ae-b5f9-00396cdfb399
1297a365-11e4-4a14-93a3-74c7aa0029e1.htseq.counts.gz	ce9b8528-2e93-4654-814b-b66432e16820	TCGA-D1-A15Z-01A-11R-A118-07	TCGA-D1-A15Z-01A-11R	TCGA-D1-A15Z-01A-01-TS1			TCGA-D1-A15Z-01A-11	TCGA-D1-A15Z-01A	TCGA-D1-A15Z	c5df9142-27f6-4d97-933e-c79ea9199362	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	884	160.0	False	false	280F86BF-4834-4FA9-B153-DE7BE312E619	1.85	0ca45a1d-6cdc-48f5-8bde-633cfd15d687	0.17	23	released	4c3063cf-1675-47f3-a500-c93c81a8404a	RNA	R	0.17	UV Spec	released	False	87d40644-23c6-4ad1-8540-d66e9cdad1a8	11	0.0	0.0	0.0	0.0	5.0	0.0	95.0	85.0	TOP	daa0e373-defd-48f0-844f-61cc55851fc8	released																				released	30.0	7a961c2f-2e7f-4eb0-945b-9f0d59923962	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A15Z_demographic	72	-26638	58	69387b62-2c68-5b85-a959-7200561ef196	not hispanic or latino	female	white	released	Dead	1936	2008	TCGA-D1-A15Z_exposure	Not Reported	48.828125	0d4b3cbd-bc59-50ad-be08-34f4e95ab20f	160.0	released	125.0	TCGA-D1-A15Z_diagnosis	26638	not reported	0		66e7281a-e104-5a39-9ca1-9645b46f893c	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-D1-A15Z_treatment	TCGA-D1-A15Z_treatment_1	released	4022dab4-2357-5bbd-a965-817f18876ff1	no	Radiation Therapy, NOS	released	27428922-0981-5672-88c7-c326046a8b13	no	Pharmaceutical Therapy, NOS	ce9b8528-2e93-4654-814b-b66432e16820
c1daf727-d2a2-4370-b9f7-9c90d0a8218d.htseq.counts.gz	a34562aa-384f-462a-b586-acc4ed526712	TCGA-FL-A1YL-11A-11R-A16F-07	TCGA-FL-A1YL-11A-11R	TCGA-FL-A1YL-11A-01-TSA			TCGA-FL-A1YL-11A-11	TCGA-FL-A1YL-11A	TCGA-FL-A1YL	5a61ef1e-61eb-4794-9429-2bddbbe7d09d	Not Reported	Uterus, NOS	TCGA-UCEC		80.0	False	false	5C686996-6F26-4A31-B53E-AC9561DAC9FC	2.0	4ad4e642-d5fc-459e-8553-bb1c9795c09d	0.15	23	released	23077028-c794-489b-a3db-90b63a17660f	RNA	R	0.15	UV Spec	released	False	f27373f9-0b42-4ed2-bca9-167a0b819069	11					100.0		0.0		TOP	b964232d-84c8-4903-bde4-524925eb2ba4	released																				released	30.0	69c9f329-8f1d-4ed6-ad22-d82371a3fc9c	Solid Tissue Normal	11	released	Not Reported	released																																																			a34562aa-384f-462a-b586-acc4ed526712
d2d69589-3744-4394-829a-ec8d2843d004.htseq.counts.gz	e56bd032-5b7b-418a-9c78-3ea9dc41be12	TCGA-EY-A547-01A-11R-A27V-07	TCGA-EY-A547-01A-11R	TCGA-EY-A547-01A-01-TS1			TCGA-EY-A547-01A-11	TCGA-EY-A547-01A	TCGA-EY-A547	3424120f-248f-451a-948c-e320c19d1b19	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	645	610.0	False	false	59662419-D77B-4C25-A888-CE993D412FD1	1.86	cc3bf52b-7b69-40c9-9358-f66cb7b1dd87	0.16	23	released	b7bd1947-631c-4d07-a754-f00c51f2e3f1	RNA	R	0.16	UV Spec	released	False	83280b9e-b826-4593-8c11-f4853156f679	11	2.0	2.0	0.0	0.0	0.0	0.0	100.0	80.0	TOP	c095d9a6-5999-4a95-b737-091795954afc	released																				released	30.0	52338734-9eec-4793-b4a7-5cd84322e797	Primary Tumor	01	released	Not Reported	released	TCGA-EY-A547_demographic	75	-27686		399576fd-07c2-54de-bfad-53f280417976	not hispanic or latino	female	black or african american	released	Alive	1936		TCGA-EY-A547_exposure	Not Reported	39.1929162432864	6e11faff-d613-5e56-81ff-596e88c2eb93	166.0	released	108.0	TCGA-EY-A547_diagnosis	27686	not reported	0	545	af37ed24-16f1-5b06-b606-2fd25594ecdc	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2011	TCGA-EY-A547_treatment_1	TCGA-EY-A547_treatment	released	4b52ef2d-c6c4-5d4f-880c-012c6315d5f1	no	Pharmaceutical Therapy, NOS	released	83f289c0-5cd8-5688-9db9-efa2c7902a10	yes	Radiation Therapy, NOS	e56bd032-5b7b-418a-9c78-3ea9dc41be12
cbd4177a-2678-4b37-b677-4e5443a95fce.htseq.counts.gz	d0fd164c-1b9b-4e55-a268-92654c3d1854	TCGA-D1-A16B-01A-11R-A12I-07	TCGA-D1-A16B-01A-11R	TCGA-D1-A16B-01A-01-TSA			TCGA-D1-A16B-01A-11	TCGA-D1-A16B-01A	TCGA-D1-A16B	bca1057a-1e96-404d-8a37-5a8dc1944ee7	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	793	150.0	False	false	1B9ED459-4046-4DD9-ABA5-E815A90601A3	1.84	90250b43-5a36-42c0-886f-32a0ed39bea6	0.16	23	released	6c1f4d06-072a-438f-9e8d-b611ed3066ee	RNA	R	0.16	UV Spec	released	False	2cce53e2-e1aa-49f8-960a-af1112950723	11	2.0	2.0	5.0	6.0	0.0	30.0	65.0	70.0	TOP	fc500705-7f9a-4126-b7af-99e123de3042	released																				released	30.0	6a59ff6e-7cc6-4d46-8983-7d9e6a48cc19	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A16B_demographic	64	-23450		75adb354-65dc-56e8-a9bb-d01ff7b9ec15	not hispanic or latino	female	white	released	Alive	1944		TCGA-D1-A16B_exposure	Not Reported	34.01764170721095	600f37fc-9483-576a-bf64-05cef7be398e	159.0	released	86.0	TCGA-D1-A16B_diagnosis	23450	not reported	0	1106	8fc243ef-6ae1-505d-9afb-c0e9901a5020	Stage IC	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-D1-A16B_treatment_1	TCGA-D1-A16B_treatment	released	c13bfe61-2eff-5ea2-89c9-1d78875a75f2	no	Pharmaceutical Therapy, NOS	released	ac7adcc2-9cb6-51c6-ac77-bd02d4346d48	no	Radiation Therapy, NOS	d0fd164c-1b9b-4e55-a268-92654c3d1854
1bac1f6a-df2a-4167-82b9-eb00cda814c9.htseq.counts.gz	02445026-ad12-43e4-8c30-54e07513a412	TCGA-BS-A0V8-01A-11R-A118-07	TCGA-BS-A0V8-01A-11R	TCGA-BS-A0V8-01A-01-MS1	TCGA-BS-A0V8-01A-01-BS1		TCGA-BS-A0V8-01A-11	TCGA-BS-A0V8-01A	TCGA-BS-A0V8	2b76cc9c-c379-43e4-9c3f-56197a3353be	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1410	120.0	False	false	A024F121-F6C9-4CDF-B0ED-B58708DB6DFE	1.84	1c908135-7fdf-4257-8b9e-92e6aa0850a6	0.15	23	released	81615c81-ee48-474e-8ada-c3dec066ce19	RNA	R	0.15	UV Spec	released	False	df819909-c92a-48e4-a2ae-5370f5d5cbad	11	5.0	0.0	1.0	0.0	59.0	15.0	25.0	15.0	TOP	a748951f-36e9-4fcd-8505-5176a2f06241	released	10.0	0.0	20.0	20.0	30.0	0.0	50.0	70.0	BOTTOM	6905cf0c-45da-4d04-9323-2eadebd2d138	released									released	30.0	cf369a2c-d3c3-4fa3-b004-e4269530ceff	Primary Tumor	01	released	Not Reported	released	TCGA-BS-A0V8_demographic	68	-24981		3fecafa2-72e6-51c6-83b4-ad54786e9d2b	not hispanic or latino	female	native hawaiian or other pacific islander	released	Alive	1938		TCGA-BS-A0V8_exposure	Not Reported	34.484157572315304	c6ebc8ea-a471-5359-801e-7ed317567e8a	157.0	released	85.0	TCGA-BS-A0V8_diagnosis	24981	not reported	0	2544	c46365fa-932f-5775-863a-dd410c14bb57	Stage IIB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2006	TCGA-BS-A0V8_treatment_1	TCGA-BS-A0V8_treatment	released	d850eaea-cb89-5162-84bc-82a88a97b696	no	Pharmaceutical Therapy, NOS	released	4ae250ef-1fe7-516e-82e8-af91b922d990	yes	Radiation Therapy, NOS	02445026-ad12-43e4-8c30-54e07513a412
3ca95132-54ef-4aa3-8cde-5137f7fb2f51.htseq.counts.gz	fd79c620-4833-4b22-8af5-34943df1e48b	TCGA-AX-A05U-01A-11R-A00V-07	TCGA-AX-A05U-01A-11R	TCGA-AX-A05U-01A-01-BS1	TCGA-AX-A05U-01A-01-TS1		TCGA-AX-A05U-01A-11	TCGA-AX-A05U-01A	TCGA-AX-A05U	e56c6abc-b36c-4667-a347-0a541ce4791d	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	500	180.0	False	false	1F51E982-37A1-40C6-BFAC-782B93D9967F	1.81	cadb8d53-b172-421d-ac3e-1583f5e55049	0.15	23	released	a5082828-9011-4e0d-b276-fedb33b198e8	RNA	R	0.15	UV Spec	released	False	dae53a81-077a-4b4c-81d3-0da6290e4698	11	0.0	0.0	5.0	0.0	2.0	3.0	90.0	90.0	BOTTOM	53d02358-c0e4-446e-8138-500a38f46eb4	released	0.0	0.0	5.0	0.0	12.0	3.0	80.0	85.0	TOP	5181e5e0-f144-48de-8a47-717286dc6d6d	released									released	30.0	6327ef54-8216-4fd3-bde4-01f3192c653f	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A05U_demographic	56	-20533		f34a2659-0257-5109-8d37-63fd9d62af15	not hispanic or latino	female	american indian or alaska native	released	Alive	1952		TCGA-AX-A05U_exposure	Not Reported	25.806451612903224	b9ebf67c-a2ac-5851-a7fb-abc18ea206e7	155.0	released	62.0	TCGA-AX-A05U_diagnosis	20533	not reported	0	903	8f4b5fbe-28bf-5a2d-b74e-970b40796eef	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-AX-A05U_treatment	TCGA-AX-A05U_treatment_1	released	02b75a17-b9e5-53f9-913b-093874a7ec3b	no	Radiation Therapy, NOS	released	2cb4a64a-ca0a-5265-93fb-ba6d2088e0dc	no	Pharmaceutical Therapy, NOS	fd79c620-4833-4b22-8af5-34943df1e48b
dd00fc79-2328-42c6-9734-96d2256de370.htseq.counts.gz	526efc17-f7b0-46b3-b435-cdfbac7227e6	TCGA-AP-A0LE-01A-11R-A104-07	TCGA-AP-A0LE-01A-11R	TCGA-AP-A0LE-01A-01-BSA	TCGA-AP-A0LE-01A-01-TSA		TCGA-AP-A0LE-01A-11	TCGA-AP-A0LE-01A	TCGA-AP-A0LE	dcff8659-ecca-4798-80a3-dd6e7642ba2b	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	2988	170.0	False	true	3EA84930-6B34-43B8-A5A8-3D2B3754155F	1.75	3701ff8a-afd6-4a3d-aae4-735325390d1f	0.13	23	released	0d452409-0ee8-4d08-952d-e0f0b912061f	RNA	R	0.13	UV Spec	released	False	930e2302-3e08-46f8-86b4-7ea5b57f5346	11	1.0	0.0	1.0	0.0	0.0	5.0	94.0	95.0	BOTTOM	96d9d98b-7fc4-4738-a05e-09ffab263250	released	5.0	1.0	1.0	0.0	0.0	20.0	79.0	85.0	TOP	0cbd9baf-9150-4e9d-b206-aec6d5b7e1ce	released									released	30.0	9c4a32cf-de40-4996-91a9-56f1c18d69a4	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A0LE_demographic	57	-20967		5ac7cfe5-25b4-5521-8ed4-023f2afa3d42	not reported	female	white	released	Alive	1945		TCGA-AP-A0LE_exposure	Not Reported	29.296875	e2738294-b55d-5312-bd0c-b06a5704885a	160.0	released	75.0	TCGA-AP-A0LE_diagnosis	20967	not reported	0	3357	32ccea2a-8907-5b3f-8c66-1b5b68ea35ad	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2002	TCGA-AP-A0LE_treatment_1	TCGA-AP-A0LE_treatment	released	f20f738c-fec8-5536-aba1-e59d5a0d8a93	no	Pharmaceutical Therapy, NOS	released	8d17aea8-a9d0-518a-b10c-71648e9d536c	yes	Radiation Therapy, NOS	526efc17-f7b0-46b3-b435-cdfbac7227e6
5fb027d6-37c1-4a46-b100-991a4a8c5984.htseq.counts.gz	17b24743-8fc7-4ef1-8bcf-837b77610660	TCGA-EY-A212-01A-11R-A14M-07	TCGA-EY-A212-01A-11R	TCGA-EY-A212-01A-01-TSA			TCGA-EY-A212-01A-11	TCGA-EY-A212-01A	TCGA-EY-A212	37981e2c-4761-4f82-aaf2-4e6963a71603	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	112	290.0	False	false	3E8012E3-97F1-48A2-B1C0-5C814DF8EE01	1.83	6c1a95ef-3b5a-49ac-aaeb-dcd8071bed23	0.17	23	released	19a77986-0fbc-41b2-b63b-16ab8eae21a5	RNA	R	0.17	UV Spec	released	False	b3e04fc4-eb30-4ac0-98dc-5b187d02203e	11	40.0	20.0	5.0	20.0	0.0	5.0	90.0	90.0	TOP	4f3f9d1b-9d4c-47df-9aa5-633e6d160b6e	released																				released	30.0	996c027f-d9c7-4a2c-8154-5ef9573fb0d0	Primary Tumor	01	released	Not Reported	released	TCGA-EY-A212_demographic	83	-30680	310	2785b834-3a90-5c9b-81e7-57fe5805f684	not hispanic or latino	female	white	released	Dead	1927		TCGA-EY-A212_exposure	Not Reported	32.03987184051263	95df1103-22f3-51e2-87cc-5668779db70f	159.0	released	81.0	TCGA-EY-A212_diagnosis	30680	not reported	0	110	f60eaf41-3996-5c10-80d0-d0d5e5ac5d9d	Stage IIIC1	C54.1	not reported	8460/3	Papillary serous cystadenocarcinoma	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2010	TCGA-EY-A212_treatment_1	TCGA-EY-A212_treatment	released	56a1ca3a-4fad-583d-87f8-37a9401cfd91	no	Pharmaceutical Therapy, NOS	released	2025919e-8fee-5a03-8d58-7d8101277621	no	Radiation Therapy, NOS	17b24743-8fc7-4ef1-8bcf-837b77610660
fdb7e1fd-f209-4199-b019-bcf19f0bd361.htseq.counts.gz	68831b6f-a03d-4ba7-873b-3fb3a4e73cb9	TCGA-D1-A3DA-01A-12R-A213-07	TCGA-D1-A3DA-01A-12R	TCGA-D1-A3DA-01A-01-TS1			TCGA-D1-A3DA-01A-12	TCGA-D1-A3DA-01A	TCGA-D1-A3DA	e17a5fca-616c-4a74-abe7-778539ecdc0b	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	128	110.0	False	true	8F3D4AFC-2E70-4633-A58F-C98ED00A8964	1.84	21fd1035-30e0-4851-88c6-35d2693e6dcd	0.16	23	released	fa0a04a5-4fbb-4897-9914-d088ffda9c5c	RNA	R	0.16	UV Spec	released	False	9008cb08-3532-4e3a-8617-99d942531597	12	2.0	0.0	5.0	0.0	0.0	5.0	90.0	85.0	TOP	7db4b34a-6726-4663-be2b-251077af3838	released																				released	30.0	24be1526-b1ca-4206-bc2f-533d51548565	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A3DA_demographic	77	-28142		2b099a95-8a5f-51ce-ace7-57107a9affab	not hispanic or latino	female	white	released	Alive	1934		TCGA-D1-A3DA_exposure	Not Reported	24.67105263157895	48224292-6770-59a2-917f-18c1430075f4	152.0	released	57.0	TCGA-D1-A3DA_diagnosis	28142	not reported	0	483	bd1f03ea-4e86-5ba8-9410-e1280da9b765	Stage IIIC1	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-D1-A3DA_treatment	TCGA-D1-A3DA_treatment_1	released	5303bc5b-0ef4-55c8-9357-e14c9c17fe69	no	Radiation Therapy, NOS	released	3e1e5ecf-534d-5c02-a40b-752b110084f7	yes	Pharmaceutical Therapy, NOS	68831b6f-a03d-4ba7-873b-3fb3a4e73cb9
293f120d-b367-496f-9918-b9706661a772.htseq.counts.gz	b538a652-f717-41c6-a403-a0577050231b	TCGA-AJ-A3BK-01A-11R-A19W-07	TCGA-AJ-A3BK-01A-11R	TCGA-AJ-A3BK-01A-01-TS1			TCGA-AJ-A3BK-01A-11	TCGA-AJ-A3BK-01A	TCGA-AJ-A3BK	503e6c30-1b62-4f85-bcb4-e34c009894ab	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	547	170.0	False	false	026350F0-3203-49E5-8CCC-9DE88B2C8625	1.35	18b41a91-88d1-4938-a57f-0464fc7422bc	0.17	23	released	1566f93a-2cd8-4490-b708-3aaf63327b4b	RNA	R	0.17	UV Spec	released	False	4dc25faa-4c6c-4edd-8626-ad39daaf379c	11	2.0	1.0	5.0	0.0	10.0	0.0	85.0	90.0	TOP	fcf9e287-fe73-4127-b6a0-236d22b0dd76	released																				released	30.0	610660f1-07aa-489f-b09f-8da0b91fee6f	Primary Tumor	01	released	Not Reported	released	TCGA-AJ-A3BK_demographic	68	-24943		0926f2b4-a18a-531b-82a7-f798da65b318	not hispanic or latino	female	white	released	Alive	1942		TCGA-AJ-A3BK_exposure	Not Reported	34.626820730927015	68c9a19c-d8ec-5df6-a715-f99a8b26f38d	163.0	released	92.0	TCGA-AJ-A3BK_diagnosis	24943	not reported	0	1031	e8ed2352-d01d-524f-ada4-cff9500d186c	Stage IC	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-AJ-A3BK_treatment_1	TCGA-AJ-A3BK_treatment	released	30f9d348-53ea-59c0-ad6b-26005004c1f6	no	Pharmaceutical Therapy, NOS	released	38667152-25fb-562a-84b4-3db79cc955e2	yes	Radiation Therapy, NOS	b538a652-f717-41c6-a403-a0577050231b
ed92b05a-d314-44a4-b020-47a4f9677bfe.htseq.counts.gz	6e325280-a8d4-41f4-a312-74c73decc848	TCGA-AP-A1E3-01A-11R-A137-07	TCGA-AP-A1E3-01A-11R	TCGA-AP-A1E3-01A-01-TSA			TCGA-AP-A1E3-01A-11	TCGA-AP-A1E3-01A	TCGA-AP-A1E3	44ac7093-a733-4c55-a964-0ba9ec141d2d	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	440	350.0	False	true	FDA2C217-5267-41CC-AC07-CBACFF8E7B8D	1.87	0aa199cd-4fa0-4773-9659-1a246e42ad88	0.16	23	released	155f6ad1-dc4a-4c80-998e-1df21d220212	RNA	R	0.16	UV Spec	released	False	f3138478-4586-4209-9ee5-ef788f030b45	11	0.0	0.0	5.0	0.0	0.0	30.0	65.0	60.0	TOP	ac9ab353-35ee-4179-b26c-617dc084f09c	released																				released	30.0	86b9fab8-8a90-4610-ac48-53f952665ac9	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A1E3_demographic	45	-16544		036e7831-79a7-520f-9b55-d3fa32a88c71	not reported	female	white	released	Alive	1964		TCGA-AP-A1E3_exposure	Not Reported	48.929203206744695	cb3b6ffc-3d77-5cbe-92c3-f71c98eb135a	163.0	released	130.0	TCGA-AP-A1E3_diagnosis	16544	not reported	0	847	b00b4a47-9cfe-5954-8223-f8df456bc8ea	Stage IIIC1	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-AP-A1E3_treatment	TCGA-AP-A1E3_treatment_1	released	2369dc6d-c770-537f-8e03-30e813bf5896	no	Radiation Therapy, NOS	released	fe48af7d-5f50-5691-bf77-ddb186acba01	yes	Pharmaceutical Therapy, NOS	6e325280-a8d4-41f4-a312-74c73decc848
0d44ebee-ebdf-442b-82ce-ce78b8b0afb4.htseq.counts.gz	5333b7f9-1eb5-4952-929e-4613c567c8e2	TCGA-BS-A0UJ-01A-12R-A104-07	TCGA-BS-A0UJ-01A-12R	TCGA-BS-A0UJ-01A-01-TSA	TCGA-BS-A0UJ-01A-01-BSA		TCGA-BS-A0UJ-01A-12	TCGA-BS-A0UJ-01A	TCGA-BS-A0UJ	ff82548a-f1bb-4daa-a8f7-b3831b5843ad	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	2180	160.0	False	false	DEE9AA2E-DA73-4074-9588-C75DDEC4D29B	1.77	835f4f9a-3c90-45d5-809c-6b4316a972b9	0.16	23	released	e1c99fc2-a876-4c13-b9fc-c8214de51768	RNA	R	0.16	UV Spec	released	False	383e01b4-82bf-48a0-b6b2-acbb3afd011c	12	0.0	0.0	0.0	0.0	0.0	0.0	100.0	85.0	TOP	f309fa46-8398-43f8-a0ee-bba9dce53af2	released	0.0	0.0	0.0	0.0	0.0	0.0	100.0	85.0	BOTTOM	bfb30bb2-a660-4a51-ad3c-e125f9056b27	released									released	30.0	2ea1339f-a5eb-4552-ac13-858fa70e606e	Primary Tumor	01	released	Not Reported	released	TCGA-BS-A0UJ_demographic	68	-25149		dcfe6a13-0521-5b95-bb52-c2c413703643	not hispanic or latino	female	asian	released	Alive	1936		TCGA-BS-A0UJ_exposure	Not Reported	21.64412070759625	768e2081-e8d4-5593-93ec-ff24fa4954ab	155.0	released	52.0	TCGA-BS-A0UJ_diagnosis	25149	not reported	0	2506	5a2afee1-0ff8-5d8a-a236-b0e0659d1c5a	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2004	TCGA-BS-A0UJ_treatment	TCGA-BS-A0UJ_treatment_1	released	49f364b9-f520-5866-ac3d-bbca23797d11	no	Radiation Therapy, NOS	released	315f5766-1e01-59a8-bbd6-ab384e315d38	no	Pharmaceutical Therapy, NOS	5333b7f9-1eb5-4952-929e-4613c567c8e2
55170cf7-4d02-4bb0-a5da-0b686b5550b0.htseq.counts.gz	0cc45c77-7092-40aa-8322-3d20ec91e9be	TCGA-AX-A3GB-01A-11R-A22K-07	TCGA-AX-A3GB-01A-11R	TCGA-AX-A3GB-01A-01-TSA			TCGA-AX-A3GB-01A-11	TCGA-AX-A3GB-01A	TCGA-AX-A3GB	aa3ad7c0-37cf-4337-945e-cefeee801bbb	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	469	80.0	False	false	50C8217A-6834-46E9-9727-5B6B3D37347D	1.78	ba01a4cb-d7cd-4a9a-ae28-978262154683	0.16	23	released	79cae173-220d-4cd5-bef0-caa6be95668b	RNA	R	0.16	UV Spec	released	False	4a34ae7c-2422-4008-92e9-1a1d90c4dc29	11	2.0	1.0	2.0	0.0	0.0	20.0	78.0	90.0	TOP	c4ecaa83-86a6-478c-8a8a-977cbdf9755f	released																				released	30.0	b473b052-e1f3-40d2-bf32-7873263973c9	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A3GB_demographic	73	-26724		c24bb733-c129-5932-bba5-c197ac5b1bef	not hispanic or latino	female	white	released	Alive	1937		TCGA-AX-A3GB_exposure	Not Reported	34.850184265342094	efeec016-4cad-504d-a436-f5726627c171	158.0	released	87.0	TCGA-AX-A3GB_diagnosis	26724	not reported	0	440	a3becdfe-4514-5c7a-9363-0d079ffb5f25	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-AX-A3GB_treatment	TCGA-AX-A3GB_treatment_1	released	06f55a96-ffcd-55c9-8436-f28ab96a839c	no	Radiation Therapy, NOS	released	a33154cb-f4bd-562c-9e08-1ea9485a4785	yes	Pharmaceutical Therapy, NOS	0cc45c77-7092-40aa-8322-3d20ec91e9be
d9cbccff-ddfd-418d-a9f3-a705ab507277.htseq.counts.gz	83ba9807-f7b9-41bc-8db1-7ddb5cd48904	TCGA-BK-A26L-01A-11R-A16F-07	TCGA-BK-A26L-01A-11R	TCGA-BK-A26L-01A-01-TS1			TCGA-BK-A26L-01A-11	TCGA-BK-A26L-01A	TCGA-BK-A26L	ab7adf74-6e87-4117-9742-54e323348e06	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	131	320.0	False	false	979388A8-CC61-4C03-BADC-BEF9EC50C40A	1.95	80b16496-74bd-4fe7-967c-31058b2c022b	0.18	23	released	5802796b-ea96-497c-b6bd-619d7f1c0f40	RNA	R	0.18	UV Spec	released	False	adeae27b-9627-4ac2-bc0c-e3a52c293084	11	40.0	20.0	5.0	20.0	0.0	25.0	70.0	70.0	TOP	fbc3731f-ad7b-4b2d-85f1-d09f9caa666a	released																				released	30.0	cfde53b1-a992-4180-b747-b4c1d3ed2e2b	Primary Tumor	01	released	Not Reported	released	TCGA-BK-A26L_demographic	71	-26002		cd6ec347-4caf-5ff7-a22e-34c0c62a99b3	not hispanic or latino	female	white	released	Alive	1939		TCGA-BK-A26L_exposure	Not Reported	32.46191135734072	457ac974-3e7b-5b32-ad48-70007f173b72	152.0	released	75.0	TCGA-BK-A26L_diagnosis	26002	not reported	0	734	d2b10490-3a90-5a92-bf52-ee5faaa52852	Stage IIIC1	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-BK-A26L_treatment_1	TCGA-BK-A26L_treatment	released	3426f7dd-1628-5a65-b5a0-df833a4a6c5d	yes	Pharmaceutical Therapy, NOS	released	a800f1f1-88f2-5f57-be1e-c504f5f2d832	yes	Radiation Therapy, NOS	83ba9807-f7b9-41bc-8db1-7ddb5cd48904
ed2f071b-b001-494b-a7c2-1cb19b9a479e.htseq.counts.gz	d24cc59a-1927-4e5e-92fc-edd1e61f91f5	TCGA-AX-A2HF-01A-11R-A17B-07	TCGA-AX-A2HF-01A-11R	TCGA-AX-A2HF-01A-01-TSA			TCGA-AX-A2HF-01A-11	TCGA-AX-A2HF-01A	TCGA-AX-A2HF	7a077812-f6ee-4820-a084-1a52c7ef062c	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	440	140.0	False	false	5454BF58-3D26-4D61-B0A8-30A06ECD0E60	2.17	2ffda10e-5941-4c80-9291-a5ebbe0d5a2a	0.16	23	released	68437c90-3f7d-4288-a8cc-94e5e058c3ef	RNA	R	0.16	UV Spec	released	False	02490372-8dfd-4f56-860b-a93a901453c3	11	0.0	0.0	2.0	0.0	0.0	2.0	96.0	98.0	TOP	bbbb2b1a-2a3b-4583-bd26-5b46adcab7d6	released																				released	30.0	137e9776-ca5c-47f3-9ef7-8726d021fbb2	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A2HF_demographic	67	-24689		558de49a-8e14-51dd-8df2-fca36ddbcf3d	not hispanic or latino	female	white	released	Alive	1943		TCGA-AX-A2HF_exposure	Not Reported	28.398718000730252	240cbb46-8a03-5e1b-b1fd-6b3ae9041fb2	157.0	released	70.0	TCGA-AX-A2HF_diagnosis	24689	not reported	0	848	24d572af-0dda-57d1-ba9d-9cb686340d6b	Stage IB	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2010	TCGA-AX-A2HF_treatment	TCGA-AX-A2HF_treatment_1	released	c287c649-8af9-52d6-907d-483fbd5bbdb2	yes	Radiation Therapy, NOS	released	1209070c-e58c-54bb-a716-e937788c9491	yes	Pharmaceutical Therapy, NOS	d24cc59a-1927-4e5e-92fc-edd1e61f91f5
2fb6c010-daf7-4121-8eb0-b5b26e75e03f.htseq.counts.gz	6529acea-bf1e-4c58-a9fb-0382024050b2	TCGA-A5-A2K2-01A-11R-A18M-07	TCGA-A5-A2K2-01A-11R	TCGA-A5-A2K2-01A-01-TSA			TCGA-A5-A2K2-01A-11	TCGA-A5-A2K2-01A	TCGA-A5-A2K2	840ff11f-f991-4e1b-861b-98d236d573d3	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	2812	70.0	False	true	D8065FA8-DC0E-4F1C-8FA4-5D8A567AC24C	1.85	4341d180-bcb4-47e5-83b4-df5ecc4f7eec	0.17	23	released	d90e2657-c847-4fca-8010-cf6426cd0597	RNA	R	0.17	UV Spec	released	False	d5840454-5f3f-45ae-86ed-3ce48932e7a1	11	1.0	1.0	5.0	3.0	0.0	15.0	80.0	80.0	TOP	3d8a11a8-40be-4314-99ef-39103d658ed4	released																				released	30.0	8494b10e-a989-49fa-860c-2b8f0e4f93d9	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A2K2_demographic	77	-28456		d090c047-cf0d-569c-beb8-c5a933d12d42	not hispanic or latino	female	white	released	Alive	1926		TCGA-A5-A2K2_exposure	Not Reported	20.811654526534856	c008c0eb-2267-58ca-8b65-27e16679d50b	155.0	released	50.0	TCGA-A5-A2K2_diagnosis	28456	not reported	0	3595	ca7e77ce-472f-5fe6-9e5a-50bf9e5b3fca	Stage IA	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2003	TCGA-A5-A2K2_treatment	TCGA-A5-A2K2_treatment_1	released	8beedc0b-23ac-57da-8692-ff5b07799c86	no	Radiation Therapy, NOS	released	9606e85e-df21-5af0-81bd-342c0ba5853c	yes	Pharmaceutical Therapy, NOS	6529acea-bf1e-4c58-a9fb-0382024050b2
b4a853ac-1836-46d0-aa99-68ffc7c7cb31.htseq.counts.gz	5760be70-891a-4790-91e6-ab19a6c467c7	TCGA-D1-A3JQ-01A-11R-A22K-07	TCGA-D1-A3JQ-01A-11R	TCGA-D1-A3JQ-01A-01-TSA			TCGA-D1-A3JQ-01A-11	TCGA-D1-A3JQ-01A	TCGA-D1-A3JQ	07c805c2-ff09-4d5a-95f8-1d7d9f84c33c	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	77	150.0	False	true	2001A1EC-1385-4EB3-BC9E-7E48143FD663	1.79	10c76952-15aa-44e9-8197-26529889bb6a	0.17	23	released	7e3259a4-3745-49de-88ac-1c2ab0215edb	RNA	R	0.17	UV Spec	released	False	6443fe4a-c1dc-4c13-815c-d437ffbfbc81	11	15.0	8.0	5.0	5.0	0.0	25.0	70.0	75.0	TOP	f375aa8a-10e9-47d6-b5a7-1fc0d0f567c3	released																				released	30.0	720b03f2-b46f-43a0-9ab0-fb0734e691f1	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A3JQ_demographic	61	-22297		95fd1298-1173-577a-ad75-1755f2ea7291	not hispanic or latino	female	white	released	Alive	1950		TCGA-D1-A3JQ_exposure	Not Reported	46.68029782801589	628ff40d-2571-5c5a-8f90-cf698fe3730b	161.0	released	121.0	TCGA-D1-A3JQ_diagnosis	22297	not reported	0	526	65a1716c-81fe-5861-8c2e-3b5efd86410a	Stage IIIC	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-D1-A3JQ_treatment	TCGA-D1-A3JQ_treatment_1	released	ae83943f-8697-5029-adb3-d384e8911b45	yes	Radiation Therapy, NOS	released	17bebdf5-1210-5e2f-b896-eef5a4b083c3	yes	Pharmaceutical Therapy, NOS	5760be70-891a-4790-91e6-ab19a6c467c7
7d6e7cb6-598a-4723-8ea1-60fee87edafe.htseq.counts.gz	30b0bf70-a690-4d17-968a-0f516492c66f	TCGA-BG-A0M8-01A-12R-A104-07	TCGA-BG-A0M8-01A-12R	TCGA-BG-A0M8-01A-01-BSA	TCGA-BG-A0M8-01A-01-TSA		TCGA-BG-A0M8-01A-12	TCGA-BG-A0M8-01A	TCGA-BG-A0M8	e055db71-f3da-43d3-a9b2-2f65dfb23d3e	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	734	630.0	False	true	42DBC6F7-E413-41A6-994E-1391099818A0	1.84	90962783-12b4-434d-9b27-6c6f8f3b8d10	0.15	23	released	bc16df1c-124c-4818-8c69-304d09b3910f	RNA	R	0.15	UV Spec	released	False	8724bdfb-674b-477e-ab2a-416912a6c1da	12	0.0	0.0	0.0	0.0	0.0	0.0	100.0	85.0	BOTTOM	a0a08556-3f92-4cec-8088-187244e2139b	released	0.0	0.0	0.0	0.0	0.0	0.0	100.0	90.0	TOP	420ea720-d899-4f9f-9687-52bd71b3dd5b	released									released	30.0	9cfb7290-ef60-4fda-abd7-9552ae11e4e7	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A0M8_demographic	50	-18308		097a59d7-4cf0-51e6-b86b-bdf1052dd68b	not hispanic or latino	female	white	released	Alive	1958		TCGA-BG-A0M8_exposure	Not Reported	81.640625	cd326d0e-def4-5d2c-a6e0-59309f61db12	160.0	released	209.0	TCGA-BG-A0M8_diagnosis	18308	not reported	0	2020	abfe679c-a7cd-55a3-8b34-2a922121b9ee	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2008	TCGA-BG-A0M8_treatment_1	TCGA-BG-A0M8_treatment	released	bef2a3e3-afc0-5318-8936-e2584a8e56f3	no	Pharmaceutical Therapy, NOS	released	173d02c7-bcf6-5f10-b06a-9c846e38021b	no	Radiation Therapy, NOS	30b0bf70-a690-4d17-968a-0f516492c66f
b4c40df7-e459-47d5-8a3a-a46573650d51.htseq.counts.gz	c8de697b-0d44-4c9f-9271-f3a0f863bb7b	TCGA-EY-A1GM-01A-12R-A14D-07	TCGA-EY-A1GM-01A-12R	TCGA-EY-A1GM-01A-01-TSA			TCGA-EY-A1GM-01A-12	TCGA-EY-A1GM-01A	TCGA-EY-A1GM	1a094c2b-9fba-4bb1-929d-bb2cdf874bee	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	323	140.0	False	false	C3599CB9-3B69-4083-AA2E-5BB52CF1ED93	1.77	9713963c-c7c7-47a0-ba01-6710bd4e9fea	0.16	23	released	f0312ff5-70ec-43d5-b9b3-0e0862c56864	RNA	R	0.16	UV Spec	released	False	935a9ad0-9ef9-4cf9-86d4-253ebc132e56	12	20.0	20.0	5.0	40.0	0.0	5.0	90.0	90.0	TOP	f2098f55-a021-491e-b5b8-d72f76fc67f0	released																				released	10.0	95fded4f-677e-4dcf-a5c4-6b344fbccfd4	Primary Tumor	01	released	Not Reported	released	TCGA-EY-A1GM_demographic	60	-22010	995	ab1d9537-bbcc-55e7-8d2b-f3582eced474	not reported	female	black or african american	released	Dead	1950		TCGA-EY-A1GM_exposure	Not Reported	28.804413972169254	feaa3c34-26ba-59ad-a575-e61f06c14246	157.0	released	71.0	TCGA-EY-A1GM_diagnosis	22010	not reported	0	210	77eb7ced-0eb8-5255-9645-643a4fed5f93	Stage IIIA	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-EY-A1GM_treatment	TCGA-EY-A1GM_treatment_1	released	4e2ae154-79b8-5258-9d89-3f465a92f361	no	Radiation Therapy, NOS	released	d6040671-c8b0-554d-bfc9-a81c40f2a1c0	yes	Pharmaceutical Therapy, NOS	c8de697b-0d44-4c9f-9271-f3a0f863bb7b
5810334f-0f7b-4ab9-b2eb-326e8af7e147.htseq.counts.gz	1ce7a986-cbe7-424a-92e6-083f095b9a02	TCGA-EY-A4KR-01A-11R-A27V-07	TCGA-EY-A4KR-01A-11R	TCGA-EY-A4KR-01A-01-TS1			TCGA-EY-A4KR-01A-11	TCGA-EY-A4KR-01A	TCGA-EY-A4KR	df27b584-fa45-4a8f-bd12-a018cc63dca1	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	147	610.0	False	false	D8669681-B1D2-4D39-B7BB-5207F901A937	1.85	8bc81bd5-9814-4a83-b78d-6d5722a1a53d	0.17	23	released	cfff59e4-7515-4805-9a23-8ce70819fb1a	RNA	R	0.17	UV Spec	released	False	4afe42f1-6b59-440d-95af-ca9d718bdb05	11	5.0	0.0	3.0	0.0	0.0	0.0	97.0	80.0	TOP	18deaa31-6034-48b5-90ac-c0c03991d7cd	released																				released	30.0	db625f3a-2cf7-4b99-8fa4-ab234f1dc22d	Primary Tumor	01	released	Not Reported	released	TCGA-EY-A4KR_demographic	56	-20669	346	9c5f20e2-32ce-5806-9d65-97b768df3265	not hispanic or latino	female	black or african american	released	Dead	1956		TCGA-EY-A4KR_exposure	Not Reported	42.38548483045806	30e92d8f-5a78-500c-8e07-b2702d3ebedd	164.0	released	114.0	TCGA-EY-A4KR_diagnosis	20669	not reported	0	196	3fc4011a-b780-5270-a1ad-0025e6e2de3f	Stage IIIC1	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2012	TCGA-EY-A4KR_treatment	TCGA-EY-A4KR_treatment_1	released	4f1943dc-bbbe-5d61-9b6d-93a9e5ce3594	yes	Radiation Therapy, NOS	released	1ce1690e-760b-56fe-ab39-f43841a3dc1b	yes	Pharmaceutical Therapy, NOS	1ce7a986-cbe7-424a-92e6-083f095b9a02
d23a9020-8382-403d-9b01-831dbc58ed15.htseq.counts.gz	a7dd92db-e3d9-4cde-9336-bd6080d56fbb	TCGA-D1-A16S-01A-11R-A12I-07	TCGA-D1-A16S-01A-11R	TCGA-D1-A16S-01A-01-TS1			TCGA-D1-A16S-01A-11	TCGA-D1-A16S-01A	TCGA-D1-A16S	0b670df6-c487-4ed6-9b48-ef4b01a1aec3	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	177	290.0	False	false	D69D2E09-B195-4F3F-B5A1-821A87852266	1.32	7c0fca0e-60ff-4c7e-a337-fb7489f69151	0.17	23	released	4e28fde9-1f2b-4abc-aa2b-608eade3548c	RNA	R	0.17	UV Spec	released	False	13f67c25-13a7-4d64-8395-aa6450bdda14	11	3.0	4.0	3.0	1.0	0.0	40.0	57.0	60.0	TOP	f3d1e93e-ee76-4682-abd7-1bbf57723e72	released																				released	30.0	8e157714-099f-4496-ad37-0b83c76797bc	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A16S_demographic	70	-25690		267743ea-2830-5b40-b683-f5e00d34c6c2	not hispanic or latino	female	white	released	Alive	1940		TCGA-D1-A16S_exposure	Not Reported	22.481329065691206	5056a931-5627-5465-9f76-8edf8b6b27bb	162.0	released	59.0	TCGA-D1-A16S_diagnosis	25690	not reported	0	568	5d61a85d-1db9-5712-834f-4150227d8901	Stage IIIC	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-D1-A16S_treatment	TCGA-D1-A16S_treatment_1	released	80f40263-8080-5cae-a72a-bd0022c8a164	no	Radiation Therapy, NOS	released	d524bd79-bc3b-5d80-8f06-656431ce8d04	no	Pharmaceutical Therapy, NOS	a7dd92db-e3d9-4cde-9336-bd6080d56fbb
18f37a89-0851-4c78-810c-1b92e98e880e.htseq.counts.gz	96619cf3-23f6-4011-8328-101e65d410d7	TCGA-AX-A1CR-01A-12R-A137-07	TCGA-AX-A1CR-01A-12R	TCGA-AX-A1CR-01A-01-TS1			TCGA-AX-A1CR-01A-12	TCGA-AX-A1CR-01A	TCGA-AX-A1CR	3abaa1b6-7513-40e0-b79c-b968e788e932	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	274	110.0	False	false	7623CA86-87C5-43E8-A0A7-25BD9526D1AA	1.83	d979abda-1498-41e5-848c-8dc20d6c7eee	0.18	23	released	8303069b-26c3-4929-93d0-1354519816f3	RNA	R	0.18	UV Spec	released	False	0889964c-c9e1-417c-949f-23ee9d0a74de	12	4.0	0.0	1.0	1.0	10.0	9.0	80.0	88.0	TOP	fb507ade-f7a1-44e0-8ace-7b1f60b368c9	released																				released	20.0	8d14edd5-b754-48af-b636-4e655fce9cbe	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A1CR_demographic	70	-25812		e6a8c88e-d05a-5bd9-9167-6afdcb41699d	not hispanic or latino	female	white	released	Alive	1940		TCGA-AX-A1CR_exposure	Not Reported	35.62901744719926	4bc8366c-9a6e-5315-a5b6-eca515c1f520	165.0	released	97.0	TCGA-AX-A1CR_diagnosis	25812	not reported	0	701	e394d111-8a67-537c-afde-898a8a049ea5	Stage IIB	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2010	TCGA-AX-A1CR_treatment_1	TCGA-AX-A1CR_treatment	released	bbf6352f-bef4-5a59-a639-3b39a64bc7aa	yes	Pharmaceutical Therapy, NOS	released	b1a9b813-6a53-5263-a6dd-ee5e7d5812f9	no	Radiation Therapy, NOS	96619cf3-23f6-4011-8328-101e65d410d7
61fd020e-b8a4-4214-b674-2dc6e3169510.htseq.counts.gz	084ce75e-8e4e-4f03-ae0f-1f51cfb02996	TCGA-AJ-A3QS-01A-11R-A22K-07	TCGA-AJ-A3QS-01A-11R	TCGA-AJ-A3QS-01A-01-TS1	TCGA-AJ-A3QS-01A-01-BS1		TCGA-AJ-A3QS-01A-11	TCGA-AJ-A3QS-01A	TCGA-AJ-A3QS	69fc74bc-e961-40e2-9169-d7b51658eb10	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	129	34.0	False	true	73D1F890-5799-4166-9F9A-F9852979FD29	1.82	6f0ffee6-d69f-459e-b401-f7dbcb17cb13	0.16	23	released	1a271df4-f21e-4ecc-886f-dc34043bbd2e	RNA	R	0.16	UV Spec	released	False	da9a0373-d011-4034-9329-44436b43596a	11	0.0	0.0	0.0	0.0	0.0	5.0	95.0	60.0	TOP	1228cf67-717b-4912-b3d3-c17ae38bf49b	released	0.0	0.0	0.0	0.0	0.0	60.0	40.0	40.0	BOTTOM	81f181fe-45db-417b-9267-1f7127d734d2	released									released	34.0	0d33f3bb-f849-4ffa-8192-c95bf69dd5cc	Primary Tumor	01	released	Not Reported	released	TCGA-AJ-A3QS_demographic	57	-21162		4b4e030a-6c7f-5469-9180-3d974b5900d2	not hispanic or latino	female	black or african american	released	Alive	1954		TCGA-AJ-A3QS_exposure	Not Reported	26.078971533516988	d749b0cd-10ae-577e-9556-19b88bcc7014	165.0	released	71.0	TCGA-AJ-A3QS_diagnosis	21162	not reported	0	513	9e06c1b9-f53c-574c-bcaf-9f3d6b0d778d	Stage IIIA	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-AJ-A3QS_treatment_1	TCGA-AJ-A3QS_treatment	released	89afbbc3-6a39-511f-b513-de30a2697d76	yes	Pharmaceutical Therapy, NOS	released	81ea6788-6a4d-594c-b016-93bb00b4cb44	yes	Radiation Therapy, NOS	084ce75e-8e4e-4f03-ae0f-1f51cfb02996
91d987ba-bb25-4464-ab8b-da9ffc777008.htseq.counts.gz	780ed1c7-4f99-4b76-82dd-5d8041159375	TCGA-2E-A9G8-01A-11R-A40A-07	TCGA-2E-A9G8-01A-11R	TCGA-2E-A9G8-01A-01-TS1			TCGA-2E-A9G8-01A-11	TCGA-2E-A9G8-01A	TCGA-2E-A9G8	9583c10b-b21a-4863-98fa-61e735e64ea5	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	957	90.0	False	false	921E6140-A03E-4FBD-9FB8-554AE96FD16C	1.84	8e9f2a41-dddc-4761-8883-ca58f5934d5f	0.16	23	released	93d951f6-1c95-41eb-b969-bf8c168aa420	RNA	R	0.16	UV Spec	released	False	38148658-9a4e-479c-99a5-f10b9bfe3f25	11	10.0	0.0	5.0	0.0	0.0	15.0	80.0	80.0	TOP	ac7602cc-7407-42e8-bbf1-19068d8a9df6	released																				released	30.0	792e23a2-aed7-40f6-966b-281697eb7c85	Primary Tumor	01	released	Not Reported	released	TCGA-2E-A9G8_demographic	59			a0452fbc-d834-54b0-a7af-54217646f706	not hispanic or latino	female	black or african american	released	Alive	1952		TCGA-2E-A9G8_exposure	Not Reported	28.804413972169254	551105cd-8da0-5696-b291-f9fb0ad036c7	157.0	released	71.0	TCGA-2E-A9G8_diagnosis		not reported	0	1249	138c08ab-6469-5248-abf2-818fc309f839	Stage III	C54.3	not reported	8380/3	Endometrioid adenocarcinoma, NOS	yes	No	not reported	Fundus uteri	released	Not Reported	Fundus uteri	not reported	not reported	2011	TCGA-2E-A9G8_treatment_1	TCGA-2E-A9G8_treatment	released	95733b1f-c327-5380-96e5-596874487088	yes	Pharmaceutical Therapy, NOS	released	b9ef309c-d76b-5d51-ac45-633e7da24e3f	yes	Radiation Therapy, NOS	780ed1c7-4f99-4b76-82dd-5d8041159375
ea0adbb9-b6ff-443f-a9b3-f4e9696f74f9.htseq.counts.gz	0bf2a819-a3a0-477e-907e-89a65e1989fa	TCGA-A5-A0GE-01A-11R-A16W-07	TCGA-A5-A0GE-01A-11R	TCGA-A5-A0GE-01A-01-BSA	TCGA-A5-A0GE-01A-01-TSA		TCGA-A5-A0GE-01A-11	TCGA-A5-A0GE-01A	TCGA-A5-A0GE	a587e62e-430e-4f1b-82b7-6fbe856fdaf1	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	2941	200.0	False	true	7686A445-554F-43EF-BE79-6EA5E5C4DB21	1.93	34294f7a-7f80-443c-854e-5fe22b4391e0	0.16	23	released	99d2fcda-411b-4a3b-ae2b-1ae8a3d61e0e	RNA	R	0.16	UV Spec	released	False	0e996dbf-881f-414c-8cf7-8897d8c44361	11	60.0	0.0	10.0	30.0	10.0	5.0	75.0	85.0	BOTTOM	a4462306-50b6-4c77-8f52-59ebb6e9d4f7	released	60.0	0.0	5.0	30.0	10.0	5.0	80.0	85.0	TOP	6ee44933-f37b-4b7d-86c7-25fdee432127	released									released	30.0	20c3f64d-acf6-45b3-9ace-2f93b3a951c8	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A0GE_demographic	38	-14170		909e5384-bc65-57da-a325-b3e37696288a	not hispanic or latino	female	asian	released	Alive	1964		TCGA-A5-A0GE_exposure	Not Reported	23.725286160249738	5ee45cb2-4ad6-5b2c-be4d-e5b9779be8b7	155.0	released	57.0	TCGA-A5-A0GE_diagnosis	14170	not reported	0	3205	0fa4bc83-ddc7-5bf3-9d0f-dbe6998d1497	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2002	TCGA-A5-A0GE_treatment	TCGA-A5-A0GE_treatment_1	released	b1de703e-7e57-509d-bcd7-73fc90e95140	yes	Radiation Therapy, NOS	released	06d9c77c-7ffb-58a7-b665-714c12ba4d4f	no	Pharmaceutical Therapy, NOS	0bf2a819-a3a0-477e-907e-89a65e1989fa
a51130ea-a4f5-434e-8606-a3a5d58b64e5.htseq.counts.gz	9cf94897-96fa-45e5-aaf6-b72ac6831448	TCGA-AP-A0LP-01A-12R-A104-07	TCGA-AP-A0LP-01A-12R	TCGA-AP-A0LP-01A-01-BS1	TCGA-AP-A0LP-01A-01-TS1		TCGA-AP-A0LP-01A-12	TCGA-AP-A0LP-01A	TCGA-AP-A0LP	efae3940-d3cc-4988-bdb4-fa05d977aff5	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1884	150.0	False	true	ECA6E3D1-141B-4DB1-90B6-FE6A2E355AD3	1.8	1fea8c9c-7f1f-40d9-944a-f542b91c16b5	0.16	23	released	9d81cb99-aa99-4872-91e5-1be657ca9005	RNA	R	0.16	UV Spec	released	False	1f2a26d7-6de9-46e0-83c2-1b57a55d59ac	12	0.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	BOTTOM	5d441afd-96e7-4841-a6c5-3cf30cb711d8	released	0.0	0.0	0.0	0.0	5.0	0.0	95.0	85.0	TOP	f7a59fe8-bb75-407e-905d-b0b5ec2c7d98	released									released	30.0	d67450c1-8848-4b28-9c16-83aa7132e8c8	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A0LP_demographic	76	-27898		23aad101-4296-5c7d-9bd5-05f34d2cba6f	not reported	female	white	released	Alive	1929		TCGA-AP-A0LP_exposure	Not Reported	21.513858510523864	a2f4f403-b2ab-5f75-bf46-00437247810c	167.0	released	60.0	TCGA-AP-A0LP_diagnosis	27898	not reported	0	1875	36b996a5-e6ab-5daf-9006-2bde00cf0a69	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2005	TCGA-AP-A0LP_treatment_1	TCGA-AP-A0LP_treatment	released	77a13d54-6031-5ddd-a756-40bb04a0c83f	yes	Pharmaceutical Therapy, NOS	released	298eb25e-d4f8-5e8e-b2f6-827091de3b50	yes	Radiation Therapy, NOS	9cf94897-96fa-45e5-aaf6-b72ac6831448
80c96dc1-c0a0-4613-b03a-369f00904460.htseq.counts.gz	5103f984-4ebc-440c-9ae0-122e70a64e30	TCGA-B5-A1MY-01A-11R-A144-07	TCGA-B5-A1MY-01A-11R	TCGA-B5-A1MY-01A-01-TSA			TCGA-B5-A1MY-01A-11	TCGA-B5-A1MY-01A	TCGA-B5-A1MY	5d2f1a0f-a01b-48c2-b749-1ca710aa2bb4	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	128	360.0	False	true	A5328E25-1433-4331-83B8-148780F6A6DA	1.48	fcb43e1a-3b34-4ff1-8d3e-849fbf901877	0.15	23	released	0f934ec8-09d8-4692-8833-f90c59cdeb22	RNA	R	0.15	UV Spec	released	False	c7791612-81f3-488d-a679-6ac20acf0b2e	11	3.0	3.0	5.0	0.0	0.0	20.0	75.0	80.0	TOP	c24337bd-b021-440a-9931-8b01fccb09ad	released																				released	30.0	26189cf5-ae49-44cf-842b-35a3063ab93c	Primary Tumor	01	released	Not Reported	released	TCGA-B5-A1MY_demographic	62	-22805	361	f29ecfc9-9382-5135-8dc7-46978064f64e	not reported	female	black or african american	released	Dead	1948	2010	TCGA-B5-A1MY_exposure	Not Reported	31.431788328016513	dd6f13e5-0eed-5287-8c4c-b0ebdedca661	146.0	released	67.0	TCGA-B5-A1MY_diagnosis	22805	not reported	0		fe06b940-4e3d-5573-a605-d51e85687e05	Stage IIIC2	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-B5-A1MY_treatment	TCGA-B5-A1MY_treatment_1	released	5a8c6402-cd3b-59a8-962e-68bae816ecb6	yes	Radiation Therapy, NOS	released	00e85cf4-17b4-5421-8aaa-f71a994d19a8	yes	Pharmaceutical Therapy, NOS	5103f984-4ebc-440c-9ae0-122e70a64e30
d0ea92d0-3da9-4bc9-afec-4e2971fb047b.htseq.counts.gz	5dd2eb6e-29f1-45d3-9489-28b181438fd7	TCGA-A5-A1OJ-01A-11R-A14D-07	TCGA-A5-A1OJ-01A-11R	TCGA-A5-A1OJ-01A-01-TSA			TCGA-A5-A1OJ-01A-11	TCGA-A5-A1OJ-01A	TCGA-A5-A1OJ	0f361166-2b7d-4ef5-9f8f-ee2488548a0b	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	161	170.0	False	true	F696BCE9-707C-4825-8A53-EFED20EBF656	1.88	adddccb0-d276-4450-a8cf-aef663a6f45c	0.18	23	released	e7ef9613-3bed-4520-a7ae-3d32846a4ec5	RNA	R	0.18	UV Spec	released	False	1a007182-c3d2-45b2-9fc3-d6380158b4d3	11	40.0	20.0	10.0	20.0	0.0	10.0	80.0	80.0	TOP	d4e86c5d-02dc-434c-9946-d5fb4503f1ff	released																				released	30.0	effd3ebc-fa75-4317-a3cb-37ca27d3208c	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A1OJ_demographic	31	-11635		e5720da2-a49b-5fb5-abcc-a6160a9f1e5b	not hispanic or latino	female	asian	released	Alive	1979		TCGA-A5-A1OJ_exposure	Not Reported	39.12591050988553	dbad19fd-fb0f-558c-a8bf-1eb2b82f744b	155.0	released	94.0	TCGA-A5-A1OJ_diagnosis	11635	not reported	0	1006	f0133f94-0d43-5f2d-9cb6-85f8dd31a950	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-A5-A1OJ_treatment_1	TCGA-A5-A1OJ_treatment	released	f7b38a93-8a10-5b74-aac3-efa65cdee4f1	no	Pharmaceutical Therapy, NOS	released	f2737e46-f6d1-5acd-a707-0daed1edd884	no	Radiation Therapy, NOS	5dd2eb6e-29f1-45d3-9489-28b181438fd7
ffea1798-2d46-4425-b43d-823c4e512a43.htseq.counts.gz	036be30b-9530-4a92-94f6-5465ee6f1faf	TCGA-AX-A1CK-11A-11R-A137-07	TCGA-AX-A1CK-11A-11R	TCGA-AX-A1CK-11A-01-TS1			TCGA-AX-A1CK-11A-11	TCGA-AX-A1CK-11A	TCGA-AX-A1CK	45effb44-0b5f-4081-a202-d85969c72f2b	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	2115	100.0	False	false		1.89	3aba63fa-86d2-4ca9-b064-fe782a749161	0.16	23	released	fd39c26b-b60b-4078-8a74-2906f6fad543	RNA	R	0.16	UV Spec	released	False	67dec63b-a84b-4828-83b1-f74e5c3f2e7a	11					100.0		0.0		TOP	dfdccf13-762b-4c70-8233-2c524d10d681	released																				released	30.0	03680874-bc46-4805-9a01-f02a24a46948	Solid Tissue Normal	11	released	Not Reported	released	TCGA-AX-A1CK_demographic	58	-21200		64bf5f32-7f0d-5ea2-80c1-8fc679a3de3b	not hispanic or latino	female	white	released	Alive	1947		TCGA-AX-A1CK_exposure	Not Reported	27.099251006812448	fd7c70eb-a52b-5f34-83f0-777da3cb5c2b	163.0	released	72.0	TCGA-AX-A1CK_diagnosis	21200	not reported	0	2441	5c32ec46-1a26-57af-ae73-42b96cd3a53d	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2005	TCGA-AX-A1CK_treatment	TCGA-AX-A1CK_treatment_1	released	84d4a50f-57d8-543e-96de-b14d52a21af7	no	Radiation Therapy, NOS	released	96416453-a6f3-5ab5-9731-ab31a7791c16	yes	Pharmaceutical Therapy, NOS	036be30b-9530-4a92-94f6-5465ee6f1faf
178b8e44-49a8-4b27-bdba-60cb65b5012f.htseq.counts.gz	6a2b7ca1-7ab5-454d-8e39-66b292e82c52	TCGA-EY-A1GK-01A-11R-A13S-07	TCGA-EY-A1GK-01A-11R	TCGA-EY-A1GK-01A-01-TSA			TCGA-EY-A1GK-01A-11	TCGA-EY-A1GK-01A	TCGA-EY-A1GK	972db411-9744-46f0-89c7-efe14135f1b4	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	409	120.0	False	false	B5024D10-E23D-4B3B-8C54-13EBAA423A04	1.75	bfbb3c82-87b0-44b2-bf2c-5c9bdc318460	0.17	23	released	705fc6ca-af31-4586-9fdd-2b0060126d79	RNA	R	0.17	UV Spec	released	False	0332136b-8393-4afd-a2f1-706593ac8813	11	30.0	30.0	5.0	30.0	0.0	15.0	80.0	80.0	TOP	10e5129b-b84e-4471-a90c-6dd02ae4fc47	released																				released	30.0	d4e702a9-8e4a-4ad7-8b45-691c95dcf298	Primary Tumor	01	released	Not Reported	released	TCGA-EY-A1GK_demographic	74	-27127		524b3bcd-5407-5806-9e56-c91529f85f1e	not hispanic or latino	female	white	released	Alive	1935		TCGA-EY-A1GK_exposure	Not Reported	41.015625	dba2b620-6c48-5f97-a199-fff7d5bb2533	160.0	released	105.0	TCGA-EY-A1GK_diagnosis	27127	not reported	0	693	4bcfe1ca-121f-5b5f-bfb9-4f8586ae8672	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2009	TCGA-EY-A1GK_treatment	TCGA-EY-A1GK_treatment_1	released	801a2fc9-6ecf-5e3f-9b60-e4e48e544179	yes	Radiation Therapy, NOS	released	eadfaefa-b7e0-5250-8054-4990da8651fd	no	Pharmaceutical Therapy, NOS	6a2b7ca1-7ab5-454d-8e39-66b292e82c52
eead04fd-8f20-43f7-adc1-7da37fccd2e4.htseq.counts.gz	9c0b8a27-5f29-4580-a14c-01078b1524e7	TCGA-BS-A0U8-01A-11R-A104-07	TCGA-BS-A0U8-01A-11R	TCGA-BS-A0U8-01A-01-TS1	TCGA-BS-A0U8-01A-01-BS1		TCGA-BS-A0U8-01A-11	TCGA-BS-A0U8-01A	TCGA-BS-A0U8	fb7475df-30cc-4316-b9ac-37cbeeb6ba2b	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	2432	190.0	False	false	EAE30BBB-B895-42B9-8AAB-937278A3EBB0	1.87	6fc8c938-15ec-452d-9cf7-16b97e0a2c8f	0.16	23	released	152234c5-8bfd-4b76-8521-570e344e842a	RNA	R	0.16	UV Spec	released	False	88b92b57-bf3e-4016-8480-eff5d29ba81f	11	30.0	20.0	5.0	40.0	0.0	15.0	80.0	80.0	TOP	4f8b0437-91c9-46e9-8bf8-a876947048ac	released	40.0	10.0	0.0	30.0	0.0	20.0	80.0	80.0	BOTTOM	299ed12a-b046-43c2-89a1-0ed6a10bd83c	released									released	30.0	e3e23393-8597-4091-a343-cd544111c63b	Primary Tumor	01	released	Not Reported	released	TCGA-BS-A0U8_demographic	55	-20402		124d1f29-524a-57e0-b4eb-6ed018678122	not hispanic or latino	female	white	released	Alive	1949		TCGA-BS-A0U8_exposure	Not Reported	28.37370242214533	6f983e36-96c3-5610-9a32-d9da195d3099	170.0	released	82.0	TCGA-BS-A0U8_diagnosis	20402	not reported	0	2963	463b376c-31c6-58bb-aacc-acdb4579f6bd	Stage IIIC	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2004	TCGA-BS-A0U8_treatment_1	TCGA-BS-A0U8_treatment	released	8950771a-2a87-5274-9f01-e72266673b0a	yes	Pharmaceutical Therapy, NOS	released	607c343e-0703-5c87-9365-10cb01d8618b	yes	Radiation Therapy, NOS	9c0b8a27-5f29-4580-a14c-01078b1524e7
1c16cfc6-d8c0-44f8-bbaa-275cdd8dc87c.htseq.counts.gz	5db821d4-86d4-4e87-bf41-458731ee3441	TCGA-BK-A0CA-01A-21R-A277-07	TCGA-BK-A0CA-01A-21R	TCGA-BK-A0CA-01A-02-BS2	TCGA-BK-A0CA-01A-01-BS1		TCGA-BK-A0CA-01A-21	TCGA-BK-A0CA-01A	TCGA-BK-A0CA	51bd85e2-2c60-4654-bfcb-83dccef8964b	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	86	300.0	False	false	883D4832-75FB-495C-B93F-904FCA1AB18C	1.85	1b0bc4c7-b2b5-434b-8d15-05c2ad8e027a	0.15	23	released	0c2b324d-f151-4899-a15a-fcef11c4f15a	RNA	R	0.15	UV Spec	released	False	56df7696-d1f4-49e3-93d4-093c8c59ba2d	21	0.0	0.0	0.0	0.0	50.0	50.0	0.0	0.0	BOTTOM	f22571d6-ffc4-4152-aaa1-8b01eaa5e3c5	released	0.0	0.0	0.0	0.0	0.0	25.0	75.0	75.0	TOP	04c00d4c-a3f4-4231-ab05-67cda5847ca5	released									released	30.0	d836db96-83fb-4f25-a16c-aaaaf55d7b12	Primary Tumor	01	released	Not Reported	released	TCGA-BK-A0CA_demographic	61	-22378		3b6442dc-a44c-5d6d-91f4-9aabb0781977	not hispanic or latino	female	white	released	Alive	1949		TCGA-BK-A0CA_exposure	Not Reported		4feb395e-390e-5e3f-a5a0-52b36201e248	163.0	released		TCGA-BK-A0CA_diagnosis	22378	not reported	0	1064	1b042946-cb3e-57aa-8321-29375cbfaf8c	Stage IIIC	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-BK-A0CA_treatment	TCGA-BK-A0CA_treatment_1	released	86795392-d88c-5bbc-8ae3-67ede9060efc	no	Radiation Therapy, NOS	released	9e810137-bf8e-5eaa-b176-c2077477617c	yes	Pharmaceutical Therapy, NOS	5db821d4-86d4-4e87-bf41-458731ee3441
ead813f7-a943-437f-9da2-0121c92a3a99.htseq.counts.gz	78fdb519-f385-4c50-9141-651f629abafc	TCGA-AP-A0LN-01A-11R-A040-07	TCGA-AP-A0LN-01A-11R	TCGA-AP-A0LN-01A-01-BS1	TCGA-AP-A0LN-01A-01-TS1		TCGA-AP-A0LN-01A-11	TCGA-AP-A0LN-01A	TCGA-AP-A0LN	60fcf50a-8598-475d-8dd0-6b3044661233	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1907	250.0	False	true	D50C7207-D840-48A2-8D73-E1C71FFA73E1	2.17	cc57fe2e-2370-4697-828f-eee51aacbe0b	0.16	23	released	fe4af4f2-7579-4b29-9e04-e7d4f8ab8ffc	RNA	R	0.16	UV Spec	released	False	0bf3b298-b2ef-4ad3-8324-195d73e2abe8	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	BOTTOM	5ca4ebf0-16cb-46e8-867d-8e2e70b3e073	released	0.0	0.0	0.0	0.0	0.0	0.0	100.0	85.0	TOP	e71e2c5f-89b3-4f47-a609-fbe5a7b5f0bf	released									released	30.0	90a221e7-8579-4af2-9b39-40de3c42f71c	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A0LN_demographic	56	-20704		92af23e2-41c0-5f21-ad67-cd16091385df	not reported	female	black or african american	released	Alive	1949		TCGA-AP-A0LN_exposure	Not Reported	43.184787342139636	ea1a28d9-bc6b-506d-b7e9-7dd02f708611	166.0	released	119.0	TCGA-AP-A0LN_diagnosis	20704	not reported	0	2510	91604168-6c6c-50c3-bc78-d7ce70798015	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2005	TCGA-AP-A0LN_treatment_1	TCGA-AP-A0LN_treatment	released	537481e1-c300-5a82-9163-d9ffbbc574df	no	Pharmaceutical Therapy, NOS	released	a1d28366-9d31-5e08-9b5a-b862b2421b63	no	Radiation Therapy, NOS	78fdb519-f385-4c50-9141-651f629abafc
b7b2c0ba-fca3-4632-a931-ed26445ca748.htseq.counts.gz	5834046f-fdf5-4a2c-a017-fe5167301530	TCGA-BG-A2L7-01A-11R-A18M-07	TCGA-BG-A2L7-01A-11R	TCGA-BG-A2L7-01A-01-TSA			TCGA-BG-A2L7-01A-11	TCGA-BG-A2L7-01A	TCGA-BG-A2L7	214a09bb-ce52-4055-b036-065e8cb7ac7d	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	141	110.0	False	true	6A14E5E4-ED0F-415A-B54B-DE16D7DC6E78	1.79	16ce8070-8c04-4cc7-b00a-c094a524b133	0.17	23	released	5631b611-fca5-44a5-b952-369d67fedf27	RNA	R	0.17	UV Spec	released	False	ffc556c5-02b0-4ae3-b880-e9c9b1b9b09e	11	40.0	20.0	10.0	20.0	0.0	20.0	70.0	70.0	TOP	2f952857-803e-4170-8807-8e1b699c14c7	released																				released	30.0	68328de4-7de9-4893-a402-f15c64c7718e	Primary Tumor	01	released	Not Reported	released	TCGA-BG-A2L7_demographic	68	-25091		608b1f93-afe7-5b95-bf1c-dfd43e6e96ae	not hispanic or latino	female	white	released	Alive	1943		TCGA-BG-A2L7_exposure	Not Reported		4337fe9e-5c79-5836-bb3d-8042e99e9b16		released		TCGA-BG-A2L7_diagnosis	25091	not reported	0	612	b17bbee7-7e2f-56ad-8810-13b9ea30fe3a	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-BG-A2L7_treatment_1	TCGA-BG-A2L7_treatment	released	82661ec9-c8f1-5cf6-b282-fbb5c7e3d043	yes	Pharmaceutical Therapy, NOS	released	9102dc7e-d93d-5801-a075-5306c4b9b07d	yes	Radiation Therapy, NOS	5834046f-fdf5-4a2c-a017-fe5167301530
676bff6f-27b7-492c-87fd-ef23dc3d23fc.htseq.counts.gz	8eb1b66d-091a-49cd-974f-56352535589b	TCGA-BK-A13B-01A-51R-A22K-07	TCGA-BK-A13B-01A-51R	TCGA-BK-A13B-01A-05-TS5			TCGA-BK-A13B-01A-51	TCGA-BK-A13B-01A	TCGA-BK-A13B	e71b3ce1-41e0-4cfc-9570-367b8c2124c1	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	140	830.0	False	false	F8B15B22-27A6-4D7A-BCDC-B46EBCA5888E	1.78	ed2e8014-4042-45fe-ae9d-78606344955b	0.17	23	released	e55a2cd6-5b7d-4522-9635-aea63350058a	RNA	R	0.17	UV Spec	released	False	cb529bbb-6538-4b3b-ac0b-db9e2fd6cc16	51	0.0	0.0	3.0	0.0	0.0	0.0	97.0	80.0	TOP	335dc1cf-c47a-47b7-8e30-7a54d85bd7a5	released																				released	23.0	9530bfbb-dffc-4a16-9444-d51e24f8e843	Primary Tumor	01	released	Not Reported	released	TCGA-BK-A13B_demographic	58	-21493		92a5ea75-6ced-568e-928f-d1aef0646988	not hispanic or latino	female	black or african american	released	Alive	1952		TCGA-BK-A13B_exposure	Not Reported	45.32871972318339	3b430ec6-98c1-5730-badc-fae97fc18bdb	170.0	released	131.0	TCGA-BK-A13B_diagnosis	21493	not reported	0	966	6f7ffb2b-4f22-5c27-ab1c-9d85a9f94254	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-BK-A13B_treatment	TCGA-BK-A13B_treatment_1	released	2b1a486b-d81a-5f2c-9f3a-8171782e237b	yes	Radiation Therapy, NOS	released	aa6aac97-328a-5955-966c-b5a21ed295e0	yes	Pharmaceutical Therapy, NOS	8eb1b66d-091a-49cd-974f-56352535589b
6d3a3b40-5634-48b6-8d31-927523d64ac8.htseq.counts.gz	84263d19-6f59-48f5-b2e0-0393b162381b	TCGA-BK-A0CA-01B-02R-A277-07	TCGA-BK-A0CA-01B-02R	TCGA-BK-A0CA-01B-01-BS1	TCGA-BK-A0CA-01B-02-BS2		TCGA-BK-A0CA-01B-02	TCGA-BK-A0CA-01B	TCGA-BK-A0CA	51bd85e2-2c60-4654-bfcb-83dccef8964b	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	679		True	false	883D4832-75FB-495C-B93F-904FCA1AB18C	1.86	c0393618-b453-496b-b53b-c774054f9238	0.16	23	released	583d12c1-59a2-42be-9430-6610b7538898	RNA	R	0.16	UV Spec	released	True	458d4241-d629-45c4-abba-6fcda89305f5	02	1.0	0.0	1.0	0.0	0.0	0.0	99.0	80.0	TOP	2b3c271e-2abf-445e-b9b5-769bff3349a7	released	1.0	0.0	1.0	0.0	0.0	0.0	99.0	80.0	BOTTOM	a82d9022-25bc-41fd-a8d0-4f4b196198d0	released									released	400.0	6d59526a-9360-4adb-8427-a97c1c419a96	Primary Tumor	01	released	Not Reported	released	TCGA-BK-A0CA_demographic	61	-22378		3b6442dc-a44c-5d6d-91f4-9aabb0781977	not hispanic or latino	female	white	released	Alive	1949		TCGA-BK-A0CA_exposure	Not Reported		4feb395e-390e-5e3f-a5a0-52b36201e248	163.0	released		TCGA-BK-A0CA_diagnosis	22378	not reported	0	1064	1b042946-cb3e-57aa-8321-29375cbfaf8c	Stage IIIC	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-BK-A0CA_treatment	TCGA-BK-A0CA_treatment_1	released	86795392-d88c-5bbc-8ae3-67ede9060efc	no	Radiation Therapy, NOS	released	9e810137-bf8e-5eaa-b176-c2077477617c	yes	Pharmaceutical Therapy, NOS	84263d19-6f59-48f5-b2e0-0393b162381b
43fae07a-6b97-4d18-8684-366ddd8cbad8.htseq.counts.gz	2ec0b70f-132d-4c66-8c0e-f3d5ab94a8fd	TCGA-AX-A2HK-01A-11R-A17B-07	TCGA-AX-A2HK-01A-11R	TCGA-AX-A2HK-01A-01-TSA			TCGA-AX-A2HK-01A-11	TCGA-AX-A2HK-01A	TCGA-AX-A2HK	6fa99ae9-1d72-455e-938e-0ec0d240f5a3	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	2045	240.0	False	false	DBC5CE66-3BC0-4A86-A53C-06DEF90A752B	2.18	28e3b0f0-29e2-4726-8e28-c6f5a2275fff	0.15	23	released	42783121-9dd8-415b-87e2-97e43b88710e	RNA	R	0.15	UV Spec	released	False	be2653dd-c013-4d02-bf20-7b07b37d66fb	11	0.0	0.0	18.0	0.0	0.0	2.0	88.0	96.0	TOP	db601690-3f5a-4087-a921-f599914fdda6	released																				released	30.0	ebe937b7-b2bf-45b9-8517-009e6f67b6de	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A2HK_demographic	77	-28316	90	2966ded1-5d55-55d5-a8b6-385a79d36fba	not reported	female	white	released	Dead	1928	2005	TCGA-AX-A2HK_exposure	Not Reported	30.78090740428403	ba4dbc62-3783-5ff5-8a78-38219ff65f27	154.0	released	73.0	TCGA-AX-A2HK_diagnosis	28316	not reported	0		50428742-f7c1-581f-85b2-57306292200f	Stage IIIC	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2005	TCGA-AX-A2HK_treatment	TCGA-AX-A2HK_treatment_1	released	dd94fa65-56d6-572e-9e15-35e4d93507d3	no	Radiation Therapy, NOS	released	493c1d58-bfd7-5470-aaa1-93dc2d495af2	no	Pharmaceutical Therapy, NOS	2ec0b70f-132d-4c66-8c0e-f3d5ab94a8fd
2613fbb7-cf79-48ea-9f0c-e7f6af0e6ad0.htseq.counts.gz	98546ded-5dc6-4954-a1fd-e3773cf3988a	TCGA-AX-A06F-01A-11R-A00V-07	TCGA-AX-A06F-01A-11R	TCGA-AX-A06F-01A-01-BS1	TCGA-AX-A06F-01A-01-TS1		TCGA-AX-A06F-01A-11	TCGA-AX-A06F-01A	TCGA-AX-A06F	f17e446a-c145-45be-8335-a856acb0b9b8	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1267	210.0	False	false	4904C404-B17E-4471-AA2F-6DC705E4FBF2	1.83	6eb1ae77-4d92-4823-ad9e-2a15cae95db2	0.14	23	released	ecb447cd-dcb2-4b6a-9aef-bbc92ef646cc	RNA	R	0.14	UV Spec	released	False	ae2042e5-8b67-4088-b3ab-9d3652c6422a	11	0.0	1.0	5.0	0.0	9.0	1.0	85.0	90.0	BOTTOM	051c6061-7851-4017-b278-8ba66124b75a	released	0.0	0.0	8.0	0.0	10.0	2.0	80.0	90.0	TOP	517f10b8-20eb-433c-8d8b-8f657c7d78ec	released									released	40.0	38df14c0-30d9-404f-a10c-f8ed4c947cea	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A06F_demographic	59	-21624		071110ba-b63c-5157-8a7a-12db64b4c1fd	not hispanic or latino	female	white	released	Alive	1947		TCGA-AX-A06F_exposure	Not Reported	30.853994490358126	39c71e3e-cf23-53e4-89b8-ecd084aa34fb	165.0	released	84.0	TCGA-AX-A06F_diagnosis	21624	not reported	0	1748	14a2847c-5fdd-5988-aa1f-84e3028a4d9a	Stage IVA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2006	TCGA-AX-A06F_treatment	TCGA-AX-A06F_treatment_1	released	3089e8d4-03ad-53e4-bb31-134d12003550	no	Radiation Therapy, NOS	released	7a55644c-13a0-53ea-a6d0-6c4a07cb84cc	yes	Pharmaceutical Therapy, NOS	98546ded-5dc6-4954-a1fd-e3773cf3988a
abda9064-e5f9-4955-9996-1767755f7074.htseq.counts.gz	41321502-1be4-4fb9-a726-11c8063c0f4b	TCGA-D1-A0ZZ-01A-11R-A10J-07	TCGA-D1-A0ZZ-01A-11R	TCGA-D1-A0ZZ-01A-01-TSA	TCGA-D1-A0ZZ-01A-01-BSA		TCGA-D1-A0ZZ-01A-11	TCGA-D1-A0ZZ-01A	TCGA-D1-A0ZZ	4d3af3af-24f4-415a-9677-20b0f366a102	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	349	220.0	False	false	4339EAC6-F56E-49E6-8EF9-2256165CADB5	1.81	b50b6ebf-8b11-47db-803b-e2739e7dd005	0.17	23	released	3e7dc345-d648-410d-8078-5a70cd90a565	RNA	R	0.17	UV Spec	released	False	41029c0c-ed80-4065-a87e-8aa811f07a65	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	90.0	TOP	c79e59d5-0e43-4474-94e8-a61d3c1b4f24	released	0.0	0.0	0.0	0.0	0.0	15.0	85.0	75.0	BOTTOM	2f2ab65d-279f-42f3-9a0b-53901ae7cbd7	released									released	30.0	c797e9d4-3f3e-48d9-870f-e8ea6bddfd91	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A0ZZ_demographic	80	-29420		f6beb124-7592-52b5-9440-69a20be0004e	not hispanic or latino	female	white	released	Alive	1929		TCGA-D1-A0ZZ_exposure	Not Reported	21.504469556417607	cd9bbc3d-b543-5d2c-84c5-027447a766c8	154.0	released	51.0	TCGA-D1-A0ZZ_diagnosis	29420	not reported	0	686	9710210a-9824-50a8-9373-b37370b16b27	Stage IB	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-D1-A0ZZ_treatment_1	TCGA-D1-A0ZZ_treatment	released	53330bd3-549c-51aa-b678-3346e83484bd	yes	Pharmaceutical Therapy, NOS	released	fdb6b901-e129-54b9-8578-85c19fc2b787	yes	Radiation Therapy, NOS	41321502-1be4-4fb9-a726-11c8063c0f4b
ae59fbb0-6b6f-4437-882f-060caa098deb.htseq.counts.gz	efc6dc93-50c9-4470-b2a9-bbcf4b33204d	TCGA-AJ-A3OL-01A-11R-A22K-07	TCGA-AJ-A3OL-01A-11R	TCGA-AJ-A3OL-01A-01-TSA			TCGA-AJ-A3OL-01A-11	TCGA-AJ-A3OL-01A	TCGA-AJ-A3OL	7f91a0c5-d639-48ea-b3f7-b6f385e047ed	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	81	190.0	False	false	B42FF342-34F0-4611-A275-B979D7658510	1.8	69fbadaa-5a9f-4fc6-b676-e938179ee830	0.15	23	released	9adeea61-6977-455f-8c72-0509202f909d	RNA	R	0.15	UV Spec	released	False	ba74969d-be87-4bd8-a178-e66169af1ae8	11	3.0	0.0	3.0	0.0	0.0	0.0	97.0	90.0	TOP	0f63b35f-5939-4489-b523-dee4e02b7bc5	released																				released	30.0	029e5e0d-9f4e-4031-a5f2-0187c2b70879	Primary Tumor	01	released	Not Reported	released	TCGA-AJ-A3OL_demographic	55	-20115	449	5c564e9c-9baa-58fe-8dce-62768d9cc0dd	not hispanic or latino	female	white	released	Dead	1956		TCGA-AJ-A3OL_exposure	Not Reported	25.0	65d04a27-4442-5a70-bc86-80258bf56184	160.0	released	64.0	TCGA-AJ-A3OL_diagnosis	20115	not reported	0	57	5b300041-47a8-558a-8468-6db414bd9ff9	Stage IIIA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-AJ-A3OL_treatment_1	TCGA-AJ-A3OL_treatment	released	58be442d-f29e-5e69-9276-8fa9f65b08e8	yes	Pharmaceutical Therapy, NOS	released	eab6425a-3109-512d-a77c-afc947890f66	no	Radiation Therapy, NOS	efc6dc93-50c9-4470-b2a9-bbcf4b33204d
318f2dc9-583f-4268-943c-2b416a316a70.htseq.counts.gz	4bc7e0c8-c852-4503-8063-12bb4d7fbf47	TCGA-AX-A063-01A-11R-A00V-07	TCGA-AX-A063-01A-11R	TCGA-AX-A063-01A-01-TS1	TCGA-AX-A063-01A-01-BS1		TCGA-AX-A063-01A-11	TCGA-AX-A063-01A	TCGA-AX-A063	e8909bdf-460c-4291-8e9b-7be12f343eae	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	1950	190.0	False	false	E911408A-8447-4CB8-8A3F-B2C24875ACF0	1.8	4c101954-7344-4cf7-a1bd-4cfcf472e05d	0.16	23	released	001177f3-efd6-48c3-b261-924d0989d2ad	RNA	R	0.16	UV Spec	released	False	d9596c8c-febe-4db2-a309-8029b6adbc17	11	4.0	0.0	1.0	0.0	8.0	6.0	85.0	92.0	TOP	884c5461-b1a1-4acd-8eb5-7317f85d3f2b	released	1.0	0.0	4.0	0.0	6.0	2.0	88.0	92.0	BOTTOM	4f62221c-1b56-4be0-bdd8-689975739dc5	released									released	30.0	d5c708b2-29b0-42e0-980d-f54fe5e7fea1	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A063_demographic	63	-23045		a79cde1d-b7cb-5f8f-9bfd-be728e18f270	not hispanic or latino	female	white	released	Alive	1941		TCGA-AX-A063_exposure	Not Reported	34.375	593f60e8-985f-5033-812f-8d2089edeab9	160.0	released	88.0	TCGA-AX-A063_diagnosis	23045	not reported	0	2417	6f64640a-0b8c-5b5d-a19e-60719689e0aa	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2004	TCGA-AX-A063_treatment	TCGA-AX-A063_treatment_1	released	c53da578-a68f-5ca8-9f73-1f1615f427e2	no	Radiation Therapy, NOS	released	08195a94-cd95-50bb-b651-52ab075fb0d9	no	Pharmaceutical Therapy, NOS	4bc7e0c8-c852-4503-8063-12bb4d7fbf47
15296112-e657-4329-993a-57b89ce561c8.htseq.counts.gz	8aaa81be-a51b-498a-b8cc-29b7ae31fb55	TCGA-DI-A0WH-01A-12R-A12I-07	TCGA-DI-A0WH-01A-12R	TCGA-DI-A0WH-01A-01-TS1	TCGA-DI-A0WH-01A-01-BS1		TCGA-DI-A0WH-01A-12	TCGA-DI-A0WH-01A	TCGA-DI-A0WH	3dab68d3-232c-4b4f-81a4-ca8f72d69a43	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	244	180.0	False	false	3D6B2D82-2F6D-40E6-8138-4DBF33DE8BEF	1.87	46b06f7a-18ed-42a6-9cb9-75e6dc98b30e	0.16	23	released	a236ce40-e5eb-4509-b18e-858ec9ef24aa	RNA	R	0.16	UV Spec	released	False	3c55e054-1233-4f41-8253-d1e0ea8a81f9	12	0.0	0.0	0.0	0.0	0.0	5.0	95.0	95.0	TOP	2a5441e5-1f83-4fba-a497-d790ba2bd037	released	0.0	0.0	0.0	0.0	0.0	10.0	90.0	90.0	BOTTOM	64122e86-c360-49a1-bd7f-0c98c36a2eae	released									released	30.0	89f499fb-e061-4002-a8e8-dc3366e14a12	Primary Tumor	01	released	Not Reported	released	TCGA-DI-A0WH_demographic	64	-23692		d4e997f3-b77d-5c7b-8e71-f598cfd8f14a	not hispanic or latino	female	white	released	Alive	1946		TCGA-DI-A0WH_exposure	Not Reported	35.751278024658355	ca24e1d6-4c02-5148-bfea-7db76ca33709	173.0	released	107.0	TCGA-DI-A0WH_diagnosis	23692	not reported	0	496	da620a34-6f3c-58dc-afeb-42eb7cdbc88c	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-DI-A0WH_treatment	TCGA-DI-A0WH_treatment_1	released	4102c9a2-0615-5daa-ba44-3e3762c431d2	yes	Radiation Therapy, NOS	released	0e7de8d6-20b5-5c37-a226-518a3b353fdd	no	Pharmaceutical Therapy, NOS	8aaa81be-a51b-498a-b8cc-29b7ae31fb55
41b20178-7fb0-4963-8413-742de3bc568b.htseq.counts.gz	ce6085ab-f374-48ff-b4e4-e53df2041f2d	TCGA-DI-A2QU-11A-11R-A18M-07	TCGA-DI-A2QU-11A-11R	TCGA-DI-A2QU-11A-01-TS1			TCGA-DI-A2QU-11A-11	TCGA-DI-A2QU-11A	TCGA-DI-A2QU	e9fa66f5-282c-416a-9dcf-46714ea12fcf	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	2296	230.0	False	false		1.79	8fefb116-ef42-4566-a5e3-8793ca8b7cda	0.15	23	released	1061d862-3835-4647-b422-03ef91345b53	RNA	R	0.15	UV Spec	released	False	292b3142-f335-4db8-b6b9-925f535e08bd	11	5.0	0.0	0.0	0.0	0.0	100.0	0.0	0.0	TOP	3af0418f-05eb-452b-9961-d3c8ee6c8c30	released																				released	30.0	6e54d197-a5e5-41a1-b9b8-d2a76b58a31d	Solid Tissue Normal	11	released	Not Reported	released	TCGA-DI-A2QU_demographic	67	-24488	946	74ad2067-0e7b-5ac0-8f46-6a3ca0f0e2c1	not hispanic or latino	female	white	released	Dead	1938	2007	TCGA-DI-A2QU_exposure	Not Reported	36.328125	848610b9-b2ba-58bb-8576-6a6c657cf90b	160.0	released	93.0	TCGA-DI-A2QU_diagnosis	24488	not reported	0		e65420d0-c503-5f87-b36b-859e397daaf4	Stage IVB	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2005	TCGA-DI-A2QU_treatment	TCGA-DI-A2QU_treatment_1	released	9cafd343-2663-5552-9e0e-03ff493eb811	not reported	Radiation Therapy, NOS	released	6464122f-f103-5a47-8273-ed662ba9cedf	not reported	Pharmaceutical Therapy, NOS	ce6085ab-f374-48ff-b4e4-e53df2041f2d
08ede229-363e-49f4-951f-95509ec3c604.htseq.counts.gz	dd915956-c418-455c-a792-1d15ffcba4f1	TCGA-D1-A167-01A-11R-A12I-07	TCGA-D1-A167-01A-11R	TCGA-D1-A167-01A-01-TS1			TCGA-D1-A167-01A-11	TCGA-D1-A167-01A	TCGA-D1-A167	3d215e20-9eea-47e0-849e-cff1fee5634d	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	841	140.0	False	false	4E67EAA4-3069-4B62-A403-9300A9FA494C	1.81	09807f16-30aa-47b0-ace0-0dfb6a5342c2	0.17	23	released	648d6071-8e87-4d47-b853-3d32aca46136	RNA	R	0.17	UV Spec	released	False	b0a26083-d54a-4a3a-a9e8-f134e04b8f3f	11	4.0	1.0	3.0	3.0	0.0	15.0	82.0	85.0	TOP	c7fa7adb-806c-47ba-bbe0-2a2aaee2b5cb	released																				released	30.0	96112beb-64c2-40bc-b1f9-784581cc88e3	Primary Tumor	01	released	Not Reported	released	TCGA-D1-A167_demographic	70	-25575		a968b7ee-1a75-5678-b036-8721f572b4d3	not hispanic or latino	female	white	released	Alive	1938		TCGA-D1-A167_exposure	Not Reported	31.16343490304709	3eedaef6-b98d-594c-ad3c-6d0c3931c92c	152.0	released	72.0	TCGA-D1-A167_diagnosis	25575	not reported	0	478	65b84fd5-a017-5f29-b0be-353641c5d933	Stage IC	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-D1-A167_treatment	TCGA-D1-A167_treatment_1	released	faedf77f-c33d-582f-9d6c-7b8f4969d379	yes	Radiation Therapy, NOS	released	002e7d33-5ad3-51f7-aa14-80e929a8ecb0	no	Pharmaceutical Therapy, NOS	dd915956-c418-455c-a792-1d15ffcba4f1
2a9807f5-03b5-4cab-93d1-9e34e089412b.htseq.counts.gz	dc27152a-7bc4-429b-b545-78710dc15542	TCGA-EO-A3AU-01A-21R-A19W-07	TCGA-EO-A3AU-01A-21R	TCGA-EO-A3AU-01A-02-TSB			TCGA-EO-A3AU-01A-21	TCGA-EO-A3AU-01A	TCGA-EO-A3AU	8e225f5f-49c1-4a39-a8b5-41fea6a79819	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	393	130.0	False	false	B1D13355-6346-4FA4-950A-84114901515C	1.87	f6c13e4d-5a10-48cc-8ce1-a535565b6006	0.17	23	released	363393d7-c2e0-4ac7-ac54-e4695acb1f12	RNA	R	0.17	UV Spec	released	False	3d66cc1b-a57c-4b92-a8fd-9c8d6e35f8ba	21	40.0	20.0	10.0	20.0	0.0	10.0	80.0	80.0	TOP	291f563b-da6e-4ea9-8475-94ff45903fed	released																				released	30.0	c9d250d6-ab13-4feb-a747-aa3ebfa43503	Primary Tumor	01	released	Not Reported	released	TCGA-EO-A3AU_demographic	72	-26406		71e171de-4fbc-5396-8a52-e362331a8fd9	not reported	female	not reported	released	Alive	1938		TCGA-EO-A3AU_exposure	Not Reported	34.666666666666664	9e414817-ff98-51ec-bd86-c640277e870e	150.0	released	78.0	TCGA-EO-A3AU_diagnosis	26406	not reported	0	1543	742571f6-a445-57d3-bf47-4142abe4f1bf	Stage II	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-EO-A3AU_treatment	TCGA-EO-A3AU_treatment_1	released	a93700a8-f34c-5c2d-88c8-7920e2cf7d45	yes	Radiation Therapy, NOS	released	6db1164d-c40a-59f7-85d8-ff4f2cd5930c	yes	Pharmaceutical Therapy, NOS	dc27152a-7bc4-429b-b545-78710dc15542
5ada4ad2-e05c-4046-a31c-f3678c78f902.htseq.counts.gz	18ab2b5d-819c-46e9-8163-5007a7e03d2d	TCGA-EY-A214-01A-12R-A157-07	TCGA-EY-A214-01A-12R	TCGA-EY-A214-01A-01-TSA			TCGA-EY-A214-01A-12	TCGA-EY-A214-01A	TCGA-EY-A214	4125e3e5-51c0-4577-9935-10cd086fc415	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	160	330.0	False	false	90B0CBB0-3AC0-44F8-9C49-310CFFE0370C	2.08	32d0d293-ce07-487a-b914-062548072260	0.17	23	released	129b0d0c-cabe-4b05-9d77-c76ca34fe42a	RNA	R	0.17	UV Spec	released	False	13e6a506-79ff-45bf-8160-c4d2e9189273	12	40.0	20.0	10.0	20.0	0.0	20.0	70.0	70.0	TOP	aab4aff1-9427-4061-8fd3-144ccc6058f1	released																				released	30.0	5ed2b603-507e-4bef-bacd-46d0e98badb4	Primary Tumor	01	released	Not Reported	released	TCGA-EY-A214_demographic	66	-24136		628a9231-6a6f-58ee-bb03-77194c4e2534	not reported	female	white	released	Alive	1944		TCGA-EY-A214_exposure	Not Reported	34.52708907254362	3e1e7dc5-308d-5e51-b63e-9491ec4dc8b8	165.0	released	94.0	TCGA-EY-A214_diagnosis	24136	not reported	0	438	85dd8c26-31ae-5062-9499-e4bec29fab1f	Stage IIIC1	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2010	TCGA-EY-A214_treatment_1	TCGA-EY-A214_treatment	released	1eff7b34-e693-58a9-880a-af3df9258007	yes	Pharmaceutical Therapy, NOS	released	1e1fe118-9a3d-5d96-9855-2075379c7802	yes	Radiation Therapy, NOS	18ab2b5d-819c-46e9-8163-5007a7e03d2d
0c94149a-f877-4be6-a5a5-1f78c2e5255a.htseq.counts.gz	f3d9e05d-e841-4427-98cd-bfbde95031b6	TCGA-A5-A0G5-01A-11R-A040-07	TCGA-A5-A0G5-01A-11R	TCGA-A5-A0G5-01A-01-TS1	TCGA-A5-A0G5-01A-01-BS1		TCGA-A5-A0G5-01A-11	TCGA-A5-A0G5-01A	TCGA-A5-A0G5	4806d9a6-e65d-4a82-b422-1b287980a0c6	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	856	240.0	False	true	C7C6ABB1-32EE-4D2B-898A-91A1F596EC53	1.86	a7ed680c-2af2-47a1-846a-2169f7dd0971	0.17	23	released	63d0edf2-0cc6-47b2-8bd1-0ad6e9f806ba	RNA	R	0.17	UV Spec	released	False	d207c224-8fa0-498e-966d-591cd06401c4	11	15.0	3.0	5.0	0.0	0.0	0.0	95.0	80.0	TOP	64651390-974d-471f-81b1-6b938cfdf448	released	20.0	3.0	0.0	0.0	0.0	0.0	100.0	75.0	BOTTOM	79fd5a38-82c7-4e63-8c0b-12f8de4fa780	released									released	30.0	fa7392e8-335e-4465-9272-4a19dc99412e	Primary Tumor	01	released	Not Reported	released	TCGA-A5-A0G5_demographic	73	-26827		8de932fa-c5e3-5a52-b36c-7989aee3737b	not reported	female	black or african american	released	Alive	1935		TCGA-A5-A0G5_exposure	Not Reported	18.75	c208c176-cbf2-5994-b4b5-e39d2b9a6608	160.0	released	48.0	TCGA-A5-A0G5_diagnosis	26827	not reported	0	1126	441b699d-7cc8-5b83-b985-f773df3101d5	Stage IB	C54.1	not reported	8310/3	Clear cell adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2008	TCGA-A5-A0G5_treatment	TCGA-A5-A0G5_treatment_1	released	ecfdbad7-38fe-5b2b-bf45-864601a0f756	yes	Radiation Therapy, NOS	released	3e333e95-495d-5170-954a-3696148539a5	no	Pharmaceutical Therapy, NOS	f3d9e05d-e841-4427-98cd-bfbde95031b6
d6cd4231-04ff-4cca-ba8d-89abe6bec9b0.htseq.counts.gz	a1aeac31-a3e0-45e9-9068-f7239e7b6059	TCGA-AP-A0LH-01A-11R-A16W-07	TCGA-AP-A0LH-01A-11R	TCGA-AP-A0LH-01A-01-BS1	TCGA-AP-A0LH-01A-01-TS1		TCGA-AP-A0LH-01A-11	TCGA-AP-A0LH-01A	TCGA-AP-A0LH	7dce4215-01f6-43e9-9378-9e22c26c23a2	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	2772	210.0	False	true	78E73020-1173-45DA-BDBA-DFB1CF7BCB41	1.94	39dbc57b-dd7d-4ebe-a905-47b500adef88	0.15	23	released	d45b6175-442c-41ea-b72e-05401dc99527	RNA	R	0.15	UV Spec	released	False	ee9b20e6-318e-455a-9a0c-ae8d3bfd7db5	11	0.0	0.0	0.0	0.0	30.0	0.0	70.0	60.0	BOTTOM	83ab6f02-cfa0-4107-8fd8-255f537c42ea	released	0.0	0.0	0.0	0.0	5.0	0.0	95.0	90.0	TOP	c2c91aea-c449-491e-adae-de47b6b24737	released									released	30.0	4c657ad4-2c53-4ea9-82b5-52996e74e3ff	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A0LH_demographic	60	-22169	1106	8bd4e246-74c0-5a87-a680-0a9764a0bde5	not hispanic or latino	female	white	released	Dead	1942	2005	TCGA-AP-A0LH_exposure	Not Reported	30.85960737656157	6f5bf2e8-acee-552e-9c10-7c07f01af7bc	164.0	released	83.0	TCGA-AP-A0LH_diagnosis	22169	not reported	0		8061a94b-839c-5815-b4d5-18d8f4bf6ad1	Stage IA	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2002	TCGA-AP-A0LH_treatment_1	TCGA-AP-A0LH_treatment	released	25f78b77-bf00-5c02-87d3-651f7dc72701	yes	Pharmaceutical Therapy, NOS	released	c4bec7c6-bab7-5e5e-9c9c-a9f1156b0705	yes	Radiation Therapy, NOS	a1aeac31-a3e0-45e9-9068-f7239e7b6059
78bab4b6-28ea-4933-b488-295f8ff3ce58.htseq.counts.gz	f08f6d1c-a80e-4170-b062-2f527765b08f	TCGA-FI-A2F4-01A-11R-A17B-07	TCGA-FI-A2F4-01A-11R	TCGA-FI-A2F4-01A-01-TS1			TCGA-FI-A2F4-01A-11	TCGA-FI-A2F4-01A	TCGA-FI-A2F4	43476c88-86bc-4a65-9327-f0d24a41c971	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	860	60.0	False	true	B57570A5-2AE1-4D8B-9284-AB5769DDFDA6	1.77	14198ecd-3508-4ece-8fea-8141d3e4b1e7	0.15	23	released	ab8a1e92-0788-4aac-8e11-d754561bc259	RNA	R	0.15	UV Spec	released	False	2ee5a728-befa-43f1-8e7e-c68f6b33624a	11	40.0	30.0	5.0	20.0	0.0	5.0	90.0	90.0	TOP	2c9c3a46-d646-44bb-a30f-75aace6c45a4	released																				released	30.0	79ca02f0-936e-4485-9cb3-85afa2cee9a3	Primary Tumor	01	released	Not Reported	released	TCGA-FI-A2F4_demographic	64	-23621		c7999b4d-27ca-56c5-bf89-79ad97db1621	not hispanic or latino	female	black or african american	released	Alive	1945		TCGA-FI-A2F4_exposure	Not Reported	27.180899908172634	a990ee00-9075-5ab8-acd1-02152e1fbbce	165.0	released	74.0	TCGA-FI-A2F4_diagnosis	23621	not reported	0	2230	e001828e-632e-5044-993e-67f821ca7c0f	Stage IC	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	yes	No	not reported	Endometrium	released	Not Reported	Endometrium	not reported	not reported	2009	TCGA-FI-A2F4_treatment_1	TCGA-FI-A2F4_treatment	released	064110e9-72bf-58ae-a402-31d992b68763	no	Pharmaceutical Therapy, NOS	released	3c12b331-e51a-529c-87e6-dce892fc320e	no	Radiation Therapy, NOS	f08f6d1c-a80e-4170-b062-2f527765b08f
1777294b-0012-4cfb-8749-d94f22b4ca75.htseq.counts.gz	d58df7ae-9c0b-4430-be09-8fd92cd8db9f	TCGA-AX-A3G7-01A-12R-A213-07	TCGA-AX-A3G7-01A-12R	TCGA-AX-A3G7-01A-01-TS1			TCGA-AX-A3G7-01A-12	TCGA-AX-A3G7-01A	TCGA-AX-A3G7	71ed7d6d-8c44-4d37-a04a-7a78df21e514	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	520	50.0	False	false	81608C78-6495-4FC7-9210-1132E9335D01	0.35	8d020165-5475-4257-87c3-c98fc2d201d2	0.17	23	released	98f01332-1246-43c8-86c7-707d7c303d99	RNA	R	0.17	UV Spec	released	False	9c3978be-6075-4408-a30a-98f2500d7fe4	12	6.0	0.0	5.0	0.0	0.0	6.0	89.0	90.0	TOP	2be00a94-4771-4979-ba22-13865aa93c6a	released																				released	10.0	b44fab01-7ae7-4628-aea8-0be35ea93180	Primary Tumor	01	released	Not Reported	released	TCGA-AX-A3G7_demographic	71	-26187		ee9641f4-f36d-5742-be0c-130144f39240	not hispanic or latino	female	white	released	Alive	1939		TCGA-AX-A3G7_exposure	Not Reported	31.20256367009614	7bddfbda-b111-5219-a376-22a9d2efb71e	154.0	released	74.0	TCGA-AX-A3G7_diagnosis	26187	not reported	0	9	12e86155-3dc3-5b54-841e-8d6078c4c32c	Stage IVB	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-AX-A3G7_treatment_1	TCGA-AX-A3G7_treatment	released	28c5e7f1-4f7f-579a-8229-c849635d505e	not reported	Pharmaceutical Therapy, NOS	released	90e2a60c-42a3-578d-9176-ab514552434d	not reported	Radiation Therapy, NOS	d58df7ae-9c0b-4430-be09-8fd92cd8db9f
3ea4007b-d856-4b61-b5fd-b0df8a76674b.htseq.counts.gz	f9b297d3-c3ad-4e1a-ba2d-b0f62aeba018	TCGA-AJ-A3NF-01A-11R-A22K-07	TCGA-AJ-A3NF-01A-11R	TCGA-AJ-A3NF-01A-01-TS1			TCGA-AJ-A3NF-01A-11	TCGA-AJ-A3NF-01A	TCGA-AJ-A3NF	9fcbef9e-2cca-4033-b574-daab2a42198b	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	85	22.0	False	false	7003815D-F09A-46A0-8A8E-E0685A765788	1.76	5ab8bc7b-9e70-426f-8f84-d8c691440e98	0.17	23	released	87b28814-67d5-4a0c-9997-881e28bf5b50	RNA	R	0.17	UV Spec	released	False	11bd5099-7925-4a36-ae85-d32f4513efda	11	0.0	0.0	0.0	0.0	0.0	20.0	80.0	60.0	TOP	a33fc984-62b1-4ed7-b246-86b1e378ade9	released																				released	22.0	964ffd81-4b84-4045-abdc-63e79975158e	Primary Tumor	01	released	Not Reported	released	TCGA-AJ-A3NF_demographic	60	-22210		606473b1-aaf5-50b5-9b3f-fd2fe9945ded	not hispanic or latino	female	white	released	Alive	1951		TCGA-AJ-A3NF_exposure	Not Reported	45.703125	46caaf66-66d0-5206-9dfd-d6dbe99934ed	160.0	released	117.0	TCGA-AJ-A3NF_diagnosis	22210	not reported	0	645	369db65e-496b-506f-a46f-f41fc34ef5f8	Stage IIIC	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2011	TCGA-AJ-A3NF_treatment	TCGA-AJ-A3NF_treatment_1	released	14770bb3-5de0-5295-ab7f-e37a3314024e	yes	Radiation Therapy, NOS	released	157e018b-720a-5b87-ae61-da6ea743dd72	yes	Pharmaceutical Therapy, NOS	f9b297d3-c3ad-4e1a-ba2d-b0f62aeba018
6764419f-5645-4106-b155-b1525a2c6b42.htseq.counts.gz	9941bb17-d184-4444-b4c4-70b9e25da4c4	TCGA-AJ-A3EJ-01A-11R-A19W-07	TCGA-AJ-A3EJ-01A-11R	TCGA-AJ-A3EJ-01A-01-TS1			TCGA-AJ-A3EJ-01A-11	TCGA-AJ-A3EJ-01A	TCGA-AJ-A3EJ	672de064-3378-4004-a3ea-f79885e10d78	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	332	20.0	False	false	FB99D237-4583-4298-844F-43B2F99F83E3	1.86	6c10f0d4-fd7e-459e-af27-8cde9dc42860	0.16	23	released	d9f6d143-3b91-468e-a4f5-a26163c642bf	RNA	R	0.16	UV Spec	released	False	6b88566b-97d0-49b7-9ace-1e35a6bc1893	11	0.0	0.0	10.0	0.0	0.0	15.0	75.0	70.0	TOP	12f3130d-0ad2-46db-9479-90740047ca40	released																				released	20.0	3960cc6d-3c1d-48c6-8ddb-4fc700060e1b	Primary Tumor	01	released	Not Reported	released	TCGA-AJ-A3EJ_demographic	74	-27317	50	651551b6-fc50-57b2-9072-7cb246435efc	not hispanic or latino	female	white	released	Dead	1936	2010	TCGA-AJ-A3EJ_exposure	Not Reported	25.864512471655328	2d20f317-ab79-5c32-92f3-1e76b49fc466	168.0	released	73.0	TCGA-AJ-A3EJ_diagnosis	27317	not reported	0		72e5ad38-31a5-51bb-9c1e-f7ed34b91622	Stage IIIC2	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-AJ-A3EJ_treatment_1	TCGA-AJ-A3EJ_treatment	released	eae709de-7991-5ee2-a4dd-2934087dc4a6	no	Pharmaceutical Therapy, NOS	released	8674bbae-61f4-5e98-a29c-ce0ef3e9f93f	no	Radiation Therapy, NOS	9941bb17-d184-4444-b4c4-70b9e25da4c4
65ae2ceb-dd35-4ff8-83f7-30e00589e425.htseq.counts.gz	41cc0f47-726c-45c9-984a-f0deffcd03c9	TCGA-BK-A26L-01C-04R-A277-07	TCGA-BK-A26L-01C-04R	TCGA-BK-A26L-01C-03-BS3	TCGA-BK-A26L-01C-04-BS4		TCGA-BK-A26L-01C-04	TCGA-BK-A26L-01C	TCGA-BK-A26L	ab7adf74-6e87-4117-9742-54e323348e06	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	347		True	false	979388A8-CC61-4C03-BADC-BEF9EC50C40A	1.92	a36f18b0-3978-4a46-bb1c-7c0839f492e9	0.16	23	released	802cd7f9-43fc-455a-b342-32bc3bbb8fec	RNA	R	0.16	UV Spec	released	True	cd5aa9f7-d96c-42fc-b031-bb1426555c7e	04	4.0	0.0	2.0	0.0	0.0	0.0	98.0	75.0	TOP	4600bfd5-9f3d-4d3c-9328-26668f3f3b1a	released	4.0	0.0	2.0	0.0	0.0	0.0	98.0	75.0	BOTTOM	eb427800-6af1-48b8-8321-5a6a7d2e6154	released									released	400.0	7ac409d7-3f50-4228-9767-6bbf38a8d767	Primary Tumor	01	released	Not Reported	released	TCGA-BK-A26L_demographic	71	-26002		cd6ec347-4caf-5ff7-a22e-34c0c62a99b3	not hispanic or latino	female	white	released	Alive	1939		TCGA-BK-A26L_exposure	Not Reported	32.46191135734072	457ac974-3e7b-5b32-ad48-70007f173b72	152.0	released	75.0	TCGA-BK-A26L_diagnosis	26002	not reported	0	734	d2b10490-3a90-5a92-bf52-ee5faaa52852	Stage IIIC1	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-BK-A26L_treatment_1	TCGA-BK-A26L_treatment	released	3426f7dd-1628-5a65-b5a0-df833a4a6c5d	yes	Pharmaceutical Therapy, NOS	released	a800f1f1-88f2-5f57-be1e-c504f5f2d832	yes	Radiation Therapy, NOS	41cc0f47-726c-45c9-984a-f0deffcd03c9
1d427a99-7fdc-4436-8f77-52d9ce81f13e.htseq.counts.gz	901bed03-d1c7-496d-8f8a-dbfe6ab740c6	TCGA-BS-A0UF-01A-11R-A104-07	TCGA-BS-A0UF-01A-11R	TCGA-BS-A0UF-01A-01-TS1	TCGA-BS-A0UF-01A-01-BS1		TCGA-BS-A0UF-01A-11	TCGA-BS-A0UF-01A	TCGA-BS-A0UF	f77d7256-2ccf-42a7-9b30-332ac24ca812	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	2285	270.0	False	false	719E2A48-0E04-4EAD-A5CC-6416450FC68F	1.84	2ae9f382-fd01-4707-8dae-3ec3c527a226	0.17	23	released	3f24d336-fd9e-4d04-bf14-aeef9a27bbd7	RNA	R	0.17	UV Spec	released	False	ffbaedb2-2f8e-432c-a3eb-3afe5f5d63cf	11	6.0	0.0	10.0	0.0	0.0	10.0	80.0	90.0	TOP	84db9b9e-1987-4f23-b6ab-4b82362b6613	released	3.0	0.0	10.0	0.0	0.0	8.0	82.0	92.0	BOTTOM	205caec2-e0f1-4ced-b843-fc1251d93318	released									released	30.0	c805f55a-322f-4a11-ae0c-4bbc365d1bd6	Primary Tumor	01	released	Not Reported	released	TCGA-BS-A0UF_demographic	65	-23771		6e7bc132-cc3f-5675-b3bf-252c8a970841	not hispanic or latino	female	asian	released	Alive	1939		TCGA-BS-A0UF_exposure	Not Reported	26.37789809801471	11095549-7a19-5160-9181-55880591fffc	147.0	released	57.0	TCGA-BS-A0UF_diagnosis	23771	not reported	0	2611	d22949cf-b9d3-5687-bf79-50ff6d30d208	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Fundus uteri	released	No	Fundus uteri	not reported	not reported	2004	TCGA-BS-A0UF_treatment_1	TCGA-BS-A0UF_treatment	released	ef1b78b1-ccc3-5c1a-aee8-0eec4a79e6e6	no	Pharmaceutical Therapy, NOS	released	02704251-e595-565e-8de7-3aed721a87c0	no	Radiation Therapy, NOS	901bed03-d1c7-496d-8f8a-dbfe6ab740c6
b7eeea5a-38ea-43df-a9b3-ffbee10b5872.htseq.counts.gz	b922584d-0a7f-42b2-96ca-5243bc0eff09	TCGA-EY-A2OO-01A-11R-A19W-07	TCGA-EY-A2OO-01A-11R	TCGA-EY-A2OO-01A-01-TS1			TCGA-EY-A2OO-01A-11	TCGA-EY-A2OO-01A	TCGA-EY-A2OO	068016e2-7829-493c-b8be-d3b85beaab13	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	715	1.0	False	false	CC94C4BA-FBF6-4F0D-93DD-C2D98D965DF8	1.85	060787cf-a4a0-402f-8534-742157bb4a2c	0.17	23	released	66b325fa-d3b3-4574-ae9c-5ea51e5e5df1	RNA	R	0.17	UV Spec	released	False	04e95dea-7512-4709-b450-97089f0c6a47	11	0.0	0.0	0.0	0.0	0.0	10.0	90.0	75.0	TOP	59b7b50d-4699-4f11-b093-c5fa6c797e45	released																				released	30.0	e254c2ba-0de8-42f1-bc83-94adb11c71f7	Primary Tumor	01	released	Not Reported	released	TCGA-EY-A2OO_demographic	56	-20797		c37ab2c0-3978-59ee-a387-6e4a98de35ec	not hispanic or latino	female	white	released	Alive	1953		TCGA-EY-A2OO_exposure	Not Reported	25.79591836734694	226a951f-b436-5594-a465-e8b8ae31a09a	175.0	released	79.0	TCGA-EY-A2OO_diagnosis	20797	not reported	0	1392	baa98524-f76b-54a8-8de1-9c3ee7b39b65	Stage IB	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2009	TCGA-EY-A2OO_treatment	TCGA-EY-A2OO_treatment_1	released	e01f2849-0f29-5eff-a940-5422e4c675b5	yes	Radiation Therapy, NOS	released	3a7d238a-3953-589a-a4a3-fcd675c993a6	yes	Pharmaceutical Therapy, NOS	b922584d-0a7f-42b2-96ca-5243bc0eff09
94a8bcf0-2761-4f53-8919-f49669f95e55.htseq.counts.gz	1b483083-e869-4c7c-8e73-51827fd4dd16	TCGA-BS-A0UM-01A-11R-A104-07	TCGA-BS-A0UM-01A-11R	TCGA-BS-A0UM-01A-01-TS1	TCGA-BS-A0UM-01A-01-BS1		TCGA-BS-A0UM-01A-11	TCGA-BS-A0UM-01A	TCGA-BS-A0UM	a7c565fc-c711-4b63-9549-4cd74d1f57c2	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	2072	90.0	False	false	97354B28-9E9A-4DBD-B0C7-79C1165AD1CA	1.71	40c2c93a-81a9-4baa-91b3-3c950042475a	0.16	23	released	6b1a07ed-0468-4034-a319-44f1ca87b058	RNA	R	0.16	UV Spec	released	False	be6309d2-1155-4ecb-8a48-e7d02ecd82d8	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	75.0	TOP	46f4a264-659e-4f14-b663-4bdedb899e44	released	0.0	0.0	0.0	0.0	0.0	10.0	90.0	70.0	BOTTOM	09c675dc-fc1b-46d0-994b-2112d909fcec	released									released	30.0	6f70f18e-5c53-4f1f-a63d-62bd27039b8d	Primary Tumor	01	released	Not Reported	released	TCGA-BS-A0UM_demographic	64	-23400		ee82158d-3054-55ab-a9f7-25cc3d32151e	not hispanic or latino	female	white	released	Alive	1941		TCGA-BS-A0UM_exposure	Not Reported	35.15625	b8e10fe8-86da-5348-ba4a-85c03f9505b6	160.0	released	90.0	TCGA-BS-A0UM_diagnosis	23400	not reported	0	2644	46329a92-6677-51db-ab6e-891dca8b0683	Stage IB	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2005	TCGA-BS-A0UM_treatment	TCGA-BS-A0UM_treatment_1	released	f86d765a-e914-554f-8902-7c44d38b72c0	yes	Radiation Therapy, NOS	released	a3b8a104-e7ae-5ca8-a261-a1af91f2cb9c	yes	Pharmaceutical Therapy, NOS	1b483083-e869-4c7c-8e73-51827fd4dd16
798607d9-d840-4be5-aac0-765aa9a97913.htseq.counts.gz	c4eb40e1-89e1-4e8a-9740-b50c173c86c5	TCGA-AP-A0LJ-01A-11R-A040-07	TCGA-AP-A0LJ-01A-11R	TCGA-AP-A0LJ-01A-01-TSA	TCGA-AP-A0LJ-01A-01-BSA		TCGA-AP-A0LJ-01A-11	TCGA-AP-A0LJ-01A	TCGA-AP-A0LJ	b4a520ae-f259-48c8-823e-c10b9b8a133a	Adenomas and Adenocarcinomas	Corpus uteri	TCGA-UCEC	2290	680.0	False	true	859CBF70-D72E-4843-B3AA-6226B707AA2B	2.02	db3d4b8a-6ef3-4bb9-acca-2cbc4cf5f8c6	0.15	23	released	e179ce6f-dc2b-4e58-9e34-d38dd13d96b3	RNA	R	0.15	UV Spec	released	False	331b9dd8-b4fb-429f-b744-cbb412f8dbd5	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	75.0	TOP	610d5a0b-dfe0-4641-8681-3c7f871b728e	released	0.0	0.0	0.0	0.0	0.0	0.0	100.0	75.0	BOTTOM	952c6eef-4b26-4d1a-9d74-cfbe45c44df0	released									released	30.0	be3ed392-4d9f-4eaf-8a56-d251846df4da	Primary Tumor	01	released	Not Reported	released	TCGA-AP-A0LJ_demographic	42	-15577		f8f23111-a666-52f4-aab4-9640dcf8e425	not reported	female	white	released	Alive	1962		TCGA-AP-A0LJ_exposure	Not Reported	34.62603878116344	bd0aa32d-5cfb-554f-b5a0-119b095f4dce	152.0	released	80.0	TCGA-AP-A0LJ_diagnosis	15577	not reported	0	1421	4b5538b8-395b-5c6f-aad4-0cca187eccf8	Stage IA	C54.1	not reported	8380/3	Endometrioid adenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2004	TCGA-AP-A0LJ_treatment	TCGA-AP-A0LJ_treatment_1	released	0aedb67e-1ddf-58bf-9679-462d6162fcf9	no	Radiation Therapy, NOS	released	0b8a4d89-5041-5499-afde-a3403664b1de	no	Pharmaceutical Therapy, NOS	c4eb40e1-89e1-4e8a-9740-b50c173c86c5
de7ba496-046d-48ee-a24a-10e43a126de3.htseq.counts.gz	6f2833f7-d319-4f6a-87f3-9ad3a84a3354	TCGA-EO-A1Y8-01A-11R-A157-07	TCGA-EO-A1Y8-01A-11R	TCGA-EO-A1Y8-01A-01-TSA			TCGA-EO-A1Y8-01A-11	TCGA-EO-A1Y8-01A	TCGA-EO-A1Y8	de4e13c8-5ad0-46d2-ae54-b9ca22b939d8	Cystic, Mucinous and Serous Neoplasms	Corpus uteri	TCGA-UCEC	204	170.0	False	false	61143E14-52BD-499F-901C-4BD1EA83DAC1	1.86	a1d4b9ef-6fe5-49b5-9bb5-686d253baa4c	0.17	23	released	2f1086f9-0f75-4d9f-b6a7-0bcf3ab35035	RNA	R	0.17	UV Spec	released	False	96be0012-4ef0-48ad-9fac-8216582ce84b	11	0.0	0.0	2.0	0.0	0.0	8.0	90.0	90.0	TOP	f2965d7b-6213-468d-8e0e-6a39a1c26093	released																				released	30.0	5b0a8519-3fea-46d6-8f6d-ec85c403b416	Primary Tumor	01	released	Not Reported	released	TCGA-EO-A1Y8_demographic	87	-31971		79264be9-ce83-5574-b4de-74e520602570	not reported	female	not reported	released	Alive	1923		TCGA-EO-A1Y8_exposure	Not Reported	27.20960780634265	32b589a1-f122-5c3c-8816-f299c0391668	146.0	released	58.0	TCGA-EO-A1Y8_diagnosis	31971	not reported	0	901	4a9fc05f-f6e7-5a58-8645-d028796719a1	Stage IA	C54.1	not reported	8441/3	Serous cystadenocarcinoma, NOS	no	No	not reported	Endometrium	released	No	Endometrium	not reported	not reported	2010	TCGA-EO-A1Y8_treatment_1	TCGA-EO-A1Y8_treatment	released	1b8397cd-9088-5192-8703-05ed16bc9429	no	Pharmaceutical Therapy, NOS	released	828ab711-9d7a-52de-99da-4314be36d2d8	no	Radiation Therapy, NOS	6f2833f7-d319-4f6a-87f3-9ad3a84a3354